%PDF-1.6%‚„œ”
1 0 obj<</Lang(en-US)/Metadata 2 0 R/Pages 3 0 R/Type/Catalog/ViewerPreferences<</Direction/L2R>>>>endobj2 0 obj<</Length 10843/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:ExtensisFontSense="http://www.extensis.com/meta/FontSense/">
         <xmp:CreateDate>2024-06-13T14:21:20-04:00</xmp:CreateDate>
         <xmp:MetadataDate>2024-06-13T14:21:21-04:00</xmp:MetadataDate>
         <xmp:ModifyDate>2024-06-13T14:21:21-04:00</xmp:ModifyDate>
         <xmp:CreatorTool>Adobe InDesign 19.4 (Macintosh)</xmp:CreatorTool>
         <xmpMM:InstanceID>uuid:ba2d9261-cb5d-d041-8b28-87ea34c1774f</xmpMM:InstanceID>
         <xmpMM:OriginalDocumentID>xmp.did:436bea68-88f9-4f60-9b76-86ef3f193c18</xmpMM:OriginalDocumentID>
         <xmpMM:DocumentID>xmp.id:da8b9653-ebcc-498b-b7f5-d57875b5e1a7</xmpMM:DocumentID>
         <xmpMM:RenditionClass>proof:pdf</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>xmp.iid:86dd4cf6-8e45-48be-859f-a7dc12650abb</stRef:instanceID>
            <stRef:documentID>xmp.did:f82cd9b1-4f06-4f64-9a69-40530a27c600</stRef:documentID>
            <stRef:originalDocumentID>xmp.did:436bea68-88f9-4f60-9b76-86ef3f193c18</stRef:originalDocumentID>
            <stRef:renditionClass>default</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/x-indesign to application/pdf</stEvt:parameters>
                  <stEvt:softwareAgent>Adobe InDesign 19.4 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
                  <stEvt:when>2024-06-13T14:21:20-04:00</stEvt:when>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <dc:format>application/pdf</dc:format>
         <pdf:Producer>Adobe PDF Library 17.0</pdf:Producer>
         <pdf:Trapped>False</pdf:Trapped>
         <ExtensisFontSense:slug>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>4027012699</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>4027012699</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-It</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.100</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>1911993744</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>1911993744</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Roman</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.020</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3030352917</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3030352917</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-CnO</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3691150952</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3691150952</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Bd</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3261192849</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3261192849</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Cn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3357634683</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3357634683</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCn</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>4073973744</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>4073973744</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-BdCnO</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.035</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>1252007918</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Arial</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - TT</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>1252007918</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Monotype Typography</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>ArialMT</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>5.06</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>1392107873</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Arial</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - TT</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>1392107873</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Monotype Typography</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>Arial-ItalicMT</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>5.00.2</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>3939600684</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Arial</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - TT</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>3939600684</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Monotype Typography</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>Arial-BoldMT</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>5.06</ExtensisFontSense:Version>
               </rdf:li>
            </rdf:Bag>
         </ExtensisFontSense:slug>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj3 0 obj<</Count 11/Kids[14 0 R 15 0 R]/Type/Pages>>endobj14 0 obj<</Count 5/Kids[5 0 R 6 0 R 7 0 R 8 0 R 9 0 R]/Parent 3 0 R/Type/Pages>>endobj15 0 obj<</Count 6/Kids[10 0 R 11 0 R 12 0 R 13 0 R 16 0 R 17 0 R]/Parent 3 0 R/Type/Pages>>endobj10 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 18 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R>>/Font<</T1_0 21 0 R/T1_1 22 0 R/T1_2 23 0 R/T1_3 24 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 25 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 35297>>/PageWidthList<</0 612.0>>>>>>>>endobj11 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 26 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 27 0 R/GS2 20 0 R>>/Font<</T1_0 22 0 R/T1_1 24 0 R/T1_2 21 0 R/T1_3 23 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 25 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 36348>>/PageWidthList<</0 612.0>>>>>>>>endobj12 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 28 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 27 0 R/GS2 20 0 R>>/Font<</T1_0 22 0 R/T1_1 24 0 R/T1_2 23 0 R/T1_3 21 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 25 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320031005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 36711>>/PageWidthList<</0 612.0>>>>>>>>endobj13 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 29 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R>>/Font<</C2_0 30 0 R/C2_1 31 0 R/TT0 32 0 R/TT1 33 0 R/TT2 34 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 35 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320031005A>/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[463.0 0.0 3.0 -270.0 -360.046 270.0 -349.446 1.0 0.0 0.0 1.0 -195.0 -285.046]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 15792>>/PageWidthList<</0 612.0>>>>>>>>endobj16 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 36 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R>>/Font<</C2_0 30 0 R/TT0 32 0 R/TT1 33 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 35 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320031005A>/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[463.0 0.0 3.0 -270.0 -360.046 270.0 -349.446 1.0 0.0 0.0 1.0 -195.0 -285.046]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 11429>>/PageWidthList<</0 612.0>>>>>>>>endobj17 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 37 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 15 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R>>/Font<</C2_0 30 0 R/TT0 32 0 R/TT1 33 0 R>>/ProcSet[/PDF/Text]/Properties<</MC0 38 0 R>>/XObject<</Fm0 35 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320031005A>/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[463.0 0.0 3.0 -270.0 -360.046 270.0 -349.446 1.0 0.0 0.0 1.0 -195.0 -285.046]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 36872>>/PageWidthList<</0 612.0>>>>>>>>endobj37 0 obj<</Length 17006>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
/GS1 gs
q 1 0 0 1 37 658.1473 cm
0 0 m
538 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
-0.018 Tc 10 0 0 10 46 714.5273 Tm
[(G)0.5 (en)0.5 (eral)0.5 ( )0.5 (i)0.5 (n)0.5 (fo)0.5 (rmati)0.5 (o)0.5 (n)0.5 ( )0.5 (ab)0.5 (o)0.5 (ut )0.5 (th)0.5 (e )0.6 (safe )0.5 (an)0.5 (d)0.5 ( )0.5 (effecti)0.5 (ve )0.5 (u)0.5 (se )0.6 (of )37.7 (AUG)0.5 (T)0.5 (YRO)0.5 (.)]TJ
/C2_0 1 Tf
-0.003 Tc 0.003 Tw 0 -1.388 Td
[<0030>0.5 <00480047004C0046>0.5 <004C005100480056>0.5 <0003>-73.5 <00440055>0.5 <00480003>-73.5 <005600520050>0.5 <00480057>0.7 <004C0050>0.5 <00480056>0.5 <0003>-73.5 <00530055>0.5 <00480056>0.5 <0046>0.5 <0055>0.5 <004C0045004800470003>-73.5 <0049>0.7 <00520055>0.5 <0003>-73.5 <005300580055>0.5 <005300520056>0.5 <00480056>0.5 <0003>-73.5 <00520057>0.7 <004B00480055>0.5 <0003>-73.5 <0057>0.6 <004B004400510003>-73.5 <0057>0.7 <004B00520056>0.5 <00480003>-73.5 <004F004C0056>0.5 <0057>0.6 <004800470003>-73.5 <004C00510003>-73.5 <00440003>-73.5 <0033>0.5 <00440057>0.7 <004C004800510057>0.7 <0003>-73.5 <002C>0.6 <00510049>0.6 <00520055>0.5 <0050>0.5 <00440057>0.7 <004C005200510003>-73.5 <004F0048004400C0>0.5 <00480057>0.7 <0011>0.6 <0003>-73.5 <002700520003>-73.5 <005100520057>0.7 <0003>-73.6 <00580056>0.5 <0048>-3.2 <0003>]TJ
-0.012 Tc 0.012 Tw 0 -1.1 Td
[<00240038002A0037003C003500320003>-30.3 <0049005200550003>-30.3 <00440003>-30.3 <0046005200510047004C0057004C005200510003>-30.3 <0049005200550003>-30.3 <005A004B004C0046004B0003>-30.2 <004C00570003>-30.3 <005A004400560003>-30.2 <0051005200570003>-30.3 <005300550048005600460055004C00450048004700110003>-30.3 <002700520003>-30.2 <0051005200570003>-30.3 <004A004C005900480003>24.9 <00240038002A0037003C003500320003>-30.3 <005700520003>-30.3 <00520057004B004800550003>-30.3 <0053004800520053004F0048000F0003>-30.2 <00480059004800510003>-30.3 <004C00490003>-30.2 <0057004B0048005C0003>-30.3 <004B0044005900480003>-30.2 <0057004B0048>-12.1 <0003>]TJ
-0.021 Tc 0.021 Tw 0 -1.1 Td
[<00560044>-0.6 <00500048>-0.6 <0003>13.7 <0056005C0050005300570052005000560003>13.7 <0057004B0044>-0.6 <00570003>13.6 <005C0052>-0.6 <00580003>13.6 <004B0044>-0.6 <00590048>-0.6 <00110003>13.6 <002C00570003>13.7 <00500044>-0.6 <005C0003>13.6 <004B0044>-0.6 <005500500003>13.6 <0057004B>-0.6 <0048>-0.6 <005000110003>31.7 <003C>91.4 <0052>-0.6 <00580003>13.6 <00460044>-0.6 <00510003>13.6 <00440056004E0003>13.7 <005C0052>-0.6 <0058>-0.6 <00550003>13.7 <0053>-0.6 <004B>-0.6 <00440055005000440046004C005600570003>13.7 <0052>-0.6 <00550003>13.6 <004B0048>-0.6 <0044>-0.6 <004F0057004B00460044005500480003>13.6 <0053005500520059004C>-0.6 <0047>-0.6 <004800550003>13.7 <00490052>-0.6 <00550003>13.6 <004C>-0.6 <0051004900520055005000440057004C>-0.6 <00520051>-0.6 <0003>13.6 <00440045>-0.6 <00520058>-0.6 <0057>-20.8 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.1 Td
[<00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0003>0.5 <0057>0.5 <004B00440057>0.5 <0003>0.5 <004C00560003>0.5 <005A0055004C0057>0.5 <0057>0.5 <004800510003>0.5 <0049>0.5 <005200550003>0.5 <004B00480044004F0057>0.5 <004B0003>0.5 <0053005500520049>0.5 <004800560056004C005200510044004F00560011>]TJ
/TT0 1 Tf
0 Tw 0 -2.54 Td
[(W)0.5 (h)0.5 (at )0.5 (are )0.5 (th)0.5 (e )0.5 (i)0.5 (n)0.5 (gred)0.5 (i)0.5 (ents )0.5 (o)0.5 (f )37.6 (AUG)0.5 (T)0.5 (YRO)0.5 (?)]TJ
0 -1.46 Td
[(Acti)0.5 (ve )0.5 (i)0.5 (n)0.5 (g)0.5 (red)0.5 (i)0.5 (en)0.5 (t: )]TJ
/C2_0 1 Tf
0.018 Tw 8.375 0 Td
[<00550048005300520057>0.5 <0055004800460057>0.5 <004C0051004C0045>]TJ
/TT0 1 Tf
-0.01 Tw -8.375 -1.46 Td
[(I)0.5 (n)0.5 (acti)0.5 (ve i)0.5 (n)0.5 (gred)0.5 (i)0.5 (en)0.5 (ts: )]TJ
/C2_0 1 Tf
0.018 Tw [<0050004C00460055005200460055005C00560057>0.5 <0044004F004F004C005100480003>10.3 <00460048004F004F0058004F005200560048000F>0.5 <0003>10.3 <005600520047004C005800500003>10.3 <004F004400580055005C004F0003>10.3 <00560058004F0049>0.5 <00440057>0.5 <0048000F>0.5 <0003>10.4 <004600550052005600460044005500500048004F004F0052005600480003>10.3 <005600520047004C00580050000F>0.5 <0003>10.3 <0044005100470003>10.3 <00460052004F004F0052004C00470044004F0003>10.4 <0056004C004F004C0046005200510003>10.4 <0047004C0052005B004C004700480011>-17.9 <0003>]TJ
0 -1.1 Td
[<00260044005300560058004F00480003>0.5 <0056004B0048004F004F0003>0.5 <00460052005100570044004C005100560003>0.5 <004A0048004F00440057>0.5 <004C00510003>0.5 <00440051004700030057>0.6 <004C0057>0.5 <00440051004C005800500003>0.5 <0047004C0052005B004C004700480011>0.5 <0003>0.5 <00330055004C00510057>0.5 <004C0051004A0003>0.5 <004C0051004E0003>0.5 <0046005200510057>0.5 <0044004C005100560003>0.5 <0056004B0048004F004F004400460011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.658 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<003A>0.5 <004B004C0057>0.5 <00480003>0.5 <005200530044005400580048000300460044005300560058004F00480056000F>0.5 <0003>0.5 <00530055004C00510057>0.5 <004C0051004A0003>0.5 <004C0051004E0003>0.5 <0046005200510057>0.5 <0044004C005100560003>0.5 <004C00510003>0.5 <004400470047004C0057>0.5 <004C005200510003>0.5 <0029>0.5 <00270003>0.5 <00090003>0.5 <00260003>0.5 <0045004F005800480003>0.5 <000600150003>0.5 <0044004F00580050004C0051005800500003004F0044004E00480011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.316 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.012 Tc 0.012 Tw 1.8 0 Td
[<0025004F005800480003>-33.1 <0052005300440054005800480003>-33 <00460044005300560058004F004800560003>-33.1 <00460052005100570044004C00510003>-33.1 <004C00510003>-33.1 <004400470047004C0057004C005200510003>-33.1 <00500044004A005100480056004C005800500003>-33.1 <005600570048004400550044005700480003>-33 <0044005100470003>-33.1 <002900270003>-33.1 <00090003>-33.1 <00260003>-33 <0045004F005800480003>-33.1 <0006001400110003>-33.1 <00330055004C00510057004C0051004A0003>-33.1 <004C0051004E0003>-33 <00460052005100570044004C005100560003>-33.1 <004C00510003>-33.1 <004400470047004C0057004C00520051>-12.2 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.1 Td
[<0057>0.5 <004C0057>0.5 <00440051004C005800500003>0.5 <0047004C0052005B004C004700480011>]TJ
/TT0 1 Tf
0 Tw 8 0 0 8 46 529.4274 Tm
[(Di)0.5 (stri)0.5 (b)0.5 (u)0.5 (ted)0.5 ( )0.5 (b)0.5 (y:)]TJ
/C2_0 1 Tf
0 Tc 6.799 0 Td
<0BD8>Tj
/TT1 1 Tf
0.047 0 Td
( )Tj
/C2_0 1 Tf
-0.018 Tc 0.018 Tw -6.846 -1.125 Td
[<00250055004C005600570052004F00100030005C0048005500560003>0.5 <003600540058004C004500450003>0.5 <002600520050005300440051005C>74.5 <000F>0.5 <0003>0.5 <00330055004C0051004600480057>0.5 <00520051000F>0.5 <0003>0.5 <0031002D0003>0.5 <0013001B0018001700160003>0.5 <003800360024001E>0.5 <0003>0.5 <0003>0.5 <00380011>0.5 <00360011>0.5 <0003>0.5 <002F004C004600480051005600480003>0.5 <003100520011>0.5 <0003>0.5 <0014001A00140016>]TJ
0 -1.35 Td
[<00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <008C0003>0.5 <004C00560003>0.5 <00440003>0.5 <0057>0.5 <0055004400470048005000440055004E0003>0.5 <005200490003>18.6 <0037>37.6 <005800550051004C0051004A0003>0.5 <00330052004C00510057>0.5 <0003>18.5 <0037>0.5 <004B0048005500440053004800580057>0.5 <004C00460056000F>0.5 <0003>0.5 <002C>0.5 <005100460011>0.5 <000F>0.5 <0003>0.5 <00440003>0.5 <00250055004C00560057>0.5 <0052004F0003>0.5 <0030005C0048005500560003>0.5 <003600540058004C004500450003>0.6 <004600520050005300440051005C>74.6 <0011>]TJ
/TT0 1 Tf
0 Tw 0 -1.35 Td
[(F)0.5 (o)0.5 (r )0.5 (mo)0.5 (re )0.6 (i)0.5 (nformati)0.5 (o)0.5 (n)0.5 (,)0.5 ( )0.5 (go)0.5 ( )0.5 (to )0.5 (w)0.5 (w)0.5 (w)37.6 (.)-39.5 (AUG)0.5 (T)0.5 (YRO)60.4 (.)0.6 (co)0.5 (m )0.5 (o)0.5 (r )0.5 (cal)0.5 (l)0.5 ( )0.5 (1-877-284-8976.)]TJ
/C2_0 1 Tf
0 Tc 32.962 0 Td
<0BD8>Tj
ET
4 M 
36.5 489.327 539 241.98 re
S
q 1 0 0 1 36 450.1749 cm
0 0 m
540 0 l
S
Q
BT
-0.018 Tc 0.018 Tw 9 0 0 9 36 473.2749 Tm
[<0037>0.5 <004B004C00560003003300440057>0.5 <004C004800510057>0.5 <0003>0.5 <002C>0.5 <00510049>0.6 <00520055005000440057>0.6 <004C005200510003>0.5 <004B004400560003>0.5 <00450048004800510003>0.5 <004400530053005500520059004800470003>0.5 <0045005C0003>0.5 <0057>0.5 <004B00480003>0.5 <00380011>0.5 <00360011>0.5 <0003>0.5 <0029>0.5 <0052005200470003>0.5 <0044005100470003>0.5 <002700550058004A0003>55.7 <002400470050004C0051004C00560057>0.5 <005500440057>0.5 <004C005200510011>]TJ
/Span<</ActualText<FEFF0009>>> BDC 
0 -2.111 Td
<0003>Tj
EMC 
52.592 0 Td
[<003500480059004C005600480047001D>0.5 <0003>0.5 <001300190012>0.5 <00150013>60.2 <0015>40.2 <0017>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-52.592 -1.671 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.018 Tc 0.018 Tw 49.194 0 Td
[<00160019001300130010003800360010001500170013001300130017001C0003>0.5 <0003>0.5 <001300190012>0.5 <0015>40.2 <0017>]TJ
ET
/PlacedPDF /MC0 BDC 
q
236.563 420.062 138.874 19.075 re
W n
/GS0 gs
q 1 0 0 1 241.8615 420.5045 cm
0 0 m
-0.143 -0.296 -0.449 -0.487 -0.778 -0.487 c
-0.909 -0.487 -1.036 -0.458 -1.155 -0.401 c
-3.866 0.914 -5.299 3.23 -5.299 6.299 c
-5.299 9.764 l
-5.299 10.241 -4.911 10.628 -4.434 10.628 c
-3.958 10.628 -3.57 10.241 -3.57 9.764 c
-3.57 6.299 l
-3.57 3.905 -2.503 2.175 -0.4 1.155 c
0.028 0.947 0.208 0.429 0 0 c
-2.556 8.032 m
-2.556 7.542 -2.16 7.145 -1.67 7.145 c
-1.18 7.145 -0.783 7.542 -0.783 8.032 c
-0.783 15.104 l
-0.783 15.594 -1.18 15.991 -1.67 15.991 c
-2.16 15.991 -2.556 15.594 -2.556 15.104 c
h
0.187 8.237 m
0.187 7.748 0.584 7.351 1.074 7.351 c
1.564 7.351 1.961 7.748 1.961 8.237 c
1.961 17.746 l
1.961 18.236 1.564 18.632 1.074 18.632 c
0.584 18.632 0.187 18.236 0.187 17.746 c
h
2.93 7.583 m
2.93 7.094 3.327 6.697 3.817 6.697 c
4.307 6.697 4.704 7.094 4.704 7.583 c
4.704 16.119 l
4.704 16.609 4.307 17.006 3.817 17.006 c
3.327 17.006 2.93 16.609 2.93 16.119 c
h
5.674 6.454 m
5.674 5.979 6.059 5.594 6.534 5.594 c
7.009 5.594 7.394 5.979 7.394 6.454 c
7.394 12.222 l
7.394 12.697 7.009 13.082 6.534 13.082 c
6.059 13.082 5.674 12.697 5.674 12.222 c
h
f
Q
q 1 0 0 1 258.4387 428.5874 cm
0 0 m
0.002 0.053 l
1.118 0.437 1.809 1.108 1.809 2.307 c
1.809 2.49 l
1.809 3.866 0.691 4.998 -1.59 4.998 c
-4.746 4.998 l
-4.746 -5.739 l
-1.361 -5.739 l
0.856 -5.739 2.378 -4.625 2.378 -2.841 c
2.378 -2.733 l
2.378 -1.341 1.558 -0.322 0 0 c
-3.365 3.786 m
-1.787 3.786 l
-0.283 3.786 0.484 3.216 0.484 2.197 c
0.484 2.089 l
0.484 0.858 -0.581 0.463 -1.979 0.463 c
-3.365 0.463 l
h
0.964 -2.717 m
0.964 -4.046 -0.083 -4.543 -1.61 -4.543 c
-3.365 -4.543 l
-3.365 -0.672 l
-1.586 -0.672 l
-0.082 -0.672 0.964 -1.172 0.964 -2.548 c
h
6.89 2.39 m
7.288 2.39 l
7.288 1.132 l
6.966 1.132 l
5.678 1.132 4.834 0.488 4.834 -1.215 c
4.834 -5.739 l
3.546 -5.739 l
3.546 2.39 l
4.834 2.39 l
4.834 0.933 l
4.896 0.933 l
5.126 1.669 5.724 2.39 6.89 2.39 c
8.435 2.39 1.289 -8.129 re
9.865 4.214 m
9.865 3.586 9.579 3.292 9.079 3.292 c
8.578 3.292 8.293 3.586 8.293 4.214 c
8.293 4.842 8.578 5.154 9.079 5.154 c
9.579 5.154 9.865 4.842 9.865 4.214 c
16.87 -3.5 m
16.87 -5.065 15.705 -5.892 14.002 -5.892 c
12.284 -5.892 11.149 -5.156 11.057 -3.5 c
12.345 -3.5 l
12.391 -4.497 13.128 -4.819 14.002 -4.819 c
14.876 -4.819 15.582 -4.436 15.582 -3.592 c
15.582 -1.613 11.149 -2.978 11.149 0.227 c
11.149 1.562 12.13 2.543 13.925 2.543 c
15.567 2.543 16.656 1.731 16.778 0.151 c
15.49 0.151 l
15.413 1.102 14.754 1.47 13.925 1.47 c
12.99 1.47 12.407 1.04 12.407 0.227 c
12.407 -1.69 16.87 -0.509 16.87 -3.5 c
19.843 2.39 m
21.592 2.39 l
21.592 1.255 l
19.843 1.255 l
19.843 -3.239 l
19.843 -4.42 20.15 -4.665 20.932 -4.665 c
21.147 -4.665 21.392 -4.635 21.592 -4.619 c
21.592 -5.724 l
21.346 -5.77 21.024 -5.801 20.794 -5.801 c
19.199 -5.801 18.555 -5.172 18.555 -3.438 c
18.555 1.255 l
17.189 1.255 l
17.189 2.39 l
18.555 2.39 l
18.555 4.998 l
19.843 4.998 l
h
25.398 2.543 m
23.388 2.543 22.315 1.163 22.315 -1.076 c
22.315 -2.273 l
22.315 -4.512 23.388 -5.892 25.398 -5.892 c
27.407 -5.892 28.481 -4.512 28.481 -2.273 c
28.481 -1.076 l
28.481 1.163 27.407 2.543 25.398 2.543 c
27.177 -2.197 m
27.177 -4.129 26.502 -4.758 25.398 -4.758 c
24.293 -4.758 23.619 -4.129 23.619 -2.197 c
23.619 -1.153 l
23.619 0.78 24.293 1.409 25.398 1.409 c
26.502 1.409 27.177 0.78 27.177 -1.153 c
h
29.843 4.998 1.289 -10.737 re
43.559 4.998 m
45.746 4.998 l
45.746 -5.739 l
44.381 -5.739 l
44.381 3.51 l
44.304 3.51 l
41.558 -3.962 l
39.886 -3.962 l
37.172 3.51 l
37.095 3.51 l
37.095 -5.739 l
35.745 -5.739 l
35.745 4.998 l
38.039 4.998 l
40.745 -2.46 l
40.822 -2.46 l
h
52.011 2.39 m
53.315 2.39 l
49.711 -8.347 l
48.377 -8.347 l
49.282 -5.801 l
46.643 2.39 l
48.008 2.39 l
49.956 -3.945 l
50.018 -3.945 l
h
56.777 2.543 m
54.768 2.543 53.694 1.102 53.694 -1.076 c
53.694 -2.273 l
53.694 -4.512 54.768 -5.892 56.777 -5.892 c
58.388 -5.892 59.339 -5.003 59.661 -3.484 c
58.342 -3.484 l
58.111 -4.42 57.59 -4.758 56.777 -4.758 c
55.673 -4.758 54.997 -4.129 54.997 -2.197 c
54.997 -2.089 l
59.706 -2.089 l
59.706 -1.076 l
59.706 1.102 58.787 2.543 56.777 2.543 c
56.777 1.409 m
57.82 1.409 58.386 0.794 58.401 -1.076 c
54.999 -1.076 l
55.017 0.794 55.688 1.409 56.777 1.409 c
64.483 2.39 m
64.882 2.39 l
64.882 1.132 l
64.56 1.132 l
63.272 1.132 62.428 0.488 62.428 -1.215 c
62.428 -5.739 l
61.14 -5.739 l
61.14 2.39 l
62.428 2.39 l
62.428 0.933 l
62.49 0.933 l
62.719 1.669 63.318 2.39 64.483 2.39 c
71.385 -3.5 m
71.385 -5.065 70.22 -5.892 68.517 -5.892 c
66.799 -5.892 65.664 -5.156 65.572 -3.5 c
66.861 -3.5 l
66.907 -4.497 67.643 -4.819 68.517 -4.819 c
69.391 -4.819 70.097 -4.436 70.097 -3.592 c
70.097 -1.613 65.664 -2.978 65.664 0.227 c
65.664 1.562 66.646 2.543 68.441 2.543 c
70.081 2.543 71.171 1.731 71.294 0.151 c
70.005 0.151 l
69.928 1.102 69.269 1.47 68.441 1.47 c
67.505 1.47 66.922 1.04 66.922 0.227 c
66.922 -1.69 71.385 -0.509 71.385 -3.5 c
81.626 -2.901 m
81.626 -4.819 80.307 -5.892 78.282 -5.892 c
76.38 -5.892 74.815 -4.972 74.616 -2.917 c
76.042 -2.917 l
76.211 -4.129 77.07 -4.696 78.267 -4.696 c
79.632 -4.696 80.245 -3.883 80.245 -2.978 c
80.245 0.074 74.785 -1.69 74.785 2.314 c
74.785 4.031 76.15 5.151 78.052 5.151 c
79.892 5.151 81.426 4.246 81.518 2.13 c
80.092 2.13 l
79.969 3.433 79.141 3.955 78.037 3.955 c
76.732 3.955 76.165 3.187 76.165 2.375 c
76.165 -0.325 81.626 1.27 81.626 -2.901 c
87.447 1.409 m
87.384 1.409 l
87.036 2.126 86.375 2.543 85.53 2.543 c
83.52 2.543 82.6 1.163 82.6 -1.076 c
82.6 -2.273 l
82.6 -4.512 83.52 -5.892 85.53 -5.892 c
86.375 -5.892 87.036 -5.475 87.384 -4.758 c
87.447 -4.758 l
87.447 -5.739 l
87.447 -8.347 l
88.736 -8.347 l
88.736 2.39 l
87.447 2.39 l
h
85.683 -4.758 m
84.579 -4.758 83.904 -4.129 83.904 -2.197 c
83.904 -1.153 l
83.904 0.78 84.579 1.409 85.683 1.409 c
86.788 1.409 87.463 0.78 87.463 -1.153 c
87.463 -2.197 l
87.463 -4.129 86.788 -4.758 85.683 -4.758 c
94.653 2.39 m
95.942 2.39 l
95.942 -5.739 l
94.653 -5.739 l
94.653 -4.696 l
94.592 -4.696 l
94.285 -5.355 93.626 -5.892 92.598 -5.892 c
91.08 -5.892 90.144 -5.033 90.144 -3.116 c
90.144 2.39 l
91.448 2.39 l
91.448 -2.932 l
91.448 -4.236 91.985 -4.804 92.951 -4.804 c
93.887 -4.804 94.653 -4.175 94.653 -2.595 c
h
97.596 2.39 1.288 -8.129 re
103.818 2.543 m
102.961 2.543 102.308 2.126 101.963 1.409 c
101.901 1.409 l
101.901 2.39 l
101.901 4.998 l
100.613 4.998 l
100.613 -5.739 l
101.901 -5.739 l
101.901 -4.758 l
101.963 -4.758 l
102.308 -5.475 102.961 -5.892 103.818 -5.892 c
105.828 -5.892 106.748 -4.512 106.748 -2.273 c
106.748 -1.076 l
106.748 1.163 105.828 2.543 103.818 2.543 c
105.444 -2.197 m
105.444 -4.129 104.769 -4.758 103.665 -4.758 c
102.561 -4.758 101.886 -4.129 101.886 -2.197 c
101.886 -1.153 l
101.886 0.78 102.561 1.409 103.665 1.409 c
104.769 1.409 105.444 0.78 105.444 -1.153 c
h
111.218 2.543 m
110.36 2.543 109.707 2.126 109.362 1.409 c
109.3 1.409 l
109.3 2.39 l
109.3 4.998 l
108.012 4.998 l
108.012 -5.739 l
109.3 -5.739 l
109.3 -4.758 l
109.362 -4.758 l
109.707 -5.475 110.36 -5.892 111.218 -5.892 c
113.227 -5.892 114.147 -4.512 114.147 -2.273 c
114.147 -1.076 l
114.147 1.163 113.227 2.543 111.218 2.543 c
112.844 -2.197 m
112.844 -4.129 112.169 -4.758 111.064 -4.758 c
109.96 -4.758 109.285 -4.129 109.285 -2.197 c
109.285 -1.153 l
109.285 0.78 109.96 1.409 111.064 1.409 c
112.169 1.409 112.844 0.78 112.844 -1.153 c
h
99.027 4.214 m
99.027 3.586 98.741 3.292 98.241 3.292 c
97.74 3.292 97.455 3.586 97.455 4.214 c
97.455 4.842 97.74 5.154 98.241 5.154 c
98.741 5.154 99.027 4.842 99.027 4.214 c
f
Q
q 1 0 0 1 373.928 433.6175 cm
0 0 m
-0.73 0 -1.323 -0.594 -1.323 -1.323 c
-1.323 -2.053 -0.73 -2.646 0 -2.646 c
0.73 -2.646 1.323 -2.053 1.323 -1.323 c
1.323 -0.594 0.73 0 0 0 c
0 -2.832 m
-0.832 -2.832 -1.509 -2.155 -1.509 -1.323 c
-1.509 -0.491 -0.832 0.186 0 0.186 c
0.832 0.186 1.509 -0.491 1.509 -1.323 c
1.509 -2.155 0.832 -2.832 0 -2.832 c
f
Q
q 1 0 0 1 373.6636 432.3338 cm
0 0 m
0.284 0 l
0.377 0 0.45 0.024 0.502 0.07 c
0.554 0.118 0.581 0.182 0.581 0.263 c
0.581 0.348 0.557 0.414 0.508 0.461 c
0.46 0.507 0.387 0.531 0.292 0.533 c
0 0.533 l
h
0.308 -0.223 m
0 -0.223 l
0 -0.834 l
-0.276 -0.834 l
-0.276 0.755 l
0.283 0.755 l
0.466 0.755 0.608 0.714 0.708 0.632 c
0.807 0.55 0.857 0.431 0.857 0.275 c
0.857 0.168 0.831 0.079 0.78 0.008 c
0.729 -0.064 0.657 -0.119 0.566 -0.158 c
0.923 -0.82 l
0.923 -0.834 l
0.627 -0.834 l
h
f
Q
EMC 
Q
endstreamendobj35 0 obj<</BBox[0.0 792.0 612.0 0.0]/Length 344/Matrix[1.0 0.0 0.0 1.0 0.0 0.0]/Resources<</ExtGState<</GS0 20 0 R>>/Font<</TT0 39 0 R>>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.75 w 
/GS0 gs
q 1 0 0 1 36 743.6949 cm
0 0 m
540 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
-0.018 Tc 0.018 Tw 0 Ts 100 Tz 0 Tr 12 0 0 12 36 747.3099 Tm
[(AUG)0.5 (T)0.5 (YRO)]TJ
0 Tc 0 Tw 8.4 0 0 8.4 93.7399 749.4308 Tm
(\231)Tj
-0.018 Tc 0.055 Tw 12 0 0 12 101.9858 747.3099 Tm
[( \(rep)0.5 (o)0.5 (trecti)0.5 (n)0.5 (i)0.5 (b)0.5 (\))]TJ
ET
endstreamendobj39 0 obj<</BaseFont/QULRDW+Arial-BoldMT/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 40 0 R/LastChar 153/Subtype/TrueType/ToUnicode 41 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 333 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 0 0 0 778 0 0 0 0 0 0 0 778 0 0 722 0 611 722 0 0 0 667 0 0 0 0 0 0 0 0 611 556 0 556 0 0 0 278 0 0 0 0 611 611 611 0 389 0 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1000]>>endobj40 0 obj<</Ascent 1010/CapHeight 716/Descent -376/Flags 32/FontBBox[-628 -376 2000 1010]/FontFamily(Arial)/FontFile2 42 0 R/FontName/QULRDW+Arial-BoldMT/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 136/Type/FontDescriptor/XHeight 519>>endobj41 0 obj<</Filter/FlateDecode/Length 325>>stream
Hâ\íœnÉ0∆Ôyä€C§Ö¥Bö∫V‚∞?€–ƒtH#DÅx˚Ÿq’Iã˛E˘¸Ÿ8$«˙πv˝,ì˜0öfŸıŒò∆[0 /pÌù»î¥ΩôÔª¯6CÎEÇ…Õ2Õ0‘ÆEY ‰ß9,rıd«¨EÚ,Ñﬁ]ÂÍÎÿ¨e“‹ºˇÅ‹,SYU“BáF/≠mêIL€‘œ˚yŸ`Œü‚sÒ U‹g‹å-Læ5ZwQ¶∏*YûqUú˝wÆRNªtÊª¢T$NS»{Ê=ÒÅ˘ÄºÀ"c@÷Ãö¯ÃåÖ \E∆ÄºcﬁÁÃ91{Ê‰Y∞æ }±eﬁ≥æ }¡˙"ÍOÃ'bÆ[P]Õ˝kÍ_≥ß&OÕ=hÍ·@>*S*‰˛Â4ºA˘òªπÖÄ#è◊gMSÓ<˛?zâYÙà_ ®…õ‹endstreamendobj42 0 obj<</Filter/FlateDecode/Length 19205/Length1 46026>>stream
Hâåï	XWÄ´¶ª´ÅÅpãä3›3–ìHX„
ÀFó<◊›¨£ªâÇ"á†‚ô®∏AóÄºV¿º/EEçàäá:„Äg‘q%q˝L‹&oÄèÕ~˚ÂÀæ˘™∫ÍΩ™ÔÕ˚˚Uu⁄‘È±‡È¿Aƒ–·ÔıÇ∂abìùöÕóΩ ¿P ˜œbf§…mÀ+ƒQq©ì€¸.,FHúò4;.‡~ÀP i$ÄÁÀ¯ÿË	uoòÙ
âgmÒAòÚèONõ’Óoæûîç™±≈ Ò≥ô_ó=+µm}„0¶‰…—…±´äÀò?Äüòö2-Õ ∑ ÚÎÏÎ©Sc€„Ûdˇ∑8Ó∫Í‡ ¨Çÿ)|€û\5ƒ©<ïZ‰Uˆ¡7@ÄÌ4ÃÍœRÌ˘#ÜÙóÅ˝lMBmÀ0√`8†Õfc˚ÑR˚n¿3≠l›–ãÒcveB–>…û*ï=Êø[‰xÅDG'µ≥À[ÆnÓû^ﬁù|:wÈÍ€M£ïdùﬁœ_1º˝N˜Äw”„ΩûøÌ¸ªêﬂøﬂªœB?˚0ºoø˛˙„‡?˝˘£ø˘xhƒ∞OÜè¯Îﬂ>˝l‰®—c∆FéãäÜÒ1b„&∆OJHLJûúí:eÍ¥¥È3fŒö=ÁÛ/ÊŒõüæ‡Ô_f,\ÙèÃØ≤≤/Y˙uŒ≤Â+VÆ ]ΩfÌ:ÿ∞q”Êº¸Ç-[∑m/,⁄±s∑{œﬁ}˚<T|¯H…—c•«Oú,;u˙ú-?Wq˛¬≈ KóØ\ΩV’5µ◊o‹º∑ÔMwÕı¿ªÖ±É≥£äÛ–¶íU#U{8?n(ó¬MÁÊqY‹b.üª ΩÊ]¯°¸"¡S8/<^Gﬁ‰Kı°H≤â…öM¢Ê¨¶Rc”Œ◊Æ◊~Ø}#yKi†4D˙T)çñ∆Js•b©\™ïåR£ÙJjë]eΩlê{»=Â`πè*á…‰H9Eû/ØîÎùßŒGß◊t=tÎFË"u∫U∫"ΩJOzWΩáﬁ[ﬂU/ÈªÎﬂ’÷GÎc˝T~n~:ï‚¨∏)^Jg•õ‚Ø*¡J®í§§+J¶≤XY°‰+ªïÉJ©rB)W.+◊î€ cC®!‹–œeà1ƒ)ÅIÅ3{¯v-‘YU÷k®5Ã⁄◊:¿z¿˙‘jkﬂ¸aÛÀÊ¶øñ&[ì˝û±ñßïN5JµóÛÁ"∏4nó¡®-Â∂pU‹¸[|ü),™ÑÔHÕ®iIG·%FhÄQK“îkZ¥†M◊Êi_J uñdi∞—Nmúî.ë*§õ“]È•Ùö]vF-ÄQÎ%˜Ó†ñ¿®Â»y≠‘:µS¢ÆÕ®ÂtPsg‘∫ËµÌ‘¢ÙZ©…ø@-¢ÉZéíßÏÏ†V…®’1j}:®≈µ®¿4FÕßP∂¢Uc}üQ∑ˆ∑≤÷Zõö"õ√Z©…-Èvj∂¨>ô‘∞~ÙìÓˆÇkôd◊|≥⁄J∞©™Èíêœû5ˇ)À! ç|„ À|Ä«¨∫-ﬁOãª≈’‚bq∂®-NGãh!ã`·,*<≥ø#hX»dìåÜ7˜äf>O`v…ÛﬁLg5Ã®O®ü›PjπÚ ∞a©eM}Q}Æ9◊\`Œ0o∑Á◊˚òßò«1Øß9‹dˆ724ÖözõBLA¶û¶Ó&Ω…◊‰eB„£≈¯ƒ¯»xﬂûe¨0û2ñKòuŒ∏Õ∏œ8–ÿœÿ◊Ëo‘uFÌ√µ'éòè«˘ƒy¨[äƒı‚:qm€9È)Öπ‹q©v~& ”⁄µX◊ÁXÁ«0bò§ôL/é≤hg&!T mÀv–2ÈÈ–ÀaÇCû£¿©ì}÷…£]¡Øß`ßOòf}⁄i∆œf[˚v€å”Ü_Ã]dßÃv/„◊ˆ˙YÊß»{‘ˇ⁄a≈©C’Òˇ¿¡»ÄÖ\$‰¬cXK!6¬ÿ
nê≈ê~	+‡;¯ñ¿j»Ddﬂ”Fÿ;·_^AÏÜP{`<ƒ@LÄJàÖÛpÆ¬%∏W‡[àÉj∏U∞&¬X◊°j!ûÇæÇòâêI0Ú ¶@*LÖi0“`ÃÑ'0Ê¿l¯Ê¬P˘0Ê±Ø¸xœ·Ê‚jT!á<
`Ö&\ÉkqÆáfhAB¿Üp#n¬Õòá˘ËàN®Fg,¿-~¿≠∏∑c!·‹âªp7Ó¡Ω∏˜„<àá‡G∏ÅYòç≈xè`	E|èa)∫¢∫£4¿=ÙD/<é'–;·b<âex
O„¸}∞3ÏÉ˝ÿª‚Y,G_ÏÜ‘‚9¨Ä7o∏PBu®«Ûx/b%^¬ÀxØ¢˙£ÇºÜUXç5Xã◊°ﬂ∆w∞;¿CxÑ7(ã≤i1-°•Ù5Â–2ZN+h%≠¢\ZMkZKÎ`;≠ß¥ë6—f £|*†-¥ï∂—v*‰¯D*¢¥ìv—n⁄C{iÌßtêQ1üƒ'”a:B%tîéQ)ßtí Ëù¶3Ùù•r:Gtû.–E™§KtôÆ–U∫FU|ﬂÃ∑6T'Ç ê 
Ç£‡$®©öj®ñn–M∫EutõÓêëLtóÃTOtèÓ”zHèË1}KOX≠?#=ß“ºâ∑∞o„4™=D7—]Ù=E/—[Ï$˙àù≈.¢ØÿM‘àZQeQ'Í’ûj/µ∑⁄ı'öÎ;∏À"ç¯ªœ˛û›Áyü˝Aj §'êÜ¢Çëﬁ	EDEE—≥ÇŒ(ä"*-°JÛÓD@@E≈9QO=≈JG∫î–!ÅPìê πınÓè˝kgggû˘ÃÓ˜+Âêî»a9"GÂòór“]vÆ“Uπ+Æ⁄’∏´ÓöªÓj£ATE¡∂≤≠m≤M±©6Õ¶€õâ…“PŸWÌx;¡N¥ìÏkˆu;Ÿæaßÿ7Ì[ˆm;’N≥”Ì;”Ÿb;ÀŒvÌú`∑ùkÁŸ˘˛ıZ‡_±Ev±]bﬂµ≥∑ˇ∞Ô{ÇΩ¡æ‡ÄOÄ˚ÌR˚æ]fó€ˆª“Æ≤´Ìáˆ#˚±]c?±ü⁄œÏZi,Ò“DöJÇ4ìDi.-§•$I+i-…í"©í)äSß»t'u¶ª®uçå°n‘ùzPOÍEΩ©ı•~‘ü–@*§A4òÜ–P∫õÜ—=4úÓ•˚Ë~ô-Èí!ôí%Ÿ“F⁄Jéúí”R*erFr%OÚi*M£È4ÉfR”,öMsh.Õ£˘Ù-†Ö¥$™£ë(â™\ùSÁ’ÍÇ∫®.©
U©™‘U≠2Uç∫™Æ©Î*Àg´ |–@0`ÅÄ!TŸ ‡ 
u†.ƒ@,ƒA=®Ø⁄@h®⁄™hç!ö@SHÄfêÕ}F{€Áç$ï´Ú†ï á÷ê)ê
iêê)“Nˆ…≤_ŒJπúìÛÙdA6¥Å∂êπê˘P Ì‡∏ë~¶_‡x∆¡K2ºØ¬xò aºFø¬Î0ô~£¥ë6—f⁄B[imßﬂiÌ§]¥õˆ–^⁄G–~:@Èï–a:BGÈßtíNS)ï—:KÂtéŒ”∫HóË2UP%U—™Ü7`
∆`,’–Uå√ztçÆc}lÄ±’r¿äc<ké0≤aÀƒÃ!;lÇM1õa"6Á(◊·∫É-∞%&a+éÂ8Æ«ıπ7‰F‹ò„π	7Ân∆â‹ú[pKN‚VQ√…ú¬©ú∆Èú¡ôúÖ≠1ô≥π∑ÂŒÂ<ŒÁn«7ç‹ûo‚õ1S˘Ó¿˘VæçoÁ;∏ﬂ…ù˘.Ó"‰"wÂnQ•(G√®DwÁ‹ì{qoÓ√}π˜Á<êyÊ!<4ç÷â÷ç∆›<åÔ··|/ﬂ«˜Û~Ä‰áx$?Ãè_x?*óx4?∆èÛ_˘	~íü‚ß˘~ñ«X~¶¬4ò3`&A1ÃÇŸ0G.√\òÛ·X a,Ü%¸ºTH•T…(ì˜e©,ìÂ≤B>êï≤
Û•ŒBπØ'Í◊Ùd=EO’”u±û≠ÁÎEæ,’+ÙJΩZ§◊Ëµ˙˝µ˛NØ◊øËçpNo’;ÙΩ_óËc˙î>£Àıy8‡"\ÇÀPïPÖÌÒ&ºYVÀáÚë‘»Uπ&◊•÷p™°Æ¬5∏µ:–JÉ÷:e1≥ÏÄ∑‚Ì˛t'Ïå]∞ˆ¿>8 „0›Ô√ÒçO‡3¯úN≈eüã&‡$|ﬂ¿7ÒmúÜ3|FöÖspûÔïu&.∆wÒ=\é´c¸?«u¯%~Éﬂ˚fÛn∆≠:∑„.‹áÒàŒ≈XäÂx+±k}Ô±>√◊5±¶ûi§KMºiÊ[PüËìLkìb“LÜ…2mLéngÚLÅiÔ“≠>Ìw2ù5ôªL”’t3›M””Ù2ΩM”◊Ù3˝Õ 3–öAf∞bÜöªÕ0øsè¨ëOˇ?j—ÓÛ1√Õ3“å2è ZŒ∏–’qqÆ°k‚]íKqi.√eπW‡⁄ªÓv◊ŸusΩ\?WËÜ∫·nÑÈFπ—Óq9mçW˚’uPR%Í0◊ÜA®Bu	14°)‰0%ta4¨÷c¬ÿ0.¨÷WG‘—HE§2Rπ©é‘»&Ÿ,[d´lìÌÚªÏêù≤KvÀ8	ß‡4î ˙`M	ºi÷´Ç`myΩ:||¸ ?ÇÔÇ…∫èÔù|áÍØ¶™iÚì§Î!z®®√Îa≠¡euBîÄ∫Q¥D‡€»À¡W‚ø[±#±nì€Ï∂∏≠ñÏÊgÇKÉ"u[0]›°ûS3Uë*VœˇT„ÑÕ3÷<? ≤NæîØ‰k˘ó|#ﬂ w¸ø¿ØlÄç∞	6√ÿ
€`;ÄÉpJ‡0Å£pé√	Ø≥£◊8qênÆ[Ëñ:…õ|G‚√ﬁi_Ïá˝Ω“˚q>‡Âˆƒ^ÿ€[˚◊„èﬁ€‹àõº›gqéıäüƒßiù™”t∫Œö_ƒq¯íó<≈{ûÏ=øÂ}ø¢3uñW=SgÎ6∫≠Œ—π:OÁÎØÙ^∆
/∂œ‡YÔ4∆Kç˚ÛNÔ4—åˆV3èÎR}⁄Ø2ÔÚ/ÛN/˝ñ‡aØ7›NıÜ3±ã…1πﬁt≤˜úÌﬂb:òéòéÈ∫ùæA_‘óp]êﬂµ,Hà§	ˇ·ªjÄ¢∫Æ9˜›]Q÷D@Ì[ûÀÇFuÖ]‘RDÕ.j∫ã–c#©∆TõÁIMåìTcS[„_~.j#j4òéùL¢µVcç5âc4F#34÷jçÓÎ˜$“ô¯ﬁ˛ú{œΩ˜¸ü{ëuÒﬁ7Rm]¥qˆø∏äﬁ•oÎ∑ÌŸÖ ˙®Ùt⁄Õ∑)ân°ÇLH“M‘Ïo£æ}âz“TZè
¥?ı¢i45p2{®û7X≠+4ä^†Õ÷^^fÌ ˛yTÈ∑¿¡gíi8M¬˙i®‘Øhó(h˝ñb©é:”Hö¬Ω(åäÂ4› /“::ƒœX∑@µ'¸Ô £±4÷:l›°L™ókg:˝	˝vZ≥≠jÍGid
èu⁄˙ú2(àŒ‚‰·&9û‹®ÚW“Àú¨˝–KË/"/fié˜@iMG˝ˇ4ôË,>‰Ó\Ï8„h±~e]&'ı†‡©öÆPû(∂»xk¥uñf–>˙ Ú⁄oìú!∑:fD∆XØZÔS"ÌEçˇ.vq¸ÊÓRÎ˜÷[~C#ì@ß=Õat(ˇ¢oD≠UK„©îè†*◊Qk‡”®%ûœi'i §ùnü¢ﬂëÇEˆ”:›¸5ˇ%T¸©¸c.GÃ|ÉÍ§B◊6h{¥SíÂvË€†tËh¢Îùhtú8ˇa.Ê9<=À´|^(qM‹î±rπ¸VﬁudDŒGæµ&Y7®7•–O–ı‘B∑à∆ˇ_ÈcÙ[◊È?Ë9r∏
}åB6∫ÜÍ(ML5bΩÿ"ﬁDnX´ñCeæ|\ìg´c¬1ë;ØG^åº9aÌµN¿w∫‚¸*ÑFó¬+∂–{Ë∆>F˙)]∞˝Áè‰2~TÊÛ*^á~Ë∫è´êí¢oö)|†:O¸zZΩM∑ ÿ9‡¨¯T|-nh-$ÓD•5j”æî.ô! ¡r≤,CO0Ô8dÑméùé˜-àõ
gçÛ+‘‘+bèﬁÕº˚YÑ"UŸﬂçÖ'-Ü&6°€|∫8ÄÛ(4Ú	¨oX!Ω”C‡{rO‰Gy&WÚ2ÆC.{ô7†”{@‘ìi¬#∆äRï®ﬂÍPÏ¡ªπÏ¥8#ö¡yíf w÷&he⁄Ì	»∞@{N[ÕÆ’vh«µì⁄eÌ+≠VKí˝‰Sr±|Enï{‰	dêü„›å{≤…q¬q«q«)ú)Œ>ŒA»)€úbú1√bä—'úäπ[É.0úÎtﬂ#íÉ˝ƒ—S÷r3&˙≤§HÓÅJ◊iåÅ]∫⁄xñ(íe{ß”+ˆ/‡4îèP≠ShL$œ”.>'ŒÀ?ãQËbCú,∑jO8>n⁄âl¥Fº+p>Ìyb∫ÿ®_‚mt	˛˛KZ«èÛ|⁄…ÕúÀœÚpÆ•S¢óV +(œ⁄,$w‚	‹B‡Äñ 
zå¯:GW"õd˘ÚS#≠áEﬂ†œy;›fáuŸMC6
#À‘√ﬂWíùıf!Œjè…» sù«i;âbÜ;GÀ≈‘Bˇ•+é˝®|d“ÀëjπI~a∑≤aà2⁄Ü∏´¢qàòKíÉ€£ôàÙ8‰í!àÍb*£
zYo≠•¨ç÷rkë5è>¬ﬁ€ËCnÛkààFÏ»£>Oüjƒ·∏À˘}O§ÇöË*˜ÊtÇxhv,ƒÕ¥u’!«1Á`h{mÄG_Ä7«AÇŸtÇÆ“MéÖmí)ãø9‡=@sEP;HúB5àŸ»„˘míÃ«)À†ΩçàÁÉàç‰âôtàŒ∞‡$H4ÙcqNÙ¸S¨~\Œª1SÅ¨ùI_CÓÆú#Äû'≠G÷jOÁËKh€äÚïÖº‡„È8Î&=J†0åäπxáF ≥˙¥£–wvQ>ßÒ±/ÑÌJ}iÑ„îôdÂàjÌ ÓÛØ·ˆJ•Q¸$∏HÄw)ë'”–»pí5©¯ÔQ.^ïVùˆtd.}D€aØ\„ÛéùÍ3zTﬁ»‹9√á>Ú£!É40;Àì˘√e§˜7“‹˙˙ıÌìöí‹;©Wbœ›ªπ∫vâÔ◊)6∆Èêö` ÚÖ!]eÑîÃ0∆èœ∂«F·˚&BJ«Ta«5JEóÈWz±Úgˇ∑“€∫“€æí]zÂegÈ~CW«|Üﬁ»e%¿øˆA]5G·âQxMÓÿÌ∆›ﬂª ß+È~U∏∞ Ùá|8Æ°s\ÅQPóùEqùv§íåöNÕQ@$˘s≈vS*≈˘U≤·≥9PZ∫?\°äK~_™€ÃŒR\0€(Wd‰´Ot	D…(gÅäâí—´mihµﬁê’d÷7∫®<‰âØ0*¬3Jm›<†ÎSIã/ˆ˛nà√ªÍÓ«¶j¶øwµnM≥NWM%Å˚±n˚7ƒÿ+“Cf!H◊CâE•:®âï¡Ä‚ï ©€íÿRµ Wi¯Ìô–]u2Úç*sN¶I1MY‰ﬁïí‚›gùßønNn5&’Ü}}zí9e—ÓdØû‹ìù’‡Í÷™ÿÜÆ	m@|ó˚Å v\ä.∑°¢)Ìöeõ#cBÈ≥up0 Sé˝SôCÊÏ,√dÏR∞HµÍT2]πˆºΩ_9“]Ünﬁ xÄ—|≠„L∏m∆ôÓ∫A6h˚Iª´Vè Ã¥]$¶ 6è££„°ŸY≈0£∆•„Í£bË6Ãıª›∂ÅW7z©µ§$–:÷©<uyyÇJÑlL”=L‚4≥‰¶}{»Ä'Ô!\Nî®b3⁄?	Æ^=¸Uπä{= ]Ÿä/*5äJ ∫ﬂµÈ∂hjáQ+>ß◊©-U¥A"Uãb·î3€€É@ºíÈ¯8£N]°48etÇıBÂ
ço˝∆π›ﬂªß1&ˆæMçVãΩ+˙˜›∂6.UÆß„xdáqÓ‚M¸ Q4µÃ4„:‡
ëÄL≥––Õên¥ñî∫À0˜â≠b´Y„›3h£µu™*¨Bà*ŒÖ≥
 o0xUIÉóWï˛èÍjèmÍ:„Áú˚<◊ˆıµ}˝éìÎ8/p±Û(æ%<J£ê[∫Ç“mçQ°tiVAÌ™V*
0÷5⁄V—⁄°‡§@cL‚ü≠•¨”T¥aö‹Mmîf"æﬁwùµ”ÓΩ˙Œπ«÷=ﬂ˜˚~ﬂ„lÈW“Ü6vû&ò¥l[ﬁ’UãàÈn(”Z~Ü`É≤$•ª«í÷¿»/ÚúAòÛ∏
QËN}»Ufí˘dª2ùlÀ'Q
Ê à∫XÿvTÇ¿PÒÁ4frNÁ–}§±ì–+†'çıd'w)hï.◊ÿè1D§Q9≈∏QÑA"rPóË÷£c	õ%#cé7û4wLÁÚ”9%áR)%©¿^8ç#U$°∏Î	q´NØáløtdÙâé˝ì√›ﬂHDåıS¯ÛøCIn]0>06ˆK„Õ£;LMZ@Ω®…›WM™•n“-Dﬂî**ßbÍÑ¿‚¢Ngƒ/∏£VSgOã©M.˚ˇïq-cq¬‘{únU Ã +,Ÿ1¸˛°cÀ[OÎO_ú˝t˜g¯WxÒ£tˆÉ”∆}¯ÆŸD@[9ËK¯°q$nÍ¥±9Œ◊Ä≤ÖIù÷$‚ºﬁnÍÎ¬’àh!ªê´ë[õP#ó≤ˆ†≤ùŸ¡Ìª•{å˝õ‡2•¨@1t?Ç
MOYV„xï„xQ“°eíπÖ%äKïÑaxñfÒy]Ê¬±pö≠^o e…„∫•œ8˝ò¡YR°”2äc¥ü:A*ˇ†á9øÂ—'|Q‡E∫-ÔüIg¶”_æ}ÂˆwÅ$ÄS*Ÿñs8õ'Û—hrê[‹wepëœ%ôºrÂOZ6vû°qjã£h €z“≤°ıd)D–8b
∆iëï&
 5wägõÃ´g“—‚3p„∞ãa∏˜çã˝˘≥œW…R‹º⁄U‹fåqs/-À‰¿∑
S‹‡ÄÜnÍ´öJ[K;Ñ=‚ÎqøıÄwêÚ^>ËÙ:É5é_M†¶T|ÿ≤ï›H∑Xzÿ∞ﬂ˜=8+üU~gª™‹P¶ô)·5dÇYh.ÉØWå=%µ<uÍ≤3Ól]Î¬.›Ìãª≤∏F_Ë©µCSé5ˇc∞\ÌÏ eö∆êÄV+'Â˛ÍQ	€•2)&1Rñ¸x,‹˜˙<®ô∂\ªíû1ÉNôŒeäH¢T~:öæMÂ&ÆôhñÎb(ç”iú;x6R^AqgcCΩ∆zπ™™H9ÔVúıKLäÙ•ç◊ﬂΩkºubr¸•±◊?`|RvºˇÚù{Á”Ôµê‡ó˘Ïñ·K∏˚˙¸Ì«÷‹π÷¯ù}3ü˜ç˚k‚¿ﬂ.@q
P¥C√˜s}”!ÓêxÿzXfE,»¢]U˚ˆ“gú¬3éΩÓvX∂»ú√Íê{»;‰Xß®
∑3†|ÓÄ‡™µQ≠¿x™-a$)í6èÅÆ≈Bzh[®7‘ÒZË_!R™G∂£2ÉÙeU“˜õØÅjS“ôsÇRπTŒ–t•]Ò∆Ü	‰PPXCX5ÅHƒMP∫Zñº›=<ù£œ∏`å}∏ÓÓ©S˚Àπs∑»G∑˜ûé>h|œ¯âÒöÒ~Ô¸∑Q(Êfãq<q|‚ÿç¬hVæŸæ∆æYË±ÙXﬂ¢«‰—»Y˘&ïxëóº¢GjêW…´ÏÇ®Pá*´vUiêÏ´ÌªÂgïÎíe/›Îﬂ¢C˛ÅO=*µ⁄ÂÚnyø|P˛ÖÃ…öÕ™⁄lVª’mÛz*]ää∑©£*QU§ÖÅuƒ&Àn$ f W#õb#∂èÇ’£¸I~íˇœÚÉΩ¨Eb	ª5»1P>K^+Ø˚o‰ŸebóõNÁæ
€|∏ñŒ¿àÅ^ÕÉã¢iyür;ö—WtÀ§”ıéÙ‰º‡Òx]afâD ÿD∏∫*!O˝„„˛Àó∂ÌÎ3~ˆ«]›ë¸Û«=…µWúô‚&÷^{˛ç%M«çø‚‘ÒÆp˛ßL{EÁÚG∂Z93bÄÉÔx1WÓ“#ãiåçqÎh/d°W®¿céTBÛ/ ëB“büÉlî≈µ∫ƒê∑–s¶ïÍ`‰u§óÙìWK¸b˛ƒºÕ≠Î;OΩ©+ŸˆÁì  g›„MÀì≈ÙE-vá¯S£ç}…hg/œŒﬁ_ZΩ
PZ˘—zì 
TP¿…tµ∏ö
õiá2¢rvıSŒyn∏Ô3º≈fµbDÑJµZ4€Ôe,ÉÙr=∏.∏-»Ù˚ÉD∆Ç£¡… ƒDCö?ÊüÙ3~”QÅ∫›ˇsî…Ú]3È˘2ú+:ÀT6„
;TØ«SÑJ≤"ìHy∏ Ò*Æ±∏^˛a_ ◊ƒ~tÛùˇ‘ßÜ -ﬁΩ–¥Âª›#Ô0—9√ò˝d§ÎÒ£õ˙f ıBò›	ˆâË∑„à-\‘óYìfñc\‹¸\#X%W4^Py^¿¨¿¢¿bÜ0îEú$‚h/∫uœs√8∫HÔ/|õ'ﬁwA‘…Ô9¸51wåQ≥§@ıO˙ï€>%??ÄoRI≥Ú*3∑MF:õM&zõNo≥YWD 'åæ‚"-9(*WLdP\∆8à'?Ö∑‚.¸Mº)éØÎÛÁ…äπ∑ÛG`Á¡¬=ˆ XmG%Ëµq‰,ÃÍuñÊ∆‡Í qvRáß√◊UÚ•¿'ÿ•∂•ÆDp%€jku≠éP…*ch≠YÚÙiNPa–]ãIﬁ∞Ë-≈• ¬TŸ≥xÅn≈Ω®ˆÛáR›öÅôOﬁmW23fÓJöŸ+NE»Ëˇ!ªj`£8ÆÃÏﬂÌ›ﬁ˛›ﬁ›ûœ6>lÃ©q¬1ó8‹RªÑüRácŸÅ∆¡!%6ëêRJ†@¬Oàm@Ä⁄ã 0vcŸ§iT–îê !“î˛à*T`ê∑ÙÕûIiª“ª∑7Ûfwﬂõ7Ô˚^˘|À”¿7∏fc.WõFµ18t⁄£Ò	:4ÿ„±~l¸w5m≠Ì>a€ô˛ö£ñûò˛JÌ/÷=ˇ‹zÓXÊ∆;ˆ˚∂}√æXìﬁC∆øWŸ‘˛~Ôª{È9õæßÿ…ê—ˇ¥fœW“z:∞Xi‘´ÕWBm§M:•û2ˇ¨~nÆﬂÄˇﬁ7…7…?Cüòj¶•FIxL/îöÃJn•≤Å[ØluÍ˝zo@î${ÃpÇÍt#!«Ωt$îüp¥¢%º«0ã‹3]Û Lëv(æc|≥Ñ©Ç†ÄÈ(é†/ΩÒF*·ÂÑÖà ôü%EÀ·⁄YÉ±°¡ÖI@…EÀhZ≤ö°f·@4hÃJ9û/M°!>!¿>b_ìU6Æ^≥§™¡èçÿ–Ÿ˚û¯˘j¬‹ß∂¸hOÕK%ø;Å£ò≈sÄ‚¿à›XàùÅrÒØ˙ë
y3’ì‹%Óˆ∂™ù‹˜á‚áﬁæóÀ¿”»ì¸Twe~ß∑óÔÕ9Ì˛£Ùπ˚È·ñ◊õ´‰˙≠p^¬o…ZBÒˇﬁˇôüÒ;—…O9ZÇ&oY zï\/Ÿ‘1LÙÜ¬	◊)È…+H8ztqV«æó’fÆ£-EV¥!S·≥Ît≤¥áıË&Õ÷"èÄ"∏ƒüjI~]˛K˘Ì˘læqY^%·
Â5fCÀ2ÚZËó,√¥∆)” W‡'¨¬OÆñ¢‰,ù ¿<=K«{¿BßFé;™ªÔõÑ;ÑŒYÄ`BO“èÓR’’#∫';ßDR1DÌ/«†‘:Øó-àíL_*”◊À9uhÁ2`ûXã;UN¶[^ ÖëÓ9b"NÕÙ—ú¯ πÉÕGéÿ◊ﬁhƒ∆˘A¨ÛãY˚Ï˜åe^Æ~¶¨„9%ªﬂ˝`˚ﬂ±«Ï”ˆG´7O√/ÆZS^æúÊ¬8Lá†Ü–ﬁje?!Ë)Õù≤ƒ*ëº&vâ«≈s‚uë%÷ãkƒ‡^Ä∆ãQ∂–9t	V÷B·9^`›DÄ<s:ÇHQÇπReŸi¡¨Ñf8ï¢ ÖÅÊ⁄e1T≤áÏ+8ƒˆb÷æ˚Ì6˙ÌEÿ˚ÌÄ®i»÷ j∑L¡Ù-p-v±},N∏jÖ´BP9û&Dû&»^^ÚxÄî ´†(q–íc“Ø
å.Jl3;L“dﬁ0…uõnOTR‹l≈I8X“!·ñB¡ëØo^ﬂØ™¥ô$ã;éCÔ†ÃÕ·ëàñpN*Ôo"~®x˘ƒœ¶Ì+E≥ì”Á∏ÕÁkwWé"˘áûõTµÆ€≈F˜¸¶|Ò∫WÈ^ÃÅsπ<ıBUk≥¶]≈W\∑|∑¸Ïirï#zàâ$≠V˚™i≥çÏ‰w∫⁄§>Ò˘+˜7ÒÇóøÍU∏ŒêO¯ìÆS∑¬µë_Áb4Z·›û ë¡
FR»©7ÖIXé†ˇ*CŸbÓQßê7C%’Ω!–h≤òrË :∏Ö¸Ú¢Ë„?e|Œ¶Ãûõ8a¸’€ˆ≠M∏†uÈ“ññ•K[…Ë71ø…>}˝¶}r›ΩŒ}ùù{:;©øõÌŸ6W¸⁄m=4…7ÕGÙìÙ&}âp3›;›Wæ)ñ•ı,ö∑√.H∑q+‡Ò®ä|∑¥bYV¢™ä)ty˛πfñ¡F™óˇª vk1xÏ•ÿ’®g—ãßN˚`'©œ#‡•E^o∆|¸˝òÿw˚Áo≠Ñ-liX∏v˝¢Á	[[ıc˚v∆∂ˇ2u^fÄÈÔyoœÅ˝ÌêêbJﬂ;≠qme<ók‡VpLâ>_^,7È¨[T§QŸ*›ìHJ™îà‘GVZ≈Ç ˘Õﬁ=â™¯0êKVÃY£∑Î§N_£—œÈ¨Æ¢(fˇ	yw –á¥T?ŒE˜·˚ªtÆÕ∫åLÁlBv''dC—åfv°ßù=ÌQ˜ÑIáàì”â†‡$πÜ;hFó/©®O?˝‰èœ)a£mK*&~˝–îÉˆMq‘Ω´d;∑≤˘¨U∫ãï«‰rZB~d2?
Í>ub`ì∑ ô}[

vªÇL=®„A&ÿáŸnÄ7Z˛ëüË¶ÀíG,qó TÇÎ¿?∞∞∆ôL4®œÛßåv„à¡‘Ø€ås∆ÉCÜj, ÔÀ#˝◊≤ô]•‡·„‡a?2Óß‘˙nñY´C!îAJ≠©Èe®‹Z\ÅãF˚5É·“ ?BYµ¬âÒâc4≤Í∏glÓÿÊ¬ü˝pU“#æ˛:Œa£óÏß÷∆r√««gˇ‡ë¸Ÿ•Ûø∂7BV~A6ú”+ËO÷‰§é«h„ıRçŸ%˝A;£3?ëñª_ïòπÓiëõy√ΩYjq33=ÿÚTyZ<åG”Y@¨·câ·Í√?∑$ëpóΩíx¨W¶q‘U≈í’ÑrX´◊Èç~ÿÄ·nóKÏ#≠›‹ß¸ÎEüƒ@∫PÃVÃo…>ËœbQJ´- √°é« ≤eØå∆%SFIm0â≥›-p57cFBÈ‚é_®1ÖåÜ/d»Æa ≤LK+fˆmÌ"»{[∂djòxÊí∏{ñºïYNÖ≤;†Ûdküw…∆:•ÏkW»ÖËµˇÀ≤<™O≤Moﬂπs7£"ólE∫Dòlˇï´ËŒù;´‘Ïs∏º˘ë!íëÉ®è9ÉöÿÂHô*‰°4w-¿W–30∑§ú…CπÏ!4ÏW¿ˇÂ†wê‰ΩÿWÉÏâÉÃâÇ‘Ä<="sA¶¿öèA¬3ÍËs˝%zA8ãûÄw!êVêgAﬁ·™QÃµÒI¥êé√ªﬁÑg¬˝.ﬂÀD€·~'Ãß©≠£È˙Ís_ÓA^ïe~øs˚±`-KB ãKª¨q•,nÓÆ\åÅ»¡`bƒ¿òX„Órç0Y(j(D›¥tÕ»qƒV2eNüÁ˝ù≥s8,`˛”ô˘ŒÛ>Ôıyü˜π˘„y¥;•æÔïâGü–>OsŒ_§2C;p˛{äív'ˆ˛:„≥°%–‚@ﬁl”>¢kÃ]ıésµç~f–øÛ¿HÙ£ÎX◊æåˆ»’z#hlã¥eNÔ‰ù≤⁄ôÛÔÓ-Êﬁ‹£ÓN»od∫4JTæ(êIÔuTÇ◊"≤≈Qv¶»=÷ÌÊ˝ÙŒüΩíïrzπ†˜ré˙gÿ›[‹k'pÏ1“%%˛‰ÏÎlìr¯B–€`ä$ÏU2…:Õlì'‹eÚs˙%Ÿ¸G⁄'?ê∑ΩtG√ÿˇA0ñ=˜{£2¯@[€G%áΩ8{®'’¸ ﬁusk’–Îè¡xtP&´|úüØ:Á›œ&J/º¿‹CúsøÇ3[p˜Ãª YˇˆJòs2Ôê°ÄÒ	ËÙW‡%∞[eaÏ,ÄŸkÉX…˛)Ë@®’ﬁ¿√†áŒ·¸,Êg{≈f‘6’>‘6úΩ∆VPŸ3w0æ0/ôGY?¥ ›çÚPÄéÃU˝åVõU	˜V€Rõ	©±Èâ∆Ó˜È=’¶"tâìñ!*É9€
©˙˚NSj532≠∞™dÅ⁄¨⁄[HU/jkÍèÍπk^‡#y¨oel[i®ã:˙™¨`œRw!vZ-ÌÉ2–zE:”†ã∏ﬂÔË„>v1Ï6îJK.o9àµÀc¥\·U%&p÷OÌ
tQ%´ç^´ímÌ™Ñ„T¯«IÏw*í3Lªç#ëŒå)UD«Æµˇzê|”©êq¥O8Uæœ}©Ox’â–&§ÙøûùR∑% S€ΩiÍäúìÏ"ÈÈIw;-}ÌfRÑû⁄”_‚ﬁg‚Óˆﬂõ®ñ2ﬁÎ'^3ig'6rVÚMÚ–˝°ﬂäÿ—E6∑•êÜˆßj3w°¥~∑Ïºcè¿}ö4>õ¸@åe{ıO÷ŸÁ~Y}:¥œòùväŸß∑À8’‹¢Ò›‰¸9 ¬˚k|‘ß1R„úÊæp~úF÷/%v¸›ƒ·J¯u.( ˘Ï±+à#;©QN„£«‹◊˝ù^_ßu¿ﬂÈ.˜ü˜&˙˚‹m˛*Óù[óS”ôX¶˛ÊR’ìÊ≈0è:d\œVòπúoÚh©â‚N√ˇ&»hˆ}EÛ™˙°µ
øCüÏ7À^/ﬂ∑Àdob˝:”o? 5&⁄Si”OL◊Ò¨f|®}J¶⁄π¥◊CW MÆ'S›?Íø“Ù…åiü3Bû¡ÓÚÌπÚgã”∑“{$ÔË€„Û9©'eµ'ÿaYaü„ŒiÓ∏◊–ï∆ûtÌVˇúﬁœÎ%_r,ÓßsÄÆ°>oËcô—E⁄Ëh©±at°{∫oòzCú∑òˇ3ôû í©[âOg$«#ñò≥∂»É©"£w€‰Îèèjl¨DÊ8_Ù?1ˆø—˜≠s¯P5˛•H0÷LZ8’≤_öcÙì°Û‘¨ji¶6¬˝äM=Qçç?'ì›
ôÔ¶±ª*rAÔVÕ]& ◊h/¥+¸Êˆg—≥ÈbÍÕSE˛kÍ/^Z≤Ω"Œgé `Í?Œµé"ÔbôC,Èó™ñg›6R@z‘¢±ËíÅ·gÇ`~¶ØiÜ&naèÈ⁄ü+˚ê")‚'‘ÏΩï“œ˙•dŸ„®N»¨dæÃ∂bw'…ñLWﬁŒìé÷Iπﬂ˙ÿ‰üŸNñt7Ûöì«è…`{8Î”2∆~Q∆X>Ìl∞{dù≥]F8èPgçbü …n¨i$É›y¥Û˝ç:œúÒ±ﬂ\aOìB≥.#kïy]DÊ•‹ÍGÿÉ K;*Ø Z'g „•‰3˜‘}YgÊ¸S˙°ß∑A˚Ω0$Y&`mÚ uxZf$ñ˘;–ÎΩ1àÚˆåƒ0ÿˆYÌ=™¿*∞¸ÀæCûbÔ›–≠˙_†H˛Åÿe¸9{N8Öûs©˛(Ï˜˝Qﬁ)îäd1=Ô‚13çtµ'¯;÷T…R∏ç%◊KInÚ0˝•¨ãÒNGy∆ûƒ‹°b5$”ï¿W—cQÙé·{@õ_ﬁé–6JÒØŒöü?ç|◊ﬁw&¯û—ˇZ˘™±°c‘‰ûø'±KF%˘ÁàÁÆ"√Ké—Áπ)|'˙Áò˛ÿ˚a+›TÁÒ~⁄Ω!◊ÜxˆEh!ºB)RÿÔ0ƒyÚAë¬UÀ´œ◊ù{9KWÙtØ]å,áÎÛnS…W$É/g¸}πUQ«KÆBÁ*–m;∫ﬁ°Hñ[÷P∆Üö˘}ΩSΩZi]k÷õ˜	Ì<˛>¨˚Oƒ£˜®ôã%'N£>˜€x_K.5'Êó€Ûˇ	¯Œ∞¸˘3=;O∂
ö
5›Î‘õ©UüÂÛe)9?G§f∑HÌwàC‰‡⁄MÙï–Ó ˝d”7J6™9D˚1∆ﬁ ï`≠›RÍ ˝3kœ?Ï◊>≥^◊ù£⁄©ÈñY_3¨§˝Äï’ÏÅ.Åûa˛f÷áR‘ŒÇvÖ∞á⁄ø¬˜‰˝⁄û‡8@ŒZ ò⁄|÷ØSµπƒËˇñ^Êˇ„j)2N ﬂ65'Ú∆ˇ!ÆöÜÔŸ çˇkÑÔﬂˇ%Í—@‘|ëü+˛„Ñî˜¸$¿i°=◊?OMÈô:öZ÷‘‹Z?‘‘€U¶ûLòö2†ËSÂ∏Qkg≠_°´Ãﬁ´»3Eæâ\•FÆ0èDbk2O∆ÇÊà{r7s˛Ü<ˇ&ˆ4!øû°∂\†êÃ7*ˇerWbÓKâ]˛h%¸Õ‰≤FaNckΩ[?ß}¶¸µÊ»Î»©Éåè!Ï >û†≠"ûãØÂÓÎŒÂó…——<˝i˘0œáh‘G
^r’ØK„u@C|CuÓµÚÒ∫#¬oQ\a‹Ò∫$‰„®7^ﬂˆ2ıL˛"Êw◊
¸Ù.{íˇè–_C‚~\ÁoÔŒî{@ˇê&÷KG‚H.ò¸wµ£MÙü–¸ñ™ï¬‘&)Ñˇ¯m&Ê¯√3πœüüÿF-}VCŒÖß‡=ª“Ã`xCˆ∑[≠œM}àŒåÏxã”ízÅœÉ-‡—∫∑Êí≥˜Yd^˝œµﬁÛœ∞◊ôÀ’Çó£¸ÁM÷ˇ=¯&Mà≈-›-“ IÀJ⁄≥°Y–,‚˚x]bvâ≥◊?Ôn5sb¨ÿ>(âÛ„K&ŸG¸çƒÙ—N6øìeëÊN‡±v9kÁ“n	m‚}(ÀÿgÎü÷‡eìOIâ€OZ—7OÛ0√‹G–Ìà‰ª“ä8ﬂö±ÏÄvv'p˘ Õ59¶1}Õm·^G§'nwìN†c∑Éë÷9ˆ^g÷ŒKﬁ)õ≠ŸloíRˆ€ûµAñ4⁄+KR‹ßQ©¨ˆæ,´Ì…≤8´ßîÛˇVøPÛUòW—˝Ö∞MÌ∂¡ªYÜÈΩŸ˚+-ÔØ	å|›à´=¸u—s√uˇ•Ω\`¨*Œ8˛›sŒ=gwA
lXXA-(Ÿb©œ
[)≤,PÉÖ÷§(⁄F≠µ÷ *DACQ\¨÷WŸU1¶>k—b≠XTKÅ*´†≈Á.i-∫w˙˚ÊÃπ˜rÿGLÌM~˘fÊŒô˘ŒúôÔ˚OI5kS√˚ø(k©ØÍL€0Œhá`z>ÕÕ˛ ÛJlÂ:ó„/ŒÁ¸2ëqFRn◊vΩú≥Û≠±πöúùÌ 8]≠Ôvç”æ$s±.≠Ìi°Dõ¿πvﬂ4…b›c‘GA/◊Vku¡9èÔ5˙foíæ¡r©Ò6ò-˘>h&›G¡vªgó´üäÓ/∑ÁnÛ‚å˛Mzi9ÿ!∑Òçnp\À>}@◊68(+¨èı<˚ÿHkµø g+èŸ‘3ó¬z©?éu¡Tª?˚πΩY|&ÇáÏû9ñ˜/µæÆ]ª˘Ï—o:œ8Sâµkuêu_.SÏ;¢©¸zˆ-Î„ØG_5…¨§o…∑•6Z∆~}îΩ≥òy«…¿p-íæ·©Ë√Âº˜π<ªXñzüJïíYiˆyeQ|ë™ eNÏëÃπ–YÊ≥^k·ßp;Ô”¢h?€∑AÊ8æ¶x2ï¸ø	íÚqqŸ∂Ω‰hq<P˝Ã€π˜!sW2æá_≈>˘=ÿ´)xÊ"áp^0ìµ:íÍ4<´ˆî4¥´=1çkÔüÜvµc”–>∂?⁄Î◊ûÌµüîÜˆìæ?⁄wp⁄w‡ﬂ§4¥O˙~¥∑ŒC“–>§?&ß°}r⁄‚”£Ó®ø”¸IÆæ
˚ˆ,ÏÂeÓΩfÆ´ou˝.)†?3–ÒòCÚ±˘ ÓÇ©t.”;~&ô«\Fπ˚›x.}6∑)û€‚ÊÃ=‡|}û.™´ÔÃù€œgÁ∆è\c¨cÃùÆˇnﬁcøs«cØà˚Îˇ˙éˆπéü!é∑ÍªM+†æÁ6Ræ'÷Lπß‹Zﬁœ€ =—ÙÉÓˇ•Ö∏ [π'ﬁJ<\§π∫ƒQ´±÷∆‹y“´(WYçA˘WÔBº	Œî!é1 T7h∑˜I‚æΩOæÅ>A+XÜêGvPõ1~Õ>ÏF‹\"Cué‡SÙ
ckﬁUÕ·Ôê©ä’õmÆ£˘†Ï,π <üI∆/è∂Àäp6Ò4æÀvâ.°~1∫„g2#ådQ…zYΩ…ˇæå#_U'Ì…›6º¡òÏpÈíÿ.ßÀ•øß}	Z™øL“˘¢Se:k6:ô;øzœµﬂ]◊<,Ú≈◊·<Î3˛b{bÀm.VÌ§k≤Mñ‚œpÕü¨[œ #«Ñ«sÆæê°Q)˙‚	YZÍ…—˙È\w´ÆÀØ˝ˇ†Ù_ó·ŸÎ•∑]Î˚eA∏ãu˝	Z⁄YÚ√äË9>€¿{’…ù¡V∆™ìAŸﬁ“œjáùvÏÿ&cl@œîuÏâ˛i]ìË®ºæyï=Å»œ·ﬁG≠ÊŒ¢˜∑∂Hoÿuœ>&3ÉÀ‰[¡aßS6Ò)⁄)u·Nªf[˝u∂ÃéÆ&∑>,„¬-Rù≠FßOîÍí˛2(∫_˙©>ãÊ≤7UØë£√A2"ªN8„¶öÔ≥{%ltÁ{Ü;so@Éã5qª=õ¥µﬁÈ⁄/Ök`^¸ø˛g~ó[?é«∑ˇ]˜o’X≈YÀp¢r;Z·?ÓÃ~¶Â¢u^c5˝—÷Èzπ›È÷émJ∂gıÛù˚È·XOm'cœHÍúœ◊cTÀôÌâéN[˙÷Ymg≠9ËÏg_÷Ω¶Z/mãtuõ∂=˝Z–±Óú%6÷’7µc/HÙug6Øø€±yΩﬁôùaå∆©ƒF7K§4±.éu-XßÀ˜ß¥]çN€Ît¨Í˜	¨˚Õúπ…°˚N	[LsÿRlâë‡ˇô›a˝*D¢GLsÙH¡Í]±#¬[xÓÚÀ@”\2∞ÿJ/üoç1O¿ÿ¿„∞Ÿœòf?√<´L3ZΩ»í;VŸ˚IM[ÑuÃ[«<”ôè(m√_¢ÄÊªé@≥Kî„πãÏ;∂h.ÏêÌÃÉZ(πëyn‰ô√Ãsÿ⁄%Y˜dìu·›ÿÔï¯úÃÔ∆˝_ø#cÆËàˆøãiQæ™˜Ó»˜ÏãÊ5ÿ£eŒ“nw/¡ö%ÂÛJÎ˜~ﬁ¢ô1zûÈ€Ïha]ﬂÖøkår<õ‡=›[>{@aÛ§˜Aã√’ı,*·~Ûf4—Ï—s‡?e)™•⁄ZüËGÊ5ˆ‡ûhv;œ\jÔH™ΩvsVÀ4æ+.ˆUñæB˛"P§πæd#{[à?œ…‹#5üôÊbΩå#ƒãc√«•÷œ…Ã∞ûªmWb“_Õ~Öπñ8∂9V≈⁄œº å◊Ÿ∂ˇ∂ˇd©P(üŒ|ÃbÍúﬁVª &w n/¯ïƒﬁ %Ã]Wx∑ÚΩª[˝ræ›!Âhû™léË.ÇE≤MŸMıáÍ{ (taç£íu©V£õdöÂ}˙’õœ’Dˆ;5…‘pàLﬁ‚´çãƒIˇ–Ã≥†9ßÀR˛;Vµèé°zPuëﬂƒ:S¸{π„¢ú˝ﬂ`ß«>ˆ© ,@£Ó•º*h?{%\E˘$Ï’0\˚œ•*€ã±≤îïJ˙=[ã„Ω„b⁄ΩóË∑DFyÕ¥çá2ò‡–>œ†ÒÙø±∂_ï˜>sú'e~π+WÛﬂ.(AÅËx4ªˇí>c}≤ ∏≤µh™„`ôiÃé1çô˜•"®ï|”cÄ/ô”˚–ìNGqZÕXO˝ÔYôß¯ãAŸl˝ª¿ŸÏV9-ªZ™¬>≤8€O&qv'OÜF†•ß«w¢úﬁÌ.	ö/¯nK¸ù¯ÒñÂ1g√ø»…•K∏˜¢≤p]Î’63›ÊNaoIF’[}¨»≤ÔöÎYKtnÙπ9∫-yèÃr±HµñÊíûö◊)ü¶{';L∆2Ÿ«åç5æ—Û0çÿ†Áwû;√ÛÇerüÓ-ßµÉﬂG~ÅÌ≠eŒí
˜Ïxò ◊∫5ú»∏Î≥U¨x√…Å@˘LÖr£RÙˇWR÷sæÆ"∂å§<ÚË:ﬂsä„àoU…9J∞ó~J≠åÚ7£√kyf_Áı∞áú¢xÛ©Øm£ﬁMÜE%2Ã>;£Û∫∑O*øÜ5Æ9∫Œ¸g+˘˜Ó§Óﬂ%ÉïdøÂ˜t{ÔﬂdûS≠q4†e≥^)+Ïe√ªÿKïÙªﬁ˚Ñ3ªõ¸πåc8Ò∞â}˜|f˜ﬂMÒxËÛâyËi˙Ã◊°Xc+⁄uÆÍRø—l—8ßZ—ÍAÙü>kAÁcßÿ{ŸŸ2’∆Zb*ælQ-™˜4É ,°∆çAôO§D„å˜)ı+®W∆qIÀﬁ"N√J ÁÛˇÑ8NiÚÁÃ⁄«1À∆LçmzâW˛90õ˙?ƒ Ô,¯œ∆~xÔIgauåÊú‹›öõlÏÙ‚qΩèòá≤ﬁ]Ïπù!zÈ7¶3Ω‰Ùe¢1∑§ÎùÈB˙l+&˝øˇﬂ†V˙ìoF¢iZÒ´èj˘¸Ωk°÷ú~√ﬁWl‹·[ñÁuæÊ<Õì˙ùÙ{-ìûƒîÚ£Óæ\Æﬂ6['É4w±NÇEvNåÕ”∫él¨Ã»˜Ìƒ8∑ÔB´kÙ~ßwáÊï¢ª_róÎ„ˆ÷PﬁmypiˆiôÏÚ˝3åùs‹ß®ﬂqƒï	˛≈.πÓˇ;≥MÇs:&;æ@ÿëJN8í“æùSÜËr~Ã1¶»M∑˜‰øÏñml««üù1w6·|ã„Ú∂Ç}`◊ˆÂ08-ﬁî~Hê∞GUÑ|Å+Œ›…>áÏ§älú¥ï˙¢÷ó»ª±c#_íFäZ•ú˙¢8ï™‹áÙU‘Oï*˜?s´™Z)i´J≠Î7ˇggÁ7;ª≥^L·%"Û7eVœñ©Y˙ˇcÕ'çF£—h4çF£—h4çF£—h4çF£—h4çF£—h4çF£—h4ÕøÖA⁄Eü–óËàëI≠‘M¯3{ãV‡ò®öÆ£Â$ˇ}]µ≤“82®¸oó±ÕØ9≠1ıÎ
‘~@=‚◊AzÃx#çä*9ßq◊Øj`è˙5£j6‚◊˝ﬂÚÎ
‘û_P‡◊X[¶WHPå¢¯Ÿç™ãNPyê“îYzö2™géQÀ∂˝I5¢g¿è†√Ë;?KCÍ(ÅL`ÙSh˚1“AùÑ+«&’ò>êUÛıcÃì»A:âæ4=Ò/¨EŒöR3ñΩn%q$Ø.Ë™>uTær
Ω≠j°Ê>°÷*ËéÜq6´V+G∑º"b—Ën—u"!¶SÈÏ”ôÑÿóÃ§˚≤…t™E8‚pÚ¯âÏê8úJ>ïËo9‘˝·˝è49É…æÅÊ”˝ª>]ó™ErHÙâÏ`_‚…æ¡ì"˝ƒ?ΩºH¶DÁ∫S…l¢_…ˆeêS˝≠ÈAë∆ôAq,=ú &C-ˇ≈Ì>Ñx˝˚Èj˙ªÕo¶1◊ ∆ƒı•w|@m˛ßs˛ì£˛g_JˇÛBÀzü˛¡ø]£Nà_£ÄoZrÄìÕØy¡PÃûE÷¨UÈ÷6≈Êñ(æ∏Sı7'6∫¿ßÈ(ÌD˜¥€-ªß={LÂŒ=ÂlΩ_•[Y>\≥ú–Z£∞_uÇ`,Ç 4MÇe¿˘U~…=`aÜ+ò(Ï¨ÂWe≥—ﬁÀÄcıWp/WËÆﬂSÅU]ˆ™V…À_V÷F~V≠	F¡∏VPÌ$X’%úªDå_‚]”2ùï¸«4ˇÖÉ,Ã˛=œTœÊ˚^xMÃvL˛]äFy~ê
Äa⁄ó†ΩD√rõÔWè!oeuÃƒ¯q,z«%shul9~‹[S+ßˇ¶^≠º3n¥≠\xf],éß2xÇßË>≤¯Y‰‰1‰f‰„ºüBjù∂6c£∏^Üwu¥ß^ãﬂsãÔÁh£6ÏVóØ3Ïnoå·é˜Ò:5$ÃC‘Ü¨‰A7fâyn´áˇ¢Wuè\ﬂãÆπ.vãø¿É¥£F1jΩæ≈WbgW™;ÈÚ™B±	gÔ¬mv·±XX£ÅßúR•\L‰¨Ê_Êõ®ÁNÚÕ¥yÄoQ˘~ë ‰5l≤
Û¸€ zYNäÀÔ-øZ{ΩPu¨‡TÒΩ8õÁÁ±Á’≈'ºÜb‰4Ìœx’àzÈ«Pça◊∆∞Scÿ©1,joÒs8scZ˘i S4&QÀ◊jùã:ßäm€cs¸sº∆ú«£4–ª¡´™ñ+´sk÷®auﬁ™ÍX«->Ñ˜|s⁄<Î≠Øã•Áy£∫ïœ{u•êqÒ∫ﬁ‚ÎÀ[±Vn…-æ	B>òÕ|ãªŒ ;éÂãlë¡~ŒäÚ!±_≥ﬂ Ìf∑q,Û~æÁÁ/Àπ\`≈Ú/˚ïÃí≥â˝ìeøßITåÕ≥∑ÒÒ∑ÿÔÿ¨\˚ÄÕQr	«˝»9‰N‰ÓΩÔZ≥l÷C`Ì?tCµÚfŸ€nS´_Xı~±~£_‘‘∆úzˆ{ì6aä˜ë€êo≤mE."Îêñ•wëØ±]¥˘S?∆‰+Œ^g7È§ÁVÀ%‰›†å7 „∫KÂ£x´µ¿Æ≥i⁄Ä°Ø∫–{’kÿfÖÁ1ü¡Æ∞¨ªŸ™qV≤ãFèÒ' —íL™aó‹v9…Ñª ¨96¡&Ï∫vªﬁn∂ßx¥>⁄ù‚¢^4ãv1%ìù«dí·˜óç£m'¡ˆ L∞snE{ﬁ˘ÓIﬁ£Q¥9Uı¢Õ®ä–ö;˚GUu∞®0ÃqåÄQ˛`õ`ß¡xVıd¡08ÖØIFFFFed‘’áÅ4zaÙ¬ËÖ—´å^Ω0zaÙ*CÆ∑FØ2‚0‚0‚0‚ à√à√à√à+###ÆÜ√Üa+√Üa√∞aÿ ∞aÿ0leDaDaDaDïÖÖÖUFFFTÜÄ!`eÜÄ!î!`B&Ü	√TÜ	√Ña¬0ïa™˝“(¡(¡(¡()££££§ååå;uÉùw†°°ïRÑRÑRÑRTJJJ—øı¨zØÕY0FÅtppp -®◊kH7###Øå<å<å<åº2Ú0Ú0Ú »¡»¡»¡»)####ßåúzqáÅ4>˚K˘ô∑Ü=gÙT‚ˇZ6jÏP9BwTû•%ïœ“ïœ–î 3Ùº ”‘ÆÚ5®ƒ|*≥dUÆ’vjÒ	ËGALÇ∞Ç™∫>ÀlóΩµ"ÏNgÇã¡3¡RêÖùÅ…¿L`1∞b&P
0·ld!ı≈ßÖ.®vÌ]ÄˇD–v®™Éµ·∫m¯ŒÓ¬Ok≥W,Ó6∑ç≈Fc¶—∏–h8UÏ+FÖ˙“	jgX∏—cØjÿk-ÅˆÜ»^|ôŒﬂº≥ﬁrv[≥∆B9vÿM»;‡òœÉvÕ†X™Ø„{Ï≠˛î ÓB^ÇjkÒbÕÍJ{éÖå)ÔùU…ÎD∂√õw#Qƒ¨ÈDºÓF∑ú*„&E‰_E∆kÿπi‰åk}Ñ”Øñ„ökÕ#Æ∫V‚17“Ç¯öyœrBF7YRÌÚÛÓ[Êa◊˙*Ür≠à&7“ G7‚Bı8ª√Ë°èêıæµ≠|•˚\kb´k}AéÆ§à‹x#@Õjy+ÄLÓaAwÁåû
√æ«˙¯Ø§WAkGûY©ﬁç€≤#ÇUùUñURoWW	6—j≥õ“Ï≈∂‹≤õ∏ ;íSízQ”Ç°¶8
ÖR(Í≈ÑÊ2+Q≥.¸zuo=‰÷zÍU}oV≤]™[Gö˜fﬁ˚Ê}£7OZ˚Ü˝	ÀˇÄƒBy¸¶ÜqPøÍ!˝ÿL∞√¬ Æ∞n%Åxx>ÕQˇÃˆÙmˆ=ƒ¢˙>˚é]gœ
°Êÿ˜∂†Ë≤/’Pza^dOŸ{¨YxÕÏ.[g+ÏÏ]∂∆qõƒßûÙbü-A¿·SË]ˆÅä-ﬁaü1ì]e7’CÃ/π≈-1d.bÚ;£áX„ïB:eŒ»…ªÚ}ŸídMæ"ø-gÂî2≠$ï	ÂÇíPeLâ+íBîTÿˇ›4îmj,âj,é2.∆I	%êD¢äDÓ~1ÊJn’¢.ıÄ∏*ˇª™Ö4±|èø°YîOªƒ]µ¯√Â˛
/.óóÓ{•œ|∞rÈ´êíU/§}4me¯Ùmpí≠ùÃ°ÙÕ≠ﬂ'ÈKèÀÈÚÙ≠©õwÏ¢6ê∆iKüf˘∑n’„?e}>áÉ~÷w˘UuÕ;ê&•q«>ê&P˘ﬁA|SötV–ﬂ¥}ÄΩ0®Ê	Äë´® ¶XDE¸ûXÉ3äpyX∏*¿%∆I^‡ÚâqÅãSƒ«™c™*0:!«s¨ì3®Xk˘º@i*ıE=M{Gb & ˛◊â@å
2>{
—ê˘»º‡ä—Sã0©kCLÍ`åˇŸÍñA{≈V˚»©kNMsÍ–k¸Î«”¸ÈÜ™Ì:TÀ◊6<DΩ^Á-≠nÛ∂f´AÒhÑ˚›EÕ»ë≥ÍGf›ÓÕ¢£≠€~ØºËU˛≈µ}¬Â-é∂à¡<‰*WF∏+Ë.#Wπ*»U6ÀÇÀyÑuø‰
±¸€këÓIÁP√µLŒ∑.%7oaA,‰“ÌÃÀ8°œ…y√Á4ãèCGW°R®†ægËö Û‰¿ïn/‰2/ÈÛÅ+	Ê)Õ"√‘π|~ŸÂπÍ=KÖõÎ£œ¨ÅM∏”ƒyd√ÊM—·uI#[sTkµZ-£AàÀg™.v"À@U≥}∞]⁄b1aŒùs¬˛+p∞	⁄D:‘Äö	∏u…Rg¨#KxUhˆ.gÁ>˝û‡üCá{úÙ§;[∑à'Ω+:ﬁ_öΩŸ˘H√uu˜rnz%XäZè¥9UÄ¡Ææ[ÿ-uÙN°SÎ˛Ÿ>Jª≥{1“4√D¿∞ÈC≤a[»˜c˜≠¨ Ó‡¿0|£AEæ˛õl:L˙IbÉ®æ9<ê»ﬁÅìàÿ[√e≠¡"·lâEQêhv"NÃ˛` Ô•heendstreamendobj20 0 obj<</AIS false/BM/Normal/CA 1.0/OP true/OPM 1/SA true/SMask/None/Type/ExtGState/ca 1.0/op true>>endobj38 0 obj<</Metadata 43 0 R>>endobj43 0 obj<</Length 5767/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:illustrator="http://ns.adobe.com/illustrator/1.0/"
            xmlns:xmpTPg="http://ns.adobe.com/xap/1.0/t/pg/"
            xmlns:stDim="http://ns.adobe.com/xap/1.0/sType/Dimensions#"
            xmlns:xmpG="http://ns.adobe.com/xap/1.0/g/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/">
         <dc:format>application/pdf</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">bms_logo_cmyk_blk</rdf:li>
            </rdf:Alt>
         </dc:title>
         <xmp:CreatorTool>Adobe Illustrator 27.9 (Macintosh)</xmp:CreatorTool>
         <xmp:CreateDate>2023-09-25T13:28:08-04:00</xmp:CreateDate>
         <xmp:ModifyDate>2023-09-25T13:28:08-04:00</xmp:ModifyDate>
         <xmp:MetadataDate>2023-09-25T13:28:08-04:00</xmp:MetadataDate>
         <xmpMM:RenditionClass>proof:pdf</xmpMM:RenditionClass>
         <xmpMM:OriginalDocumentID>uuid:65E6390686CF11DBA6E2D887CEACB407</xmpMM:OriginalDocumentID>
         <xmpMM:DocumentID>xmp.did:5b0707f2-3331-4669-a1f8-b3bb5fecb5f7</xmpMM:DocumentID>
         <xmpMM:InstanceID>uuid:e9ccb478-a5e7-984e-a54c-e534a8c2b689</xmpMM:InstanceID>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>uuid:db5659f3-6411-f742-bf8f-b16bfaa386c3</stRef:instanceID>
            <stRef:documentID>xmp.did:4edd90c1-b301-4d0d-b22f-f129dd224159</stRef:documentID>
            <stRef:originalDocumentID>uuid:65E6390686CF11DBA6E2D887CEACB407</stRef:originalDocumentID>
            <stRef:renditionClass>proof:pdf</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:b521286a-9a99-48db-800b-c0dd2945b62d</stEvt:instanceID>
                  <stEvt:when>2020-01-02T15:36:11-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:5b0707f2-3331-4669-a1f8-b3bb5fecb5f7</stEvt:instanceID>
                  <stEvt:when>2020-01-30T11:01:24-05:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 24.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <illustrator:StartupProfile>Web</illustrator:StartupProfile>
         <illustrator:Type>Document</illustrator:Type>
         <illustrator:CreatorSubTool>AIRobin</illustrator:CreatorSubTool>
         <xmpTPg:NPages>1</xmpTPg:NPages>
         <xmpTPg:HasVisibleTransparency>False</xmpTPg:HasVisibleTransparency>
         <xmpTPg:HasVisibleOverprint>False</xmpTPg:HasVisibleOverprint>
         <xmpTPg:MaxPageSize rdf:parseType="Resource">
            <stDim:w>415.562183</stDim:w>
            <stDim:h>104.989900</stDim:h>
            <stDim:unit>Points</stDim:unit>
         </xmpTPg:MaxPageSize>
         <xmpTPg:PlateNames>
            <rdf:Seq>
               <rdf:li>Black</rdf:li>
            </rdf:Seq>
         </xmpTPg:PlateNames>
         <xmpTPg:SwatchGroups>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Default Swatch Group</xmpG:groupName>
                  <xmpG:groupType>0</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>Black</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>Dark Gray (CMYK)</xmpG:swatchName>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:tint>100.000000</xmpG:tint>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>11.000000</xmpG:magenta>
                           <xmpG:yellow>7.000000</xmpG:yellow>
                           <xmpG:black>77.999997</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
            </rdf:Seq>
         </xmpTPg:SwatchGroups>
         <pdf:Producer>Adobe PDF library 17.00</pdf:Producer>
         <pdfx:CreatorVersion>21.0.2</pdfx:CreatorVersion>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj30 0 obj<</BaseFont/QULRDW+ArialMT/DescendantFonts 44 0 R/Encoding/Identity-H/Subtype/Type0/ToUnicode 45 0 R/Type/Font>>endobj32 0 obj<</BaseFont/QULRDW+Arial-BoldMT/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 46 0 R/LastChar 153/Subtype/TrueType/ToUnicode 47 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 333 333 0 0 278 333 278 0 0 556 556 0 556 0 556 556 556 556 333 0 0 0 0 611 0 722 722 722 722 667 611 778 722 278 0 722 611 833 722 778 667 0 722 667 611 722 0 944 0 667 0 333 0 333 0 0 0 556 611 556 611 556 333 611 611 278 0 556 278 889 611 611 611 0 389 556 333 611 556 778 0 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 500 0 0 0 0 1000]>>endobj33 0 obj<</BaseFont/QULRDW+ArialMT/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 48 0 R/LastChar 32/Subtype/TrueType/ToUnicode 49 0 R/Type/Font/Widths[278]>>endobj48 0 obj<</Ascent 1006/CapHeight 716/Descent -325/Flags 32/FontBBox[-665 -325 2000 1006]/FontFamily(Arial)/FontFile2 50 0 R/FontName/QULRDW+ArialMT/FontStretch/Normal/FontWeight 400/ItalicAngle 0/StemV 88/Type/FontDescriptor/XHeight 519>>endobj49 0 obj<</Filter/FlateDecode/Length 226>>stream
Hâ\êœjƒ ∆Ô>≈wãŸú%P∂rËöˆåNR°eby˚é6l°*„˜˝‰sÙ≠Ï)d–o›Ä¶@ûqç;ÑÁ@Í⁄Ç.]››bì“˚öqÈiä –Ô"Æôw8=¯8‚YÈWˆ»Åf8}ﬁÜ3ËaKÈ§txú‰°gõ^ÏÇ†+vÈΩË!Ôa˛{Bhk˝„¢«5YáliFe©ÃìTßê¸?˝†∆…}YV¶-ﬁ¶ë£xè€B…Á‡…mÃí¶N†∆(·}H)&™,ı#¿ Ÿ∆o0endstreamendobj50 0 obj<</Filter/FlateDecode/Length 13996/Length1 39220>>stream
Hâåï	TgÄ´¶ª´ÅÂg∫g†'ë∞ÜUñç.!xÆõ]#âÆâG‰œD%t‘‡Ö∑‡≠x††®QÒ‚ûq¿3Í∏ò∏>≥Ó ìÄ«fﬂæºÏˇ^UW˝’˚˚ˇ∫´˛¥©”„¿“ÅÉàa√ﬂÌm√ƒ$*&9:5õ/o¿P ∑œbf§…mÀÓ+hD|ÍÑ‰6ﬂÁ	Ä–8!ivºm}Ï Ì6ê{Û¸√2 …í¿&⁄‚•¶¸í”fµ˚£ÇØ%•ƒDÉ*†`DOÊﬂJéûï⁄∂æàòí'G'«}8u§Û |Pj ¥4[ ‰,i_Où◊ødÄ∫8.s@ aù–õù¬∑Ì…’@º ›AP©âWŸﬂ ∂S0k Ku¥Áè:@ÜpêmMB]À«ÿ[√‚p@õÕ∆ˆ5eˆ›ÄgZÿ∫°'„«,Ï∆ÑΩ+∂cDï ÛﬂÉ-rº@¢É£ì⁄Ÿ•SgW7wOØ.ﬁ>]ª˘v◊h%Yß˜ÛWoΩ›#‡ù¿ﬂÙ|7Ë∑Ωzˇ.‰˜ÔıÈ˚á–˜√>Ô◊¿¿AÉˇ8‰O˛˘/C?ÒÒ'√G¸u‰ßüç=fÏÁë„¢¢a|Ll\¸ÑÑââìíí'ß§Nô:-m˙åô≥fœ˘‚ÀπÛÊßı∑Ø3,¸{Ê¢¨Ï≈Kñ~ì≥l˘äï´rWØYª6l‹¥9/ø`À÷m€ãvÏ‹≈Ìﬁ≥wﬂ˛≈>RrÙXiŸÒÂ'OùÜ3g+œùøPuÒ“Â+W´°¶∂Ó⁄ı7·ˆ£ÈÆπx◊0v–`vTÇa⁄T≤jîjÁ«„R∏È‹<.ã[ÃÂsW∏◊º?å_(xÁÑg¬+‚»ã|I¢æI61Yì®ô§9£©“ÿ¥ÛµÎµ?hﬂH^íF$ï>ïFIc§œ•π“!©B™ìå“Èï‘"wñı≤AÓ)…¡r_9Tì ërä<_^)÷	:ù∑NØ3ËzÍ>“ç–EÍ2t´tEzïûÙùıÓz/}7Ω§Ô°G?D≠èÛS˘π˙ÈPTä≥‚™x*>Jw≈_	TÇïP%IIW2îLe±≤B…Wv+≈J©r\©P.)Wï€ cC®!‹–ﬂeà1ƒ&RìgˆÙ.ÏV®≥™¨!÷Pkòµüu†ıÄı©’÷4æ˘ÉÊóÕM-~-M∂&˚∆˛∞<®t™—™Ωú?¡•qs∏Fm)∑Ö´Ê~‰;Ò|¶∞L®æ' 5£¶%ÖSî°F-IS°i—Ç6]õß})Å‰#…“)¢ù⁄8)]:"UJ7§ª“KÈµ≤;£¿®ıí˚tPKd‘r‰ºVj]⁄©’◊ça‘r:®π1j]ı⁄vjQ˙ÿVjÚ/PãË†ñ£‰);;®U1j∑µæ‘‚âåZT`£Ê]([—™±æ«®Ö[X[Î¨MMëÕa≠‘‰ñt;5€Vü/ò‘≤~Ù>ìˆÇkôh◊|5≥⁄J∞©∫È¢êœûµˇ)ÀF÷ì^/ÜXÊ<f’mÒ≤xX‹,ù-.gã⁄‚dq¥à≤Œ¢≤¿3˚7ÇÜLV1…hxsØ®aÊÛDfó<Ô√tV√\Ä˙ƒ˙Ÿ•ñÀñZ÷‘’ÁösÕÊl Ûv{~Ω∑yäyÛÇÃ·Êﬁf”`” S®©è)ƒ‘€dÍa“õ|Mû&46-∆'∆G∆˚ˆ,c•Ò§±‹X¬¨≥∆m∆}∆A∆˛∆~F£ﬁ®3jÆm8—pƒ\ÔÔ.î≥‹ Æ◊âk€ŒIO)ÃÂéKçÛ3∏ò÷Æ≈∫>«∫<?ñ»$]»dzπpîE;3	°Òh[∂ÉñIêC/áXá<G3ÄS˚¨ì{ªÜ_N¡Nü0Õ˙¥”åüÕ∂ˆÌ∂ßøòª–.NôÌ^∆ØÌı≥Ã±NëˆËˇ#>¥√äWá™˛'ÄÉ-ê∏Hv˚<ÜÖ∞≤a#ÏÄ≠‡
YÈ◊∞æá`	¨ÜLDvüæÄM∞˛	/·¿n8ï∞∆C‰@,TAúÉp.¬%∏ﬂA<‘¿U®ÜΩ0a\ÉZ®Éx
Xâ0&A2$¡d»Éò©0¶¡tHÉ0û¿,ò≥·ò_B	‰√|ò«n˘Ø‡<ácòã´QÖÚ(ÄöpÆ≈u∏ö°	Et n¿ç∏	7cÊ£#:°ù± ∑¿k¯∑‚6‹éÖXÑ;p'Ó¬›∏˜‚>‹è∞¬ø‡:fa6¬√xK(∫`'<Ü•ÿ]—›°Ó°zbG/ÏÇãÒñ„I<ÖßÒ[ÙFÿ˚±+v√3XÅæÿ5®≈≥X	o‡ﬂp†Ñ2ÍPèÁ<^¿*ºàó2^A?ÙGx´±k±ØA)æÖocÄáØSe”bZBKÈ °e¥úV–JZEπ¥ö÷˛¥ñ÷¡vZOh#m¢ÕîG˘T@[h+m£ÌT»'Úì®àv–N⁄EªiÌ•}¥üP1§C|üLáÈï–Q:F•TF«Èï”I:EßÈ[:Ctñ*ÈùßTEÈ]¶+tï™˘&æôo·m(®N‡A AG¡IPS’R]ßtìn—m∫CF2—]2S=5–=∫OË!=¢«Ù=aµ˛å,Ùú˛Açxo‚-ºçw–®v]E7—]Ù=E/±ãË-˙à]E_±ª®µ¢$ ¢N‘´=‘ûÍühÆÔ -ã$‡ÔÙ|=”˝ˆ|ÏíY¬õwañ†…9g=DŒH®BD…"9É$ÔND¨ıîS@$É‰úsÜ]`ÅΩπ∫∫?ÊØ©©©Í˙’ÃÛó9)ß‰¥úë≥rNŒÀπ(ó‹}óÎÚ‹˜–=r˘Ó±{‚û∫ÇhUQ∞ïleõhìl≤M±©6Õ¶c¢îêíˆ#;“é≤£Ì;÷é≥„Ì«vÇ˝ƒN¥ìÏd;≈Nµ”Ït;√Œ¥≥ÏÏ‡@p“Œ	ŸπvûùÔ_Ø˛[d€%ˆ3˚7˚w˚˚yp88NÉ„v©˝¬~ióŸÂˆ+ª¬Æ¥´Ï◊vµ˝∆Æ±ﬂ⁄µvù]/•$NJK)+Â$^ K©(	RI*K¢$I≤§DfDfR√»0zÅQcjBM#É®5ß‘íZQkjCm©µß‘ë:QgÍB]©uß‘ìz—ã‘õ˙Pﬂ»lIï4Ió…î*RU≤‰≤\ë´rMÆK∂TìÍ4ô¶–TöF”iÕ§Y4õÊ–\öGÛÈSZ@iITG#Q‚’MuK›V«‘uW›Sπ*O=P’#ïÆÚ’cıD=U>[‡É&hà Ç° Q(1Ö°Öb™
á™™ ÇíP
‚†4îÅ≤P‚°ºœhì|ﬁHPŸ™TR’°2$B$C
§B§Ké‘ê£rLéÀπ)∑‰6mÅ»Ñ*P≤ ™Au»ÅPj—Ô¥Ü¡˚0>Ä!|#aåÜ10ñ˛Äq0û∂—v⁄A;iÌ¶=¥óˆ—ü¥ü–A:DáÈ•ctúN–I:EßÈù•stû.–E∫DWË*]£ÎtÉn“-∫MwË.›£˚îKyÙÄ“#¯&`,¶|zåE∞(=°ßXãc	,I∞b¿R«ö#ålÿ21s»¬Kc,ãÂ0Àsîq«b¨à	Xâs. ≈∏8ó‡í\ä„∏4ó·≤\é„π<W‡äú¿ï¢Ü9âì9ÖS9ç”9+c"grÆ YúÕ’∏:ÁpÆ…µ∏6?√œb&sÆÀı∏>?«¯yn»/p#nÃM‰é‹Â¶‹,j£Âhï®„Ê‹Ç[r+nÕm∏-∑„ˆ‹Å;r'ÓÃ]∏+wãF£Ö¢1—XÓŒ=∏'˜‚π7˜·æ¸øÃØp?~ï_„øp~]ÓÒ ~ÉÚ_˘M~ãﬂÊw¯]~èÒ`ìa
LÖi0f¿Lò≥aé‹áπ0Ê√ß∞ ¬"XKx®‰Jû<êápMæê•Ú•,ìÂÚï¨êïX]¡∏©GÍ—z¨Ø'Ë…z™û©gÎ˘zëÔ KırΩBØ“´ıΩ^Ø“ı&ΩUÔÄ[zèﬁØÎ„˙¥>Ø/ÎÎ˙¶æ∑·‹Ö{pr!`m|üïUÚµ¨ñ|y,O‰©∏ ¬#»á«ûBÅ¥“†µé¿5çòÇXÎb}l‡O7ƒFÿõalÉ∞ˆ–Â±7æåØ· |ﬂ≈!:á·üãF·á„'8	ß‡4üëf·úÁ{ÂBùéãÒ3¸ó·J¸◊·w∏¿üÒWﬂl∂·.‹£3qƒ£xœÍlºàWÒ&ﬁ≈<Ã«ﬂ{¨œ1¶∞)jJÍ´&ŒîÛ-®ÇOÙ	¶≤I2)&Õdò*&K◊0’Lé©ÌR}üˆöFöLc”ƒ45ÕLs”¬¥4≠Lk”∆¥5ÌL{”¡t4ùLg”≈t5›Lw”√ÔÙî5≤ˆˇÛ—°Ì˛7”ÀÙ5˝LÛ∫¨w‡å]!Wƒïp•]ºKpI.≈•πóÂr\mW◊5pç\3◊ µsù\7◊Àıu˝\7¿î—R—8u\ùP'’)uZù·Ç0U°#!Ü&¥!ÖÜ°Ñ.åÜÖ¬ò06,	ãÜ≈‘Yu.í…ã<à<å<ä‰ÀNŸ%ªeèÏï}ÚßÏórP…a∏ó·
\ïM¡ö‡[¯ƒlR9¡˙‡ª‡Wu>X¨~ìÕ¡®`c0^∑ÒΩ≥ÉÔPÌ’d5E∂ËŒ∫ãÓ™ªÈé∫S¯4,ê ∏Ø.äPµDK~âå~ˇ›äïX)Ïv∫]n∑€ÂH0?∏¸;XÃPœS’ÛjàöÆf®ôjhO5\ÿ2ÉÕPÿ,ﬂÀ˘A~îü‰_Ú≥¸"a¸[·ÿ€aÏÑ]∞ˆ¿^ÿ'‡$úÇ”pŒ¬98‡¢◊YœkÏàù∞≥.Ø+Ëä:¡õ|˚·´ﬁi[láÌΩ“>ÿ_Úr[b+lÌ≠˝Üõp≥˜∂w‡No˜=ÑÉΩ‚∑m|G'Îù™”ºÊ˜q8~‡%Oû«{œΩÔu∫Œ™ßÎL]EW’Y:[W”’uéWzÔcÆ{Ø„Ô4÷K-Úﬂ;Ω”x3¿[}√‘WıøÆyóœ{ô/xÈß4ûÒzSΩ·do8õò,ìÌM'zœô^qS◊‘√TL’5tM}Wﬂ√Aú_•Ò?åW{xT≈?Û∏ªa…cyÑ<·.◊§íÕäÑRBH√íÕ.– /›MÉÏÜ§$ÿJPQP!·Ú≤|HÖRmã
JKo“ÄÅJ©˙ŸOm+∂ jA?ëÙj+∞∑øª	1È˝∫≥˜ﬁ3sŒÃú9sÊÃÔÏßôMÈDÊ%<ó≠o¨…ºlÒ≠/ˇHº≥Ô!:@ødM¿‘ø£¨á,¸x>•Q	Ì
ﬁI-d£¥l¢
Ì;YÜŸAÄèûn»ﬁú|åF±tÛS`Ê‚]Ù⁄@I4éf–| Ì≠léπújÈº\OShw3[kÜÃmÊÛyx≈QÒñyìÜR&ê˝"Í6øPﬁ7ˇF^ÙxûsûÌrò|òe-$ÃæG,êÃ\l~‹@Ó›$©å∫Y˜`Ù∫ƒ“Ÿj·«(˚L√|R£iÚÄ=¿¥ìŸLÓVjÕ2≥õFaéu7µ„ÅMé”,QÈ1ü7{(Éri6÷”A'Yóà›\õã)∞“xö
ŒR˙-Úè”¿ŒØÒ•J¢íá∏¯®˘ç§âTm˜£ÁﬂŸó∏…qóã7e–,¶dÿÂáñµÈ`˘L`äyÏn Ö•¸YÒ %`∆â(ı»T6—3˝PÀ íSbü<(Ø€nã]0ì±#ŸÙc‰NØ!CH¢ê=§˙˜ÛÖ∏_.äùÚ%y∆≈™ÔEæ≥ï"˚ŒÚY9˚.kd´YNﬂn‡˛”Ï2ü¡´¯}∏i≈2q\£T Âzx¯f€ÂX(ˆzÏè±/Õ<s#ï√÷A˚ßëïu¿ONKû•Ûtë)»síQ¨‹¢ö≠By1„ÁÒLß≥úfŸß¿c◊ÿu‡.ﬁrYò	E„GpGÓ≈π∂NˆÁ¸ﬂ"Må√ôö,
EX,ÖV-‚)î√‚Cô)OÂÁ°ÏRû√ùqP9°ÙÿÌO$P¬;7ˆ›Ãπy.F±÷ÿÆX{¨√¸êR±áô∞¬X*ÑˆQî%ÿÔ]∏_—ª»Ã“±9¨àÕÅe≤%l[K>â¨ÓÖ∏Óáêgu#∏
ùìÄ¯,ùÔV+ÊÛPÓÂ|Ó˘ºÉˇô%Ï∏RD™»3≈— +≈.aàwp_ˇ7PLÈêcÂ8ô-=r¶\(óÀgÂ%yI©EÙ˘ƒÊ∞˝¿∂˘œ?Ïﬂ≤ŸÁ€ÀÌÄèÿﬂKàXq˙cÄ‚0m„ìdb„I¯ÛB™eû ∞VæÜu€ï∂i|õK=2∂~ì?0Mî±RVIK¯ƒﬁ—l#ÂÀ¯ ﬂ”˘*÷v#Ø∞%≤«¯U["µ3‚S1Á‚.Èo”‚<≥Àü—_•ôÁæ_ÃáóEJà‹b/Àÿ:ÃDéÎ	[‡«sŸÀàU,è˝Kò$¯\x—Ò≠ß˚¯˚∏°V˙´óãiMb´ÈΩàS1^π0ï˝Å7Iùè`ƒÂKX›Td¨BIO≤bèÌ*?KÀÈît–9Òhäe≤G©`ç8kh#-3◊—J%$œ∞≈∏∂Ô¶,y—mµ»ìn|GT©EL;Ç”}q`Ü(CK:<g¸¢b 3à‘Ñ3~¢ÿIÍ∞UÒNZ¨$3D"˘v¨ÇjÃi∑πòÓ7wêÒ†≈\ç–'¥ù∞±U‘LcprŒ±9JêüRÇ¶óÎ¸,Ø‰ªÔ/¨ù≈“È3îC®)ø!]˛Ö*i∫π≈¸º˚Dÿ›TGﬂ°è± /0√,—EìbsyõÕXÔy*7˜õcôÉÕÔ”<zï^∞+µ{∞«;ÉıÆ¢^a>$bM∞√vX¡k-G¸Ÿ‰ÛWWÕM/˙v·¥Ç©˘S&sRﬁƒª&‹ÈÕı‰åø„ŸY∑k„‹Íÿ1∑çvef§ßçJ9b¯0gJrR‚P«êªMëÇ3 h¡àjdGô≠ÕöÂµÍZ—CESp∞å°F‚bÍ`I$ø˜_íæ^I_ø$s™ÖTËÕUöjtóhj'´)ÅﬁZ¢ÖU„Jú.ã”O≈È$–n7:®ÅÙ∆’`5`n‘ë◊6‘·◊¸o.µ9ÜÇ
 H”ö€XZã<-P–∆)!	JôZI¿»–J,ëà÷ÛÀCÅó€ˆÊÃøH´3H+6R<qÚ«ß1l~√üFm≤VCõ’∂‹.}KßìÍ"ûƒz≠>Z2D4lÕ1ÃÉyKå¥G?Nˇ∫ä¡á˚C-π.°“õT´™Î-™Ò”Ú–@Æ€zá√}yV0¢1ı±¥R≈l|C8d∞òRµVb≠™w}Z¿jâ,Qç!Z±÷®/â`k2uÉ*V∫€33}GÕîPı™êÊ6¶ª¥p¥dt€H“+V˛:√ßfÊxs€ú√z€ñú“G$&$˙yq*.nQ•˝ñeñF⁄l8Ñ°.R°IH√öÚ≠WC>ÈãÚ!Ü_ò°óQèi2Ü¯#∫≥¿j∑˙JñSSık–Æ|>∏%⁄◊bÀr^#ã¥¸§ﬂ’¿øEèëìcπà›è=ÖéEÒ˙doÓ√ù\”öù*>0Õám£·Ç	0ø€mmÊN’°b¨-ı÷U™sµìoÇ'là≈È∫≈I≠∂8koq˙ªG4xr1çT#!ªˇü‚5"–X`∞QˇÉ›–À/≠‘JÀkBj@èÙŸ∂¥jP≠óüﬂœÎ£å˛êpÒ>äªDúß¨Ì∂*°DCf·oã;u}ß=^oaj–pFfıæ√∑˚ˇÏ‘iˆXΩ‚üØªı©ix◊ß™R/QPWeiUçÆ;Ò‡jΩŒÓ˚¿„©*‰V˝U„df·ﬂivÂ[Oÿe¯`2ø% ˇÎmÍ´tı—a¸,ÔÙÊËt=®©A=¢G;ÕµuöÍ‘Ù£¸?°7"∑ß”<∂Ÿe∑Ña´FVÄC¡©∏Mc≠Âm>÷ZY:Í$R[´BÌúq§8lí˚´Bw/~$¬^‚,o^∂πáπáe·≈pÂ›PE◊üB◊Iï]˜Öoﬂˇä:faJ·µ◊∏/˜‡™™+åØ{Œ>Áﬁ òHÀcQ0Ä!(!*"ÑÇLB£->2hç(äZÎX	ç$AI«⁄íAPÑJpê
≠fl¡∂öbú:÷JäÃTimÎ:ì”ﬂ⁄˜úx=AhˇÈù˘Êªkü˝X{Ôı⁄)õ≠‰çR˛ïYÙË±≠Ì7ÁH™'b˝uHNÈò#óÊ»±≠«ÓœIœìÒÎ5¡õ¥“Ò¨ÛÜ|√,ñ\039XæÂï»ºDçî9õÂÖ;X
Õπãæõë/Üõt,˝ã¡_¿dPÜm≥¡`Æ Ù}A«2«"ù«Úb)Kë;ºí†ùıÍΩfY ÷Úø¡êM˛$YàºÅq;ç»˘⁄á1ı˛fYE˚|øâ∂µ<‰ı¸øéq˘·ˇ¨dØ5¯¥èdûG¬˝Êπ/…D≥8xõΩ|ç9ã@5k\	O≥Ë”æ‘$ö•6—4ñ*÷Ø—v0-‰Ã≥åÔS7πäˇ—√á≥¡P0¬Ÿ"ìú~Ú"<ñ˝ó¶˜öÂ›sÁû–?‘©+“:Œ k˛úÌL
¬Y∫≈Q√LwºT¬`∏ Ÿ#ÕW%¡y=ÓWÅ›È9˝\d er=Áz€eµ `∂≈‚†›<!Î‹√rﬂÓ˜ÎŸG9ÁMÌÎë±Œﬂe¥?\ñ`_”ò)XÀú≥ˆP.◊∞˛xº9hm®¨`≠FÁ§gÉºî{Ωöµ>R`¸\p9˜R	nS}X¨ûπﬁ{¢§c}ﬂ•œu
⁄øl¡ﬁ’&uåégÆ·°6|Ã“@ü:ŒıØ∞π™Ckg!¯ˆ
Û >∆ÄÉ†TÄ¡,0ÇµÖu]kØÿå⁄¶µl√kÊ—Õ⁄lzkÌ}¶}f}8óÆ3‘ﬂ"!ÜÍúÍ/j≥Ë≤-ö[}Jm&bkﬂ÷Ó?–}™Mu2æg…Â™ÉıAl+bı;tV®wä•^çW©Õ™~Îπ®≠Ÿ3¡'Bûú±◊|Î#∞+rvhÎUGg—…∑»Êºﬁøëò≤Nfòª©æø/7ö…4w§åÒÚic?Ù}÷9$Wß®ÃπÀ+êèÒ*E≤%q´∑ã}6rû-Ú$gzßiqŒ2-	œkﬁÛ$±€kt¥ˇªpâ]Èo äÃo'€~*pˆyçƒÃ∆‡}Ø%ÿœcÍ…Câ|pfƒ¥ˇTÇQ©s´RâÁì≈í„ãwòBπ–+îÛI:SM.q_†Ωÿ{[v∫u≤‹¥o&*•“iëÍdÆ‹¿*[◊rˆIïBÁáeÿ—'l.nKGˆgç˘°MÅ}¸ooàwC≠ÿ—,lrÄÊçœ6?£Au⁄^Écùˆπ[ûÜâÏ3fß1˚Ï∑À8€‹B|è¸=ñG˚◊¯®1Nc§∆9ç3Qˇ8gåÿŸåkﬁ#e°_ü¢ﬂ	}ü8Ã}óÅ?=ÿËo6π}ÇM~ˇˇ º`#˚æØ3ßŒ:¬|:2 •Èv9- £ﬁxY∆≥6ﬁ|(?¥y¥ƒÍóÂoï%^˜N¥˙Æ}êÛDÔ
s=gæZV∞èn˛H;∏NœƒﬁÖHÕö›ïú≥Ê¢:©rﬂ¢^–±„•∑ÕS•›w€6r™≤∂y•“‡íSL¨›%ÂzW∫’GÔ>uèÙJÂ'Zdú˘1}r•˝÷Ÿ3(îç÷.tlgëºIíÿÏ˙Ë|ÎÌòBÈû«{v<µà⁄∞ûs˙πrµ≠'…S^±î‚CÎìï≤ﬁ/∆Áres<Õ∏b’Öqmæ^)◊‚_µƒ¶ZbéX˚/⁄‹Fˆsq∏ïúQ£Ù˜*9√
ª˜i&ck‘‹Õré⁄àøí8¨ıƒJyÿú+ó˘RG[µ‰÷}Ñ∂áﬂ||w9„áÑq[X{9Ì:v™÷2Z#®ø$•Ø_iÎ ±:hù¬˙Ó{≤ﬁ-íZÏ¯‚‘JŒaôå∆§µh<åK√ ÜXëÜmÀIsb®õ#ﬂ—vgººŒ
ßâöC_0KÂõ¶D
‹q¯nom~áØï5n∂Ã7Ø Ûº¨PŸÙï.5∏ªù⁄R€_ì+µ›yyïîô…åØï€Õ|YÏn√ˆ~/=ÃÓöqﬁ˜∞ìaåˇêyC$Hô[ÇoUÛˇh∞E˚Ÿ5∂•
3CF€q∞∫FàÈÏÃbWE‹)˙ÍˇOËãÆùzF:G?ªOùóq⁄«¨ë…ú”~0<ÕW9u“÷9îK›ŸÚÌƒ¶†âsù√åLŸLH< ∆ò	Ú3∞îˇÁ¡ø [”2µ€y,cÓó‡ÁÙ]†p.ëâ ¥≠´¿o£oô–ué◊û	oP–Ù	yπ$MäxŒy"ÎM4M
l±H·/ë~…{•üõG˚åã…ﬁ ¸iás%¯Ow:}¯ÂgúcaÊ£˚Äøtÿü¡g*áπ·îu;UpøK¿◊Ì˘~ πií”˚Ç˝pIbü‰∏˜`É y4rﬂË<£{¢˝∂=vÿäËô«€„r¸^ªìùÁd~&";Ë¥á«dä¬L•?àÀ©›2E·øÃ∑óª fc7(ìQÓj’	ÃÎ*˚WHû¬ÜÆu>:Â◊à@˚⁄ÒΩ‰rÖ˙Æ¬ŸŒ{t~ü ó)2Œu¢û´ª:˝=∫üË^‚˜É~ÖfØÃÑœÅ'¡s·¢à3}6Ó∑Ò∂(ñØOÃ7Ú?mŒˇ'‡;ØÇf ˇz≠Ñ`´ ¯˚©C¶RG∂Pü\+U"Ìƒíè∆ÇáÆÅﬂ†çÏ›1Ù‚o⁄nÜüikÂˇ]¥∑§8fê¨Î ¥˝4õ
Áõõﬂˆëcá¡÷Ù¯∂Õ‡V˛ˇêœ€˛øØ¢ˇ˚å{˛e˙{˚|‰{¡ã»áêoÛ¯ˇ(úü˙Ç>åØWh=“Â˙ÖÛÒﬂ' ‘,7°Á∏	~ ˛Ü8aéÓ≥éø5¢˚ÔéΩ-—ï”Á¿õÈÍæg3ﬂ>üı∆âò˚Ï»Ñ)⁄©){j≠µ¨÷œ∂~ŸæﬂlÀ∫"˝"Fü,≠_µv÷˙÷˘k|œÍSå^◊[Ω¬ºë[áe-»ÉBÆ†œQ'/ÿKÏ…∆æ[ymP üJ“^#weìÎvw[·=»É·÷(ßE±µKåÌ&ß}—Ú…Ê»S»©!Ê«iÌ.1Sœ≈'ãÓr˜)ÁÚO…—ôy˙Û Qûèê5E
…¬†IØKª‘›»›’π'+«ÎéìñcuI$«—Â{‹ˆ¢zf†ÏDÃÔN˙∂0;>Æ˝#‚~‹Èo°Ã]ñ	‚¿à0á6/®ˇÉ¡Ä<F€É©è§ ıå Ô ‰Õé¿Â˙~*Q'‚	⁄ëøãúcˆÿæÛBîwgœqª’˙‹÷áúôçÉè™˛2|Ù€¿¬ËÆı…⁄o:d]}Áö≤†’Ï±∞[û wÇgê≥ë≥â≈˝¸ﬁƒÌBŸ»ˇj∏‹É¯~X@,ø“k⁄˝˚mü"æM7wÀ‚¸Ì¶Ö9ø&¶/4íùÏ)5‰Œ*rËæ◊3∂9Óü<S60œÛˇeΩl`´¨Œ8˛‹˜ºΩeµB€•m†∏–ïéú:\ª°]md0‰“¡‹Ä0áP¿®€∞å!"nq#ÅÅíns¢†A∑åÈ2ÉFl¡ #JÈ=˚?Áú˜ˆˆmoõEnÚÀÛûsœ˜«Û¸Ío‡‡^AúäxÊÿÅ~kh;xeßÿWhìËE•hß–˛î≤çÍ¥“léWÓ‘AÃCﬁ∑`ãï˝îÜŸ3®åF{#9÷à&úës®ã¯ce”11ôéŸ˚h1⁄€ü£Ì·7i{Zî “V“f7Fõ≈6Zçºmﬁ/hõ[Bu‹ÜW9&˙ﬂS!Øüä˘ëŒ76‚œ9®	‘¯f–$ƒÂóì˚ıÎ•ï!ñ^¡¸—7èµ'mÉøD1ˆz∞?^#+&ﬂ—ñÊôø,Ûkh∆9ö◊T≠Ì™+Ó„òŒ˝ÔÜ˝Õ¥üfçÉcÒ˚¬∫¥•“Bæ6¡˜T0û˜YAî≈ÁJù%MµsAÌ◊ﬁ3'w8ì˜_·ıQ<ÅÚÂŸóŒèì¡˘ Îk;ÓË"‹úAªö)Fk(+w´zTΩR∑
å∆∏j—OLûmá÷∂#œ⁄’¥^Åı‚˝≥≤Âÿ≈÷€Ëke™ı[Ç15`ü=Dîèu‰yÁ⁄≈»ÁÛ˘¿˛Éü#]®Ên¨Z´1®óâwœöJ!¬i‚~÷WX7S÷;Leﬁú◊^TÊ†BÒ8ÙÀ·Î˙bÔ ±Øô¥Z|BˆwhéËMQ&T&OÖ.¡B©3÷E‰ˇv#“u4›züfbΩVÅ`=Ê›™8	≠ p_~bòÀX±–7ˇ0Õ|˜”ﬂ»Aá~1⁄ù …O@´µ	}G(jΩÜ>v`,ËG‹é˚ u5õ~∆ŸSq«:Ú@‘e{g‰≥˝fìü˘l#AêÈb© •G™¸¢ »/∫„H’ÓÄ »–Õ¯&A˛ƒˇc©÷π0Úª«‰ »ü¸ﬁ±Ò„xõÓÉ˝¿ƒ˚∞ì`q˙‚¡7ﬁ≤÷§?0Â~∂Ä¿51¿Á…Y(S˚o∞T∂?€ó‘œÔG6ÇA†F˜≈u„Guﬂ
”g¸ÄÆﬂˆ™oR:˛up^˜ß˙fﬂ€; l5ÂÎMø˚ıÿ„çÌÂ˘û£™∑ø)¿˜Òÿ™v‚–»◊a>oÇ∑ÃwÅYûÛan´›/–{+5∞?‰XÌ≈àTÃ~í&)ü˚náX•4‚ÃÂÔ$|ﬂHÓf@áºD÷Ï√ùπ™¸'äÿD–'–
J/|Lé˝Â9ÁhñΩàJ≈!Ë‚q∑Ë√˛5=¬m≥ﬂfÕ!÷—É†Çc¸&«¬âπuÈï~πe≤Ìœ0ﬁ®o∂zÁaÍ≈˛‹ÇÙØ0óùÙÑÛ$-O[H-ÓÁÎi™EºÍÔŒ¢Œ34ﬁ€∫)Ï|∫¿ÿ^!öÓã¸‚Óy*◊A◊ΩGX≥{˝æÎ‡Q6Úyœ†Ù‚Xπ8ˆ˛f	ò§∆åÒBáŸv	Ù4ìä◊?¿öD’x&s¸¥˜í-V9óª'P±Üˆ∫ìÍ√π¥√Ωéy∏Ë´Ñu]bÌáäy?¢aN9’ÿ£ËÊ≥XÁá(›∑Ì-ﬁÚúÈ≤⁄mß=OÈ≈>vÂ*ÌÄÿï∞~1⁄‚¨¢úâ!A]„Î®Ñ¶p‘W˚}$ÊÀÒ31cìÙÜZw‰ó€9T‚‰‡Ï@wt≤fL^ÌAŸæûıZ®‹∞ª©÷}ñ™ú±.YTÂΩN}ºqîÀ˙ÃÛîÆ[»1⁄˘Z¥ääpˆ0˜˝gÄÔ“8s«ó"ˇ}∞OﬂGæ_úØÓ&Ú⁄∂ö¸Éß¿|˝?ˇ'WÍÔ∂À∫}ıﬂS∫|Ó°l¿≤Y¨Gi‘;‰édù™Ù®÷÷mB◊´ÛS÷£ËœTñÔ0ŒHVB˚z≤≥mÑùÁß°Û>¬}uÔ ÆØ£Ée7C£¨–ViC∂ªå}ÖœkΩ†MËÍ6ï~M“±˙û˘VÎÍµ;”ÿ"__˜d˙ªÉï“§oKËıûlÖïÓ4÷{˛‘∑&?3…∫ùﬁO…VÌ		£cYøó≥æ∂w@ãvü;∆}g†#5åÿHèvÖãH¬x:bt~J‹_¢HÎD^e0Êß5ÚE√%√Àå1ˆ∆ Ú™Çﬂn]‡æÑ~A⁄`çwB£Ù7`»√NÎ£¨À±∞[†2Ô≤aÉèîåøÓ˛:˙ÎÇπù«ºÁ%∆Ï˜o⁄˝™˚¯U˜ÂVÕªª±'É;y¯÷e∫7ˆGqU√˛	e≥.÷ı(h'çÓJ>ÓÌ≈\ú'ê\ß”9xoS∆§˘.2.îùó´ÔﬁH54≠´ıÒÊÍÛÁ‘Î‰¥“l£ΩŒaÏﬂ„˚
√¥S˘ÇÍœæqóÔ˘P˚OT€QÛ…*úõ<æàì ˜vñRôı∂|≈Yüπ|ÀY	- –◊√	√≠˝‰ÔaÔSÎ<Çé¿ÓMo€ÜÀ†ø%`ó—€¨ck‚üÈ¸ˆq˘æW|Åy¥RÎ{Â)˝2üÍ@û∏Ñˇ°0áz1õ∆rÃ˜@[A∞^PwÅ(À>´…¿∫Tà=I˜ªÑ÷ÿ’X'¿öHÌ”qƒ .\’œ7~±ò˚è¡èˇã˙[óPˇ°^=∑·§Â¨ã^ŒúãJî≠î[`«æ ã0ﬁöo≠°¡¢ñÜ[ÔAÔ‰ ˇß‡q|Á¬fÇi`XF√T~+Œ…î¬F˙Xá¢`∏ı•°A√ˇá"µQö8äˆtπ”™é∆•hËœ™Ø®à†=î≥RP"«|ª¯-Íµ@Å†Ω–%›ñ˙œ/n/„¸á “k©ÃÕÎd≥3V6á.–H{:ı∆ûfÄª±◊ßÃ˚Åu‘ª ´%∑#}“:@≥qÅ [e≥åu^•˘Œ(Ï¥A|às1çtÆ”ãŒh*v+«ˆü•˚øÌjÌ%Ú&Œ]ïuZû
Ì¡Xíp¶ú4{H∏‰[´	¿Ü™U<"úi
±zk“äÔaÓö“π^)≠∆=.⁄i≠ïç∫È|˜=E≈ÿ]‘OÎ8~C≈±ZíÔC|C:ÍTö;\âÛ¥ìœñ—Ç®*˜Y„w≠º◊ óÕVò∫èËw©\6År¥ªÔò˚ò–5πôIJ73∑:m?M˜ÿwÉQ¯’9ç˝nË∞∑ÓÛÙ]∆çrÃt$∂r]Ω◊=•›)4ê±
—G~Èïx◊-√€êÎÙú∂“ Fù∑Åù”ò”˜òƒº{Jg‡lˇº%Œt™˘/ë¨ëÀWZ‹ò<çÙa∞˛ı∑åMR‚ø#FØ≠Ωp∑ó‚:Å
µáo\B_vŒtønè≤‡õ"Ï·Áorå0ÒØÌ∂≤.πˇÏÀ†M˚¸NœıYÁ√ÔM`ﬂÁ|õ™Ÿ◊≤OU1Zîﬂi7Qˆ-÷	∫À∫©}PË¥Çÿâﬁå1¢¨˙∂ü°∞uÊ“®ôÚÑÚI∑iü%ÌΩ∆˛ÒW˚´~"_˚/ÎÔ⁄YgP∆Á∏H√qéi8Êƒ˜™ÿtC˚IÂ·ß˘õﬂ.Ê˝î…w˛blOz…hÀ¶Ä=Í€ût·ˇÿ/˚ÿ&è;éˇÓ«vËÇíP?OﬁL≥85Ö °âúçP 	≥îCiåbÍ§ïß⁄êäX	Í$∂1≠AU5©cé3e Ö)]≥Æ†ç2âæ•›¥≠ö∫4≠„ØÏ{gÛ“çUSˇ®4È¸ËÛ{π˚ﬁ=óªÀsœìms&€Ê?ı€©ÕÚ:ˆ…i¨ù8ì_° úz‡Œw—21ˇ9íﬂ+ÎP/ﬁAÓæÁã3Oúìrù∞F[NÙWbˇ˛]`yÉ⁄ƒ⁄Ê…%Œ.Ã”%pıﬂïAû”bˇå˜≤y8w7»{‡á˛bü˛=;NÒ}≤˚Ùÿùoø€ﬂr∑ø5àÍ,œ”ã⁄º’–∫Ïy·ûÔ€büeû∏T•P(
ÖB°P(
ÖB°P(
ÖB°P(
ÖB°P(
ÖB°P(
ÖB°P(üå(o9›§5Ù≤''˘i+ë•œRL9»âÊ”O`5øΩ“äÿFÁê1 ¸ñ≥Úl¨—|…∆ƒ{≤±ÒÅll£«Ÿ7†dñ\—'õ…∆å‹|}6Ê4üÔŒ∆ ŸÿÇ¯D6∂"˛q6∆x¯ØË%2(@5∏V jß>ä¬o§Ç=I˚e…ZdCàÖÌFyøTT£&D∏jEŸ¥OP\fQ¯(‘a{°!ÓG[°Ìóönêê˝ıBÛ¸ÌCYåvÜ±à^eèôv[êı#w7®Q∑Ã2wD©_ˆ`»æ˚‰XÍAv µ	9Z°Æ~…‘‘¨0⁄˚¢∆∆ÿ`,Ò‰˛®±66¥?6‘ùËèV°Å£µO_"n¥F„—°É—ﬁÍÕ[6¥Ü∑˘BC˝›€?-ìŒËè›Fb®ª7˙D˜–>#∂˚øﬁœË4®€2ÿüàˆmâÓDç{˝±!#Üö!£'v`01‘çWéÎª3æÂa⁄Fæ{V{#Ó*‘{0Ørç?M˘YÎ˛owWˆ9AsKË$›Á7AÌ⁄Ccﬁ"˝ ≠íf ◊*Sæb}B[¢ßÍÙ`Z+s-8B_“<¸“∞1pLuiî;aúì‡
∞‚A‰ëµàÅ0#j¥bÕù2tghâ∂m·I„–
iÃçtX?h]`å ´‘âí8&¡G≤&®¶û[Ü±¶éI7∂w  ”ÓL⁄˘∏L«∂E2~„Êå?ñë≠Œ»~$S\›òÒKñfº´"`
?//p1T†‡è,¿¿˜√2˛r0F:ù÷RpÕö-	jÆ±ro`dR≥”∏∆∞ê˙‹Eç•ÚÚ°y|éœíãt˛7˛a¶Ü86??0Zœﬂß≥`h¸}\ÔÒ˜Ë0üs€ F¿$∏fÅïœ‡z◊;¸r∑…@ì`ÿ¯€∞N˛ñ8§q‡¸-X'÷õ∞~—u~C˚]™vU`B>6–+≤A·‚l‡*§˘oS∑*±£ºXiÏ®ÛZ)’”2≠4UÒ∞û÷äRk˙ı4ˇ√ò·”Oáj¯UJút∞N`ÄM`'ÿ¨àÆ!∫F&8NÉ$¿.ÉuÉOÉ◊¿5™A∞	ÿ˘ïnìÊóSﬁF=T¿_ÁØP!f¸78¨Ñç_í˛◊¸ó“ø
ÔÅüÊóRùB†û–∆	ÔÑ˜£>áˇ|¨‹•œÖÚ˘$ÊNáıÉ–∫¿0∞ÚI^öÍ’]Ë‰<M€	 } ˝È;˜ÍAÔZl@CÔÍG¡å#^Ùû¸Raº«üC$å˜õﬂB$å˜kO#∆;pë0ﬁﬁΩàÑÒnÔB$å∑•Lö?ˇ≥Ú%zmÀ>fÑ¸fÈfÈfÈY¯!q—-ã€˜SUUò±SA_eïnûcÊf∂2ÛfFô˘3üfÊfÓ`¶èônfzòdÊy∂Sa≤‡O?ëÆ
1söô/33ŒL/3+òYŒLÉ’”º$ıÿ2Èö§â:¯GÎÒÙqÃh	ˆ|	û	ì∞ó¡úÃÇ•Ò"è•cUôºzu Z«ß–p
À0EÔh
€h
ùL°lË¡,òV®K1ai∞~– ∫¿a0¨r8≥ÄS,;ƒ≥r`˛Ï†[D∆ßpï‚*·%¡bß€ÈsÆ”Ü›Ã·a-û9Ø•Ç<ë]˘ˆ¸4Àˇ8ÔüÁQn(óÁ√TåÖ8ëı√©[≈zö}7Â=Øá≤Ôê«Ç]«VëóU¿Ø§∏Ãóì€.¸#x+;Hπ∑¢ô#Â]™ücÛE´q˝ñ˚è˙Ó4G¯˜y˝˜F⁄¬R˙(93Æ_u’_ıßÌ(π‡M3∏sÜîN∏WÍ/OKÈ”®8ï“ün\ˇ∫˚+˙>∑¨àf*vƒëz´wªæ˝Ö›ªÙ`}éÎÓ˙öåjπh3Æ◊`æLXÖ¡V∫ÂMÀ<≤√-µi÷\j;iÎ∞µÿVÿ∂•∂õn+∂-∂-∞ªÏN˚|˚ÏÛÏvª’n±s;Ÿ§ÁfÇ>¬“-∞:Ö≥ZÑµ»ÿ…Ö/‘‚°«Ïú÷SÚãZ3onkdÕ…ã=‘ºÀH˛£≠,ÕÊmﬁûÃ)kdIW35∑7&W˙ö”∂π÷d≠Ø9i€Ù’éQ∆éGPö‰œ§µw§Ÿú(:≤8ÈZ€1AåÂyv±y6°¢ÇÉEÆ˙¸U_ﬂ«ÏÃZﬂ›_—'‚‚‰…Ê∂é‰èä#…ÄÊä#Õ…o∑ùÏ&˚®)<¡nÈò–ÍŸÕ¶VQÆ’á#ëÊ4€*ud∞–a«‹ê:;f°#√Ó…ËNeth]πp–ÂÊRÖ‘U‰ÊJùÖ	›hºº)<Z^.5Ö≈•&^h‹´ôÆÄ¶¢Bj
LöñöÈShíıR‚vC‚qK	{ê‹R‚fJ…÷ªVrÙé‰®ºì∆Ój‹MﬁÃmMﬁ4æˇımÙ˘ÿX]§ß≥)Z÷¥≥¨)
v&èÏ+Jöªc¥'"*å§Ê›π´ßO¯Óh2R'{ ¬∆h]Á}™;Eu]Yxî:õ⁄;F;É—p™.X◊T÷˝/πDnv01G±´nóI √@ÜôÄÏr7«"mívŸe≤ÀdóªÉ;ÿ.pàÿ»¡‡È°73qs”kÇ¥b§ìò@Å8ÒZ+J‘IÔ∂VV0pkGn‡Qv⁄¿ƒ )]G]Gê0OÅ§¯Ä¬¸P)â:kEÈ]å+†R@aAe'Ìí“‚R	◊L*†PI)(¿!§v1. îs›‡êËR\¬¿‡ΩA+ÿ{É}`TƒFvv†h»K¨`b‹‹Æ;˛ÄÍ≠@ÇÃÃpÖ 1ê''T!f¸óBigP.h`⁄Ωô—Aéÿ9âdﬁ Á¬,
B¢Ä~çâäÿlKÅ™á‚H†ãµãaf@ù≠≠Õ ·3Ä¸√%•P4,J†4D'PK1,H‡ X⁄+—÷0 FîÌ”endstreamendobj46 0 obj<</Ascent 1010/CapHeight 716/Descent -376/Flags 32/FontBBox[-628 -376 2000 1010]/FontFamily(Arial)/FontFile2 51 0 R/FontName/QULRDW+Arial-BoldMT/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 136/Type/FontDescriptor/XHeight 519>>endobj47 0 obj<</Filter/FlateDecode/Length 511>>stream
Hâ\îÕn£@ÑÔ<≈ìCÑÅÓû !KéùH>Ïè÷ªÄaÏ ≈Ä0>¯Ìwää≤“"Ÿ|hÍs…M∫›Ôˆ}7ªÙÁ44á0ªS◊∑S∏∑©	ÓŒ]üdπkªf˛ºZæõK=&i‹|∏_ÁpŸ˜ß!©*ó˛äã◊y∫ªáM;√cí˛ò⁄0u˝Ÿ=¸Ÿ]z∏ç„G∏Ñ~v+∑^ª6ú‚Éæ’„˜˙\∫l{⁄∑qΩõÔOqœø;~ﬂ«‡ÚÂ:£L3¥·:÷MòÍ˛íjèµ´ﬁ‚±NBﬂ˛∑n∑OÕ{=%UéõW´xä¸L~ó‰º%o¡;Ú¸J~ç\d«S‰úúÉÖ,`#ÿì=òπrÊ»-6‰¯çT%Ãd	≥YRê0sπ¢d”A‡ t8BÅÉºê_¿ÏA–É∞A¬==û n›*=ûJOÖß“S·©ÙTx*›nJÖè“G·£tP8;1tbÃ2d≥Y∆,Cñ1ÀêeÏƒ–â1◊êkÏƒ–â—¡‡`t08;1tbÙ±≈áù:1vbËƒ≥èN<==<===<===<===<===<===<=›<‹J<'_e)Öü˜‰Yû/CÒ˘Ô«xƒ)v_≥◊‹¶)é›2ÍÀºa“∫>|Ω∆atq>…_ YbLendstreamendobj51 0 obj<</Filter/FlateDecode/Length 29018/Length1 58964>>stream
Hâåï	XWÄ´¶ª´aîSTúÈûÅûD¬™´,]B\˜0íËn‚DA≈3$AóÄºV¿º/EEçàäßÁåûQ«h‚˙ôuòº>6˚Ìó/˚Ê´Í™˜™æ7ÔÔW’©Sß«Ä+§·√GÙÏ≠√Ã$2:)*%ã/}Ä! ÓüDœHï[ó=Và£cS&&µ˙]Xåê01qvÏw	us§Q CÊ∆≈DM∏ÈÒf8@Ã5«&Z„c5L˘«%•ŒjÛ{’%&GGqÀ^¨Áò3)jVJÎz•â)yrTRÃ™¢•Ã∑Síß•⁄‡@›x«z ‘ò∂¯∫/ÿˇ≠é´Sù úÑuBv
ﬂ÷'W±*'A•yïc`?≥≤TgG˛»ae`?{£P€¸!ˆCÒ`†›ng˚Ö«n¿3≠lŸ–ãÒcveB–6…û*ï#Êø[‰xÅD'gµ∆≈µCG7wO/ÔN>ùªtıÌ¶’I≤ﬁ‡ÁØﬂzª{¿;ÅøÈ—≥◊o{˜	˙]ÔﬂÌ€Ô!ÔÖæ÷¿¿AÉá¸qËü˛¸óø˚`x¯áç˘∑ø¸…®—c∆~1.2
∆GOàâù7)>!1irr î©”Rßœò9kˆúœÊŒõø ÌÛ/æL_∏Ë_ef-^≤ÙÎÏeÀW¨\ï≥zÕ⁄u∞a„¶Õπy˘[∂n€^P∏cÁ.n˜ûΩ˚ˆ8x®Ëë‚£«Jéü8YzÍÙ8[vÆ¸¸Öãó._πZY’5µu◊ÆﬂÄ[∑MÊ;ñz‡›BŸAÉÿQEÇ˘hW…™Q™=ú7úKÊ¶sÛπLn1ó«]Â^ÛÆ¸p~ë‡)úû
Øà#oÚ%â˙QŸ≈$mº6A{V[°µÎË÷Î~–Ωëº%≠4X&},çí∆HüJÛ§"©L™ïL“Èï‘,wî≤QÓ!˜íÉ‰~rà*í#‰dyÅºR>¨ÙûzΩAo‘˜–†©è–ßÎWÈ*:<ﬁÜÆ…–›éa®! „ßÚsÛ”+†®≈MÒR:+›%P	RBîD%MIW2î≈ 
%OŸ≠TJîJôrY©Tn)èå!∆0„ c§1⁄kL0&&ŒÏ·S–µ@oSŸÇm!∂P[€ €€õΩq|”˚M/õõ˝öÌçé{∆nXÆ
Tz’h’^ŒüÁRπ9\:£∂î€¬Uq?Ú¯p>CX&T	ﬂêÜQ”ëû¬(R◊£ñ®-”6Î@ó¶À’Ωî@Í,…“P)ºç⁄8)M:"ïK◊•;“KÈ5ªÏåZ £÷[Ó€N-ûQÀñs[®uj£6L?B?ÜQÀnßÊŒ®u1Ë⁄®E&¥PìÅZx;µl%WŸŸN≠ÇQª…®ıkßcåg‘"S5üŸÜ6≠Ì]F-Ã6–6ƒVkklåh
m°&7ß9®ŸÔ≥˙|¡§Üı£˜òtw\Û$áÊ´ò–ZÇçUçóÑ<ˆ¨˘OY>x¡ø`] àU∑’€Íiu∑v¥∫Z]¨´⁄Íl≠d¨úUeÖßéwô¨bíﬁÊna√ÃgÒÃ.~÷óÈÃÜy ıÒı≥J¨WÓ6,µÆ©/¨œ±‰XÚ-Y ñÌé¸zÀÀ8Êı≤ÑY˙X¸ÕCÃÉÕ!ÊæÊ`ss/sw≥¡Ïkˆ2£Èπ…jzlzh∫Á»2ïõNôJM≈Ã:g⁄f⁄gl`ÍoÚ7LzìÓ¡⁄ÜìG,«c}b=÷-≈‚zqù∏∂ıúÙÑB]oªVª<ÄãnÈZ¨Îs¨ÉÛc±AL“Ñ¶óGY¥ì` è∂f;ÈòÙrÍÌ4¡)◊Ÿ†Ó‰òU{¥…¯ï°Rƒ4Î”Í?õmÈ€≠3Íøòª»!Íå6/˝◊ˆ˙YÊXuDª=˙ˇài∑b5!ö∏ˇ	‡`§√B.r‡,Ç•êal7»dHøÑ=¸ K`5d ≤ÔÈÿ;·ü^A>ÏÜP{`<DC6LÄ
àÅÛpÆ¬%∏W‡[àÖj®Ñ*ÿ·9,É:®ÅZàÉ'`ÖØ &A$A"LÜ\HÜ)êSaLáTò3·1ÃÇ90>Éy0ä!¿|ˆïˇû¬38Ü9∏U»!èÿ†◊‡Z\áÎ°	öëPD'∞„‹àõp3Êb:£5ËÇ˘∏^√è∏∑·v,¿B‹Å;qÓ∆=∏˜·~<ÄÒ¸Æa&fa∆#XåG—;‡1,¡éËÜÓËp=—è„	Ù∆N∏Ob)û¬”xøAÏ˚`?v¡ÆxÀ–ª°uxÀ·¸Ó¡}îPF=<^¿ãXÅó2^¡´Ëá˛®†+±
´±k±J-|ªc <Äáxç2)ã”ZJ_S6-£Â¥ÇV“* °’¥Fßµ¥∂”z⁄@im¶\ £|⁄B[imß>ûO†B⁄A;iÌ¶=¥óˆ—~:@ÈÒâ|¶#TLGÈï–q:A'©îN—i:Cﬂ–Y*£sTNÁÈ]§
∫DóÈ
]•J™‚˘&æô∑ ††8ÅÅQpúµ†°j™°Z∫F◊È›§[tõLd¶;d°zj†ªtèÓ”zHèË[zÃj˝)YÈ}GœÒ:ﬁ¿õxo£I„!∫âÓ¢áË)zâﬁb'—GÏ,v}≈n¢V‘âí(ãz—†Ò‘xiº¢πæÉª,“8Äø˚ÏÔŸ}û˜ŸÑPC	HO ÅPî"Mz'tDTÙ=+eD§wQÓDE@D¿9QO=,t§°∑Ñ	$@nΩõ˚cˇ⁄ŸŸôg>≥˚˝JY…ì„rBN )9-g‰¨úìÛÓñ+tEÓ∂ª„ä]âªÎÓπ˚Æ4DUl[◊&⁄$õlSl™M≥Èò(ï§≤}›N¥ìÏˆM;ŸN±SÌ[vö}€N∑Ôÿv¶ùeg€9vÆùgÁ€¡˛ œ.⁄Ev±]‚_Ø•˛{ﬂ.≥ÀÌˆoˆÔˆˆ√‡Pp88Û	®]a?≤€OÏJ˚©]eW€5ˆ3ª÷~n◊Ÿ/Ïzª¡nî*'U•öTó/5•ñ‘ñ©#u%Qí$YR"s#Û®Mdµ•vÙ0µßëQ‘ë:QgÍB]©uß‘ìzQoÍCπ‘ó˙Q@i¶!Ù•GiXdÅ§Jö§KÜdJ=©/YrA.Jæ»%…ñ“êf–LöE≥iÕ•y4ü–BZDãi	ΩKKÈ=Z’—HÉxuE]U◊‘Í∫∫°n™BU§n´;™X•´uW›S˜UÜœV¯†	"Ä`¿C®2A¿A @YàÅrÂ°Ç™°í™Ø≤†2TÅ8®
’†:‘Äx®È3⁄;>o$®l’ Í®ÜP!	í!R!“%G…˘Cé eπ"WÂmÖ»ÑzP≤ @C»ÅF–ö–œÙåÉW`<º
‡5x&¬$xﬁÑ…Ù+LÅ©Ùm£Ì¥Év“.⁄M{h/˝N˚h?†Étà”˙Éé“1 £„tÇN“):MgË,ù£ÛtëÚ©Ä.—e∫BWÈ]ßtìnQ!—m∫C≈L√,G%tc±<›£˚X+b%¨L•∞b¿*«ö#ålÿ21s»¬´b5¨é50krîÀpYé¡ZX∞ó„X.œ∏"W‚ \Ö„∏*W„Í\É„π&◊‚⁄ú¿u¢Ü9âì9ÖS9ç”9Îb"gr=ÆœYúÕ∏!Áp#nÃM∏)?¿b&s3nŒ-∏%?ƒ≠∏5∑·∂‹éÊˆr]npÓµQär4åJ‘q'ÓÃ]∏+w„Ó‹É{r/ÓÕ}8ó˚r?Óœ¢—hôhŸh‰A<òá#<îÂa¸?ŒOp~íü‚ø~ZnÚH~ÜüÂøÚs¸<ø¿/ÚK¸2è‚—<f¿Lò≥aÃÖy0¿Bπã`1,Åwa)ºÔ√2XŒc•Pä‰∂‹Å˘HV»«Úâ¨îOeï¨∆ÜRó·äû®ﬂ–ìıT=Mœ–≥Ù<Ω@/—Ô˚∞BØ‘´ÙΩVØ”ıW˙[˝Éﬁ¨—€·™ﬁ≠˜ÈC˙®>°œË˙íæ¢Ø¡5∏7‡&‹ÇB(Ç€ÿ¿eç|&k•DÓ =π/•.Ä;P%pÓ¡}(’ÅV¥÷(–à)òÅÕ∞9∂ƒV˛tláÌ±#v∆Óÿ˚· ]á‚„¯éƒÁ%£ìqNπhæâS-|ﬂ¡ô8€g§˘∏˚^˘ûN«e¯~àü‡j¸7‡ó∏	ø∆ÔGﬂl~√ù∏[g‚^<ÄG0OÈl<á˘xo`ñ`©Ô=÷g¯≤¶ú)o*Î|gj¯TÀ'˙S◊$ôìf2L=ì•ô&«4ı©•O˚mL;MÊa”ﬁt0M'”Ÿt1]M7”›Ù0=M/”€Ù1π¶ØÈg˙õf†‰wÀ:Yˇˇ˘ËPãvˇõèbÜô·fÑyZ6:p∆ÖÆåãuï\UÔ\íKqi.√eπ◊‘5w≠\;◊—uu=]Æ‡Ü∏an∏·F∫gÂX¥J4NU«Tû:ÆN®ì\°
!‘a$ƒ–Ñ6§ê√0î–Ö—∞LX6å	ÀÖ±a˘∞Ç:•NG
#Eë€ë;ë‚HâÏêù≤KvÀŸ+øÀ>Ÿ/‰†ÇÛp.Bæl÷_¿€f≥ 	6_?™3¡˙`Cìl	&?Suwﬂ;{˚’KÕP3e´Ó´˚È˛zÄÓ£s√˚a©¡-uNîÄj"Z"}dBç¯ÔV¨ƒH9∑√Ìtª‹nò.áÉ%¡•‡ﬂ¡ä`Æz(ò•Z´1jéö´Ê©±¡?’xa3 å6caã|%õ‰k˘Fæï…wÚΩ¸ [·g¯~Öﬂ`lá∞v¡nÿ{·‰¡q8'·úÜ3pŒyù-º∆>òã}uM]K◊÷	ﬁ‰8üÙN{`OÏÂï>ä√1/∑v≈nﬁ⁄O∏∑xo€p;Óv_∆Q8⁄+~_¿u≤N—©:Õk~«„´^Ú4Ôy™˜<›˚~MßÎØzéŒ‘ıt}ù•≥u›PÁx•7Òz±x	/{ß1^jÏüwzßÒf§∑˙åyVÁÎã~xó≠ΩÃ∂^˙q<Å'ΩﬁTo8ŸN«ˆ&Àd{”âﬁs¶W‹Ã47-0Su#›Xﬂ–7qSP˝øÎ„†z$È?|WpT’>ÁæªõY~C†oÛH§ŸÑ
Ñ`Iv4∏¿ÓÊßì ïXU¬Ôƒy–
äå§ñ˘ÛÁR	 Ï–qJ)Hë¢2"HfR)Ö"ÏÎ˜6!íŒ»{˚sÓ=˜ﬁÛÓ9‘ó»∫xÔ©∂.⁄8˚_\EÔ“Øı€ˆÏFe˝Tz:Ì·€îH∑PA°â$È&jˆ∑QﬂæD=im@:Äz”töà8â=¥Ü7Z≠+4ö^†-÷^^nÌ˛yTÈ∑¿¡gíiM∆˙È®‘Øhó(h˝ñb©é:”(ö Ω)åäÂ4› /“z:ƒœX∑@µ'¸Ô •q4Œ:l›°Z#◊:Œt˙*˙Ï¥ ≠jÍO©d
èu⁄˙ú“)àŒ‚‰·&9Å‹®ÚW—Àú§˝–KË/"/fk˘é˜@i"Õ@˝ˇ4ôË,>‰Ó\‰8„h±~e]&'ı†Å‡©öÆ0û$∂ xkåuñf“>˙ Ú⁄oìú)∑9fF∆ZØZÔS/⁄ãˇ]>ÏÍ¯Õ›e÷Ô≠∑(¸ÅF&ÉNzö√ËP˛EﬂàZ´ñ&P	(AUÆ£÷»ßQK,K¥ì4“Œ∑O—ÔH¡"˚È Ñn˛âöˇ*˛˛1ó!fæAuR!ékµÌîdπ˙6(:ZÄËz'⁄gŒòãxœCœÚ*üJ\7e¨\!øïwÈëÛëo≠…÷ÍC…Ùt=µ–Ì¢ÒˇW˙˝÷u˙zélÆB£êçÆ°:JSDçÿ ∂ä7ë÷iáÂ0ô'ó«‰Yƒ√ÍòpL‰ŒÎë#oFNX{≠ùÆ8?ù
†—eä≠Ù∫±èQÅ~Jlˇ¡˘£∏îï˘¸ØG?t›«UHI—7Uå>Pù'~=-èﬁ¶[ëÏpV|*æ74áñäxw¢“µøi_JóLóÉ‰9Eñ¢'äw<2¬v«.«˚éƒMÖ≥∆˘jÍï±GÔf‹˝,Bë™àäÏÅÔ∆¬ìCõ—mæ]@èy˘V¯7¨êåﬁÈ!=í∏ê'Ò£<ã+y9◊!óΩÃ—ÈΩ	 Í…T·„DâãJ‘ou®
ÓG.;-Œàfpû®»C¥âZ©6S{2,–ñh+°Ÿu⁄NÌ∏vRª¨}•5√jâ≤ø|J.ñØ»m≤Aû@˘9ﬁ-∏'õ'wwú¬ôÏÏÎåú≤›y!∆3<¶}¬©òÎ±5Ë3¿πN˜="	1ÿ_Ï=e-7c¢KJÄ‰ÿ°Qqù∆jÿ•´çoΩDíÏaÔtz•¬˛|ÄÜÒ™u
çâ‰y⁄ÕÁƒy˘g1]làì‰6Ì	«á¬Mªêç÷äw≈Œ£ë+fàMÒ%ﬁNó‡Ôø§ı¸8œß]‹Ã9¸,è‡Z:%zk%ºír≠-Br'û»-hô¨†«ËÅè§st%≤Yvëœ ?5“XÙ˙úw–mvX◊ê›4d£0≤Ã¯˚*≤≥ﬁlƒY-‚1	dÆÛ85∞ì(fÑså\L-Ù_∫‚ÿè C&Ω©ñõÂ÷+Ü(£Ìàª*èàπ/9à±=öÖHèC.ä®.¢R™†gëı÷Y ⁄d≠∞YÛË#ÏΩç>‰6øÜàhƒé\˙ ÔÛÙ	ØFé∞úﬂ˜D*®âÆrN„°àáf«B‹L;QWrsÅ∂W“FxÙxs$(ßtïnr,lìDôÙ¯ÕÔö+Ç⁄A Ád™AÃDœkìd>NYÌmB<Dl¥ OÃ¢CtÜ'B¢r–è≈9Ö–ÛO±˙uXpÔ¡L≤v}πªr∂X z^ú¥Y´	<ù£/°m+ W&ÚÇèg‡¨õÙ(UÄ¬p*‚zX‡âÃÍ”éBﬂÿEyú ƒæ"¥+ı£ëé/XPfd≤ï-™µÉ∏c,ÃøÜ€+ÖFÛì‡"r‹•^<ÖÜE¶Çáì¨I≈èrÒä®¥Í¥ß#sÈ#⁄õxÂ¬üw‹4Ôÿ1£sGÂåÃ1ÏëÚ‡AYôûå|(=mÄëÍ÷–ø_ﬂî‰§>âΩ{ıÏ—Ωõ+°kó¯Œqùbcú©	¶LøQ“UzH…tc¬Ñ,{lÑ1æo"§tLt\£ÙPtôﬁq•+ˆ+Ω≠+ΩÌ+Ÿ•ÁRnV¶Ó7tuÃgËç\Z ¸kü‘UsûÖ◊F·.Ä›nl–˝}™|∫‚êÓW´L»á„Í;«Â˘ïqYôT◊`g@*—®©Áƒ1D¢?ß^Pl0•íü_%>õ••˘√™®8‡˜•∏›¡¨L≈˘ÂFô"#O%x¢K(?JF9ÛULîå^mKC´ı˙Ã&sM£ã Bû¯
£"<+†¥p–¶—Õ∫>ï∏¯büÔÜ8º{~†Ó~läf˙˚TÎˆ–4Ît’T∏Î∂ÉAúÅΩ"≠ dÄÙ(±∞D5±*Pº
$u[[™V˘*ø=ö£´NFûQeŒ	¡4…¶¢©ã‹ªììΩ˚¨ÛîÏ◊Õi√≠∆¶¡∞Øo}O2ß.⁄ì‰’ì:b≤2Î]›Z[ﬂ5°àÔr?PŸéãB—Â6T8µ]≥lsdLÑC(Ω\'2e€?ïŸdñgcû có™ÄE™Uß¸êÈ ±ÁÌ˝ ëÊ2tÛ¡åÊkg¬m3Œ4◊≤A€O⁄]¯{∞ÚxTFÜÌ"1˘∞)xÀ \ÿ(Ü5.PA∑·`Œ`®ﬂÌ∂º∫—Ke®•≈Å÷±Ne)ª…;ÿT"dcöÓazM∑1KÔa⁄∑áxr·r¢^*6Ω˝ì‡Í›√_ï£∏˜–ï≠¯¬£∞∏4†˚ÕPõnßuµ‚≥€qmêÍë–RD$R¥(N9´}±=ƒ+ôÜè3Í‘JÉSF'X/PÆ–Ñ÷ﬂ`ú€˝Ω{cbÔ€‘hµÿª¢ﬂmk„RÂx:éGuw‡.ﬁ‘¿ØLÖ”JM3ÆÆ 	»4Ω¿ô·Fkiô°ªsüÿ&∂ô5˛–=É6Z˚Wß®Ç5AQ≈9pVAyı?W\ÔÂˇ—]≠¡M\W¯ﬁªwµª“Æµ+Ÿ≤û∂‰áÏ¢∆ñë-[ ™ìƒ-1∆≈¯ëŒbO(òGö¡å;<B€IxLZíí:)tbZ∞1√‰Å1»àìi°°Õ`JÃdRh∆I'¢¥q]:XÎûï!CT⁄Ω{µ⁄ªÁ‹Ô|ﬂπÁÓ^˛dÎàåêwSÎqÇIm«¢∂∂G1‚¡¬ñi-:A∞n‚í$°⁄Kuô9™c‰‚M¨Nòwq	Pù:ë3$O≈”Ò•Údº>G	ËÀ”–TÑJ@)Ü√ä?ÌgFßU›C~:
µ⁄†7íµÏ$£«‘¨RÎ Cx#AF6˛,.@¬–"Úäjæ˜˚iòö$?Ro0,j©ÙdJN°DBéÀ`k∏0H™d{¥:BHN∂-◊AVøˇzﬂ™ÊÁG˜t.®*‘o·~5$πyVø¨∑‹>§Ÿø∆§<Q3û|[uñês'È4˜¢G≤8Åó6Ÿ	¡å3>ù‡øb˜ãÜ7∂ıµÜ7©Ùƒˇ:cˇSUIòà√ñìÕÊ—ÂãÁy◊ÏyØw`—ícz„Òswotﬂ∆É∏¸öûw˜ÚﬂıI˝û·I∑>Çc£<Lº≈dÊí8Oıò‡ãŸ¸,rEVîè¸(à∫ƒŒÕŒ¿Æ’O§¡v}j2çïRb±ä∞=êìm2q%—hu·O±kN˜ì’+Í»nÏ˙pÀœ6˙7yüZaÿ[àwëu§‚=WÑ±
UD5D_f¸Lò°ÃbVŒÿbêã~⁄∞5°’Àüi®<•Å	àÓBR
ı∑Køeºm4«¿{©9§ôI!oÈ◊ﬁ¶_+¬øœÿ◊Õé˛≤£¯fUÿ@∂í	«ﬂjg1õ$+OÒãë(¿6¥ˆ'òh™ƒ"öO˝ÙmJ©À|@A7k$^op»òàOj) iÅÄb‚™¢E’&®ﬂ˙≈Âg0	O–¬óù)˙pß·AJi<·Ñ⁄>Ï<ÈÒ\§úcŒ1◊òõØı‘zk}ÕÆ˝ÙUÁQ⁄ÔÂMn?*5UªÎh≠≥÷UÎÊãúEÆ"7„“f∫€y¿s¿{¿w‘{‘«€êOˆ˘}æÕæÁ}/˚Æ˙x_rfTudÁT˙à,Z}Ãƒ¿I‡Ø!õ£%…¡!ÇEk7´Ö˘bπHDÓã˝vVw8†Ü¬»ùoó{à+Ô ôy◊O¶ñ S]ÒxΩ¡∆t®k‰“∫‚ä-ÜïHHÉ6Ç|3£«ïò·√qkÊ¢f…1 À1ñW‡™ƒBôO€;&R€‘™ZèÀC<vllB‡Ephm…ó4∂ûEXcΩp˙fn÷‘‘¥·.M”∞à⁄™£’—™ `aÅâ+éEÊByf‚L‘ƒQq∫DÓ˚Ú\hﬁÍ∂÷µº˛πÛÁØﬂ}º>¢O=Ó¿¨~Ô,|¸N¢e≈ ’Î∑z?ø¯∑7W=µprY¥[ZDCîÃHB7‘òËóbÇËC‚rqÉ¯©hJIÿD¥òñJu“˜§Èît^0·ëhí8÷lë8$äíîƒo™nÜf3@t"Râë5#NïF•1¯qó¬éî‡'•0 %qÎ	ˆ%36'1Qm2˜˜«pnkÇÏ Ñ∏≤N„'p]Ü}]êûÍÅÉê”Zh∂Xe.ªÿ≤›.ˇ∆jµ>Ä¯qÅX/~$~"≤h\i!»ùU8¢Dr
¨`Ú\˙ŸˆÂ…ì˙˝-\2≈¸zzÂøıÎ$ˇK∑ 2-3∑Ë@&¢≥Í¸ıñn~ﬂÎ`¯¡¨£ˆë¨ì Y˚®r….Â∞Qe±º≈1L˛(èesg–%N1Á¥…?Ñ⁄†DpÕ”oïÚÂ0òËOX∆ÑÅí∏aË-åq‘Ç|ZŸŸxÜˆÁ∞xı‰ç7àXt;«mÆ¢‰Ãp“‘,5'µ)≠+ÍJ¿i¿c`£3GfÉﬁD#s!¢¬§»Ñ≥ëπ˜IE≠˙sSm€Vy›Å∑ÔÈw/˝Yˇœπ=q˙‡sçK◊nlj‹HóÁ5-ÎKo”'ˇÙ˝n√{>¸˝3”_ÏyuÀã/Ω∞‘lr≤˝êqwé :sS≠∞*ïfã€2è÷òÎÿfÀQÀ9ÀGñÎs¿Ç-áÚ-ÂRnIX,å≈ò±Â¥ë@Ò±SÑ` Ò"D*Á0¨úji`0„ñ`ŸÔ£7Ù	ÏHgíìú »?ò{≤jéâê‹ÄÕV›¬ºﬂ3ıc¨ˇÉKùß1˚án˝;∫˝&?¸$äÂ3ü—\à∑°0ñÜ√º/ø2òúπ´>ù ˚5ˆGªÂÕŸœÀLÕ£hæ¯zB|ÜÆ‚;ïµ9=%ªJz•◊úá§AÁ†ª?o†§ˇõÉ·˜©º‹˚N˚ŒÏ]%¥‚ÿHyÀ^É^H0˙≈Lô1ıDYC);MˆBUeá≥r£˜G^“Á≈^Ø…Vj∞HÄ«¬•j))MíΩ™dì§¿]`‹qõÿ¸q°'4ﬁ`≈V˜\◊8”S<ÓpU|Mô…áHì
iâ¥íïXπ÷Ji°l∆ô·N¡.ui°´*£˜ìéZZXPb‹≤?D!Ê°>Æ˚¡™ø^π|k}«ñz˙⁄Ô^¯ÂÊëˆÜeÌK;‹=m-œnjÎ\Õ‰ñÏ8tıÍ°5oÃ©xwÎÔıu€∆{.‡∆¶ïÌMÌÈõ~≤}sÁˆΩFûZ—…æØ∆1µuæ≤DYmŸ¬Ô·ŸAæ?´ﬂ>åFò·¨§r¬˛[tQµ+ïˆfKõ‘Æ|◊ﬁa7πÿ«Îπü»7≤Ÿµv<+Œ|O9àSù&+¸ Ld9#Œ∞ÄÑ¬ù˚‚ÏõÁ∞Î#¨£ògVüísº¡ÜmÓ‚YùäÈÛÿˇWü ∂;Ë™Mˇeª\Äõ∏Æ0º˜ﬁΩ´Ω+À^Ø,…ílke#[»ÿ±îhÑ\c'PúÛÜ“`hÅ(√+$¥q¶¡ƒôÃ‡NJÀ®0)ÑË–WJ_Éß…ƒìRìk›sW6F£Ω+kG>˜‹ˇ?Á;%≈xl¨…ZR\ä¨\∫¨º&ë™<Û‰¨uπÀv∏áÿÖ+®»ºtsˇE<gC›¥%‡œ®æ®~F[ˇzdøtÂöø6◊òÀÕ˜éëÇ◊Z÷Ô¯ŸñdÒ4Êã•ëV~Rç$©ZTX¡X*E:çRL;‰˚,&‰ËÔ°$z3|ç(˜'‰%æˆˇ'√XXŒﬂJœ	~@îMFDR≥ù1™™ZÏ—¸GΩ}÷µÿ∑œ&1∑S0ºÅ,4U‰t·üVﬂ˙[m;QÅRÄ¿∞†≤†Í÷›ÿÌÊU©^}œÑA‰·yÖ´V3≤ó"¥ÖÙÌ/‘ÙµdπVc¡	(∂ÑÀÛ{=S¥z¶D`¯Ê ™ÎÀmZÒ„føi⁄ëˇ⁄7®ËG˚góß¢÷UeΩ‹ˆY`‘∏∫5Î6Ëùw”{ìøzsJÉ©Y€≈'˚ì¥≤®†'é∂ÅÀ´™âIa∏ÿ,£Ü«∆$.È≤1#Xﬂ¡e∏ÅûVFfUU4ëµLXÜë≈t©ºDπAr¶Hàc;Qm!]∞Â	§Mu*ÂQ*…ä·+|\·ˇ¬Ó+å)!Là$ÇBOŸíSQDÇúÂÒ¯ÄwÊˆ ¸ä¢"®3XÄ°(K1Ã∫Ò0AÑ'ò4ËµœY0ì^PÈÌdS~z⁄ìã&^É¢
˘MƒßˆÇZG˚î«y∑›∂·Ã∂ |æÿ‘x|€ô3ôæ˚ã1GL(Á∑ˆ†Ωæˆ`Ãf«2`ñE•{¿ÑLıíƒÍÍA∂…êQ0H‡ÖÇNBËIÛ∑©Ù—óÃ≥x™âú?ã¶öù¥ªˇu¨ß{¯$’ôüôw„ç.âüD–“Ï#◊ƒ>QdAì¬#Ç!∑pMw·®´√Ö]Æºí‚êÊîıº∞øl•îí∞T.ÎÄ
ÃÒêŸc†ø¿ÏïFÂå πï++SïÕïmï≤^ÖíúW¨∫3ÍƒŒ.¸Fg≈®˙!(N&õ˙ yAMˆZ≥[’BC◊@Ípaçã£°è/©CNNÉ≥·°Ô‘ÄLÆr WáÚ-€]Ñáä-LpéÆzÑÎπ¨¥$<¯°¥§O˘Õæm+∑6'±väy’t†ÈëÃ™ù2‚œÌHk+_oºtûv>ﬂ⁄∏dyŸâW~‘‰ê±x÷<@Ÿ¨ß&>Àh˙∏˘"ÀJNˇ|Ñ”˚ºÅÎtLq>·í1m+€û∑›Ω[xG˙î]$Ìˇ%,ƒ¬Ya«º·Ó5t€Jeõ”ÊÒ8=û·8BB‘¶≠t;G>±”öìPù*†·òáß<7?f≠
Ë•5û¸
QŒ6≤µXvmc‚ÌÀpÂ«Ä÷√F±V°êúõŸ3ÖõÇıSæ(¥DWYõÂÿ∂(p#ú^ß„‡π4Ò˙ê‰¬B£€@_îÛïﬂ$yy@™©$ñËº–uè€ìA§\ïóZ1Å„Õ_õˇ4_CÎP9ˆ.m˛√∑gÌ˚øˇ¨mm;ˆ?wÎKÙ&j@À—Œ›sNZµ˘+ÛÆ˘’◊-ºæ
ù
U°∆Ωbå	É›üÚ,e—àß∆3Ÿ=€Ω‘Mk<è¯∑˘[iãùrπ,ùZ(GïΩeu2ö‰ª2ú© “ÉQhMπ®Pç™XÂ*‘™¬˚‰ªlB\F∑†œ&ÒWIFDècÆP—€∏ÿ‹WªÊVT-û∫i˛/”ü£ø^Æö‹èøPˇ¯⁄]Pz⁄º˛á#õ⁄‘F‚È˛±Ÿ⁄ÃO⁄€è.÷≤πFvBÕø;µÕ∆c2\IZÄ¢(ÌÄ6BCaÖÖÏÇlìj	û¨Ä}>›u0àLG|LI¿é≤æª#Î ÅÎ‚∑„±?÷Pÿä>`+B°"çäéÓæwäâ˛/qOZ'ch˜∑ÊáwÃ¶;˝.à~3DœÑUF¢óh»¶ÀQ˘§|EG Õ2ñe!≥Ò'§ÈP5Í1ÿß€£vl0~ÂaÒ'„ó¶„˛aÒÌ"ΩÈqxa˙=€ûo”oÒÃŒ˜}Ó”°¬M™.™-öi[+ØÕ⁄"oŒ⁄‚ŸÏgíGÚkÕŒÁá}·"y≤˝9Ò÷`_&Æ◊ÂØˆÕ>™~Í8´˛UΩÆfìIÁn3æö ÁMåêª†Bb7úV;›âú‹mNÓ∂àª"á–7ºçÁ2m&Ë:Å-GÅ4Ωem
 QJT!
w]p„Ó\«7ØﬁÓm≤˙E∆}`æﬁ\ﬁ=ö „V¡≥à∆s¡Å≈√@å0‹é—≈A∫Tç≥–Xí¿ìÊÓ#◊Ãˆ˝ßéˇÙ/0≤ça˛=∞/u˙Íç…'`ˇùtW√ˆè—íœØ¢ÖçO_=_ı¬ÜæoÃ{ÊΩßc›∞Oﬁ+"ñ>ﬂ7BL§
¡L	âZDê(Ö£¥…2®ì ∫ÙGk»x√(63sd•#Â¿\™m0√älœˆ)hBπÆy–Ä´˙¨€°ñ	~Êñ^â•Wíi|˘û^á$qˇ’Ç¬x"
õó”'hw˙$~‚Ó$¸jöOX;@¿ûà∞¬ÚAÁËXåÚÇQ≤V#ëÁâ	‘†3häˆP†sÈJzãä)
ïA∆‰oH
=9≈Î1ﬂ‘ü‡ì(,GÊ™¡≠$‚|åjZ—Ú¯v†0Ìæ;	‚hÖ‹˛éÁΩe¯d	iö¢PÇâÕä)LV(ìô”€1£‹&ÂŸl·£ ƒ(
hQ#≤ûfÅ¿ª]∂…b^xòNña14õU(˝ÃïâˇœªóK.?SËÔß›yáÓÍ©‡∏í_.nPœX72øë’∏|Ük<√-Gònwƒ‡\ŒñÀÄ_8¿~hxK•2÷,æ#µâ≈S¢m≥¥Wº!ˆQ‡≠ÅûŒ™∫„	7!È1e5ŸJZI+{Wi'›‰Q>˛Ÿ’≈qÜwfÁvvfo˜ﬁO˚‚Û-∆?sú6¶ﬁ„`\¿‘º¨‘ëï ò∏J±Q S	0§ì–™6–(+Õ£Åîó[¿H⁄H§RA·—îñ¨¥@—î ^˜üΩıÏùπçvo˛ˇ˚øˇ˚‰3Ú=.O„è…x9hT“”÷Í‡AÙku ë—a+‡—ÍH•Ü¡¨#IÕ_ø‰Ã†'ñùçHvÜŒõú9∑Ô†®ì≤2
9#»ë)Tà‡ü˙~HZà~8r7ÿÎÌgÄÆGV‡G~o=ﬁˇ{dr'‡ÎÆΩíKöf≈õ©@	Å.©ƒßX{Â—°±gÑÃ…Åƒ¡oh'ºÔ≤kÔ›∆ˇ
2ÎuTr„®•iÚxuº&®>†lãÂ◊dx≤fj∆âfn∂^À/áU¿–ˆ/™éÛ Œ'^V¿M\Jí¨Çw‚•§ÉuÒU∏óº∆vÛﬂ∞£¸vááwë≠lüù‚ÁÒré]‰◊0˘˚åÎ´X/o!œ±-|+¶ãµ‹E:ŸRæØ&¥7ëz÷ƒ©ãÿbN£º¬»‡íaSyùAeÏ&
c<Ñ„$¬h6Vä3óõ“¥b∏” OΩ2VõU=£â¡9•»R-£8£âñ^±º‚ã¶ ¬Üb %U`∑ÆV 6õ»6æÊÏu±êwdt™UoIï±¥LÇ≤L∞∆yZ∆√cd7¡ÿE≈®Z` „“A/í£xäCO¥eâ!“2?„JSãÆSëz|d·∏ñ‘‹¯ûb˘Å,ÿ(Y∞IJaè—«yoÅm-Ò÷ﬁ÷∆cﬁëûëû⁄x‘V ºW{‡«{ù À€oêÛÅ@º:z˘Äñ¢øÕ˘8åR"AE l ©Yƒ˙∂°ﬂ"é(:f_∑/ŸWÏøÇÙè √w»Üªk≈ò⁄Ãcäæç˛hLV‘òQâx¢+â∫+é-fk"úHNS(HïUå©Ã ^+ôàqbíVNÉÏ≥¥f≠]ìªµ>h'4úÌı*À=‘©y£•%√“_È|L? õ·~KÄ;áIÖ‚N™ÆﬁT. ‚HÙáÀT®…,FNf5éô*qËh∫≥´ÔêV•ˆiUŒ¡¶≈À3j.9,ßeK&ÚÛ [‘ÉÍUY˘ù|Z˝≥*'Â
5#OUÁ™?ñw©Ú>uø¸é™eMÍ§™∂&9&ı≤•W§38)¨ÇïÌ+,œ‡˘08ªI¬*¶4äÂ-≈≈t*ûDÁ`ã~/§,àÛËl<ÉæL˜–?‡ãx_£_b≠O†≥h/ÌßocEtìÂ%˜?“}(¥Já ﬂîƒãQ¿>?r  P&xßA>vØ^®ÎVPF◊@y§<ÈUk¡v◊vuá{áATD’C£≈—^∂ OW˘zC…fu≥{£Òºs∞?‘Èènåª©ê˘„¡x4ßÅ2ù≈ ®.ﬁ«ëƒΩ<ô’5V≤2a%⁄›âæƒ@BI&˛ù¿	oÒÄÑ< Î+ùúoÃ_˚ﬁÒ„h6GÉ_Øª.±≠|\\öP7Y£!°†7 øAË¥NOˇ™sÛ ™Gœ€kÌ„ˆêΩ=˙ÈÅW.>|üΩº£˚`Iç˝]˚e{ßΩÏ∆“/Ì———{∑Ôä8Ì}™@ƒaïU§∏ÜÇCQ˘qÍtùsaøØH7)œ+‘´GR√ˇÁ+¬â ‹˘\	Øg,ÀÁ’Z<p9˚–]@¬¿:Â™i∆0-ÁOä>F∆7◊Ó~j˚úÆS'_›∑r˙ì3´\G√Öóˆm:Ú¥/4rûºk∑ó?ııÊ•:á≠ZG
IÖ“mkCµß—≥àvi]Ó›ÏMc¿<d\`\QQ√|≤—`4x®Íeæ†ÙΩìç…û«=+å’ﬁπ÷Àzc+˝¨?∂1°∞pêπ=Fã±¬¯æÒ„ÜÀHÍÓ†Æª=Óê	ºA‘‚`PJäpA‡Bí
4zÃ*ñt/ê≥y≈ ~ÂÑrF! ¶n%ÕJõÖ°±QKç’%Æﬂj{ K áÄ⁄–"»W-›óƒ=m"†i'û4é
Ârlö>ﬂ√®ö/·eˇ¸®Ô›ìÌk∫Ìüü[>ˇ…%µ‘U;wÊ∏__sù˚¡Ü◊œÁOŸ∏«˛;™€”Z8Úä<g‹‚«f=·vân<kÙSÚ9‘N):cMÚIö~)°ä"°hIá´c¬≥JØ˛ÏÑãÓs¶ªï/0§ZÕ•Ó%˛Œ¬ß'tñÆJlLºTËˆõ¢c?Rê≥’ãgÊ•Êô'S'M“ìÍ1◊ß÷õü§>1ï>QógVÎ≥â7Èı©ÈfóﬁaÆ÷øó⁄¨øêzÉø©ˇ2 π®+)≈åÒòN—î…uÇ"£V,ôYEÀ¢ª¢8zwHy¿Bn∞0y(Ø,(K3ë†•∆x2Sâ,‘å⁄—V4Äˆ£HE7àØˆD &≤ËÕ—äXÅH&“Dã««Àäº˚Ωÿ€Ñn˙≤	åï˝)á˘¶ñ≈$kJÎlëΩ9ﬁ/`.YiÛr´≠‰jv^^r∫]ñ∫AóÇx‰%æf
añùØTß <0¡›©É~qw∆Ú¯´ı§øö;óG¨[Ü÷ÙjW†∫dÏß5'5B5ºFØJUAıÈ©Û˛VäKm≠πRÖ√Yb)v˛™2ìZ*™ÑÇë0qêEÃ§4%„ª6˝h€¥odÜn¥oZwÛ-Dj_¨Y≥æ±¢t
⁄z≈ñQÈ˚3˚∫îø≠ıºLcûø|Í¬’{ªﬂ[Ú˘zœ∑´R’ô¢ä%œqÌ_æÉê¿W)p“‘0ïñ[f´$ïÆf÷Õ˙ÿVF‰¬ED∆TRY$'ÎDøEeWhUJÎD¡≠O6öq7Ó√[1¡1u‰Ì\VÊ->Ä!+µ≥°æFjaò—Q5«Iµé¸Ñ∆QUÒ7{6˘Å=á¸èÓjçç‚:£˜Œ˚µª≥≥œŸŸ›Ï¿⁄∆,¡∆^c^≈ÉjÃC∆› ÏXUã]UE©JSäì¥iR†bG$jîÿl	≤†?**TëÑ°TÄk“U£ Sÿqø;≥P˙£Ú˙~Û∏ª˜ﬁsœ˝æsÜ∆∆ÓœÖYÌÅäëÜYÈË%k/"ØBD~çÿ¢ÓS˜˚_ıÑè™ß¬üÜnrw8Ÿ£(Q|Y@T‰îÁUé14V∫”ÿaP)£⁄x”8g0ï“´ıs:≠ìD˚ø∆∞‡$«PL?lIÿ9⁄PÛT/5qB9Ÿ∑=xíxÂŸÌ;bxRıO?{˜ÚÁ€É	(Ç∑ŒŒX˚Ωˆ}Ô“ô∂=vu_ncœÍÌwÍ<B¸/à∆∆„ññ°3\JÆïƒaŸäÕ Ç«ÿ—ë~,ˆÈu†bÜ-1ñ»J:4 √;DÓXr™s·DñIA√ÉÏÂî
âï®L‰G§aÂÆxO∫´∞ÿ?Jî´Ë/†≤Ø(∑—MQ<ŒbèKGî3L?{F:°\dƒ©Ã∂JJ)=Ã∂G˙ç"∏å˛@¿^G*í◊tÖö íM2Âﬁ~W?˜Z!¢¶7ì;ô£ÊA2ãéb,ˇ´òù§j|0$3lj`º∫ü¡<0^c}áFJ
—ï¬($ï8ñ≠ë•†,K"«Û)A
Ç»»äRí÷0≠ 
3
ÕJ2/
ú¿Û,±®Pë•¯[z W[Rä;+üµ™àßÅ[%d•{û*UÉòæ¨òèEã≈ò^ÃGómo=RÃjÈœô=|¸Nã¸DH/{\Iˇop°#§ªJ*ä4]yõP—ìò?º≈˛-Æ∫Ü»ã¯K<ŸÓµœ€µØó¸Ù? Å™^x ·Ò"‘ﬁV`êÄ>DÃ¯G÷\πÓúÑöaiûaöuØSŒì«ì≤è8Ï
MÅÆF¨$‡–ÌñÃ‘`P($Hg®¸6GENÄO!pëS¯QÈlÎ	X*ú]ΩŒ¬p∫K›πA “f˙h¸%ü!@˘Ñu.@ÃÈ‘?XP∆ÒƒNP·‚0^ás¯[xuÒ&’AØ,~H5>¯}Ò úõ›ˆ&jßì≠VX5\5k±[èË¶ô°òz¨"ç¶8
÷ØÇte{"{˚gL„B˚≥ÓÑ’B!OÊòn¿ˇ¥ÍÄﬂMÙ◊Üv„€õ¯5◊˛ΩÈ9´Â0f‘≥—ö‹¿6;CV3ñ3¢ÜTû„®'ÄK£òez–uÿ≈‚°πcùwGÇQyX,‰ºZˇƒ:*j{á°˛è˝Ó{@u—¯ﬂô©Ã\4’‡.Îi>&ƒŸD8∂ÿX_TˆÖz›/N◊õÙ5Âmz{˘ÆÚ›˙ûÿ€±A„BÏ¢°pú'ÊÙpW È€®]‘€‹	Ó<ß|ú˝\•Èöi˛)û¥ïôöM[&A£'≤[”“T∫)Aéqµ◊ó˝F£Ñöx/q/¡$Sp-≤‡)QŒZmZqÉi*4—X÷†~xÇ·è4ÖdxÁDxÌDË1zXVPNN+*≈Iû‹ AÖè:6’ÚÜ≥J¨9ã≥ ﬂ_UdµïÊ˙æ¡Õëıë≠:¢◊vÃ+ÈÙ@=Ô*‰ó´˘;˜ÓÜìô·¸@J´ÊTyG´e‹D’Wï¿]π¬C´ñsf$≤´“õ”T>ìÀ√7Äú¥WuÀPWûî„
(æD»—¡pƒ$ıò„ Ωìö\?ΩﬁˇòhÊP* <ö^á∑åg._˙p`	mîŸ∑eïßŒ>€“≥˚ì•+∂.YÖüö~;]ﬂ⁄∏t~≠*Sõ˙˙ﬁ‹ãßÏÅ_˛|iº^öö˙^X˚ÚíxY*ær˛l˚≤V≠ò3ª•¶º>Ω Ô6ÏuºBΩ1à¥Ò1kö<≥ﬁX`PZ◊"µÑ[¢π¯]û´cf{fÍå˘Ãœí¿|c/@î/$4ÉMËc˘ ŸãÄ,˚ê1ÖXg'’Jä.˜‡JK¡ùhQSâÔÆ9À
≈9∑ñÉápDÅ‘@ê,]yúˇf´%∑qmR[∏-⁄gÛ‡ 3 Ä˝ ùf	 ´†H>ÚK›Xæo»∂ãÉÎﬁ∑¥Ï¢gÚ?€Ÿæe{∫¯ı^{ÿægm_]óÎ•&iÓ<x¸‰[oê∑÷ﬁ 'AG_Z+[}9-~⁄◊°uÑüã>£Ôßˆ+Á’Û—O’+—nD	åÑ∆∏¿å¿å–bmq∏)öS:~ñVÆè“€ÿmænvóÔE˝òv4<®ùã^á°FñƒZ0Î≠ıê'z2ÎDü?Î9ç$fö_FtEÙCµØOOCAb‡U*¬cÚõ® C.<f3Héò¡õA=÷ÍBπåà—¸≤Bf¥ê5:öøå-éf2]ò:jœe’ÙzñêéÿN†"3Õ˛ ª©π„πü|wE[3£±ø¬·¬–MÍ5ﬂ^ıÎwŒˆÆ€Zı—.«ÊqŸQ‚1WvKºy’zRÀq9)ßπly®1&äù…IjùUfÖ≤˙b∫QYj‘àb–°ãLXcyeﬁÎÉ≠ê"ï^O9&LÒ˘PÏ¬S–≠s≠∞ÎéÀßæ∂îúp≈”¡uHöÀ.ü3Õ∫“µ⁄öàﬂƒèSÖŸhﬂü˜˛⁄Sˆ}{®Ôy¨µ™∆o|ag˚ÊÓﬁu9\¡ãıΩî˙†Ûù•ﬂ?r¯‘[aΩÛ`Ω¿ï ä„CÉHÖs“$œ< æÓŸßcèJgƒ3ûÅò ÒBj◊$5'èyNr'c§ã È3eåøÎÒƒ}Òê"dy˝Y_Ë„–•rÿêlp¢7ëzŸ[™≠nRﬁ®FúÃI›»‚Zë>âT÷â*›òy“ç—∏-§”7R§¬¥◊k¿‹œ»Zî¿ùñyd‚™êK¢™‰˙‰÷‰¡$ìÙôÇÂÒeR6ÃƒÛÑT£p8`d¨`‘ölàZI4êÇ£$W;>§°Ë&=42Ë§ïR5â}ªéñdâÛ/¥ôd“}ﬁÎ•πŒÌ<≥¡.π$ÉÊˇCwµ EqﬁÒ˝æ}?Ón˜{w<ÑpÀÅäxáëzÊV!TÀ® ë
ï@lEHS¶F€‘»DbT2õÒD%N[…ƒVã1Ö¥ùI[”Igj„ÿô¶5fZ[tF”&nÈˇ€„|‘)ÃŒ>ÓnøÔˇ˙=ÏÂù&d…IuíÂù&$À7%q g∞[ ñ¢∂Ç¥@§≈sA4ìßËê≠ß=)«„«_†¿ºk'¨=ﬂéº∆ëõKöÙsè-n4ËÕık‚qÑVñÙøzzœ%ËÖbÎúıˆñﬁ%ËâÔo≠®xä‡F ‡üÏJßFÃπÛTƒ‰™πZ”`ÊL ˚t{›∫ÊÙ∏(’ÈAîäΩ¢‡íQ≥<%côB‚êÊ“—îétr;CÖ˜ﬁÄWsØ$F¬
°F†ÖBµDk÷∞6Ç”·ÙÑ±∑ô‘œÍX'=!*1=Ëﬂ<ä€©TÕ R'A
L6Å	
^°0&M]Ò$ ?∫ Á∫‡oöá<Q€ŒıÛ6*¯¢†IBZ^`†¸ïçõü
W<¥∞Ï˝˜≠±&\≥Ωß.ˇ◊jymı•…_–KÌŸ∑jô[Aî†ÂÊ⁄MŸ/dc∑‚Ë,›ÓË.erQŒ£Á†(é“&™¿Ù7\ﬁÜÇ˙H=îÍ€Æœµœ=Óé®æ†0:≥⁄Q©WVŒº°$˝“n‡lYq»Eä√pÍ~ﬂ,á÷4êO&‡¥=v£;5ªIN…JÍ\XîÄºÇ‘π4ñ—ói3K '«eêìSöE.˚¯@ê+ä»·å 1Ã»Ë+E• A#¶DEÛCÓ‡ú€ËÛÈ4˛®„jÚJö¨íünHIÏ4ˇSˆÊÏ≈á°8v˚"¢I)"‚…A¥Ë4≈uŸ∏Âj˜∂¨è¥∑ópÑÂ¸¨ÓOÛ~@ÿt˚À¿ÇÃ°‡Òﬁ¡≤Ô°EBva}«É«≥gˇ¥e-Bg~”ç¯á:Ÿg˝˚oì€Z÷Ôﬁ—∂n[ï1ﬂ7#§óÊ=z¯ÈæãHF?›;˘’_Ωıx|t∑o{Ì–´á<xà(_äb ◊ujÿ,v°TN
©.Fãµ—-$Ú¨ŒÊ„’Zõ∆"Ñ=^ÕÌ°ΩπHR≥i^î$ØO“)Jñ¬ÇhÊÊ«NàhJD"§J¢?ê{)0¿ùÅ|=Äî7¨˚lÿÇÔ˙–Ú˝âT‚ª6«ó%„ÄDp51}óÚw‡ë∆!ß~[^	q[‹7!"f`¥rÃ¶;é\¢◊wº˝ÿ¿älk,∑vaUG‘5ú¸«ë%ù;˙í{pÈ±∆≤ ù€ìC––€/√ áKt¯¶QJÑù%4)aä5"ÓOäg≈Û‚uëÕ[ƒ≠‚ <`iéß¿ı ãô‘yÍ#¯eh"éÂxF¬<p¶›ã°¸¶„∫G¬OöµmBJ$n(ˆêM√Ò2
Zc(»ºâkÚÀØ1·/?Ä
ÌÑ
5√eÍ?£=uÈîCK–dç-¡Y1ûVigà≠‹	ÈåÙÆ¯ûÙÅ$’—-4v±ä˚∫4«æ)^f∆ôIÊ3é]Œ/Zπ-ÃãÃAfÄÌÁ˙˘~A a‹\1SÃqE|ëP‚®f™Y	4©(âÇƒJ"Õ12Àp%%À/—í$3#¯;f["îÁÄ%ZÁ¿ruS(6TœLKlwPùË
¿D©∂]±+	ˇƒπ∑&ƒ””DOΩ;,ÜbT⁄–vQ@Qòrpº∂—R‘hÌEœ[¥>€ˆu=m˝ ˘(∫¥”:Kﬂ©f›(≈Bé"§ñlãªŸìÏYˆ<{ùesÿv+;XâIFáïÆdÓ´⁄tù¢©±o}Qk=KQ‹@E-•"Î&XXHÒq∫£cB,À´ƒ*Ûî\∫$R'∂D∫#G"?‚éÒ?QNsßïìëÛëè"N*R©ÅŒD.G∏àôëK¿}∑˝!Àá>#õ–∆∞ƒálˆ`xU”åÃ¨¨∞!AÎπ‘∞[3ÀZ4Ù$4“Æ2]ô·Ï,xˆdj…BYÏçÇpÿ äkò¢[Ñà	r6Á¡æ¯™a.Ç#Gæ3ÃØ,åï0.¥À»1∫ö2rç9∆î¡¡¬ø«”&*â≈)¨åO ﬂ%Mt5ëSztU{|„ é66B>7ZB≈ûêè¯#øÌí¸∫= ∆ÌQæ3’œ"∫˜lÎæ9UG◊l<Z≥ùm‘.hõmçÕHÃ[‘6Àc¬{^{d’™Gö◊TH6‡Ê√≥„Kz˜YWlúY’ÛJrj∂á†‘Lßéòﬁ„˜4
m3¬ ®ñZ)T∫Æ©,gCõ∆;ú"À U1
ÎîmöÇó¸?hì‰∞‚$˘u8î€ß†¿r˜"úù©˚@.5iï∫“Ï$–1÷X~m˘“ÔP∞Ωö˙W‰‡«◊ÕØÈ∂rò¿m=œ\[	˙µ"uÄ€Ÿo.πä∆Ñõûõ>Êæ bwêä∏A≠˜‘ÎÅ˝¯ w@ÿØåàÒ_ÿøäï1våªÍPè	Ô·ﬂsÔøUÿç¬NÆG†5ªe?Iëó·ΩÂ|FKfg&ŒtÜ®{ÏI ‰•D{ö˝ƒvµ4{{ÄAÑ˙Pì'ÊÜ∞(ü^~∏‡.û[π+9	äYø˚¯á÷Õ](w_G«ﬁΩ˚/"nóuÓ˙'÷;=SCááÜÜÜHºΩ÷Ã~àW“oŒûÔY‚¡Ó]Ó(˜ƒ2+È•é•û Ã[ô"Ò∏iﬂ2¡ﬂ `~Óˆ≥∫,´.g⁄œjß”VU€®»ˇÎhóç«°êÍï˚<≠ÕMÑÔâßΩÀßÄÉJíòßM-±*w¢ÓE\Ùgèè"lMéÆÓ[%÷w∑Æ}n˚7◊ÔÄ“÷|À˙–JZ÷ü´V%Ø—£ß^?tÍÿ—#–ê/P˝†˚êY∏üE¢’±≠ÏFñ.qØv∂9;›å$∫î˜)S
N(+¨å‡MfÑÁ°øiÃIÖî®äsƒNë3∂∫è∏q≥{´˚Ñ˚ºõq´T—v¸w£AÑQPKå¢¨îÌ∫´ù'öÇÀR22›]>7ïä.™˙§øÆ˙dYm„ÍüKsÁCBvOﬂ§úÜIGW¸óÔjçç„™¬˜Œ‹ôŸyÓŒÏÃŒÓÿ±wgΩèxÌzÉwÌ¨„f'i‚§qú8iLj™m¨¥°™¢P•Qâ)®My‘iŒ£öHàµém;…TëçZm§&B¬B.T¶2&ı.ÁŒ:¸@Ç’Ãπ˜Ã„Ó‹sœ˝Œ˜ﬁ22º€ΩˆvêÙÈ√[äˇ∏g”˘Íﬂaéy»ÁÃ±ïy€õ„u>»ÿ∫ù<cú1Og∆[E¡Ï3„Í¨v%ÒQÚ∂∫ÏÚk’!ıê:.ü6~‚Œ*¬¶§◊≤%˝ò˚hzÃ3üwø÷"vß∑Ú}Úuw∞/±Ÿ‹ñL∫[)&än1Ylxâ”≈DTÕ(ÆÎ&Ö◊k;¶åö_≤æ∏ˆ©÷ì÷◊[_±∆[ß›È§zøl3z∂ıß≠mºùàxâd!‚56ö#¯è@˘;â¡‘À)&ÂE◊RNEPw∞Á€pGnkJ‰C8‘âhô˝©◊%QÖ∫îù°!ˇ–Í—[´í;J=¿·[®^JΩ"è1è#8Ìv%˙˚∞˝(~‹^∆∂‚$\&V&Î òÙeÂA;}a4îæﬁ=+Gfë[ªJwb¶ﬁ∫3µ˘©¶ÍœO5∑‘˝ò„˚^t´∏ÀÌsœ®ﬂw/ª∏|¬UTB¥ ÈQ'e˜Sv{Ø
@ﬂwS⁄zk†ˆ!ú«ƒdü¿ãòE8ﬁ&˛ì·<â±7Ä>@	CßÒ`ËHßÌ¡∏∂É⁄^±ª`{π{¿§÷ÇÅqÉv≥}¿~¬&ˆê„z<Ë‘fuÚGsKïz-[»Qw)∑Z›®&•¡®ﬂÆ+™£´T|Y€R˚ç' F9òq¯ÎõjI1ïÌN*%à–Õr…óÆﬁ<ß">È/B©À@“Å6£’è´ÀUÀ•–=êŒc«¯¬#G∫S¶uıg=s„£d´ˇ‘<¯D>ﬁò∆ø~pÈo◊WpGnÔP∂±#nôzˇ∆œû}Ò≠oø¥n„ÊÊH≤…j¸¸é˛Áø˜˚	ÿEÕµèôÔr?ÑöÆ∑6é@∫IkÉ=⁄m8(ƒ,e#≤ç∞âmÉ1qîIP¢4‹Adü≥'lvö9õµA¢NZòBÊ≤xÅBß¶»bá‘Å@% î†"6e”∂1dïÕWÕ7Lvƒ<a~«¸ùπhr»ôq3o3ÊåûªK&˙'∫'6 NÃ"≥6∑~∏Æpó*Ω°%_·º‚¬£@#ÙŒUÖ[¡ gM?¶6ZB™'ãù≈îŒ<='g3;¢ø≤ÛÈí,>˜vHzæ∫Ô´π∆Ü≠ù{∂Æ«øùˇ«’ >ﬂîyÄ§Å¸¿≥˜ÎèÈß8V‰c|/”´˜3˝˙_¡W>:ë#H≤LS˘∞ô∂,DRã¯,!Çk∞ÁˇKˇ°º¿Åˇ-ÄÍ%ÊøÿA%Q‰˝iÅ¯”ÓÍ¢]vWœ/?|~'é5Ô-o≤«^:¯˘SÃπjt˛–Ü›O-‡9ê0Ox–Á`û2n,.Îtjxj‘Ä¿¯p
Z_Ãƒùû¬+Û¨Hääç1XGt$µÀWdˆˆ¢Y/HàìMìS®U.†yâuHöñ∞™¯c…¢] âòG*ó{asîñ<CFë%QdÃC_,©Ùçhc∂ ´Õj^ıT¢⁄∂í “n!3Lﬁì	SíIôÏ&,πƒ‰Å†ùÇJ·8@ãc e»≠MÆ\t‡V*U%∂kÎ°-ˆ}üüRrjî0|ÇøµsP∞Ë>Ö_'¬vWwWw»≈Í>ú˘uèÕk°wp¢
—[˘”œ∑F⁄€ô¶zLE–Î!¶
ìÒ÷Ad%ƒ3í¿â(¬4ùsSlítE1rléO %∂ƒog∑Ûgÿ3º®—ôé∂mÉ ÑpDî%¢4 áD8SåIñ¢$Qñd∏v1+eîu®õ€(ˆ°mÃ6nªpøxçí„‹®8*W∆–I2∆ùOJc utù\„Æâ◊•k Mtì,p‚MiAπÉÓêeÓ∂∞,ﬁëñïvn¶ˆæ'6ÙHå8Sª·{ıîª˜ıxä¿±ös°ï=0´K¿¿òÈ}qæ>µ†#{‘ìy q2H§ãN5ETäá˛ Oø-.>Sò‚%⁄ùﬁgX§ƒ·-VA&
ÀI≤ ¯Ä p!4?	IZYc4Hä¿&k(1?Çd8=ƒbm:écÍÂYÏ‘πäXq¢++Nl%ZOT_˛Ú™F	ı˙áÓ[§˚_	yÅÍ‡Ìc8TDëZˆ‘Ã¯ˆ§ZÇ	ﬂÿó=Ö^YÿgÎxÛì2ıÊÔøäP^DÛ+Lú`Y<\ù¿˙ïã8x·*∂™ØU?π89∂ùô°Áøn0Ø≠Añi’=d/dY¶ç,á√¥ÓFï`!QÉÅû.◊∫Õ∞{AñU÷¯É¬<	3˛àoxH«~∂^PÌ–≤(nÂ≠ã]Ñ-ÓWÂtÅ∂û—ÿT∞ »§ƒz—X·Yñ¬å'2æ«`Üz.!Ø±´Gy íÕÀ´®ûXâÅ•;p≈èz.wÙ…Å–“ËÉJG=Ù∞˚t_˙°¥P/y=‡ï˛âÖ(
ì$Ñ.’aó/^`Cx=¸Ü˝Ã’>ˆ4U/áC·#ZÜú^úá∂ì‡◊«Æá[–ÿ§õ…P‡Ï÷pÆz'´/‹ó∫oˇ≥É{v≈6>É–kÃ'ü2≥ïÉ˜∫˙‘c√Te|»åA^B2—;ﬁ∆íÅSz´—≠≥gïÀ˙UÉ=¢ìæ¨∞H)èHÏ7§óîqâÌó±' „2+ÎFP1√Ñ13¯OnAU$ë U£u÷=-TæÆè¥cºn¬Â…@@úaNMrÔ	‡Ωâﬁc]X"xÑ}ã˘≤–ª8
iZŒUzóVññ°n,ÁñóˇÕ}˘Uq]q¸ÏÓ››'¢"CDQ,¯#—gmåiF‚@¡$ZkL‘v	L¥#Iù¥‡(∆_ ˛¨55M¿¶˝√ÇmüµS≈HõLÚ“åÕd,∆®⁄…DM
<∂ﬂswóYWm“¥˝ßÃ|8˜ﬁΩ?Œ9˜ú{Ôëm_Ÿ|oF¯∏EÊqî;?ÃWT§‡≤å+èr∏ßoJ_-EÎ´Ñ#ÍÆõJÅ¢UU+⁄˛£’G‘rı–ÊÕë⁄ò»yulgìZ)fÿ3/hOkÙ≥∏Y®(ÿ€à2c„˚ıâV¢≥Z˙ùP{ƒˆA¯fıl1πñbƒíAÊ}µZUzííJØıÍw_t¸ÍﬁΩz•F/J|Í-∂∑_v[Ãá17#%3Qƒù√⁄óˇÿiä2O®Ò∏¸sÃ-Â}]WF<S8!˜aµB	£\R À⁄”çk+W%?sœíπ]W∞….≤À¥≠;Ãvî£;≈ê6ò-=≥®O¨Àµ˝Z≤¢â¢=vdyÌ»JéŒå˛;~r	¸⁄öt¨ˇ°R∂ÈÒ/oûÄÜ9∆§xÀÍ|%—6D)Ô¶$/)úê7C≠–Îœ≠›Tî\KîƒÓ"úN§´/éºp.oaüÏÅƒ Òﬂ¡KŸXû´∂µ∑wFb('o1Eé Ê‰ÆöCÌÌÌkcdã˜Ø◊8√iR':‘“	ÌZ%ä)L7PÅ~Ü
ï+Ùæ≠ ”¥tè8LyË_Çz1‰vu¢Aˇ|på3A*X Ê9ÃS1¶‘béÖ<èîóhπŸD`-’‡;`áûOU¯∂”òHãπkm¬)(ÔB˚>£ñ∂¢\ÉÔ‹WJüOﬂ∆˜tî∑Î˘ñeVíâ6B9Çˆx¨øçuÜL≈˙≈¢ÿjCy8Ê~ﬂÀ!Û s}˚ÀÚ%#me7p˛)C˚V0l‡üâqÉPØDπ'ÙÍz¢{—'[}Äé@éƒ˙”ªI⁄;∫mÇ˛Rß;ì«˙yÅNl◊5–ﬁÙËÊßÚäÈ[⁄πls/0Im¢o¬/]ló~Ÿ˙åA‹ΩªÄ.ñ–® Yµ–sä~újP≤%≈§àΩ¥Rªé=8Nkçj˙)⁄In“ıcJ2Ü–¯o>Êüûƒúße<,a¨è!âÀx?”"∞k7∫~bﬂ†>˚:};9‡◊¿2¯†¨f˝∞~˚˚˛ôíﬂı*˙^ƒ:è0Xsê∂€˚J%_ÑππéΩ∂¯æ>}¸úb\dú9»πjISk≠O!˚Å$–∂rºÅE`"˜¡˙QË%„1√±…Ò¡±°üë±:óu∑mêπ∞—…ôÔc¸êÜáÈ1áaËÀ˛YÃ1À˘‚ŒÕ±≈1„J”+d‹üe;9¶<rá¢Ÿ¨É\±ÂJŒ;ÃªÜ•'u⁄≠Öi«,«õ+Ÿ/kúèúéúÂ±5›…ëtå(c±ËJ◊›ÚO¥sÊ[ß≠î#.PévûrÙ5ê€`ﬂØ–{Dgÿz4¢4ÏÂ£ªÀ'k3¨,«Z/ä:¯"L˚§_√ÍΩ"¨ËzùuM'•QØSÀd˘6ÈG	ŸﬂX2ﬁoˇn˚WA}WØ£•(∑ËaÀÇ=€8'ÃV%$ªÌØÉÁ¡¿•&∞B9aÊQåAt¨A∫_“¢)"éÇ”¥Á…swÊ?£¥R%ˆÎ«f•h◊p6b-ı]‹ÄÁáúÈâ£[bŒKÆt„’/9f¯‹Ö‘!ëwı†\p¯+hF<Œ Ò›¿Á≥ºpFÉJ;^≠∂Ó¯l§Ωêõ›¯Ù≈Èp_|ö˛∏ÙKæ[¯|ówÚzT∫ˆÛ˘»güë|ŒÒ›Áˆ˜Kœ¯*úñÁp:yù2AÊ8Èú#x?^Gé^5ﬁ∂Ã)VÉvŒj0vY/õ+¨≥∆qk/ÏNÎæSCˆY∆˘‰ﬁ•Ï'æ›{TO••Œy∂[ˆ≈˙ÚÕóÁ kêÀi1Ê=œ˜*Á°∂ybæı‚˙ûh¶-–ΩèˆKª]Ã•>E) h«ôŒﬂ{j[‰˜9‚S*i(øπá˙&ïø„1Vìlªd„6Ωêv"Ó2ƒ˙ô~îÊÛ^±Í8ÎÔ=r>)<Ì3	1‹LªE;l¡∆3RÓëÒƒcèYÌlü9âtˆq¿cÙ}îÏ¯£Z˙"$}T%cæ‡9çw‰{ÉÙ˜–ˇ'¥.EªCq>›†$gâ\Î(Õ•ﬂÖºØ?A~¥"∆Ú®Bˇöıˇá-KkGµ"øﬂ‚(Qo•=»•
È[n‰¸—Z)écˆÂ ˜D+b¸≠6ÍhìB‹ÖqÑ±o≠∞ee°ºU‘YË˚ Ê ^Ì≥Â˚ÑÔ©†ı&Áã¢˛fÎ£Î ﬂXWª}∑SŒí©ÅVz…‡_Ü§£q e#ÎœÅ2∞…F∂≈ÿRå9÷qª˙$ùÖ*ë•p.àWë{{h™ˆsäKÒ~h°ıjïk9àª6‹≠„∫HßaZ=¢}.Ôür=ä&»~Ò∏«Ø“,QÄÒ!Z"^ß%öÖrPÖxƒ8˝Íﬂ≈;Î	Ã„†é«ò4ÀÿàrÜuò˚…5>∑‚±ÜFÀq§Æ.¨ÛAèŒU∞Íáà÷eØæ¨k∑ûééw“O⁄…ÛbúÏÛö
?ΩÜÿ≤k∂ZIu‡ÄzÔï)’V=¸:›«o]î)`¢åˆCéÑla∞ú„ËGò˚‰1˛]¿®ø¡ŸâÔá¿Ø¡Ó7/ºŒù⁄Ωàè¨zo]M5gz˙≠ﬂdˇ˝4V<ãs8”™g¥Räbåﬁîf(MmF{>∆˘Í˙0⁄)V¢Ô“æHß˛2=~zmt˜2˛KæG&≥D~ç‰˚˘?—Ô´Ä˝}<%˝Äæ!cË*ﬁ‰¶uZ9IO(≠vúÁc◊)I˙s?ıu˜	Ì≤›∑àïÒÏs; Ÿå[˜ÔÎ’1Ô2/n∏ò£)»à–¯Î∏Çå¡1ñ~{Ω{›ªëKc·ßÈ"∫4ﬂ^7b(ÉQW°^ÉÔ—P¶ªûKi˜e‡€æÆg‘fÃhsméÏ?ôÒ¯u>˚UÒX9^ÓèÁ˛˝¡Xø«yÙ!ﬁÃπî‰óﬁúıÁ≠øÕ=KÓ‘«óôwõÛˇ	‰Œ9p¸·∫‚\!ƒ*à!ºÈﬁ∆{„ﬁ™/·7ÊTI© Í8E‘πÁÓ‡Œ_†-ÂT»O@¥-Éƒm‘qÂU¯ˆhƒ◊ÈYÁ]ôà˙Éˆÿ»ÀŒ|CÏÒ<ÆØùéÒˆ¯ér∞Â?DY«i»ê7–ˇ∆@‚–πr,Í≥ ‚°Û-‘'‹˚ù˜Ék zv‚”ôÅÒ˚A)øGÓ;Ùø+ÔÚ˚„ü¥ópU≈«ø{œπÁ$ç"è@J °Xù‘GÖjÖ-¬¿ÄIêja¥«—Å≠ujá¢F‰5îá°-—ÚP*Z¥ïZ:<,P®èäU”B¥hSEr∑øoœû‰z¬MDÌù˘Õ∑ªgÔÓwˆÏ~ﬂ?≠≈«©]´9Ò7yá¯‘6˛ûmÿ‰]#˛˛mŸ¯.—¬∫u@ÛÌRrÓ>≠ﬁqbÀ˜¸»qé˘sL#ö2¥:-k5∑ÍGg≠ﬁ>`ıd jJgYOı£ùjg’ØÿGÌ=o/˛LóQ¯Um˝äÛHNlM˜ìõ°ìÉ∏'ÙŸá?Ô{ä…Ø'–ñÛâ~#ÃK‰ÆbbÓ©ÁÕ	ÏnÍ›»eÖqNãckã€2ß˝_Îgö#?CN„òí nüÏH>Ë∏@IÊ‚3•≠‹˝ôsyûùõß?o=ŒÛ1ÖWJπ^ÖﬂWµ‘•I–VΩ-ù{¶ı§Ó»©oTZynÎI]◊ì¥xﬁrÔEz¶+Á-&qÓŒŒÈPˇÛZ|^cíÁ∏Èºπzpü\√bõzB˙G˙Bçªwı¢L4˜h~+8%ÂÎ•ú˙”∞9ä9fBî˚LMÍ∑hÈˇj»…ﬁO=Ùw€æ◊9&¥µüì˚Vıπ’á¨ôı}>ﬂ‚∏Ñ¡–6¬ÌMﬂö;$sÔ»ºzœı˛iN0÷â|Z0üÂû7MÔ{‘ã©ãKÉçRñŸ*+(?à-¬ﬂß¿çƒÏ™Ãv”l≤}n‡Y•ˇ∫å&ŒOŒxrá_g÷”o îp’ò&5wB»óÒﬂ9îK±≈·1Y¬8Î˘ˇ<Õa	y∞A™Ç!RF€Cöá·˚Ù˝k˚ùÙ€RFúÔŒ≥g˚Sôá|Ùµ9Ê⁄:˘¬{’… ò‡_*¡Â<˚\ÔùdÏUˆø•Øêﬁ«≤¡_/’å˜l—Y\∏]>Ö’R~Ij˝i≤®hê,Â˛∂î˙ÕWq^eÌ≥qÌ∂&Ï&◊È{3vog+„wNjÎﬂ•ƒ’ÀÕ™‹y„ˇT∞6„xˇÌ≤î˙Ç∂¥„\˝·8JŒßπŸÎfvGV~Ír¸-M9øZÆaúØRÓg◊v•˚⁄˘ñÿ\MŒŒ¥cúv÷wª∆I_‚πXó∆|Z(÷&0ÃÓõ:ô©{å˙≈–¡µUZ]0DFÒΩ∆@IÊA)ÒÁ ∏Ù≥≠©öI˜ëø«ÓŸπÍß¢˚ÀÌπEÈ'8£ØI-˚˚eﬂË~«Oÿß´um˝£Rc}\/≤èçåc≠5√Ÿj¬Ú◊2ó¬z©?é˛Xª?ª∏ΩYÍ(#¸'Ïûiœ˚Z_ÄÆ›ùÏ—K”âgú©ÿ⁄µ: ∫œï1ˆ—TﬁZˆ-Î„≠D_’…ıqﬂÇoJe8á˝˙{g&ÛóÓ¡R8.%¡%Ë√πº˜0˛;Sfß?êr%5œºìˆ)„à‚âî˚(sbè§ÀﬁKr'Îµ~ãyüE˚ŸæÎdí„"%Ω&’ìÁœA\>?*€∂]é«ÍËgﬁÜè”Ô1wO∆O„◊"üºsŸ´	¯œM∫·˛<kıI*í_µì–ÆˆÀI\{◊$¥´öÑˆ°ßÒ#_ø|~‰kø0	Ì~~‰∑W⁄{µ‚ﬂ»$¥è<?Ú≠sÔ$¥˜n≈è—IhùÙÉ¯Ùº¿ıiÕü‰Íª±±W`ÔÄ')sÔ5ì]}áÎwk3˙3›W√$˙êèÕª(åmFÁ2£ˇƒÛò€(◊cøÕ•ˇÕ>ÕmqsfW;_üÅﬂÂ‘’wÊŒæÕgÁ∆èÏñH«òÂÆˇ`7Ô„ëﬂŸŒÿD˝ıπæ£˝ﬂ„Õéü!é7Íª]€å˙û›@˘Wëf >Î÷rU4o#˜D”˙ªÁ≥õ„ÇÏ‡û8üx8CsuAZD≠∆ZsßHáú\e5Âükº∆ˇÜt–påQ§∫Ac∏ΩO˜Ì}ÚÙ	Z¡“õ<≤ü˙€åÒKˆ·9ƒÕY“GÁ?@Ø0∂Ê]’ﬁ~´X≠±’ÊÍ!öäÆê	¡ |:.]ø4‹#5¡D‚itó=+ºï˙-ËéIu åÇïRæ sOÜìØ*‚ˆ¯n‹oL¶üú€≥…Ñ¬ﬂ”>-’UFÍ|·%R≈ö]œ›¥ÎÙûkøªÆˇX/rÍ+0 ˙åøÿÛ∞•6´v“5Ÿ)≥ÒßüÊO÷Ì<?%gù9Wß§OXàæÿ,≥”≤,úD?ùÎ™Îö÷æøwT:˚§_Êg“—Æıc2-xùuΩ-Ì,˘°&,ù3ÎxØZYÓÔ`¨ZÈëÈ(]¨v8`«él<∆ÙÃQY¡ûËö‘5±éj“7{ŸhÅ¶9‹˚®’‹ôÛ˛÷ÊËªÓôç2ﬁøMæÓüt˙0acü¬R∞{`¢’_W ƒrÎzlìäL:˝©(Ë*=¬«§ãÍ≥p2{Sı9:Ë!˝3+Ñ3n*¯>;±w¡wæ´›ô{÷πÿ1.j∑gì∂∆ÂÆ}*‹S¢Á˙Ã‹ïèE„€g˜F˝5Vq÷Rú®Ï1G#|‰ŒÏáZŒYÁ%V”∑¥N◊Àbß[[∑	˝ôœÍÊ;ó‰Ë·HO∂¥£±É„:Ás_Ñj9≥'÷—IKﬂZ´Ì¨5Gù=ËÏK∫◊TÎ%méÆ>≠Õß_õu¨;g±çtıÉyÏÑX_∑eõÙw€§◊€≤’∆húäm¯∞Ñ™AcÎ‚XªfÎtyÛ˝)i¢”ﬁt:Vı˚÷˝aŒ‹Ë÷–}ß¶>h»µƒH˛Bé>A˝ D¬'M}¯d≥’ªbkèøG»/›M}A˜\+|ûa6√6xﬁÖM∞’Kôz/≈<L=Z=«í;ÿ˚…∏”‘2o-ÛT1Q<‹âøDÕw≠Åfó0Àˇn≤Ôÿ†π∞Uˆ0j°‡ÊyÄˇúdûì÷6(Ò∫«ÎØÔvÿ~ØÿÁx~7ÓÁ˝éåY”˘øãiPæ®˜nÕ˜ÃvÛ2‘2gÈw/¡ö%·Û<Î˜!ﬁ¬ÒzûÈ[Ôh`]ˇ◊ÂxûÉÎﬁÚÿ
Û8ò'πÆÆgQ	ôW√kÃA=ﬁ≥Ê∏¢ZÍtÎﬁl^fó`˜ü©ˆé§⁄ÎŒjë∆w≈≈æûÖª…_ƒ =4◊l`oÒÁè2˘ìöœ\Îb*∆‚E˚`ìTzY¨Ân€éòÙ7sHaÆYéùéëˆ3Ü?EÎl€ìã7@  ÉòèYL≠”€™cßEdGÌÕ~≈±◊G	s◊ﬁÌFæw±’/Àmôî¢yjT/ÿQ,#¸2MyéÍ’ˆ,Lóã—Ö„=YóJ!∫±NÆµ°ﬂZÛ±¢ö»~ß:Ùñ±˛[@|µqë8È˝Í˘ÔªhŒ*ôÕ≥ˆ™}t’É™ãº:÷ëò‚≠‚éãrˆ~ç≠ä=ÏΩRûöÜF}ìÚ(£˝Ï]p7Â±˜¿ı∞ŒµˇX 3+CYÈIøÕëµ§#“{#ºÃA{z˝f…≈Èz⁄æE0¬°}ûG„È≥°∂_y˙såí"Ø‘ï+xˆ:†@t<Í›≥∏œ–Ê>ô˜dx—R4’˘0«l…1[RG§ÃØîs˘¶g_2´˜°gúé‚¥ö1∞í˙˚È?»≈õÅ V≥≈{úÕÏêÀ3•<Ë$33]d$wÅ!A1y¯:ÈC¸ÈèñÆäÓDYΩ€›ÍO7ß¯n≥º¯Òñe£≥[Çø Ä¬Y‹{ˇ«~π GUùq¸€sí]I≤Ñ∞ƒºˆ"$ÂïdπÇä…. £ 6ZßZ6%lâª;…∆"I«:Ö0b§è°	ÔbC!Ω€!†A©c€±8∂é ÿñAùv:ùJùN€±£€ˇwÓÖâ¢ÉÌ8ù9ªÛªﬂwﬂ9Áû«wæã(CßãRHW´∫;	{ã\Ω⁄YÓŸÚYªÁz¢Ù∞gb…=Ù«q¨≈w…æ◊°_À{'w-BK∏}≤ãÏ?ÀÁa|üﬂ∏sÜ„9[i?Ô-'‰˙á•èÄl;17Pïc{∏lvÊ≥hwWÆâ9b6Ó@ }!˝83¶¸cIÁÏ¬˘∫æ% =pyÎπ¬·=kÎ1)»‰¸ıòÕï£à√#∞9Â¥€KıåH!ΩÛ“Ö4√3éf(€[ØúÁi
#[0«-óß—sÈΩØêñﬂ£©Ã≈˝viOÿ˚øñ=≈14˚QO%ÎŸ¡œ%t{9ã≤≥ÿKSPÔAqgˆU‹ˇ&øÌ√·_√æ;˛•ˆﬂ◊ÏˆüW√Á!ûFùﬂ≥oEÏ∫ñ„Ry<{ö˝«ä*D¸«∂
ƒ˘±+‘wY≠Tæ>c9Õ±(ß)îØp≥üa‰∫@˘Äÿœàø!ùFzäÌóXw„4láF˘Õ∂üb$W√f5Úﬁ∂}ñÚôÏ€¯¬_… ¯"“vÄØC˘Ñ=Ò'2qvÿùÛÓ ﬂM w
ª]ÒWÙùø]‘πΩï™¯¢^ËJÒí_^å1Oø?}•∏u~1ñ˜óÀ◊±*√}@LÛ∆Â„X˛“wWMÂ;€›†æWîﬂ¡Zñ_äÛ˘Œ„{í◊â◊k+MÄO)øÏª@Rí◊6˜12¯Ó¬<=~;FÆ∂Q˜4œ„ïØt—ù™¯8gﬂπU\√ﬂw¸ÌÉÏscæ˝.~À˘úΩ5Ôˆ-‹É[ráÈsŒ}møÎ∞ü·q€ó:˛˛Å]“;Ï@—6ç}‰Ï∑…}¬∆˝GËDyÀàÚ±gÚˇr9Wùµ)àbºEËÀ{éhÓÆb¯„âËØe%Ø⁄¯M∆Ur5fª˘wUŒ∂©Í'20∂)àvØYk3ÌêMı.õöbáçÔe:ÓÜ_%ö9J4kà®c©ÅùDsÄyùM⁄lxÅh˙òü"jå-∏√Ê⁄ —B‰ﬂÄ16m'j>O¥Ë&õ≈œ|∫YrÓìÀçXﬂ•õ4çF£—h4çF£—h4çF£—h4çF£—h4çF£—h4çF£—h4üp\DÛË-ZHèêõy©ûZâ‹oãß(i¢B:Çß$˛}Y=Y˜–q§\dˇÊπ¶9∫§âÆ€=zá£ª°˜8∫áÓtÌ@MWN∑Èz”—]T#nwtAÖ¢«—%ÚvÙËGwC≈—1ë•«… ì¯œá°ıÉ\NIJÄ4›G)ï≥©NË¸lC~\’®CIà:7®yÎ`ü¶.ïäA∆P˚n<€Q3=[ÆWu⁄@Zµ◊é:wAv“‰%iÌˇ0n5°Z¥ÌZëä#≈Ω¥
ZõJŸ='ê[ØZ0T€Î’XZÉT7J”j¥\ªÓq√Êëı1cy2ëLﬂóäãìù©dg[:ûL‘°é£%æn}∫Àhâu≈:Ôéµ◊≠l]÷≤‰∂Y°Œx[GÌ¢dG˚Ú»GÀR∫Ô2⁄åtg[{ÏÆ∂ŒFrÌávoƒFe≠âx:÷n¨J∑•c0N¥◊';ç$J:ç5…ÓD∫3Î™˚?.˜J,¿2‰/°€h÷ò≈Ø•Eh´uñ£∂[á	ÔPãˇ—l>ŒZü⁄MÈ∏ ~Ü^¢¯˝(“*êáÈ(Äè¬” ªÅ§†<úÒò¡cê≈%JZæYÊpv u*øˆfÔ	9H´©ŸÉV+gfÇKL%Æ∑e˝%≠qv±ßƒÙá `V9⁄
 O74H Y Â!π◊ZÍG–PQ®DÄg‚ydÅƒË‡]–õNNFµ/ì7ûªﬂß¨ Â>X·ÈΩ‡(8r)âÁ »	m/ ˆíê{ÂÀÎ˜ÜÚÂ.ÍB~áä\.Ú£ıùØöõogä&ö¡êW~ì¬@–ê\N£@†ŸGaˆ(	Tø≈™ù£¶ñL~°ÈE˝mÙ6d∫‹çßK•ÉÄÎoÀLÙqÛZEî›˝V`Æ≠dº•f≥p/πdL&h*˘Âf»*»5êïê_íÌT†∆ÃyÕ^Ù◊åÍÕrÕ@qH˙pŒ˝râ,£rU≠€*¥˚È∂¶œ4Ò∆ãe©™R$h.‰8È±Lø1"ÉjÚ∑dÚÆ‚Òm±ºìÃìÚ!È°‘ÍE≠…˛¢ì2+õØﬁ$í…+0˚C„eØ¡¥¯1Ff9°JXh(4Aﬁ(+»á≤≤í&A.ïUJ~_Ó°•êèej*¸£#ÚÎ j7äÓõÏ≠’î)(4GCy≤	•Cr;`ªÍº?S≥¿§PçúN 0«=–z‘¶ÔÉ÷áUÎ√Jıa•˙0®>Ï>í[Q≤uÍÂFJ…{®@Ám5…¬Ñ+e⁄tsX^-K11ﬁL•πeôºBY©U<QU+Õå/4õO .ÏÛ.¥îÈÃ‰R39"g™Wôù)-gÉîÖÌzRN∂óÜ>^íì≤¡S)´¨I˛°êiﬁ»~râ_äÁyíƒoƒãº‹‚“,Â»Á˘k[fG≈Ûˆ°/∞<™o†±’‚w4 MàÒ4úø_ú«x‚1LÕê/#›9Ÿ y‹öÚ¨ˇò8ñÅ¿ÿøk¯¯e≈”÷¨zGÒW; ‰rG)ˆô°jÒî8Eh‚%»iêßƒ(]˘$d)‰®H”≥ê?ÛËz»;Ú¥8¡[\¸L¸î@f¨B¬êÂaq‘r≥8bëù
◊˚Oà#bê PıáVMrej¶˘ãF–ûKi´“_ {\üw˝ïv”À,©XÏµπë~ÎÑ·˝¢?X⁄¨÷ @u†6pP’F≠—h4B^±d@‡¸ämx6í!∞{@Ùã≠VN„PËºøó†^<w+-ägJiÑß˜RÈ•5ãáhhc3ËΩ‡+ÿ˙≈Fp?ÿP9i–ÓÅ7I¡"ã,R "ã,R∞H)ãîÍΩ∞EQXDaUQXDaÖETYx£∞à*ã0,¬∞√"¨,¬∞√"ã∞≤¯Èe€FÜ·ôçÎ›§M„Ñ(BòMÃ⁄ç7Nî‡V≠‚µkÉ¿á§I@k⁄ä4U§r¢ím"˛“R©ÍèÑÑÑê®πDeº¡iÉ)‚àÍc8·Coï◊Œgß-"óäMøy«3Ô3ﬂxf∫Îù1bäÑ¬··Äp@8 "áàààà1111"b b bDò L&ìÑ	¬aaÇ0AòD@@@àÄÄÄ†˝)"QQQQ'¢¢¢¢NDDD][,∑‘íø ©©©RRRR#§§§÷¸ÍZ«f	qq°ÿ∞`7¿nªA«´àP¨!AHí	BÇê $Ñ!â(Å(Å(Å(QQQQ"¢D∑àPƒ” ßﬁÌSÓx÷j¯ÈyˆÄtâmë~¬ §≥e“èÿE“YútëÖH1iÅ	É{"ﬁëÏ¡-`Ò‚=ƒƒ
‚.Bß⁄=ƒÔàmm‹ÙuËì˙}Eø´ÔY—Î∫÷·üÙﬂØ¯Ô˙˜¨¯Î~ÕLˆiÌt≈≠Ö]£Ú< á<DP&®ñ–∆êw˜Ÿq¸çicNÁüÊ√ø·w#|%¬ØEx≤U{ç˚ËNg≤∏Üâs◊Ÿö[àx(<Å;”’’œ
/Ùä®ÚıÜ96Ù¢åXF\Dƒ£à(¬Bjã¿Ô:ÉÕ!◊aƒ ¬T)XO~ vuŒö÷Œó+ø¥≥Vï'| ‹/ÉTΩ$‰'/</í≠|ïÖ’Ø"˛#vÓt≈˜—˝CCæ˜ƒ»MOåANy·Éê^¯WëlÁo2·SËlSgΩïN{‚-ÿé{bb{·êrGê»BÔwŸ}®’§^jd
z‚d–áï€`aµÒ‹œ¢4Ω=•-LË·w}‹Ÿ+˛_à¿ˇ¿¬‚x¸fV}ê{VïøÂ¥âıË70'ÖólS~< MïJÀ÷eÒ5∆‚÷™¯JW£UÕW0ÔÀî¬Õ™vÀyF\1QàﬁyÒÜ8-¶≈)Ìû8)÷’4Yéª⁄≠U1Ö_«∑∞<ÒöU•)æ*>éã√Ê∫Z_v®1n<∫ÆVÄç6≤øåıçXUu∆ﬂåWyß—ˇ“ØÎ'Ùî~DÍÉ˙ãzøﬁmtcø±œh3√o¯Õ`FwuªÓÿ«∂€P‚˜©“GıÄ¶J(ô∆çΩ¡‰3-Y-;ì‚YπqÜeÁM˘˜L∞ €éø-˜S\veYv6%ŸŸ™æ=-„vVÍS'‹2ÁWshï⁄gUŒf›*ﬂVMó˙d◊1t≤KW˙÷Áœ]∫íÀ±ﬁû˜ΩâÆâŒ√Ø¶w)Êö•˝¯Í}≤⁄/øÃŒ∏Úª˛úUïÌ˛\V~:cût◊¥≠=ì^”ˆ+…πkæsZGfZµ˚Œ•s∞›'NÛ~ÿXX	lFäô Ü˚IJŸ∞G_8|J‡kkg!ÚÖ⁄⁄…Á„ Wﬁ23È≤ií«blã<[{¬É6]Ö»4π´\‹ö4±!HX¢Ç,øÎh ¡)ô~l±öñÒGñq ’¬{D√”}`«”} ˚^)õWFäKõôÖ`f.òY@Ã…œﬂ?€+/Ãõfy©®:LŸöõ?sVÈÈY.§ÂR0mñG6wÈﬁT›#¡tômff›Ú¶≥êˆFúëLt:WIuìˇ u˘Q.˜Ë.ÉUÉπ*W"πKwRu'TÆ§ ïTπNÇreﬁUÁ~ -,ï;v≤°moŒ\ﬂ@.’87°Ù⁄ëÅﬁ•æ€>∆o≤ΩvNÓ¶d;BuEì—§Í¬ˇ3’µÕÕÆﬁ•#}∑˘ÕfW Õù¡€YZ¶LY9~<+fﬁv’QëŒÈ›˜,Ø.ÍÓeôw”¯áœ
¸=Èd˘]Ø¬nW±XÃ´¢hÁÀ »LVær3—u§öKÁ–vpß≠•Ö⁄ ≠≠ôÍˆ:mLÇT:U≥πçt⁄÷•k%I◊‘´B°Ú|ˇË{?„	~Å˜8m—°∑à≈ †•ﬁ_
ï·ÒÜ‚uU©˜¸¿(2T‚@ïZu:£®\∑ÆGØ«KV)Zä˚—∫∫åF±¨•ﬁr+ÿ˘ùÖ@µê√bcZ*ﬂ∑ﬁ˝î∏§*∂ù≥Ûú÷ÎøãÕw˝—¬Êõ£Êi¯¬ŒÜ4⁄ÛÕA∞çÏ≈¨ÿÑ®≥HPcê∆ßG≈„ü˛` V€V<endstreamendobj44 0 obj[52 0 R]endobj45 0 obj<</Filter/FlateDecode/Length 568>>stream
Hâ\î]ã‚0ÜÔ˚+r9s1¥IN¥é‡≈~∞Œ˛ m£[X€RÎÖˇ~kôÅì„˚Q9yπ€Ï⁄fT˘œ°´ˆqTß¶≠áxÌnC’1ûõ6”F’M5>)}VóCüÂ”˛~„e◊û∫l±P˘ØÈ:wı≤™ªc|ÕÚCá¶=´óﬂÂ˛UÂ˚[ﬂˇçóÿé™PÀ•™„i˙°oá˛˚·Uû∆ﬁvıtﬁå˜∑iÊÎ∆«Ωè $÷ò©∫:^˚CáC{éŸ¢ò^KµÿNØe€˙øÛ‡;û™?á!]∑”ı¢0≈2ëá,4á<¥ÜfP	Õ°-T&“¥Å4Ùh°nQ◊i»A¬ô≈ôê@3»A∏∂∏÷+(@d∞d–d∞d–hΩCÎDgÇ3É3¡ô¡ô‡Ã‡Lpf"x1xº‘uÉ∫†nPóß:Ì
ÌZ⁄⁄µ¥+¥kiWh◊“Æ£]ãkákãkákãkákKüé>-ÆÆ-ÆÆÖ^<Ω
A¡£ (xèÇ–íß%Aœ£'<1œ‘˝SùŒ<ù	ùy::ÛtÊËÃ”ô£3OgéŒ<ù9:tÊ»»Á»»Á»»Á»»Á»»Á»»Á»»Á»»Á»»Á»R>g∆ï‰õ·sçœY:”&9”s·&â÷èõÊÒgO$M¨ü-˘œNÀ‚Îõ4±ﬁÃ“D±JÂπ9´e⁄ÄÍsoU∑aòVVZìiW=∂T”∆œM⁄wΩö¶ÔÏü  çˆ>eendstreamendobj52 0 obj<</BaseFont/QULRDW+ArialMT/CIDSystemInfo 53 0 R/CIDToGIDMap/Identity/DW 1000/FontDescriptor 54 0 R/Subtype/CIDFontType2/Type/Font/W[3[278]6[556]9[667]11 12 333 15[278 333]17 18 278 19 28 556 29 30 278 36 37 667 38 39 722 41[611 778]44[278 500 667 556 833 722 778 667]53[722 667 611 722]58[944]60[667]68 69 556 70[500]71 72 556 73[278]74 75 556 76 77 222 78[500 222 833]81 84 556 85[333 500 278 556 500 722]91 93 500 131[400]179 180 333 191 192 500 380[604]404[604]3032[83]]>>endobj53 0 obj<</Ordering(Identity)/Registry(Adobe)/Supplement 0>>endobj54 0 obj<</Ascent 1006/CIDSet 55 0 R/CapHeight 716/Descent -325/Flags 4/FontBBox[-665 -325 2000 1006]/FontFamily(Arial)/FontFile2 56 0 R/FontName/QULRDW+ArialMT/FontStretch/Normal/FontWeight 400/ItalicAngle 0/StemV 88/Type/FontDescriptor/XHeight 519>>endobj55 0 obj<</Filter/FlateDecode/Length 42>>stream
Hâö˘ˇ˛˜¸ˇˇˇa )¡ÿ¿ÄpÄ—(†h 0 “Í	Pendstreamendobj56 0 obj<</Filter/FlateDecode/Length 31006/Length1 63326>>stream
Hâ\UxMW˛◊ﬁ˚‹yâg^ZÁ:í©‹§Í9nn(Ç<êè{%WEBi£ﬁUèﬁz’ß¶Tµ5’ìLîéÍcÃß≈ùØÍD;ô˘>5S‹3Î&jò≥æsˆ⁄kØ˜Z{ùY3g˚ÜEêË2"∑s*öûC¸z
_ò•7m©`Àõ\^<≠io/¥õ≈SÁLNK;J@ƒ†Ïzâœ[tˆÿ’èÄ˘CòÈô&4Òœ_ƒüé%”fU<ÿo∫üôZVË’*Áﬁ™ôﬁ˝‹4oEy”y˝H˛Ë”Ω”|Cfén≈{¶´.Â3}ŒˇÒ.ˆ1§\Ak°!D€§uc/„õV˘&ãñ!ö≥)|‘%$YGP·b—fA˘º,óétË÷=Ìt õ∫Ÿ”®:dY€I‘>
Zá“"ñﬂ8m'bU"b ´ûﬂk¡5Pj]ûWÒÛÔï¯ÄJÒ˛Ä£‘¿R‚ jp—»¿fÃ√z,ácôÚ*r4¶ØßX´ù±ïÎ∞µÃ;pm)∆˙±Tûf©•à@¿Hîa≥fc.™%ËâaòérZdÂ[´≠u÷vÏ¿yÃ∫œïçC!C≠uS;g˝),Ò6‚"≠k∂ó30Ü+@æçôÿ$«+≤ä≠üÿ^d≤PKGÑìµ˚PO14O∫XÀ6À¥>cÆvèl¬AÍAÉÑCgeYµhÀ6*XÎFTc√~∆7Æ5X€≠ƒ"œr<58AGd‡˛‚@Œò∆YÍÑﬁ|RÜèÒGú$É>eZ∏ñ™•k/Yg–]1äΩ›…íß;b√B˘Ö ¥"íÛÚz0€¯ó)é:”-:â2±EŒD[Ï PÑRŒ˜õ¨˝9iüurõ⁄≠Ó⁄û\≤"π"âxo„ä‡Huzû^¶ØÈ[·≈[‚ä\Øv©Sv/G=”∞
ªqáZR/ ¶_Q	Õ£ÂÙ:m§Z:I◊ƒ ë'û∑dâú!´ÅπÍyµD[¶Ωfª»|¯*p«Jµñ!õ˚a1{ˇ∂pdPáÛqÖ4
£Hù4äÊ2,†UÙ™§]T√VN“˙û˛E∑ÈÆ ÉMƒáË¿`àô‚E±^lu'≈uÒ-;HßÏ!˚…Y∆^-ókˆ À*N’)ãÛú™m–ﬁ—*µ›⁄Q≠¡n9!_ﬁ€v?È˛Ö +’ÅÎ2⁄p„8Ì—èΩ˜2L·zo‡é˚ß)úsGIîF√83i
Õ†
Œ‰+¥âv4˙æáqñŒ“-ˆ9B¥kÙ˘i—C#&üò!÷äu¢F|-~ív&õÀ62Ií„•OŒís‰i /Âﬂ‰˘£º«`©P’^uPâ ©©âj∂⁄¢ÍUΩ6N;Æ}gµM≥-≥Ì∑˝”˛å=Õ>“ûmo_cﬂg?‚·Ó¸{Ò{<Ú–%πX∫Â^¨›T¨8!Np?ODëÃ‹©¢íVà˘T#:j∂æ¢/GÉJ‰\!ﬁ?äæ2ãÜR.¶àÆM⁄l≠’˚ºÙSü‚Ü:ƒ±ù`Õ∂pZ nŸ¬QMΩŸÊÁ≤ãr „¯F^$ª⁄äø®Pä¶bß…]pX•i˘p»Õÿ#g–|Ïn Ùn»JÓ„·Ù>œÖ<J•KRÁ.Í)ø≈<'Œ·ﬂ„¯5©b¨F7öázº«∑¢ì6›ñdkC• /ZQÑ⁄≈—ı¶é$µ÷xÖ∆ÀM∂[‚<f£NÖ‚Ç¸-{_'ˆ»,’†ÂP	ﬂÄ˘XÜ÷bÃ—Ú’)*Ü§—H‡AªÛd™r∫êß 8ûi˚¯v‰90@f1%Ü;g˜≈(ûõﬁ‰9°∏ÉJ˘éè·)v5∂<±≈Z$Ò‘·y|<êÉ±÷{ÿhc∫µ)<ñ[ÛXc%æ√T““¿\î„Iæ9hòñ)Í¥L+E¯≈yë+6<^_Œv≈‡Ü=ºI„YÔWgëã˛÷JÎœ‹›OÒÑ›àIÇ´ÂM∂0XA∑¿pQee ré˜"≤≠ùV{
Eâ5#¯_π√Æ¡kwrçM:≈ÒŒÖO‰X≥§/P yX√YHÁlÕÊ˘Ûj∫kTﬁÄÙ˛iøÏ◊∑OÔ^={tÔñ⁄µKÁßSíùIùû˙EbBG£ÉCoˇ‰Ì‚„bc¢€∂i›™eã®Êë·a°ÕBÏ6MIAHvô›LÙò*—<8%∏7ºL>Bò:ì2Á1uO#õ˛8g:sN˛?ŒÙ&ŒÙáú•˜Cøîd›mËfmÜ°Ôß±Ÿ˘åØ 0
tÛF#û’àØmƒ#w8X@w«îdË&yt∑ô˘BâﬂÌ…`uUa°.√ÂMIFUh£aåô—FyEßQ#"¢›}™B"ÿ)3Œ»põ±FF–S&∏ΩEÊ»Ï|wFº√Qêílí´–òd¬h6w6≤¿’h∆¥πL{£Ω4^”´íè¯WÓè¬$è3º»(ÚéÀ7•∑ h£ÖìÌfò—/]ç˘ﬂñï∑tÂ/Ù4^˙›1•zpÎ˜/◊Õw≥Û=uø¨ÉeEB¶«ü…¶WráÊÍlM,-»7i)õ‘Éë£jäœg∏Éœ›lf4J¸S<\ö8øâú9éÍ∏∏Ù÷%ƒπu^æ·0˚«ﬁåvU≠·œôÛªÿt=ˆÒìî‰™®Mâ≠äl˛ 	èxÒ=<kƒŸÉÿ–úáô•†G∆≥‹¶^®≥'˘«‘+¯ÒıÇø∞≥ÒS@,eqEJÕf.è?™Oêî7µÑ(C˜ﬂwÄq„˙„Ôä-!Í6Çh∞O∂üˇåõNßôîl˚Ø˙‡&é+æª'ù¨ìt∫ÛI'…gŸ'T€Padê-D‡√ÆùÇÎ[2J∏ô⁄|upúbÇ]ë⁄¡˛`l¶3ù1Â√Ä·–÷CZhí∫iC'êñêé'a⁄àd:Ü)Ò©ÔN∆©ìôN˜nwﬂÓª€{˚~Ô„∂0WË„í¬≈{ƒÔÔ‰dË@}hËvc¥"Í˜˘4Ä%¥	£˚Z“cmí."%àéívç3ÒÑ„l“8˚ûpÊ^o˜É%è!¯ŸEŒ—å¸π€ŒâBÕ÷äQ,˛ˆñ4øn≠øÆ°µEÆâ∑œÍ∂Æqﬁ(Õ/õ„ÕR£Bu%ëYäHîŒ£\?˜∞6h±éÚ‡¶u£˛v¬îV©œ`πvîkˇf∫ç2>ﬂˇ˘R"ıôˆñﬁ}Ò⁄¨ò£Å˘„ßÊçÁâgçS 0§ ∫∆÷xúô«SKp’lè[|rı(jœÃÉ;ëö(”jTU@e’⁄`È©Ÿ·º•Y:
E≥Œ¬≈µË‚ÒZø\oèoL§ˆmÚÀú?~ç‹ 7‚ù5ÌO'ë?$ç÷æ]m≈‡U]„˛Ü
Ó_€⁄rçÉ”AcÀEÇIu{UTS$©nl˘oÙtóà"Çıﬂ[#Jê	!Ô„Û†¡êÚ>ó©âœ#zåd√$_‰L}lào#	Â‚•JﬂBoôóòf/i∂_Æfﬂne?Ú“ò8ëŸ@9êŸHÛráÃ'1VÁ∂ŸMúãÕ§y+P+ßãıß€ñEúìM9$∆K9‹∂öw€ri^bI Cfålnwûãu∏\¨ì‰9(
q¶<ûN‡+JÀ⁄lcFí€Ìr!∆Èp‹
÷D”YÅ‹GmÆ£∂<V·ÀüeáX¬Óˆ1G%ÛQX∏ÃóÀ‡	rÍí<≤’‡∆…)njÆüéD∏H∫EïI∑‹Ld&¬ó°Ì3.	ºƒ˝∂oâ[ÎÏ_*Kãp,÷Â¸%!¡W‚BîVCN?Âs˙(ø‡£ü‡˚nÛ»≠’Íß8ÿ<ÿåüj>÷|ˆÌ:,™h\ßﬁlﬁç+Í‘ﬂyÈ‹1Äœ™kµ:†®Îiu©ƒÄ`KÍÆ±  Ö3E/W~ﬂÌ‹!Ópu/È¸ Ù˛\$?ˆÜIoˆqªk£èàNE‹é®”9wD≤3{ßóÏŒ⁄!ë›ËEëƒ]ΩqûIoN\&q¶7õº-ﬂ, ì‚âåg›têm·qëlsm	ë-Aº.¥>LjC≠π§^¨íHQVy.…óæ&TXòS∏Ñaê$ä^ß,ä≤<Œ:¶0áãÂTPÈ†◊ﬂ÷.t
√ÅıvcwÇ¥*Ÿû9;d/ˆñï-j∂a€“6ŸÑM€KªéÎ∞%ßcIn:65ùåAÙ™úJV&˚ÿ%p1±ë>VÎ∏àNË∏|•†Ÿ>è¶˝
ÚKä√•˘ZZ?;F.u—&—e «·pIqæÌtà.åi≠-Sì—wª?<–q˛‹Ê™wN˛F˝'6z^/znÀæΩ/®9ªk6<Ωj£ﬂèÎ’+?˚Œk/7ú=ªyÛÒû˝ÔØ›ÒZ’Å7˚ˇ|TΩ–≤k·Dœ¡Á◊RØ‘l≠¨€–ˆçu_ü)¡'öVE'∂Äπˆ®§êÊ–rÖ)∞cƒeö28.ÅCó–õΩ¬õÜÿ6DqîLQ‘˛‰´∫íf&πáI0‰ à∂úO¯‚“pià6¡Â‰0˛`‡èı≠◊˜Ô-XÓ‡Ä⁄p?¬ÏÉ;3èˇçæ˛+5WïÁ}ãb]HrƒÃpeö5	ò!
C?ÜÜ®6bÛ«ë& çŸÌ:15f≥Èƒ'äùaHìùÕ∑<ì9+c  ó‰¸à/.»á+$¬_'Gfˆ„@`¡ÚÇÓ˝◊[ÎﬂQ=¸·ıkÉÒ÷wœ‹y†˛KÕ )O´wq/öDzÊ2Óó-÷(˘òäÇA°`ÄË2S≈≥pä˙>ú	Ü![Ni&5õû‚í∫ﬂk-ó‰fíòœ,_Z*	9¥© .Ω2π¶yY9‡>Ÿu(øﬁ≥Òy¯ÓJú €…‡ëãO'È§H=ÆáO˙…2v¬CÁO‹Åg∏©˜
÷'ó°.ÿdâœπí,¬âÀó· gÑ˚@z
Â)n¢	IãxÜÅ?l8ï6¸Ë)ôj|rrR{•>&ÂÄÖ÷^CTÍÓEG9I§Ó*≤£¸Ö	5Dùßµa¨í ÖÍ>"˜∑¯∏·R7¨Q/…•1–"\Ï•¥œN¬x‰à⁄‚1~Úoáñö 7∆	∞/n∫@¥t£0Y9£#«fsô©˚:ˆ°x4Õ<≤j3H¥Z°µjs(¿OB3	˚—v$]†ø∫“4¨Dk+}V§è≈BkKr⁄‚¨V≠’ÊÊñ¸bÕ1ZˆpŸ`ñâl˘5¸ÆäP3°⁄S˜îM∫èÙ[˙Ìo≤F≥…‚&5¬∑ú´=’R£∞ﬁπﬁÛú‘aÍ∞læÁÏ¥K{…Ë=ñn{}‹4»ΩÈæCﬁ£ﬂ≥ºoœöwßYÒ˘ããÃô931…Âwj9GaaVÜCAGrnöM:–tí≥b‚Xä°2≠`®—®¿ej1HÃ„◊#ì¿iÒÜÁ ôË¶é€√{.Ó™⁄~˚‘_ˆ˛Ù⁄HOœ»»{V«»ml¿Àœl∏§¶Ó®™˙∆Ÿ„WÒIıÿßü·≠x˚Ém5[˘  |ÿ1Ëº"Säç/Ó0¸à&'2gÿåh#°ÃFl%¯-Fóû—ˆÑ∞û6S˜tÔ‚
Øö≠ ÍÄÇñè◊Lt|≤¨F≈f/6>—DëÀF≈HåÀ8é‡WP⁄5∫†ó@∫¿ R?éXÈ*«|π¶¯¸<MõJ¿C‰Òÿ €ç«˛‹exqEOÓπßﬂ⁄†Ì-∂¸∫´8™ÍüsÓ›Ω˚∏wÔc_7õÕÕM+!êD ÑU¶πå8S*ß -ô… %8´(Ç1ÜáC-VtêÇ<¶	Y∞*S¶µ0ÃPÀ‘Œ ciCÈ4M;ï,˝ˇ≥ª:v≤{Ô…ûª{˛sæ«ˇˇÏÕ¢g≤\ÚÍöbÉÓ:©§Î|p√Òjå¨êÀBäFÒÀ¬Y+ÄK∆»≠ÎwdÊãFÌBMgÃ.7®∏pØÁH≈ FZÉ◊ÅIH^6∫†lå/ËxUùÂ÷˘“ÒAVgÖ3¸Ìn¯iîäﬂœÍ¢Ëé¸øi5‰3Æá´Ò≈ú©∫t˜ªN∏˚•3ûœ‚“,π^~"–,7÷kÉõç„∆’ÿ’¸õ1˘Ñø/»Úµ∏V†Yö˚∑o	»ÔÅª–äY>Õ„vüç«BÒxÃèÅ[xbqA±¥€s∏VßzäöΩ∏¬èC•LˆµDœ√i#◊i?{âÿD£”YÔ≠açl[œDvåçÅ≤Òµè2d_.C{sô^38“pE7Y∏‰“u∆iIN”HmXU_?6\î®ƒsÈMòÁf`ºDÈV5ãé˝Ÿ€€ˇ÷Û≠;È—‡ø???¸Ì}üÏ^`uuÕòæË‰ãW7øæsK7óÆwÕ?x|œ¶Ö˜SÊﬁæ&FÄ)e¥>ú?œt¸Õ8°H’2˛°•%>EïUÀÁ+[q—*çªJïE6Û ˝Ÿíﬂñà">û®@˜9WÅƒH÷‘@¸Okßç§6P6	ﬂàﬂ8óQV⁄Òa}û˛Læ›»rmY®)≤Fy.‘Æl	mŒﬂ´¯\∂¿y„óïÄ(QXó",l†üö§î(¥™Gñ√¢yåÌ!yl©sDÈÇ0£•—^a3€D&€§ñ˜¶%	-¡ ‚°>úItN4StZwﬁyzåNÉDr“Òﬂq´	)˙„èrÜ≈QDœ*k»¯÷»$'‰Iƒ3'H µ“ïı¡ÍzN™Ê0D%ºíí‚ƒ‹û¬ÕÎÌ^7yv»∑§⁄ó˝∞#‘St˝Égœ6/njÌLuÒ‘m˙≤˘÷∆[_x/Ù.{v›¢÷∂6ª˜ÃíÓ¶∆ùÂ÷«€N¶ˇyÇéÅhÆc‡o
M8Sç˘ÚR˘m˘Ä¸ôÏö-ÃV~"
pú»nAr˘¸ÇDd˚YAÑC¬dEîÑ~÷O<–.Ìr|D·r÷'¶ÿ‚>óÀÁNÒÂú–óIL|pÉg(_äV;ä‰óLë6UIù*C:˘ï–¬4f3Å·óÒ;0∏rø√z)⁄¡O˙Ø‡~‹á–^¶k◊4ÓÉ–ëC˚ÅáúLn,/3ù˜CÊ%
‰|#	ñs¡ÒON
≈ìÇXP0¢¿ÄgúêÏ¯ìÚÜ«í≤ìH ≈q∏OLr∑≠á∞äN÷°G—ù≤7F⁄ÿ;Øü>›ìÆ¢ç{Ö#∑æ≥7˝àz«H3sëÎ}ÿπÂ%ˆß‡Üh<‡≥¬·∏ÅV·WE—ä+J$ÚØ¯Ä´=UÇ<çÄ2P•˜^ï_â=W∞•‡ç‡æ‡/ÂãÚ˘o–åè	ﬁJW•ˇ¯ò Í–Çæ∞û®°@0Pêàƒ@ú¿.(4™¶Ÿ†˙TëûG˘Ä´96Üß7j+¥ı⁄kö®ÅHL.ìS3ôôâŸi«iQÈ ’¥Ó@Ô7â•^±‹ëKVî†æ—Ë!¿ÆlÙîóπ E¬çè{]	’÷=≤≠±mΩêpHÇJ Q˜q¯≠Â≠=]Û:∆ÿ∆.çÙ’∂m?I=´∑˝jÑn–∂º:∞˚ÌÓ⁄ö˚˚œ”œ,H~f{˜óXµÕ‰¬‡yd<≠Õ∫^°Ji#h˛8ÀÅ.KÅTïÔ*∂Bäœ¢d¨ÜIåWpö’¡(˜º(Ø‡¢ŸrÎ‹Ös⁄ß9$°h@$'6Á—ôíûô7”˛ûÒÑ›,4IMûeFìΩ⁄≥&˛äß=~—s!¢K6Ò}M∏ÎJ∏··®àOH8qü]b·ÑéQ>¶0à3üûoD ¡Ùºπò°ûùÊ§wlã∆ÅÑEï¬.nˆaE¢uN!rM:ëöhctEt}TåFp.¡Â¢)6ÊpY¶H%éÇòu<Ót∞«,b(tªz*A∑Ç•ô[Bs30Aï]´F´£°ª æ>lNò’<wF›ìl∆Ò%=#?˙m€ü“WﬁŸ¸U◊ÂëÍ⁄mèÆ⁄≥˚˘µ≈«À*ÁT~Î∆˝ ˝Øﬂm|ë>B_†NÌˇ‰÷ÂÜÉı©wﬂ<t`!¯]ƒµè(‰i'0†P^Ã#z¡ÀPÖïåä^YiÜGRÀS¥¿b™ß≈˚Rÿ72°n+Ëz(ÛY?
˝– ÈsÜ’Ü±√Œ ≥wROfR5ê;7‹R…T√®^(Ùv§ô™Zˇ±Y¸OW«é¥ë˛:ıEΩNœÏ$ÿù ÛÄÅQRB*…p∞G&˘V9z$‘a¨Æº‹(≤‹Æqñ°X^…Ü]¿ﬁEî©ÿ_"’\·Ñ>©öBÆ˘rO	£Ù∆Ñe|<Ã1ÃÈæ”-‹€ä`≈5òLév$}<w.w&ê+º3Qsû]?É¡-ß?ƒeÒõangaæ”;˚À-k—äl π7*®∫*BK#≥"≥◊‰?W∫ºïtYG_W{V˙W…kîµ—W…⁄!∂{^Ú∑…Ì ÷ËØı”A£î“∑cx≥Ì
ºM¥(´‘ñâe¬ÿUNÔ:Èñ^ÍM±%éV÷¢:6hG•D’T¶¶Ëˆ#ìÃñ*¿|˜òñhKv¬,‹yˇhK3⁄ Xﬁ`vo|sò¥≤ä·>◊∞j%YY_Oâ™)Ÿr.W	¯$∫K-wKá.{z˘µ'Ø7?µqkz¯“•Ùˆ'€õóæ≤yÒíMÃÍ|¸•˝]≠Î˜	˘•o.€ı˚?ÓZ¸”“	õéﬂ&îû|Ì}bi€Àçã6∂›∫=ß≥ˆ˝≠˜ÁzY‰§Æ¯Ao!§Ä±:$Äa(fÓN&∂8„QSÁêÍº”—M}Bôú•
µ!ë«(Âe§¢AWA1”cçß2P÷0âõ»$~0Ä6“OCΩ¸Èh'qWwrß3û'Où≥¯ˇ¨zÔZˇ≥T≈›9SàÕé8%ﬂèÃ+Y,,è<[R≤6∂ÓøåWypTEÔ~˝Ó7ôysd2ôd^ﬁ0…K»pÂ 2U—P
¡2≤ÕÅ∫"bê≥ã .ªÇ≈Â¢ fπBäD™êlJÀ≈ÓRÀ·ñr,‘fç`!´dÿØ{2,Ó˛±˚j^wøûw|˝ıÔ˚}øœXÁ_klˆÓÒı_Û^6oöÓ1ﬁ≠ﬁV/5¯"óKÛn¿‰ö¢ôg<lÇ&ŸL˙I|™:A…m‘à¨N\é4`dÁœ”jÀ ”mî¶ùw±‰å:9gK¯£{’&ÖRÔΩπ3Iª(÷ÄcµôÚ>ndq.e[ËÄ…Â‘9ö(1ÉL*√R}´w…¨…/Vó‡í˜∂ﬂ∆“áÎ{_X¸›Œ˜>„NÏZÙÎÉ{ñº∏O÷?5·•≥ı6_Õ,üΩÄıÕÒo‚◊„W‚á˛påoiÔ~sP.`¶ üUºå&°2–%Ö#<â`ëWπËƒô‡ãÚéﬂ¡ä *(B5¿ˆÅÖÉ{dQ*Å≥£ßßá‘ˆÙ‹~ßßﬁ˝n¸<^ŒﬁmG+£√õ¥Â⁄FÌ-≠O¿óñZ™V™5Íı∞˙µ*i™]¢ﬂî"¢(ÿym/àœÍhHàÃåe	¢·’2mî0úÀs&è˘é§IëÔ/Ç∫‘#å€ı˛˛^ù]$åD˙«î‰QcC“PSÓ•Ì`oıî¬Úí¥∫a≠Uï>ÎqÃù~¯d-®o	Ÿq];∂;t&sØ∑n±0‚(/◊2JeÙ(∞v∏>BØìÁ)3ı5§EˇX¯P¸@Ô”5Y®≈5\µ>O€Øﬂ∞›HπaWxü¬€â¶*œCm$ãídÉ±,⁄$å|&Í†ÇL…ÊÅø8BË\*ù#&oÛ¿Sä!≤!ÒWUêlªÂ0«ubËBã∫l&ö#ëI’¸I˛OZ¿qG0éj’∂§6“b√6z≠;§ì˜í‘,q“F«È3	«¶√	?∏“üÆÜ}c#˛ﬁ±¡π[-áA˘≠Êc=Éh˚’zw∑Ωª{µêË¡˚„˜kì«Ô7ô6µçwYÍº”™ÛÅZ‹H’"=B∏áHê∏Éƒ %¬˝ôõ˙Âﬁ˛-;Œ·Ôﬁ®îY$t˛Xâè∆ÔÁ¶·MœΩ∫ñÊ‚M†Æ¬N9ôtw ˆdú¶âèÒ|e®&47‘§¨Pƒ_˙üÍ@°∞\sΩ
ÒÂÊﬁÄ¢∏]F~˛‡¡(3`Äﬂ≤√âdü%⁄h°*äQ“]î∞Dëz^îÈ€E∂◊¢á‚@|4«≤e“'l*ΩœFqëJÔ≤˘á”2Èˇ(A≈z/~lcõúàt–UÈ{Q,<zzB¬—#∫e"ª®Í˝>1»√,=ÅX"Â√ùÂ¥äM±†È¬EŒ‡=U™ù·`ai	MEVJ¶¬R <tºâ≥vühö[∑r˝îÊ„Î‚ÒòeeçØ|yk¸sºpÜU1m‘£øYo:k;ÊÃxª(˜hs›Åôdí”;∑Í¡ßˇ¥]≤ï-®úÙ|–
ö{Áä¨p
vÂ‘·Ÿ‹¸ áRá≠Ôo—'Ë»DÖ)≥Q=ZhF+-h≥∞óÏJÈ m)•|ä.núvW¿ê|1œôüifçK©ÒLI≠Iü',º‡ZÎ⁄Lﬁ∞oŒ‹çœÌv˛’ÓF‰◊=∫üá»<0Øú•Æ°yÂ∫a>√mÿHÜ¡+∫ÂxY&‰Vöe X∂Qk‰tcˆt¶√±*™°–ÀNÊLÿÅX84åqö»áeÉ„\ŸEÖ|ödQíÊR=.J”|[◊ò¯/ı∆œlŸá+∫æ¿CF+Í⁄∏ÁõÈ/ØzÎké+¯ˆß„¯©ø\¬è¯Íƒ–ÌØÌåª·˝¯’WéRVﬁ
‹3Ì ﬂ]ä7≥pÖú@ßS7HìúeJíÅJQ)¢õa–cî‰œ
Ëˇ7Ù~HBÔVz∆Bo`˚7‰
FT<-!í, ÇÃÀºòÓÛ˚8QS!T"¶z=^∑óà$-à]vh|rf{UgÅ√·|8ñ·Ehö7ÕÂ¯Ã	ñ$ 
µHp+˛ÁﬁiKk5M\º°ge¸ .ﬂ∞´‡Å™ﬂ˛jbk¸°350·…¯…Ów‚Ò=≥
[K
∏˙ˆÂÚX5»"~%¯QAØF√¢`»Úz	K"<ı%í•7MŒ‘8ŒØÒ ˇÙSTcé≤ 8˛_ë™é¿N“aU,XcUÕ˚4>F¿jSÉÏ‹Mæº}â€ﬂ_-t∂∆GµˆœB‹t@‹‰`w‘ü·…HÂfÊ‚≤ªHv6
∫“∏dpÿ&µc1Õ∞P¿
∆VnN∂I¨+w&TG	q?êπËJ`€qñπ2ËÛ\cs.ŒX¶äU&’tkˆ„w√†Jè›XOã∆ª•EÑ]SÆÅìñR Ü˚˘PF¶?3=ìà6KœIµ≤,9á∑B9æî@yÓ ‹Ïqõ\rÇ8STxú–J0à≤	4àï£† çáì≈	ä·ë9ŒüEû7M∆AËâH$¡WÍ$∏ÖÎ„ün?ﬂ÷vWæ„◊¨}¡'€ü^Ÿı\∞l5Ê6,Ìªè˚Óˇ™±©œ8{7µ’y}D}s’#+^≥≠;~´yV)v¬~2[("Ëì√5ú Æ?T6¶òıE≈â~ËàDü78—ár}¿HÙ>?ÎA˜Í≈¶–"Ï`ó ≈ØG€—~ƒGQTç.†>$∏LòlAÑ›Æ1¯˘`˘˜$,ˇëÑÂÕ®û–ñ;˘”µ˜Ñl≈Ù©õAƒj#˝±§##ÄG
¬"Á±.öPaç•wÆêY,áÓâÍs∏:q˜å∏&eçST“⁄4
¥#ÿ’x√°(ñ™ ñF=µå®AZ".ÿ Aıt&Í•®“b¶õÓ®ª⁄=”Õª±E≥@í|Æ%£ÈãÅhÔjOÆ§Wè5$V‘À^ooÃG±ÑhñÄÖx®l∂FÔìÍg?8?Ø´ˆ¯À«{vﬂÓ%MK…ı€ÈG˛4ˇ<ÕI†ÑI∞N«£TZ.+£r’ëbâ:NùBVë3DzV=GŒu—¯`Ñö'¨„_ﬁÂØ…Ç „ë¸iûSh™∏Ç≈ƒ§§öC∂rù=Ù/ ´6™¨ﬂsÓÎÃ‹πœNÁŸôŒt•ñ.m)ÖÀ#πQÂçã-:ÅÑ∞>ve≥≈ ’›ÂÂ]4]àhñlÃÇä¬JS|4ƒ∏»™ªq7ÄQW4»˙Ç"–©ˇÓ4v⁄{ŒwÔmÁﬁs˛ˇˇ˛ÔÉsVô%úS|t"x˝]o^ûY(ÃcÅx|$m `AYî§åÀ2ú±å™Ä÷SÇAA¶°™∆©FiòŒˆÃVôº,óGÂÀ≤$/bxMkUI¥€qUTáÈ./§e>®‚∏QÂ±–ú#(˛*9ûeÎ5T˝Xãs!u`¿ÍÂüÅÚO˝'Pô5óÕ±±ó±áZÏ“¨ﬂå‚…ı¡êç˚u›ãP,√Ó`ñau-®¡nÔ∂¸YÏŸÅÿ∑©qW¬£!ÈBqº;q‹VÕqYCÿïº∞ã€|™ ∞÷mæˇÈ¡/&[ü,5(71˚Iñ¿Øjú•óà:~ê~yBøy]o¢«x˜ Ω˙è≤‰gçÙ!»YÿÏÖïƒ¥,0t √ÙUœT©¯–MˆÊMVy†…^-˘Ì’/—l-ºﬁo°Lˇuq@ﬁƒ¢WNPSp oMÃ–mŒÎ@ `áﬁ˜¶ 
9x[6Cb@ î4C`‘^ªV•poÒ¬µ‡ÂÆû¨¨‰Vu%w˝ïLÉw¸5ÄBFG≠∑ﬁµAf67˚—í~§ΩzïÛë¬Gëèe>2Ã∂" €)¥
ÏC∆}‰£ZµY7¨QQ&°L–È0˘ áDÅö¿°A\8~¸KŒ–n¡ÅΩÍˆÙJﬂV™€œøV ∏ñ±iêÎ∞Âê’˛bJ˜sØŸO«§∑S†&”$ìûÌ
ùÉ≠--4≈&©†O5Vãk•ßıgå›:”®Ã\Ω”XNãÛUè-’?l–É‚Ä:¿éàØ™äCM√hï)T;e!]oï@zÃ|åx`‹5‡}√∞0NÎù~á:#Ùà†ì∂◊‰&m^0fº–Nçh#∞HÉhpáÉ›òêàÊãX√¥˚tF^/˜À–JËëA{0j\›XinÚå;:¿â{'WJ‡Ô`¨I?	p}XËªwpõpÔ};˜!4qrÇ@'.p7∑¯xÓM·’ØO‹:aÒ*1ûæ3îuç©YW8”5⁄grx™Æ∂T µ¸ ‘(t≠HâvŒ$Y;gì±ê<Y€âœ Îà|¶‹˝£Újy‰Œç?∂‚[‚›€§7ÓÃê.ﬂ¡b<L_è⁄èÏ8·hÿJÉ5µ,ä–.˝G£–ÖUtÀ®*ä, QPô$fEÆˆ[”ï7bŸØ$À^Çßs)£ëå∂B[Øm—˙5Yc†#|ò{8A)UÂÉ˙;8gR3o.°‹ÇV»âu$OY«ÒÂ∫ª%°*—äóOø≤'SîSÉìÃ[‡¬ÚGá∏Ãk˜aª´ª¢aäl˜!^ÕqËi9W5¬p‘‡˘ÿP¿îS kﬁ:qèn…§“ÅN'@cªCØãt‰ıªeÿó§ù¨˛;˝Ëv6Äﬁ˝£¸é`I·º∑"aí∞'£…§$YRXãjIÈht»¯Ö!F£±$Õ§<{yÕÚ®óX-Ø¨≤∫Ïu5k¢Îb›âU…ØDR+ûE'≠jãê˚®20jU5∏Œ˘XE›Åª`åÇäa…rÍIÙßH ,bïI‘Ø´:Dﬂ"ñ™ÃΩ‘˜â@Ë¡&÷XB∂]BC√’ÍLKòﬁ.ÿl¢∞ÅÏ!ùoêﬂ?Y˙ŸõÂë#ÁHÍ‚ÔI≤ÔÔ/˛¶|ëû'õ…∑œñø˚á?ï_>ué¨˘i˘ﬂÂ7IIÌÂø˙QáÏ÷Öòö7u£˝Dò.∂á◊Zk√íJ√—òÔrú"‚∫ôU·ﬁäÓgâLÇ¿o"¶PÛs˚Ûü‹∆x[fmÂõÉS±?‹0¢àÁv/Mao≤Y=ßGõˆ/›¥øÁ˝Ú/À{»~¸ù“í∂Á {Â√Ÿ8¥˘Ly|¸"yagÔ≥µ:fŒa®Òc∞1°Å‹ı≤éfß≥nM˝„lsΩ∞xÁ‡£ «<
Y\áéÒF™≠
ú·âø:âòØ64vÿxûjÏ∞*≥Yô·˛•¡T—øoUfºÔ-P0’- ¨‘zÎ6◊=x∆Ë3üÓ1_“èö√Êﬂå˜L∫]∆6√∂m⁄f(‡$i6	*émÈ!9D¢âx:äT«MèFÖlèg,föKçC
¶6ÜJ©ÜJA]⁄ÄÎP\±R ‰∑‰˚Ûbæ!ˆ∞1V˛/ÂP˛è¡≠@¸J¬ÃF%÷ÕpoÆ;*±£Ón„ëf"ÜøyÚG®¯/»<”5≠Ÿ∂3iÉlÂ√ ˆIƒ]¯…Å√Í\dû’P«=¬¡>—â‘Ü5çDkr‚#“)«Ss+ó=L˜˝¸W€œøΩtJ◊íâ±≥]ü]’í]¸gr¯˘Åe/ΩRnïGñüÎ;t!U»/€VﬁJ⁄û{añ¶éoßœÏ˚Ëßv°sËùxO˙ß¸∂–JkΩ∆‚È)ÒÛíThú!∫u™KRè÷œœ/h\)ˆ®Ω©USˆ÷9ËúzÚUP®Çb4VAéá¬ˇc™†XçË˜ ö¢Û4/6:Õé‹¸¬£”÷d∫s]ÖM⁄gÙ'å«√c}⁄v}ªπ√⁄ñ™∞K‹ßÌ’˜ô_µûœ?[ÿØòµÈäRk…ùd1(6Å!öé‘ﬁV6BqÈ-}…ΩIö,DÙñtcÅ‰àå‹¡ïôún	§”ës^≥Ì∏%8*Sâ†åövÕˇIz-Öº°kr∂.ïN2UëD™êBæÆ)r:Ÿí0Ìæ<t-"¥†ŸÙxóµHÜ¨ Î…Úu¢Äı<Ó’¥‡#Ò—∆ãE°â4!ÖÌj¬W”ÒˇöÌ∞&Rt∞}„-ßö‰Ê≤…´¸XÒ∂kyBóñ^·>¯¸&ßÚ1üÃ≠ÒRÛ∆pEê∆6∂[Ä=Ë?∑ﬁœb‡¸öôi:›œ∂∆bæ±Xú——Ÿ9≤2™ÅÚï⁄p4"EyíÇUÕ{OÎÎŒÌ¯‹˜VÆËùSﬁÙÒOÚã7æ˘ v…#Ê±£«ª≥»Ô˛Kuπ Euùq¸û˚⁄˚~,{wÔ.ªÀÚX(ã∏ä·∆à¯BHåc7AG≈î6M:‚t¢1∂—N'm'ç≠©ù⁄%
°jGkôd¨µ:ôåmlLcå∂2:ë¥ç¬“Ôúe—¿ﬁsá3{œ9ﬂwˇﬂÔﬂ‹˝˝-wﬂ¯ }˚5Ù7£Ì«KfvŒ™{∫–∑<^Ωg’∫?Æ\ÛóÕ⁄ˆó7/k¨¨\[2Ω∑k„ŸŒ◊q¶V@m8™Ë¢∂9*GÁ√ÅSpÓ+ˆ”ùáàmAË=>åËr1–ÔED0…DÑ1m¯2k[.gEb8+
È@„o˙^ªﬂ¡¿qù\I]≈bêë˛I3R±"&ùìŒc_JÁrÍ˛˝wn„’˛™¨÷C}ÏH1ΩômN	¨ßÅ*¡Nf≥ÛÑ.}/wMw)mˆ”GÛ¢'Fg˘åÁ3⁄¿¶±
âΩHÖΩ(ÏmÚ“-ﬁıﬁn/„Uca	IYîàJY9î≤ô"çÀ°ƒéYäåJ„r(•,åg˜‰0ûl0†ÓìÉ»– ©vq*Ö*Õ1
®ÚxΩê(&€rre˙ÓGMﬂY≤~ˇŒ˜qGÜ{.¶á˜ºå‘ÎL„ª«{WúD|F~äru·:á˛·ƒJ©òYÍéŸIjäôtO±ÁRıÊ\wΩ›L-1õ›Kl„U·Uù{Ω+«≠óPfq≥î˘÷c‹c 2k%∑RYkm‡6(œY:gaÂ Ï¥Ä+L-˛¡èﬂ‰d2◊…gX*ºK8	NET5]W<9n∑ÂıŸ∂’?Zsà£Ï0æ+nﬂù«-@aä£i‡aBîÕ	Bæe{,Àv+¢òoπ°Î6]¶«0L∑®∂≈È¶1Ü%qåmË∫(
k≤›n”§ÑÄœ0—#TòR†µ‡r(=“#Ñ¸˛~¥Ω'S§R√XõëÄƒ^X∑j÷’Ò˙îµ6∏6¡˛ÃÏ›pø—˘Ê¢∫U3†©»ˆÓo¿˘Ë‡|Lp>Ô∫%r)cáä`∞åÿ!jÙƒ‘•cÊIÉëCä√90	‰u§"®2áòù 7‹r*¡ƒäyBøH?˜¡?£Å©Ú˝Î√∆¬‡ƒ´J∑Mü.v˘<ÈSê7µ?ÂﬂQÊ”ë@˙∆ÌÌáôw ÆS?
Ø™øª„+P“l»µˆ	‚4Üù.ˆè~q»ÌK ~·h–a˝–0∏1◊ÿ¸Øø;”°√ñ@„é±•BôTÆ±´—j~µ¸)œr,√ÇK‰yëgDIÅ˜HK≤Gídû·Eó*/e¬4Ú@yEÊHí˚iø#Jí»– LZ?m;¢">ÍH›-ı£^Gïe%L1è6“;hö∆#"dê'K.éL‰Iì§Àc"E€}™v2“·èˇ'„ëÜR ·ô€U¨D‡lájÃLÿ∑>è@$/Èm’ ê4Û˙ @A–aAˆ»Ë8™!4˚[¨¸àã(ëp±‡ëz¸FñéWÑàâ*3÷Ï=}‰Ùi™õ˘
^yè~ÜiHœ~˛˘ŒùË¿°ëübñù7zç≤R%T5=—ô ™bô_îï™eeIuäUù;≠lnYJMïµ™k Z*^R∑îæÓ›¯≠jï`ƒ*Uåú–‚^ˇæí>ˇ—íˇŸí≠ã%¬,/ «“ƒ"ÊvìN
y÷ ≈∏ÚÖÏ¯Ñ≤DíMNòÀŒô-ai¸)aMºKŸ™úRæVøéõ’	±Fy4·õÒÿOñÆ+•KÉÂZ≠∂C{S’∏7µ⁄Mç— óf3?ÿ2~±¶`Â‘x]áV2æ~z_ü˝ä'tQxRÄó∫birêëKóÀ)ûπ(≈Z?ÜR72Zeq‹·Ô+∞y“"ß ùOpÉyP4[µ¢˝Ù2G+v®ò«*bb\;ÃÄXÁ˚Hgs‘¸¬DEÚDíﬁùDI^€C¯}EvAyÙ8ñßC|-OÛ¡oíäºM∏[¡ã·âQ‚5¬‡~8?iÍ=w‘Ä7  0méêöë¯Áü„∫q%^;8r≈ƒ=6ø=ÉWIÇV8	u¥√çj/¬@Ap£ö¸V%ä1p∏ä§	x-À„ı∆ﬁ•ÅÂ¬≈&15+ﬂz‡X}Áú™µûFïu/nz6Ô†›vn€ã˚ö—Wp,Ë[1∞Ó€ìüY≥˙W±º.û˝ªn^Ë—‘@¥Hjõ8ciª›æ}æ≥|ﬁﬂªu˜ÖS—≈í†Q“P>ßeY„åÔBFoÅåÅÓTÍvv!N—£\W«qµ°É!:*Vg◊ávÜ¯i95ﬁö¿ÔÇ@JH©Õz ˚D†U¯é∫ZoÛ∂NÑ>V.¯.¯/Á‹›ñw)4ÚáπrΩ‹S¡’Í∑@o‚û‚.‰}≈ﬁ1√“Xû¶rÉ ùí‘d;zNFÜÏ»-r∑ÃÜ-ô‰®lì>.˚c.…!bqÚ@ÁI<‚î„x êYIë‰£XAïLMü@¿©ª—At±!TãÉ0&·§ÖŒ∞ìá”ëTASêß
"©3˛wgôÍ≈èF6~.Ú‡G ~}ı7`gEGMÉ1#Ä®˜	x¿«ƒ˘í´ˆ™=R‰<öO[UXPÃ éB"`oT¿£âø9‹—≥‚@ªì˛Ú«÷“â≈?Èz˚◊ªﬁÊéå|µ£q«ü;”7”Áﬂ@?;æx˚ô”Áﬁ?U•iÙ3z@è˜–Ñ5⁄&È2r®&j=≈P¨;(ªÏ +#Õr	x˜.≤{óÇwÔ2Ó]$√œ|Ù~Ü∑RìÒ5©"◊©
>úÛ∞oQŒ"_KNãoΩãy]}Àx+†™_j•◊0≠‹FeΩ⁄≠ÓUz≈>©WQº Â3ö—
û‘◊ÈõtFG 1Œ≥^T,k'µõ∫D›¢DJ◊eÍﬁÉ∞Ù®&}*»Ö˝EÂx™PÖC‰êËÃ!1	êòÃZ—≥.r’∫hóÜ'π$<…E‰’5)710∆≈ïÃÀüÍòø®p>aÑY`∞c(>ÿAˆ/ªô,7RW‡C‹ƒm)Ú·wõ2nl%∆ùéS”ìwÛùÈˇv\ﬂ∂ˇì–ˇπ.˜ÿ(Æ+åﬂ;sÁqg<;3ª≥3ﬁı⁄ÎµY€∞[Ï⁄<∫äáÄçcﬁ úöÚÖ∂¡	!1“í»BJ⁄¥òBIì‚Ä’$4*nA¸QQàT“™öÒPö∫¡`‹sÔ⁄ƒä,Ô<vΩ„{æ˚˚ŒwéFû[∫˚çC;÷æå_ﬁÈ∆≈X{€è(Z˜˝S|¯Á±Sö]"m rÅHàë4≤∆TC™v™cãÑ˘⁄\g^Ïqa•¥äÆpöc]Ò“≈–«ë´°´Œ-ÔÛ»UNûèß¢◊Q∆Æ2Zaåv'	’∆°Œ®w¶«iç«ç´Úø›>¸e¿¬a1†[&©+6$EΩ0ÉQ“6ìñuŒ∆ñÌ€Õv´h≤=ë‘2rlﬁ¥™∂ÃvêÕÅµy‡g∑¨‚p}ìSj≥x˛S«ﬁqRÈV.+
a5(¢R¬∑˜i•$øπlº-)º˚(ëíÏúa§5µÃ∫—?∫ú≈2Eè˜Ï˜kŒZö ≥jÊ≈`∆y¡Ä9Ï|Õô8a’ÈÁ.nZ{·˘Êü>tºøÙÕMõsdÎñ;µÁÓ¡˝X¸q„d!–W/œ˛ÂOg.ù=Õ4õ.ZúÖA≥yæG±0d™&©â.–WâÎ§'Ë*]≥.»ó'˛\vVcØï¡øK}NoîåNäåçMŒäNé5óEÊ∆ñ]€"o	˜
ΩÖr±ixﬁóMJ¢3€¨vK∞,R”tBxÉÌÿ!7Î†Ó–ÒJËÒ|∫.ù¶{¥¡˙?+©¡>O+Ge;lD„pu<YëeG2k≥qw3÷≈1*;§TÈ0•b\©<`1ÆëÀı•Ü{bSjVœl´“_ÀÉ¨:dá´)◊ﬂí„Ûì7Òä[6!f°Ã8d;JÇOg8Q¡õ®¯ÿâÙÕ˜ÆﬂøÖù\ƒ|ÔövÏÖ{˙/	çæ¯ÃÎx°w∞«¡Ïp’˝OÓﬂ±JèûXÉ_Ÿ9eÕapëHÿ*}Ä<l¯%≈f‰°»òàY˘E¡k∆ÎÜ5™åéHWÑDX=™¢Òl±jàfL√a!ÂÑà(#møÉùÅêOº$A¢∞lâqÏÑ,;˙©X<€ÜpƒgòD|0ÀU<(ó1pPz0.ëükë√ÍâÚçü| úÙΩ√cÿ¡¬»˚¯J†^¨°°L=ÑO◊0B›∞n‹h GÎ~¿f®±c¶<Â;ñ-SEV!!Y4XÑlŸ,¬)úµ};N'2vyu¶:;æ0[cÆŒÑÀÌc˚˜á¢œoûπ¨h¬∏πSªª≈üÔiYó≠_¸•Vﬂ¸›=˜Vè‹o?"J–(¸Ñﬂ¨Îíì÷ìŒLΩŒëiq§8≠W8ÈÚâzçÛ®^Ô,TÎkÙ>Ìø·¿ËÚtÂ√ÂWŒ¨lK∑ßïöDÕ»⁄tΩ^ü®9?1‰˜îâ#õ”≠ÈKï◊7ÀoU⁄û+áﬂﬁÓ¨äÖﬁI¨R4Ü˜ëV‘ÖŒ!à≠¬6úãôZ]Y¨@s√ôdFKûÛ∞Â˘^≥◊Íë4î\XêÊ∂Êq[Ûÿö«mÕs˘{†Fﬁ÷ÿßdvù∑5èÖÇGŸ¶˜6ö8â ‚#Nö›Êes¿$q≥÷lÄF«â1£L[≥å}õcﬂdro3π∑ôëTzcÇŸ[jˆ0{˚ÚÜıáÎÔÈÕ<=åüvÃ1bZ†)yûÎÂd%P#‰}Œ´Œÿ°°af∑˙®>n ∆mªxs«G∑x˛•˜ü>ºÍ£ˆ?~∂Ô∂géºıÙñ#ã£ç…q+óéÔ¯	Œ}¸*∆{^mΩ∑ˆ´Ó-øGùÔ:yˆ‘ôS⁄Öêx∫ñÉóøá\ÿ¯aòUŸÿ¬„uíTãu‚	É[ìºH÷SÌ€%åÃò§8∫Vê§~¶&;@q≈.Ô1Æœd†U¸’aP6Xÿ¨pîg;eü£|ﬁdÖ§ìÑ≤£≥ÁRç·¬ﬁˇ=´-ùÌ2ΩlM∂√ΩÌ
Î›v∑√pâ+8IŒ´o¡ˇp÷ÉJaÁ\AÑ°÷98‘ˆ˘ß4+UˆhD	ÌÀÁA$p,9gáßÕÉ™¡Ùêc#≈∞Ñ»oÉÊÚqêMΩúŒÄPíπ†*pâ Ã‘vP„T&ü]7ló€\F9lÔÍ|∂kÛÔftnZ7Á•D¬/ˆ6z≠ˇ;¬Å][ÁΩº≠ˇ¿‰n
ﬁÇ‘ß†ø˙è—∂Ç⁄F€iÌ¢óÈm™ ßÎi+›?xÎ
†ZúB∆Rà RY|#Yíâ&+I	ë˝§ùtê.rÖ»]‰6)%Á‡äê|Vêu#ºnDcO%‹Ÿ»ê≥¬YÕÉHc5$≥’oVoTèŸXÌﬁ"ÿ/€ÚZR°ÍLXÑ™ÏÓÏÏ$üwwﬂìäªó¿÷~}øO‚k¢ã~ëí“∑IF⁄)Iû*I
!ëB∫ :ƒñtÖ≠Póïòm∂Å£{Pi$5≠M«qΩVo–Eù≠h<[ënÒ…Ñ
:ü)ı>ô∞EÈ*üI8€z$‰ºïò6újN1ÃπŸV›™©ü∂†⁄Yl&ÄU'>Xüù…Ï≤‘\~G®ñY°ZZ¶•Âwnbk«„9“PGƒwvﬁ_SV_”ôô¸≥È‰˙˘Ûw∂ÓLﬂKñ›m?=k%„ˆÇ¯‘Eñ˚Er>[…Â•T4çˇHΩ≤Hòz2õ±ÿÚ¥°:t(_Û-ˆáƒ'5!(óÜYÜ≥„¡ ,eCÉøë‡7¸pG&D"Úx:§êø•-÷û7ióƒ… aóÀJRù(O†µFÉ±Ñ,ë+KË6Úî¥èûëˇF>î{‰Î ˇ‰;j8®ií(AñJU∏†™öTdGQdëê§§9í§i∞aâäa[J≤¢±H#Ôb”ßa⁄He*ªJîÚÈ¿‚±%⁄HO"!	≥"¬µ®»ÅÌÈèÂÏs≈WÒùåÇ‹¯8Å¯hÇ"∆?”V◊öK}¢Oo™	Ïú#o¡lÁúÌM‹%çNëm÷i8¶p¢ÄÏjN‰ØoÀ|v3fPß;DÅvº†e	Ïˇ)À˚MO§jqq˚‰XÒD8\8ˆ∂´5∏âÎ
Ô]ÌÆ§›ï¥z≠vµzY/ãc®E[¬+8ò$$ôK¡CL[‹`0îîí:•ƒm”!.-C¶”6<–ív „2¿ÑâßÖ2·1qHõ…ì¡°!îîå'%HÓΩg%§œﬁ≥´{ØVÁªﬂwæÅ·PE=ºB3væÿˇR©^qå‚&Ü+Í1à√É2>îÍ9cÄ;ÜCÇ±8’åY®ª.3»‚ëÒ∑y<≥‡ÇWç*dÒøi∆tîkÎF¢.–+TáPô1C—˛ÎÖÙŒGÖ]?dèﬂ},l»∑—·ÔZ»π‹Ç/3ÄØWè∞ P,±Q3æûÜ1=Õk¶c4£û¿Â∆¡ÜŸ7ŸQñYÇ/∑XSò]√ˆ∞,É’úßMÜ¿ìù@ËΩÿŸºI°a‹f“Âjˇ≈}µñ©ΩÅµ·«,E3fH&¿ P˜¥ãjb‘."^©î!_P•◊èIf∂±«ÔÃ/÷P.â=Sù>FŸ0Õ»ˆñ£≈ 3Ëü˙b¡ñN0cÃòıcﬂ'ˆ;°}ñHÃ™h´…8/±fƒ≈¸™ƒè$P_¢?A'∞éŸ}N‰d†cS†[#’TÄéÕC~§ì0⁄G~®ìÜæd€BÙ,wÓuo≈.ÂtQIÙiHÉÌ¥{€i∞æˇ\wíÌ4®íO∂”ó†8k"ŸﬂﬂÖç5≤üL—u±°0˜˙):L˛ôÄ¡Øóíã¯n…#ﬂ÷=Pä(Ï%„â£h„·áä
ÓH§≤'7Àäs.ﬂ⁄ºñ"Êó 1¶+ô6dYÙ∏ì—©!óÕ[*‘≈÷„ÎùM&πÂ|ty·ﬁUª∑c√ŒÀg~∑ˇp,;{ÕØÜûk{¸ï&π£i˘äÁé8íØ§ªzy√éÅ¸Nzp„∆'~˝ã¸%œuüm÷›¨âs”øóéJWMˇrﬂ2çª9ÜHÓ,|`^í–“àrEôPòà≈c˜».Ïπ'€xõ]¥«Y
x.‹ñ nK∏Á∂ ÅÖ$√‡∂p[¯˛ø†∏-Å∏1êCùÄø–§“˘âÛRn)Ù•_9®+åb¢Îº2ps|»È4ò˜ˇˇê·rñ.¶»ƒa›ı∞ÅkÚI„πÆ˚òbﬁˆ¿S¸w´1Òa∏ﬂsa2Á¥ÚﬁÃõ8)È‰ÏrÆ"»’Øªçè†L¸òÔà{wØø‹∫Î	â™^µp›>&πÛ¿º5ãk7Á◊—Ø~∑Ûõ€œÂﬂ∆Öö;Ò)SâQ¥Q*Zuƒ´ê_‚∆Lí9%◊ëHÖ\f^p-œrÕñosÌKZjp5»”îyR£´QûßdŸ¨ı))Á …O)ùlßµMÍtu m ˜ê◊ ±∂””Ï”|ã∏⁄¥í]…Øy_Ä1;±dx‚Ù>3Èr†˜1+‰©Y*>Ω5DÚx ÄJ@p«È3¢Ãí9b6ôßébç œ≈“58∂«)—N⁄^–Y|ÄØ5X˙C…Ä∞é∑$r@SS˝ÈD\s˜ëì∫RπÒ\ÆK‹enb©≈}l)[÷•ÏRÎ
vÖï!µâLqK30hîö"™º)ö;”S"y”ç◊F7èˆæ:xxkÔ ÌFï€6>ŒüøÒ#B∂sgœ˝˝‘Ÿ3¯ÖzÌLF–EÖ–
}õ(}M˙Ü‘(1ô»¡éLc¡ZompNpM§/bi5hã|ã¥fKãòıeµÀ*±]ÍÙ≠“Ü#<óïÀ˛°1œXËJd""«òîîÚNc§˘Ã"iôÙâp#Xêß›$DÂÂÄ]†Ïj|ÑGØÛ≠|œD ¬¿â}€5] @ÚJÒ˛N…–}XÇ≥#Ú‰¨≈H≤˘n‰Æ£Î\	ä∆.ı£ÉËb¬(Éñ "u‘Å#Pc'âdKD»L∞É©–!ëlå%„ä‘Ç
J5I	±îø=vøÕÕua3‡âAk©)úTóª$™≤◊CìÜ∂“i*CØw†a˚w~2“±~t”≤◊ß8˜nÿ¯÷æÓuá
ÌÏâü=˘‰œ'ﬁÿS¯Úµ«Ú_öŒü<{ÈÏô.,¥õÆ`%*Ä¶Î€:EW+3ÈF˙%ëÀx3j£⁄Í±iwZÀÑÊ∫ÁjK›Kµ‹/h≠°û–EÓíÎw]¸Lë&—Q1Â≠ßßâè—Û≈et;˝Å¯°rUæÆ^”Ó“ƒÿ<˛Ä`∂sû ÉÅÛŸÎ®Ñ$ç8ê‰–≠é“úŒ†Áp%t≈2:8íváüA!%©w»$◊D*ÄÅ0=Í—Ìåøc~œ<jû03alró`2∆Å…~≤–nÀÜÒ>´¡PwE∫¨JÊ∫ﬂÃß pöÖQöıU`®.‰&9”ﬂ4Ï˘ P1MÆﬁ˘Ãâ¬^ºÚ©Æ›˘ä?n\∑˜¿Üı{
Ì¥eföÇÃ˝Ö-{∑›y‘ÙßÛÁˇz˙‚˚ßIÖ€ä°˘F≈IΩ´œ|ƒç$≈ò4Û(≥î˘”ÕpVß≈j±⁄‹N´ç2Yê î†xkUüY¢7r”Qßa¸tÈ·¬PÊıæ–ùeÖÜ!z¿Q¿¶∏2ìﬂ‰ZpÚ¡ˆWñ1)w{ÌNIM=˛áFéíﬁÌµo>IµÂJû¿g&y1„B±u˜ÏˆLÀÛ≥ÁÃô˘º'ƒ$wu-lÿWπ ”∫6ëd!3Ò©ÈŒBç…ßob¢ûhÉuëun¸ŸË Ë¨€¨?éÔuø5˘/&õ’ÁW|5çìﬂ˜±˝MKµàW≤ñ¨5ÀgÖ¨òµuX:¨|á–!vÿÜíCïé dº2>iz|ﬂ,¥%€™∫c›Òû¯/˘ﬂà€´vNﬁQ3¿ˇA‹S9Pu8y*)Wïúh¥ƒJAºT›aq	b• ^
Ç∏Ø–]°˙eñ Ñ»3˛H“ÀSÇ˛£Ù~=™N&…´uâ∫\=†æßr5¨æ®é™LX}]•’/>˚)ÑQıêÈ“-°‹Ë!	—à¯|èúF ª›ôFhJ6∏:H^3C^É,¬¡5 ò∫õ Ã¶a?Ú«U›≠§k…ÚGÌT≈∏∂®29#jÑ¨T#dï
ç£*Cï>J∑ö„’xÈüı#’®ö|YQMËI∂©.Òü!ã™˝Uï’È÷⁄·Z:S€SK◊J°8•~é\ƒ»2ñvê ÅÆíóàƒ ¿x=G§®w˛Gvï«FuúÒôyÁÃ;ÁÌ≤kÔÇΩ^≥∂Ò#ò‘kåR?D" .8%ò∞=bDBπRh±Uì(°M#Ë!“T*AäZllì¶µ‘Â®ZMhQ-ï§(ä•4r˘£‘∏ﬂÃ..iwﬂõô7ªÔ˙Ê˚~Gîë∏·J`∞%(dˇz€÷ñﬂ-ò`äº≈∞˚–ÌY-%íò⁄Æ∫COÄjùÿ¥4ùÄ∂Ï ŸaÉúO’ST{WEµü_√˝¿è˘äûu2iDÎå4÷ÓÇ¶"áUnue´€ú«“∏Æñ2=T”®“ü#tVËÉ*+6¬ÅÜıaOO∫épaœÓB¨9QÑö⁄ö⁄§)ø®πHPcRã≈ì†Õí§Hˆ5≠ßΩgûÏ⁄◊î{Ò¸Òˆ•ãÎ_Xw‡çMºœ~b[◊câDC˙–oénÿv˛¿{‡˚f?æÁ—˚Ô´.À}aeœÍÂ˚Î*√On-[ªymsıÏ916∑qi◊ÊM'~M‘È‹ÈœHΩv%—˚#àAV◊‰©XŸ•0Ë.«€√
J¯4ÙP∑by~e±‰l<mò–∂ªån„˚Üä@9ΩlÙ£∆C7Y¨2äd-üÃ2ä~¨4ê®^T–EM&∏FzIöU•qé<Ü ¢˛Œˇ1©@ø†è˝k·'Za(û76˙o€Üπ§à_MØ|o$´Êqz‚ßæ¥‰k€Á:tfp0÷U¸ÙÑˇ≈G_!_€o=ˇ‹‘ã´ÊßDåæX6Æ÷¿›€GP
bCg%Û$K‰=Ò¥çA<∆\3ñ∞q,aòsjL‰ í¬N§§WIJóíD í“vä$%|'g¸IR˙ì§ÄwÈOí“p&Ö?qD<¶ìx4âì´Sbçf	kí˙4Ev•^Nı•¶Sj Œ—‚†—Ω@«©Joù!*ÔLô∏+◊ó|A•7°D‹õÆ.ﬁs&⁄P\ˇoBÄAD‹[óôCQJı]«sànò∫©ô`DT;çìßë∞!ıı=¿øpnUì\öZXúF	/
bë+≠]óæÚ≥vﬂ∞¯é5ké‹;„ÅﬂlozÇ¸`ÍÃÛw/_≥Ó{áIÀÕ+∞:∞D uXÜ?Ó'dŸ˙çQR33u¨3§QS√Dõ+“OkØé˘W« 5€âGM5iey¯Ó
63oäÜ “ùÅóz¯«˚≠® £:h§Ó§Ÿ\%†Å£+—¡∫yîÅ∆≥Á°:Z√ZP[Åñ≥xÈ07“N‹I∂ô€Ë>¥Ô%˚Õ}t/Î≈Ω‰iÂ„∞˘,˝	:F_`Ø°Wÿh»Ëgo£ﬂ±+Ë˚˝ç›Dìl>º+C	VájX3kG£Z$Ú§Jæ_óÔN·}ƒ´#!ë#O,#CCE,ƒúî≥"*rñhöm¡≤5\!6∞èÖc!jhmïKôéöôaö9 ‚î2§¬$é1<…böÑ`›`TAXk∞±ù5£(¢›î–aúå¥nçh0ähÜD8k}¸GëM©Ú©¬T!U6q≠ §ÜP≠K\∂BÈˆj¬ﬁoˆ.(]ê0GtßÈEÖé*‹K$5«1˛≈≠Ìøæñ´,?πµC≠ô:¥uÁ˙oì√êê:B⁄dG†Œ)f«
Ñ2ïË£K¢“K„‚ÄÌHäΩF<cp}˘P´ÒH3Æ`dÉ¬∫—pl]îÕ1Qô ô8‡∑ÅéÎåç˘ó«¸ã·ò»>`¡8%Z≈êÜ
å„zu#ÚG¯Æå\ø·Èq	ÅÍÌ∞C+´Ú˛Ï9µÆ?çÜ*ÁÊU›¶1=MÀME™nQÀ5≈î∏1€L[s¿¡Êåz3tÛ®…∏«º◊Ω_YÆG∆*≥ÕZÊ-ÁèxkÉ«çoò[É˝˙wåoô#˙9ÔlO˝&≠≥x™sj›:Ø6hà/FÕ¡^ÛiÛòr‘>â_%ØZ?∑—Y˝ú˚ñzYˇÄ^WØ{&ı—Ÿñ.ûÿñ≠/[W∂ûlÉR⁄¶ôÎ©‚¶aÊ/Á
ÁäÉÌú3<}9j(Â@ˆ’KØÊ‡xLgØa!_ØÆeõ˘vﬁ≈üÂå3rQ,Gqa˛ÍÇîµ·$l‚ÿø&æEˆá-≈M¿24 ò	Ö˘úæ∑ù—P öee‘…<7Û[nòÉA®qM3\XÁú„∆«5¡ÓÑÃå√ÈHõ©D∞®¶«m◊ëè éõ¶aà“	<œuãﬂº≈ŸÂt;ä3åOF,”ŒNˆ#lò|9¢ÌÔ‰Oq¬≈ëÂkxã∂äKÅ‚:9àoƒntJITæj≤P(]õ(≤BŸG3ïÂóæÍ∏Tu\∂Ω´Ó,∏œwêïΩÆˇ¶·˙Kƒ.∆boÎ´\∑q¿…ÿÚ´Èq–¥„»ùæ0Äzô r/.}:⁄˙ÚÎ†‚ÃÈ˝∆B,'™÷µı5ÆŸ$g«˚çLq6ÄŸ
9:RÆhu·¥±P\Ò4ZLŒÔ4sÒôÛíÚ<>=~Üe‘? l‡eõÂ’.ûZ–|ÿ°¿˚c-F%2€#†DhE∞ÇP$ûƒíT™ïZ∑›z˝‹©VµÒ‘»â¶˚Œ˛Ú÷¿ÎßÊ˝	 ÊG◊¯;d«‘±w«HÁÕ+§kﬂÔ“x¿Cˇ §ÒÒ_J<4À√ñÆ™›ÅåÙ§"˜Bôî<)˘«∞ó-o—ˇ<Tﬁ≤…{I}…<Ó˛–’FıQ„]èzQ¢%•ƒË,'Â7·{¨|ƒ2Çá’£√⁄Ë≈«ÿ1kà€oYÔ∏ø˜Ø(óËú?˚≤‡vqY6
∏WÊÄ∞–∫πb‰Èà8à15"Ä2`HtÈ®S◊√§Î:’T$ü|Ó`œs|Dq,≈ˆôÓè˘Á—yJ¸¢qÑ®BúÛvr∂∑mÖQ™(D'`€àµ8XÈ¥≥Ã˚™NFòa(““ªuE&À"7£$ŸvàÂJﬁ%çja≤H¿˛á˛‰ƒGÖœÂ≥‡äB)[ˇ√zπ«Fq‹q|fˆÓvoﬂØª€{üˆôsc√˘ëWÿí`´"\RC\ÑxŒZ%êg©ÉHi%B”däJäë1ÿÅ™©·èB“Pí&¢IGÖ§nPÎ8¡Œù˚õı*U™‘=ÌŒovˆFªü˘ŒÔë˘Åz—◊WîÁ8G•cWh®t”\∫ änŸä¶ [à¶ƒ‚@äÅìˆªb)ï˙xﬁó¬≈±î◊é§∆#NS&ãÉ@(pízÍ¿ô`?ùﬂˇ¡°ª#SNºïˇ1nø˙ŒΩ˘Î$éÛ7ÁVÕNé‰≈‹E‹–îœ¿w≈Ú3ˇ çÑÁçDySa&Ttè‡1l])l±®†ï`e"t5d˝1TiCÖ3‡Ñç	%Ç˙Î"©∏πHÈ‰[≤aAä‚U’*Ω∞¢W˜Kñ^&îâeR≠X+’»˚5!Æ«ç¸Mzì—‰[•Ø2V˘⁄<õ•6mãπ≈˜åÙ#Ìy˝ycó˘"D¯≠zF;m~ÃˇÕ¸L ©7Õ—»]„äÚB$ÏRÓWûV%xÎıù˜É5»tTß(¢
æ2á†iStﬁÑé"Ç3ú"¶ ÜÆã¢‡°†à!ïëæâÙíY'`aõΩ§—fÈ∂NñÈ}:—{ÒÏS
.Fs¬<rhŸEbï8_dà£"·âï
∞!≥∫√E€¿1º\ Eòñ:ÿT˚3ŸÅê•8≤h·0Æ(î≠ïêízŒ—x=ºçﬁÊGØ!aÙæ›◊ò£=Uó‚ãÎR2Ï≤ìæîVÏK‘ûrêèQFs‹:˙õHa TA¸Ñ9£"˝@@+u˘uÁÆ&ä'%>ÏŒØ˝∆‰™mã™Û+£∆'á◊(QW<∑”Œmõ…öë◊:g7-§YN|œe–ïå;mIÔ%8¢„Èz†|ËE€û	Y+ÙŒŸ`îì∏∑RM·ˇ Æ'ı‹Éﬁ˘Í£∏ë4rãΩ‘µ∏ô4s´Ω[ÒFn´∑?√ÌÚﬁƒÉ$‰Jq9ó¶∏√‹[ò•ª•GıUpØêÑ\∂KÙ&˜zy¬Ò¸L ¸q—Cw'‡˘«%$—‘ÎDÛÑÃì^¨tC0t{Œê%!˝tê-ñ …∂¸òºCæ!ªe˙ø…tHﬁà¯Ìw"<≠G£àAΩçÇä∫1F›Fbﬁ x˜ÙCÍÄö£FB§ãõÉ2%ëV?ÇÒ#ç∆¸B™© Á∞ÜN$p“1XÕìÂ∏î#xúGYBÔ\•HQ:‚lŒ8kœÅ˚P(ÑBs≠'úÚr˛◊ir÷H9eÔOŒê¬±$k∞ß$VÛa∂6Û≈…ØZøùüœ|'wv}€j¸…^ÜÛÏ˝^nÈVÔKêI†Ãr‘˝&P Õx)d˜I‰≈ﬁß|ΩdwÉaÂwüT ÌyJ≤nê∆1Îmé+»eÄ \ßU’µ…È~üI´Ø:ì*≤¶∫¥§ÿ≥„PÀ∆éC≠-á÷5◊œinûSﬂÏ˙]kGGkÎ°éçıÕÕıp¬[|@⁄=üªO#ôËÁˆ§åÄSZçﬁ†’Î.(%ôE.]Sói∏à…ı‚U]^(»rrdﬁÎBí¨ ß…r§‡]⁄1˝4ûÅL≤ºã„ºΩƒ›Â>Ã“getò1UÃc√}yﬂçúœHÊá`1áÜÜ`U!¿ëÉ4ÑÅo™PúÅS£dcZLKFR+—òF√◊Û_êüÂáä◊.˛·¸∂?m}ó¥ìSmmπ¶2∑â¥˘9ñk$ßrî¯BÊ_dqÅ¯€ˆ£ÇùAÚ)˚©Aﬁcﬂ3»%ˆíA˙ÿ>Ét≤ù9¿0»vèA∂≥€2¬çòd-∑÷$ãπ≈&9—$¶¡±Q£‹îôõDñ”JK∏/∞+çıÏÏña±qèôñ%1)¢UÀõ0{ó&•f¡$heÌd}ê:–Ø%“cöï&∞®°≈cY.R/®†Ëh…f≥8[8p˚Jj™¡#<6võçÕ≥ESóT‘U3¯ß„ñÎ¸áüM/(Ø,yd¬RsôÎdû˚ÇCÍ]{ûCÍw√$ò√&yü}ﬂ Ø≥Ø‰UˆUÉgè§ÉÌ0»^vØAûdü4»vÉAVp+L≤ê[X •àÉÃ£e#JÄLXò; “U î∆XV“"*ì3EQ¢∏§MÑ0i» P∆xµCÀ—O?eDQı´éõÇ2 å∑_ÖuãS6‹p∆®I˙L÷√ñ’÷÷%o≥9;)±§¢∂Üy{‹p}Äf<\>◊øl·ÑÆ!f® áÇ(ä#ˆ◊¸ú y.∏›BRÑ√I0]◊4óãÒÑ||¿ÔáCv‘
#ë(≠˜J–®JkÀËX≈
ÂfTT!≥É˛«vπ zæu ⁄ç2—–§¯„PKƒu›8£ô¶œFnóäìΩ ©w¥ﬂ©o¡¯ªS´ÇÒœn:√›Çpk»„Ÿ<ùö	ﬁµmÅ#ø1G´0 nÃ˛Ã<u(;6FÔ;€∞∑äë\‚ÓÄ{Z’}m∂,+Vf’0ÇÍ0å8±s'l€ödıWñ∫(ü/È+—0Äg¥§÷s‡“‹©©»‹Ò"^‘››Õº‘æÚóG/zæ?ß˝ÀÆO.]ÒπJGﬁçRÓ≠c‹q‘ûJ©3<gYdò4Z%òs∫AøQÙv0h—Ë„ ∑dä»∫Ö‹rê[yÖÉ‹Í≥F-∆
ÖoCnB)˘¢˙/‘·w¯áyßi¬\Hp
:	ˇˇé=ˆü»ÔÓ>=\O=g⁄Â*aÜëÑ¬ê¢L˜C∏A%≈Ê¨{<æÒ∞SJVØøº9ü?’ìœoæº>ÛÚÚ+˚ˆ˝y˘ÀÃpÀÂ∏áIOÎõ-ﬂ\z|Èæ+WˆAAmbÓ;f&kæ;1◊Wg†y“m«¥±æ¸uÊ⁄ÜeJ˙3.Ã9#ñM•ÌÔ]^ÓÃ≠T'B◊œ”¿…ŒÃœC˜©h∏sxÀøπ/˜‡™™+åØ{Œ>Á&(&<“JDT &ã-bıâIh¥≈G∆Z#æPk*°—$ÈX+ôàìL,4¡+¥ö±;’;‡‘i∞V˙Pd¶ö÷∂±£òú˛÷æÁƒÎ	@˚OÔÃ7ﬂ]˚πˆﬁÎu≤cÎäå,Ù√&gˆ 6;Ø…7Õr…ì‰;^ô,I‘IÖ”!+Ó)2õ‰V∆v üwÈ\∆óÇøÄ9†‰ÜmÄ´¿bï˚¨ŒeçõuÀÀ•"c¢‹‰ï˝Ï◊ËuÀµ†ôˇmfèlÙgÀ2‰vÊ=oDŒ–1ÃiÙ;§âˆGËøÜ∂fx	r+ˇØ`^^¯?3Ÿ „îÅO˚4÷Yûwä˚ÇÃ2ÀÉ79À◊Y≥‘≤«≈∞à1c‡sA]¢[Í›A˝∞‘∞ù∂É˘!≥ŒΩÙœcﬁd‰˛Á¢ágÅI`™≥I®∞‰9x&Á/OùtÀuzÊ¡3°®”P§t\îˆ¸8—ôÏÖ3”tã£&ÜÖnÅT√U`<∏ƒŸ!ÀÃ◊$¡}=‰ÌWÅ›È=˝úm*ÂB‰z.ˆ∂»zï¡ÀÉ~Ûà¥∏˚ÂL˙ÓÚ9G%˜ç1;ÔÀLÁÔ2›?IVb_ÛYhfÕøY{®îÀÿ\`ˆZ™kŸÎü—=È› Ø‚]/eØè‘òøúœªTÉTˆü©wÆÔû(òÕÿ∑sÖÇˆ/[pvµIù£ÛYÎ§–€>ficL˜˙WÿÄ’!Çµ≥ÙΩƒ:„Ä&Ä`/hU‡,∞Leoa_◊⁄+6£∂iÌ€∫πCt≥6õ:C≥}œîœ¥ÜkÈ>ì¸MRbíÆ©˛¢6ã.OEk´O©ÕDlÌª ⁄˝{zNµ©A∆˜LØúØ:Xƒ∂"VøCgıáFßTÍ·ıÿqç⁄¨Í±ﬁã⁄öΩ|"‰9igÕ≥>ª"'Ü∂^qtÉ|ù¥≥Êï˛’ƒî)6∑I±˚Cπ⁄¸KÊª”dÜóGÁaÏfßW.Õÿ&ºÂE»≈∏IëÏI\Ôm„úù‹gè< ùﬁbzúLO¬Û:Éw<Il˜:ùªÌˇ!Gb[™OYëﬁw∏ÌGgó◊IÃÏﬁızÇÄÛ<†>ëÏM‰Å„#¶˝ß†úíqj¢)£*ÒL≤T≤}ë˝‡&S$gyErÜŸ∆˚‰ÁÒ⁄KΩ7Ây∑Å\÷ºû®ñjßGjì9rï”HLc/gó‘(t}¯Ê4;˙ÑÕ≈m)‚»^„¨1?¥©â∞èˇÌÒvà˜Av¥õßπA„≥ÕƒhPõ≤◊‡√A˚‹.è√k"˚åŸiUÃ>èé€eúmn!æG~ä´£Ûk|‘ß1R„ú∆ôh|ú”ÊﬂÁt`«áwHEË◊'Ñ(A«∑Bﬂ'ÛﬁÂA‡/6¯[ÇçÓË`£üœˇ? /ÿ¿πÔÃ©KÇÅ0üNãri™]éäÚ®W À¬x÷n„Õ>y–Ê—2´_¶ˇ§¨ÙÓƒ@´oKËÉ‹'zWô+πÛı≤ñsåsÎG⁄¡z'ˆ-Dé’º†9—]«=k.jê˜Íù[ £læò'ÂËæ›∂ëSïµÕ+ó6øWÚM)±võTÍ[È9T}˚å€edFq¢GN7?aLéå`\ãΩÉ"Ÿ`ÌBÁVQPq…k$âÕ^»]Ø’Œ)í—·}¥€ª∞Û©E‘Üı.X”œëKm=—+èy•Réµ&´•’/≈Árd#k<ŒºR’Öyπ6_ØìÀÒØzbS=1G¨˝W‹NŒs'q∏’‹QßÎUsáUˆÏÛM*∆÷©ˇ∏r≤⁄àøé8¨ıƒ:πœú*Á˘U“@[ÉGúdﬂ5¥›ÉˇÊ·ª´ô?1å€¬ﬁ´i◊πÛ¥ñ—A˝%Y$c¸j[à’AÎˆwﬂëV∑DÍ±„s2÷q˜ tLZã∆„R•©-OUæ;ƒ⁄l[väì‹l˘û∂;Ú*;%h}÷¨íoõ2…wO«wG…tÛ;|ıyÿÕí•Êeyÿ<#kU6cd™ªôÛo°∂‘ˆW‰bmw^Ení
3á˘ır£Y*À›ß∞ΩﬂÀs-oÕ<Ôÿ…dÊÔc›â=R·ñ·[µ¸ˇ ÿ§„Ï[ÇrÖ)ñÈv^¨Æb:;ã8U	oäæ˙ˇ˙¢Î†ûëé—œûS◊eûé1ÀÓi78)≈ó8“	Zú? W›‰ªâçA˜∫ Ü‚tŸ&VÄ¶P~VÒˇ4¯ó‡…îLÌV(oÄ{Y˚¯i˝.P8Á ,e⁄öA¯m‘ó›Á`ÌÈ∆]üê∑ík@b–•àèÁûg±ﬂ,sv–•¿K˛JõºC∆∫Sh?éy1Ÿè?mï…ÆˇNßœøº¥{,J?cÙóª”¯xÂ07±nG
ﬁw%¯ÜΩﬂ˜$'eCrLbW∞.KÏíl˜vl OG›gÙN¥ˇ»∂«ﬁ[ΩÛx{\éøÎp≤Û¥,MGdÉˆÄÃUòyåq9cªÃU¯/“˜‚PŸlräª^u¬ßï˝ãdä¬ôåÆπ:üÉÚ+ƒ†cÌ¸ëræB}W·l·{ˆ yä¥{ù•˜ÍÆOıGÔΩK¸}–Ø»ÏîÖ…lx1\q∫œ∆˝6ﬁ≈íÉçâ˘Fﬁß≠˘ˇ|Áe–^˙_Ôïld7u»<Í»ÍìÀ•F§üXÚ—Lc‚–ek¥ëΩ¶Åë¸E€∑‡GEÙÒˇV⁄{R3^Z¬∫rm?ÁfÑÎ-NÕ?ë˜É'SÛtÄÎ˘ˇo@>?'¯∏âÒÔ2Ô¯W©˛˛•»wÄÁê{ëo K¯?úü∆Ä—ÃoTh=2‰;ÙÁÉ*S≥\Éû·.xE¸‚ê9zœa8˛≠ΩˇpÏÖﬂC9u|3ΩE›∑9˝€Á≥æq"Ê=“aJÉ~j £µé÷ZVÎg[?ÜløﬂlÀæ"c#FüL≠_µv÷˙÷ıÎ|œÍSä^WZΩ¬ºë[˚•dÉÒ!W1ÊgJ∞ìÿìÖ}˜Òm‘Æ@>î•ºBÓ "◊=O‹ÌÉw OÄ˚¢ú≈÷!1vòúˆEÀáõ#è ßÊáX√ßµG83ƒBE<.ÜÀ›GúÀ?%GßÁÈœ+Gy>BÊ\…W$ãÇ.Eº.R#WÁÆØ;[é’%ë«ê˛∏ÌEıLÆ‰"Êwá˝∂0[?Æ˝#‚~<Ëo°Ãùó‚¿‘0á∂/®ˇÉ	Ä<@€›I~∆íèºê7˛Wj¸X¢Aƒy?ËG˛>r∂Ÿa«.	Q9ú=«ÌVÎs[rg6ﬁØ˙ÀL0<ñEo≠ﬂêÏ˝∫C÷’Ô\SÙôù VÀÖrx99ãX<÷E‹.í¸ØÖG¿#àÔóÄkâÂ{›AøóSBﬂsõÁo4=¨π'¯51}ôê¨‰—RGÓ¨!áN§øëπı»9±…„•ùuûa˛Õ˛>Ú`9˘0Ss˚ñI3®bÏEfü<Ë%ÛYg≤Ÿ#cC˛/Îe[eu∆ÒÁæÁ˝Ë-´Jó∂Å‚B-ï‰cÍPpe(Ìj+ É!ó6¿sh lÅ∫âu	Ë pã	§êtõ∫eLó40¿Ã`D)ΩgˇÁúÛﬁﬁæÌm≥»M~yÓ9Ô˘˛xûˇ‚¥–éWÓ`‘AÃCﬁ]∞% ˛ìÜ⁄3içˆFr¨ç8#ÁQÒ«ÍM«ƒ:fÔ£%hofú∂áO–ˆåE3V—f7Nõ≈6ZÉºmﬁœiõ[Jµ‹ÜW9&˙ˇ!¶B^_Û!]`lƒüsP®ÒÕ§…àÀØ¶ˆÎ◊Àà"ñ˛ÛGﬂ<÷Ó¥b¸√<lÿÎ¡˛xç¨∏|W[öob¸ÚdÃØ¶ôÁh^Sµ∂3©B¨ƒªèc:˜øˆo4À~ò5é≈ÔÎ“öN˘⁄ˇxüD9|Æ‘Y“T9’~M‰=s≤pá≥yˇÂ^≈(oQæ}‡Ò8úØ|∞û±∂„é.∆]¡¥†ô‚¥÷Ä≤r∑™∑P’ÁVÇ—W˙âÀsm–∫6‰9ªä6(∞^ºVoyvâı˙AŸj˝ñbLıÿÁÔC`yﬁyv	Ú˘|>∞ˇ‡gH©π´÷jÍe„]«sÑ¶Éâ-C<¿˙
Îf zá)Íç¡yÌAQÁ â«°_~_◊{WÜ}Õ¶5‚S*¥øEsEOä1°®<∫•ŒXóêˇwÿMH◊“ÎöÖıZÇòwã‚¥¿}˘±ac≈Cﬂ¿˜≥`∫˘ﬂWˇGﬁ:§€à”ÓPN~
Z¨—wÑb÷Ëc∆Ç~ƒÌ∏PÁ1CâÈgº˝ÓX{Ç∫lÔÇ|∂w1˘Aêœ6˘ëN∆ëÆ\∫q§À/Ç¸‚[0étÌˆÇ¸˛]åoR‰O˙?∆ënùãÇ ø®ãqL	Ç¸)¡q¿?·õ8é∑È>ÿMºø;ß/Ò'¸«˚B÷òÙá¶‹Ø¿∏"¯<9ejaˇvÉä6'a˚ê˙˘˝»0TÎæ∏n‚®Ó[a˙L–ı[_7„MI'æ.Ë˛TﬂÏ{õ`˚É≠¶|ùÈwø{¢°≠<Á9™z˚€ê|ﬂ˚¡V∂ë¯ùFæ	˚8ﬁ6ˇÕzús[m~Ånÿ[©û˝!«j/N§bˆì4Y˘‹˜⁄≈*•1gˆ('·˚F“07:‰ä∞n`ÓÃSÂ7:1ƒ&Ç>ÅVPz·rÏ∑(ﬂ9O≥Ì≈4NÇ.ã>Ï_“£‹6˚m÷b== 9Ü¡or,úü[õyPÈó€Q¶∑˝∆˚5„ÕVÁL£ÏœΩ¡H?èπÏ§'ú'iE∆"jv?«XœP‚U?w6çpû°	˛€÷]DaÁk–∆ˆ—‹p‰«w/–∏p-t›˚Té5ªœÔ;πıF>Ôî^+ó¿ﬁﬂ,ì’ò1^Ë0€.ÖÉfRÒ˙{Xìòœéüˆ^≤≈j"Á
b˜D*Ò¬–^wS]8èv∏◊1}ï≤ÆKÆ˝ßbÔ4‘©•bß
{T
›|Î¸0e˙æΩŸõKû3C∂@ªÌ¥Á+ΩÿÀn§<•ªí÷o#N[ú’Tè318®k|ï‘é⁄„*øè‰|`9~&ÁoläﬁPÎé¸2;óJù\úËé÷å…À•=(ª—◊≥^3ïyv7’∏œR•Û÷%á*Ω7©ó7ûÚXüyû“uã8F;_BãVR1Œ˛ÉÊæˇ]oÓ¯2‰ ˆÈ˚»˜ãÛ’›D^ÎVìˇCX†øÛ7πJˇoΩ¢€Wﬂû“Â[qe=ñÕb=j¯X£ﬁ!w§ÍT•Gµ∂noì∫^ùüh∑6†?”Yæ√8#9I=ÏÎ…é∂væüÜŒ˚wÙ‘Ω∏æéZî›ç≤R[•ŸÓ2ˆ5>k¨ıÇ6©´”ÿt˙5E«Í{Ê[≠´◊Ï,cã}}›ùMÍÔvVJìæ-©◊ª≥’V∫”XÔ9¯ChPﬂö¸ÏÎvx?•Zµ'$åée˝^∆˙⁄ﬁ-⁄|Ó˜úÅˆT3b=÷."	„-lè—˘iqÅz £_yï¡òü÷»óóØ2"DƒÿõÇ»´
~ªuÇ˚
˙É4ﬁIç“ˇ]Ä5 78£ó≤.«¬.Å `º+Üç>R2˛∫˚ÎËØÊvÛûü≥ﬂøi˜´Ó„W›ó[5ÔÆ∆û
Ó‰y‡[óÈt‹ÿ≈U˚'îÕ1∏X◊£†ú240∏+∏∑ˇÛpû@jùÁ‡9ºMìÊª»∏Pv^ûæx#]“–ÙŒ÷«õßœü7@Øì”Bsåˆ:èyd±gåÔ+
ó”NÂ™©˚ƒ]æÁCÏ?PM{Õ'+qnÚ˘n N:(ﬂ”YFQÎ˘ö≥>·s˘∂≥
Z †ØµÜìÜZ˚…ﬂ¬ﬁØ÷yÅ›õ
ﬁ∂ÖóAK¡.£∑Y«.—$>”˘m„Ú}Ø¯Ûh°|÷ˆ W˙e’Ç|qﬂ°0á:1á∆rÃ˜B[A∞^PwÅ(«>´…¬∫îã=)˜ªî÷⁄UX'¿öHÌ”qƒ .\’/0~±Ñ˚?Çˇı≥.£æ°^∑·§¨ã^ŒTúã
î≠ê[`'æ ã1ﬁjZ`≠•A¢ÜÜYÔCÔ‰"ˇ'‡q¸œÉÕ”¡6∞úÜ™¸úì(ÑçÙª∞≈¿0ÎKCΩÜøá"≥Qö8Üˆtπ3™é∆•XËè™Øòà†=î≥RP"◊¸wÒ}Í5CÅ†Ω–e›ñ˙Êó	∑ïq˛M—Ãä∫9`Ωlr∆ ¶–Eiœ†ûÿ”,pˆ˙¥y?∞éz`µ‰v§OYh6#.Rôb´lÄ±ŒÎ¥¿EÉúVËÉèp>°ëŒuzŸM%n9‚ÿ>‚≥Ù ‡∑]çΩTﬁƒπ´¥Œ»”°=K
Ó4 øE„±áÑ˚Aæµl®J≈#¬ô¶´∑F≠»ÓÊÆ)ùÎç£5∏«Q†}ë÷ZΩQ7ìÔ˛OU1vı’:éﬂP	¨ñ‰˚P	ﬂêâ:ÊW‡<Ì‰≥e¥ ™ }÷_¯]+Ô≥
dìUNÖ¶Ó£˙]*WÇA⁄›ÜwÃ˝LËö‹Ã§§õò[ù∂ü¶{Ì{¿(¸’1ç˝fh∑∑ÓÙm∆çrÃ(∂r]Ω◊›•›©4Ä±ä–GA'ÈUx◊-«€êÎvü∂RFù∑”ò”wò‰ºªKg·lˇº%œt∫˘/ï¨ë£à+Õn\ûA˙0ÿˇ˙k∆&)ÒÌà—kÎE‹ÌexÉN§"Ì√·óR!¸W°]è≥›Ø€£¯¶˚F¯˘õ#L¸´Eª-¨KE¸?˚2hE”>øì&p}÷˘{Ÿ˜9ﬂ§*ˆµÏSUÃÄÂw¸Må}ãuíÜ[7µ
ùQ˚"—æ#Ç1FîUˇ≠Å∆ßD(l«\4"[ûT>È6Ì≥°Ω7ÿü!˛j’Whˇe˝U˚ Î, ¯\óhÓ¬1«úƒ^õnh?©|!¸4ˇÁ∑ãy?eÛÑø€ù^2⁄≤1`è˙∂;]hÍ4ö:Àœ†J˚4Œ…Ï«‰tó3çz$ﬂ]D√y˝ùÍΩ2ﬂYÉ¥È|éyˇcø|`õ:Ó8˛ª{ém“&v<HBq¸^Bböò≈¡¸	•ò,ê?êP bàCà£ƒÄ:iÂU+“¶Æu€ÿ÷ Ñ*µ]áÁTôHa ∆⁄å‘Q&QJS6iÌ÷6MÌò&eﬂ{œtbl™¥™’ŒOüﬂÔ{wøªwÔÓ|˜û8'çy¬5·ùËœƒ˛ıª¿Ú5àπÕíKú]ßs‡“æ’ƒ8ß≈8˛Ôeô8w◊˜¿áˆßaù˛%›OÒ}2ÎÙ…~˚}¸-˜Ò∑—À3tBŸÖw°
Zù>Ôœ‹Ò}{B ÷ôπ„RŸ›aÁo£ôXÄ´∑…hÿΩ3.„ÕivxÏøˆkD˜a´øˇ:Q6ˆb«ﬂâr^%raùÜ7ı<ƒÂ' ﬂvw»$öÅr7⁄˜ßπB§uö~Ö®˝(∆MÒáxdú®•cË2ûm∂≈§ºáhŒ‡e,ÔwMÊóô,∏xo·ﬁKt¢eÛà™ﬁ&
>K˙—ä?≠<D¥
o¥·ô◊‡?.'™›ä#}\á7Œ˙ÁâÉDMx∆Ê˜â6·yIm¡ôº}!Q˚f¢ù/u¸‡ÛI¥Ë?”ô˝˘e7∆∏´˝øg÷XlµDÚƒâˇ1W%âD"ëH$âD"ëH$âD"ëH$âD"ëH$âD"ëHæ‡º+ëH$íœFî5ün“R˙!Ÿàìì¸¥Å»“a)†§â≤È«∞
â_ßaÖ∂—)§ôø˘¨8≠ f-imÅﬁï÷VËΩim£-ÏÎàdñ)¢M6û÷å‹|MZs Ê;”ZA~<≠-–á”⁄
˝£¥F¯ÀÙi†
\†©É"µ£nßG©«»YÅT/¥∞m»èÂ(	Q.çÍë∑ı„‘g§"DÔÉmGd:ä∫"6jƒ¥Å∏—^;bˆ¿˜“n‰≈hÁßËãhµ€h—¨◊ÑT)qwç†⁄åîyÁn‰˙ç4£Ì£ØÌ@j/J„FoEt˘sZ†¢bÅ÷ÿ—jc›±¯£=mE¨∑'÷€è∆∫ÀµPWóV›’Ô”Í#}ëﬁ}ëˆÚıMkÎk6˙BΩ—∂Æ⁄∆{•ßE˚¥6-ﬁ€÷Ÿ”÷ª[ãÌ¸∑˜”¢›ZeM›—x§]kà∑≈#®‹›Óèıj1îÙj;b{ª„Ω—H_˘g8øÎ1‚kë_C…w«l◊‚Æ"z∆µÀò„{E~⁄≤/ÏÍ¶FÂ¡AoæzÒåRJ„Ä+•I_Å:¨ÃR
íK‘`Jô9ËöpÑæ¨h¯«˚´¡∆¿I0,‘™xêÔÑ= tpåÄã¿äç∆cîj ¿∏(Q
wRSù°Y t‘ùéùƒ°‰—ò
©∞~PZA? V#N‰ƒ¿0>0JÇJ^ÚÈπË{^ÚI√vvådõô‹º≈Hnl1}Ìz”◊<lÜ-6√ÊÃ3≥Àóõ~÷l”ªJ∫ôYÅ≥°\%ôãé˜¿2˛sr0F*S¶Qp≈öŒ	*Æ¡bo``D±S∏¬0QÍ‰YÖ%≥r°L>…'»E*üøgñ˜≥s°5¸:ù#@·◊qΩ≈ﬂ¢|\å9l5 #‡ò V>éÎM\◊¯5r7»™A+ #`ÿ¯∞N~UÏ˜Ü∫p~÷…_«cΩÎ‡W†Æ+Ë⁄oìïã√Ü˘”B-Iãºi· §¯´…[•XQ^Ã4V‘i•à™hÆRî,ô£¶î¸‰“®ö‚ø‘|Í±PøD	Äì÷	4∞l=¿
uÍ2È‡08 ´÷	4>ŒÉÀTÇ`∞ÛãI‹&≈/$ΩÀ’P.ˇˇ%Âaƒç√H¯Û¸ú·≈a¯W‡=c¸\“£RË>îÍ8·ù~îgüª‘…P¡ÿ©∞~PÍ@+ËV>¬ãíÌ™çú¶1;!2IÔ˛Y:nß`ßÙÆ¿‘ÑÒ.^3†xy–{‰{H
„=Ù4î0ﬁ'æ%å˜´èC	„Ì⁄%å∑ΩJÔ¶V(aºuçP0)˛ÃOãg©ïuªôr˝•˝•˝•˝d·˚≈E∑,¢oﬂOñïaƒé}•e™~äÈgò^œÙ„Lè0˝1¶?ŒÙ•Lﬂ t”›L˜0=»Ù”l!ÜBg¡ó>ë\Ãg˙”_dz”ΩL/az1”5VLÒ¬‰√s∑“pÉ!ÒßÉ_VÖ›«¡1¢ÖXÛÖÿF`/ÄI#DêVdO˜_4XVm¶Àb°’|G1£Ù&∞`ÇF±åF—»(p¿VÉVpLÄI`Et:ﬁoX¨TÉVp L ´—ù	¿)ñÓ‚I£c˛tßÎDäè‚*¬U»ÉN∑”Á\≠Ùªô√√Í<ì^IππxΩrÂÿsR,kË£¨ø~îESBS¯!ﬁOòà√iﬂüºU†¶ÿwìﬁ”jh˚y,XulyY	¸BÍ3“Û…m~ﬁ∫^Ä$›PÕëÙŒVO±lQkHΩÂ˛É˙é;≈!ﬂvüVß•,,©æÜúÜ‘KÓo™Ø¯Sv‰úÒ¶‹)Õv/T_3BG¡—§˙òpCÍ◊‹©ª›FAƒ,ÿ⁄áT–°÷{7©´—^ç{ªÏCõCjµ{´∫‘åö/Í©ËÇœîeËl©€∏ÈLè—`Seäug€éÿömu∂∂Äm∂≠–¶⁄
l3lSÌ.ª”ûmøﬂûi∑€≠vãù€…>559Ù¶n™’)ú’"¨≈–N.¨xaõ≥sZCâ/)anXŒ¬â≥;(º]K|ÿ03≈2◊oJdÃ\ŒÆ0Öó'˙¬)€d}¢“Nÿ÷=“¸∆µ 7¡øëb‘ÿúbì"Î‡åÑkEÛ01ñs©¬?x©ñ œ›Wù_Ì™ Y¥™Ê.f[⁄˙nˇÚ?°G¬ÕâÁZ!&Z¬âo7hõõáŸMˆ¡ öavC∏ñÊa•ä›\Y/Úï™öññpäm0‚Hc7ás√à≥„`q§Ÿ=f‹Q3ÆıW,‚˛¡xŸ≥∂Ñq¸Œ
§™„6]##´Cè¥ãAïTQ$4xq©)ñ— «í≠pR∆‡’‰ãd<’KqóŒ˛˘&ÕÛú^íRzËt“ˇˇ”=∫Gß7U%¶‰LUï‹E.ÁﬂÀ…ÈÑKÜÈœô≠	åiJ¶Ω$[…l€KdƒôD4êû&zL4âhÙX"_üê%≤™ëïå§–'F+ò÷C≈¥Äaˇ[ó1∫∂√E‰'Ü~5w7W±º‘ı|¢°Âm|π∏¬vûà–H<±0<=∑£vÑ∂mx9â¸…4èúƒ˚n;∂oÃΩpåá÷±Vu¨·xGgcÏlà±kám°`,cY+pã»9>ûÊ/à^DEªn4_¬|çª˝–m~;ìì◊Ównª¯Zπ'Mä√-®hùúüú£˜ZØ@~]Zù[ªﬂ›–˚“:˘ç·ñf<#ˇ⁄+§4√Ñk∆ˇU¿ÛÖ3˜xJ»Hº˚2ü>œ¶˘˛>®1IúVZ≥Èˇ¯˝´ﬂÉxä¢¢‘ jQS’¸˚˙ge{Åw¡≤ÒsMùÖüèPΩ—§èÇ…∆Õ¶¯ñ¬◊aÄú2 ´> ”få˚«\’4+∑ \§e[	á*%u¡d±:c)cè f√endstreamendobj19 0 obj<</AIS false/BM/Normal/CA 1.0/OP false/OPM 1/SA true/SMask/None/Type/ExtGState/ca 1.0/op false>>endobj36 0 obj<</Length 24418>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
/GS1 gs
q 1 0 0 1 37 506.4476 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 37 355.5014 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 37 268.0289 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 37 91.3563 cm
0 0 m
538 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
-0.018 Tc 10 0 0 10 64 714.5277 Tm
[(F)0.5 (emal)0.5 (es )0.5 (w)0.5 (ho)0.5 ( )0.5 (are )0.5 (ab)0.5 (l)0.5 (e )0.5 (to)0.5 ( )0.5 (b)0.5 (eco)0.5 (me )0.5 (p)0.5 (reg)0.5 (n)0.5 (an)0.5 (t:)]TJ
/C2_0 1 Tf
0 Tc 19.79 0 Td
<0BD8>Tj
/TT1 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
-19.205 -1.284 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.9 0 Td
[<003C>92.1 <0052005800550003>0.5 <004B00480044004F0057>0.5 <004B00460044005500480003>0.5 <0053005500520059004C0047004800550003>0.5 <0056004B00520058004F00470003>0.5 <004700520003>0.5 <00440003>0.5 <005300550048004A0051004400510046005C0003>0.5 <0057>0.5 <004800560057>0.5 <0003>0.5 <004500480049>0.5 <0052005500480003>0.5 <005C005200580003>0.5 <00560057>0.5 <004400550057>0.5 <0003>0.5 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>0.5 <005A004C0057>0.5 <004B0003>55.7 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.314 -1.284 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.9 0 Td
[<003C>92.1 <005200580003>0.5 <0056004B00520058004F00470003>0.5 <0058005600480003>0.5 <00480049>18.6 <0049>0.5 <004800460057>0.5 <004C005900480003>0.5 <0051005200510010004B005200550050005200510044004F0003>0.5 <0045004C00550057>0.5 <004B0003>0.5 <0046005200510057>0.5 <00550052004F0003>0.5 <000B0046005200510057>0.5 <005500440046004800530057>0.5 <004C00520051000C0003>0.5 <004700580055004C0051004A0003>0.5 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>0.5 <0044005100470003>0.5 <0049>0.5 <005200550003>0.5 <00150003>0.5 <0050005200510057>0.5 <004B00560003>0.5 <00440049>0.5 <0057>0.5 <004800550003>0.5 <0057>0.5 <004B0048>-18.2 <0003>]TJ
0 -1.14 Td
[<004F004400560057>0.5 <0003>0.5 <00470052005600480003>0.5 <00520049>0.5 <0003>55.7 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.314 -1.284 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.9 0 Td
[<0025004C00550057>0.5 <004B0003>0.5 <0046005200510057>0.5 <00550052004F0003>0.5 <005000480057>0.5 <004B0052004700560003>0.5 <0057>0.5 <004B00440057>0.5 <0003>0.5 <0046005200510057>0.5 <0044004C00510003>0.5 <004B00520055005000520051004800560003>0.5 <000B005600580046004B0003>0.5 <004400560003>0.5 <0045004C00550057>0.5 <004B0003>0.5 <004600520051005700550052004F0003>0.5 <0053004C004F004F0056000F>0.5 <0003>0.5 <004C0051004D004800460057>0.5 <004C005200510056000F>0.5 <0003>0.5 <005200550003>0.5 <0057>0.5 <005500440051005600470048005500500044004F0003>0.5 <0056005C00560057>0.6 <00480050>-18 <0003>]TJ
0 -1.14 Td
[<005300440057>0.5 <0046004B00480056000C0003>0.5 <00500044005C0003>0.5 <005100520057>0.5 <0003>0.5 <005A00520055004E0003>0.6 <004400560003>0.5 <005A0048004F004F0003>0.5 <004700580055004C0051004A0003>0.5 <0057>0.5 <0055004800440057>0.5 <00500048005100570003>0.5 <005A004C0057>0.5 <004B0003>55.7 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.314 -1.284 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.9 0 Td
[<0037>111.3 <0044004F004E0003>0.5 <0057>0.5 <00520003>0.5 <005C0052005800550003>0.5 <004B00480044004F0057>0.5 <004B004600440055004800030053005500520059004C0047004800550003>0.5 <00440045005200580057>0.5 <0003>0.5 <0045004C00550057>0.6 <004B0003>0.5 <0046005200510057>0.5 <00550052004F0003>0.5 <005000480057>0.5 <004B0052004700560003>0.5 <0057>0.5 <004B00440057>0.5 <0003>0.5 <00500044005C0003>0.5 <004500480003>0.5 <0055004C004A004B0057>0.5 <0003>0.5 <0049>0.5 <005200550003>0.5 <005C005200580011>]TJ
/TT0 1 Tf
0 Tw -1.9 -1.284 Td
[(Mal)0.5 (es w)0.5 (i)0.6 (th)0.5 ( femal)0.5 (e )0.5 (p)0.5 (artn)0.5 (ers )0.5 (w)0.5 (h)0.5 (o)0.5 ( )0.5 (are )0.5 (ab)0.5 (l)0.5 (e )0.5 (to)0.5 ( )0.5 (b)0.5 (eco)0.5 (me )0.5 (p)0.5 (reg)0.5 (n)0.5 (ant:)]TJ
/C2_0 1 Tf
0 Tc 28.222 0 Td
<0BD8>Tj
/TT1 1 Tf
/Span<</ActualText<FEFF0009>>> BDC 
-27.636 -1.284 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.9 0 Td
[<003C>92.1 <005200580003>0.5 <0056004B00520058004F00470003>0.5 <0058005600480003>0.5 <00480049>18.6 <0049>0.5 <004800460057>0.5 <004C005900480003>0.5 <0045004C00550057>0.5 <004B0003>0.5 <0046005200510057>0.5 <00550052004F0003>0.5 <004700580055004C0051004A0003>0.5 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>0.5 <005A004C0057>0.5 <004B0003>55.6 <00240038002A>0.5 <0037003C00350032>0.5 <0003>0.5 <0044005100470003>0.5 <0049>0.5 <005200550003>0.5 <00170003>0.5 <0050005200510057>0.5 <004B00560003>0.5 <00440049>0.5 <0057>0.5 <004800550003>0.5 <0057>0.5 <004B00480003>0.5 <004F004400560057>0.5 <0003>0.5 <00470052005600480011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-3.114 -1.32 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.014 Tc 0.014 Tw 1.8 0 Td
[<0044>-0.6 <00550048>-0.6 <0003>-23.8 <004500550048>-0.6 <0044005600570049004800480047>-0.6 <004C0051>-0.6 <004A0003>-23.8 <0052>-0.6 <00550003>-23.8 <0053004F>-0.6 <00440051>-0.6 <0003>-23.8 <00570052>-0.6 <0003>-23.8 <0045005500480044>-0.6 <0056005700490048>-0.6 <00480047>-0.6 <00110003>-23.8 <002C00570003>-23.8 <004C>-0.6 <00560003>-23.8 <00510052>-0.6 <00570003>-23.8 <004E00510052>-0.6 <005A>-0.6 <00510003>-23.8 <004C>-0.6 <00490003>31.4 <00240038>-0.6 <002A0037003C0035>-0.6 <00320003>-23.8 <00530044>-0.6 <005600560048>-0.6 <00560003>-23.8 <004C>-0.6 <005100570052>-0.6 <0003>-23.8 <005C0052005800550003>-23.9 <0045005500480044>-0.6 <005600570003>-23.8 <0050004C004F>-0.6 <004E00110003>-23.8 <0027>-0.6 <00520003>-23.8 <0051>-0.6 <005200570003>-23.8 <0045005500480044>-0.6 <0056005700490048>-0.6 <00480047>-14.2 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.14 Td
[<004700580055004C0051004A0003>-8.9 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>-8.9 <0044005100470003>-8.8 <0049005200550003>-8.8 <001400130003>-8.9 <00470044005C00560003>-8.9 <00440049>0.5 <0057>0.5 <004800550003>-8.9 <0057>0.5 <004B00480003>-8.8 <004F004400560057>0.5 <0003>-8.8 <00470052005600480003>-8.8 <00520049>0.5 <0003>46.3 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0011>0.5 <0003>9.2 <0037>111.3 <0044004F004E0003>-8.9 <0057>0.5 <00520003>-8.9 <005C0052005800550003>-8.9 <004B00480044004F0057004B00460044005500480003>-8.9 <0053005500520059004C0047004800550003>-8.9 <00440045005200580057>0.5 <0003>-8.8 <0057>0.5 <004B00480003>-8.9 <0045004800560057>0.5 <0003>-8.9 <005A0044005C>-18 <0003>]TJ
0 -1.14 Td
[<0057>0.5 <00520003>0.5 <0049>0.5 <0048004800470003>0.5 <005C0052005800550003>0.5 <004500440045005C0003>0.5 <004700580055004C0051004A0003>0.6 <0057>0.5 <004B004C00560003>0.5 <0057>0.5 <004C005000480011>]TJ
/TT0 1 Tf
0.013 Tw -1.8 -1.428 Td
[(T)74.7 (el)0.5 (l)0.5 ( yo)0.5 (u)0.5 (r h)0.5 (eal)0.5 (thcare p)0.5 (ro)0.5 (vi)0.5 (d)0.5 (er abo)0.5 (u)0.5 (t al)0.5 (l th)0.5 (e med)0.5 (i)0.5 (ci)0.5 (n)0.5 (es yo)0.5 (u)0.5 ( take,)]TJ
/C2_0 1 Tf
0.018 Tw 28.567 0 Td
[<0BD80003>-12.9 <004C00510046004F00580047004C0051004A0003>-13 <005300550048005600460055004C00530057>0.5 <004C005200510003>-12.9 <0044005100470003>-13 <005200590048005500100057>0.5 <004B0048001000460052005800510057>0.5 <004800550003>-13 <005000480047004C0046004C005100480056000F>-17.8 <0003>]TJ
-28.567 -1.14 Td
[<0059004C0057>0.5 <00440050004C00510056000F0003>0.6 <005200550003>0.5 <004B0048005500450044004F0003>0.5 <0056005800530053004F00480050004800510057>0.5 <00560011>]TJ
-0.017 Tc 0.017 Tw 0 -1.428 Td
[<0037>110.7 <0044004E004C0051004A0003>41.2 <00240038002A0037003C003500320003>-14.1 <005A004C0057004B0003>-14 <00460048005500570044004C00510003>-14.1 <00520057004B004800550003>-14 <005000480047004C0046004C0051004800560003>-14 <00500044005C0003>-14 <00440049>18 <00490048004600570003>-14 <0057004B00480003>-14.1 <0044005000520058005100570003>-14.1 <005200490003>41.1 <00240038002A0037003C003500320003>-14 <005200550003>-14.1 <00520057004B004800550003>-14 <005000480047004C0046004C0051004800560003>-14 <004C00510003>-14 <005C0052005800550003>-14.1 <0045004F0052005200470003>-14 <004400510047>-17.1 <0003>]TJ
-0.019 Tc 0.019 Tw 0 -1.14 Td
[<00500044005C0003>14.2 <004600440058005600480003>14.1 <0056004C004700480003>14.2 <00480049>18.4 <004900480046005700560003>14.2 <005200550003>14.1 <00440049>18.3 <00490048004600570003>14.1 <0057004B00480003>14.1 <005A0044005C0003>14.1 <0057004B004400570003>69.4 <00240038002A0037003C003500320003>14.2 <005200550003>14.1 <00520057004B004800550003>14.2 <005000480047004C0046004C0051004800560003>14.1 <005A00520055004E00110003>14.2 <002E00510052005A0003>14.1 <0057004B00480003>14.1 <005000480047004C0046004C0051004800560003>14.2 <005C005200580003>14.2 <00570044004E004800110003>14.1 <002E0048004800530003>14.1 <00440003>14.1 <004F004C00560057>-18.9 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.14 Td
[<00520049>0.5 <0003>0.5 <0057>0.5 <004B004800500003>0.6 <005700520003>0.5 <0056004B0052005A0003>0.5 <005C0052005800550003>0.5 <004B00480044004F0057004B00460044005500480003>0.5 <0053005500520059004C0047004800550003>0.5 <0044005100470003>0.5 <0053004B00440055005000440046004C00560057>0.5 <0003>0.5 <005A004B004800510003>0.5 <005C005200580003>0.5 <004A00480057>0.5 <0003>0.5 <00440003>0.5 <00510048005A0003>0.5 <005000480047004C0046004C005100480011>]TJ
/TT0 1 Tf
0 Tw 0 -2.58 Td
[(Ho)0.5 (w)0.5 ( )0.5 (sh)0.5 (o)0.5 (u)0.5 (l)0.5 (d)0.5 ( )0.5 (I)0.5 ( )0.5 (take )37.6 (AUG)0.6 (TYRO)0.5 (?)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.428 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.003 Tc 0.003 Tw 1.8 0 Td
[<0037>111.1 <0044004E00480003>-20.9 <00240038002A0037003C003500320003>-76.1 <0048005B004400460057004F005C0003>-76.1 <004400560003>-76.1 <005C0052005800550003>-76.1 <004B00480044004F0057004B00460044005500480003>-76.1 <0053005500520059004C0047004800550003>-76.1 <00570048004F004F00560003>-76.1 <005C005200580003>-76.1 <005700520003>-76.1 <00570044004E00480003>-76.1 <004C005700110003>-76.1 <002700520003>-76.1 <0051005200570003>-76.1 <0046004B00440051004A00480003>-76.1 <005C0052005800550003>-76.1 <00470052005600480003>-76.1 <005200550003>-76.1 <00560057005200530003>-76.1 <00570044004E004C0051004A>-3.2 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.14 Td
[<00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0003>0.5 <00580051004F0048005600560003>0.5 <005C0052005800550003>0.5 <004B00480044004F0057>0.5 <004B00460044005500480003>0.5 <0053005500520059004C0047004800550003>0.5 <00570048004F004F00560003>0.5 <005C005200580003>0.5 <0057>0.5 <00520011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.356 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.02 Tc 0.02 Tw 1.8 0 Td
[<003C>92 <0052005800550003>14.3 <004B00480044004F0057>0.5 <004B00460044005500480003>14.3 <0053005500520059004C0047004800550003>14.3 <00500044005C0003>14.3 <0046004B00440051004A00480003>14.3 <005C0052005800550003>14.4 <0047005200560048000F0003>14.3 <00570048005000530052005500440055004C004F005C0003>14.3 <00560057>0.5 <00520053000F>0.5 <0003>14.3 <005200550003>14.3 <005300480055005000440051004800510057004F005C0003>14.4 <00560057005200530003>14.3 <00570055004800440057>0.5 <00500048005100570003>14.3 <005A004C0057004B0003>69.4 <00240038002A0037003C003500320003>14.3 <004C00490003>14.3 <005C00520058>-20.2 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.14 Td
[<0047004800590048004F005200530003>0.5 <0056004C004700480003>0.5 <00480049>18.6 <0049004800460057>0.5 <00560011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.356 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0037>111.3 <0044004E00480003>55.7 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0003>0.5 <00440057>0.5 <0003>0.5 <00440045005200580057>0.6 <00030057>0.6 <004B00480003>0.5 <00560044005000480003>0.5 <0057>0.5 <004C005000480003>0.5 <004800440046004B0003>0.5 <00470044005C0003>0.5 <005A004C0057>0.5 <004B0003>0.5 <005200550003>0.5 <005A004C0057>0.5 <004B005200580057>0.5 <0003>0.5 <0049>0.5 <0052005200470011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.356 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.005 Tc 0.005 Tw 1.8 0 Td
[<0036005A0044004F004F0052005A0003>-11.4 <00240038002A0037003C003500320003>-66.6 <00460044005300560058004F004800560003>-66.5 <005A004B0052004F00480003>-66.5 <005A004C0057004B0003>-66.6 <005A0044005700480055>55.2 <00110003>-66.5 <002700520003>-66.5 <0051005200570003>-66.5 <0052005300480051000F0003>-66.5 <0046005500580056004B000F0003>-66.5 <0046004B0048005A0003>-66.5 <005200550003>-66.5 <0047004C005600560052004F005900480003>-66.5 <0057004B00480003>-66.5 <00460044005300560058004F004800110003>-66.5 <002700520003>-66.6 <0051005200570003>-66.5 <00570044004E00480003>-66.6 <0044>-5.1 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.14 Td
[<00460044005300560058004F00480003>0.5 <004C0049>0.5 <0003>0.5 <004C0057>0.5 <0003>0.5 <004C00560003>0.5 <004500550052004E00480051000F>0.5 <0003>0.5 <0046005500440046004E00480047000F>0.5 <0003>0.5 <005200550003>0.5 <0047004400500044004A004800470011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.32 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<002C>0.5 <0049>0.5 <0003>7.7 <005C005200580003>7.7 <0050004C005600560003>7.7 <00440003>7.7 <0047005200560048000F>0.5 <0003>7.7 <005200550003>7.7 <005900520050004C0057>0.5 <0003>7.7 <00440057>0.5 <0003>7.7 <00440051005C0003>7.7 <0057>0.5 <004C005000480003>7.7 <00440049>0.5 <0057>0.5 <004800550003>7.7 <0057>0.5 <0044004E004C0051004A0003>7.8 <00440003>7.8 <00470052005600480003>7.7 <00520049>0.5 <0003>62.9 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <000F>0.5 <0003>7.7 <004700520003>7.7 <005100520057>0.5 <0003>7.7 <0057>0.5 <0044004E00480003>7.7 <004400510003>7.8 <0048005B0057>0.5 <005500440003>7.7 <00470052005600480011>0.5 <0003>7.7 <002D005800560057>0.5 <0003>7.7 <0056004E004C00530003>7.8 <0057>0.5 <004B00480003>7.7 <0047005200560048>-18.1 <0003>]TJ
0 -1.14 Td
[<0044005100470003>2.8 <00570044004E00480003>2.8 <005C0052005800550003>2.7 <00510048005B00570003>2.8 <00470052005600480003>2.8 <00440057>0.5 <0003>2.7 <0057>0.5 <004B00480003>2.7 <00550048004A0058004F00440055004F005C0003>2.7 <00560046004B004800470058004F004800470003>2.7 <0057>0.5 <004C005000480011>0.5 <0003>2.7 <002700520003>2.7 <005100520057>0.5 <0003>2.7 <0057>0.5 <0044004E00480003>2.7 <00150003>2.7 <004700520056004800560003>2.7 <00440057>0.5 <0003>2.7 <0057>0.5 <004B00480003>2.7 <00560044005000480003>2.7 <0057>0.5 <004C005000480003>2.7 <0057>0.5 <00520003>2.7 <00500044004E00480003>2.7 <005800530003>2.7 <00440003>2.7 <0050004C00560056004800470003>2.7 <00520055>-18 <0003>]TJ
0 -1.14 Td
[<005900520050004C0057>0.5 <004800470003>0.5 <00470052005600480011>]TJ
/TT0 1 Tf
0 Tw -1.8 -2.58 Td
[(W)0.5 (h)0.5 (at )0.5 (sho)0.5 (u)0.5 (l)0.5 (d)0.5 ( )0.5 (I)0.5 ( )0.5 (avo)0.5 (i)0.5 (d)0.5 ( )0.5 (w)0.5 (h)0.5 (i)0.5 (l)0.5 (e )0.5 (taki)0.6 (ng)0.5 ( )37.6 (AUG)0.5 (T)0.5 (YRO)0.5 (?)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.428 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.02 Tc 0.02 Tw 1.8 0 Td
[<003C>92.1 <005200580003>14.4 <0056004B00520058004F00470003>14.3 <0051005200570003>14.4 <00470055004C0051004E0003>14.3 <004A0055004400530048004900550058004C0057>0.5 <0003>14.3 <004D0058004C004600480003>14.3 <005200550003>14.4 <004800440057>0.5 <0003>14.3 <004A0055004400530048004900550058004C0057>0.5 <0003>14.3 <004700580055004C0051004A0003>14.4 <005C0052005800550003>14.3 <0057>0.5 <005500480044005700500048005100570003>14.3 <005A004C0057004B0003>69.6 <00240038002A0037003C00350032>0.5 <00110003>14.4 <002C0057>0.5 <0003>14.3 <00500044005C0003>14.3 <004C00510046005500480044005600480003>14.3 <0057>0.5 <004B00480003>14.4 <004400500052005800510057>-19.8 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.14 Td
[<00520049>0.5 <0003>55.6 <00240038002A>0.6 <0037003C00350032>0.5 <0003>0.5 <004C00510003>0.5 <005C0052005800550003>0.5 <0045004F0052005200470003>0.5 <0057>0.5 <00520003>0.5 <00440003>0.5 <004B0044005500500049>0.5 <0058004F0003>0.5 <004F004800590048004F0011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.32 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.009 Tc 0.009 Tw 1.8 0 Td
[<002700520003>-48 <0051005200570003>-48 <00470055004C005900480003>-48 <005200550003>-48 <00520053004800550044005700480003>-48 <005000440046004B004C005100480055005C0003>-48 <005800510057004C004F0003>-48 <005C005200580003>-48 <004E00510052005A0003>-48 <004B0052005A0003>7.2 <00240038002A0037003C003500320003>-48 <00440049>18 <004900480046005700560003>-48 <005C0052005800110003>-48 <002C00490003>-48 <005C005200580003>-48 <0048005B005300480055004C00480051004600480003>-48 <0047004C005D005D004C0051004800560056000F0003>-48 <0045004F00580055005500480047>-9.2 <0003>]TJ
-0.014 Tc 0.014 Tw 0 -1.14 Td
[<0059004C0056004C00520051000F0003>-20.6 <00500048005000520055005C0003>-20.6 <004F005200560056000F0003>-20.6 <0046004B00440051004A004800560003>-20.6 <004C00510003>-20.6 <00500048005100570044004F0003>-20.6 <005600570044005700580056000F0003>-20.6 <004600520051004900580056004C00520051000F0003>-20.6 <004B0044004F004F00580046004C005100440057004C0052005100560003>-20.6 <005200550003>-20.6 <004B0044005900480003>-20.6 <00570055005200580045004F00480003>-20.6 <005A004C0057004B0003>-20.6 <00450044004F00440051004600480003>-20.6 <005200550003>-20.6 <00460052005200550047004C005100440057004C00520051>-14.2 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.14 Td
[<005200550003>0.5 <0053005500520045004F0048005000560003>0.5 <005A004C0057>0.5 <004B0003>0.5 <0046005200510046004800510057>0.5 <005500440057>0.5 <004C005200510003>0.5 <0044005100470003>0.5 <00440057>0.5 <0057>0.5 <004800510057>0.5 <004C00520051000F>0.5 <0003>0.5 <004700520003>0.5 <005100520057>0.5 <0003>0.5 <00470055004C005900480003005200550003>0.5 <005200530048005500440057>0.5 <00480003>0.5 <005000440046004B004C005100480055005C0003>0.5 <005800510057>0.5 <004C004F0003>0.5 <005C0052005800550003>0.5 <0056005C0050005300570052005000560003>0.5 <004B0044005900480003>0.5 <0055004800560052004F0059004800470011>]TJ
/TT0 1 Tf
0 Tw -1.8 -2.58 Td
[(W)0.5 (h)0.5 (at )0.5 (are )0.5 (th)0.5 (e )0.5 (p)0.5 (o)0.5 (ssi)0.5 (b)0.5 (l)0.5 (e )0.5 (si)0.5 (d)0.5 (e )0.5 (effects )0.5 (o)0.5 (f )37.6 (AUG)0.5 (T)0.5 (YRO)0.5 (?)]TJ
0 -1.5 Td
[(AUG)0.5 (T)0.5 (YRO)0.5 ( )0.5 (may )0.5 (cau)0.5 (se )0.5 (seri)0.5 (o)0.5 (u)0.5 (s )0.5 (si)0.5 (d)0.5 (e )0.5 (effects,)0.5 ( )0.5 (i)0.5 (n)0.5 (cl)0.5 (u)0.5 (d)0.5 (i)0.5 (ng)0.5 (:)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.428 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
<003600480048>Tj
/Span<</ActualText<FEFF2004>>> BDC 
<0003>Tj
EMC 
/TT0 1 Tf
0 Tw 2.039 0 Td
[(\223W)0.5 (h)0.5 (at )0.5 (i)0.5 (s )0.5 (th)0.5 (e )0.5 (mo)0.5 (st )0.5 (i)0.5 (mp)0.5 (o)0.5 (rtan)0.5 (t )0.5 (i)0.5 (n)0.5 (fo)0.5 (rmati)0.5 (o)0.5 (n )0.6 (I)0.5 ( sh)0.5 (o)0.5 (u)0.5 (l)0.5 (d)0.5 ( )0.5 (kno)0.5 (w)0.5 ( )0.5 (ab)0.5 (o)0.5 (u)0.5 (t )37.6 (AUG)0.5 (T)0.5 (YRO)0.5 (?)0.5 (\224)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF00A0>>> BDC 
34.215 0 Td
( )Tj
EMC 
/TT0 1 Tf
-0.018 Tc -38.054 -1.248 Td
[(T)0.5 (h)0.5 (e )0.6 (mo)0.5 (st )0.5 (co)0.5 (mmo)0.5 (n)0.5 ( )0.5 (si)0.5 (d)0.5 (e )0.5 (effects )0.5 (o)0.5 (f )37.6 (AUGT)0.5 (YRO)0.5 ( )0.5 (i)0.5 (n)0.5 (cl)0.5 (u)0.5 (d)0.5 (e:)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.492 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
<0047004C005D005D004C0051004800560056>Tj
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.316 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0046004B00440051004A00480003>0.5 <004C00510003>0.5 <005600480051005600480003>0.5 <00520049>0.5 <0003>0.5 <0057>0.5 <004400560057>0.5 <0048>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.316 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0049>0.5 <00480048004F004C0051004A0003>0.5 <00520049>0.5 <0003>0.5 <005100580050004500510048005600560003>0.5 <005200550003>0.5 <0057>0.5 <004C0051004A004F004C0051004A0003>0.6 <004C00510003>0.5 <005C0052005800550003>0.5 <00440055005000560003>0.5 <005200550003>0.5 <004F0048004A0056>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.316 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<00460052005100560057>0.5 <004C005300440057>0.5 <004C00520051>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.316 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0056004B005200550057>0.5 <00510048005600560003>0.5 <00520049>0.5 <0003>0.5 <00450055004800440057>0.5 <004B>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
24.786 5.264 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0057>0.5 <004C0055004800470051004800560056>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.376 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0057>0.5 <0055005200580045004F00480003>0.5 <005A004C0057>0.5 <004B0003>0.5 <00450044004F0044005100460048000F>0.5 <0003>0.5 <00460052005200550047004C005100440057004C00520051000F>0.5 <0003>0.5 <0044005100470003>0.5 <005A0044004F004E004C0051004A>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.376 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0053005500520045004F0048005000560003005A004C0057>0.5 <004B0003>0.5 <0057>0.5 <004B004C0051004E004C0051004A000F>0.5 <0003>0.5 <005600580046004B0003>0.5 <004400560003>0.5 <0049>0.5 <00520055004A00480057>0.5 <0049>0.5 <0058004F00510048005600560003>0.5 <00520055>-18 <0003>]TJ
0 -1.1 Td
[<0046005200510049>0.5 <00580056004C00520051000F>0.5 <0003>0.5 <00500048005000520055005C0003>0.5 <0053005500520045004F0048005000560003>0.5 <0044005100470003>0.5 <004B0044004F004F00580046004C005100440057>0.5 <004C005200510056>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.376 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0050005800560046004F00480003>0.5 <005A00480044004E0051004800560056>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.376 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
<005100440058005600480044>Tj
-27.8 -1.388 Td
[<0037>0.5 <004B00480056004800030044005500480003>0.5 <005100520057>0.5 <0003>0.5 <0044004F004F0003>0.5 <00520049>0.5 <0003>0.5 <0057>0.5 <004B00480003>0.5 <0053005200560056004C0045004F00480003>0.5 <0056004C004700480003>0.5 <00480049>18.6 <0049>0.5 <004800460057>0.5 <00560003>0.5 <00520049>0.5 <0003>55.6 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0011>]TJ
0 -1.428 Td
[<00260044004F004F0003>0.5 <005C0052005800550003>0.5 <0047005200460057005200550003>0.5 <0049>0.5 <005200550003>0.5 <005000480047004C00460044004F0003>0.5 <004400470059004C004600480003>0.5 <00440045005200580057>0.5 <0003>0.5 <0056004C004700480003>0.5 <00480049>18.6 <0049>0.5 <004800460057>0.5 <00560011>0.5 <0003>18.6 <003C>92.1 <005200580003>0.5 <00500044005C0003>0.5 <005500480053005200550057>0.5 <0003>0.5 <0056004C004700480003>0.5 <00480049>18.5 <0049>0.5 <004800460057>0.5 <00560003>0.5 <0057>0.5 <00520003>0.5 <0029>0.5 <00270024>55.5 <0003>0.5 <00440057>0.5 <0003>0.5 <00140010001B0013001300100029>0.5 <00270024001000140013001B001B0011>]TJ
/TT0 1 Tf
0 Tw 0 -2.58 Td
[(Ho)0.5 (w)0.5 ( )0.5 (sh)0.5 (o)0.5 (u)0.5 (l)0.5 (d)0.5 ( )0.5 (I)0.5 ( )0.5 (sto)0.5 (re )37.6 (AUG)0.5 (T)0.5 (YRO)0.5 (?)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.428 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<00360057>0.5 <0052005500480003>55.7 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0003>0.5 <00440057>0.5 <0003>0.5 <00550052005200500003>0.5 <0057>0.5 <0048005000530048005500440057>0.5 <0058005500480003>0.5 <004500480057>0.5 <005A0048004800510003>0.5 <0019001B00830029>0.5 <0003>0.5 <0057>0.5 <00520003>0.5 <001A001A00830029>0.5 <0003>0.5 <000B00150013008300260003>0.5 <0057>0.5 <00520003>0.6 <0015001800830026000C0011>]TJ
/TT0 1 Tf
0 Tw -1.8 -1.428 Td
[(Keep)0.5 ( )37.6 (AUG)0.5 (T)0.5 (YRO)0.5 ( )0.5 (an)0.5 (d)0.5 ( )0.5 (al)0.5 (l)0.5 ( )0.5 (med)0.5 (i)0.5 (cin)0.5 (es )0.5 (o)0.5 (u)0.5 (t )0.5 (o)0.5 (f )0.5 (th)0.5 (e )0.5 (reach)0.5 ( )0.5 (o)0.5 (f )0.5 (ch)0.5 (i)0.5 (ld)0.5 (ren)0.5 (.)]TJ
ET
4 M 
36.5 37 539 694.308 re
S
endstreamendobj29 0 obj<</Length 28255>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
/GS1 gs
q 1 0 0 1 37 675.3987 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 37 271.8011 cm
0 0 m
538 0 l
S
Q
q 1 0 0 1 37 128.5179 cm
0 0 m
538 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
-0.018 Tc 10 0 0 10 250.7117 714.5277 Tm
[(P)74.5 (A)74.4 (T)0.5 (I)0.5 (ENT)0.5 ( )0.5 (I)0.5 (NF)0.5 (O)0.5 (RMA)74.4 (T)0.5 (I)0.5 (O)0.5 (N)]TJ
-0.537 -1.138 Td
[(AUG)0.5 (T)0.5 (YRO)0.5 (\231 )0.5 ([Au)0.5 (g)0.5 (-T)0.5 (YE-ro)0.5 (])]TJ
0 Tc 12.132 0 Td
( )Tj
-0.018 Tc 0.018 Tw -9.326 -1.138 Td
[(\(rep)0.5 (otrecti)0.5 (n)0.5 (i)0.5 (b)0.5 (\))-18 ( )]TJ
/TT1 1 Tf
0 Tc 0 Tw 6.762 0 Td
( )Tj
/TT0 1 Tf
-0.018 Tc 0.018 Tw -5.578 -1.138 Td
[(capsu)0.5 (l)0.5 (es)]TJ
0 Tw -23.924 -1.768 Td
[(W)0.5 (h)0.5 (at )0.5 (i)0.5 (s )0.5 (the )0.5 (mo)0.5 (st )0.5 (i)0.5 (mp)0.5 (o)0.5 (rtan)0.5 (t )0.5 (i)0.5 (n)0.5 (fo)0.5 (rmati)0.5 (o)0.5 (n)0.5 ( )0.5 (I)0.5 ( )0.5 (sh)0.5 (o)0.5 (u)0.5 (l)0.5 (d )0.5 (kn)0.5 (o)0.5 (w)0.5 ( )0.5 (ab)0.5 (o)0.5 (ut )37.6 (AUG)0.5 (T)0.5 (YRO)0.5 (?)]TJ
0 -1.498 Td
[(AUG)0.5 (T)0.5 (YRO)0.5 ( )0.5 (may )0.5 (cau)0.5 (se )0.5 (seri)0.5 (o)0.5 (u)0.5 (s )0.5 (si)0.5 (d)0.5 (e )0.5 (effects,)0.5 ( )0.5 (i)0.5 (n)0.5 (cl)0.5 (u)0.5 (di)0.6 (ng)0.5 (:)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.426 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT0 1 Tf
-0.001 Tc 0.087 Tw 1.8 0 Td
[(Central )0.5 (nervous )0.5 (system \(CNS\) )0.5 (effects.)]TJ
/C2_0 1 Tf
0.001 Tw [<0BD8>-0.6 <0003>-68.4 <0037>111 <0048004F004F0003>-86.5 <005C0052005800550003>-86.5 <004B00480044004F0057004B00460044005500480003>-86.5 <0053005500520059004C0047004800550003>-86.5 <0055004C004A004B00570003>-86.5 <0044005A0044005C0003>-86.5 <004C00490003>-86.5 <005C005200580003>-86.5 <0048005B005300480055004C00480051004600480003>-86.6 <00440051005C0003>-86.5 <00510048005A0003>-86.5 <00520055>-1 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.138 Td
[<005A00520055005600480051004C0051004A0003>0.5 <0056005C005000530057>0.5 <0052005000560003>0.5 <00520049>0.5 <0003>0.5 <0026003100360003>0.5 <00480049>18.6 <0049>0.5 <004800460057>0.5 <00560003>0.5 <004700580055004C0051004A0003>0.5 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>0.5 <005A004C0057>0.5 <004B0003>55.6 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <000F>0.5 <0003>0.5 <004C00510046004F00580047004C0051004A001D>]TJ
ET
0 0 0 0 k
/GS0 gs
64 619.397 242 -13.4 re
306 619.397 260 -64.601 re
64 605.997 242 -13.4 re
64 592.597 242 -24.4 re
64 568.196 242 -13.4 re
f
BT
0 0 0 1 k
/GS1 gs
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
10 0 0 10 69.8567 609.0569 Tm
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
<0047004C005D005D004C0051004800560056>Tj
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
22.986 0 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0053005500520045004F0048005000560003005A004C0057>0.5 <004B0003>0.5 <0057>0.5 <004B004C0051004E004C0051004A000F>0.5 <0003>0.5 <005600580046004B0003>0.5 <004400560003>0.5 <0049>0.5 <00520055004A00480057>0.5 <0049>0.5 <0058004F00510048005600560003>0.5 <00520055>-18 <0003>]TJ
0 -1.1 Td
[<0046005200510049>0.5 <00580056004C00520051>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.244 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<005600480048004C0051004A0003>0.5 <005200550003>0.5 <004B004800440055004C0051004A0003>0.5 <0057>0.5 <004B004C0051004A00560003>0.5 <0057>0.5 <004B00440057>0.5 <0003>0.5 <0044005500480003>0.5 <005100520057>0.5 <0003005500480044004F0003>0.5 <000B004B0044004F004F00580046004C005100440057>0.5 <004C005200510056000C>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.226 -1.244 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.574 0 Td
<017C>Tj
-0.03 Tc 0.03 Tw 1.8 0 Td
[<0053005500520045004F0048005000560003>0.5 <005A004C0057>0.5 <004B0003>0.5 <0046005200510046004800510057>0.5 <005500440057>0.5 <004C00520051000F>0.5 <0003>0.5 <00440057>0.5 <0057>0.5 <004800510057>0.5 <004C00520051000F>0.5 <0003>0.5 <00500048005000520055005C>74.5 <000F>0.5 <0003>0.5 <0044005100470003>0.5 <0056004F004800480053>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-25.414 2.248 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0059004800550057>0.5 <004C004A0052>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.34 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0046004B00440051004A004800560003>0.5 <004C00510003>0.5 <0050005200520047000F>0.5 <0003>0.5 <005600580046004B0003>0.5 <004400560003>0.5 <00440051005B004C00480057>0.5 <005C>74.5 <000F>0.5 <0003>0.5 <004C00550055004C0057>0.5 <00440045004C004F004C0057>0.5 <005C>74.5 <000F>-17.8 <0003>]TJ
/TT1 1 Tf
0 Tc 0 Tw 19.092 0 Td
( )Tj
/C2_0 1 Tf
-0.018 Tc 0.018 Tw -19.092 -1.1 Td
[<0044005100470003>0.5 <0047004800530055004800560056004C00520051>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.34 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<00450044004F00440051004600480003>0.5 <005200550003>0.5 <00460052005200550047004C005100440057>0.5 <004C005200510003>0.5 <0053005500520045004F004800500056>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-3.014 -1.444 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT0 1 Tf
-0.009 Tc 0.043 Tw 1.8 0 Td
[(L)0.7 (u)0.7 (n)0.7 (g)0.7 ( p)0.7 (ro)0.7 (b)0.7 (l)0.7 (ems \()0.6 (p)0.7 (n)0.7 (eu)0.7 (mo)0.7 (n)0.7 (i)0.7 (t)0.5 (i)0.7 (s\))0.5 (.)]TJ
/C2_0 1 Tf
0.009 Tw 14.209 0 Td
[<0BD80003>-25.1 <0037>111.5 <0048004F004F0003>-43.2 <005C>0.5 <005200580055>0.5 <0003>-43.2 <004B00480044004F0057>0.7 <004B0046>0.6 <00440055>0.5 <00480003>-43.3 <00530055>0.5 <00520059>0.6 <004C004700480055>0.6 <0003>-43.3 <004C0049>0.7 <0003>-43.3 <005C>0.6 <005200580003>-43.3 <004B00440059>0.5 <00480003>-43.2 <00440051005C>0.6 <0003>-43.3 <00510048005A0003>-43.3 <00520055>0.5 <0003>-43.2 <005A00520055>0.5 <0056>0.5 <00480051004C0051004A0003>-43.3 <0056>0.5 <005C>0.6 <0050>0.5 <00530057>0.7 <00520050>0.5 <0056>0.6 <0003>-43.3 <00520049>0.7 <0003>-43.2 <004F00580051004A>-9.1 <0003>]TJ
-0.018 Tc 0.018 Tw -14.209 -1.138 Td
[<0053005500520045004F004800500056000F0003>0.5 <004C00510046004F00580047004C0051004A0003>0.5 <00440003>0.5 <00470055005C0003>0.5 <004600520058004A004B0003>0.5 <000B005A004C0057>0.5 <004B0052005800570003>0.5 <00500058004600580056000C000F>0.5 <0003>0.5 <0053005500520047005800460057>0.5 <004C005900480003>0.5 <004600520058004A004B0003>0.5 <000B005A004C0057>0.5 <004B0003>0.5 <00500058004600580056000C000F>0.5 <0003>0.5 <005A004B00480048005D004C0051004A000F>0.5 <0003>0.5 <005200550003>0.5 <0057>0.5 <0055005200580045004F00480003>0.5 <00450055004800440057>0.5 <004B004C0051004A0011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.246 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT0 1 Tf
-0.018 Tc 0.014 Tw 1.8 0 Td
[(L)0.5 (i)0.5 (ver )0.7 (p)0.5 (ro)0.5 (b)0.5 (l)0.5 (ems.)]TJ
/C2_0 1 Tf
0.018 Tw 7.186 0 Td
[<0BD80003>4.8 <003C>92.1 <0052005800550003>-13.4 <004B00480044004F0057>0.5 <004B00460044005500480003>-13.3 <0053005500520059004C0047004800550003>-13.3 <005A004C004F004F0003>-13.3 <004700520003>-13.4 <0045004F0052005200470003>-13.3 <0057>0.5 <004800560057>0.5 <00560003>-13.3 <0057>0.5 <00520003>-13.3 <0046004B00480046004E0003>-13.3 <005C0052005800550003>-13.3 <004F004C0059004800550003>-13.3 <0049>0.5 <0058005100460057>0.5 <004C005200510003>-13.3 <004500480049>0.5 <0052005500480003>-13.4 <00560057>0.5 <004400550057>0.5 <004C0051004A0003>-13.4 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>-13.4 <005A004C0057>0.5 <004B>-18.2 <0003>]TJ
-7.186 -1.138 Td
[<00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <000F>0.5 <0003>4.3 <0048005900480055005C0003>4.3 <00150003>4.3 <005A00480048004E00560003>4.3 <0049>0.5 <005200550003>4.3 <0057>0.5 <004B00480003>4.3 <00BF005500560057>0.5 <0003>4.3 <0050005200510057>0.5 <004B0003>4.3 <0044005100470003>4.3 <004400560003>4.3 <0051004800480047004800470003>4.3 <004700580055004C0051004A0003>4.3 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0011>0.5 <0003>22.4 <0037>111.3 <0048004F004F0003>4.3 <005C0052005800550003>4.3 <004B00480044004F0057>0.5 <004B00460044005500480003>4.3 <0053005500520059004C0047004800550003>4.3 <0055004C004A004B0057>0.5 <0003>4.3 <0044005A0044005C>-18 <0003>]TJ
0 -1.138 Td
[<004C0049>0.5 <0003>0.5 <005C005200580003>0.5 <0047004800590048004F005200530003>0.5 <0056005C005000530057>0.5 <0052005000560003>0.5 <00520049>0.5 <0003>0.5 <004F004C0059004800550003>0.5 <0053005500520045004F0048005000560003>0.5 <004C00510046004F00580047004C0051004A001D>]TJ
ET
0 0 0 0 k
/GS0 gs
64 493.038 242 -13.4 re
306 493.038 260 -13.4 re
64 479.638 242 -13.4 re
306 479.638 260 -13.4 re
64 466.238 242 -13.4 re
306 466.238 260 -13.4 re
f
BT
0 0 0 1 k
/GS1 gs
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
10 0 0 10 69.8567 482.6978 Tm
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<005C0052005800550003>0.5 <0056004E004C00510003>0.5 <005200550003>0.5 <0057>0.5 <004B00480003>0.6 <005A004B004C0057>0.5 <00480003>0.5 <0053004400550057>0.5 <0003>0.5 <00520049>0.5 <0003>0.5 <005C0052005800550003>0.5 <0048005C004800560003>0.5 <0057>0.5 <00580055005100560003>0.5 <005C0048004F004F0052005A>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
22.986 0 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004F0052005600560003>0.5 <00520049>0.5 <0003>0.5 <00440053005300480057>0.5 <004C0057>0.5 <0048>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-25.414 -1.34 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004700440055004E0003>0.5 <005200550003>0.5 <00B30057>0.5 <00480044001000460052004F005200550048004700B40003>0.5 <00580055004C00510048>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
22.986 0 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0051004400580056004800440003>0.5 <005200550003>0.5 <005900520050004C0057>0.5 <004C0051004A>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-25.414 -1.34 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004F004C004A004B0057>0.5 <001000460052004F00520055004800470003>0.5 <0056005700520052004F00560003>0.5 <000B00450052005A0048004F0003>0.5 <00500052005900480050004800510057>0.5 <0056000C>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
22.986 0 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<00530044004C00510003>0.5 <005200510003>0.5 <0057>0.5 <004B00480003>0.5 <005800530053004800550003>0.5 <0055004C004A004B0057>0.5 <0003>0.5 <0056004C004700480003>0.5 <00520049>0.5 <0003>0.5 <005C0052005800550003>0.5 <00560057>0.5 <0052005000440046004B0003>0.5 <0044005500480044>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.214 -1.444 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT0 1 Tf
-0.024 Tc -0.014 Tw 1.8 0 Td
(Muscle problems.)Tj
/C2_0 1 Tf
0.024 Tw [<0BD8>-0.7 <0003>32 <003C>91.6 <0052005800550003>13.9 <004B00480044004F0057004B00460044005500480003>13.9 <0053005500520059004C0047004800550003>13.9 <005A004C004F004F0003>13.9 <004700520003>13.9 <0045004F0052005200470003>13.9 <005700480056005700560003>13.9 <0045004800490052005500480003>13.8 <00560057004400550057004C0051004A0003>13.9 <0057005500480044005700500048005100570003>14 <005A004C0057004B0003>69 <00240038002A0037003C00350032000F0003>13.9 <0048005900480055005C0003>13.9 <0015>]TJ
/Span<</ActualText<FEFF00A0>>> BDC 
<0003>Tj
EMC 
47.461 0 Td
[<005A00480048004E0056>-24 <0003>]TJ
-0.018 Tc 0.018 Tw -47.461 -1.138 Td
[<0049>0.5 <005200550003>13.4 <0057>0.5 <004B00480003>13.3 <00BF005500560057>0.5 <0003>13.4 <0050005200510057>0.5 <004B0003>13.4 <0044005100470003>13.4 <004400560003>13.4 <0051004800480047004800470003>13.4 <004700580055004C0051004A0003>13.4 <0057>0.5 <0055004800440057>0.6 <0050004800510057>0.5 <0011>0.5 <0003>31.5 <0037>111.3 <0048004F004F0003>13.4 <005C0052005800550003>13.4 <004B00480044004F0057>0.5 <004B00460044005500480003>13.4 <0053005500520059004C0047004800550003>13.4 <0055004C004A004B0057>0.5 <0003>13.4 <0044005A0044005C0003>13.4 <004C0049>0.5 <0003>13.4 <005C005200580003>13.4 <004A00480057>0.5 <0003>13.4 <00510048005A0003>13.4 <005200550003>13.4 <005A00520055005600480051004C0051004A>-18.1 <0003>]TJ
-0.012 Tc 0.012 Tw 0 -1.138 Td
[<0056004C004A005100560003>-33.7 <00440051>-0.6 <00470003>-33.7 <0056005C0050005300570052005000560003>-33.7 <005200490003>-33.7 <0050005800560046004F00480003>-33.7 <0053>-0.6 <00550052>-0.6 <0045004F004800500056000F0003>-33.7 <004C00510046004F00580047>-0.6 <004C0051004A0003>-33.8 <005800510048005B0053004F0044>-0.6 <004C0051004800470003>-33.8 <00500058>-0.6 <00560046004F00480003>-33.8 <00530044004C0051>-0.6 <0003>-33.7 <005200550003>-33.7 <0050005800560046004F>-0.6 <00480003>-33.7 <00530044004C>-0.6 <00510003>-33.7 <0057004B004400570003>-33.8 <00470052004800560003>-33.7 <0051005200570003>-33.8 <004A00520003>-33.7 <0044005A>-0.6 <0044005C>73.9 <000F>-11.9 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.138 Td
[<0057>0.5 <004800510047004800550051004800560056000F0003>0.5 <005200550003>0.5 <005A00480044004E00510048005600560011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.354 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT0 1 Tf
-0.006 Tc 0.062 Tw 1.8 0 Td
(Increased uric acid level in your blood \(hyperuricemia\).)Tj
/C2_0 1 Tf
0.006 Tw [<0BD8>-0.6 <0003>-6.8 <00240038002A0037003C003500320003>-61.9 <00500044005C0003>-61.9 <004600440058005600480003>-62 <004400510003>-62 <0048005B00460048005600560003>-61.9 <005200490003>-62 <00580055004C00460003>-62 <00440046004C00470003>-61.9 <004C00510003>-62 <005C005200580055>-6 <0003>]TJ
-0.012 Tc 0.012 Tw 0 -1.138 Td
[<0045004F00520052004700110003>-12.2 <003C>92 <0052005800550003>-30.2 <004B00480044004F0057004B00460044005500480003>-30.3 <0053005500520059004C0047004800550003>-30.3 <005A004C004F004F0003>-30.3 <004700520003>-30.3 <005700480056005700560003>-30.3 <0045004800490052005500480003>-30.3 <0044005100470003>-30.2 <004700580055004C0051004A0003>-30.3 <005C0052005800550003>-30.3 <0057005500480044005700500048005100570003>-30.3 <005A004C0057004B0003>24.8 <00240038002A0037003C003500320003>-30.3 <005700520003>-30.3 <0046004B00480046004E0003>-30.3 <0057004B00480003>-30.3 <00580055004C00460003>-30.3 <00440046004C0047>-12.2 <0003>]TJ
-0.016 Tc 0.016 Tw 0 -1.138 Td
[<004F004800590048004F0003>-13.2 <004C00510003>-13.2 <005C>0.5 <005200580055>0.5 <0003>-13.2 <0045004F0052005200470011>0.6 <0003>4.8 <003C>92.3 <005200580055>0.5 <0003>-13.2 <004B00480044004F0057>0.6 <004B0046>0.5 <00440055>0.5 <00480003>-13.2 <00530055>0.5 <00520059>0.5 <004C004700480055>0.5 <0003>-13.3 <0050>0.5 <0044005C>0.5 <0003>-13.3 <0053005500480056>0.5 <0046>0.5 <0055004C004500480003>-13.2 <0050>0.5 <00480047004C0046>0.5 <004C005100480056>0.5 <0003>-13.2 <004C0049>0.7 <0003>-13.3 <005C>0.5 <005200580003>-13.2 <004B00440059>0.5 <00480003>-13.3 <004B004C004A004B0003>-13.2 <0045004F0052005200470003>-13.3 <00580055>0.5 <004C0046>0.5 <0003>-13.3 <00440046004C00470003>-13.2 <004F00480059>0.5 <0048004F0056>0.5 <0011>0.6 <0003>4.8 <0037>111.5 <0048004F004F0003>-13.2 <005C>0.5 <005200580055>-16 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.138 Td
[<004B00480044004F0057>0.5 <004B00460044005500480003>0.5 <0053005500520059004C0047004800550003>0.5 <004C0049>0.5 <0003>0.5 <005C005200580003>0.6 <0048005B005300480055004C00480051004600480003>0.6 <0056005C005000530057>0.5 <0052005000560003>0.5 <00520049>0.5 <0003>0.5 <004C005100460055004800440056004800470003>0.5 <00580055004C00460003>0.5 <00440046004C00470003>0.5 <004C00510046004F00580047004C0051004A001D>]TJ
ET
0 0 0 0 k
/GS0 gs
64 355.87 242 -24.4 re
306 355.87 260 -38.28 re
64 331.47 242 -13.88 re
f
BT
0 0 0 1 k
/GS1 gs
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
10 0 0 10 69.8567 345.5301 Tm
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<005500480047000F>0.5 <0003>0.5 <004B00520057>0.5 <000F>0.5 <0003>0.5 <0057>0.5 <00480051004700480055>55.5 <000F>0.5 <0003>0.5 <005200550003>0.5 <0056005A0052004F004F004800510003>0.5 <004D0052004C00510057>0.5 <0056000F>0.5 <0003>0.5 <00480056005300480046004C0044004F004F005C0003>0.5 <004C0051>-18.2 <0003>]TJ
/TT1 1 Tf
0 Tc 0 Tw 19.743 0 Td
( )Tj
/C2_0 1 Tf
-0.018 Tc 0.018 Tw -19.743 -1.1 Td
[<005C0052005800550003>0.5 <0045004C004A0003>0.5 <0057>0.5 <00520048>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
22.986 1.1 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004700480046005500480044005600480003>0.5 <004C00510003>0.5 <005C0052005800550003>0.5 <004400500052005800510057>0.5 <0003>0.5 <00520049>0.5 <0003>0.5 <00580055004C005100480003>0.5 <005200550003>0.5 <005100520003>0.5 <00580055004C005100480003>0.5 <00440057>0.6 <0003>0.5 <0044004F004F>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.244 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0051004400580056004800440003>0.5 <005200550003>0.5 <005900520050004C0057>0.5 <004C0051004A>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.244 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<0053004C0051004E0003>0.5 <005200550003>0.5 <004500550052005A0051000300580055004C005100480003>0.5 <005200550003>0.5 <0045004F0052005200470003>0.5 <004C00510003>0.5 <005C0052005800550003>0.5 <00580055004C00510048>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-25.414 0.048 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<00530044004C00510003>0.5 <004C00510003>0.5 <005C0052005800550003>0.5 <00560057>0.5 <0052005000440046004B001000440055004800440003>0.5 <005200550003>0.5 <0056004C004700480056>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-3.014 -1.492 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
/TT0 1 Tf
-0.021 Tc -0.014 Tw 1.8 0 Td
(Bone fractures.)Tj
/C2_0 1 Tf
0.021 Tw [<0BD80003>69.4 <00240038002A0037003C003500320003>14.3 <00500044005C0003>14.2 <004C00510046005500480044005600480003>14.2 <005C0052005800550003>14.2 <0055004C0056004E0003>14.2 <0049005200550003>14.2 <00450052005100480003>14.3 <00490055004400460057005800550048005600110003>14.2 <00250052005100480003>14.2 <0049005500440046005700580055004800560003>14.2 <00500044005C0003>14.2 <004B004400530053004800510003>14.2 <005A004C0057004B0003>14.2 <005200550003>14.2 <005A004C0057004B0052005800570003>14.3 <00440003>14.2 <00490044004F004F>-21.2 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.138 Td
[<005200550003>0.5 <00520057>0.5 <004B004800550003004C0051004D00580055005C>74.6 <0011>0.5 <0003>18.6 <0037>111.3 <0048004F004F0003>0.5 <005C0052005800550003>0.5 <004B00480044004F0057>0.5 <004B00460044005500480003>0.5 <0053005500520059004C0047004800550003>0.5 <0055004C004A004B0057>0.5 <0003>0.5 <005A0044005C0003>0.5 <004C0049>0.5 <0003>0.5 <005C005200580003>0.5 <004B0044005900480003>0.5 <00530044004C0051000F>0.5 <0003>0.5 <0046004B00440051004A004800560003>0.5 <004C00510003>0.5 <00500052005900480050004800510057>0.6 <000F0003>0.5 <005200550003>0.5 <004500520051004800030044004500510052005500500044004F004C0057>0.5 <004C004800560011>]TJ
-1.8 -1.354 Td
<003600480048>Tj
/Span<</ActualText<FEFF2005>>> BDC 
<0003>Tj
EMC 
/TT0 1 Tf
0 Tw 1.956 0 Td
[(\223W)0.5 (h)0.5 (at )0.5 (are )0.5 (th)0.5 (e )0.5 (p)0.5 (o)0.5 (ssi)0.5 (b)0.5 (l)0.5 (e )0.5 (si)0.5 (d)0.5 (e )0.5 (effects )0.5 (o)0.5 (f )37.6 (AUG)0.6 (TYRO)0.5 (?)0.5 (\224 )0.5 (fo)0.5 (r )0.5 (mo)0.5 (re )0.5 (i)0.5 (n)0.5 (fo)0.5 (rmati)0.5 (o)0.5 (n)0.5 ( ab)0.5 (o)0.5 (u)0.5 (t )0.5 (si)0.5 (d)0.5 (e )0.5 (effects.)]TJ
/TT1 1 Tf
0 Tc /Span<</ActualText<FEFF00A0>>> BDC 
41.744 0 Td
( )Tj
EMC 
/TT0 1 Tf
-0.018 Tc -0.037 Tw -43.7 -2.578 Td
[(W)0.5 (h)0.5 (at )-36.5 (i)0.5 (s )0.6 (AUG)0.5 (T)0.5 (YRO)0.6 (?)]TJ
/C2_0 1 Tf
0.018 Tw 0 -1.498 Td
[<00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0003>0.5 <004C00560003>0.5 <00440003>0.5 <005300550048005600460055004C00530057>0.5 <004C005200510003>0.5 <005000480047004C0046004C005100480003>0.5 <00580056004800470003>0.5 <0057>0.5 <00520003>0.5 <0057>0.5 <0055004800440057>0.5 <001D>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.426 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.014 Tc 0.014 Tw 1.8 0 Td
[<004400470058004F005700560003>-23.3 <005A004C0057004B0003>-23.3 <0051005200510010005600500044004F004F0003>-23.3 <00460048004F004F0003>-23.3 <004F00580051004A0003>-23.3 <0046004400510046004800550003>-23.3 <000B003100360026002F0026000C0003>-23.3 <0057004B004400570003>-23.3 <004B004400560003>-23.3 <0056005300550048004400470003>-23.3 <005A004C0057004B004C00510003>-23.3 <005C0052005800550003>-23.2 <0046004B0048005600570003>-23.3 <005200550003>-23.3 <005700520003>-23.3 <00520057004B004800550003>-23.3 <005300440055005700560003>-23.3 <005200490003>-23.3 <0057004B00480003>-23.3 <004500520047005C0003>-23.4 <0044005100470003>-23.3 <004C0056>-14 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.138 Td
[<0046004400580056004800470003>0.5 <0045005C0003>0.5 <004400510003>0.5 <0044004500510052005500500044004F0003>]TJ
/TT2 1 Tf
10.27 0 Td
[(RO)0.5 (S1)]TJ
/C2_0 1 Tf
[<0003>0.5 <004A0048005100480011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-11.484 -1.354 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004400470058004F0057>0.5 <00560003>0.5 <0044005100470003>0.6 <0046004B004C004F00470055004800510003>0.5 <001400150003>0.5 <005C00480044005500560003>0.5 <00520049>0.5 <0003>0.5 <0044004A00480003>0.5 <00440051004700030052004F0047004800550003>0.5 <005A004C0057>0.5 <004B0003>0.5 <00560052004F004C00470003>0.5 <0057>0.5 <005800500052005500560003>0.5 <000B004600440051004600480055000C0003>0.5 <0057>0.5 <004B00440057>0.5 <001D>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.318 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.9 0 Td
[<0044005500480003>0.5 <0046004400580056004800470003>0.5 <0045005C00030046004800550057>0.5 <0044004C00510003>0.5 <0044004500510052005500500044004F0003>]TJ
/TT2 1 Tf
13.717 0 Td
[(NT)0.5 (RK)]TJ
/C2_0 1 Tf
[<0003004A0048005100480056000F>0.5 <0003>]TJ
/TT0 1 Tf
6.06 0 Td
[(an)0.5 (d)]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF2004>>> BDC 
1.741 0 Td
( )Tj
EMC 
/Span<</ActualText<FEFF0009>>> BDC 
-22.849 -1.282 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.57 0 Td
<017C>Tj
-0.034 Tc 0.034 Tw 1.9 0 Td
[<004B0044005900480003>0.9 <0056005300550048004400470003>0.9 <0057>0.5 <00520003>1 <00520057>0.5 <004B004800550003>1 <0053004400550057>0.5 <00560003>0.9 <00520049>0.5 <0003>0.9 <0057>0.6 <004B00480003>0.9 <004500520047005C>74.6 <000F>0.5 <0003>0.9 <005200550003>0.9 <004C0049>0.5 <0003>0.9 <005600580055004A00480055005C0003>0.9 <0057>0.5 <00520003>0.9 <0055004800500052005900480003>0.9 <005C0052005800550003>0.9 <0046004400510046004800550003>0.9 <004C00560003>0.9 <004F004C004E0048004F005C0003>0.9 <0057>0.5 <00520003>0.9 <004600440058005600480003>1 <0056004800590048005500480003>0.9 <0046005200500053004F004C004600440057>0.5 <004C005200510056000F>0.6 <0003>]TJ
/TT0 1 Tf
46.591 0 Td
[(an)0.5 (d)]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF2004>>> BDC 
1.709 0 Td
( )Tj
EMC 
/Span<</ActualText<FEFF0009>>> BDC 
-49.614 -1.282 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<017C>Tj
-0.018 Tc 0.018 Tw 1.9 0 Td
[<004B0044005900480003004A00550052005A00510003>0.5 <005200550003>0.5 <0056005300550048004400470003>0.5 <00440049>0.5 <0057>0.5 <004800550003>0.5 <00520057>0.5 <004B004800550003>0.5 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>0.5 <005200550003>0.5 <0057>0.5 <004B0048005500480003>0.5 <004C00560003>0.5 <005100520003>0.5 <005600440057>0.5 <004C00560049>0.5 <004400460057>0.5 <00520055005C0003>0.5 <0044004F0057>0.5 <00480055005100440057>0.5 <004C005900480003>0.5 <0057>0.6 <0055004800440057>0.5 <0050004800510057>0.5 <0003>0.5 <005200530057>0.5 <004C005200510011>]TJ
-0.021 Tc 0.021 Tw -3.7 -1.318 Td
[<002C>0.6 <0057>0.7 <0003>14.6 <004C0056>0.5 <0003>14.5 <005100520057>0.7 <0003>14.5 <004E>0.5 <00510052005A00510003>14.5 <004C0049>0.7 <0003>69.7 <0024>0.5 <0038002A>0.7 <0037>0.6 <003C>0.5 <00350032>0.6 <0003>14.6 <004C0056>0.5 <0003>14.5 <0056>0.5 <00440049>0.6 <00480003>14.5 <0044005100470003>14.6 <00480049>18.7 <0049>0.7 <00480046>0.5 <0057>0.7 <004C0059>0.5 <00480003>14.6 <004C00510003>14.5 <0046>0.5 <004B004C004F00470055>0.5 <004800510003>14.5 <005A004C0057>0.6 <004B0003>]TJ
/TT2 1 Tf
-0.061 Tc 0.061 Tw 27.007 0 Td
[(R)-19.7 (O)-39.3 (S)0.5 (1)]TJ
/C2_0 1 Tf
-0.021 Tc 0.021 Tw 2.557 0 Td
[<0010>-19.5 <005300520056>0.5 <004C0057>0.6 <004C0059>0.5 <00480003>14.5 <00310036>0.5 <0026002F00260003>14.5 <00520055>0.5 <0003>14.6 <004C00510003>14.6 <0046>0.5 <004B004C004F00470055>0.5 <004800510003>14.5 <005C>0.5 <005200580051004A00480055>0.5 <0003>14.5 <0057>0.7 <004B004400510003>14.5 <001400150003>14.6 <005C>0.5 <0048004400550056>-21 <0003>]TJ
-0.018 Tc 0.018 Tw -29.564 -1.138 Td
[<00520049>0.5 <0003>0.5 <0044004A00480003>0.5 <005A004C0057>0.5 <004B0003>]TJ
/TT2 1 Tf
4.894 0 Td
[(NT)0.5 (RK)]TJ
/C2_0 1 Tf
[<0010005300520056004C0057>0.5 <004C005900480003>0.5 <00560052004F004C00470003>0.5 <0057>0.5 <005800500052005500560011>]TJ
/C2_1 1 Tf
-4.894 -2.578 Td
[<0025004800490052>0.5 <005500480003>0.5 <00570044004E004C>0.5 <0051>0.5 <004A>0.5 <0003>37.5 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <000F>0.5 <0003>0.5 <00570048004F004F>0.6 <0003>0.5 <005C0052>0.5 <0058>0.5 <00550003>0.5 <004B>0.5 <00480044004F>0.5 <0057004B>0.5 <00460044005500480003>0.5 <0053>0.5 <00550052>0.5 <0059004C>0.5 <0047004800550003>0.5 <004400450052>0.5 <0058>0.5 <005700030044004F>0.5 <004F>0.5 <0003>0.5 <005C0052>0.5 <0058>0.5 <00550003>0.5 <005000480047>0.5 <004C>0.5 <00460044004F>0.5 <0003>0.5 <00460052>0.5 <0051>0.5 <0047>0.5 <004C>0.5 <0057004C>0.5 <0052>0.5 <0051>0.5 <0056000F>0.5 <0003>0.5 <004C>0.5 <0051>0.5 <0046004F>0.5 <0058>0.5 <0047>0.5 <004C>0.5 <0051>0.5 <004A>0.5 <0003>0.5 <004C>0.5 <00490003>0.5 <005C00520058>0.5 <001D>-18 <0BD8>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
0.586 -1.426 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004B004400590048000300510048005500590052005800560003>0.5 <0056005C00560057>0.5 <004800500003>0.5 <000B00510048005800550052004F0052004A004C00460044004F000C0003>0.5 <0053005500520045004F0048005000560011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.354 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004B0044005900480003004F00580051004A0003>0.5 <005200550003>0.5 <00450055004800440057>0.5 <004B004C0051004A0003>0.5 <0053005500520045004F0048005000560003>0.5 <00520057>0.5 <004B004800550003>0.5 <0057>0.5 <004B004400510003>0.5 <004F00580051004A0003>0.5 <004600440051004600480055>55.5 <0011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.354 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.018 Tc 0.018 Tw 1.8 0 Td
[<004B0044005900480003004F004C0059004800550003>0.5 <005200550003>0.5 <004E004C004700510048005C0003>0.6 <0053005500520045004F0048005000560011>]TJ
/TT1 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF0009>>> BDC 
-1.214 -1.354 Td
( )Tj
EMC 
/C2_0 1 Tf
-0.586 0 Td
<0194>Tj
-0.014 Tc 0.014 Tw 1.8 0 Td
[<0044005500480003>-21.2 <005300550048004A00510044005100570003>-21.2 <005200550003>-21.3 <0053004F004400510003>-21.3 <005700520003>-21.2 <0045004800460052005000480003>-21.3 <005300550048004A005100440051005700110003>33.9 <00240038002A0037003C003500320003>-21.3 <0046004400510003>-21.2 <004B0044005500500003>-21.2 <005C0052005800550003>-21.2 <0058005100450052005500510003>-21.2 <004500440045005C>74.2 <00110003>-3.2 <0037>111.1 <0048004F004F0003>-21.2 <005C0052005800550003>-21.3 <004B00480044004F0057004B00460044005500480003>-21.2 <0053005500520059004C0047004800550003>-21.3 <0055004C004A004B0057>-13.8 <0003>]TJ
-0.018 Tc 0.018 Tw 0 -1.138 Td
[<0044005A0044005C0003004C0049>0.5 <0003>0.5 <005C005200580003>0.5 <0045004800460052005000480003>0.5 <005300550048004A0051004400510057>0.5 <0003>0.5 <005200550003>0.5 <0057>0.5 <004B004C0051004E0003>0.5 <005C00520058000300500044005C0003>0.5 <004500480003>0.5 <005300550048004A0051004400510057>0.5 <0003>0.5 <004700580055004C0051004A0003>0.5 <0057>0.5 <0055004800440057>0.5 <0050004800510057>0.5 <0003>0.5 <005A004C0057>0.5 <004B0003>55.7 <00240038002A>0.5 <0037>0.5 <003C00350032>0.5 <0011>]TJ
ET
4 M 
36.5 36.5 539 694.808 re
S
endstreamendobj31 0 obj<</BaseFont/QULRDW+Arial-BoldMT/DescendantFonts 57 0 R/Encoding/Identity-H/Subtype/Type0/ToUnicode 58 0 R/Type/Font>>endobj34 0 obj<</BaseFont/QULRDW+Arial-ItalicMT/Encoding/WinAnsiEncoding/FirstChar 49/FontDescriptor 59 0 R/LastChar 84/Subtype/TrueType/ToUnicode 60 0 R/Type/Font/Widths[556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 667 0 0 722 778 0 0 722 667 611]>>endobj59 0 obj<</Ascent 998/CapHeight 716/Descent -325/Flags 96/FontBBox[-517 -325 1379 998]/FontFamily(Arial)/FontFile2 61 0 R/FontName/QULRDW+Arial-ItalicMT/FontStretch/Normal/FontWeight 400/ItalicAngle -12/StemV 92/Type/FontDescriptor/XHeight 519>>endobj60 0 obj<</Filter/FlateDecode/Length 268>>stream
Hâ\êÕj√0«Ô~
€Cqæ;ò@◊µê√>X∂Hl%3,∂q‹Cﬁ~≤]:ò¡÷OHY?uœù—¯ª∑≤« ì6 „jØ^"å8k√ 
îñ·Ê•W.Écúƒ˝∂\:3Y&
Æ¡o∞;*;‚ûÒ7Ø–k3√ÓÎ‘ÔÅ˜WÁ~pA†Ä∂Öz‹Î∞ $;tä‚:l“¸e|n°J~ôõëV·Íâ~032Q–iA\Ë¥ç˙Ã™qíﬂÉg¢.)∑(»0—<%&C|Œ|é|…LıƒCïòqùπé‹dn⁄ÿAU$èLÏ‡ˆWÏÖV˜AÂ’{ö1Ì5«“Ô´w÷©‚eø &ÆÄendstreamendobj61 0 obj<</Filter/FlateDecode/Length 13290/Length1 31997>>stream
Hâåï	TTW@´~ΩÜﬂn † ⁄˝7¸6G5n!îDç7AEDƒ%q—1jåäà®‡æÔä¢qâàä((∏v€‡öV∑8nç›yNÊÃ……ºs™~’´™ˇ˛øÁΩzâ	ì#°.ÃÇê˛ZµÅ™a‚ê™  ˝ ÍÊG$% Ua' UXT¸òÿ*ﬂ#ä˚£∆ƒLã⁄—Ÿù«ùK∆FÜè.Y˙rÄ>É'µÀ'™ÚıWπÚõ8µ⁄–4$&."µJË»˝Å±·S„´‚”πí'Ñ«F∫ÌÊr?ÄÕàèõîh◊: HÍ‡à«'DVÁ'p⁄-¿PÅ®JWµ-6Æ|Ü“à‹DïP€â	Ç†X‘≤LÌŒK—Q?0∏ªÃ-Ÿ^°*∂∆∂Œ]pø?‡…“∑|]É*«±0ÆÖ™|‡¸∏Öﬁ\ú™_‚xô 8r˛{ 1ïì≥®ÆUªN›z.Æı›‹=4ÙÙj‰›∏âF+…:ΩèØbh˙I≥Êü∂¯[ÀV≠ˇﬁ¶mªœ⁄wËÿ©ÛÁ~_t˘“øk∑Ó={ıÍ›ßopø˛!_}=`‡†o;$tË∞·#FÜÖ√®à—ëQc∆éã;!.~b¬§ƒ…IS¶Nõ˛›˜3fŒö=ÁsìÁÕˇÁÇ.Z¸„í•,˝iŸÚ©+”V•C∆öµÎ2≥÷oÿ∏iÛñ≠€∂Ô†ùªvÔŸªoˇÅÉág9ösÏ¯œ'Nû:grœÊù;!ˇb¡•ÀÖEpÂjq…µÎ7‡÷m£ÈéπXùΩ¸GÚ_uÜÜ0ÌÇ,vëıß8öL3i!-¶,∫LoX]÷üÕWπ´Œ©û®^k¢5„5g4˘ªvñvµˆ•ˆΩ‘@“HR∞4X"ïÜK3§ÉRÆT,•Á“k…&ª»zŸ ∑î[ÀÌ‰Œ≤ü‹EÓ!èê„‰YÚr˘êN•s◊yÍÙ:ÉÆ•Æün†nÑ.Y∑B∑U/ËùÙ.z7}Ω∑^“7”™“áÎ#}Wùä†‘Q\≈Ki¢¯*-îväü£ÃVíï beôí•ÏTˆ+9 q%W)P
ï[ #Éü¡ﬂ–Õfà0D∆‚Zƒ¥ò““sã˜ùU∞∂∑˙YªXªZ{X˚€|Ïv{Â @–	°¬nÚ•J§ÈîÃπ,°TDoY=¬®ñ™äT/4¿πƒhr56-hgk3µØ$êº$Y
íB™πåîfKá•<È∫tGz%ΩëAv„\ös.m‰N5\¢9ó9≥íK√j.¡∫∫°úKJó˙úK#Ω∂öKò~t%˘O∏Ñ‘pIQ2ïÌ5\Ú9óõúKÁ.ëÜhŒ%¨E"Á‚πE∂¢UcÌ»π¯[ª[m≤Éã˝>?2
ëÀ$.#á∆6Œ°~∂lÕ´éQEQ≈≈ÚÄÚMÂO,á §ÒgK/KOKÄ•ª•õ•´≈ﬂÚ•ÂãüÂsK'KGK{Àgé ≤y\VpI.{wkŸî«µπùmπÕı¬≤ •—•” r,1wOï-±t(›ZöjN5Ø7/0ov‘ózö'ö˘Wô[õ˝ÕmÕæ¶@SÄ…œ‘…‘ﬁ‘÷‘⁄‘Ã§756yò–¯ÃXn¥Ô9™åy∆ì∆∆lnù5n2Ó1ªª}çz£Œ®Ω[xgÿùA∆a£è⁄ß:¡èMÜÛjÁtÁUŒiµd¬ ﬁ‚¡˚FÔ?]xØ58˙≠*öÎDÔç™gºﬂy9%;ßW±+µsEïà≠·/Ü®yáCπÑ˝a6¥RWŒàÛˇ¥6ﬁ!bBµ7·Ø÷˙Ce†Tc˜¯?Úˇ3E∞íaûP©Ê√Xk`lWX»°ÕÖe^¬è∞ Ú{Ì9¨ÖÌºÇ◊∞v¬y»É]0
" FC>D¬9∏ ó·"¿%¯¢‡
BÏÜ1ñB	\Öbè°~Äh„!b`dBLÑxHÄI0!	¶Ä¶¬tòﬂ¡¯≤!f¡L~€ŒÅ'éb*ÆD	™¿
òÜ´0W√G∞°:£vÃ¿5∏◊a&f°kam¨ÉÎqºÅ∑∏7·f‹Ç[qn«∏w·n‹É{qÓ«Æ·B\ÑÒ∆l<Çu±≈tAW¨ènPw—=«ºc/∆üÒûƒSxAOÙÇ=∞°7û¡\låMPÉZ<ãy>¿=∏è ®C=û√ÛxÛÒ"‡%ºå>Ëã
∞ã
^≈b,Åläü`3l‡!^£Stö~°3îKg)èŒ—y∫@˘të
ËøéP!ﬂÒõÈ
]•b*°ktùn–M∫E∑…H&∫#ÿ;ô©î Ë.›£˚ÙÄ“#˙ï,ÙòûR9=•”3zN/Ë%Ω¢ﬂË5˝áﬁ–[zGÔÈY©Ç>íçÏ2ÅcL≈ú(Öñ“O¥åñ”
J•ïîF´(ùVS≠°µ¥é93ë©YmVáﬂ_ıòseıôsg¨k»<ôkƒºYc÷ÑiòñILf:¶g>ÃØ„ºâ∑6≈ »z≤ ÷ãıf}X_Ã˙Ò€+ˆ5¿≤AÏ6ò}+ˆ{ã}ƒ Ò≠¯N|/~≠bÖ¯Q¥âv5®ó´W®S’+’iÍUÍtıjuÜzçz≠zù:Sù≈Ü∞P6îc√Ÿ6íÖ±p:*ˆÉŸañÕé∞£,ác«ŸÔL◊yxOGsŒÃú;WH,±WΩµDîÿ%÷¢ˆµv™°¥µ∑E)â]ÏDbØ]K$’ )¥µãX€⁄≈bﬂ∑◊õﬂ}O˙ˆè˜ŒsüﬂøÁπ3sÓù˘~f∑ﬁ£˜Í_ıo˙wΩOÔ◊ÙA}H÷GÙQùAÜ>Át∫>ÆOËì˙î>≠œË?Ùü˙/}Vü”Áı8‡"\Å≥pY_‘óÙe}EgË´˙öæÆoËõ:Sﬂ“∑uñæ£ÔÍ{∂ù˝»∂∑lG€…v∂]lW€Õv∑€ˆn{⁄^*Hï3 ﬂDö—fåk∆)k∆õ	f¢ôd¢Ãd3≈L5”Ãt3√Ã4≥ÃlmÊòkÊJVŒ7ÃB≥»,VÂÌß∂∑Ìc?≥ü€/l_€œEó\Âj◊ÿ˛vÄhˆô˝ÊÄ9(Ú8léò£&Õ3ÈÊ∏9!â{ ú6∫k‹µnú»Ò>∆'x	ü‚3|é/Òæ∆7¯o¨ÄoÒ?òç>¨(∆ë"MÜò≤bÀ\B~îõÚê?P^ G˘© b%*HÖ∞2V°¬TÑäR1*NÔP	zóJäï¢E•∞*V£“Xù PY
¢rLÂÈ}™`Ÿ¡ˆô}n_∏Ï:Æu]ìM)Ñ*Qe™BU©UßTìB)Ã¯åG£iç•q4û&–DöDQ4ô¶–TöF”ôX±f√Ã[v9˚qnŒ√˛¿y9ÁÁ»πñî) ≈∏8ø√%¯]˛ø«•∏4ó·≤ƒÂ8òÀÛ˚\Å+rW‚ \Öf–Lß÷qUÆ¶‚UWÁjΩ⁄†6™DÆ…°∆µ‘&µôksÆÀı∏>¿∏!7‚’èjã˙I%©≠j7Ê&‹îõ©Ì*Y•®üπ9∑‡ñ‹ä[snÀÌ¯#nœ∏#w‚Œ‹Öªr7ÓŒªÎ¯Áû‹ã?Âﬁ‹á?ì=e'Œ_p_Ó«˝y ‰A<òø‰Ø¯k¬C’.ı„ox8è‡oy$è‚é‰—<Ü«∫π\?«„›x7¡]Ônp7∫â<Å'Ú$é‚…<ÖßÚ4ûŒ3x&œ‚ŸÕs8∆›‰nvt∑p,œÂy<üB^ƒã˘;^¬Ky/ÁºíWÒj77œ?^Àqºé„9Å◊Ûﬁ»âºâÊP≈“\öGÛi-§E¥ÿÕCﬂ—ZJÀh9≠†ï¥äVÛf◊ﬂpÛ⁄óÓœÓºåW0Ø‚5ºÓ‘tBù0ßñS€©„‘uÍ9ıùúNCßëÛ°”ÿi‚4uö9ÕùNKßﬁ¿õ‚ÛŸ"—9b—X{Àﬁ∂YˆéΩkÔŸ˚ˆÅ}hŸ«ˆ	e—∫K˜ÏHÇ≠4KΩ≈ê)∞3alá˝ˆ&D¡o0ùÓ”zLÈŒ¡õIœË9Ω†óÙÑû⁄∂¶Öx€ÜŸZfk€:Ù´ ©∂Æ≠gÎãöªC‹°Ó0˜ömü¬Rx ø√:òè ·HúáÛqéÇ8÷6P©j∑⁄KÌY{Œû∑ÏE{…^∂Wl¢√tÑéR£t:N'Ë$ù¢”tFNtEˇæ„°òÇ" ﬁmπ≥r~}Ωá9ˇ˘Üx◊)Gr…ˇ‹ˇªRa/DÀl„•%A^‘¢àHQ»lô˜]ò%∆òá€E£≈$k‡‹MC°á†∞HaTAÂùÖå√<¿ê_‰ë]aûã¿äBc—ƒNI≈≥ﬁClÜ_ÀY≤84Åéê¢¬9â´˙¶àÓÖ»◊«§Sw>(a–⁄A∏å)A∆z .b∞iÏe¿{–:Iœë"•µpc©/}KqÍ∞È‚-Û§yíÖ h&Æ*£ÀdèDƒô™à^·{Í{„≈…ÃÀAhM≈:aøxÈ<d¬kÏÇ˝®uVC%E˚{ÖºÌ2ÊPZIk]†∑8hÇTl%$—ZÌ€Ô{%∫ï®Üu‘ë˘˜êZ•√ÒIQD9lÅùp†¯Á≠Ï©µeˇä£W ®`i°rRJVóE O$E#Ù-ˆÛÇΩ÷ﬁ /¬[ÌÌıÆIMKB0¥ëgÜC/Ë#≥%˙ö3‰m≠ê∂VÀ∑î;`'ÏŸe¿5±·+QR5¨ãı∞~âb™d—”	<M=©≠°t9…ˆêæ„DM‰î6\üˆÅØñ/⁄ó‰;Ó˘{[ΩCﬁ}/[™YRj^V*›≈ñì`™r©Ùòò„*iª$9/â&_ãÌ\1Y†ò´å)D≤!€cÏÅ˝qFb∆‡\Ò·
—›6ÕQÿÃídz*ïë2KŒHzî˙'⁄Qö.{∆&J¶Ti'È:G)SV›ïOJ+%Y€BµR·jàäPëjºJîz¶©´+(@Îäzä^ß∑Hˆﬂ”oåü‰Ï≥ƒdöL…Ü˙≤Îê˝lüwî”¡ÈÁåw&8QNä[⁄nÇ≠≤:íd¶ˇwQ∏(¯ÓÅ+Ø)€SÇ8ÿ_Å¡j9û2≠a&’£ü∞-RœduèÑÇj>ØßH≤û√
:øáTYI—4ò"t v”t6éô(∫	ÒÙ0ß‘	“€H99}Örf¢˛‚ÙUi'oaòÏ!´ÿ•πÚﬁc!àZ@MlôÛnËë»>Ú…Ó2H÷I6Æ5#Ë≠≤(7t≈l ¿∫fÙ„º0	∑Q;ïÜ7eÂ• ˜“ˇÀxµ«6u^ÒÔ˚ÓÀ˜^?Æ±ù8$◊πN0πy 1y’ÉK{°i2AÿWNê©¥eäî™[M›§u„üv”÷
‘^C–L–hV±á™1!±©ù46mtìçn£õ ±wÓç»&MÛ„|Á˚Œ˘Áúﬂ˜8§è¡Î˝º–Ôë]hÄºåæGdn√Y¨‚AfáËª‘6Í ºÆ˝W>Ûúö`ˇÍgh/˛&Ï˛õDE€»—w®‚?£¸"}êöÄUæ@h¸2ÏÖãË2’Gã®ÕP3Ë:>O›¡*zè~?è_/≈”Ë˚6˝.ïg⁄ÈÍ“á≈ﬂ@∆p´4K>E•©]≈É¯M∫ˆÂã∞{èÇáDt˙ø	'∆€»\=Ï«Ø^+‡l„aó'‡‰z=ãˇ;ÊeR;£ARáë≠úÃBé ≠EÔîåù¸<Zá?¢œ√˘0´m÷∂l˛\Ù©ÓÆŒéMë∂ç÷∑∂47©çÎ¬kÍCJ]PÆ≠YS®™Ù˚º∑À)9Ï6´(ée ™5≈ïDF÷2:›†Ùı5ueFüh»Ë24%VÎËr∆TìWkj†y‡?4µ%MmEKrEõõ‰∏"Î7{πÄGÜí¿ø÷´§d}ﬁ‰Lûn0+6®É–Cé˚'zeg‰∏ûòö»≈3Ω0^^bJlø–‹ÑÚÇ¨úÓSÁ±o36‚ãwÁ	≤ÿ`Uzï“◊+ï^c	:U◊∑%„ΩÅ`0’‹§„ÿ>eLGJèÓPM3ß—ŸòŒô”»ìÜ9Ë¥úoöÀù)Hh,£Z«ïÒ—ΩIùMs8Uò∑W˜ˇÉˇqw≈íŸ'•*˜O F5óÀ ˙π°‰ì“†AS)˙í˙D&óÄ©œ^Ù∑¬BåÂ¶,µ_â-ôÁdùWzîâ‹sHUNG;é/UUiWKwQU\Œ'ï†æ%†§F{´Ûî€qÏr•&WÆñ47Â%Áí7ÛvGô±⁄ûdˆØ»LŒT7∏˛+Óƒ∆äîm ]ﬁ'√Jí
“iê˝ù(∑Ø‘‡ì¬–Ká0LÍ|,ìì∫çv£øŒ‘Käú{Ä Ï ¸_V∑åñ[ÿzÈ2X+ ˘2Ø´™ﬁÿh‡ÇãA açõÕ˙¶Ê¶©iWK2‡>¥=	›R›≠‡Û`–àÍÈÇÜ∆†¢O%óÍ2\BZ´ö“I∆êÃ-K*víÈe…J˜åùÅK°
›“∞ÚsH^w|¢[«ﬁˇ!ﬁø$Ôﬂ©Ùç$Âx.Sˆmˇ™⁄íºsEVÊtw,IHô# î˜Æ(ï§UßÎ·«öH/pÄ¢ŸÇÂÑ.e˙ñhJˇœNÖ“}£óY<ÓV^¶ﬁ≠ÆÆ?µ™æjy÷¶HˇH.'¨í%‡‹…Âäú»er£Ö“Ùò"KJÓ*yãºï;œ,G¥Pö=–gR`ƒÓ¥‘ìW©°ºÜOÌI^ïíO'/A¬ÀÙ§RÕêzB@¯¬˝¡°ßÛ_√-¶‰H«%ƒ–‹2C!Å3ò+UZX∆êD·ÿe~œuø*}]åJˇà,F—‡• ÷ùAg=åh¥ SsÉ!ôûÉã∑¬twò9∏5Ni5˝‰$&)åªÑ>ºM&IÅDqa∏0L¸H≥SBògƒ0≤
êKâå4ÒÛ€<HÍäﬁ@»7ãü∆ç»Ø™j´«•O· I€ZÊmQ£Êøu>À¥®'•÷„4:í∫Y¶£=‘—ﬁ—ÜÒ¸üŒÔ◊e1◊Mo“;ß>ˇ˝ˆw∑Üªj0„òÒ∂—ø¥›.pE-ÆÃXöÁ-Ç¿PT$Dkñ¨†‡.¢k¡√0«≤5º≈™,c\Tc≥
<EâM¬òàaá,Lwh6€Qå±‰@≠‡ƒU‹¶•Ò†t|-õç∫|]ÿ	ƒíhQ0*€‚W-P2%)Qîì,—<Kb√IMd˝VgÑóÅPÖ“-Õ.:#¨ﬂéÅ¶ªó†D™˘Iô.:
[aÜª¸¨¶⁄pÖÉ+S{∆ØS’ÿ≥∏ˇ˝„b™xsúô]‹L>Xº∞˘§¯†@~ÉX;xÕç˜iì_¢¶òcv™Àû≤`&Ì”≥÷⁄awN	Sbñºj„,º pvá$Ÿú.∑$π%õªÏK+xU‡< &íÕV√«QHPÕçX›6iÑÑmVkÓB[?‘™¨<!'0 «jå [≠èxHaß9¬+⁄:ƒ√ 'ƒª›'¯%w£œy¬†∏‚|0_‚" Kä™ÅBöàﬁ7!v|‡wº§%®Õ·Jqi≥4%F„cÖr”Ô°0„gå6ÉŒCLÕ¡dfOﬁ(«n9ñY˚çYiô,Úä$÷gƒJ¥´t‰ˆ˙ºæˆwD©a-ÀQ„∏Ì˙?èÙ4l¨õyø¯ãäﬂmw®≥¨è.éøsı«‘≥‘Ó^¯∆≠ÖØÅÆï>a[ò_"	≤ë≥Z’Z…1˜W=ƒ/\|©6à¶ø,Jë(µInæ⁄ÎT”a‹ÁﬂÌ¶÷4STE≥çØjd•πÀ°ŒàYÍÃRÉeF¶YÃùçÎÏQå"rd»Ø¬±í>20?(}ñ∑ÄÊ∑Ã¶M\Çùn	e‰Ù¿¶‚X•.D:<^o€∆ˆv◊¶QÍ–5HvbÿÖSª∑˛‰»ŸÛzÒ∑ﬂ˛—°€_>ÚÛÔ¶Ã‹+û#)¸«‚≈€w~ÍO€˚Œ„Ês/˝˙¯°˜±/˚1¶ã_Å rOƒ¸
êÎC!ÙWÌ•†,9#kå≠≥[ƒ6ª]î\.á◊Ú¸^7œ‘÷ªΩ!üØåVó√Qc=†ÂràTΩΩ°Vt˘¯WºÅå?ËıVT %4ÄÎsÑv;≤ÑBºœw¬<‹∆·v•ûØmîŸı,acˇÊº⁄£™Æ≤˛Ω/°ÒP‘FÆ$".‹D•Âc˘(‘RÅÇ¿h˘Hà4…AkFW-üòI9:9∂ã	S4muÂj,1u¶ñ8æ0µ®4Ω˜Ã∑œ}àÿ3£Îcüﬂ>Ø}ˆ˘ˆﬁÁré[9»õﬂ‡∏4˙ˆg≥ú§('‰7eÖªí≥B›Õ°Á√]ú'\»KìdN^éQ∏7ÅXYYÃ.˚9!¡°ÿSagg”`6uä—b{«∆∆ƒhùÏ©‘Ù4|ÿá:}◊æôó=∑G˜…œ,=˝¨kxÍ3sõómSBˆπÊ¨»ylJôßß±∑ˇ+Î[b˙πøÍiQ¬÷ŒôÏû´≈¡9Ø<ë]–ìsƒ*q¡( „2ËÀ=Ù(X’1,-ûY’çÏÚíñÙQù∫”ñi◊Çú(ËLCß=,˛”+Ÿô∏6XÈˇhíŸ%= I.%*™ã¢§«$v—ÃƒÙ e!5(˝≤;ˆéèÔÆÜÑóÜ´·™£>3(>Ö)˘ ∂Jiåä∏0í?C{∆•EGˆçTì#ˇ˘U§Ÿ†æVÔ:å´˝~rYB´ª5·*HZvµ’ÀQ8<Ãï⁄⁄ÃNızíÈ ¢SÜÂÂhzZÔX˛õûÊt:§ó-+≠wxkôùŸﬂ¯œæ◊¡ÏU‘úùu{RRˇµc`ÒîäkÎÍò£|‹yl’§ﬂOú9<Ì‡∆¨—π´ΩsÀsH˘G∏c‹Ú'ﬂ,‚ ,˜xuQŸÆ¬˘á'EÑàÈ?÷1,cís\ü®‹°qÈoæx‰π/Ÿ˚<ﬂû[¥)€Ÿ]U¢)⁄rjö™ŸSS„LÀÚ±⁄PÌ®h2¨iYÛµJUqX€{¶±ÃÓ˘ã¥dÍKuxZ¿›ávŸdë^πGQÔ÷h/{∏®›_¶ÒêÈÑ0u•3'€{Ü›B˝9ÆÑxzƒËKb<1ûFß≠[∫J‰}“–sBuAH÷˜∂álƒˇ˛¸_ˆ≥<h6OΩ}÷==8»∫çË¬xûX<94ËÅö€gz*8àÏDõA'L9)¡@π˙Ö°óS¨EçF.Ω≠,UtµÜv®5¢Jã¢Ωè•@W 9OuâıøZ/Wí!Á•¿d`∞∏	TØb¸\ûÀkPÆË∂4«»_`ø	F#Ì&°ùØü£…¶v4R.œ’âC?	k=e÷–DËK–ˇ!t„!?¬w!⁄´0O†˝7¥=÷rÖ∞ˆ~¥ØAüäu:Ô¬Óe⁄«[.©5J<÷ú∆Âê≥Ä«ÁHgΩ“H˝ïFaCˇP¥ùÿê_N%X„
˚>·˘9ÏK|W¢Ωvl“I∏—∆Îë‚‘Zö©v¶}j≠ãÛoÒû‡s„ÃÅ3¡~üM˜√k„å∂¿û/µ≈]€ÓCe;Ï’J‰õ@60@=F≥ı'pÁhÑqûûfÿHÈ?MƒØÍ%Ta#±vækÏƒ<|PN#ı‘Ak•LÙ˝ \G7†'5¯Å∂™-¥“ÏEÇ_yXø®≈öÛ$Jh,Ê'…uŒ”√høﬁ±~?±o[¨Â¥~ø√ÒÄ˘ßÄìJ£bÛ+±ˇ|ˆ9ﬂªíÎæàu∆`ÃT¿˝âr
ÜØˆ‡^oÄﬂß∞÷2ÛÔJ ˜Ò6 ∂¡…3§ÔkËp 8úÜœV √–~®≤Òm√ﬁ›¿£X…WpÜπ)˘n0ˇ˘Æ$gΩg/9&c´FÈäu÷€ÃZZl∂aÃEéÊ,€È_õπ≈úÒK…ÔôÙ÷qÚ9ôS…±GTàApÀ/9Óò˚,’l d©9»…úeæ˘%˚E⁄èx‰ò»ªg∞ØªîM4€«ıJøÙ˚" WQûÙ˜˚¥Ìi˙ÛT§ΩBCÙœ©DıPùëâªú)ÒŸ‘+Ù¢Ì qûÖÔÍvr=√jRf‡€7“üMÙ;»2ΩIÌ©7)Ü±]\2H9blW…ˆ}≤=îﬁ>ñå∂}ˇ´˛ˇÅz“ÿN”–æl4	ÅÛ¨·ò∞Æ(}ÅhøÑ˛}†à∑%(Îm3ïkÖöD≠&«B6=fdS~‘‘#êàzA?Œ¯'Õ’ñS?˝
˝R©D-hR"¨‘ÄuÙÔ•û§óº>di›√πˆ\ÚK?_€KŒ˘>NI…|Ê|øgøÎ∏6p~ñı9ZBÚU<‡Á*ÇÓÁÁΩ<çm¯ŸÇıªµÁe{)kÚª?N96¸ÁÁ¸»9és$Á9’•ƒ˘«∑ówÁ„ıY#ke∂~å&˙b{-P£/v~Ö∏]»π{ù0GQ±yàû—"©»úà˝Z®–tPwú˚õ@Mù"Z|ı4’_KŸOËoÒ◊Q£/@úœ>°<ôo>°DYGa◊OÛrõ]»ÚÕΩ∆q(c∞åÜ=Ë”hùæF\¬96j¿ﬂ–Îy¥Dˆei◊≈1ΩH\‰ö®U…T¢ø.öµfpèÁN≥çœhÉŸèJÎÒH÷±˝ÊüÈÇé3€dÕ_Âœ«|˜∂•‚≤uÁˇòŒÎª1&ä.G˘,A∫<”9w≥¯5ØeÂä›˙%*6ˆ@»9‚äœπm}!9Ãæ¿öfæ¨Ÿ˚ç„Ë+¶”÷d ≥ä∞o]∞∫B«{-«˝'Aæ é z]â˙ñH%⁄∑‡÷,…≈∆bqHk†˛:¨5"Ó^ßå
»È ü]J‰}ƒè|oÄ#Ê{xüÒ{¢
5˛z√‹BÃOiÅ~ìÁ0>ùj◊G:⁄C≈E_ﬁ¢ô–ˇHSôﬂﬁ∑å˜=cßÃMrø!“~ßî”K⁄u Sw”@‰í1∂p%üj—5êHTõΩ†yêﬂ˘‡ˆB9 ˘»$Ù?≠Ö“¥G®ZB§EﬂA‹Ÿl}1EÈπ‚ﬂZ
xÜ:úrï[4J°z˝(ruΩÜÔ}z'⁄¶’ë•Ì§:©ˇîbî[‚¶˙ô∏ÆØGÀüÎÀhÉ^@ÌOÙûvB|Œh<œXÅ˜◊#‚k¯}∞è°ú?si£˘[Öıﬂ‚q@)÷Ô –áâØÂº6ê∂˙—Œfu$%j#»≈ˆ¢ùsèΩ∞5`Á2ºìÿ∆ü±èœ-◊≈<£øÖ_ç$Œ Ωº“3¶çÏÚ_‡LÕw∫ÖÎÇπ9Ô$rﬂºY¬©k∂πvc‹x»Ë˙°ç˚ôhAá{ˆ‘C>LÉcƒ_°¨wG¨xÛ‘BËf†øz‹≥˚0æ!âÓ‡ßÃùΩp„W◊ù’@∞
êWﬁ>ÎµGåÜ\÷ªÛ:Ê¸ào⁄’¿≠ˇ∞^6PVUUﬂÔ~Ω«à•†Ç òA0† ,	SÑDEAI¸@BÜïâ–ZÅëãÄq®ÉÆIlAÇ"¬®È
(D…`d¯ º”oü{ÔÛyôl≈[Îø˛Ôú{æœ>{ˇ78ñÇü”gﬂœC)O∑®m£kN87œæ*Á≈±^º√ø'c“WÊ¯>è√…ÿﬂˇÒ8OÉ&8<áxy±¥…ò3CÂﬂ|>™Ø˙eıçÍè≠?äÿÍÄ–/–œ∆˛K}±˙C|ÒK¯√ôîHÉnÑß∆Î‚ç-∑˘Ózº–«Ú†’;ÂAı◊ˆÃõeYûvπ6l€Ù±öyí›ˇ@‚∆Õ^ùÈ™Z≈="?K7≥˘aOŒ‚∆XhYc±-mäb]|L\πäs⁄©k0m|)ÂÙπJc.q}öfÒfôÕ#â;ƒ›6«xŒÊ-ÚÖ>6ó.‡KŒ‡3ÊòÜv‚ŒîÍn◊Ò5üp/√èÆíI:^æº˚ ∞0<(F√?$=©õ~{)∂y„‘¯~yãG–4™—ÇúVãˆú¥Mª>1Oiú…ü7ÓóÃù~$^NüÁçEÒægƒ˜5¨„ÚÚç§Ì}9ˇ„]g∂ª˜õﬂÂ¥f)Ã[±àŒ8πñx.Æ°Gco2~#¸ücÌf≤=”Å™É@ã®N1—Øê©™£¨¯ ¥"ßÈm4∑Ía1éµ8≤¬;$eîÀ‚±∞Ø¬º8˛:¯êˇiØ\ä–
wD(¡Zÿ>èáö"Ë ˙ÿÛãñ¨Œ√úY=70≈Lü¡r1˜∑√az9¡ƒ∏-ÊŒÆhÀàâV£—nvæ˛≥◊^Z˚∏*Âó¡f=pÜ=´Sô£∫l\®uú´M°ŒÁ.¥{ºïv™g•oóÒÈã¿fÔ_œyUÛ6´–DéåÚ;ëèn‡≠Ìeå^räÛc)V»g¶"µQäA{mgâ{≠eõSC‹üM≥#’ΩùëÓNΩ ûtﬁñ=‡-õÜxR¡∑∑A)Ë
:r^9ßÎ·œ9ãª–˜√)aEZ TêõnóÁ•ø≥-ˇ[òy–Gãí†Ìç!Ãf∏lGK/J†$	˙*wOÇzÂ≥íàÍOOÇzÂIP?†Åu4÷Æ±u4Vﬂ9	Í;üÄu46ÓIPFÎöıCˇáu4vŒg&A˝ôM¨„≤$®ø,π¸ˆ¥PèeU´Øé¥˚#p-oj˘è’ò≠√6∂zQZÇA‡/ÙW›πÏ“Ê>∞†π≤™˜É:–|ã˙é0Z.˚x0gˆ0ı7¡˙Mµ›≠†3·¥∞=˝Î€ÒÕó}úˇøÇ—±Ÿ£˘¥ˇ.PLç)?‰ˇp ÃeÓ‰ˇ…°ˆÕ~wé∆;ÆEø«»ÍÿÏØæêÚ˘†¬§@ﬂ…]ö’0Ü9ÖÚª·k5ØÅK)◊Ü~¡ÏÁù^ÓÒá˛≥r(˝5)S∂~W}nπŸñ´ûµæ∞NFπÅŸÔÚ¥æhÈìÂoâ6ô}¡‰"7âj˜ß·nﬁifãj´˛J˛∑IÊ¯ü2ﬁrÀ·rÅ≥GÈ^s°_4ÓÍ|Ólæœññ√lÆÊÑ3
n£Ôã2&hçøÌ!›”Ω•Ñúd†µ©∆◊¶ ì–-À•ùØîdŒóí‡m´Ü∏kM}Pô:›ﬂ*õrÒØµd…É*b.-Î2s©_ ˜Wel¡ Yóv4vf_éÁéµ˝{sû•abmÂNé^≠yÜ’h‰∑™ô¨vÍ¬˚˚Æ]œM6~∆ZÒ#yﬂõ+˜§; Hˇrÿ’hñ5VC∆∫Nyº’Vƒ»ÙyÚæ∂Ts∆ª–êí˛~k)åYıF¨K}è9ªHWøÃÙfôùå5îÿ’5÷ßπ1û@3î”ûê]I]Î®<MaµjN˚∆˚Å5~ÊˆÒ1zcûî∫á–aÌÿ∑jÛ$GkJì9ÎÏ˘Q˝ë^"CÇ*¯'©L–ñX∑?ïaﬁµÈùÊ`G≥3s:ˆX)˝¨^#F˚ª≈dH	˜˜ÓÁÜ&'ìª¯œ[À˛ûˇﬂ·ˇõÄ‹ŒPü}ö∫jëTO (èßLæ&ÚˇΩ»<√‹˙}«YÚ≈,oKxs¢omzËÑ5µ*/g"¸‹≠uyZÌöPO&8O◊Î˛|C¢<Ú´Êr˙Ü±ëQ9=Î…cÿ‘c∑üƒetﬁ†‘ÊÏ·Xœ∆::…¥Æ9bÇ;ÖúU.U;NrNW7¬«À-sÔ,Ê/ÈkÛqÇ{«˙˙xÈÔ…˜Çk8ã«‡ß‡ª∫˝æFs…ë¯r¡ò”ÛR¬∑•1Ár√G∫<ó?%ÿﬁâµè•ë~/’<Œ[@æ◊‘ÓAπ¨[Û∏Naı}⁄K9®J?%ï`CÃﬁD¸xÊ”oæTe
•l»„Z≈yA√pSR™º_H%ÿê«µì√¸ â`	Û.aﬁsôÔ\÷[√zkËß˙ø	p∫«ôVvèuõƒtπ]ë)`û˙¨`ûñw+‚sèœ1>óxπ5«ÛG„˛ø˜ËMƒÁ7Å„›Àâ⁄wSkœ∫dújíà…o‰É/ØYœçuóÀ†,¯˛ÕÇ¢Ì⁄uçŸQ‰∑¶∏?í7@m∑F®;∆ö}QYﬂ¢Çy˛∆‹º˙ç	ëÍ⁄–˘§ô˚+KÄı¨æ!È('[¿}´ñòØ>>Ú}%Õ
dtzût∑~¥N%ÓÓ–<’€(7Gzo–ò5ê˝™^Ú∫ôÂÍÔ¸@∆;•¶–œ‡∂òy˛ï2E¡˙⁄G°¨¬ˇe¡k‡^Œdkz ÑtV∏ÁôÁ¡zæo¡µÙﬂg^Ùwˆ≈P´Z\’ﬂj—lEÏ{]c∂˙ÎÕoT7x)Èo5”D¥œD9€›$U/∞˛ÌÓ0i√∑æÓBÈ§˙√´ì≠Ï±ˇO9ã∂úÀL˜1[7¡~øÑ±[√Ì‰{Oì•Éøêú∂~6Ùã]t.pï∑À¸«_œÌ£c†ﬂT]‰˛SF˘œ…%ÓrônQñD8(ÓÎ2=5D¶;´(/éL˜ÓÑk¿+‡mæ.s›ô¸_	Œë=Ó<y‘Ô –π¿"ÁM|ÿs≤‘π_ä˘^Âû¬Ü-ì—n'ôÖú?ÀyÄÔFäù)pæÔêyJ∞⁄9$≠S§Ç±ÊªÎÒ}=dö≥[^uÁ»∑H∫8 ;ns÷2SªÕ—9∆ÏMÕ6’¥oNª+‹"≥Ü6◊ªÕÃ~⁄¥¢ÕdˇIÙÚÖ≤‹Ø'ŒÔñ4ZΩ⁄ˇ∑\Ó˜√÷áôwΩU2ÕÛS@.S_«˝≈F˛·º≈]` ç=;U N]i„ë`[í˙5‘ÎœOFD6?Mz ˝ôënâ¶k.∑Z?∞Yn‡~†ÔÖ^ùŸ»∏£AgØR»œRN§√Æa®ì‘Êx£˙ÜñÈò ^)ö:–‹Q5ôQ›7¿Ÿ*gj.§ÒRı1ªñ\Ö∏a÷Ç∂ÿ¯2Ö∆zæΩ∆Vs»=â;æ[¸‡TŒ–æ74.∂ç≠ıÛfJ«ºÒf˘Â“Cµ6}≠æÁõ9»∏wÍ∏Ó©¶ó⁄§∆ı(vójﬂ∑Ÿÿ∞÷¨FøOµ1AÃ+Œ£∫kÜwùŸÁ6ìŒ;≤‹‚û-+‘^RïÚŸØ⁄ÿ∂™3¸ûk„{ùè∆˝Hâ“sSSu≥'u†Èµùÿ¥‡Ñ4_`g†b”xMÌŒq™VHÌ§™bà¡<Mbà?EJ©R
·∆ôÇ¶µ˚9	°iÇä˚—i˝’≤uö∆>EΩÁú{ìîâ©’¥!M∫˜ÊyøŒsŒyuœõ„sÿ[ï¢nî´Ù‘NxŒBú˝ÀR°}®Åèî£∏S¡Fî©Jµµﬂe 55Ã(W®uÚ[‘÷¥Ìttbèò¢I‡;®õ˝ 9Íë¯SÚ#á˜Òmqó≠º
Tg∞÷9‘yjz;∆lGV√ˆäs¶π«cü¬:°vÍÔˆ€v∑3¡›~√Ô∆wºI/ é|N ∑œ`c=PwDQy≠íg ⁄kêo⁄Õ3ñÿóƒ^-œZ#ï3W%ıØg7‹Ö‰Ô=j¸Á• ß¯>œ ÁÄ◊‹*>`ÍÚ∫y/π›ØæL^Ï5’÷ﬁ∑„oGNø∑æ[õ®W‘ZÁ ˘|˘ºΩ|$:‚¸%=È8É;”N a¸/0ˆVËÅ wõ€¢ñ1ˇÂ=‰ø¸z†åØ¬˘ vï-´p};ÍQ˚ÿÜ6lÿ∞a√Ü6lÿ∞a√Ü6lÿ∞a√Ü6lÿ∞a√Ü6lÿ∏'0"˜«ÙG⁄K#t)‰°6&RBJ/9Ò≠°YHâÁ€R
[•%xåÃÁaˆ†e;h=KZ∂v÷≤]∞œX∂Jœ∞◊¡dN∑ì}nŸå| !ÀVhçÚíe;ˇ±e;aˇ‹≤]∞oZ6Úq¨ßã§Sê⁄ÒÓÄ5D„îÜÓ•eÅù§c2“/[»‚…†%Bxu@Ï0˙hRziË4ÿ«!«¿å¿Œ†Ø‡f$'‰xc‡ÖŒ”ƒrÙ¸êã5+G4˚√À¿≥Î4+%=sÊ,¢mr]é=.s’iﬁZ2[¡\‘ÉÌÌ;Ù°Ò¥ﬁõÀÊ
'è•ıÓ\˛X.ü*drŸÄôò–2á«ì˙@z2ù?ûÙ˜DüÚGÚô‘DÎcÖ‘Df¥wËﬁÉ“”3ìzJ/‰ScÈ£©¸=˜¸øMBœdı⁄Ü≥ôBzL,§
itŒéµÂÚz-y}47ï-‰3È…¿◊∏Ë˝XÜƒ£Ù˘Ô(ÅVzL.»¸QÃ<$˚∆ßüêepÔ˝˛Ãˇ€RMÂOÆ¶ 6zçæ‚ôjˇ@y€FXô)ÌÍóïôyœ˙†–%U∏ÁkÍÉß#kïÙp∏8©≤88–˝BÈÇ°tH™˘'˙Éﬂ∫ß7(˝SW’ö⁄Ω€‘ÌÇw~>vB¯ÁÁÉªMﬂ∑›Ù‹äÈ= y‰xK :»6 úúò¸¸¸˙&≥õ{ùË6=ˇ@c∞Ó≤2∆4˙MÀß√UhÆÔsı© ≠H'ªâ—ŒIyZ CRÜ§lì≤ŒjΩ!fóÚ≤îÔIŸ&eH >)sRJ>˚ﬁœﬁƒ{É›◊S#Œ<-Ã√Y∏ÖÖ9[dnV]zàˇ∞Ã™√ùÒÄﬁÕÉ@áæü∑@s‡ﬂﬁ
4˚¢ºìa\r3Ö4⁄∏ÀWøVóŸ;Ôﬂ~±ˆãk…]f°íØáG‹l7-9≈t;Ä7 g…óÁ?Co]∫D∫r©ƒˇ—ZfOñ¯ﬂyYc%˛7^VX¯~˛W~ùˇÖ¿?ÁèÛ_¯.ÒE∞ﬁ(Ò2/;¡z”WV.ÖÎ¯À| …]Á'¯œÍ≤i¢*\ÕG—iƒ7¬zYÃÚÑ.gŸœ1Ãè°1Í+3∂¿√¸%ﬁ—*ªE◊æùÁyÄÀÈZÃÈæiÊˆ°¯6L∂EŒ„√µÓZwgÒ◊jqF-^Pãß‘bD-ÓQã;‘‚√j±]-∂©EøZ‹™õ‘uZΩÊ—÷h5Zï¶i.Õ©)iÎ ïka?aÕ÷π<BπúB:•ÌQÑÑøπ
”zúå˚q%>ÿ≈‚∆ïQä?ßÙñYUˇàqü∑ãıqäu5;˝Ò≤Z0:˝qC=¯≠ƒcØ&5îÔï% lìùm4ÍªãX’Mg_i∫rˆïdí65ÑÍ˜≠›ıhÙ+ƒ≥ñÙØ>˛/=ÒÉ'± âyï?¢¬Ñ[nQ∏M∆kÒ¡ÑÒvS“
£“îå?‘üN,≤YˆN,∫»ﬁ*ôXt¥∞ŸÿÄà;Z¢…dK#y(˚Y¡õ
<Ì*ÖèB⁄U…s2ìÁï<îù…€†ìWÚºÙ/Ò6≥wœ'xØ—f…€ºÒ⁄ºπ%o,:Áı.èµ$9KÊX∆^I·îf.)¯W·í¬ô")èÆRZ-J`Öê39ÿ*áõúZ}ôS+fÚﬂ”ìÓÚ˚cQ+su%ªü6ıœ±}r›k7Ì{´qâ~Â∏I’˛§QÂÌ2™Ω]
5¯={Yõ´∆p!§ÇΩßπ·T„íìÿåd◊ \k5µFZ#¢	’+ö÷ \g55ú⁄”‹∏ƒf¨&¬k1«y
Sx®!ñâÆ¸MZœî•7|Éq#‘?íòS’ò~6öD¨}9V]+WÆò¡ Ç{E–·X!Æƒ‹nãàØ±–◊¬˙8ÎD
Iˇ$R¡Dw~¡¬§î˛
0 W\˛Üendstreamendobj57 0 obj[62 0 R]endobj58 0 obj<</Filter/FlateDecode/Length 382>>stream
Hâ\íÀäÉ@E˜~E/ìE’èD0öÄãy0ô˘ £eF[iÕ¬øü∂o»¿4(∫ÍV›ÍÚÛ≤(u73ˇ›ıÖf÷v∫14wSª“≠”^±¶´Áπ›W£Á€‰À2Õ‘ó∫º$a˛áΩúf≥∞M÷W⁄z˛õi»t˙∆6_˘eÀ¸À}®'=≥Ä•)k®µB/’¯Zıƒ|ó∂+{ﬂÕÀŒÊ¸E|.#±»qàfÍ°°i¨j2ïæëóˆ§,9€ìz§õ˜qå¥k[W∆Ö«6<¢ utÂé¬¬Qú9ä∏#Ç(e Â(é@g""c‚†=HÄr–¡G=âz**\Çb4%494%4˘$AËS¢O~ÌA®.’O†#sëòã@(ù@.·]`∫
”†‡A¿ÉÇ
<(x†‡A†OÂ˙<kdô{Ó«ªÆo˜ì=∑™æc -±€§uá:Mœ=áëŸ¨ıÛ~ %« endstreamendobj62 0 obj<</BaseFont/QULRDW+Arial-BoldMT/CIDSystemInfo 63 0 R/CIDToGIDMap/Identity/DW 1000/FontDescriptor 64 0 R/Subtype/CIDFontType2/Type/Font/W[3[278]15[278]29[333]36 37 722 42[778]50[778]53[722]55[611 722]60[667]68[556 611 556 611 556 333]74 75 611 76[278]78[556 278 889]81 83 611 85[389 556 333 611 556]92[556]3032[83]]>>endobj63 0 obj<</Ordering(Identity)/Registry(Adobe)/Supplement 0>>endobj64 0 obj<</Ascent 1010/CIDSet 65 0 R/CapHeight 716/Descent -376/Flags 4/FontBBox[-628 -376 2000 1010]/FontFamily(Arial)/FontFile2 66 0 R/FontName/QULRDW+Arial-BoldMT/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 136/Type/FontDescriptor/XHeight 519>>endobj65 0 obj<</Filter/FlateDecode/Length 28>>stream
Hâö¿»¿¬£†⁄¡ˇ˚˚	ÜQ@O– ` "˛∏endstreamendobj66 0 obj<</Filter/FlateDecode/Length 18934/Length1 45932>>stream
Hâ|U	xT’˛œΩ˜ÕL6!ê˙í!ëf÷@ÄêÃ(Å &ÏI aç"P5†iVêEe´†»n_ dˆ√Oƒ“HQS$_)îÇHÊıÃÑ∂ÿÔ´˜~ÔΩ{Ó=˜úˇ¨Ø|Œºb‡HÙù€=≠„0?Æ¬ärΩï§h¿Z0•lÍÃV⁄Vh”ßŒX0eÒÏW“Ä†øqI%≈Ó¢∆êÔG=Éò©O	o¥Ú˜Ã‚WóíôÂÛ“SÅ^ÁfÃ.tSS‚,†d ”ç3›ÛÀZœ7∂Áó>À=≥xM›ﬂé2›PSÀÊ?<ﬂºh˜)§<'CÉM[ß1Eµ~e¶àõ&¨JxájBÇYè˘^~ﬁ˚„FfÈ‡i>–Œz∆POÎ ⁄õ2MìıƒkΩ⁄°¯Ì{∂!Z≈É}`^˛˜„)5/{œº_qùuwj}éΩÿç?SW“±èÓ#˜(ÇR0
wŸ”@÷ „∞ñB–ÒÜìbûD,ßıfÖyÒ2∂ò˚© ‹…Á/·}‹c_*B_åb˛'PåkÚ
ÚÕu∞°öc8 c©#‹8œÛcXÖ’8Jœö˜Xk(™X^:Ü`ày‹|Ä,W+¥Fø?b%ë≈,4K—±®âÊyÛ+ƒ#o`7cJ§z51òé•xï"‰˚ºZÉ7·°@1Ifi«X”på«,<ÉÏƒI
°≠Qªi˛ º
⁄£+c*≈5ÍM#≈Vh2/`ﬁ≈lØw÷´	jõ6¡3ÿ‹hæáÿO˛tòék©⁄ÔZôõÕ∑»xRÿ#£Xœd,∆q|àø„ñ®4+1π¨˘u"ù‚Ÿ„ÁEÑx^</œ¢[;â—Œ√ÔapD‚é∞o˛Ç&\°Pä¢_–dZI∑D†(g‰zY'œ)R;ÿﬂvƒ±è ±Ô‡N„i,øÂ–4öMØ–FjÜ∏!Ó*õZ¨~P-Zºß…ÛÉ9 ºÉpD‚q,D%˚ˆÏC>∆g∏Ö€¯'S?*°ÕdP›~"Våeb≠ÿ*ˆ»Qr•<Æz´L5]ùV¥_kÀ¨n´Á¡[ûUû=ûsøŸ¿π”ÜÂ«#õ=∫à≥b+é·,Kˇ_‡í7X˛ *†ßXÀ\˙≠¶=tÇË:[	ﬂåÑÉµŒsÿOUbïXÕ⁄œ¸D\_àÔƒ©…XŸG>-7KCêü»oT∞äW›Tä≠
î…ëI’Üjπ⁄vmóˆûv”ín)≤îYæµVYóÿNµ$¥|ÈÅßƒcxˆqÓ⁄8ì≤'6aÁ}«‡${ÙcF‹Ñp")Üc‹iîM#h$=I©ò™®ö^¶Wi=m°∑Ÿ∂AX{¢"rÖ[ã%¢Zº(ÍxäÛ¢Q43Ú0ióâ2EórÇú≈6îÀÁÂˆÏJπSûëgÂU˘≠lÊ®Ö©ŒjûZ®^S€Tùj–◊fÚ‹¢”ÍµÌÅˆ¿",ëñhKwÀ4ÀvÀ%´≈⁄«öc˝≠ıúı∂≠å¢)ÅëÎxdàÆ¡ŒbßUï‘ÃùH°-[û»q»Â™∏ç¡“√qi„=glDÑÚˆ9X2î¡˜ÀÈz”	TZÑ$ÓCMÿKEì˙ìàœ»Ejõú•ù1ÿ≈›hÖ8,Q&ÍD∫/6H–⁄é+úÔÛ±ö¶”\Ï¢fÍOœQ_™ƒ9—QÊ“§õ[Ñ"?N7¡∞H·)¸‰†4\ƒ5œ&§ûÂ˛t k9¢ªÒÌ¿}“Ã‹›$w#7wôÂúÔK·Ìzì∏Œ*π#∏ÉÃ∞úAY¯“◊2H-ƒM|èk⁄AŒ®LÓ§W=•jì˙⁄Ïk&sÖqïa;◊]	Ür≈\·,9¬¥óö»ïÓœΩ$ï´:(¬s‹ıVöÜπ¡\l.0g„#æ{üíË>ΩŒqÄo§„û/·sZ∆u8ÙßÌ¸√SÑz\ßpä£TÆáf≠B[°Ì‘Í¥£⁄iK
{{	÷sF_‚lˆg
—ÄÎ∏K6éMí–ãÒˆcÏyò!ÚÂdQ$ ∏fªrœ|h…\ñR≈ﬁ€¿ı|Ñk„&˜ââ8äF∆≤~À¡~˛%sø≈\L˚xßàªvæcª€P?QŒ˙2X“ZÓZıåÈ"æaoõ>\I‹4ûe›≈ì(b}êCµÅwê∆ù’!O±øªP02)ñﬁ‰{.Æ–6ËÑ4ÌkHÚå2˚âRyÑˇ1&ÔøŒØ(§ßE[∂£h4z{∆2Ü≥$ïAü˙Pº&äÕj˘åg>¬éIÜ™∞:2ÜåÀ<h`˙Ä˛i˝˙ˆÓ’35•G˜n…Iâ	?Ô˙X|\{lå˛≥Œù¢£"#¬√:vm“.∏mõ†¿ ?õ’¢))IN{∂K7‚]Üä∑ñÏ•Ìnﬁp?≤·2tﬁ ˛1è°ª|l˙è93òs ˇpf¥rf¸áìÇıt§''ÈNªnúvÿıT0&è◊/:Ï˘∫—Ï[èÙ≠W¯÷Aºéâ·∫3ºƒ°‰“ùFvEIç”Â`qµ˛Yˆ¨bˇ‰$‘˙2ÄWFòΩ¨ñ¬ëo!¬ú˝klA à¥;úFÑ›·E`»8ßª»»ìÁtD≈ƒ‰''îUhül¿ûi¥MÙ± Àß∆∞dVüΩ‘kñÈµIı5Àc≤+1∞»^‰ûògHwæWGªD÷Î0¬^ˇ/…¬C≤Ú™=çí5ŒR›K÷‘TÎF˝òºGOcºÔ¸|ñ¡wE\∂´&õU/g'é»’YõXöüg–RV©{-ÒZ’j_±›È›qM”?{¶Ω§föãCYc`ÏÇòΩëëÔöMàtÍ5„ÚÏ1∆‡({æ€]äÒ]ı±QW|fˆ{}∑∑˜e˚Ó8{◊k˚\ü}ú¡ﬂ9Â6vp ◊|ƒ&¯.µ™b£`L*‡€DÂè*°U⁄∏≠"$Âlrv°q(¢
R•∂$jU	•"µñ¢ñ∏©≠˚ˆlú¯èv˜vvﬁºô€ôﬂ˚Ω7ÛRœôÙËäg•¶∫j\∂/;.Ÿñ*Î7+{óuπZÆªYkvYlŒH€ ÑH+ªòI∑kj4ãΩç(µª∫¡√0*Ω,Úù¥–öH…Õfª9>Õî…öí˙¥Ÿ¨lŸµ‘¬ñ…_"≥jÚdôj†\OÉÈ Jì"\+ÿÊ¯dNÆ´ÆÃêz≠_V‡°-ÄÌÆXÛjÄ_UMü Ë®Ñtrk˜¢¨†^ﬂ“Wcií053è5Óm¶&˘X≥<<°ì/#ÿúê;Õó/ˇlræs›˛Ê4Œˇ?ÍΩã˙ˆN≠}kO∑≤.ïX¬∂ΩkÖ¥®o\÷-’“Œ÷n GñjƒGÂ¥@ ÀùM°€í¶À‡«ÊHΩ'M)sXiKÀâıãeLT’ˇ9&√ÒﬂîY¯¬ï{}=liñÈÊ‡J˘âÚäŸYRÃó.'Ì]=©î∏B◊(ïj”î∂T"µ+≥êÏ’YKMës‰\™]‚±A3”ß|È∂”1Xƒ~‹d%®e\√£[«u<⁄Ÿ”=%CÊ2⁄’=A0iM¥ƒb’àòˆ`‡ÜmöC-ó	6X.C¢∫1¥A!ë£å<<ÀÑ∫äÀë ß”BTîÁ"Ÿ»&˘a§#AQ®ÀÛP‘ÑUªj/É√é?ØP3Û:É!ÖûÅ≥:dL·∑±yäæ+y¨»epëÓcﬂƒçy¢xós•6TŸUF{,˚Éâx«gŸYÌò}ò≈ˆ&doj™	;U∑ãeπ@}}Év{*ı4l[OF±Á√ó_ÎW^Z’ªŒLê ¸)áÃµÖt’àY∂ëÖK!l9Vò0CòK¸Ô.òÎâõãàÃ°Ëlt> Î¿|à=∆»l¨Ê{˛_fi˛≥â⁄˚ê‚qHƒOM!n·é.44’≤PpôÖ]®®´eu(@∫£oQ†É‚[®íÆd*ƒ’ñF‘¿D-}®èÏ•^dˆÛ˚ƒœ)€F^¿î(4'`8≥p.8±M+ÎbñuØˇI—¸Dû◊_+ñäbi!ÉØÍÀÜÜê∑xQÜÏ“Ûäq.3Ib
gH©.8,$"LìRDCAa0„…{a˜‘Yœ\|‡a|†0ªi›ﬁßÔÉiîh§c÷ÓhZ…Éë&9zc$Thæ89πqcú%≠]›óÖZ¡ZãÇ±ö0nOÁu∂ßãÄ˜SàZ0&xZú^0 ©˘qñn4Øàsó™Rpc’IQÃ˚∆ØìŸ+Gåõ‰	‹TyÎ&Ó0&ôÈ˘Q≤wMñæ»˜ÚN†I∫£GW‚˝“PÂ}zé¶’-∞UjYæ£ÿΩŸM¬ÓKn‚vª¥í2áìW\e_†üM¬˘ΩΩ"p…Ç-Ä‰§êWk…ê”∫È°-°D®?îù	çÖx%ëê´DAä3Ï$Œ95Y]”πñ…˝9>0 r∆gs~`>ˆ¶’ÒS»Ωêú7π·#^Ûïw6¡Çc–	¢ûe¨lÄ’∏® .qw™käpúÀœœ1ùeTl_ª¶°ææÆ∂<PÆQvuI(◊^'ya§Á¿Œ·3Òün4ÓV\q˝bÂ∑∑∑o¨˙√yÏ∂tÍGn1”˛?⁄πÔù`‡ÍÒ=◊¨<°oa˚3OoòÏî1$X‚õZvTöæ⁄ªÄπ∆‹îÔËmçEÌEœqÉ¸†Âˇ™ÂD¡´>Å-`}éáØ¬^QX·≠(‚◊Á=Ow	=y}Ù˜Èó_Ú^ëÆ»øµﬁî?ë»µäUêI⁄boS1¸{¡8U5+8t…QÎhﬂÏƒN›]XÎÃ‡
Ω2ø⁄)V<;°9‡xé+
EºJI∏Ñîxc"∂â≈bX§D∞⁄§zÏ≠E{Ä6…Ò9”,Ú√ŸÅcQ4˚0ˇ,ùµõ¸Frê£8é«qùjgi≠§î‘’:Í◊*tpñ∞nŸ±vM}C%«‚∆[Ôﬁ7Œø33ı⁄±Ø≠2˛\|!y˝ﬁÁW„øj%æg3='?¿˚nﬂ√{vn∏w´·ªGÁ˛i<2m®ùÜ8 ä68ˇ\ﬂˆÛ÷rV¢yÃIºç+	á‹a˚ê{ò>…ü¥K'']£Ó—Ç—¬aØÖs.ŒÎvx]ﬁB∑ósV[O5GÂ.ââ≤®,b†+aøÓO¯˚˝IˇòüU¸_¯â_å!l∆”0∏ç	‘™cøY*«[≥≤Ô é`]-p DŸe§*ªL Äd J¨uÕ≈}''!O8a3ÆS∆1\s|¸o}ÔΩª‰£ªg˚'ÇÕ∆˜å?1‡‡˝ˇ1Êøzd∆K”kØÇ◊∫ëäæ“_i≤m∞mÁ˙Ú˙,ÁÖs“òvE∫#à,œä|æX/µIm6éóªKrŸ\rΩTo{∆vH:"ﬂÛÜÑ!œ†Tı˚Y!ﬂ%XlRßtHzU˙°Ùâë´≈eµZl∑µ øÃ)ªp¬5Ê".RT`±JíÒí0»*[âı#_`åM≥3ÏÔYöÈ◊∞¢Ö5¢©nõ;A¶”ó‘Ï˛⁄Èsÿ-y|.<f#”Âóº∫i$åKGÂπÌjânÒ¯ZŸú;ÉS8U*D4ÕN˝ÿß¡ë¸˝„‰ıG˚&çü˛È`◊/F˛Úq_dÛ˙“ÀòÈÕ∑^y˚ìUç√åOqÙBLÕæIm*ÌnŸ¯ºÖ1=∂
!z*∑'‘µ’Bò3[Ñ~àˆgé≈)É‘àCº õ}¢~WÎ"À¡˛Äéõ´—NI[H?Ií3ˇ•∫ZÉõ∏Æﬁ›’ÓJ˚‘Jª⁄’	dŸF?$€;x©çy∞ùÄc·™Ü6òh“õ4…îÑRb'm…¬#Còí¿§mÃ€√$ê?fËL^ù”éÅ:‘3¸`ß±‰ûªrô÷≤ˆÏÓΩ⁄Ω˜úÔ|Á;$Mö\ÓèÖ=∑vtù%≠%ÈÜupïÑ‘Üqÿ<ﬁyCFî¸Í®5ÛV~Ω?øûæ:=˝˝2X’»Ä¨ $~c-a9÷…*dÁJn•ì}‹Ÿ©Rªﬂ‘éÈßï˝sÌ63≈¢  O≥Eß¿Gƒí ÷|+–ÿ†˙{d$Px;p%@	‹lVòWL ƒÅÚW>ÛˇÏºc*S)ìv∞b˚=Q∑◊ßÎ∂Î°»+π`~BP} ïûW˘¸?*©¯’Ôﬂ¸Úyo œùKK6˝l€°˜©ƒL>?˝’°ÙñcüüØœÊ Ÿ]∞?é¯då†g?≤ñÒ’W\à¶h≈“–é:
ÁyIŸw"ã9—,≈p,ç(ír“Ñ√≈°N_€,ûa
D
¡π.í>x6C˙ÜYñã‰(ÈAÅŸ{ŒâK7V/¶2n(πÇÅÿ4¬^·35é©÷a$˙Í‹™Ø◊o¿	÷∞O ”9ÂcÏ"!å"¯wìzÓ.ÍFiÙ(⁄òªMf©é‹ádÛÃürG‡Õ´gˇI/¶óà*‘o=…˙π†#§˚◊VW˝MπÂv÷ò-Ê„Ò^s[| ˛Üy¿ˇÆ,p›ˇi@`Q”S/fJµ¥πì ﬂeÜôkåp9ı•BÜbUïÓ21f%ßb÷¸8ò°‘ˆÿLååµÑp©ê‰‘#!DÑî–°ÔBt(TÜíÑw1◊ëƒ∆®t7F≠Ä√üäéíø¶YAtï·Zc∂Öa€¬å2òaY^>\ÁJù%bzûpB Á	hÙÅ%È)¡ﬂñB©ÕÄÊW*B…“hè›Ú°6_èoªèÚô…ÏÚ9f›J†2ÉÎP¢p5ncä>§ËßƒÉLb‹fãDA4ïáPz≤p1FƒfØåB©±'bd&ë∆
	HIJ!—˙AÙ#–ΩIL%îW˜E∑≈ ÆNaÚÆ-–5¬¢AÛÍX3‘÷T£≠≥âõ7>m•E˘oxÖ•Vù ú∫‘yÏçO÷∂oo›Ä~TÛM¨∂´yÌä§¬ìˇX|Ù`˙Âë¸ËÔ^\¨5πññ°ó6ÌoEÇ+ÍÛ7’*£∏°æ≥*^€
.4Ñêâ Ò÷°ŒN[ï|]m`eÄT;ôNWßﬁi§Éﬂ≤L5]/÷{™+ËV±’≥"pê=‚t	Ç6ƒAr∞^œÀÑÀÂ¸}aVJI*.è¢RK@}ƒxüj,¯ªÑiÆ·Œz•
W≤\À¡MD?‘˜¶.ãÔez]ΩzØë:2i"ì 
vÉÎT(o‡∞bÕ4∞¬"sÔ–’|>7÷}÷RS´üÕ¸zﬂ∂≠éπ˚ÛwÛﬂÂÔÁøÍN'æ”÷w‚ÁOæÖYw#ÏΩ2¡$˛nut…i5≠?)g’¨æ€x÷<LÆ)◊åœïœå	fÇõLh”ågâgâ∂F]£∑i!+∞K’ZΩ÷†v:v Éé˘eÛåzZSœÎN…Fh ÖÌ∞ÍMIIﬂ1√)€ Óîx—Ñ|¶∫y¬Ç©ÑÛà‰kÄ”∫0ä¯XÑÔ¢(Q.‚1⁄§Í∞QØÈÔ*∏kß©Ã∫…ƒÉ…M†ôX;%¿‚÷–CsÚ£™¶÷ÅAáÖ@ëÆÃﬂì~“ñ›˝¬SÌΩÚ&¸e"ÈìWoìˇ™zl√ÎÔ]:ﬁΩΩ¸£´(éhƒ¢¢”Xl ﬂmô√Õk÷"5Õ§]iµÄñ7”Ng_xOò\J•Ñ•Z \C5k¥fÛà”Èµ·¬c‘XœJ2Ñ¬Â+ïƒ8¬Hëe¬ˇ*∆Nî3C]wÿ?U@å]ª
 «ÆÕÄ1Àd]YµÄ&ìéF´Á6»ÌˇBÖﬁíˇ~˘ŸM#†ÙÆÌEfN-o~nÀK˚∂=1xº;çäá$d$ïôæ˜÷˛¸ùS#'O¿~ó√~ã+^"à~?F(ê'-|›ÁQÒêr∆q⁄u—yQısú≠"W2-Æ∂Ò<sﬁ›ı©ôÎaö˝VÉrP≥Ä!4KrßdÌ≤vC£4·F€J>∞‰~Ñë⁄.mñH…Pú7)îT±?ä§l;ø¥`ã
÷⁄÷íÅNA=ÑÀÓQUpÛ9öWÏÓœQTÆ@TÓ	oü”a9 Y¢úáœ±a¢†«T∞ÃÑÜ»ÚVâ∑—∞¬2ÄÇÃ’∏L7ÊÏÜIÖE¿/&©sTçÌ–ßÕ⁄m£˝†ë¬„>l>8Át-≥/óGû?é4cø^≤¿K~©Ñ_/Y‡,¬~®›‹ÓÄ˛⁄,[# [ Ò»åqÇä⁄ä¡ÉsÄe|‰øëQ3ÒÁ¸Ω≥»˚◊I§29ã⁄ªÂõä©]ù?lh@Ë—Ú£'á_ˇ∞ê»_œ_⁄˝€UËßœΩ–‘Ù4Ê‡t:1jU’–h!Q"Ó4Ω«ppÙeÉ‘t7ÈUu∑‰ë	EÚ B!ΩNNÊQ?Àì<ÑãAnYG≥:“ÒeXÅÁﬁáG3ØÀôl‰⁄∏vé‚Jîrwèõtè"⁄%OúÙˆoÎWtR«òp
)›ÙÌ#≥D!f@©3†Íf2 ÛÃq¬Ä4¡¬æçp®´í·oÆyí∏‚@r∞6+hIm–Î„x›ëgv=oZˆHıÕõ˘ª«Èx˚¿æ«b+u≠_œåP´Ì‹œw–õmQé÷[?ﬁë™ ˆUà{*ÈNU†$ô§,‘D6Q›r⁄õ.Í,ÌÑP=%Oªß=jΩò‘ÎKíe≠b≥ﬁZ“\v_»˘\Ø@ÕÊë_(à≈íÓ”âÇOßçŒÄa;l†Kn$Áx°`K`AQ¡V¶
â‡‘v·Ôq`¬ô'c#πaáˇáÓjä‚º„˚Ì{˜vèΩ˜∏ÂÿÂ8áJ≈ﬁj¢q¢¯å0!“TbK¿VìL™2ï˙©IÇ/Í¥[)hÜK⁄—i⁄öéù©ù÷Œ4m¢”&Éô	£∂kKˇﬂﬁùè:ÿŸ˝ˆˆnøˇÎ˜∞y8Ä-â⁄¥†ÉéÉ]3—LÄ†C$*"ag†¸>˙|û¡eLô¸8KVìüo∂z9ñÂ¬⁄úıÚ!(é’æÎ6Ï$™ÅıZÜ‚⁄-‹ iq∑må6≈Z XÃr>∆ÎÀÚ~%@X¶Å}`w›†t@(∏‹∞ÏU4üœ/^”:ª»%oø¯Ám/ t·◊à˚r€ª]Ê?ˇ>±≥q„¡=Õv&ı9ûiaÔÃ¬Áèú9ﬂuŸP'›O˝¸ù´SÌ‰Œ”«æ¸á˝« YØÉ©\˜CF,ÖP.§≤ -p|ÑÓ!ÅcºLÑ\Îhv0ë.∑√È¢‹$ ¡IÕß8A›—K6Q„£ ?+†)	êf(âWçƒøÎÔ˜ìm˛[~Ú¶˘	∑ÊıX∞œˆ{–-Ú|ât‚€7«∞˛_ä≠@l<≥≤[∑1»©œíWºeÄ∞@òFz†ï„›±¯ΩµÁ_9∫,ﬂ-X>/ŸZaÇõ¸‰ƒ¢∂=]ìá»ôßÍ+kˆÓö¸ÇÜﬁ~Ò\R‡≈^NÏ,·ÜP+ê¬†pQ∏"‹òê–(Ï˙·C±Œ XÃ Æ◊·õ†âXÜÂhë‰Ä3≠^G‚tÄœƒı éÑ5û£‡à“"qsÃÖ7«(`é¢ ˝6¢Õâ/û¶µ/>Ä
ÌÖ
≠É⁄à•jÍ√aŸë†;∂¶«9J°\¨.4±g≈‚˚¬eÒQ\I5R§Ã˘Ö$˚,øïeﬁÆ—cÙ}áeñrK˘&v}Ä>Be˙ÿ>ÆèC¥ìç—1¶Ñ-·J¯2y	ΩÑAì
¢¿ãå(P,mch¢$l6û)Q¥—#‰◊ç S∆WÖ8ƒmêIõÜ:Ç§ƒkâç„(„Ì~ò(Ïqàt%·ªÏh¯ÍÏ4QSÔ	·8´√≈m Tﬂä´¿¥À·{Q -Fıf7˙é˘ÛŒN0{„h´˘≠…Á—á{Õ3ÿ¡ﬁØÊ ¡@é¢∏ñL-Cv0ÉÃEÊ
sìaBL#≥ÉÈáÑDÅ$£4Dd´FË«™ñ©SE∫FÃ;ˇI¬ª∂€®®£π)"
ﬂnÄwI÷+≈©8˜«k»Ö¸BM°T@ïEW
ç—éËâËÿS‹è§ÛÏyi0z%z=j'¢e—Z¯‡BÙZîç¡ºx÷÷á¶π`>¶ç!ë[ÏAsä√°ÁÊÂi∫≠ó£hNáQ_ŸË@/A#çêI#'ò´ÂÁ¡ΩóÚPc É{Áä4M«äkà tKÑ	|6f¡æuxT7Ê√QGDèÎ∆óÊ≈ÀÙﬂÎ◊t*GÈ:EËzπ>•”z†¯’YïÜƒX+´«ÅÔÅí∆€);∫ä5æâ1Ïo16B>7«0-°ò+Ï¡˛»gπ$ü◊e˝˛(?òÍÌà⁄±ÈpyÚ‰s[N√lÁÎÀÁ6œ0Gß%fÕoûné“⁄°”´VØ^µÓπöﬁ…:r›Ò’ãˆ6I2y§æ4Ÿ˘Ê‰‘ÏF;®ôó8a¯9óœUœ7ÛÙç†ZJ_ìÛ©¬∞¥98ªÃJ6HUi^¬Ç6M¡è¸?hmöd«˘ïeÈ>¬IË∞‹£geÍ1êKFVÂÜÅ4+I ttù9Y^µ¯õ1 
fˇ˙ñÖ»ig6Ã©Ì2C¥vÙ‹ìÕùØa\[˙µ"ï¡ÌÙãn†Q˛ÆÎÆáæDﬁ`HgÄ	dù≤∆µ∆[ÁÔ!{Ÿ^æGÆíe˛&\ïFôQˆÜ¨ú‚/ìøcﬂ„#1[¯Ωl'O9¨.¥˘pä‹4ÁÆ‚ÇçπmπdÆ=L<bO“&/-⁄≥Ï'¥(M†Ÿ[¸4¬‘á\q'ÑEx‹`"Z—C<∑bﬂ‰—€(n˛ˆ≥◊Õª˚P¡·÷÷ÓÓ÷÷√§z ±˚ÃK7oõÔuNË?:0Ä„›o~çÓÅx'}∆å9ÆE.“ß™‰*W<∑ÜZ,/v’‰ﬁÀ∞«Õ˙ñqÓ^.ÛÛ∞üı⁄lJé=ÎgQª=GSÀ®ÿ˛◊—>3VÖT>~Ã”Z‹Ñ˘{⁄á|
Ë0®$é9cj±Uyı~ƒV¸Ù≈"Õâ‘⁄ÆePbÔ¡¶æΩÎ´˜@ik◊õôìÊ∏˘ó‰Í…O©‘[«ÜOù<πõ ®ŸVÏFqÉ;Z…41[™Ãπ÷ﬁlos“¢ê#Ö$≤Köí»Ñ¥L"•Úe# q–ﬂ…ä≈Ñ†ÂBõ@¡ŒNrùsáÛ¨Ûäìv*ÑÜ(+~íÏ@˝àDG"ÖÚ“"¥˝°vo<ìñ°ê	ËÓ™'“©h'ñ˙V.¨\^øˆg‚s a´ßÔR÷Å˙qG?π©¶±ÓŸßÊÕ]QFk=õj*ÔÃòˇcÛ6ƒX˝¨@å%‰/çã¨É-‰uü√WÿÎÏu˜Ë›%ÁN∫IÁªr ~)¸I·øÂqïç ´Âr∑≠«yJMI‹¸B#R£mT◊kªùª›ª‘ùa∂∂êM⁄ûñóÂ$√TNçË⁄l©2\©VVF8VdBÿ/Îí™™Ö\D5Jø!Ω‚~’≥5∫•dèß≥§œ”]rN=W(w†.ﬂˇõ%ßKKY_ÿkÑ„^#/y—5ê¸|∏∂®´à,2¸˘Ò¢`)F†nm)*/Ee•®tZ∏\AJ
d∂ŒHöóx)ˆ N˘†-(‘ˆ±Çƒ⁄Ò
pxåHS©Q…"ƒ"/“‘Y·dx™Û≠G-æq$"I√*YÏí%≤8∏éFt≤ÿVD¡§ãœ ˇXæfèÜˆ‹°N]∆ä;<í>´#S◊áßE˙˙p(í^Ç÷⁄»ÖãM2ö•&’^˘{ÍØ‘?©lXïdöMOT`u?Ïõû@h≠’¢8>˘¿}*G™Et#Í@∑E Vçà∂ûty·IÙ_Œ´46™Î
ü˚∂Yûg<Àõœ`∞¡ı∆@m gå¡S¡¡¨6‚@›@hJ¿ZUâ(u$ †–(™RÉ ⁄ñ%Uù&K±5uö¢˛†,P≠∆-ïÖÁı;wfê„.R˚§Ôù˚ÓrÓ=ÁùÂëöMöX¶ıi
ãNÅuxb$æëòFR5µâH*˛eºJ+Òﬂ¸HQdYdMDã4«Ràﬁ˘117f«î¨k„˝mô\v=Œü˝Òlv„öîïëlÕTTkÒ¥µ…≤ˆKˆÖîÀ4‰W‡=‹˘π'ôgÂ%πy</	}vÃL “U`=‚a∞4,/˝5HuÂ0:‘fú˝ÙLπ≤P!Z® ™E,Ìo<][jÖM^∫˘ÚçÀø´HﬂÛ/[º¶∫∏∞Lº€∫∏ˇ/UÒ˘ÕÖU≈!Àﬂ8µeÔﬁyi€Ñ©”ä¬%£BÖ+g5æ∞Û∑G·EEˆMeá~ 9°'UYL(›‹ï˘uﬁYﬁ÷|G4Dj8Dë@–ëÄbâ’Âp;Ú
X›˘99QóÉtG‘J‘„!¡!ÛÖáNoûÈ™rW™ƒeà\ƒV®eë@s®¡z√:b©À≠-÷vÎC´œ“…ÚY≈Vµ•Y—ÿwÊ.çGk'&#Nú&ÀÓ~®5S·ˆ∑’˚˙eÖãäàã©◊qçOÃV∏mÂ¨%ua•ïA•˛íöâ5•~eS∑Y^X>´†˝{èmJöÆÁû1≠ÏJz·ÛÒ¬ó«Nú7c¬.Ò¡ïèﬁJoÖ~:ehe∏ÏOE˘øÈﬂ≠´.#j‘+ı˛F•—ˇ©‚êïè_3√‰Yñ€e≠≤Pà8@z√Úñ6|˛ø‹\Œ◊ßËs
Á.Ä2)fÿÌ†mtç!≈¨¡’@ä=i7’¶∫_>µ∫Î1-öﬂ0s›X}£π˝âÆ› ¡t¡ïìÁ¨ø.∫QR@N˜†%ê”#R!Ω"VïpÀ‡óì_(0>9*ãô‚X]bü&’t:›y&*6%†∆\1˜oû3Û‡€}©»‚Ñõt”¢®YJcÕ’ô/í+íN∫Ö'OÚ2]ëÑ&»%rSCC=~cúØÖ…©ÄInÕtª\ä"¥]IØ((¨Hòû"Oµ'Â—<ëHÃÁnpœArJ©Nôöí4µmé¶jgîj\–∂§ÚÛjH#Ñ®"ö˜>l+ ∆/ò}∑ô™-⁄4c≈√ñﬂÚ~ ó”@R‡“µ„HXÏßxFã—¡»§⁄IµA øH/ÂÁÎ"Ü◊wQåNC{ÉW6#<~º2*£Sozû6:äƒ…@Ö.ÇÚÚŒ∞'?·‡ó¡/=å>Ö%+Ç^Q0h”k¯
ZP—TU‡J\étpJÅRÚ=Uﬁ
*Uáñá‘>(_∆À≤”T†pT"ùhI5UM<´r™.Oπ˘•Öø"I©¬Iâb™Ê˚ãı~÷ﬂ‚≥£x≥n•R‚ÒµÎf˚˙Ø„Ê÷Vï—Ù‚ówvË«ütx}∏ﬁPV?mçG}p◊:∏ÎqÕGgÏ>ËøÔòÍ·iï¡Q∑o¶º®XÉæ`Ø@AÉk9Å¶«Òù·’Ñö^µdLy9õt≠Wƒ”ˇ%È≠”Kß/zvÓº¶Ë¥öˆ'¢PºW˘Î}Ât[˚î1˛?z:ZY˚Cû	ôo]y˘Ó˙Kﬂ]ñ_ˇ7g‘)GﬁºV?íÈ{⁄3;Ó˙»¬\¿+ «‘tM˜—¿¿¿&ﬂ0æDû#€•$≥Ë¢SÍoË≠É¿◊#©U?GKƒßÙ8∆V”’ëT®¶fÃ_èÔ–Wî§=à˘-¿õ¿D`6P,e± ¯*÷\ ∫¿cÛëÙ≠rÙ–ÏE¿n‡Î¿´zÌ¬ÿkFí⁄π{˝<J–ﬁã˛FÌ@{∆[yÆ§ºæÖfa|⁄ØË-∂ÌË$˙ÌAÙá±ˇN>3hˆÔ–:ÏªhèÔG1˛"h3Ë¬Ïyd˚Øë≤≤å[π˝lFˇ`>∞X
˝˙j¨+¬w'⁄&ŒÂÕº—Ã©W¶–Q–ÒÿzVnírCé2·¸ÚLˇÕ|æ°¿ôXÆ[@·ê≥GÁ–A´Âˇcô=¿d•á¶A/iñKøaﬂc¿Ó>Å\g]{í&8…Ó¬9Ùì¥ﬂ_Í%:Hh˚iç⁄èpí6ªÈGË'∆¨¸ùJï;3J©˙[˛ãÄ‡˘û¥á'˘ˆ–"Ì≈¿k9∞
{_»ÈâuÉÔô¯Øã1˜>˚Ù˙}‡)Ë`∞éœá˝´XÁ¯Ô˜DK˙'ò{˚42∞gëdœ¸WZèık¡K»}2ˇ!CåØÇN
¸
xóœêÉ¥≥,$Ø.Rï.˚s– zÄlo¿r …s∞øÛ›“^a3lõll˙9i´¯Ï§/lÀ˙Ã”Xøà∆az<ã
Ãe˝¥≥Õ≤ø‰x≥m±Õ‰®¥È’“Óœ≥úlSCË´z7Õ„3»}a[9 ~æô™!y¶}j/mgõe{ÀQ÷€˚#˚DñŒ"Î∏¨èå√˙Q“÷aã9ö”≈˙ÌœcÏÙ65ió©IΩDM˙F–ùêÔ4˙ è÷ãß9Œn™ƒøúÉµ{á—=GØXÖΩ^÷AΩt@ÍµW£ı
]?dﬂ“I\–)õe˚_ËpàÓÃS∆–±ˇµˇˇÅÚ±~àV¢˝ôﬁk€êg'˚Ñ„∂®äs˝«Å-¿Xg\ÏqÆßÕ‰3à˙Å5ZäÍÙ’j›‘†Ö(=ï¢øŸxD∆›Ì‡N‹¶N¸Ø!*Qo!6b/Âc‰Ä˘ÉŒbG_∞π·∂î£9{NŸf8ÓÇÍ†Q¯›‡,p9ã?Waè3ÅG87p|ñ˘1ËÃÿ´}˜Å}^†˝†/ÂÏsòùéfüé·v9úrn·¯.s¸ÁËÃ…œÒëc«Hésú˚rÛá”!Îw!v¸^∆·ZíıÎJ†®èw≤q‰,Óµ˝—õ∆GˆYGÉ}VΩhü5ˆ⁄?v¨∂œ'Ì˝êªÚANÌŒƒ2ˆß\.e=q^ÃÂQΩåVf„Ÿ>9˚À<⁄"„ ·´®|/q^e?T˜√Ô†O{^{õæ•]•Ì8{æz$”Ø-†&éâ⁄¥—èòŒ„¶∫]éœ◊>ßZ%⁄oÉæN~√Aå_ÛªGˆ]ÀåqüæÑ^É›Ui[È-˝-Ê≈r(5ˆE˛˜˘òspl¯*Ì” s7d<'ÈÎ“ûxÌ	{ÄÂsL¶r_Ó¡]TW?øﬂÓo˜ó@,è ´<ìÚö°≠0ºQ¶ä 2∂:¥TÜ —ÅÚyDä√£*‘j)bçï)l-ô*uK≠)Z
Lë<∂üsw7¸‹®ˇtgæsÓ˚û{ˆ‹sæ∑M¬‚|:Ëﬁìù{¨1∂(76Zm|[ËöŒq√7$Ò6„üìy…tYóºç¯tQ2]bâŸkèLLÊª€&_ü„~T‚c„•8—“˚‘¯ˇNœ≥.sá*π_ä}≠§m¢R÷sóäç}|πLÔèU)≠‘G8_Å·ï¯¯ôÌÏêßø´ Tﬂ*9ÀπìÚ
{áW≈ÿa¨!∫7Ìc?—<ïÎ˝IÔã[.n.˚3Fu0¸è}≠ø£ÔJ)&ñ‰%+ÂyG9∑ƒî4v©©°ßZ_ ÊÉ¶≠π/cùYcû∂«íChÒbzÏ_p˜÷Kûµç∑“T¯√G≤0û-ã≠Q¯›YrÜ%Û¥ngIÎ¨å∞.ô¸≥8ë.˝Õ∏÷‰Òeå]»¸rôbˇJ¶XÂ∞d^bØ‹õxûUƒ:‚˝òì&cúeî≥Ωù:ŒÏq…k≠∞ó3/F◊™ÛÊùWs™ü‡™/ÂT}U◊:=Ø¶ü9ßÆÀ<3Êoíáùﬁ›|Y;6˛îÏ õ‚'‡·Â2?∂∆€á]áGù‘∫=?V∆ €û/•»^»è@ÿ ˆÉèÌæ≤àµ_Gæ®ÔE¸wƒ.$˝[¿´‡Ω∞/∫œ’⁄SaüÒˆ•÷92@œ"¶g}∂œå/ï>ˆ\‚pooü¬ö#È
ÁÈÈ&•g¸Ìò©'z»3ˆL∆é´1ùÆæﬁ)vÃM=c¯?ê≠ØÔ¶»N*π_Ω4?˝n¸ﬂ`ö±ˇ&π√¯–ápr◊{#∂_äbÔ{óâÁé¬ØK¶±g©¥ˇÌ≈¶=Úˇï~jÛh;Âªa=˙_´≥ÓÙTÑ~¬Õë\Ö˝„A¥N>»U8ÍcYıÎu˚6ÑÈÉùÜ€Ër™~›i.Ÿä¯,ÍkÈ?#∑)ÍÍ“S°cÿ∂ã[ÔSƒOIgÖ5éæqf¸Eä]'©]≠rùkÊõˇ˙yÙˇ0WÏƒ£‡Ãíï©w6zo£ma,π⁄ò»›Ë›–öˇO‡Ó¡æ‘}Ûò‡´†π¿È˛ﬂÿW}û7ÊyJ§¶X§ÍuëÍ…ƒ!rpı.⁄∆SÓé<2hõé$UΩOy}«¡Q∞…n's^Ÿñ˙0nÕ÷`Ωn˛|ùw∂S’œü_µ¨ß|‡eUo W!/2~7Û
ëpÄÍÖ»>‘« ¸°˙œ‘á Ú~ı@OÄû’–òÍlÊóÇ9 GÆÚ˝beÔèÎïË¯¯æ·úË}C\∑ˇg#2˙÷ˇc2|K‘ìÅ‡|á)oükæqB…ˇ¸4¿âΩƒ´ÅS∫ÜG√eÁV˛H√∑+üåNHÏ©z4UÓ¨¸π¡ºÛﬁDü«d$zM0zÖy$%∂∆≥‰!–: qOÚÛ˙¸õÿ”å¸znπ\!˛W‰√;BÓjFÃ}-∂ﬂªà<JΩ=π,-Ãial≠cÎÁ¥/µ~£9Ú&rÍË ”#€ßàˆg¯∫"öãoçÂÓõŒÂ‰Ë‘<˝yÎaûë6Drn.zÁ÷Á•Q–XΩ1û{£ı(ÔH©ÔQ\£ﬂ‘£º$¨GQØøæÔ˘|&ì˚"rÔn‹”°ˆLÔùæÜ:DÔq›}ÍŒπelªÙ éÙ%¡ª´er†˜ÑÊ∑dµ‰$wIıó¿À~ÃÒ
˝‹Áïƒ~ó˛ØÜú⁄E‘]˚®;)@ac˛ı[ÂÁÜb3£˚r˛≈…É¿≠`x¥Ó_ÛÜdÔCôWﬂπ÷ﬁE÷∫ÿlHÚŒõ≠Ô=ÍÕ®7#∑sˆHáDπ¨ßºôéL'æO? fèOÙjúÕò˚È+∞O»(‚¸‘Ñ%3Ì”ﬁNb˙âû≥Âgö;ÅÀ‹gôªÑr;d3˜Y√:ªòˇ¥Ê 7É<x^∆;y“Å∂eöá¡∆>àmÔçüîƒ˘éÙe≤óÛ˚êØúû&«‹B[k[8◊i
Ì~r;@ﬂ7¡}÷e÷ﬁlÊ.ãñ›VïÏ∂w…÷€õ^&´“ ™$ÁIõ ›Ø…F{∂¨L(kyø≠•æBÛUòW±}mXÜªïπÌeíûõµª≤ <sî˝˙WxõS˜Á%Û±Õ8ŒP÷R_—∑aù˛†∏ ŒD˜”‹lµ˜é˙R~‰¯iu9Ç‹√:Ω)g€ñ vO≥ﬂì´…Ÿâ¶¨”‘Ënl’%‹ª‘4ƒÖBnÜø9-’«®˜-É∂√Úd$ˇk4»H,ñ{©åãóyÍ∆¿ô‘èÏc∆gó™û
ıØ¿ÁV∆∑sGﬂëñZ∂èÀJ˛—¢ ÛÒ”≠j[ªRJåé;¿ÔÒcO∆a´3W¿›™Éw∆ﬁ¡^
Ï•˙Xoè5˛Ÿ6Õvˆ%˘ÆΩ›¯Ã≠ú?ÕË∫®Ìf·£˝<F<„NÖ“ÿ™ª/ï—Êåp*k~ã}¨R¯’iπ/õ¸ñ∏K◊ùÖÏ;\::k¡…p˙¬órÓaÃ](≈Òsí£à=Ìùä€îQDaâ‰ÿ0sbèƒ˛!˜[GdˆZ~VqûÛ
g∆Óî…nWƒÀbùÈÑÂØ˙e”v8¿˘ [S¿8Ô$®äüeÔŒ¨GØè}ù¨Ê¯jÃy Ä⁄£˛t{"∂˙,Ú£`Æ Ï(hWŸ-ä†=3
⁄UçÇˆ°W—£°qÈ—P{˜(hÔ˛Ë—–∫]¢†ΩÀ5ÙÌ#n@èÜÏ‹5
⁄ª^CèQQ–>*™ÒÈo‘ó4í´Á"˜ #gÇ_RÊ›ÎMÍáÇq_Å~^« wÉ…å!{ˇ¿ÿ+–ΩºV˛úpoÂˇ øÌÔ•sk_Ò˜6ˆ¨›Ë˙€î∫ÍŒﬁµß¸˝ÃﬁËQªœÁ1ﬁ∫`¸†`ﬂmæﬁµmê?Ù«køû—Ã€v◊œ#é◊ËŸæw™{Ìn ?˜9SÌﬁ¿ñõ˝}kx'zmAØ†ø¯J\êCºóÁhÆN∆ETj¨51w∫¥L…UÜcP~F„ùÉ6ˆ]“ﬁÅ√±F∫Úç·Ê=I‹7Ô…ø¬O‡
]…#«©üdçM¯·-ƒÕ'•áÓaüÉØ∞∂Ê]Â÷q´0\£‹‰Í<ÕÈÉ•–àN$ìı€π«§ƒ)"û˙oŸ&Ó√‘ß¡;ó	é+sí•R‚æMø%√…W˘a{¯∂uy^"KöÑ≤…@)L{ïˆ'·Rô2B˜s˚ xl÷?‹ªŒ;ıùk˛ª⁄øÏ©˛itF_dd;ìãï;©M˛(≈Ëì•˘ªµ∞cÚß˜™Zz∏iãó•8-.œ∫ìß{=ßºÆŒˆΩ¨JiÂº%YâüJ+cÎ-2€9Å]ÖKí¸P‚í6âùúk£¨≥±÷FÈîh%mw®0k˚2\£>S)ÎÒâÃ(Ø	yTøyüÄ‘ÌúG•ÊŒîÛô¬7å›{d¢=CÓ¥/¸0"Cù‹
ŸËT(2¸kàπOê[w…pÁÄ‰'Ú·È˜H~2S:π[§≠Ú≥ˇ±_6¿QUW?Ô››˜BÜdà)L^@»á“Ò£öG‰;l†å£…cñŸ,àï
SïA†0ñ+ Af§a≥3VS∆¢≈∂ÿ
µS˚aQê÷ötZãí◊ˇπÔn≤$$qîq⁄ôõÃoœπ˜›ØwÔªÁ˛Ø]èoìıŒhÀ°ˇ	{‹ùÑı9˚ ÿØˆ˜µÁ˛ ˆ™ÿQÌÂÀΩâºO´¸≈`àyœ˘ôª“Û/úı⁄óœVxÂ/p¨¬^3∞£:œ*.Äˇ®=˚)˚ÛºYj˙ﬁVÈzzJÈ÷˛m˝ŸóÂ=åuû°á==Ÿ€NáΩ9ù∆˛¸≠k9˜HZG˜¥(ªMj;i›ø*{\Ÿ_Ò∑∆ZØßÕ–’ó¥}È◊n´ˆY⁄z∫˙Ò>Ïº¥æ»vÈÔ>ló^»Œq]éSikØ#õ5h⁄™86∏€*]ﬁ}Íi7AßùP:ñı˚dÃ˚:ÏπÈ˝¡ﬂcu∏ÌVG¶Eå‚◊8£/ÅUàrÖDˆ>∑›ﬁ◊m˘Æÿ÷‘€ÄÛ•»mœ* ¥î«`Ãﬂ˜p_á¿		HÅÉ¬p€ÖÅ~6∫Ì–Íg«Fy?©æ÷6Ùª˝‘†?Dq˚0∆ã(¿Á]@≥ì›âz˜…wÏ‡≥∞_é†®Ö¨«–œc®s˝úó∂ÉIœ{z”ÛÇw;-◊+=Êtˇ™›Ø∫éhÛ…˛Ë{]‹ÊrΩwc˜ˇ¬}g{Èò∫ó¿∫Lè1Øó„>Öwˆ\ﬁœ(€ÆË¿º~˛Ã1JÒ:¯	¯òø-ÅoÄA?
Ù”Û;ËP®4ÔE∆:Â˛—æ”=Œ˚@ºÏ˛ìa-u©˘±£Ó€¯è€õaè†ŒbyGbÌu{5õ„;£b_Ò†∑p~!¿w¯¨œ⁄èoõ^£˙ã5ü;[≈‡f¥CàC≠ED'ÕµZp∑åòÙ{˜ÉæV++6z⁄œ}¸Ãõgôø'QJÖ¸õ–zq∑)ΩÕ:6·—y⁄ÀÔW:ˆ˙†Ñq◊%º[-÷; ıÀVåm+@Û<…zAûöÏ[FÎ°)sY∞^ê{°â&@V+ä1/ﬂ&Ë∆ì4[rÂZ‹œ÷DrùN“,ÎjöÂ{ æ ∏à8)ﬁÌ®˚	4g=ÅgCY˚p¨YâìòGƒ—å;.î≥ÿ[„·∞+(d$†QO¿ﬂ
ë?
ˆA∞˛µ∞ﬂwÅΩ*ˇa
˘Û–ñ>Sår/yVbzòG=ÑÉ>êoæâr´iÇŸéº;@6ò¨‡2†Ò¯Y•,2œ†è©î-
î?	œﬁYP ‹û¥´gÈ2ï›e¸£€≥∑@Sk‹6ÿm3ŒP°/BA¨i¿JvÚ}Ë«JGa∑∫3¿v§œôØRåÀ0Ê†€&û ˙I7˙7Q» ßÔ˘Ø§)∏Ñ≠ Œ·o”uà?%–“5ﬁù®ìÔvã|MÓÁX∑’‚å„}…ã ∂Yø°“A´qÔÖ ¬–)mÕ k‘»≥ìmë¡Í≠≈Sd˛è‹Û^KÎ\˚^ZgÔÑñ‹Iw©XƒZãœí!|Æ√øëøˇ™DK8}‹JO„ªºf#6˛ç©=Û≠°Á¯€RZêÀÔ˘Ù]ÿoö[0ﬂ¢BU˜0<¢ÊN¥ª›¬sŒ@ ˇ~ìÒ¸≤§}€±øñ#∂î√/Ôù∆zŒP\¥∂và*ﬂ	îc"4AÑè†Œß≠ ï1Ê§∑\"ùKcÏ,#ÎŒ8m~@≈å®∆W˜N£ˇ[ôÆ˜ -û°—L˙{Î˙¶˚zˇìÓk¨°9é⁄W±Ôæﬁ|À.ûΩão©Â5œaœ√˘y1Ò$æªÁ¡ßÚ˚{‹k˙¸ƒ<ËiîY¬gk`é≠–Æı¨KEõ{à„kE©°ˇ∏Æ:1vÜºó›J≥d¨EL≈X±Â{öåAŸã„« „e‚8c˛È$“≈^\bﬂ\Ü›∞˛L<üÏ≈)éAb>ÍÃGﬁy/f…ò…±ç˜!‚ï® ˜ ˝bê˘!,Øz„0?¶ˆ¬&>s:wŸ$cßÈµk˛˝¿Áªã‹∑s®ê˜  Ö“KJ_¶5Ê°ûÈÅt! Œ§ÁsÒ!÷ B#pﬁîC”\¿∏ÚYÀw›ªöh4üŸ÷xy_ëqkY–•Û˘Ã„sí◊â◊kAL)Ëu/Áµıo#áœ.Ã”œ¡Ô2Ï|yNÛ<ûñ±“†ªeàqÍª≥§Æ·˚ﬂ~‰æïq˜KﬂÂÚ’∑uﬁm3Œ¡'¸Ø–tuﬁ@€ùäÁ∑q©·+pÏÀaLÏs?f`xo¸˜ÙèUﬂç˝¶G÷ΩDÉ*.&{bˇÆ" Aπ‹Dº„êÂDCA^ÑË
Ê_ﬂ÷]âÛfƒ8¢ÇëD#á+>'rê_åõ…(ú£∑wsÕHçF£—h4çF£—h4çF£—h4çF£—h4çF£—h4çF£—¸O2N£—h4_QŒ‘N∑–≤»§ ïQëuﬁ|ù¸HÂ“>¸
‚ø≈Úó}õ⁄ê2»˚ª¡∏Z˘ÇÜÛîÔÉﬂ†|˛JÂ€t∑±	%ﬂ n”8´|ÉÆ5Á)ﬂ§\s•ÚÚ◊)ﬂ?•|˛üîèÒò.Ì!áBTéˇâ"¥à¢∞”(Nç I—ô3	©|˛≠E~Lñ(≈ì05‡ﬂ°j‰-D˝$5…T6ä“À[áía¯1‘Â≤1Y¶$e{u(Û lÇÓG^úÍøƒX∏’FŸ¢WØ©R‹ªC≥·’ î◊s#rÀdél{ë´CêZäßI9Z.]∫«	ïóOt"ã¢Œ¥xc<˘–í®3)ûXO‘&cÒ∆R'‹–‡T«.J69’—¶hbY¥ÆtVÕ‘Í™πc√âXmCIeº°nZ‰ãeIﬂâ59µN2Q[}†6qøØÔ≥{'÷Ë$Ò¨¶1ñå÷9≥ìµ…(*7÷ï≈NOŒÇ¯“∆d"m*˝ó{`*Ú´h.çÕX¸™D[(3˝sΩÖòπ¯_¨ŒÂ,ı˚QæYŒ{ÈÄÑ_<UàΩ);'TÒ2Ï–<i[Û«Ü^q¬πiºÃ/y*¥ÍÄh°˘4Ÿ-≠5ú›í™®
I;˛fœñ]/mkñ˜ÿŒÖG†Z0)†º`ÿ~
,®Öﬁ.‚y—‹z{ZÿçÜ·<±ë´øGÅFøÔ≤õŒ™Fµ+5h0wøK÷*ªP+Äﬂ X^ GÅü‚¯›\ ‡5„Y3ô¢YÏl√Ÿb;≠¶xöÜAEh}K*(Áfk*0,Tä–L`“~1çÕnDµçd¢¯î÷íÎÂNIeÁÜÇ(øÉ^ãÅ¨Eóœ‚◊êÈ
¿Â◊¶ÜÂsÛè∂Ü»z∑ñOúTpxh&fa9"*i4âG`a¿^{ü®£9ŒäT ZÖ˛nCÒ€ƒ4è√"˚∏HTâT ã-˝/ÈÂ€‰q«Òª{å'‡ƒ	!∏ÑpO0∂É]ÉÒíäü'ÿT´_`HZŸÖ™Ü.R´I≈R‚¢—6	HH$i¥Jì¶jã;ikÛ¯Ò†6IÑª¨Rµ©√⁄4-ù4Õ/ÿ´Q—”ﬁMŸ˜ŒÊœ§º©Ê‰{ﬂ{Ó~üª{Ó~~l[mçyÚV Ç;>Æ∏eHª‚$pá¢ZÆ-+∫‹¸k•ñ≠b}◊,◊é»™rUQI¢¶µì∑Ø*≠8ŸVy'£•gdﬁÿ¶å‚6G±-k§ÿÂ7Â@oZ»ËP n“çæÔ+Ωd¸Ñ≤G˙/îè»	¯OJæ›º∫¨| ©äA1˝P#µÜJŒ∂H’hQÜ–k*s8Ä99˘|…w8Bü“O¬√O°6%ì~µYú⁄,Nj'5ãEÕ"˚à2ÉûƒT.ëúrëÃC®ã¥⁄aaC+≤≤Ø?RQûQ‹ÿ◊2∂í¢uW©•M¨ÃmunóaÓ“∂∂HlUGûècL]ô(ÌtG.,+y+œñ‹=»YH◊Ueg„h vã#YUvc#ƒ∆Ù*{¨‹48ÆE"sBŸÔXMl˚˚≥8nv◊¬ﬂÙ/õ˛áÜoTY≠Ò¶`^7v≥`∞WŸﬂ»jå-≥5<‹9˚++ãU∞ØXÖƒ‡Î∏˛ºˇ¸é’˜/≥r	Üµh9ª≈Õ≤5+x∞Y·ﬁfegO≥“Ÿ1ºÏ7Ï3≤C¸æ˛´íΩªp7º &»[lêÖˇ∫Èøe+"≈ŸßÏ69/Ymb	¶•
[≤Ï¬>±H„*uêØ∞OÿM≤°[æ]hΩQÚÌ„ÌÀè≤ü≥	´ów≠Ï#ö¶ˇBPÅ¨'ùÏgVT2o≠hº¬ÊŸºÓéÍ^=§/*ao8^T4Ø“¢⁄¢f∏ÿ Ô_ˆ (—≤“°y6cŸ¢¶Ò‹ì∏/F¶Qd-ã2'k•ÎqÔ7≤cW…IàaåIh
öÜ.„Ÿ<ªΩΩΩ+[&†<tOìàààú$r r r rí»…ŸÛê ≤ ≤ ≤ ≤í»Ç»Ç»Ç»JB¨7"+âàààî$R R R RíHÅHÅHIB°É–AËí–AË t∫$t:]aaaaIÑAÑAÑAÑ%ñÑB°Å–$°Å–@h 4Ih 4ö$\ \ \ \ípÅpÅpÅpI¬%œ'	¢¢¢¢.â:à:à:à∫$Í Í ÍÏbQ©ü©©©I§§§§&ëêêZÛ÷'‰f0§Õ$4MCÇ≠Ç≠Ç≠Ç≠J∂*”+	÷aÇ0Aòí0Aò L¶$L&SI@@@$QêâõáÒÌìÚ[ªL”|÷≤i∫_˙y }í¨Kó•øC•øMÆHøD¢“/ütå'}Çpµx¥›Ë∆#‡$Ù*tZÄñ†ªê*k˜†øClPﬂkkWO™ÍízW›≤§÷U÷n?i_∞/ŸÔ⁄∑,ŸÎv¶=Ã)ü£x¥ê˜e9ÖÚ!Ñî1Yã±Ã;ÄÁÏ ˛ÿÄﬁÒµˆ0@ÔË› ]
–˜‘haœSõ|“i$ ∞pö÷∑˘Ü¯:ı˘ádöª˝`'∑|œÒ2]iÿ~= °EË
Ö"PÚB\∂ü÷˜6á\Å¸P§â)Hw7~$vv8Ù
s“≈“ÁN“"ÊÒ˜É[∂¸aXŸÚüÑ}j˘œs£Öﬁ&~Ò≠àﬁ¬…›Ñ/Y¸>∫?nÿØ,æªaÒÿ+ñˇ ÏåÂˇíN˙"·6Åé6}˜-¸¥≈_Bÿ)ãÔá-øOD0ëΩ˚iö‹á{õ‘æ∆LãÖÌµ¯Ì ~q‘NBry[ ·J	zX°i’∑ÚØ˘¸bcë_ieÏû∑L_“[˘JËß6∏e¥äx|>õn
ø≈Ω3¸CåEΩ∑˘è˘>*;–|ÎûëSX¸äVf7ıÌ|öá˘DË>Á/s¸4≈ãvãüÂ+bô$C”ÏÊmû¬Äﬂ≈]x-˛º∑,óxÇˇÄÎ‹œèh+b…·∆∏—–äÿiÃ˛,ˆ7‡-ã1Z¶z@˝FùWœ®√ÍQ’£ÓU˜®Ωjó£”·r¥9∂9Zá›as0qtï7Ízê mªÏ.avõ(m≤Ób¢DÅí0Í`‰bnWí,92Lìfı5í<ØôˇÒîiÎ©óÕ-ûajv&Irtÿ<Lñ’ç”f4ò4’‘ôtë“πZMv≠L…h∫L7D”’≥Û8:…’Î=BÈ3WØg2ƒ›˝VÃÎÍ8r"æIëmñ¡'/˜”’^ÛG…ë¥˘ÀﬁåïçﬁL“º<¢ùMWX;s&‚÷&,ìÆÿr¨=qZ¥€rÒ¬ÓÀ0ds¬à_¬√Daxûã0úQ#Œq}¬◊Í$>Áku 8q≈u-/jöåÒ≤.c÷Ω‰©dÿx—ÁìQç¶EM{4π∞˝r Œ‚2Ñ‚{ùàS9ôyIà∑2¯8dPŒ•–'1º”’ˇ(¶´1¡ˇÛ56§•C˘…µƒò'ëı$∆†¨˘ﬁ[ØªÕÈÛöVúÃãÕT|ŸÛØΩ.¸‹òô˜å≈ÕIO\+Z€§{MtÚƒãd-1ö.ÆÈcqÎê~(·9œîb«“∆ˇÃ5ÛxÆÙ±M;&Kãπb∆&›ÜËéâπ1ó!ÊäÈ19W‚ë˜©t—AÜ3«œ6ºƒ∂∂"á≥=}ô·nWnH$tÂhü{≤Áéç–dk0cnÛõNHtÖåê!∫>]mhnovπ'èˆı‹°7ö].4wxÜ…£≠%"(iûJö}#/ßE™ò˙πÕœl\ºd∑õ$ﬁà„◊R¯{:íåo˙öÿÏïœÁ«Eëéí4#IÛπSXâ™b™l<É∂è⁄E∂[ZÂç*:ÉXù”âZê±Éz+~u©¨`/®L¸Tò(ÌÍç\X≈'¯ÑﬂqÏø*ﬂ§oÓEîoVRı_J6ÎõBh`wDoíR4⁄∞Ÿ®D´BhA] cÇÍ›	ÊTË.0gän[î_™J7È/cf(—.ÜêY	l†≥@ˆ-‹$#∂xà°≠©]Ã/Ã¿fÑ:<`ã°¶Éç/ÅEDºj0& ∂ó¬¥ïB5Å%K¡ö Ü@xpÄ<Ä  =€^sendstreamendobj28 0 obj<</Length 31316>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 127.08 681.4523 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 127.08 659.9485 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 649.1965 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 638.4446 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 627.6927 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 616.9408 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 606.1889 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 595.437 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 584.6851 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 36 466.506 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 466.506 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 155.88 466.506 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 466.506 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 235.44 466.506 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 155.88 681.4523 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 155.88 659.9485 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 649.1965 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 638.4446 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 627.6927 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 616.9408 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 606.1889 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 595.437 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 584.6851 cm
0 0 m
0 10.752 l
S
Q
1 w 
q 1 0 0 1 36 715.1481 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 715.1481 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 235.44 715.1481 cm
0 0 m
52.56 0 l
S
Q
0.5 w 
q 1 0 0 1 127.08 703.6761 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 127.08 692.4542 cm
0 0 m
0 11.222 l
S
Q
q 1 0 0 1 235.44 703.6761 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 36 692.2042 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 692.2042 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 235.44 692.2042 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 127.08 573.9332 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 573.9332 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 563.1813 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 563.1813 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 552.4293 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 552.4293 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 541.6774 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 541.6774 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 530.9255 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 530.9255 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 509.4217 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 509.4217 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 498.6698 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 498.6698 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 681.4523 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 235.44 681.4523 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 195.66 659.9485 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 659.9485 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 649.1965 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 649.1965 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 638.4446 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 638.4446 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 627.6927 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 627.6927 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 616.9408 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 616.9408 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 606.1889 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 606.1889 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 595.437 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 595.437 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 584.6851 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 584.6851 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 573.9332 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 573.9332 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 563.1813 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 563.1813 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 552.4293 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 552.4293 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 541.6774 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 541.6774 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 530.9255 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 530.9255 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 509.4217 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 509.4217 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 498.6698 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 498.6698 cm
0 0 m
0 10.752 l
S
Q
1 w 
q 1 0 0 1 155.88 715.1481 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 715.1481 cm
0 0 m
39.78 0 l
S
Q
0.5 w 
q 1 0 0 1 155.88 703.9261 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 235.44 703.9261 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 155.63 703.6761 cm
0 0 m
40.03 0 l
S
Q
q 1 0 0 1 155.88 692.4542 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 195.66 703.6761 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 692.4542 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 235.44 692.4542 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 155.88 692.2042 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 692.2042 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 127.08 670.7004 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 670.7004 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 670.7004 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 670.7004 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 488.4178 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 155.88 488.4178 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 195.66 488.4178 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 235.44 488.4178 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 36 487.9178 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 487.9178 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 155.88 487.9178 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 487.9178 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 235.44 487.9178 cm
0 0 m
52.56 0 l
S
Q
0.5 w 
q 1 0 0 1 127.08 520.1736 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 520.1736 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 520.1736 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 520.1736 cm
0 0 m
0 10.752 l
S
Q
BT
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
-0.017 Tc 8 0 0 8 36 727.248 Tm
[(T)74.2 (able 9:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Efficac)10.2 (y Results by )]TJ
/T1_1 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
0 Tw [( )-59.8 (Gene Fusion P)24.2 (artner in TRK TKI-Na\357ve)-17 ( )]TJ
0.017 Tw 0 -1.062 Td
[(P)24.2 (atients)]TJ
/T1_1 1 Tf
-0.012 Tc 0.012 Tw 7.6 0 0 8 36 706.5562 Tm
(NTRK)Tj
/T1_0 1 Tf
0.048 Tw [( P)24.2 (artner)]TJ
0.012 Tw 12.209 -0.186 Td
(Subjects)Tj
0 Tc 0 Tw 7.6 0 0 8 154.1703 705.0702 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 131.6344 696.5702 Tm
(\(n=40\))Tj
7.603 1.248 Td
(ORR)Tj
-0.211 Tw 8.7 0 Td
(DOR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
1.662 0 Td
( )Tj
EMC 
(\035)Tj
0.048 Tw -13.211 -1.434 Td
(n \(%\))Tj
4.909 0 Td
(95% CI)Tj
4.381 0 Td
(Range \(Months\))Tj
/T1_2 1 Tf
0.012 Tw -26.626 -1.389 Td
(ETV6-NTRK3)Tj
/T1_3 1 Tf
13.405 0 Td
(12)Tj
0.048 Tw 3.911 0 Td
(9 \(75\))Tj
4.905 0 Td
[(\(43,)37.2 ( 95\))]TJ
5.565 0 Td
[(4.7,)37.3 ( 31.4)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -31.047 -1.469 Td
(TPM3-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(7)Tj
-0.012 Tc 0.048 Tw 3.677 0 Td
(5 \(71\))Tj
4.905 0 Td
[(\(29,)37.2 ( 96\))]TJ
5.565 0 Td
[(3.8,)37.3 ( 23.1)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -31.047 -1.469 Td
(EML4-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 2.641 0 Td
[(Missing,)37.2 ( PR)]TJ
0.012 Tw 6.823 0 Td
(NA)Tj
5.498 0 Td
(14.8)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -30.232 -1.469 Td
(IRF2BP2-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.537 0 Td
[(PR,)37.2 ( PR)]TJ
0.012 Tw 5.927 0 Td
(NA)Tj
4.389 0 Td
(3.7)Tj
0 Tc 0 Tw 1.163 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 0.588 -0.125 Td
[(,)37.2 ( 20.3)]TJ
0 Tc 0 Tw 2.098 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -31.341 -1.469 Td
(PEAR1-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 2.623 0 Td
[(Missing,)37.2 ( PD)]TJ
0.012 Tw 6.841 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
-29.195 -1.344 Td
[(Unkno)-9.8 (wn)]TJ
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.49 0 Td
[(PD,)37.2 ( SD)]TJ
0.012 Tw 5.974 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
[(A)55.2 (TP2B2-IT2-NTRK1)]TJ
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.23 0 Td
(SD)Tj
5.234 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(GOLGB1-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.23 0 Td
(SD)Tj
5.234 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(IL1RL2-NTRK2)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.23 0 Td
(SD)Tj
5.234 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(LRPPRC-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.23 0 Td
(SD)Tj
5.234 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(LRRC71-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 3.362 0 Td
(Missing)Tj
6.102 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
-29.195 -1.344 Td
(Multiple)Tj
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(28.6)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -30.232 -1.469 Td
(RBPMS-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(34.3)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -30.232 -1.469 Td
(SLC28A3-NTRK2)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(SQSTM1-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(15.7)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -30.232 -1.469 Td
(STRN3-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(23.9)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -30.232 -1.469 Td
(TMED3-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(TPR-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(43.9)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -30.232 -1.469 Td
(TRIM33-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(CR)Tj
5.225 0 Td
(NA)Tj
5.498 0 Td
(17.8)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
-0.017 Tc 0.048 Tw -30.232 -1.604 Td
[(PD:)37.2 ( progressive disease; PR:)37.2 ( partial response; SD:)37.2 ( stable disease; NA:)37.2 ( not a)-9.8 (pplicable)]TJ
0 -1.062 Td
[(\223+\224)37.2 ( indica)-9.8 (tes ongoing response)]TJ
ET
/GS1 gs
q 1 0 0 1 127.08 395.4483 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 127.08 373.9445 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 363.1925 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 352.4406 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 341.6887 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 330.9368 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 320.1849 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 309.433 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 36 204.2576 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 204.2576 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 155.88 204.2576 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 204.2576 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 235.44 204.2576 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 155.88 395.4483 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 155.88 373.9445 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 363.1925 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 352.4406 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 341.6887 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 330.9368 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 320.1849 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 309.433 cm
0 0 m
0 10.752 l
S
Q
1 w 
q 1 0 0 1 36 429.144 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 429.144 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 235.44 429.144 cm
0 0 m
52.56 0 l
S
Q
0.5 w 
q 1 0 0 1 127.08 417.6721 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 127.08 406.4502 cm
0 0 m
0 11.222 l
S
Q
q 1 0 0 1 235.44 417.6721 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 36 406.2002 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 406.2002 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 235.44 406.2002 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 127.08 298.681 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 298.681 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 287.9291 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 287.9291 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 277.1772 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 277.1772 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 266.4253 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 266.4253 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 255.6734 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 255.6734 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 244.9215 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 244.9215 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 395.4483 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 235.44 395.4483 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 195.66 373.9445 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 373.9445 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 363.1925 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 363.1925 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 352.4406 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 352.4406 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 341.6887 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 341.6887 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 330.9368 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 330.9368 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 320.1849 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 320.1849 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 309.433 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 309.433 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 298.681 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 298.681 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 287.9291 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 287.9291 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 277.1772 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 277.1772 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 266.4253 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 266.4253 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 255.6734 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 255.6734 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 244.9215 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 244.9215 cm
0 0 m
0 10.752 l
S
Q
1 w 
q 1 0 0 1 155.88 429.144 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 429.144 cm
0 0 m
39.78 0 l
S
Q
0.5 w 
q 1 0 0 1 155.88 417.9221 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 235.44 417.9221 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 155.63 417.6721 cm
0 0 m
40.03 0 l
S
Q
q 1 0 0 1 155.88 406.4502 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 195.66 417.6721 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 406.4502 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 235.44 406.4502 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 155.88 406.2002 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 406.2002 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 127.08 384.6964 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 155.88 384.6964 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 195.66 384.6964 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 235.44 384.6964 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 127.08 234.6696 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 155.88 234.6696 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 195.66 234.6696 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 235.44 234.6696 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 36 234.1696 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 127.08 234.1696 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 155.88 234.1696 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 195.66 234.1696 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 235.44 234.1696 cm
0 0 m
52.56 0 l
S
Q
BT
/GS2 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 36 441.244 Tm
[(T)74.2 (able 10:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Efficac)10.2 (y Results by )]TJ
/T1_1 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
0 Tw [( )-59.8 (Gene Fusion P)24.2 (artner in TRK TKI-Pretreated)-17 ( )]TJ
0.017 Tw 0 -1.062 Td
(Subjects)Tj
/T1_1 1 Tf
-0.012 Tc 0.012 Tw 7.6 0 0 8 36 420.5521 Tm
(NTRK)Tj
/T1_0 1 Tf
0.048 Tw [( P)24.2 (artner)]TJ
0.012 Tw 12.209 -0.186 Td
(Subjects)Tj
0 Tc 0 Tw 7.6 0 0 8 154.1703 419.0661 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 131.6343 410.5661 Tm
(\(n=48\))Tj
7.603 1.248 Td
(ORR)Tj
-0.211 Tw 8.7 0 Td
(DOR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
1.662 0 Td
( )Tj
EMC 
(\035)Tj
0.048 Tw -13.211 -1.434 Td
(n \(%\))Tj
4.909 0 Td
(95% CI)Tj
4.381 0 Td
(Range \(Months\))Tj
/T1_2 1 Tf
0.012 Tw -26.626 -1.389 Td
(ETV6-NTRK3)Tj
/T1_3 1 Tf
13.405 0 Td
(24)Tj
0.048 Tw 3.677 0 Td
(16 \(67\))Tj
5.139 0 Td
[(\(45,)37.2 ( 84\))]TJ
5.565 0 Td
[(1.8,)37.3 ( 26.5)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
/T1_2 1 Tf
-0.012 Tc 0.012 Tw -31.047 -1.469 Td
(EML4-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(5)Tj
-0.012 Tc 0.048 Tw 3.677 0 Td
(4 \(80\))Tj
4.905 0 Td
[(\(28,)37.2 ( 99\))]TJ
5.859 0 Td
[(1.9,)37.3 ( 12.9)]TJ
/T1_2 1 Tf
0.012 Tw -28.08 -1.344 Td
(LMNA-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(4)Tj
-0.012 Tc 0.048 Tw 3.677 0 Td
(1 \(25\))Tj
4.791 0 Td
[(\(0.6,)37.2 ( 81\))]TJ
0.012 Tw 7.021 0 Td
(5.6)Tj
/T1_2 1 Tf
-29.129 -1.344 Td
(TPM3-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(3)Tj
-0.012 Tc 0.048 Tw 3.911 0 Td
(0 \(0\))Tj
4.905 0 Td
[(\(0,)37.2 ( 71\))]TJ
0.012 Tw 6.739 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
[(A)55.2 (TP1B1-NTRK1)]TJ
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(BCR-NTRK2)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.23 0 Td
(SD)Tj
5.234 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(ETV6-NTRK2)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.248 0 Td
(NE)Tj
5.216 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(GP2-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(IRF2BP2-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 3.362 0 Td
(Missing)Tj
6.102 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(KANK2-NTRK2)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.792 0 Td
(23.5)Tj
-28.895 -1.344 Td
(Multiple)Tj
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(PRDX1-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 3.362 0 Td
(Missing)Tj
6.102 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(RBPMS-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(SEL1L-NTRK1)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
/T1_2 1 Tf
-29.195 -1.344 Td
(SQSTM1-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
6.026 0 Td
(5.5)Tj
/T1_2 1 Tf
-29.129 -1.344 Td
(STRN3-NTRK3)Tj
/T1_3 1 Tf
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.792 0 Td
(11.1)Tj
-0.017 Tc -0.115 Tw -28.895 -1.479 Td
(PR)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(partial )-162.8 (response; )-162.8 (PD)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(progressive )-162.7 (disease; )-162.7 (SD)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(stable )-162.8 (disease; )-162.8 (NA)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(not )-162.8 (a)-9.8 (pplicable;)]TJ
0 -1.062 Td
(NE)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
(=)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
[(not )-162.8 (evaluable)]TJ
0.048 Tw 0 -1.062 Td
[(\223+\224)37.2 ( indica)-9.8 (tes ongoing response)]TJ
/T1_0 1 Tf
0.017 Tw 8 0 0 8 36 181.0076 Tm
(16)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(HOW SUPPLIED/STORAGE AND HANDLING)Tj
/T1_3 1 Tf
-0.02 Tc 0.036 Tw -3.375 -1.471 Td
[(AUGTYRO \(repotrectinib\) 40 mg,)37.1 ( Size 0,)37 ( white opaque ca)-9.9 (p,)37 ( white opaque bod)-10 (y)55.1 (,)37 ( hard shell)-20 ( )]TJ
-0.017 Tc 0.04 Tw 0 -1.044 Td
[(ca)-9.8 (psules,)37.2 ( \037lled with a white to off-white po)-9.7 (wder which may a)-9.7 (ppear as a plug,)37.2 ( imprinted)-17.1 ( )]TJ
0.048 Tw 0 -1.044 Td
[(with )37.2 (\223REP 40\224)37.2 ( in blue text on the ca)-9.7 (p are supplied as follo)-9.8 (ws:)]TJ
0.017 Tw 1.192 -1.535 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Bottles of 60 ca)-9.8 (psules \(NDC 0003-4040-60\))]TJ
0.017 Tw -1.508 -1.422 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Bottles of 120 ca)-9.8 (psules \(NDC 0003-4040-12\))]TJ
0.047 Tw -2.7 -1.516 Td
[(AUGTYRO \(repotrectinib\) 160 mg,)37.2 ( Size 0,)37.2 ( blue opaque ca)-9.8 (p,)37.2 ( blue opaque bod)-9.8 (y)55.2 (,)37.2 ( hard shell)-17 ( )]TJ
0.04 Tw 0 -1.044 Td
[(ca)-9.8 (psules,)37.2 ( \037lled with a white to off-white po)-9.7 (wder which may a)-9.7 (ppear as a plug,)37.2 ( imprinted)-17.1 ( )]TJ
0.048 Tw 0 -1.044 Td
[(with )37.2 (\223REP 160\224)37.2 ( in white text on the ca)-9.8 (p are supplied as follo)-9.8 (ws:)]TJ
0.017 Tw 1.192 -1.535 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Bottles of 14 ca)-9.8 (psules \(NDC 0003-4160-14\))]TJ
0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Bottles of 60 ca)-9.8 (psules \(NDC 0003-4160-60\))]TJ
-0.005 Tc 0.112 Tw -2.7 -1.516 Td
[(Store a)-10.4 (t 20\260C to 25\260C \(68\260F to 77\260F\); excursions permitted betwee\n 15\260C to 30\260C)-5 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.044 Td
(\(59\260F to 86\260F\) )Tj
/T1_2 1 Tf
[([See USP Controlled Room )37.2 (T)74.2 (em)]TJ
0.017 Tw [(pera)-9.8 (ture])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
ET
0.5 w 
q 1 0 0 1 324 701.298 cm
0 0 m
108.198 0 l
S
Q
q 1 0 0 1 324 652.498 cm
0 0 m
120.362 0 l
S
Q
q 1 0 0 1 324 612.1981 cm
0 0 m
39.882 0 l
S
Q
q 1 0 0 1 324 571.8981 cm
0 0 m
134.742 0 l
S
Q
q 1 0 0 1 324 540.098 cm
0 0 m
41.14 0 l
S
Q
q 1 0 0 1 324 508.298 cm
0 0 m
51.179 0 l
S
Q
q 1 0 0 1 324 467.998 cm
0 0 m
60.639 0 l
S
Q
q 1 0 0 1 324 353.938 cm
0 0 m
26.074 0 l
S
Q
q 1 0 0 1 324 322.1381 cm
0 0 m
48.829 0 l
S
Q
q 1 0 0 1 324 242.078 cm
0 0 m
40.946 0 l
S
Q
BT
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 324 727.248 Tm
(17)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(P)54.2 (A)55.2 (TIENT COUNSELING INFORMA)55.2 (TION)]TJ
/T1_3 1 Tf
-3.375 -1.471 Td
[(Advise pa)-9.8 (tients to read the FDA-a)-9.8 (pproved pa)-9.8 (tient labeling \(P)18.2 (a)-9.8 (tient Informa)-9.8 (tion\).)]TJ
0 -1.647 Td
[(Central Ner)-17.8 (vous System \(CNS\) Effects)]TJ
0.017 Tw 1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.106 Tw 1.508 0 Td
[(A)0.5 (dv)0.5 (is)0.5 (e p)0.5 (a)-9.5 (ti)0.5 (en)0.5 (ts)0.5 ( t)0.5 (o in)0.5 (fo)0.5 (r)0.5 (m t)0.5 (he)0.5 (i)0.5 (r he)0.5 (al)0.5 (th)0.5 (ca)0.5 (r)0.5 (e p)0.5 (r)0.5 (ov)0.5 (id)0.5 (er)0.5 ( i)0.5 (f t)0.5 (h)0.5 (ey)0.5 ( e)0.5 (xp)0.5 (er)0.5 (i)0.5 (en)0.5 (ce)0.5 ( n)0.5 (ew)0.5 ( o)0.5 (r)-5.1 ( )]TJ
-0.009 Tc 0.087 Tw 0 -1.062 Td
[(worsening CNS symptoms.)37.2 ( Instruct pa)-9.7 (tients not to drive or opera)-9.7 (te hazardous)-9.1 ( )]TJ
-0.008 Tc 0.095 Tw 0 -1.062 Td
[(machiner)-18.2 (y if they are experiencing CNS adverse reactions )]TJ
/T1_2 1 Tf
0.058 Tw [([see W)17.9 (arnings )-37.1 (and)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(Precautions \(5.1\)])Tj
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -2.7 -1.535 Td
(Interstitial Lung Disease \(ILD\)/Pneumonitis)Tj
0.017 Tw 1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.005 Tc 0.106 Tw 1.508 0 Td
[(A)0.5 (dv)0.5 (is)0.5 (e pa)-9.5 (ti)0.5 (en)0.5 (ts)0.5 ( t)0.5 (o)0.5 ( in)0.5 (fo)0.5 (r)0.5 (m t)0.5 (he)0.5 (i)0.5 (r he)0.5 (al)0.5 (th)0.5 (ca)0.5 (r)0.5 (e pr)0.5 (ov)0.5 (id)0.5 (er)0.5 ( i)0.5 (f t)0.5 (h)0.5 (ey)0.5 ( e)0.5 (xp)0.5 (er)0.5 (i)0.5 (en)0.5 (ce)0.5 ( n)0.5 (ew)0.5 ( o)0.5 (r)-5.1 ( )]TJ
-0.006 Tc 0.105 Tw 0 -1.062 Td
[(worsening pulmonar)-18.2 (y symptoms indica)-10.2 (tive of ILD/pneumonitis )]TJ
/T1_2 1 Tf
0.068 Tw [([see W)17.7 (arnings)-6 ( )]TJ
-0.017 Tc 0.048 Tw -0 -1.062 Td
(and Precautions \(5.2\)])Tj
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -2.7 -1.535 Td
[(Hepa)-9.7 (totoxicity)]TJ
1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.012 Tc 0.073 Tw 1.508 0 Td
[(Advise pa)-9.7 (tients of the need for labora)-9.7 (tor)-17.8 (y tests to monitor liver function and to)-12 ( )]TJ
-0.011 Tc 0.079 Tw 0 -1.062 Td
[(immedia)-10 (tely report symptoms of hepa)-10.1 (totoxicity )]TJ
/T1_2 1 Tf
[([see )36.8 (W)17.9 (arnings and Precautions)-11 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.062 Td
(\(5.3\)])Tj
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -2.7 -1.535 Td
[(My)-9.8 (algia with Crea)-9.8 (tine Phosphokinase Eleva)-9.8 (tion)]TJ
0.017 Tw 1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.019 Tc 0.036 Tw 1.508 0 Td
[(Advise pa)-9.7 (tients to inform their healthcare provider if they experience musc)20.3 (le pain)-19 ( )]TJ
/T1_2 1 Tf
-0.017 Tc 0.048 Tw 0 -1.062 Td
[([see )37.3 (W)18.1 (arnings and Precautions \(5.4\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -2.7 -1.535 Td
(Hyperuricemia)Tj
1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.008 Tc 0.092 Tw 1.508 0 Td
[(Advise pa)-9.7 (tients to inform their healthcare provider if they experience signs or)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(symptoms associa)-9.8 (ted with hyperuricemia )]TJ
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.5\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -2.7 -1.535 Td
[(Skeletal F)20.2 (ractures)]TJ
0.017 Tw 1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.01 Tc 0.083 Tw 1.508 0 Td
[(Inform pa)-9.9 (tients tha)-9.8 (t bone fractures ha)-9.8 (ve occurred in pa)-9.8 (tients taking )36.7 (AUGTYRO)-10 ( )]TJ
0.007 Tc 0.167 Tw 0 -1.062 Td
[(and advise pa)-9.6 (tients to report symptoms to their healthcare provider )]TJ
/T1_2 1 Tf
-0.007 Tw [([see)7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(W)18.2 (arnings and Precautions \(5.6\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.011 Tw -2.7 -1.535 Td
[(Embr)-17.7 (yo-F)24.2 (etal T)74.2 (oxicity)]TJ
0.017 Tw 1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.01 Tc 0.085 Tw 1.508 0 Td
[(Advise pregnant women and females of reproductive potential of the poten\tial)-10 ( )]TJ
-0.008 Tc 0.092 Tw 0 -1.062 Td
[(risk to a fetus.)37.3 ( )37.1 (Advise females to inform their healthcare provider of a kno)-9.7 (wn)-8 ( )]TJ
-0.007 Tc 0.101 Tw 0 -1.062 Td
[(or suspected pregnanc)19.6 (y )]TJ
/T1_2 1 Tf
[([see )36.7 (W)17.6 (arnings and Precautions \(5.7\),)36.6 ( Use in Speci\037c)-7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(P)18.2 (opula)-9.7 (tions \(8.1,)37.2 ( 8.3\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.015 Tc 0.207 Tw 1.508 0 Td
[(Advise females of reproductive potential to use effective non-hormonal)15 ( )]TJ
-0.009 Tc 0.088 Tw 0 -1.062 Td
[(contraception during trea)-9.8 (tment with )37 (AUGTYRO and for 2 months after the last)-9 ( )]TJ
-0.017 Tc 0.058 Tw 0 -1.062 Td
[(dose,)37.2 ( )0.5 (since )37.4 (AUGTYRO )0.5 (can )0.5 (render )0.5 (some )0.5 (hormonal contraceptives )0.5 (ineffective )]TJ
/T1_2 1 Tf
0.017 Tw 27.298 0 Td
[([see)-17 ( )]TJ
0.048 Tw -27.298 -1.062 Td
(Drug Interactions \(7.2\)])Tj
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.002 Tc 0.142 Tw 1.508 0 Td
[(Adv)0.5 (ise )0.5 (m)0.5 (ale )0.6 (pa)-9.6 (ti)0.5 (ents)0.5 ( )0.5 (with)0.5 ( )0.5 (fem)0.5 (ale )0.6 (part)0.5 (ners)0.5 ( )0.5 (of )0.5 (r)0.5 (epro)0.5 (duct)0.5 (ive )0.5 (p)0.5 (ote)0.5 (ntial)0.5 ( )0.5 (to )0.5 (u)0.5 (se)2 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.062 Td
[(effective contraception during trea)-10.2 (tment with )36.7 (AUGTYRO and for 4\035)-75.2 (months after)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(the last dose )Tj
/T1_2 1 Tf
[([see Use in Speci\037c P)18.2 (opula)-9.8 (tions \(8.1,)37.2 ( 8.3\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -2.7 -1.535 Td
[(Lacta)-9.8 (tion)]TJ
1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.004 Tc 0.156 Tw 1.508 0 Td
[(Advise females )0.5 (not )0.5 (to )0.5 (breastfeed )0.5 (during )0.5 (trea)-10.2 (tment with )37.5 (AUGTYRO )0.5 (and )0.5 (for)4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(10\035)-47.8 (days after the last dose )]TJ
/T1_2 1 Tf
[([see Use in Speci\037c P)18.2 (opula)-9.8 (tions \(8.2\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -2.7 -1.535 Td
(Drug Interactions)Tj
0.017 Tw 1.192 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.016 Tc 0.216 Tw 1.508 0 Td
[(Advise pa)-10.3 (tients to inform their healthcare providers of all concomitant)16 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.062 Td
[(medica)-9.8 (tions,)37.2 ( inc)20.1 (luding prescription medicines,)37.2 ( over)37.2 (-the-counter drugs,)37.2 ( vitamins,)22 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(and herbal products )Tj
/T1_2 1 Tf
([see Drug Interactions \(7\)])Tj
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.044 Tw 1.508 0 Td
[(Advise pa)-9.8 (tients to a)-9.8 (void gra)-9.7 (pefruit or gra)-9.8 (pefruit juice while taking )36.7 (AUGTYRO )]TJ
/T1_2 1 Tf
0.017 Tw [([see)-17 ( )]TJ
0.048 Tw 0 -1.062 Td
(Drug Interactions \(7\)])Tj
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.004 Tc 0.111 Tw 1.508 0 Td
[(A)0.5 (dv)0.5 (is)0.5 (e)0.5 ( p)0.5 (a)-9.6 (t)0.5 (ie)0.5 (n)0.5 (ts)0.5 ( t)0.5 (ha)-9.5 (t)0.5 ( h)0.5 (or)0.5 (m)0.5 (on)0.5 (a)0.5 (l co)0.5 (nt)0.5 (r)0.5 (ac)0.5 (e)0.5 (pt)0.5 (i)0.5 (ve)0.5 (s ca)0.5 (n)0.5 ( be)0.5 ( i)0.5 (ne)0.5 (f)0.5 (fe)0.5 (c)0.5 (ti)0.5 (v)0.5 (e w)0.5 (h)0.5 (il)0.5 (e)0.5 ( t)0.5 (ak)0.5 (in)0.5 (g)-4 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.062 Td
(AUGTYRO )Tj
/T1_2 1 Tf
0.048 Tw 3.706 0 Td
([see Drug Interactions \(7\)])Tj
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -6.406 -1.535 Td
[(Administra)-9.8 (tion)]TJ
1.193 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.013 Tc 0.072 Tw 1.508 0 Td
[(Advise pa)-10.4 (tients to s)-10.5 (wallo)-10.4 (w )37.3 (AUGTYRO ca)-10.4 (psules whole with or without food )]TJ
/T1_2 1 Tf
0.013 Tw [([see)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(Dosa)-9.7 (ge and )37.2 (Administra)-9.8 (tion \(2.6\),)37.2 ( Pharmacokinetics \(12.3\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.015 Tc 0.06 Tw 1.508 0 Td
[(Instruct pa)-9.7 (tients if they miss a dose,)37.3 ( or vomit a)-9.7 (t an)-9.8 (y time after taking a dose of)-15 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.062 Td
[(AUGTYRO,)36.8 ( not to )37.2 (\223make it up,)36.9 (\224)36.9 ( but take the next dose of )37.2 (AUGTYRO a)-10.1 (t the next)-11.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
(scheduled time )Tj
/T1_2 1 Tf
[([see Dosa)-9.7 (ge and )37.2 (Administra)-9.8 (tion \(2.6\)])]TJ
/T1_3 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -2.7 -1.899 Td
[(F)20.2 (or more informa)-9.8 (tion,)37.3 ( go to www)37.2 (.AUGTYRO.com or call 1-877-284-8976.)]TJ
-0.012 Tc 0 -4.162 Td
(Distributed by:)Tj
0 -1.26 Td
[(Bristol-Myers Squibb Compan)-9.8 (y)]TJ
0 Tc 0 Tw 11.215 0 Td
( )Tj
-0.012 Tc 0.048 Tw -11.215 -1.125 Td
[(Princeton,)37.2 ( NJ 08543 USA)]TJ
0 -1.687 Td
[(U.S.)37.2 ( License No.)37.2 ( 1)80.2 (7)20.3 (1)40.2 (3)]TJ
0 -1.687 Td
[(AUGTYRO\231 is a trademark of )37.2 (T)74.2 (urning P)18.2 (oint )37.2 (Thera)-9.8 (peutics,)37.2 ( Inc.,)25.1 ( )]TJ
0 Tc 0 Tw 22.988 0 Td
( )Tj
-0.012 Tc 0.048 Tw -22.988 -1.125 Td
[(a Bristol Myers Squibb compan)-9.8 (y)55.2 (.)]TJ
ET
endstreamendobj25 0 obj<</BBox[0.0 792.0 612.0 0.0]/Length 542/Matrix[1.0 0.0 0.0 1.0 0.0 0.0]/Resources<</ExtGState<</GS0 20 0 R>>/Font<</T1_0 67 0 R>>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.75 w 
/GS0 gs
q 1 0 0 1 36 748.9131 cm
0 0 m
252 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.008 Tc 0.008 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 36 750.2881 Tm
(AUGTYRO)Tj
0 Tc 0 Tw 5.6 0 0 5.6 74.7566 752.2021 Tm
(\231)Tj
-0.008 Tc 0.055 Tw 8 0 0 8 80.3099 750.2881 Tm
[( \(r)18.3 (epotr)18.4 (ectinib\))]TJ
ET
q 1 0 0 1 324 748.8025 cm
0 0 m
252 0 l
S
Q
BT
0.008 Tw 8 0 0 8 476.407 750.1775 Tm
(AUGTYRO)Tj
0 Tc 0 Tw 5.6 0 0 5.6 515.1636 752.0915 Tm
(\231)Tj
-0.008 Tc 0.055 Tw 8 0 0 8 520.7169 750.1775 Tm
[( \(r)18.3 (epotr)18.4 (ectinib\))]TJ
ET
endstreamendobj67 0 obj<</BaseFont/RCVXRU+HelveticaNeueLTStd-Bd/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 68 0 R/LastChar 153/Subtype/Type1/ToUnicode 69 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 296 296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 685 0 0 0 0 0 759 0 0 0 0 0 0 0 778 0 0 722 0 611 741 0 0 0 667 0 0 0 0 0 0 0 0 611 574 0 574 0 0 0 258 0 0 0 0 593 611 611 0 389 0 352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1000]>>endobj68 0 obj<</Ascent 975/CapHeight 714/CharSet(/space/parenleft/parenright/A/G/O/R/T/U/Y/b/c/e/i/n/o/p/r/t/trademark)/Descent -218/Flags 32/FontBBox[-166 -218 1078 975]/FontFamily(HelveticaNeueLT Std)/FontFile3 70 0 R/FontName/RCVXRU+HelveticaNeueLTStd-Bd/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 144/Type/FontDescriptor/XHeight 517>>endobj69 0 obj<</Filter/FlateDecode/Length 325>>stream
Hâ\íœnÉ0∆Ôyä€C§Ö¥Bö∫V‚∞?€–ƒtH#DÅx˚Ÿq’Iã˛E˘¸Ÿ8$«˙πv˝,ì˜0öfŸıŒò∆[0 /pÌù»î¥ΩôÔª¯6CÎEÇ…Õ2Õ0‘ÆEY ‰ß9,rıd«¨EÚ,Ñﬁ]ÂÍÎÿ¨e“‹ºˇÅ‹,SYU“BáF/≠mêIL€‘œ˚yŸ`Œü‚sÒ U‹g‹å-Læ5ZwQ¶∏*YûqUú˝wÆRNªtÊª¢T$NS»{Ê=ÒÅ˘ÄºÀ"c@÷Ãö¯ÃåÖ \E∆ÄºcﬁÁÃ91{Ê‰Y∞æ }±eﬁ≥æ }¡˙"ÍOÃ'bÆ[P]Õ˝kÍ_≥ß&OÕ=hÍ·@>*S*‰˛Â4ºA˘òªπÖÄ#è◊gMSÓ<˛?zâYÙà_ ®…õ‹endstreamendobj70 0 obj<</Filter/FlateDecode/Length 1632/Subtype/Type1C>>stream
HâlîP◊«wÛ„∆ o;6fnñ[-6$¢»hÍ*»Ùó8Å,ÑDìHûéºNô>UtÜZÖ>}⁄±ZÍØ h[f™£Ùçæ÷é3¥éøh€äµB«⁄ZŒ∆ì?z7}ÛfﬁÓÃ=˜‹ΩÁsœ˜‹Ωóe4*ÜeŸÈÂÖU/ñØ»\$56K≠wô¥^*©¨à¯û}ŒßL∞»fVN—»i…<Œ¡¿√kµ2ˇÑ\0ÂÀ4ùk*£R0V6´0∏vC»ø∫>":<yy≥iÎ±'⁄ÏŸ¢”nwä|¡I¨ÿéHMaqq†6Zy#íœ&.hl¡a1$Ö•P≥2¯8%—Ωb$‰ıIMﬁ–1X'ñ¯¡»ÜµíXH)6¥⁄Oπ!…'˙b§^Wÿ*lb•"¢7‡+Gó÷’˘k•ƒ`ìwÉHs˙ﬂËZ)ÒR§òêÿ∞>‰˚¸µ0~xõ§ˇìE0$˙©ÇFäÑ%Èøüüo™YdÀ*Æ®Tú—'’1Ùa=ìƒXôôåù…fr3á)d2≈Ã¶î)cñ3Ã
¶õ·iÖôe‘mg˙ôªä˝D5MÂVÖUÔ©@]†ﬁ¶>°˛M„÷Ï‘\◊¶h´qÒñ”Úÿiñ∂ß’[4r[¨,ﬁF`û„± ﬁ÷¬Ç"ûÂAq‚ù∫8©NÙ° ©O‰3º“C≈„‚Osò€¸pFî=V5îƒÇ|6Va)ŒJE˚itﬁ¿4í»»Éú©êuó!]xw_â”‡˛Gò˙)î¬¨T∞øNL0â\∆G—âŒTÃ™G«n˚æf»Ωº$ æ+UøaÑlÚ/»÷¬^“è‘∏	ÓçUk1ó\«Ö|¡wµ¯·Æo”≥ÕË¡¶©Ω‡ê∞N6…øÔ…F<ãzp√©ô≠eï3Ãò^…0¶ú•&˝Ú˘ö¸=xÜÄk#
#¯î◊°=Xè5@-¨∏tõœ-‹]E˛+òXÖoá∫∆˘GsËk‘@=RK	∆âÖ ˝,&„ú\EM˙Dwíä>X	; 8B…F⁄92ÿ”0ßÂÌÚˆ‚VO¢~ƒ÷·∂æÕó÷_)ÿ;©C7x¯ËÖ·T`Ê‹¬!Œp «√|ÚuoSq°‘Td¡˘Ñ+⁄◊,“¥!J…•hÍ6Ä)~M–@∏+∫F£ÏE∫ÊgtJÃ´Ê—/#È´_F¢◊Ærô2¢√*–ÿ†*Ä¸+Æe_s¨: BßÇÓT≤>H`è\¢≈BBØåc8éi±à¿?‚ã¥\QÀ∏Ìè√“Ë‘~∞¬ÎˇŸ§~#òÈÊ\Ï–ï∫πj˛‘CPÀQ=î±ti∏™ﬁ“]h%ÚÒW˘‹∫|∑ªn˚éœœ8±eú2ÈÆX’Ú«#¶V‘|ÖúÛ3q2Êb÷TÅ“Ó^ÅÈ{,8ùî¥Jﬁ≈fg‡÷Â´˛t˚¸Ò∆Â;,	Ã¥Pç≥=
È$Dx»~«3q°"&aÊ¸äpÉ˛Ê‡NXp
Y”∫≤æ‹úøÍ‰»õñÕâé_èòIÖ].>ó÷Ω;zÙÏ9
<g´‹MUP›/Òh•§ïpŸté˚óY†I‘c%≠G≠ÜˆìG>πvÒ}ØK¿>Í£ÉÈ&fñæ\æZh#Ükó–¨S
:!∂”5za'èyê∏ y‡±ÉntYëAè V„Pœ–ËXO^û'ê˜Lf`ËÜ¿—„
˘t«6ûHc3M„ª~zniˇ≠Ú‚—Ûkø4CÊU‡AÄßüÉiËZZ™Ù[⁄âaÏ"Õ∫„˘|÷öoá-ÜÔÜ?∫s˚àÀ#∆‹MsmÙ2Ë£üÑ$L”Êƒæ∫[à°ÁˆGW~ﬂΩØΩ≠K0tÅIgËŸ÷˙Z«ÎÊ‚¢Í%Î¸£äLºÒwz@Ó≤?)7 ﬂb9J˝≤rgèÁH∆’Ë⁄∫}ø j]€¶ñ∑6ô_ym◊gÿÒ˚›'u\äqﬂ≤¸}(ÖﬁQı√ÂÁ6ì‹ü˚µò∑èB_˘˚¥‰Ë”v`ﬂ(âîÌ<ﬁözºynÇûpw«™wcC7Ã€B`˜é˚;‚◊∫uÉª&¡ÅŒ{ùÒüwÈ«ì¿:y¸ù‰d∞æõ¸ó≠…úJâÕ„ˇ` ØÀ~Ûendstreamendobj22 0 obj<</BaseFont/QULRDW+HelveticaNeueLTStd-BdCn/Encoding 71 0 R/FirstChar 29/FontDescriptor 72 0 R/LastChar 239/Subtype/Type1/ToUnicode 73 0 R/Type/Font/Widths[240 487 537 240 0 0 0 0 778 0 0 296 296 390 0 240 370 240 332 480 480 480 480 480 480 480 480 480 480 240 0 0 600 0 0 0 556 556 537 574 481 463 556 556 258 463 537 463 740 574 556 519 0 556 519 480 538 519 760 537 520 0 0 0 0 0 0 0 481 500 463 500 463 296 500 500 240 240 500 240 758 500 480 500 500 333 444 296 500 444 704 462 444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 990 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 240]>>endobj24 0 obj<</BaseFont/QULRDW+HelveticaNeueLTStd-BdCnO/Encoding/WinAnsiEncoding/FirstChar 49/FontDescriptor 74 0 R/LastChar 84/Subtype/Type1/ToUnicode 75 0 R/Type/Font/Widths[480 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 537 0 0 574 556 0 0 556 519 480]>>endobj23 0 obj<</BaseFont/QULRDW+HelveticaNeueLTStd-CnO/Encoding 76 0 R/FirstChar 31/FontDescriptor 77 0 R/LastChar 122/Subtype/Type1/ToUnicode 78 0 R/Type/Font/Widths[463 240 0 0 0 0 0 0 0 241 241 0 0 240 352 240 278 0 480 480 480 480 480 480 480 480 0 240 0 0 0 0 0 0 500 519 519 556 463 444 537 537 204 0 500 444 704 556 556 481 556 519 500 463 519 462 722 481 462 0 259 0 259 0 0 0 444 463 426 463 444 259 463 463 204 0 444 204 722 463 444 463 0 296 407 259 463 406 648 406 406 389]>>endobj21 0 obj<</BaseFont/QULRDW+HelveticaNeueLTStd-Cn/Encoding 79 0 R/FirstChar 27/FontDescriptor 80 0 R/LastChar 239/Subtype/Type1/ToUnicode 81 0 R/Type/Font/Widths[463 497 240 497 463 240 0 0 480 0 759 556 0 241 241 352 600 240 352 240 278 480 480 480 480 480 480 480 480 480 480 240 240 600 600 600 0 0 500 519 519 556 463 444 537 537 204 426 500 444 704 556 556 481 556 519 500 463 519 462 722 0 462 0 259 0 259 0 0 0 444 463 426 463 444 259 463 463 204 204 444 204 722 463 444 463 463 296 407 259 463 406 648 406 406 389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 407 407 500 500 0 0 990 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 289 0 0 0 0 0 400 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 204]>>endobj79 0 obj<</BaseEncoding/WinAnsiEncoding/Differences[27/f_l/lessequal/uni00A0/greaterequal/f_i]/Type/Encoding>>endobj80 0 obj<</Ascent 932/CapHeight 714/CharSet(/f_l/lessequal/uni00A0/greaterequal/f_i/space/numbersign/percent/ampersand/parenleft/parenright/asterisk/plus/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon/less/equal/greater/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/\R/S/T/U/V/W/Y/bracketleft/bracketright/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z/quotedblleft/quotedblright/bullet/endash/trademark/ordfeminine/degree/idieresis)/Descent -212/Flags 32/FontBBox[-164 -212 1000 932]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 82 0 R/FontName/QULRDW+HelveticaNeueLTStd-Cn/FontStretch/Condensed/FontWeight 400/ItalicAngle 0/StemV 84/Type/FontDescriptor/XHeight 536>>endobj81 0 obj<</Filter/FlateDecode/Length 639>>stream
Hâ\‘Õn‚0‡}û¬ÀvQ%±ØØ	!•ã˘—–y öòN§!D!,x˚ÒÒA≠4Hêc˚~πJ\nv/ª°üM˘s:∑˚8õc?tSºúØSÕ{¸Ëá¢∂¶Î€˘> øÌÈ0eöºø]Êx⁄«s±XòÚW:yôßõyXuÁ˜¯Xî?¶.N˝a~oˆè¶‹_«Òo<≈a6ïY.Mèi°oáÒ˚·Môß=Ì∫tæüoOiŒ◊o∑1õ«51ÌπãóÒ–∆È0|ƒbQ•œ“,^”gYƒ°˚Ô|c9Ì˝ÿ˛9L≈¢^ßã´J5}7À4ﬁ§±µ*»/˘‹™BﬁÚè¸˙5ßIc[Â±≈u÷1;dœå9Vô˘ô˘πaŒÎ¨òW»t•C f¯,MÈêÚñyãLS:GèÉ«’Ã5≤e∂»t:8ù0„ûÕfG≥ÉŸÊÄLøÉﬂ—Ô‡wÙ;¯˝~GøÉﬂ—Ô‡wÙ;¯ÖNÅSË8ÖNÅSË8ÖNÅSË8ÖNÅSË8ÖNÅSË8ÖNÅSË8ÖNÅSËîÏdü}ˆÏ≥Gü=˝~Oøáﬂ”Ô·˜Ù{¯=˝~Oøáﬂ”Ô·˜4{ò=ùNOõáMYWQWYWQWYWQWY7?” ∫˘9VΩ?«»¨´®´Ïõ¢oJC~Œï}SÙMÔÔ< æÂ˜Gi”lcﬂ}”˚;Éæˆ-†oÅ˛ †?¿Ë˙¸Å˛ †?¿Ë˙¸Å˛ †?¿ﬂ`}[’07¬s„s∂04 ˇah∞é≠Ûˇ+Æ≥¬:kﬁÀ˜≤Â=nπÒ‹wlAiß4ü˚[{ù¶¥µÂÌ4ÔiÿÕ˙!~Ó∏„y4iæ≈? 3ŸG¥endstreamendobj82 0 obj<</Filter/FlateDecode/Length 5357/Subtype/Type1C>>stream
HâlT}PSWøè‰ΩêÁc%+…ST§
PA%.EI¥¯Q≈ò< 	&äH´n≠8étt≠≠„∫]µT∂""R@*Pã,´ı©ïƒ™åƒÔ°„¯µÁ·ç3˚ªµ;Î˜‹sÓ9øsœ=ó@R7DDP∆Ú4mJÊ¥T.øò≥õ˙tÆàK[¶≥√íÕ.ï¿B†Tò‡Õ‡Xú˚jÛ´XRòÈ+‰èπ0>–Õ…D7Hä|–Xƒ¢`"ñXêùïüœŸl‹∆"}~ëŸ§V'©s¨úﬁŒYGé≤≥L…ñ¬R´)'◊ŒF∆≈©ß≥Qjuõd¥¨ÁX]©ÕŒÿXçŸ`±Z¨"ÃŒ&ÂÁ≥# kÂlúµÿu¯k»¨…∆ÍYªUo‰
Ù÷¨%õM3ô-ˆ“BéMΩÑã†ìÕÄë5ôY{.«.◊Ö≥KEÔf;´7Ÿeø¢ódgõ‹»aÅæîc˙_¥Å≥⁄ı‚n›XŸº"´…f4Ï&ãŸˆ_Áf}˜ñ(,V÷$æ _to∂q‹ı¢Çı©·uÀ\¬÷»e#1©Ûä(y†âh6Bsöá–¸@dB»Çê°Ñv!t °√ı bá≠q’„]îéjâ9DüõØ€"∑R∑ÉnÕnº€∑ÁíIÅ§M#]/≠'É…U‰u*ï“STuâz"õ*€.ªÌ>ﬁ=—}ù˚˜g§«L£«&èè!œ9ûvœØ9^Gº⁄ΩûzyÁzÔÒ>·}—GÁS„ÛTÆëêw˙∆˚⁄|+}Ù}ÌÁÁgÚ;Ï˜xÃ¸1á∆Ù˘«˘[¸øÒÔ¶Èt˙S∫â˛◊Xè±°ccL8√1{ò+åìyN@˛ßªZÖ°VB§ìZ%ª§B≈Rgï∏ì¡Û‡O$<§0ãøg¿%8˜ ú‘⁄ÊaQ¶Ñv∆≈aó$óó˝µÙ<ÑÛêUBJnTË…ó‘F¨'G˘˚|,ı'˘xÍ+»"5îgë~√O”R‡p2RsãzÖÃÀi%áÉÂÁ†˙‹Ò?”û›Ï¢t;,‰åÆ¢„÷≠ éééJ]\\ÖNß⁄Áœ¸D¡≈·lrE‹y≠˛∫›
ux}˛‡…ìè`/ÏıQDH»Á‡•¢ÑP|ˇÌ:yWywvÒxﬁˇ+«á˝‹ﬂ‹O7“µ∞MX…l:J’ü<Æh8V›¯ÌﬂÃÎWo∞l»WÇ1FW†˚=›∏ ˝Ã`oÛπÛ'T]gò™√‰ŸÜ≥Õ?)Ü“Î#ïtÌÏT›¨ïUÜ*ÉÍpI7f…åµFMíbÒ)ÛØ7U∑ˇ†§ãøK%S¿ê_◊~>ÌäxÍì¥mÜÚwπXëY≈ØJà∆	dØe¶„ÄxéV‡®vÛ3 Ô®$ŒÅI£Äàjòyïop@H⁄qÛ⁄`D+ *b¬ÄQÆ¶zpI<	«(pÑœúç]∏IBC	hE‹î.	L0lCQê¶Ñ∞÷ÏÓß›ì[Îy¢®ì]OÇ◊ô¸πÿ*Ö<_Ú¯2ÄáBQ¬"—‡B\®ÅBJæÎ%—Û@“–d£€Jr7)ﬂó›9≤ÁJüb0B&^;˚âsP!9;®Ë«o^FPrlﬁ[<º©Ñÿ
mí≠ÂO¡Ê·MbÉ…À yaê'N9‡á>.g@∑åÃﬂZ¨√∫-ÿà’xÓ~¨ù
Säıò–<QTÖn«¡a¥Ç!TÈÍz°∫k	§¯ÉyÄæzY®f`ö≥zÄ¢ÎÜW,ë—WwÑƒmâ˙ƒ]^∂´_¯°õhr¿áDX‹œ‡Û‘g-«Íkûéªq•˘< ≈Öç@ãﬂ˛dù+îÍt%ê@Ù}≠Ièœ^ß]•ÃXEŒ]îâ«)v‰)pÇﬂ^Gxˇz«<«∑pÿëÍ†{∑@*‹aö)«ÈÃXÏùæ1SE∑lôΩ°˜í*zïøœ-åøtò_V¥Õ9®‹-£õPœ°ìØ)nò^‡©¯w⁄XÏ#^ﬂæÔŒ√+Gﬂ[¨§˚PJﬁÚD•Ë:ãôÛÑnÅÎ]/6XùpôŸç∆©T¬^f.Ï√	ês˜Åõ%âqH¸˙â”∞;$ù0¿ÙÌ ˇ\ﬂ˛èª’qÒ…eXV˛∞NMi´∞
Ê¬‘Nê¿8Mò∞˙˝“\≥rÁÓc‚øª˚Ò’—7ﬂÏ-Ô_Î ≥#ŸAø†!I®ej !«a˝Vl«18‰ ŒÄJ˙åªÚÇ ›˚ÿ7~›{ÀU;;®∫ΩêûJZË™YªT%ºóÈ9tÔëh˛ËPdRí-2ZE—∂{=™ëÚ:˚âS¬T…)¡…¿uja§6Dú5—å›>d›°æÄ…ı‡◊D”Àé;ımÓˇtN}w3õyˇ:á∆È"°ü’A&ﬁÑ›!¢õ¿˝·c√ﬂcé)È°k’«œÙ)ÄZ»c)ñ.‘`*·¯ökf%˝,∆bX:]AAñ†c~¨^ï™1Ø¸√bK+˘ÿŸK*˙ñ9ó2∑k.ﬁ∫UìõóówÒ∂r‰vm7‹te)Ÿï'1KCm†fÚ‡ à˝g`áòR.∂º+Ix‹¢â8^PÉo„˜UTªuTŒ«xì4¥$ÔLßJúë^&±4*L4+Ω€€{ÙÆCE9éF%™ƒ—Éñ—È&1Æ˘sVJG∆ç‚≠É-£fœø(&ZÑJIÿ°óëºÃôôÇ∏\¨ÎD˛<yPÚˇ±ÎÌxg%ÖèHGô7>˛(™†åÏq‚¶ë	â8”).ÚﬂtWPT◊veﬂ}ƒƒ-ÂÒ†≤ˆ=©∫±¢YÏ™HbÉõ˙áäÄ"∆†é´Q#¢≈8J÷Õ÷Ñ®E#àf4FqD1qE¸	Üb©k”¨W•´º‡R„5Íy;fzﬁBLt¶3;ÛˆÓ›sﬁwŒ˝æsŒ5l!‚¶π·^ª=7tÉZ*\›ÓcÁ çÉ<v”8√ô˛L{1°ÌºIt∞€xè√ôÃ∞◊ÓÜ
πCÎXÈÔ#^ô†M|ƒÆ6.åˇ÷§!2æƒÃI"Ãb”¸7®,∏dÆêIYÍ≈Úc/FÇ<Ïƒ	ó3%IºœnUΩÒÏiywël"Ák›ÍwË)lÛ˜	ÌBõMU-˛Ω¬Ë~F4¨ÅH:±ë”√ Ì∑˜çÂê}˙OiFì”≥©jMƒâ˚qÃìÖ6zB¿¯µ(ª[Ω‰÷]R`á/‚¸·"ô≈o%ÅKV@ïl∞ ù¡ Õ	„®j§/áx\)„f»∂{`´ﬁÒËÍI∂·Í/=x∂BôÀà<á=3§RB[~˙è-œÓ_ÎNÆáçn8⁄ü’%‘µÍZµT¨⁄º	íp˛” fV‚òBï Û’ÈÂ≤É	É\*è+í äjøã&4<õI®m˘Ùı1[d√qr◊Œ\6*Ø´®Îô—â6pö;3∏6º´P_pV‰¯3sªÒ˙3ÕÃ0n≠€? W∑«Øë°^3$>≈¸95a⁄;’ı“YÀ4~¯©W‡Eà>‰A“XÙì(fMÌêÇwπ{◊©Ò∞Œp1Ìxü≥¡}rüj˜¯C∫ˇÆ<¯Ö?Ñ~Ö‰Eﬂ™kP‘¡JPA—;º‹©Áz¯ıú£SO∑˚w4r6z®ç-ÈT°◊†ı
Ù%S¥ª!ÉÄ0a©z≈¡C~«zkÅ	ª:⁄l<©m2¶,D3√b√AˇRÒ)u*â:Èê^	3à≥a¶ÀIz0|åëTQGÆ°«sôóÖîÒ:RÖ[À¯*_ u†c–˚fÙÅ˘h∂OñÒı.æ∑T•%Nô˜G˘7œ·PˇÙÜX{6…≈’∏∑?yŸ˝ÚgÅù9^∫˜†î|N,*XΩq≈säË9t”®’)≤µav
gÿK»æq√±Êiíz§Å˚^dÇÍ¸rcLâ¸!9óÃ⁄YÿÁ1À)]∑ª¯⁄F0¸™¯¬‚3ìKÇI¥è˛Ω{≥'∏±Të%\£EÒà5◊Ãá“`{™œ[∫T{PÌÉ|%…'\Æ™)Í>"lìˇâ}çh]éVY∏å;°^¿Ã»WS“«I¬w(n∫u]63\;⁄°wåîÑÀ∞[Ò%ò˘ÌâÍ&I∏Í›üJï5õh‚—¡TV>ıáà0—”1#&tÜ(Å °1˜4±P	:ãEåvç¶©§ﬂøæÉ_KÍfs«f>zy Ô‚ó‘>“ñºaâΩ=Aco®M]$ºc¬Aœ`"’º8W∞_á_cZ?’Ok‰ÿ!u?RÌ#ˇ,!Ö?a¬‚áÍŒ¡Ó’û0à&sb[)Í:nêπIΩA√∫)u¥ ∂/ÈíL ä©P)b•ï<$´„ÈEÖ-ÿZ∏A$œı8…Â/qÈ<û †0¡eÚó¥ªp¬œˆzÇ¿J2≈	÷ˆŒìh3u≠+π˛ì=]°î1^HÚ
_@®⁄K¸Ä/∑ﬂÚùˇlYz¶Ω`JûÑ‹N®üÛVÍò»ÿìSú>{‡‘~â MŒ¯-’ˆC∆ä=[ﬁˇPn‡ﬂ+ﬁd+2Æ∞WÏë·,ﬁ~-ñöÇ	˛äoãBÕÃY3ßÁ˝≤fG≈˛]“—ΩM%+ÉŸZ…SG∏aDnhùÊ*B-Ò¥B¸°Ïq´g˜HCCÆ9qX˛Ë)	Ö£±BºŒÑZóÉœ⁄^ìUoÑê3±†œßã’¿î¥esÛdl∞he wr »•;§¿toê*©/à_I∑
é\Åq$ÉIuC…8Ús‡oJñºÊ’$”f"§ù€wˆ”R•g–— 5◊KË~AË lw≥ßµ,™?
ÕCsõ!LÇ£Ít—ÇlÏd^⁄Å9FåÕßãûO!B}Muıv≠JZØÛZ˙·MƒªtU
Ã¢SÉ´‚n˛–6Ë°4ïèù*-„´xòæ˙”Ä˚`”aËÛŒ*≤$∞CH3›(÷”ÿïÌÊ÷]˜]˜™Ÿ>W\#´*€qD:Êû¬F-û?JûîhıÜl¢›’Aı…n
Í5/eG∏+‘ïb ¢û˘√áZ÷ÅÆ%§,‹Å©ıbÆM∞ÒüeT'±Ôö~é›ÜÈ‘=OÔwñ…éql—ñÿÉFﬁyÀkãe√» ⁄+ç–£©‚“TWjô‘—9Oˆ’J∆<>s~˚óâoJÃ´Üçˆ'(Õô∂tﬁj©Îµ§VÊ˛˜{]ÉóÍæW≠¥∞fΩ˜˚¿Nrœ…Òœß›–Ø‡Ñj•hÈ®cÈˆ¨‘ıEé˜◊KB^/87óñ⁄Jç∑´N(≤øDoâıZ1πÖŸö ÿ-"X SkE”–ŒŸ‘DKg¶¨Ïk/ƒ`u´ß≠∞á?”¢I^ãIÀc£∆hü∞æBmc 0ÔÖOé}˝c`åfŸg‘Ã93VI
}2Ÿò:c˘Ï’≤ç	7¯Æ\i~©úˇ7WQ;âÏÆjvƒ+u¨Kw@ÅEJ–"*∆≈àÉ!«2â]ƒ§!0c%ÍK≈· ÇÀ‹l›ç¡ú˝2∆Â¿Ô›Íàn§À]Çaß“¶	≥Jπ#IòèêF”PÌÖı6∑‹πÏî‰#
µÛ‡PHŒ» *“ªÎ“˚πﬂ.E›ÄfÚ€??jò¶#	zÎ⁄vö©pl“¸í°?#ÅnXm|u˝Ñ9»°MG–ˇ£º¸c‚(¢8Óe›]¨x÷ΩDŒÏ·lÀè∆´?âÄ!–£$Ç)Iä˘—ä6J°ÄJ!Â∏ª\¯q•◊bNh)$@ìV!ZÏù–§GO∂bN4xí§öˆ
±‡õÀÏŒ.óçâÏŒÏÏLÊÌÏ{ﬂœ{∫âoáæì”5>D≠4–P3(+	7MŒñôª?]ªlokÔ∏s,7m;›h≠”Ê-.¸\6j»OäÆ= ©E\
ºÄ7ôÖM4zñ˜∂∑¬8Iõêz0SwNÃ◊qwgéã_dD¶Âû<ˆFÌ≠áV¨Öú’_¶Äﬁ»ÓœÈ#0 ÓÀÓÒF˛ÍÈº<˝eiñü≠>/*¡I|îƒ°ƒ0Ô~U∂t•œf=+Ã≤ÌÕßLµ⁄√MΩ„:x∞"&@±kS}>´Ÿˆ¥KÒoÜI›_Yî÷vÁ1ØIœ±FsDªo~ﬂ'ÎÚ	#òdÛ∆^Ÿ¡#ÏHC¿ï®πœ@,Q∏'•÷ƒ°tÖZªÃ¡∑´QNê À
#»“jÇY¢Ç¨{R…ÚÅ#+edΩNMÃÚ*ûIR˙“'¿JV¢I’Å
v√0+&ˇÇÚøqπ\'ƒ¬0DÅùÏ®«˘Ø@æºu2ŒCë5*b"o5ÒıáËON’Uïh´Î-÷F]6€ÓpòF¥k}‚úSâhñ,⁄≠ÿΩi{Iÿ_Ù©†ô∫ÜJx®g)ÜŒÜEnf°	Ùœ¯7ÚQÒƒ◊®~_û!©‹»Àæ»|›Ìº“+\gU≠YiëØ.≥8y„±„jX|*3j£¿Ú$jÛIm$õÅ,@*  !^ÔO	˝˛`0≈Ø◊ß§Ë≤„˙∆ˆvÑºâ—ˇ™ÊpÚ“„Ü’¯CDç}0¶âà.1ﬂ¥á˚lÒ£Ê€—	GSèç9kæ~k‘y≤≤ ‹ÙQì¿U•◊–Ö’ï#ﬂ)π}u¥wËqÑ
K„Ä÷È∞Zl:ndåm7ù1µhÎÃés:Æ*oî?V˛iYEcˇ¿@w˜yª–·Ü’ÈS£ÊPåGπ"îä0'RêSºÎ†Ò‡Ö<xÅ	ÌƒÎºàíàRrxk`ñ÷KI"¨ê|\áWËk§Å‚;Íù(aﬁõTπ‰;ÂB7yÉ◊∏∏Ëı..ΩÉ—h&5ÓÒq∑{º¯¿Åb˘w€ä;÷"jÁÕÛ<∑≤•˚‹zjêü_Ke`ÔÀJ´Ë§åΩ˜˘"¸H$jÚüÉ”“ëMI)"Òe9ÔR›pQ®‡ÔaÒ*d“§ XÖ⁄√J1∏å.dQ,˛ÅwI˙BV≠ÃF1. çÊ¯<‚Löîqù«¢h(£]¨?"≥„Ÿ-√Óˇ/ªîo|∞E∑G®»ÅíÉÅÅŒ•Ni™ã≠Îı‚#=addµS∫◊Ûî∏#¥ß££c0<‹s—fZûG-¸? ‘‹qÖendstreamendobj76 0 obj<</BaseEncoding/WinAnsiEncoding/Differences[31/f_i]/Type/Encoding>>endobj77 0 obj<</Ascent 932/CapHeight 714/CharSet(/f_i/space/parenleft/parenright/comma/hyphen/period/slash/one/two/three/four/five/six/seven/eight/colon/A/B/C/D/E/F/G/H/I/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/bracketleft/bracketright/a/b/c/d/e/f/g/h/i/k/l/m/n/o/p/r/s/t/u/v/w/x/y/z)/Descent -272/Flags 96/FontBBox[-171 -272 1068 932]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 83 0 R/FontName/QULRDW+HelveticaNeueLTStd-CnO/FontStretch/Condensed/FontWeight 400/ItalicAngle -12/StemV 84/Type/FontDescriptor/XHeight 536>>endobj78 0 obj<</Filter/FlateDecode/Length 528>>stream
Hâ\î€j£PÖÔ}ä}Ÿ^s¯-H MZ»≈òÃ<Ä—ùThTåπ»€œ^Æ–Å	?—Ì˙XÏﬂ|≥€Ó⁄f˘œ°´ˆq«¶≠áxÈÆC√!ûö6õ/B›T„˝j˙ØŒeüÂiÒ˛v„y◊ª¨(B˛+›ºå√-<¨ÎÓ≥¸«P«°iO··œfˇÚ˝µÔ?„9∂còÖ’*‘Òò^Ù≠ÏøóÁÚiŸ”ÆN˜õÒˆî÷¸{‚˜≠èa1]œ)SuuºÙeá≤=≈¨ò•ﬂ*ÔÈ∑ b[ˇwﬂúÀ«Í£≤b˛ûûÕÃ“Ò≤ ä≈l∫Nßƒœ‰gyzfCﬁÄ∑‰-¯ç¸Ê{”)+ñÛâ”)ÒÇº /…K∞ê¨dŸ¿Nv0›ñp[Æ…Îƒ¬,Añ0Kê%Ãd	≥Y¬,Añ0Kê%Ãd	≥Y¬=»+˘ÃNù;t"ÏD–â∞A' û=+ùŒJgÖ≥“Y·¨tV8+ùŒJgÖ≥“Y·¨tV8+ùŒJgÖ≥“S·it08FÉÉ—¡‡`t08ò›˜ò£É¡¡Ë0Ì1£É¡¡ÿõ°7£èM>ÏÕ–õ›˜(zsˆÊËÕÈÈtz:<ùûOßß√”ÈÈtz:<ùûOßß√”πØ“	ÉtüåTö¸5Ø’u“®NüáiF1ùMøæ }◊á¥
GˆWÄ gendstreamendobj83 0 obj<</Filter/FlateDecode/Length 4385/Subtype/Type1C>>stream
HâtU{T◊üaw.‚;G3àXD0*"V¡EA¡∏¬†kqWw◊%(£QDä≠èSAD©zî4ö`¢V‘¶>"e—∫¢.ÒQÂ!P¥û<ﬂ¨óúÙÓ⁄<zN˙«=ssøﬂw˜wøoÜ¶îM”oÕ_òº`f˙;âRûU≤Ë≥us•RrZ™%g|Çaû+bÑ<åñÉî%>Úp«·cØ/øéadçØ<Ÿˇ∆∞!˜5îÇ§¢îtúõ•O0Æ+0ÈW≠∂à±±·°bdxx§üc\)â©fã¥÷,&≤ç¶uFìŒ"ÂÑâÒyy¢õ`MíY2Y]/‘#ÍÕ¢N¥òt9“ZùÈ7¢1WL÷åñÇuíò@≤Ñ“*=…kírDΩA¥¨ñƒÖa©ab
…n∞à:Céòˆ#{^nÆ>[rø\´+â¶ˇegK&ãé<ç$çI\≥¡§7ÁË≥-z£¡¸CrÉn≠Ù*å&QONêG“ÃíÙ”ÚÏµ+√&ÃJMsÅ(1G •à[4Ey—‘`•Ò§xä°¢B’‘äöFQ3TT2C•™ËRäöÈr6âJ¶vPW®BcÈPz1˝πG§á—„ñ"UQ°•LR~®|∆LeJòœô«(ï¢√Ë.Í˜úÈYÏ˘@5LµS’Ôï·U‚uﬁ´«{ä∑Ÿ˚∞˜5ÔÉ∂˙óœüè{N|KÌØû®6™K’/}#}À|ˇÌÂWÂ˜ƒ¥äˇQˇAÛæÊ8Ã/oî˚i	êw8Sv ÿÖØrxÏe†a_Ê¿ˆx†L˜¶aÇë|âsÕ∞©±Qçxíıu@>˝»°Äg&á}q@4é“cÌyG∑`Nıgî#∑√®S}&4¡DÄ ’O\HkST‚d|!‡u¥ß ≤ ¢ìÄS-Eg»›x‘jΩOH∆1ç]\c˘+˙+Z–vÛñÏ‚|ic–áÀ:è‘ﬁ¨ætË)3©E(s–Ø†JÒ
 8ÿÅ:ºΩ·∂Ç'·>CG^π"q“´sc>],/Sq6$undíê∫∂÷*◊]ô«ê(◊q¬Ã@π!ÁÃ`Ê!”òIõ#∂´‘µÂ˘k;-gu)‰•_AáœˆÂπì0Ëi`˜Õ+Wé •∫Q˘[`qèGO«CçB;˙bÔq`ÄÊÔU&Õ-6M]∂"q…Ï%Å„gáEq†Jâä"ú≤m≥¬õÊNlÓ‘u∞m;x¬±Œ¢ˆ∫Ùò˚ò◊ßÛì7›mÆ¥®lì˜ëOÜ<{‹	‹	ÅΩp¯yˆ≈∏jUÖß£ÊB”Å€*∂≠Ì`I?·ÒØ‚c‡ıDÕ•?“Õﬂ¨\4ßHòYòµp:üÂv‚Ï≤îO€‰%
y¨‹¬U†Y¯['¢È{∏çSÿáV·8b…g«|ã™ÌÃªËπ,1ìﬁàÔ≥AòÉnÌÄù
èπ{•Ã¡]çóæ·;ˆ«N›($fcÂ~¸ÓÓ˙ΩD¸ÇíR,¿BÇO0ˆOøÕ/Õ(XΩJ(´∞ÉéÅ
˜}ﬁz≥¡;,∞iv¬÷Æ¨Vñøê?Âÿ˛ì{¿pÀc›l¡—´<&o=û<vˆ√:Åï!®nEˆÂß.\¥>_(C˚ˇ ∞˝ı{`&xÛ◊èf¶∏ﬂÂXπµ∫æ≥áÔŸøIàﬂ¥"BÀ≥˝⁄Ìù≠’ÇªL4P≤USÂÓ#mƒ‘1sF&çH«´D’s‘ £õ¡Ô&–-ØZü4^¨æ8ÚF¸Y⁄4ˆéﬂw@H;π⁄~§sa¬*–Ú†Ω™ÓCBmØÒ⁄î˜Îæ:W}O≈ˆ:öf√J+cí02õ‚˛∏ºŸ†b˚√çÈ)÷PWƒE9ï˚€°%âEBRQˆ‚˜¯9mUBK’ÈÕD9ñR∏G5ÁöÚ'ìä)XûÀ«Ê7=™‹=Á]m≤LZy˜ﬂN¡‘¿ÆÊÍ/IYdÿ·˘ÀÚ|ÕVπíΩøï4T/d0⁄á3òg(€ô…`oƒvü
&SÉü38©Øó€°÷õÌyNœ“^ˆ%†õÎG˜øñ∆ZÖYEÀì√xÏÉF%p∞¡ÿﬁk0˙c·Pª©%¶ñ‘Ó≠Cóõ´öUl7uÔ6êH#≤'p/–ì+‚Ïaû∏%ó&ªŸÂ^;˝≤n˜ê~$üÄ(kÓë«ÍJ
±ü
d4êôöÔ⁄?kr°Åxl≈CÃ„≈Ò8'JE8≤xo?‡Îu_π]n!=æØWŒ ‚Dm¿!¯-ÉÄá„p OpK_Ü „¸O∞¯´›ÖM<NEÍrÏsÄ≈A_ïkWdwüCÅ}‘∏A:Nπ¿ É‘ÖƒËß?„¥£€Ùˇ;äÏÛØ¬6;ú∂k\áÔe/»ˇî+π˙=ü@÷˝Ïti+∑„Ÿ0ów‹l¸Ê°±Ö÷qåµ…û^è
x±B≠Ÿ8´¡∑ßÊL/‘¢ÆœgÛâ∫ø+úÉ»_@ãﬁ«g\Ün¿YFãpËwôL;∫}î°∏è 5ﬁ[kuf|‰>Ñíb—∫´J≤¬W∫«ÓïKP⁄˚|Ì9¬¡rúÑãÃXÑ[Ò¶µ¬≠∞‹·Ùsqó©j∑5gN?◊*îïCf≠NeßÊ{zÃfÍ{ÍΩÕªÓ∫k„ ßí©@«æSY‰R] ΩA.M8±ı¯‡@ŸlÉ‹‰¬§¿{úKæÊ™‹¡ÆsÎ˜˝ÂU’ëÖi€˜Dì0⁄jü∆u$Ç3jp	jTÇ,.àÄD$àÑ("®44ÿ"⁄»∞à¨Å1FA£NBDqJ¶›˙Ä(dã€xtbß⁄an=‚ô¯cÊGüÛñ™ÍÔﬁ˚›Ôªè6‡ŒnSÉ o˝'‹®1›«çLEÔLƒù}¥¸π;’‘©'Tzïn	H7_æı‡©gqy*x2_çÑ≤àe#ÿ,±Y¡˛xı∫äX‰c-™±ªê°ëï‰˝ ’Ë."ºı¥Ü£íÆ;À¶ÈñÊ⁄◊5Ì≈´Pﬂçrp#Ô¸7∫¿µRmïá·ä±Ïy˛œ√˚¡¸˘≥'døR‹émâ[_¨¸é©≥Cººká-ı,jÌM#B!x˚AÍ#ÕS¯‹‡Ò\U‚Ôc‰]Lùºœ;];º[‹ô±'7„N.X;ry€˘•z‘Çé‹≥-Ÿ∑ÕQ≈Ö¬äFÛ∞~[ úPFÖΩ´Û!”ëT}q]ÌÇ˙.5≠°Eÿ˘]c#	sÒd6.1≤'ÀÇ¡‡µÃﬂ|^¥´ØaRf[S∂ÃŸÚ’òCûÇÕ7<®Kê…zŸõg`ç˘≠£UßÍIÎQü˘—hë=ñËci†ö⁄ıXJ∞XiIOqó£ Œ"#/,9ÔQóz∆E©⁄:’!XBG™|∆›Ÿ…È9›è¥m⁄/Lå‹‡5ÖLè®¸%ˇÂSãÉ∫ßs“¡å^3/Œ_òoE∏ãd≥Ád+4ı Ÿˆ–ÆœpT÷LI`$J4ÿ+õ@€¢ÒÉ…÷œEM(D*úGŒ>°™è≤Ÿ,∆‘åß–faå»∂+7YxÉÚ˚z6ôæPC>ÙJ,óı¢Œ√z®hfº?ËÖ√å{≈rñª r±S-ˆmÉ…4H:(ïñ±RÃE-vr˝êØfÌÆ®iìQ¸òª°GoPUPQ]¡«Bg1” L¡°G/<Â◊Ã˘ïeA∏⁄¯ËÈ,∆∏‡ÊBèÀÒwZhcµ ¨.v¡¬5ï∞éëí	9)«⁄ÓëKÖaæqÚˇ}ª\w∞77˚ r≠OÙ|s€®“eO»w5«ø=©H„áÒßt%$Ø Â¿a9£V¯|obRŸz(/ˇê\U¬•Ùº«ÃÅ∞°n^Ãb´õÿISπ2÷›o%YW~1]N˚ÊXﬁWŸg
ÙÂ•Ê\§ÈL#Ãƒ∫ÿA\¬ÚÑ<ÈY˛ÈÓ.r;y∫E∆ìß9í?§<Å≤FÀF≤<©	5sê,n8Xæ°ÜÄÂ∞€√Ÿ|<ÒZ∂&'ôÛê¿ÁØú0FÇ⁄†2vÇˆÆö~BKW2t0à[›¨ÂÃûç@Ûr<1lå0¿†ª9≤ÉË±{ÛºÖd¬q}#KÜUßø/™"?§.˜âì_ﬂÿ±Öà}1bá°≈Â-∑I◊ﬁ1c∑sÏõ¶Ÿ«§|,SK∫BrW±‰“_˜¯_Mò≠~F‹&3«èë6RsÈ‘©%ŸXª&•t∞ﬁ ”*¸ó∏V5¯B£îí+îËK¡¨É‘ß,Z∂[NÍ]$}ô Éæ»Ç±|¥˛MLÆ¿ø•cL¬ÊêqE`Ÿ¬á?¥öàFU¸®n≤nü–§3¶◊^Ã®N¶Êeû bñQX*Œ^ªnˆNy∑ª‡»©uËnÄ!F:π∆√hU—–⁄"M‹¢·“Ààö1ï8§Å™=G~ôÕO∞∫Fö#j¥ŒòäØì6ûÚ l§3{õç≈â{3ÛÖ©‰¬•‚s≈ò	≠ì†πÙYÃLfF6ÂT∆ÿàêt•Ã⁄j`z◊Œk°¢S∫‘’ƒ*
∑è^˚Úπªx}Ç¸æIƒ…ºôZ
uœŸ(≤⁄%4 ÙWÜp'¶•Qˇ|§™Ö8u-û "-≈7Ÿ-R´ò˜àØ—*K‡£(U5›•Ühó∞È˝π'2FÚuƒuä”∑äÂ‡“ﬁzüCAË˜˘˛≥π3:pu‚¿yÚË§6ò€•9W˜{kˆ’¬
r˝ÏØ⁄—≤“s£ﬂ&˘ÚæÕÖKàœíO?⁄å—i±ÑsDã˛øô“•9˘?‰gÃØ'\Ô;âHT7€!±C›ÜLg∂õ”òÿ∞ª˙≤˚lK‚¡ÜŸf∑òŸ‡{∆≥Pi∂Æ˘2˛*û‹%]˚&2ÛpÅˇH,ò}$ºg§398∞+ÑÿM≥"`QT÷q_QÅ!·‹≈6ŒB8‘˝,_f‡ÿﬁ*~Ò® kéTÑ}K@6¬\‹"√¥≤m 0Ò‹∞a«ˇd2‚gòÉ†N≠âQV’ ö„<F∏'tÊ‹*ˇö˘|™¨…8÷"héß$ƒ%Ô"À÷Ø]ÃO∏ú›ƒãÂ”óÅãÌç
‚M'’•gÉõJÏ¶≠û∏]é`Í∫µ€k∑◊iµπÅÓﬁBfÌ˝˛ÔHÿïq[WÚ‰n5⁄¥úﬂΩ¥`Y˛“|∑Ùå:ÛÜ£WÙ≈‰rZêsÔ«D#ùdP=∫ßoZ*Ωl4^'mÊ«Ì‰/)…í≥Æ˚„„ìvíÄœ≤œë˘Tyü∑¨ùX
S9XEû¬£¨ncΩi‰†ú·Ì¸â?ôó~ıt™Ã)‡ Œ6Y
Óª#F√RuÂœï º;µ«[◊˝gºXRkÙY{ÎG"§cW(6ÎiZ†ÿÏ≈f=tèÁFR◊«Ë±ΩfÒqfw ®◊Ã	ÌŸàıcn≥n‘Àu¿‰ Ω2OQlvﬁ'â)¯ní»‹ï=ﬁ†Õz„`t!“¢Tá©N¡P"±ı¨ÑÔû¡WX0^ÕÄÅ4nû2ÛÙOé≈õ-2ÙåàRÈ®^≥„§≠~BXÙˆà@} 9V∆|ÓœÃL*%OOÍq<˚í^Á˚ó(·h˚¬q¬/úëFU1ıR√((A¥»öMÔp;m„J»ˆà–HGe›ÿ-•πB-è‹åVMÙSM„ˇ©° õB§~π—‹Epb2{¸3Ÿ Ló)Bëæ]o™N¥+ª«?õÖ§õ„ì'z”ÉÙ¡Ü!≠o¸[«'Nú∏úáÁ¯‚˛~ﬁ…"?‚E ˜™bendstreamendobj74 0 obj<</Ascent 961/CapHeight 714/CharSet(/one/K/N/O/R/S/T)/Descent -271/Flags 96/FontBBox[-171 -271 1116 961]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 84 0 R/FontName/QULRDW+HelveticaNeueLTStd-BdCnO/FontStretch/Condensed/FontWeight 700/ItalicAngle -12/StemV 140/Type/FontDescriptor/XHeight 538>>endobj75 0 obj<</Filter/FlateDecode/Length 268>>stream
Hâ\êÕj√0«Ô~
€Cqæ;ò@◊µê√>X∂Hl%3,∂q‹Cﬁ~≤]:ò¡÷OHY?uœù—¯ª∑≤« ì6 „jØ^"å8k√ 
îñ·Ê•W.Écúƒ˝∂\:3Y&
Æ¡o∞;*;‚ûÒ7Ø–k3√ÓÎ‘ÔÅ˜WÁ~pA†Ä∂Öz‹Î∞ $;tä‚:l“¸e|n°J~ôõëV·Íâ~032Q–iA\Ë¥ç˙Ã™qíﬂÉg¢.)∑(»0—<%&C|Œ|é|…LıƒCïòqùπé‹dn⁄ÿAU$èLÏ‡ˆWÏÖV˜AÂ’{ö1Ì5«“Ô´w÷©‚eø &ÆÄendstreamendobj84 0 obj<</Filter/FlateDecode/Length 969/Subtype/Type1C>>stream
HâlQ}h[U/ŸªçYå⁄Ùïé∑Ì›⁄≤Nõfqì⁄	∂tùk+≈‘•ıYFöº∂Ø&Ôï˜^[‚»∆¿π;k⁄çÈ¥†›¸°÷èYÍGd:Ÿp™Q,S0°˝√p^z#xÿTèÀ9øsÓÔwœÔñŸ`aXñ≈èÙvÌﬂ˚X}áï9|Xë∫z¸F∏aO∏MÒÔTõkVl8‚∞òõ<i!ØÆØ≠˜r¶Û6S∏cy˝T9c)jU≤5mÍpLì|œÓ›^7ﬁÈıÓƒ≠aµO¬˛ònHQw*!UVµ†!Ö=∏5¡%Çé5Ió¥—bÒÊ,X÷qZ0,EÉ⁄SXÌ«]≤¢±a	∑Q%»TWì¬XV∞1(·^èﬂÉª©∫b‡†∆=7Ÿæ˛~9$ïä—`”ô˛ÀIö§Q•2—d=,áYUÙ‚J0*˝œ™ÜeÍ BÂ]í˛i∑G˚:<;ˆ˘{ä‡^ñ˙Üe ∆Õ0;XfóÖ±—üc:ùyá˘çmaÁ-MÈ‚sãÊã,lØ4˘ÓB¡Û‰OöaäÉ,"ò| C&À
(P °ôPåÃO¯bFä»93j&Æc°~≤¬ïpw˛qÆ=Ìh£±™Qu!¡9üòÕ∆ÿ≈¸ÌV‰<qˇ‡†}ÉK?ÆêÛ4"¬õnH¡Ò"rúÃq'–Eò„úáop—øπU(g&∏ìhâ Cw>¿ë*TSàSﬁÉfúsF‚9Ûlé]ÅòÄZ+X!œìËÅcƒ"_Ç¢ÁEzí‡!ÅD|ƒC˚"‘VÇˇ›7æ]VN¥H$=} ûF°q|zÊEgdf2´–ó+7À†. n◊|o˛…ª≤W–ÂsCùq±˘–ÅË>¡áH¨∞çß./AÜs≠]EŒ»˛£¢F∂<´&ÜOèm/OÍÈÊ“ﬂmzÍèÊ~—v≤le˙„K3ø€\YpŒvEÏy9€Kf ?áÌÌPøªÍ°∆ıÎ7†Û«j[]hÅ˚◊UÊÆ@˝€‚ôká2w}¥m° ?˚ÃŸ”ÿ\ÀÔMÕŒ_2/Ö;‚"lEØp∞Âı˚3§B õÎˆ1J«⁄∏(ÿ“á:ß«≤˘é<©ZéæˇuZúò)Ì;vDsƒ
Mt±s‘q≤≈eÇÀÃÒk`ÁúÒt>ê&˚”pg¡Ï‰µ…Bf™ÏÈÈ|`ö•l¥≤:Y∏û∫%gá≠óR©d2ôzÀ·X•19ïL:nw8M£¬¸ôˇ[Ä `Z‚"endstreamendobj71 0 obj<</BaseEncoding/WinAnsiEncoding/Differences[29/uni00A0/greaterequal/f_i]/Type/Encoding>>endobj72 0 obj<</Ascent 961/CapHeight 714/CharSet(/uni00A0/greaterequal/f_i/space/percent/parenleft/parenright/asterisk/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/equal/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/R/S/T/U/V/W/X/Y/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y\/trademark/idieresis)/Descent -224/Flags 32/FontBBox[-164 -224 1066 961]/FontFamily(HelveticaNeueLT Std Cn)/FontFile3 85 0 R/FontName/QULRDW+HelveticaNeueLTStd-BdCn/FontStretch/Condensed/FontWeight 700/ItalicAngle 0/StemV 140/Type/FontDescriptor/XHeight 538>>endobj73 0 obj<</Filter/FlateDecode/Length 567>>stream
Hâ\‘Õé¢@‡=OQÀÓE®∫u´Màâm€âã˘…8Û •C2A\¯ˆSáczí1QRxøú@Â€˝˚æÔfìüÜÊgsÍ˙vä◊·65—„πÎ≥“ö∂kÊ«—ÚŸ\Í1À”≈á˚uéó}≤™2˘ètÚ:OwÛ¥iác|ŒÚoSßÆ?õß_€√≥…∑q¸/±üMa÷k”∆S˙£/ı¯µæDì/óΩÏ€tæõÔ/Èö+~ﬁ«hÏr\”mºéuß∫?«¨*“km™èÙZg±oˇ;</;ûöﬂıîUÂ{Z\õbùÚ.ek’#,ø´¶˜*€b9∂Xg=3÷ŸWÊW‰Û≤~√ºAﬁ2oë9/}•ºcﬁ!s^˙ *«Y≥\…\"[fãÏò≤02m6ßÃäò2ÕfG≥ÉŸ—Ï`vt:8ÖÅAhÑÅAhÑÅAhÑÅAhÑÅAh‰ç˘ô
:⁄d±±CAá¬zvË—°ßŸ√Ïiˆ0{ö=Ãûf≥ßŸ√Ïiˆ0{ö=Ãûf≥≤E? YäY YäY YäY YÀ}¶˙∏œê9K1K9K1K9kπï˝(˙Qˆ£ËGŸè¢e?ä~î˝(˙—«=ç~˚	Ë'–‡Ù¯˝˛@Ä?–‡Ù¯˝˛@Ä?–‡_!€“‚ˇwÙÏ¯†>ûH<≤ig1ü˚Asõ¶¥,€œ≤‡ÈÔ˙¯πCç√h“Uxg ùÊ\endstreamendobj85 0 obj<</Filter/FlateDecode/Length 4619/Subtype/Type1C>>stream
HâtT{TÁüawøƒaŸaÆ:;*ñ#ÎÆ[j-FêÉ
Úêàë–.ÀÄ´º‹ÂQ1D“$´ß¶¯à‚Éxå1U|E%ö–b¥*ë†ßßÒ§`h’ı^zNø≈º˙˙cæ◊‹ﬂ˝~˜˜›{YFÌ≈∞,kLÀLJ_∞‘/V»eª-E.óìñdîÂôÁÂÕ/5QDV	T+F?#∞Ï˘ŸÁô%‘_I∏1!àËuƒx3ÅÃKÏtvvy±√jç±8e[ôÏîWó€
ÛÌò_R∫∆È(XQ&˝|ˆlÎt)‹jóbÚJre)cç´L.rI	≈ˆgiâì¬Ú,RLa°4
pINŸ%;+<á?êî.…&ï9myrëÕπJ*…óí≈%ekJei>ıb°†áÀC OrKe+d)”íaëSÔ≈eí≠8OZÚ:5?ﬂaóGãlk$ Èﬂ—vŸYf£s	u„îVñ;Æ<áΩÃQRÏ˙ﬁy±≠H˛,JúíÉFPH›ªd˘«ﬂãr„-3‚2ñx63•<9ü°"≤C∆«ãÀ1"√Lˆg~°eÊ3ÕsìakΩò$è‘…L
sèù»f≤ÿŸl/˚ÿkÆWÆ◊)ïUU¨∫•^§Æ÷MÖf´Êcê,Ú!–
⁄9⁄˜¥óµÛˆNÒvxøÔ›Î#˘,˜πÏ„õÎª›˜”1‹òÖc*∆†ﬂ+~€¸ûç]4∂é„∏xn∑õªÕ=OÒﬂËS7S◊®Îà®8pW?]üØ_ÔÊM¸t~|O}á2‘¡“1§CUØVÍÜè‘hƒOú[40@P¬Ûx6#õµ#$gtsëÓârN¨–≥„8Ë¨ÓÖ™^õgÿQ©ouÌ¯ì5|oç“		¬ı¶∂∂∂&˚Ç»Zª›^€÷'N™Pÿü:–ÌÔÑ’]®C›ÍdDäâÑÅˇo‡n˙oá¸G5õGŒ˜à6\ß	'&‡Ø*ûU≤¨ÇÙ·aZmhF…Ä“q4?@´Ë&`*§ﬁ£uÑª`°»·ı]4D£UàBö(ÓXèÉ$H60O´»ÕTNUB
ÖYÓ®¿BÔ√@-rmŒ(‡Ï—SzñﬂzrkJœÈË'@œn#g◊@†ñ´+€IØÈ´Ä÷skµ˘U+ﬁcµœ˛∞Ôñ€ AZNÇ*eO¬a’Ix$†/ﬂˇB0XµN›\1\U…÷¡7™∫j‘Ë^Éj¬5V*ŸùVQ¡,≈OÄƒm∫ª∂Ábú8WãâØg$%Ø=q"Ü∞È¨¢°`+$¿2h ¿h,®¡DÃπ∆›J› j¢«W_–p÷$mTuZÅy¸fòD3âk¨µ≤¡s°a‘Hy‘Ó"õ[˜=~‰´õ¡˝7\˙ª∏ÿÎ8Mq1¯íX
¢ˆ÷∆Õ›j_Ò‚y5´í“i«”LÀöâzÉ?¨\SuÉ˙] b ç{2ùı¬˜ÌªPß≈ÒW#`¢»YG¡Ô˛Ωó≠Õ∆-¢g€±5@@ÙEDCL,E&=[Owµ∑î&à|_Zyf™òm&¸Ì”§Ø9-)˘wKcì™O›YoÙD°4†ÃJ∂‘ y2Í=xW@â–¯Z47ç∞	C)£–´†^®d‚4ÇÎFR5îıCpÅ:˚!0†÷{±Pægî®·DaDC¯˛’#Ç¬üi€‘≤Ôÿ¯+;W¢œå’Ø•%øıEª≈ﬂí»ÙŸ„!Ò‘3òÍ| 8A‰˚SlkÛKçÎ…6¯•ö_®”ÍÀ†æô>≥ôÍ¬”{ûÚäí©Ï`‚zÀâ©„ÒçZÃ¿låŸá·™ë
·◊øÅY¿g¢>9€ïÔ2Æ?Lûº€€+Ú È´2ç¯3¸\¯∂Â»Eëz°E6Õy+5÷»+Ò5üıoïFÈ€¢ƒ´Zh@®É≥Z4‚‚T,(«ho0ë=ê}J¿f{Éóvî&Mü¨QöÙÈD™Áã'‚7C∂ÚGìnŸ◊œ~mŒvëæﬂPÔÆ˝WŒ¿yÅ÷¢ôÅ∆¨˝âΩï‚z-ˇxŒZ{l∏Å¢π}M∏ºÁP{˚ûïãJV⁄l%á˛,Úè◊·U·ÍéŒ+Wvd.åØZíòXıIè8Jƒ‚Ü÷DxJƒ<™◊–Aò-‡ÑÜÅﬂ¸c<º—Èƒ8!=ra¯+ŒBæ›˙ÆˆΩÌ568»îu——"?¥ºÍÉÛ‘§∫ÑØ∂\∫÷≥uÒÀESπúûQ~‰[—S≤ _∂Aûí≈`≤˙ª˛w@7HµlWUÌp^PA7“Hæ˙ª◊G—æptıï˙zÂ<ˇeΩ¬»!0i ùB:ÖLŒ—`·æFù–@æ¿õö™\_ΩV=ÑT∑æ„E†∆+APKh"D~2Í˚Yó"∑z
FπæÎOü}iÄâ≥N¢ØàÔô$ú#◊9∆îFsI®∫ã¬∫€]ŸŒ8c·.UªïV∑˛0ıæÄz©ú¸#•V)ûº&Ã≈¬R¥`µ¢
E~ “é¿8∞1Ñ†E.]ö\t
!g«ç"ˇË Óú)Fn®ﬁ≠lp≥©”$⁄I.A%ÅåN⁄ù˘0≥çX3 Ós^å†ØÛJeR®q·öÍ©VKËI;(çY’A€Ú?s3¯‚N˙„m:øMnÒt‘j™m˜OmÉËç›?µôB5¨v/®Ä‹¶[ÇƒÉ8ÕÕ∑”rnP60uQ?ÜcR˙ˇãÔ*çä‚ ¬"÷+»8}HóMzhS"A«%"QlçKBÄ®GY≈ÄQÇäÑUÊ4¥8jç4jDM£D@ë%ÇÄÇqT\"HLÇGâc2…Ü	gflo1Ø=gÓ´M~d~pËWU˜ΩÔ.ﬂwÔ£;ÈÆZ™_QhÈj=⁄Q£5!c©ERQÉÎ#o^hY≤aì.E·-´∏›#
≠óè.	” IÓ¡∆WŒzó=Ç•–p^C›h9] Â4M*—ØIc·±á(gˆÚÈt∆`õfWÑµ5ÅΩ©@«±è/Œﬁû}≤W,•Íxûé´õ
”¡˝÷5ò.JxEßmØÁë¬Sc˘ã}0ô‚x‚Ehº4¬‡
G=ˆÇŒDa¿(K˝63)‘„µOÍ∑¡ÄC≤<∏Ÿ]µƒ⁄ÈE¨{©ÀD@∞vq¨A	Rg≤vÅëo"n÷|ŒH^ìÚ9GÉ£p‘∞mG ©•\>÷\th§∂åÑzKéÂÀœéïﬂjƒR√™ëJÉ¯„(∫	êêØ”¯ë*ƒÚtÜ`Û7òﬂFM1x{yæÜQ—à®∑@ÇEN¿Ï—‘ﬂ!0Ò]0ÂIƒÍÆ•{‰™Î$∑+>ıéŸƒJé%Ø}¢m”!^AH&=V	èª…óµqK≈$¯iu≥∫´£v"Hw»ÂcõÇM⁄›ÙÂ¸§Çds⁄ü¿c/I6‹ê˜≠¶eµ˝˘S$Â„æ√ı7a€|Á#ÂgD—h£\)‰"ce™?UË/ÖTU"O’7√\Q¯<v√¥í⁄Èl)ˆg9ˇÚ≠«œ∏4>˝•(‹i/ãY¢ÒÅó_o«ˆ8—À%¸W¬`¬˚¢„£∏©À\÷%Ωø8Ω©K,·e’ÔGû»≈yêÕ:/Äáµ‹©#”U[˝ù©ﬂ”¨¸rxˆ1ÿ¡˛,,•AÔì∂dI∆≈ØpÕ≥–≥úH˚Ì–tO◊p∞Ç∞TsÿQ]≠«∏\‚.„pr¯”yÏsÂæ·,«gòCÓIEÿèÔYã8\Ä33âP∑ çd.‚rÆºX`[åV˝^©‘Ê©ä˙—ßxíAŒøié\˜~ÊÉÖ£≥àÕú	ô}É(ölÜà `WX}9ZÉ>◊∞BÚe4ôL+Ò®P…)vıí®0†¨ 5Âë‚8¿ÇJé™"æ±¥¢±πxsÙFCfÙ6q°ûZ¶ßDGªªºS3ÔÁõÊéœE‘˝Ó-ªıÖ8Ω™sÀŒπ¿I~0æõÍ&y≠£N‚VTD6®ﬂK›∞!´ÊÙŸ“„≈√ªÀ
?3;( ñô·âº“îÕÿÚ^Q»B∑KU‡x∞ÛjÁ¡ ÍH≥¸≥;¡Q§"≈7júM.ô¯à™z}õ∏˜!"√ÔS.<Vø6Qk=ã£gLá!ªr‹’È*-ÖAK˚®@è4Ö∆w£ZÇ˚ïª‡*b√õ≠èâZë›é˙Ôt†≥˚¬˛‡pÒ7N<É∑x^Á’Qx˛2<Ï) ÄHıF“î[ÆAX:l
B+çº†Æ≠æ‰\é·Éﬂ¡ÑÅ_CÃWUÛ0o#å°s®uAmuŸáí	Œù=‚ë:ë•;“c£4´2Æ]◊6Òﬂç+·œ∫‘~i‘ºv[@*¸4îõ¶ÏE∞˝ΩŒ JÅ˜ﬁl!’ÊÉÖÖªÚ
ëbˇ‰Ö~”Ê‘¸Õœêßj˝}gÙä2∫¸ÔoÄ[≥~x8ìıMëæÑb7	´¢z§ZïP`‰;R"ã◊kË‘t:Ö*iD˚[0ˆLS˘©
≠…áÑ§≠ÖSô{∑jÖ‘≠Ö;Ã≈.[·‘Ãõ·»≥9◊o¡´¢¥èi%m¿u†ıj˚·’Ù%èåÂ+Wnª˘∆=b∑c°—æ}Äa“Y^Ÿr∫X*ZyÙioY’2ge‰_¢RD#d≤å£am⁄˜®Á—Ë<sºﬂá÷/∞˜‘gH˙ÔÛˆ´síWÔÿπÀ¥SúÃÁ9íwHN5≠?i•€T‰ü€ï…√™4õùM˜Eò≈∑ﬁ û¶p0ùQÚ.√±≈ﬂZ≈•?2@åê£hXY‡XU√¸cÒeÓ)m&
≠≤óO»µä™3Eõ◊à÷ÒlÕˇf-i¯ˇ¨Ω‰±,"1H/I{VTırÕ µi´cq˙⁄©ö∑≈otüpÁw‚'|!G0"5,˜Ó\g÷Ïf¶∞´@ã)àªKù4OÅ˘"x∂˝Ç‘à˙ÖŒœ’Rœ–)tπñ©‹ÿΩwª;äC∞Z]∂Ñø˚—]ãi§3ı‡eÅ'£Pwˇµ≠+U¯ôﬁD÷V÷Í/å[+ÙŸ∏∫^ë¿p^íΩ¸ıˆ'ûmã·}F»Á$≈Õ«…¿ZÏ2ÚÁ÷óÑéP”∆Àµ%Mï8)®PjÉ¨HBãnA/ªÌÿYsQ^û„ ÁÔÿûøC≥)<â≈æÓ6C'GOYNt<∆^i˚/¸X>™tﬁ≠È]¨áøu ◊˜·ôŸïò]Ud(-w©Ø:R˚≈°‰PúJ…``}ëæÏÌπ∏!≤7{ﬁ`,w¸Øeô±.kìÙÎ"7W∑à≈<í˝£!oFwôÍ…Ω»P‰1Ωäh®›ë8ÛyEAAï¯3ü∑}[ﬁ6Õ€7j·jN"o7)(ÌY°§√∑lB“–aêíΩ•§MîxL´◊Ûëﬂ_>wÙb%SØ8ôv{$?{Há*#Y$©8Ak≠Â`6çT+˜3H√õ’Ë%%x‡-·ìa?a89„'Bló§ƒÓ¯ïU…¡,ÃÙÈ2|`$>¯íN%K‰≈r∂¿›≤lÁ~"ÖÿC¶4^ı6x…ßæBÕx3¨‚¿ç‹ü{‘á˝¢ÓPÖ◊93˚Bg£øπô˙®:L®.ˇ≥ZpñÚÿÊæV<ÈM…Aﬁq˙Òﬁ«ÈI´4ŸŸ˘¶l≠B⁄?<f¿ÂpﬁY†≈b?|oE…ì.$:ZÄ¶:(‡ËB´ßÍL‰≠„Ü»#®Cˇßø˛ø7àı]˘ŒÚÚ˜]`KRX=ˇŒ%T˙ù%Âª\ w·2K¯ã”eêzÆﬂ¿6©√o.õèoj”e∆<Áò˜˛x%jŒ˛˝÷o÷Nˆﬂ7[≤ö≥ˇê˘ûŒzÉΩÁèÇËÂ? Œ‡40uú˝Œ•≠æK£˘Ÿ˜e„Ô%”D°5õµ]ÏHï≈9`eq£≤®ù˘3nÊÔ†ôﬂïf≤}_:È—§?á&≥WÕ˘7Áw÷t†»˚I^NÁ¸ ı]é˚‚ÙÈ'NúæöáÁ=êû8y‚DﬁæÔ-"?
E ïÒ›endstreamendobj27 0 obj<</AIS false/BM/Normal/CA 1.0/OP true/OPM 1/SA false/SMask/None/Type/ExtGState/ca 1.0/op true>>endobj26 0 obj<</Length 39845>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 146.16 675.9243 cm
0 0 m
0 19.002 l
S
Q
q 1 0 0 1 146.16 665.1724 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 146.16 654.6705 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 146.16 622.1647 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 146.16 611.9128 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 36 611.4128 cm
0 0 m
110.16 0 l
S
Q
q 1 0 0 1 146.16 611.4128 cm
0 0 m
70.92 0 l
S
Q
0.5 w 
q 1 0 0 1 36 570.4809 cm
0 0 m
110.16 0 l
S
Q
q 1 0 0 1 146.16 570.4809 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 217.08 570.4809 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 217.08 675.9243 cm
0 0 m
0 19.002 l
S
Q
q 1 0 0 1 217.08 665.1724 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 217.08 654.6705 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 217.08 622.1647 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 217.08 611.9128 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 217.08 611.4128 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 36 723.6481 cm
0 0 m
110.16 0 l
S
Q
q 1 0 0 1 146.16 723.6481 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 217.08 723.6481 cm
0 0 m
70.92 0 l
S
Q
0.5 w 
q 1 0 0 1 146.16 695.4262 cm
0 0 m
0 27.722 l
S
Q
q 1 0 0 1 217.08 695.4262 cm
0 0 m
0 27.722 l
S
Q
q 1 0 0 1 36 695.1762 cm
0 0 m
110.16 0 l
S
Q
q 1 0 0 1 146.16 695.1762 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 217.08 695.1762 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 36 654.4205 cm
0 0 m
110.16 0 l
S
Q
q 1 0 0 1 146.16 654.4205 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 217.08 654.4205 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 36 643.6685 cm
0 0 m
110.16 0 l
S
Q
q 1 0 0 1 146.16 643.6685 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 146.16 632.9166 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 217.08 643.6685 cm
0 0 m
70.92 0 l
S
Q
q 1 0 0 1 217.08 632.9166 cm
0 0 m
0 10.502 l
S
Q
BT
0 0 0 1 k
/GS2 gs
/T1_0 1 Tf
-0.017 Tc 8 0 0 8 36 727.2481 Tm
[(T)74.2 (able 5:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Efficac)10.2 (y Results for P)24.2 (atients with )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
0.017 Tw 12.783 0 Td
(ROS1)Tj
/T1_0 1 Tf
0 Tw [(-P)24.2 (ositive NSCLC in TRIDENT)55.2 (-1)]TJ
-0.012 Tc 0.048 Tw 7.6 0 0 8 36 706.5562 Tm
[(Efficac)10.2 (y P)24.3 (arameters)]TJ
16.367 1.062 Td
(ROS1 Inhibitor)Tj
0 Tc 0 Tw 7.6 0 0 8 202.8519 715.0562 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 160.5441 706.5562 Tm
[(Na\357ve P)24.2 (atients)]TJ
0 Tc 0 Tw 7.6 0 0 8 202.6959 706.5562 Tm
( )Tj
-0.012 Tc -0.198 Tw 7.6 0 0 8 171.2693 698.0562 Tm
(\(N)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.875 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
(71\))Tj
0.048 Tw 6.424 2.125 Td
(ROS1 Inhibitor)Tj
0 Tc 0 Tw 7.6 0 0 8 273.8969 715.0562 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 224.43 706.5562 Tm
[(Pretreated P)24.2 (atients)]TJ
0 Tc 0 Tw 7.6 0 0 8 280.9 706.5562 Tm
( )Tj
-0.012 Tc -0.198 Tw 7.6 0 0 8 242.3143 698.0562 Tm
(\(N)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.875 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
(56\))Tj
/T1_2 1 Tf
0.048 Tw -28.639 -1.389 Td
[(Confirmed Overall Response Ra)-9.8 (te,)37.2 ( %)]TJ
0 Tc 0 Tw 7.6 0 0 8 137.4302 686.9443 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 36 678.4443 Tm
(\(95% CI\))Tj
16.778 1.062 Td
[(79% \(68,)37.2 ( 88\))]TJ
9.348 0 Td
[(38% \(25,)37.2 ( 52\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
-26.126 -2.406 Td
( )Tj
EMC 
0.592 0 Td
(Complete Response)Tj
0.012 Tw 17.955 0 Td
(6%)Tj
9.348 0 Td
(5%)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-27.895 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(P)18.2 (artial Response)]TJ
0.012 Tw 17.721 0 Td
(73%)Tj
9.348 0 Td
(32%)Tj
0.048 Tw -27.661 -1.344 Td
[(Dura)-9.7 (tion of Response \(DOR\))]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 112.9276 648.8525 Tm
(a)Tj
7.6 0 0 8 115.2896 646.1885 Tm
(\035)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-10.433 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Median in Months \(95% CI\))Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 115.9625 638.1006 Tm
(b)Tj
7.6 0 0 8 118.4256 635.4366 Tm
(\035)Tj
-0.012 Tc 0.048 Tw 5.58 0 Td
[(34.1 \(25.6,)37.2 ( NE\))]TJ
9.582 0 Td
[(14.8 \(7.6,)37.2 ( NE\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
-26.008 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Range \(months\))Tj
0.012 Tw 16.344 0 Td
(1.4)Tj
0 Tc 0 Tw 1.163 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 0.588 -0.125 Td
[(,)37.2 ( 42.4)]TJ
0 Tc 0 Tw 2.098 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 5.793 -0.125 Td
[(3.6,)37.3 ( 22.9)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.839 -1.469 Td
( )Tj
EMC 
0.592 0 Td
(% DOR \03612 months)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 96.0039 616.5968 Tm
(c)Tj
7.6 0 0 8 98.2702 613.9328 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.493 0 Td
(70)Tj
9.348 0 Td
(48)Tj
-0.017 Tc 0.048 Tw -28.035 -1.479 Td
[(Abbrevia)-9.8 (tions:)37.2 ( CI)]TJ
/Span<</ActualText<FEFF2006>>> BDC 
( )Tj
EMC 
6.078 0 Td
(=)Tj
/Span<</ActualText<FEFF2006>>> BDC 
( )Tj
EMC 
0.732 0 Td
[(confidence inter)-17.8 (val; NE)]TJ
/Span<</ActualText<FEFF2006>>> BDC 
( )Tj
EMC 
8.363 0 Td
(=)Tj
/Span<</ActualText<FEFF2006>>> BDC 
( )Tj
EMC 
0.732 0 Td
[(not evaluable; )37.2 (\223+\224)37.2 ( indica)-9.7 (tes ongoing response)]TJ
0.017 Tw 5.32 0 0 5.6 36 593.7449 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 591.0809 Tm
[(DOR results are based on the upda)-9.8 (ted da)-9.7 (ta as of 19 December 2022.)]TJ
0.017 Tw 5.32 0 0 5.6 36 585.2449 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 582.5809 Tm
[(Median DOR \(95% CI\) are based on Ka)-9.8 (plan-Meier estima)-9.8 (tes.)]TJ
0.017 Tw 5.32 0 0 5.6 36 576.7449 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 41 574.0809 Tm
[(DOR landmark analysis is based on the obser)-17.8 (ved DOR.)]TJ
-0.014 Tc 0.066 Tw 8 0 0 8 36 553.2809 Tm
[(Among )37.5 (TKI-na\357ve )0.6 (pa)-10.2 (tients,)36.7 ( )0.6 (8 )0.6 (had )0.6 (measurable )0.5 (CNS )0.5 (metastases )0.6 (a)-10.3 (t )0.6 (baseline )0.6 (as )0.5 (assessed)-14 ( )]TJ
-0.001 Tc 0.13 Tw 0 -1.044 Td
[(by BICR; responses in intracranial lesions were obser)-18.2 (ved in 7 of these 8 pa)-10.2 (tients.)36 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.044 Td
[(Among the )36.8 (TKI pretrea)-10.2 (ted pa)-10.2 (tients with no prior pla)-10.1 (tinum-based chemothera)-10.2 (py)54.8 (,)36.8 ( 12 had)-15 ( )]TJ
-0.017 Tc 0.057 Tw 0 -1.044 Td
[(measurable CNS metastases a)-9.8 (t baseline as assessed by BICR; responses in intracranial)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(lesions were obser)-17.8 (ved in 5 of these 12 pa)-9.7 (tients.)]TJ
0.015 Tc 0.209 Tw 0 -1.494 Td
[(Among the 56 ROS)40 (1 inhibitor)36.9 (-pretrea)-10 (ted pa)-10.1 (tients,)37 ( 8 had resistance muta)-10 (tions)15 ( )]TJ
-0.009 Tc 0.089 Tw 0 -1.044 Td
[(follo)-10 (wing )36.9 (TKI thera)-10 (py)55 (.)37 ( Responses were obser)-18 (ved in 6 of these 8 pa)-10 (tients; responders)-9 ( )]TJ
0.09 Tw 0 -1.044 Td
[(inc)19.8 (luded pa)-10.2 (tients with solvent front \()]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
0.009 Tw 13.572 0 Td
(ROS)Tj
0 Tc 0 Tw (1)Tj
/T1_2 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
2.04 0 Td
( )Tj
EMC 
-0.009 Tc 0.009 Tw 5.6 0 0 5.6 161.154 493.895 Tm
[(G2032R)-60.2 (\))]TJ
0.09 Tw 8 0 0 8 179.1585 491.231 Tm
[(,)36.8 ( ga)-10.1 (tekeeper \()]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
0.009 Tw 5.168 0 Td
(ROS1)Tj
/T1_2 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
-0.009 Tc 0.009 Tw 5.6 0 0 5.6 237.079 493.895 Tm
[(L2026M)-60.2 (\))]TJ
0.09 Tw 8 0 0 8 255.5988 491.231 Tm
[(,)36.8 ( and other)-9 ( )]TJ
-0.017 Tc 0.048 Tw -27.45 -1.044 Td
[(muta)-9.7 (tions \()]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
0.017 Tw 4.039 0 Td
(ROS)Tj
0 Tc 0 Tw (1)Tj
/T1_2 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
2.006 0 Td
( )Tj
EMC 
-0.017 Tc 0.017 Tw 5.6 0 0 5.6 84.5586 485.5449 Tm
[(S1986F/Y)-59.7 (\))]TJ
0 Tc 0 Tw 8 0 0 8 105.5595 482.8809 Tm
(.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw -8.695 -1.558 Td
(14.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Locally Adv)16.2 (anced or Metastatic )]TJ
/T1_1 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
0.048 Tw [( Gene Fusion-P)24.2 (ositive Solid T)74.1 (umors)]TJ
/T1_2 1 Tf
-0.012 Tc 0.075 Tw -3.375 -1.431 Td
[(The ef\037cac)19.8 (y of )36.8 (AUGTYRO was evalua)-10.2 (ted in )36.8 (TRIDENT)54.8 (-1 \(NCT030931)39.9 (16\),)36.8 ( a multi-center)73.8 (,)25 ( )]TJ
0.005 Tc 0.157 Tw 0 -1.044 Td
[(si)0.5 (ngle)0.5 (-a)0.5 (rm,)37.4 ( )0.6 (op)0.5 (en-)0.5 (lab)0.5 (el,)37.4 ( )0.6 (mu)0.5 (lti)0.5 (-co)0.5 (hor)0.5 (t )0.5 (c)20.5 (lini)0.5 (ca)0.5 (l )0.5 (t)0.5 (rial)0.5 ( )0.5 (i)0.5 (n )0.5 (8)0.5 (8 )0.5 (a)0.5 (dult)0.5 ( )0.5 (pa)-9.5 (tie)0.5 (nt)0.5 (s )0.5 (wi)0.5 (th)0.5 ( )0.5 (loc)0.5 (al)0.5 (ly)5 ( )]TJ
-0.012 Tc 0.074 Tw 0 -1.044 Td
[(advanced or metasta)-10 (tic )]TJ
/T1_3 1 Tf
0.012 Tw (NTRK)Tj
/T1_2 1 Tf
0.074 Tw ( gene fusion-positive \()Tj
/T1_3 1 Tf
0.012 Tw (NTRK1)Tj
(/2/)Tj
0 Tc 0 Tw (3)Tj
/T1_2 1 Tf
-0.012 Tc 0.074 Tw 23.017 0 Td
[(\) solid tumors who had)-12 ( )]TJ
0.076 Tw -23.017 -1.044 Td
[(either received a prior )37.4 (TKI trea)-10.3 (tment or were )37.4 (TKI-na\357ve.)36.7 ( )37.4 (All pa)-10.2 (tients were assessed for)-12 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(CNS lesions a)-10.3 (t baseline,)36.6 ( and pa)-10.3 (tients with symptoma)-10.3 (tic brain metastases were exc)19.6 (luded)-19 ( )]TJ
-0.009 Tc 0.087 Tw 0 -1.044 Td
[(from the trial.)37.3 ( P)18.3 (a)-9.7 (tients received )36.8 (AUGTYRO 160 mg orally once daily for 1)40.3 (4 days,)37.3 ( then)-9 ( )]TJ
-0.003 Tc 0.119 Tw 0 -1.044 Td
[(increased to 160 mg twice daily until disease progression or unacceptabl\e toxicity)55 (.)33.9 ( )]TJ
-0.017 Tc 0.055 Tw 0 -1.044 Td
[(T)74.2 (umor assessments were performed ever)-17.7 (y 8 weeks.)37.2 ( )]TJ
/T1_3 1 Tf
0.017 Tw (NTRK)Tj
/T1_2 1 Tf
0.055 Tw [( gene fusions were identi\037ed)-17 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.044 Td
[(prospectively using NGS in 94%,)36.8 ( FISH in 5%,)36.8 ( and PCR in 1%.)36.8 ( )]TJ
/T1_3 1 Tf
0.018 Tw (NTRK)Tj
/T1_2 1 Tf
0.036 Tw [( gene fusion-positive)-18 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.044 Td
[(tumors identi\037ed by local FISH testing required central labora)-10.1 (tor)-18.1 (y con\037rma)-10.1 (tion using an)-17 ( )]TJ
-0.008 Tc 0.091 Tw 0 -1.044 Td
[(a)0.5 (n)0.6 (a)0.5 (l)0.6 (y)0.5 (t)0.6 (i)0.5 (c)0.6 (a)0.5 (l)0.6 (l)0.5 (y)0.5 ( v)0.5 (a)0.5 (l)0.6 (i)0.5 (d)0.6 (a)-9.5 (t)0.6 (e)0.5 (d)0.6 ( N)0.5 (G)0.6 (S)0.5 ( t)0.6 (e)0.5 (s)0.6 (t)0.5 (.)37.5 ( )37.2 (T)0.6 (h)0.5 (e)0.6 ( m)0.5 (a)0.6 (j)0.5 (o)0.6 (r)0.5 ( e)0.6 (f)0.5 (\037)0.6 (c)0.5 (a)0.6 (c)20.5 (y)0.5 ( o)0.5 (u)0.5 (t)0.6 (c)0.5 (o)0.6 (m)0.5 (e)0.6 ( m)0.5 (e)0.6 (a)0.5 (s)0.6 (u)0.5 (r)0.6 (e)0.5 (s)0.6 ( w)0.5 (e)0.6 (r)0.5 (e)0.6 ( O)0.5 (R)0.5 (R)0.6 ( a)0.6 (n)0.5 (d)-8 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.044 Td
[(D)0.6 (O)0.5 (R)0.6 ( )0.5 (a)0.6 (c)0.5 (c)0.6 (o)0.5 (r)0.6 (d)0.5 (i)0.6 (n)0.5 (g)0.6 ( )0.6 (t)0.5 (o)0.6 ( )0.5 (R)0.6 (E)0.5 (C)0.6 (I)0.5 (S)0.6 (T)0.5 ( )0.6 (v)0.5 (1)0.6 (.)0.6 (1)0.5 ( )0.6 (a)0.5 (s)0.6 ( )0.5 (a)0.6 (s)0.5 (s)0.6 (e)0.5 (s)0.6 (s)0.6 (e)0.5 (d)0.6 ( )0.5 (b)0.6 (y)0.5 ( )0.6 (B)0.5 (I)0.6 (C)0.5 (R)0.6 (.)37.5 ( )0.6 (I)0.5 (n)0.6 (t)0.5 (r)0.6 (a)0.6 (c)0.5 (r)0.6 (a)0.5 (n)0.6 (i)0.5 (a)0.6 (l)0.6 ( )0.5 (r)0.6 (e)0.5 (s)0.6 (p)0.5 (o)0.6 (n)0.5 (s)0.6 (e)0.6 ( )0.5 (a)0.6 (c)0.5 (c)0.6 (o)0.5 (r)0.6 (d)0.5 (i)0.6 (n)0.5 (g)0.6 ( )0.6 (t)0.5 (o)-15 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
(modi\037ed RECIST v1.1 was assessed by BICR.)Tj
-0.014 Tc 0.062 Tw 0 -1.494 Td
[(Among the 40 )37.1 (TRK )37.1 (TKI-na\357ve pa)-9.7 (tients,)37.4 ( the median a)-9.6 (ge was 61 years \(range:)37.4 ( 25 to 84\);)-14 ( )]TJ
-0.017 Tc 0.056 Tw 0 -1.044 Td
[(60% were female pa)-9.8 (tients; race was )37 (Asian 53%,)37.2 ( )37 (White 25%,)37.2 ( Black or )37 (African )37.1 (American)-17 ( )]TJ
-0.013 Tc 0.07 Tw 0 -1.044 Td
[(5%,)36.9 ( and other or not reported 18%; ethnicity was Hispanic or La)-10.1 (tino 5%,)36.8 ( not Hispanic)-13 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(or La)-10.3 (tino 87%,)36.8 ( and not reported 8%; and ECOG performance sta)-10.2 (tus of 1 a)-10.2 (t baseline was)-19 ( )]TJ
-0.017 Tc 0.037 Tw 0 -1.044 Td
[(55%.)37.2 ( )36.9 (At baseline,)37.2 ( 98% of pa)-9.8 (tients had metasta)-9.8 (tic disease and 23% of pa)-9.7 (tients had CNS)-17 ( )]TJ
0.044 Tw 0 -1.044 Td
[(metastases by BICR.)37.2 ( Seventy percent \(n=28\) of pa)-9.7 (tients received prior systemic thera)-9.8 (py)-17 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.044 Td
[(with a median of one prior systemic regimen,)36.9 ( )0.5 (and )0.5 (7.5% )0.5 (\(n=3\) received three or more)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
(prior systemic regimens.)Tj
-0.008 Tc 0.091 Tw 0 -1.494 Td
[(A)0.5 (m)0.5 (o)0.5 (n)0.5 (g)0.5 ( t)0.5 (h)0.5 (e)0.5 ( 4)0.5 (8 )37 (TR)0.5 (K)0.5 ( )36.9 (T)0.5 (K)0.5 (I)0.5 (-)0.5 (p)0.5 (r)0.5 (e)0.5 (tr)0.6 (ea)-9.4 (te)0.6 (d pa)-9.5 (t)0.5 (i)0.5 (e)0.5 (n)0.5 (t)0.5 (s)0.5 (,)37.5 ( t)0.5 (h)0.5 (e)0.5 ( m)0.5 (e)0.5 (d)0.5 (i)0.5 (a)0.5 (n)0.5 ( a)-9.5 (g)0.5 (e)0.5 ( w)0.5 (a)0.5 (s)0.5 ( 5)0.5 (8)0.5 ( y)0.5 (ea)0.6 (r)0.5 (s \(r)0.5 (a)0.5 (n)0.5 (g)0.5 (e)0.5 (:)37.5 ( 2)0.5 (0)-8 ( )]TJ
-0.01 Tc 0.086 Tw 0 -1.044 Td
[(to )0.5 (81\); )0.5 (48% )0.5 (were )0.5 (female pa)-10.2 (tients; )0.5 (race was )37.4 (White )0.5 (65%,)36.8 ( )37.4 (Asian )0.5 (25%,)36.7 ( )0.5 (Black )0.5 (or )37.5 (African)-10 ( )]TJ
-0.005 Tc 0.111 Tw 0 -1.044 Td
[(American 2%,)36.7 ( and not reported 8%; ethnicity was not Hispanic or La)-10.4 (tino 92%,)36.7 ( and)-5 ( )]TJ
-0.017 Tc 0.049 Tw 0 -1.044 Td
[(missing 8%; and ECOG )0.5 (performance sta)-9.8 (tus of 1 a)-9.8 (t baseline was )0.5 (60%.)37.2 ( )37.4 (At )0.5 (baseline,)37.2 ( )0.5 (96%)-17 ( )]TJ
-0.013 Tc 0.072 Tw 0 -1.044 Td
[(of )0.6 (pa)-10.4 (tients )0.5 (had )0.6 (metasta)-10.4 (tic )0.6 (disease )0.5 (and )0.6 (25% )0.5 (of )0.6 (pa)-10.4 (tients )0.6 (had )0.6 (CNS )0.6 (metastases )0.5 (by )0.6 (BICR.)24 ( )]TJ
-0.014 Tc 0.066 Tw 0 -1.044 Td
[(Seventy-seven percent \(n=37\) of pa)-10.4 (tients received 2 or more prior systemic regimens,)23 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.044 Td
[(and 46% \(n=22\) received three or more prior systemic regimens,)36.9 ( and 7 pa)-10.1 (tients \(15%\))-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(received 2 prior )37.2 (TKI thera)-9.8 (pies.)]TJ
0 -1.494 Td
[(Ef\037cac)20.2 (y results are summarized in )37.3 (T)74.1 (able 6.)]TJ
ET
/GS1 gs
q 1 0 0 1 162 127.9572 cm
0 0 m
0 19.434 l
S
Q
q 1 0 0 1 162 117.2053 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 162 87.2014 cm
0 0 m
0 19.252 l
S
Q
q 1 0 0 1 162 76.4495 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 162 54.9457 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 162 44.6938 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 36 44.1938 cm
0 0 m
126 0 l
S
Q
q 1 0 0 1 162 44.1938 cm
0 0 m
63 0 l
S
Q
0.5 w 
q 1 0 0 1 225 127.9572 cm
0 0 m
0 19.434 l
S
Q
q 1 0 0 1 225 117.2053 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 225 87.2014 cm
0 0 m
0 19.252 l
S
Q
q 1 0 0 1 225 76.4495 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 225 54.9457 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 225 44.6938 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 225 44.1938 cm
0 0 m
63 0 l
S
Q
q 1 0 0 1 36 176.113 cm
0 0 m
126 0 l
S
Q
q 1 0 0 1 162 176.113 cm
0 0 m
63 0 l
S
Q
q 1 0 0 1 225 176.113 cm
0 0 m
63 0 l
S
Q
0.5 w 
q 1 0 0 1 162 147.8911 cm
0 0 m
0 27.722 l
S
Q
q 1 0 0 1 225 147.8911 cm
0 0 m
0 27.722 l
S
Q
q 1 0 0 1 36 147.6411 cm
0 0 m
126 0 l
S
Q
q 1 0 0 1 162 147.6411 cm
0 0 m
63 0 l
S
Q
q 1 0 0 1 225 147.6411 cm
0 0 m
63 0 l
S
Q
q 1 0 0 1 162 65.6976 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 225 65.6976 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 162 106.4534 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 225 106.4534 cm
0 0 m
0 10.752 l
S
Q
BT
/GS2 gs
/T1_0 1 Tf
-0.004 Tw 8 0 0 8 36 188.213 Tm
[(T)74.2 (able )-3.8 (6:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Efficac)10.2 (y Results for P)24.2 (atients with )]TJ
/T1_1 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
-0.004 Tw [( )-60.1 (Gene Fusion-P)24.2 (ositive T)74.2 (umors)-17 ( )]TJ
0 Tw 0 -1.062 Td
[(in TRIDENT)55.2 (-1)]TJ
-0.012 Tc 0.048 Tw 7.6 0 0 8 36 159.0211 Tm
[(Efficac)10.2 (y P)24.3 (arameters)]TJ
0.012 Tw 18.849 1.062 Td
(TKI-Na\357ve)Tj
0 Tc 0 Tw 7.6 0 0 8 207.7474 167.5211 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 181.6077 159.0211 Tm
[(P)24.2 (atients)]TJ
0 Tc 0 Tw 7.6 0 0 8 205.3923 159.0211 Tm
( )Tj
-0.012 Tc -0.198 Tw 7.6 0 0 8 183.1493 150.5211 Tm
(\(N)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.875 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
(40\))Tj
0.012 Tw 5.359 2.125 Td
(TKI-Pretreated)Tj
0 Tc 0 Tw 7.6 0 0 8 278.0316 167.5211 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 244.7327 159.0211 Tm
[(P)24.2 (atients)]TJ
0 Tc 0 Tw 7.6 0 0 8 268.5173 159.0211 Tm
( )Tj
-0.012 Tc -0.198 Tw 7.6 0 0 8 246.2743 150.5211 Tm
(\(N)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.875 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
(48\))Tj
0.048 Tw -29.16 -1.416 Td
(Confirmed Overall Response Rate)Tj
/T1_2 1 Tf
-0.049 Tc -0.161 Tw /Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
13.025 0 Td
[(, )-245.8 (%)]TJ
0 Tc 0 Tw 7.6 0 0 8 144.3047 139.1932 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 36 130.6932 Tm
(\(95% CI\))Tj
0.012 Tw 20.25 1.062 Td
(58)Tj
0 Tc 0 Tw 7.6 0 0 8 197.1016 139.1932 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 182.8313 130.6932 Tm
[(\(41,)37.2 ( 73\))]TJ
0.012 Tw 9.236 1.062 Td
(50)Tj
0 Tc 0 Tw 7.6 0 0 8 260.2266 139.1932 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 245.9563 130.6932 Tm
[(\(35,)37.2 ( 65\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
-27.626 -1.371 Td
( )Tj
EMC 
0.592 0 Td
[(Complete Response,)37.2 ( %)]TJ
0.012 Tw 19.658 0 Td
(15)Tj
0 Tc 0 Tw 8.54 0 Td
(0)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.79 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(P)18.2 (artial Response,)37.2 ( %)]TJ
0.012 Tw 19.658 0 Td
(43)Tj
8.306 0 Td
(50)Tj
/T1_0 1 Tf
0.048 Tw -28.556 -1.344 Td
(Median Duration of Response)Tj
/T1_2 1 Tf
0.093 Tw /Span<</ActualText<FEFF2004>>> BDC 
( )Tj
EMC 
(\(mDOR\))Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 146.966 100.8854 Tm
(a)Tj
7.6 0 0 8 149.328 98.2214 Tm
(\035)Tj
7.6 0 0 8 151.3591 98.2214 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 36 89.7214 Tm
(in Months \(95% CI\))Tj
0.012 Tw 20.22 1.062 Td
(NE)Tj
0 Tc 0 Tw 7.6 0 0 8 197.3259 98.2214 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 182.3828 89.7214 Tm
[(\(NE,)37.2 ( NE\))]TJ
0.012 Tw 9.181 1.062 Td
(9.9)Tj
0 Tc 0 Tw 7.6 0 0 8 261.0922 98.2214 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 242.4475 89.7214 Tm
[(\(7.4,)37.2 ( 13.0\))]TJ
-27.164 -1.344 Td
(Range \(months\))Tj
0.012 Tw 18.499 0 Td
(3.7)Tj
0 Tc 0 Tw 1.163 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 0.588 -0.125 Td
[(,)37.2 ( 43.9)]TJ
0 Tc 0 Tw 2.098 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 4.751 -0.125 Td
[(1.8,)37.3 ( 26.5)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-30.36 -1.469 Td
( )Tj
EMC 
0.592 0 Td
(% with DOR \0366 months)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 106.1359 70.8816 Tm
(b)Tj
7.6 0 0 8 108.5991 68.2176 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.697 0 Td
(87)Tj
8.306 0 Td
(71)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.556 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(% with DOR \0369 months)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 106.1359 60.1297 Tm
(b)Tj
7.6 0 0 8 108.5991 57.4657 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.697 0 Td
(83)Tj
8.306 0 Td
(63)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.556 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(% with DOR \03612 months)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 109.6912 49.3778 Tm
(b)Tj
7.6 0 0 8 112.1543 46.7138 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.229 0 Td
(83)Tj
8.306 0 Td
(42)Tj
/T1_3 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 255.24 36 Tm
(\(Continued\))Tj
ET
/GS1 gs
q 1 0 0 1 324 682.7162 cm
0 0 m
126 0 l
S
Q
q 1 0 0 1 450 682.7162 cm
0 0 m
63 0 l
S
Q
q 1 0 0 1 513 682.7162 cm
0 0 m
63 0 l
S
Q
1 w 
q 1 0 0 1 324 715.1481 cm
0 0 m
126 0 l
S
Q
q 1 0 0 1 450 715.1481 cm
0 0 m
63 0 l
S
Q
q 1 0 0 1 513 715.1481 cm
0 0 m
63 0 l
S
Q
BT
/GS2 gs
/T1_0 1 Tf
-0.004 Tw 8 0 0 8 324 727.2481 Tm
[(T)74.2 (able )-3.8 (6:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Efficac)10.2 (y Results for P)24.2 (atients with )]TJ
/T1_1 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
-0.004 Tw [( )-60.1 (Gene Fusion-P)24.1 (ositive T)74.2 (umors)-17 ( )]TJ
0 Tw 0 -1.062 Td
[(in TRIDENT)55.2 (-1)]TJ
/T1_2 1 Tf
0.048 Tw 7.6 0 0 8 324 705.8362 Tm
(NE)Tj
/Span<</ActualText<FEFF2006>>> BDC 
( )Tj
EMC 
1.134 0 Td
(=)Tj
/Span<</ActualText<FEFF2006>>> BDC 
( )Tj
EMC 
0.732 0 Td
[(not evaluable; )37.2 (\223+\224)37.2 ( indica)-9.7 (tes ongoing response)]TJ
0.017 Tw 5.32 0 0 5.6 324 697.4802 Tm
(a)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 694.8162 Tm
[(Median DOR \(95% CI\) are based on Ka)-9.8 (plan-Meier estima)-9.8 (tes.)]TJ
0.017 Tw 5.32 0 0 5.6 324 688.9802 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 329 686.3162 Tm
[(DOR landmark analysis is based on the obser)-17.8 (ved DOR.)]TJ
-0.015 Tc 0.06 Tw 8 0 0 8 324 666.7762 Tm
[(Among the 88 pa)-10 (tients,)36.9 ( 5 had measurable CNS metastases a)-10.1 (t baseline as assessed by)-15 ( )]TJ
-0.017 Tc 0.036 Tw 0 -1.044 Td
[(BICR.)37.2 ( Responses were seen in 2 \(100%\) )36.7 (TKI-na\357ve pa)-9.8 (tients and 3 \(100%\) )36.7 (TKI-pretrea)-9.7 (ted)-17 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.009 Tc 0.088 Tw -31.5 -1.044 Td
[(pa)-9.7 (tients.)37.2 ( )0.5 (One out of )0.5 (2 )37.5 (TKI-na\357ve and )0.5 (2 )0.5 (out )0.5 (of 3 )37.4 (TKI-pretrea)-9.8 (ted pa)-9.7 (tients received )0.5 (prior)-9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(radiothera)-9.8 (py to the brain,)37.2 ( all more than 2 months prior to stud)-9.8 (y entr)-17.8 (y)55.2 (.)]TJ
-0.007 Tc 0.096 Tw 0 -1.629 Td
[(T)74.4 (w)0.5 (en)0.5 (ty)0.5 (-s)0.5 (ix)0.5 ( o)0.5 (f t)0.5 (he )36.7 (T)0.5 (RK )36.7 (TK)0.5 (I-)0.5 (pr)0.5 (et)0.5 (re)0.5 (a)-9.6 (t)0.5 (ed)0.5 ( pa)-9.5 (tie)0.5 (nt)0.5 (s h)0.5 (ad a)0.5 ( r)0.5 (es)0.5 (is)0.5 (ta)0.5 (nc)0.5 (e mu)0.5 (ta)-9.5 (t)0.5 (ion)0.5 ( a)-9.5 (t)0.5 ( b)0.5 (as)0.5 (el)0.5 (in)0.5 (e,)30 ( )]TJ
-0.013 Tc 0.067 Tw 0 -1.044 Td
[(inc)20.4 (luding )0.5 (24 with )0.5 (solvent f)0.5 (ront m)0.5 (uta)-9.6 (tions)0.5 ( \()]TJ
/T1_3 1 Tf
0.013 Tw (NTR)Tj
0 Tc 0 Tw (K)Tj
17.341 0 Td
(1)Tj
/T1_2 1 Tf
-0.013 Tc 0.013 Tw 5.6 0 0 5.6 466.7784 623.0101 Tm
(G595R)Tj
0.067 Tw 8 0 0 8 480.3806 620.3461 Tm
( and )Tj
/T1_3 1 Tf
0.013 Tw 1.917 0 Td
(NTRK)Tj
0 Tc 0 Tw (3)Tj
/T1_2 1 Tf
-0.013 Tc 0.013 Tw 5.6 0 0 5.6 516.2838 623.0101 Tm
[(G623L/)0.5 (R/E/V)]TJ
0.067 Tw 8 0 0 8 541.7722 620.3461 Tm
[( mut)0.5 (a)-9.6 (tions\),)24 ( )]TJ
-0.018 Tc 0.036 Tw -27.222 -1.044 Td
[(one with both a solvent front muta)-10.1 (tion and a ga)-10.1 (tekeeper muta)-10.1 (tion \()]TJ
/T1_3 1 Tf
0.018 Tw (NTR)Tj
0 Tc 0 Tw (K)Tj
25.875 0 Td
(1)Tj
/T1_2 1 Tf
-0.018 Tc 0.018 Tw 5.6 0 0 5.6 535.0146 614.6602 Tm
(F589L)Tj
0.036 Tw 8 0 0 8 547.5509 611.9962 Tm
[(\),)36.8 ( and one)-18 ( )]TJ
-0.016 Tc 0.06 Tw -27.944 -1.044 Td
[(with)0.5 ( ano)0.5 (ther )0.5 (muta)-9.5 (tion )0.5 (\()]TJ
/T1_3 1 Tf
0.016 Tw (NTR)Tj
0 Tc 0 Tw (K)Tj
10.35 0 Td
(1)Tj
/T1_2 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
0.464 0 Td
( )Tj
EMC 
-0.016 Tc 0.016 Tw 5.6 0 0 5.6 410.7145 606.3101 Tm
[(G66)0.5 (7C)]TJ
0.06 Tw 8 0 0 8 424.5682 603.6461 Tm
[(\).)37.4 ( )0.5 (In the)0.5 ( 25 )37.4 (TKI)0.5 (-pret)0.5 (rea)-9.6 (t)0.5 (ed pa)-9.5 (tien)0.5 (ts wit)0.5 (h sol)0.5 (vent)0.5 ( fron)0.5 (t)-16 ( )]TJ
-0.017 Tc 0.048 Tw -12.571 -1.044 Td
[(muta)-9.7 (tions a)-9.8 (t baseline,)37.3 ( ORR was 60% \(95% CI:)37.2 ( 39,)37.2 ( 79\).)]TJ
-0.004 Tc 0.113 Tw 0 -1.629 Td
[(ORR and DOR by tumor type in adult pa)-9.8 (tients with )]TJ
/T1_3 1 Tf
0.004 Tw (NTRK)Tj
/T1_2 1 Tf
0.113 Tw [( gene fusion-positive solid)-4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(tumors are presented in )37.2 (T)74.2 (ables 7 and 8 belo)-9.7 (w)37.2 (.)]TJ
ET
0.5 w 
/GS1 gs
q 1 0 0 1 415.08 508.8684 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 415.08 498.1165 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 465.8608 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 446.6089 cm
0 0 m
0 19.252 l
S
Q
q 1 0 0 1 415.08 425.105 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 414.3531 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 403.6012 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 393.3493 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 323.9999 392.8493 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 392.8493 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 443.8799 392.8493 cm
0 0 m
39.78 0 l
S
Q
0.5 w 
q 1 0 0 1 323.9999 362.9374 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 362.9374 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 443.8799 362.9374 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 362.9374 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 523.4399 362.9374 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 443.8799 508.8684 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 443.8799 498.1165 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 465.8608 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 446.6089 cm
0 0 m
0 19.252 l
S
Q
q 1 0 0 1 443.8799 425.105 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 414.3531 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 403.6012 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 393.3493 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 523.4399 392.8493 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 323.9999 542.5642 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 542.5642 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 523.4399 542.5642 cm
0 0 m
52.56 0 l
S
Q
0.5 w 
q 1 0 0 1 415.08 531.0923 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 415.08 519.8704 cm
0 0 m
0 11.222 l
S
Q
q 1 0 0 1 523.4399 531.0923 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 323.9999 519.6204 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 519.6204 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 523.4399 519.6204 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 415.08 435.857 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 435.857 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 508.8684 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 523.4399 508.8684 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 483.6599 498.1165 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 498.1165 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 465.8608 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 465.8608 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 446.6089 cm
0 0 m
0 19.252 l
S
Q
q 1 0 0 1 523.4399 446.6089 cm
0 0 m
0 19.252 l
S
Q
q 1 0 0 1 483.6599 435.857 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 435.857 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 425.105 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 425.105 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 414.3531 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 414.3531 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 403.6012 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 403.6012 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 393.3493 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 523.4399 393.3493 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 483.6599 392.8493 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 443.8799 542.5642 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 542.5642 cm
0 0 m
39.78 0 l
S
Q
0.5 w 
q 1 0 0 1 443.8799 531.3423 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 523.4399 531.3423 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 443.6299 531.0923 cm
0 0 m
40.03 0 l
S
Q
q 1 0 0 1 443.8799 519.8704 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 483.6599 531.0923 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 519.8704 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 523.4399 519.8704 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 443.8799 519.6204 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 519.6204 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 415.08 487.3646 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 487.3646 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 487.3646 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 487.3646 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 476.6127 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 476.6127 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 476.6127 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 476.6127 cm
0 0 m
0 10.752 l
S
Q
BT
/GS2 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 323.9999 554.6642 Tm
[(T)74.2 (able 7:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Efficac)10.2 (y Results by T)74.2 (umor T)55.2 (ype in TKI-na\357ve )]TJ
/T1_1 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
0 Tw [( )-59.8 (Gene Fusion)-17 ( )]TJ
0.017 Tw 0 -1.062 Td
[(P)24.2 (atients)]TJ
-0.012 Tc 0.048 Tw 7.6 0 0 8 323.9999 533.9723 Tm
[(T)74.2 (umor type)]TJ
0.012 Tw 12.314 -0.186 Td
[(P)24.2 (atients)]TJ
0 Tc 0 Tw 7.6 0 0 8 441.3722 532.4863 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 419.3531 523.9863 Tm
(\(N=40\))Tj
7.64 1.248 Td
(ORR)Tj
-0.211 Tw 8.7 0 Td
(DOR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
1.662 0 Td
( )Tj
EMC 
(\035)Tj
0.048 Tw -13.211 -1.434 Td
(n \(%\))Tj
4.909 0 Td
(95% CI)Tj
4.372 0 Td
(Range \(months\))Tj
/T1_2 1 Tf
0.012 Tw -26.617 -1.389 Td
(NSCLC)Tj
13.405 0 Td
(21)Tj
0.048 Tw 3.677 0 Td
(13 \(62\))Tj
5.368 0 Td
[(38,)37.2 ( 82)]TJ
0.012 Tw 5.042 0 Td
(3.7)Tj
0 Tc 0 Tw 1.163 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 0.588 -0.125 Td
[(,)37.2 ( 31.3)]TJ
0 Tc 0 Tw 2.098 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw -31.341 -1.469 Td
(Thyroid Cancer)Tj
0 Tc 0 Tw 13.639 0 Td
(5)Tj
-0.012 Tc 0.048 Tw 3.443 0 Td
(5 \(100\))Tj
5.134 0 Td
[(48,)37.2 ( 100)]TJ
5.57 0 Td
[(4.7,)37.2 ( 43.9)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw -31.047 -1.469 Td
[(Salivar)-17.8 (y Gland Cancer)]TJ
0 Tc 0 Tw 13.639 0 Td
(3)Tj
-0.012 Tc 0.048 Tw 3.096 0 Td
(3 \(100.0\))Tj
5.481 0 Td
[(29,)37.2 ( 100)]TJ
0.012 Tw 5.042 0 Td
(17.7)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw 0.588 -0.125 Td
[(,)37.2 ( 31.4)]TJ
0 Tc 0 Tw 2.098 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-31.575 -1.469 Td
( )Tj
EMC 
0.592 0 Td
[(Secretor)-17.7 (y carcinoma)]TJ
0 Tc 0 Tw 13.047 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(23.0)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw -30.232 -1.469 Td
[(Sarcoma,)37.2 ( Soft tissue)]TJ
0 Tc 0 Tw 13.639 0 Td
(3)Tj
-0.012 Tc 0.048 Tw 3.677 0 Td
(1 \(33\))Tj
5.02 0 Td
[(0.8,)37.2 ( 91)]TJ
0.012 Tw 6.265 0 Td
(14.7)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw -30.232 -1.469 Td
(Breast Cancer)Tj
0 Tc 0 Tw 7.6 0 0 8 362.7787 457.6289 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 323.9999 449.1289 Tm
(\(adenocarcinoma\))Tj
0 Tc 0 Tw 13.639 0.531 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.5 0 Td
[(PD,)37.2 ( PD)]TJ
0.012 Tw 5.964 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
-29.195 -1.875 Td
(Other*)Tj
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.481 0 Td
[(SD,)37.2 ( SD)]TJ
0.012 Tw 5.983 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
-29.195 -1.344 Td
(Glioblastoma)Tj
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.23 0 Td
(SD)Tj
5.234 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
-29.195 -1.344 Td
(Cholangiocarcinoma)Tj
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.239 0 Td
(PD)Tj
5.225 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
0.048 Tw -29.195 -1.344 Td
(Colorectal cancer)Tj
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.23 0 Td
(SD)Tj
5.234 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
0.048 Tw -29.195 -1.344 Td
[(P)18.2 (eripheral Ner)-17.8 (ve Shea)-9.7 (th )37.2 (T)74.2 (umor)]TJ
0 Tc 0 Tw 13.639 0 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(23.0)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
-0.017 Tc 0.048 Tw -30.232 -1.604 Td
(*)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.658 0 Td
[(Inc)20.2 (ludes esopha)-9.8 (geal cancer and head and neck cancer)]TJ
-0.658 -1.062 Td
[(PD:)37.2 ( progressive disease; PR:)37.2 ( partial response; SD:)37.2 ( stable disease; NA:)37.1 ( not a)-9.8 (pplicable)]TJ
0 -1.062 Td
[(\223+\224)37.2 ( indica)-9.8 (tes ongoing response)]TJ
ET
/GS1 gs
q 1 0 0 1 415.08 293.6797 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 415.08 261.424 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 250.6721 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 239.9202 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 229.1683 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 218.4164 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 207.6644 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 196.9125 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 186.1606 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 323.9999 126.2449 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 126.2449 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 443.8799 126.2449 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 126.2449 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 523.4399 126.2449 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 443.8799 293.6797 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 443.8799 261.424 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 250.6721 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 239.9202 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 229.1683 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 218.4164 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 207.6644 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 196.9125 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 186.1606 cm
0 0 m
0 10.752 l
S
Q
1 w 
q 1 0 0 1 323.9999 327.3755 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 327.3755 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 523.4399 327.3755 cm
0 0 m
52.56 0 l
S
Q
0.5 w 
q 1 0 0 1 415.08 315.9036 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 415.08 304.6817 cm
0 0 m
0 11.222 l
S
Q
q 1 0 0 1 523.4399 315.9036 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 323.9999 304.4317 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 304.4317 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 523.4399 304.4317 cm
0 0 m
52.56 0 l
S
Q
q 1 0 0 1 415.08 175.4087 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 175.4087 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 293.6797 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 523.4399 293.6797 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 483.6599 261.424 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 261.424 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 250.6721 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 250.6721 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 239.9202 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 239.9202 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 229.1683 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 229.1683 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 218.4164 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 218.4164 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 207.6644 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 207.6644 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 196.9125 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 196.9125 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 186.1606 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 186.1606 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 175.4087 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 175.4087 cm
0 0 m
0 10.752 l
S
Q
1 w 
q 1 0 0 1 443.8799 327.3755 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 327.3755 cm
0 0 m
39.78 0 l
S
Q
0.5 w 
q 1 0 0 1 443.8799 316.1536 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 523.4399 316.1536 cm
0 0 m
0 10.722 l
S
Q
q 1 0 0 1 443.6299 315.9036 cm
0 0 m
40.03 0 l
S
Q
q 1 0 0 1 443.8799 304.6817 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 483.6599 315.9036 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 304.6817 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 523.4399 304.6817 cm
0 0 m
0 10.972 l
S
Q
q 1 0 0 1 443.8799 304.4317 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 304.4317 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 415.08 282.9278 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 282.9278 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 282.9278 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 282.9278 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 272.1759 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 443.8799 272.1759 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 483.6599 272.1759 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 523.4399 272.1759 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 415.08 156.6568 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 443.8799 156.6568 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 483.6599 156.6568 cm
0 0 m
0 18.752 l
S
Q
q 1 0 0 1 523.4399 156.6568 cm
0 0 m
0 18.752 l
S
Q
1 w 
q 1 0 0 1 323.9999 156.1568 cm
0 0 m
91.08 0 l
S
Q
q 1 0 0 1 415.08 156.1568 cm
0 0 m
28.8 0 l
S
Q
q 1 0 0 1 443.8799 156.1568 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 483.6599 156.1568 cm
0 0 m
39.78 0 l
S
Q
q 1 0 0 1 523.4399 156.1568 cm
0 0 m
52.56 0 l
S
Q
BT
/GS2 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 323.9999 339.4755 Tm
[(T)74.2 (able 8:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Efficac)10.2 (y Results by T)74.2 (umor T)55.2 (ype in TKI-pretreated )]TJ
/T1_1 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
0.06 Tw [( Gene)-17 ( )]TJ
0 Tw 0 -1.062 Td
[(Fusion-P)24.2 (ositive P)24.2 (atients)]TJ
-0.012 Tc 0.048 Tw 7.6 0 0 8 323.9999 318.7836 Tm
[(T)74.2 (umor type)]TJ
0.012 Tw 12.314 -0.186 Td
[(P)24.2 (atients)]TJ
0 Tc 0 Tw 7.6 0 0 8 441.3722 317.2976 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 419.6343 308.7976 Tm
(\(n=48\))Tj
7.603 1.248 Td
(ORR)Tj
-0.211 Tw 8.7 0 Td
(DOR)Tj
/Span<</ActualText<FEFF200A>>> BDC 
1.662 0 Td
( )Tj
EMC 
(\035)Tj
0.048 Tw -13.211 -1.434 Td
(n \(%\))Tj
4.909 0 Td
(95% CI)Tj
4.372 0 Td
(Range \(months\))Tj
/T1_2 1 Tf
0.012 Tw -26.617 -1.389 Td
(NSCLC)Tj
13.405 0 Td
(14)Tj
0.048 Tw 3.911 0 Td
(6 \(43\))Tj
5.134 0 Td
[(18,)37.2 ( 71)]TJ
5.336 0 Td
[(1.9,)37.3 ( 23.0)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw -31.047 -1.469 Td
[(Salivar)-17.8 (y Gland Cancer)]TJ
0 Tc 0 Tw 13.639 0 Td
(8)Tj
-0.012 Tc 0.048 Tw 3.677 0 Td
(7 \(88\))Tj
4.9 0 Td
[(47,)37.2 ( 100)]TJ
5.57 0 Td
[(3.7,)37.3 ( 26.5)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-31.047 -1.469 Td
( )Tj
EMC 
0.592 0 Td
[(Secretor)-17.7 (y carcinoma)]TJ
0 Tc 0 Tw 13.047 0 Td
(3)Tj
-0.012 Tc 0.048 Tw 3.443 0 Td
(3 \(100\))Tj
5.134 0 Td
[(29,)37.2 ( 100)]TJ
5.57 0 Td
[(7.9,)37.3 ( 26.5)]TJ
0 Tc 0 Tw 3.261 0.125 Td
(+)Tj
-0.012 Tc 0.048 Tw -31.047 -1.469 Td
[(Sarcoma,)37.2 ( Soft tissue)]TJ
0 Tc 0 Tw 13.639 0 Td
(6)Tj
-0.012 Tc 0.048 Tw 3.677 0 Td
(1 \(17\))Tj
5.02 0 Td
[(0.4,)37.3 ( 64)]TJ
0.012 Tw 6.793 0 Td
(5.6)Tj
0.048 Tw -29.129 -1.344 Td
(Thyroid Cancer)Tj
0 Tc 0 Tw 13.639 0 Td
(4)Tj
-0.012 Tc 0.048 Tw 3.677 0 Td
(2 \(50\))Tj
5.368 0 Td
[(7,)37.2 ( 93)]TJ
5.63 0 Td
[(2.0,)37.2 ( 9.6)]TJ
0.012 Tw -28.314 -1.344 Td
(Glioblastoma)Tj
0 Tc 0 Tw 13.639 0 Td
(3)Tj
-0.012 Tc 0.048 Tw 3.33 0 Td
(1 \(33.3\))Tj
5.368 0 Td
[(0.8,)37.3 ( 91)]TJ
0.012 Tw 6.559 0 Td
(23.5)Tj
-28.895 -1.344 Td
(Cholangiocarcinoma)Tj
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.518 0 Td
[(PR,)37.2 ( PD)]TJ
0.012 Tw 5.946 0 Td
(NA)Tj
6.026 0 Td
(1.8)Tj
0.048 Tw -29.129 -1.344 Td
(Colorectal cancer)Tj
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.509 0 Td
[(PR,)37.2 ( SD)]TJ
0.012 Tw 5.955 0 Td
(NA)Tj
5.792 0 Td
(17.5)Tj
0.048 Tw -28.895 -1.344 Td
[(P)18.2 (eripheral Ner)-17.8 (ve Shea)-9.7 (th )37.2 (T)74.2 (umor)]TJ
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.537 0 Td
[(PR,)37.2 ( PR)]TJ
0.012 Tw 5.927 0 Td
(NA)Tj
0.048 Tw 4.977 0 Td
[(5.5,)37.3 ( 11.1)]TJ
0.011 Tw -28.08 -1.344 Td
[(Neuroendocrine T)74.2 (umor)]TJ
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.537 0 Td
[(PR,)37.2 ( PR)]TJ
0.012 Tw 5.927 0 Td
(NA)Tj
0.048 Tw 5.211 0 Td
[(5.5,)37.2 ( 9.1)]TJ
-28.314 -1.344 Td
[(P)18.2 (ancrea)-9.8 (tic Cancer)]TJ
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.5 0 Td
[(PD,)37.2 ( PD)]TJ
0.012 Tw 5.964 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
-29.195 -1.344 Td
(Other*)Tj
0 Tc 0 Tw 13.639 0 Td
(2)Tj
-0.012 Tc 0.048 Tw 3.49 0 Td
[(SD,)37.2 ( PD)]TJ
0.012 Tw 5.974 0 Td
(NA)Tj
6.091 0 Td
(NA)Tj
0.048 Tw -29.195 -1.344 Td
(Breast Cancer)Tj
0 Tc 0 Tw 7.6 0 0 8 362.7787 167.1768 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 323.9999 158.6768 Tm
(\(adenocarcinoma\))Tj
0 Tc 0 Tw 13.639 0.531 Td
(1)Tj
-0.012 Tc 0.012 Tw 4.258 0 Td
(PR)Tj
5.206 0 Td
(NA)Tj
5.498 0 Td
(15.6)Tj
0 Tc 0 Tw 1.631 0.125 Td
(+)Tj
-0.017 Tc 0.048 Tw -30.232 -2.135 Td
(*)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.658 0 Td
[(Inc)20.2 (ludes gallbladder cancer and unkno)-9.8 (wn primar)-17.8 (y cancer)]TJ
-0.658 -1.062 Td
[(PD:)37.2 ( progressive disease; PR:)37.2 ( partial response; SD:)37.2 ( stable disease; NA:)37.1 ( not a)-9.8 (pplicable)]TJ
0 -1.062 Td
[(\223+\224)37.2 ( indica)-9.8 (tes ongoing response)]TJ
-0.008 Tc 0.097 Tw 8 0 0 8 323.9999 106.8849 Tm
[(ORR )0.5 (and )0.6 (DOR )0.5 (in )0.6 (adult )0.5 (pa)-10.4 (tients )0.5 (are )0.5 (presented )0.5 (by )]TJ
/T1_3 1 Tf
0.008 Tw 18.452 0 Td
(NTRK)Tj
/T1_2 1 Tf
0.097 Tw [( )-59.5 (gene )0.5 (fusion )0.6 (partner )37.5 (T)73.6 (ables )0.5 (9)-8 ( )]TJ
-0.017 Tc 0.048 Tw -18.452 -1.044 Td
[(and 10 belo)-9.8 (w)37.2 (.)]TJ
/T1_3 1 Tf
0.017 Tw 0 77.53 Td
(\(Continued\))Tj
ET
endstreamendobj18 0 obj<</Length 26126>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 469.8141 cm
0 0 m
72.968 0 l
S
Q
q 1 0 0 1 36 352.4386 cm
0 0 m
30.305 0 l
S
Q
q 1 0 0 1 36 260.8491 cm
0 0 m
32.262 0 l
S
Q
q 1 0 0 1 36 205.9026 cm
0 0 m
31.295 0 l
S
Q
q 1 0 0 1 36 72.0332 cm
0 0 m
57.378 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.021 Tc 0.036 Tw 8 0 0 8 36 727.2481 Tm
[(AUGTYRO \(repotrectinib\) ca)-9.7 (psules for oral use are supplied as printed hard shell ca)-9.6 (psules)-21 ( )]TJ
-0.007 Tc 0.101 Tw 0 -1.05 Td
[(containing 40 mg of repotrectinib.)36.6 ( Inactive ingredients are microcr)-18.4 (ystalline cellulose,)29.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
[(sodium laur)-17.8 (yl sulfa)-9.8 (te,)37.2 ( croscarmellose sodium,)37.2 ( and colloidal silicon dioxide.)]TJ
-0.012 Tc 0.073 Tw 0 -1.635 Td
[(The white opaque ca)-9.8 (psule shell contains gela)-9.8 (tin and titanium dioxide.)37.1 ( )36.8 (The printing ink)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
(contains shellac and FD & C blue #2 aluminum lake.)Tj
-0.021 Tc 0.036 Tw 0 -1.635 Td
[(AUGTYRO \(repotrectinib\) ca)-9.7 (psules for oral use are supplied as printed hard shell ca)-9.6 (psules)-21 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.05 Td
[(containing 160 mg of repotrectinib.)37.2 ( Inactive ingredients are microcr)-17.8 (ystalline cellulose,)27 ( )]TJ
0.005 Tc 0.16 Tw 0 -1.05 Td
[(sodium laur)-18.1 (yl sulfa)-10.2 (te,)36.9 ( croscarmellose sodium,)36.9 ( ma)-10.1 (gnesium steara)-10.1 (te,)36.9 ( and colloidal)5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
(silicon dioxide.)Tj
-0.011 Tc 0.082 Tw 0 -1.635 Td
[(The blue opaque ca)-10.5 (psule shell contains gela)-10.4 (tin,)36.6 ( titanium dioxide and FD & C blue #1.)26 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.05 Td
(The printing ink contains shellac and titanium dioxide.)Tj
/T1_1 1 Tf
0.017 Tw 0 -1.987 Td
(12)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(CLINIC)18.3 (AL PHARMACOLOGY)]TJ
0.017 Tw -3.375 -1.474 Td
(12.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Mechanism of Action)Tj
/T1_0 1 Tf
-3.375 -1.505 Td
[(Repotrectinib is an inhibitor of proto-oncogene tyrosine-protein kinase \ROS)40.2 (1 \(ROS)40.2 (1\) and)-17 ( )]TJ
0 -1.05 Td
[(of the tropomyosin receptor tyrosine kinases \(TRKs\) )37.2 (TRKA,)37.2 ( )37.2 (TRKB,)37.2 ( and )37.2 (TRKC.)]TJ
-0.001 Tc 0.128 Tw 0 -1.635 Td
[(Fusion proteins tha)-9.8 (t inc)20.3 (lude ROS)40.2 (1 )0.5 (or )37.4 (TRK domains can drive tumorigenic potential)-1 ( )]TJ
-0.006 Tc 0.102 Tw 0 -1.05 Td
[(through hyperactiva)-9.6 (tion of do)-9.6 (wnstream)0.5 ( signaling pa)-9.6 (thways leading to unconstrained)-6 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
0.021 Tc 0.237 Tw -31.5 -1.05 Td
[(cell pr)0.5 (olifera)-9.6 (tion)0.5 (.)37.4 ( Repotrect)0.5 (inib exhibited )0.5 (anti-tumor)0.5 ( activity )0.5 (in cultured )0.5 (cells)21 ( )]TJ
0.005 Tc 0.16 Tw 0 -1.05 Td
(expressing )Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
-0.005 Tw 4.501 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.551 0 Td
(1)Tj
/T1_0 1 Tf
0.005 Tc 0.16 Tw 0.485 0 Td
[( fusions and muta)-10.2 (tions inc)19.8 (luding )139.8 (SDC4-ROS)39.9 (1,)36.9 ( SDC4-ROS)39.8 (1)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
-0.005 Tw 5.6 0 0 5.6 269.5356 545.4171 Tm
(G2032R)Tj
-0.037 Tc 0.037 Tw 8 0 0 8 286.376 542.7531 Tm
(, )Tj
-0.012 Tc 0.072 Tw -31.297 -1.05 Td
[(CD7)60.4 (4-ROS)40.3 (1,)37.4 ( CD7)60.4 (4-ROS)40.4 (1)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.012 Tw 5.6 0 0 5.6 107.8449 537.0137 Tm
(G2032R)Tj
0.072 Tw 8 0 0 8 124.0942 534.3497 Tm
[(,)37.4 ( CD7)60.4 (4-ROS)40.4 (1)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
4.681 0 Td
( )Tj
EMC 
0.012 Tw 5.6 0 0 5.6 161.775 537.0137 Tm
(D2033N)Tj
0.072 Tw 8 0 0 8 178.338 534.3497 Tm
[(,)37.4 ( and CD7)60.4 (4-ROS)40.4 (1)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.012 Tw 5.6 0 0 5.6 229.3988 537.0137 Tm
(L2026M)Tj
0.072 Tw 8 0 0 8 246.1633 534.3497 Tm
[(.)37.4 ( Repotrectinib)-12 ( )]TJ
-0.015 Tc 0.061 Tw -26.27 -1.05 Td
[(also inhibited cell prolifera)-10.4 (tion in cultured cells expressing )]TJ
/T1_2 1 Tf
0.015 Tw (NTRK)Tj
/T1_0 1 Tf
0.061 Tw [( fusions and muta)-10.3 (tions)-15 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
[(inc)20.2 (luding LMNA-TRKA,)37.2 ( LMNA-TRKA)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.017 Tw 5.6 0 0 5.6 137.5709 520.2072 Tm
(G595R)Tj
0.048 Tw 8 0 0 8 151.0667 517.5432 Tm
[(,)37.2 ( EVT6-TRKB)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.017 Tw 5.6 0 0 5.6 187.4445 520.2072 Tm
(G639R)Tj
0.048 Tw 8 0 0 8 200.9403 517.5432 Tm
[(,)37.2 ( and ETV6-TRKC)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.017 Tw 5.6 0 0 5.6 250.3515 520.2072 Tm
(G623R)Tj
0 Tc 0 Tw 8 0 0 8 263.8473 517.5432 Tm
(.)Tj
/T1_1 1 Tf
-0.017 Tc 0.017 Tw -28.481 -1.632 Td
(12.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Pharmacodynamics)Tj
/T1_0 1 Tf
-0.019 Tc 0.036 Tw -3.375 -1.505 Td
[(Repotrectinib exposure-response rela)-9.9 (tionships and the time course of pharmacod)-9.9 (ynamic)-19 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
(responses are not fully characterized.)Tj
0 -1.654 Td
[(Cardiac Electrophysiolog)-9.8 (y)]TJ
0.053 Tw 0 -1.478 Td
[(AUGTYRO does not cause a mean increase in the QTc inter)-17.8 (val >20 milliseconds \(ms\) a)-9.8 (t)-17 ( )]TJ
0.048 Tw 0 -1.05 Td
[(160 mg QD follo)-9.7 (wed by 160 mg BID,)37.2 ( the a)-9.8 (pproved recommended dosa)-9.8 (ge.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.632 Td
(12.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Pharmacokinetics)Tj
/T1_0 1 Tf
-0.007 Tc 0.099 Tw -3.375 -1.505 Td
[(The geometric mean \(CV%\) of repotrectinib stead)-10 (y sta)-10 (te peak concentra)-10 (tion \(C)]TJ
0.007 Tw 5.6 0 0 5.6 271.6014 424.2549 Tm
(max,ss)Tj
0 Tc 0 Tw 8 0 0 8 286.072 425.4949 Tm
(\) )Tj
-0.013 Tc 0.071 Tw -31.259 -1.05 Td
[(is 713 \(32.5%\) ng/mL and the area under the time concentra)-10.3 (tion cur)-18.3 (ve \(AUC)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.013 Tw 5.6 0 0 5.6 261.0466 415.8516 Tm
(0-24h,ss)Tj
0.071 Tw 8 0 0 8 279.0066 417.0916 Tm
[(\) is)-13 ( )]TJ
0 Tc 0 Tw 1.124 0 Td
( )Tj
-0.006 Tc 0.105 Tw -31.5 -1.05 Td
[(7210 \(40.1%\) ng\225h/mL follo)-10.2 (wing the a)-10.1 (pproved recommended twice daily dosa)-10.2 (ge in)-6 ( )]TJ
-0.001 Tc 0.128 Tw 0 -1.05 Td
[(pa)-9.8 (tients with cancer)74.1 (.)37.2 ( Repotrectinib C)]TJ
0.001 Tw 5.6 0 0 5.6 147.9402 399.0451 Tm
(max)Tj
0.091 Tw 8 0 0 8 156.724 400.2851 Tm
[( )-37.1 (and AUC)]TJ
0.001 Tw 5.6 0 0 5.6 185.5111 399.0451 Tm
(0-inf)Tj
0.128 Tw 8 0 0 8 195.3236 400.2851 Tm
[( increases a)-9.8 (pproxima)-9.8 (tely dose)-1 ( )]TJ
-0.013 Tc 0.071 Tw -19.915 -1.05 Td
[(proportional \(but less than linear with estima)-10.3 (ted slopes of 0.78 and 0.70,)36.7 ( respectively\))-13 ( )]TJ
0.001 Tc 0.136 Tw 0 -1.05 Td
[(o)0.6 (v)0.5 (e)0.6 (r)0.5 ( t)0.6 (h)0.5 (e)0.6 ( s)0.6 (i)0.5 (n)0.5 (g)0.6 (l)0.5 (e)0.6 ( d)0.6 (o)0.5 (s)0.6 (e)0.5 ( r)0.6 (a)0.6 (n)0.5 (g)0.5 (e)0.6 ( o)0.6 (f)0.5 ( 4)0.6 (0)0.5 ( m)0.5 (g)0.6 ( t)0.5 (o)0.6 ( 2)0.6 (4)0.5 (0)0.6 ( m)0.5 (g)0.6 ( \()0.5 (0)0.6 (.)0.5 (2)0.6 (5)0.5 ( t)0.6 (o)0.6 ( 1)0.5 (.)0.6 (5)0.5 ( t)0.6 (i)0.5 (m)0.6 (e)0.6 (s)0.5 ( t)0.6 (h)0.5 (e)0.6 ( a)-9.4 (p)0.5 (p)0.6 (r)0.5 (o)0.6 (v)0.5 (e)0.6 (d)1 ( )]TJ
-0.012 Tc 0.072 Tw 0 -1.05 Td
[(recommended dosa)-9.7 (ge\).)37.3 ( Stead)-9.6 (y sta)-9.6 (te PK was time-dependent with an autoinduction of)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
[(CYP3A4.)37.2 ( Stead)-9.8 (y sta)-9.8 (te is achieved within 14 days of daily administra)-9.8 (tion of 160 mg.)]TJ
0.017 Tw 0 -1.654 Td
(Absorption)Tj
-0.01 Tc 0.086 Tw 0 -1.478 Td
[(The geometric mean \(CV%\) absolute bioa)-10.4 (vailability of repotrectinib is 45.7% \(19.6%\).)27 ( )]TJ
-0.011 Tc 0.078 Tw 0 -1.05 Td
[(P)18.3 (eak )0.6 (repotrectinib )0.6 (concentra)-9.7 (tion )0.5 (occurred )0.5 (a)-9.7 (t )0.5 (a)-9.8 (pproxima)-9.8 (tely )0.5 (2 )0.6 (to )0.5 (3 )0.5 (hours )0.5 (post )0.5 (a )0.5 (single)-11 ( )]TJ
-0.014 Tc 0.065 Tw 0 -1.05 Td
[(oral dose of 40 mg to 240 mg \(0.25 to 1.5 times the a)-10.1 (pproved recommended dosa)-10.1 (ge\))-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
(under fasted conditions.)Tj
/T1_2 1 Tf
0 -1.587 Td
[(Effect of F)20.3 (ood)]TJ
/T1_0 1 Tf
-0.005 Tc 0.107 Tw 0 -1.478 Td
[(No c)20.3 (linically signi\037cant differences in repotrectinib pharmacokinetics we\re obser)-17.5 (ve)0.5 (d)-5.1 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
0.001 Tc 0.138 Tw -31.5 -1.05 Td
[(in pa)-9.7 (tients with cancer follo)-9.7 (wing administra)-9.8 (tion of a high-fa)-9.7 (t meal )0.5 (\(a)-9.8 (pproxima)-9.8 (tely)1 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.05 Td
[(800-1000 calories,)37.3 ( 50% fa)-9.7 (t\).)]TJ
0.017 Tw 0 -1.654 Td
(Distribution)Tj
0.047 Tw 0 -1.478 Td
[(The geometric mean \(CV%\) a)-9.8 (pparent volume of distribution \(Vz/F\) was 432 L \(55.9%\) in)-17 ( )]TJ
0.048 Tw 0 -1.05 Td
[(pa)-9.8 (tients with cancer follo)-9.8 (wing a single 160 mg oral dose of )37.2 (AUGTYRO.)]TJ
-0.016 Tc 0.06 Tw 0 -1.635 Td
[(A)0.5 (U)0.5 (G)0.5 (T)0.5 (Y)0.5 (R)0.5 (O)0.5 ( )0.5 (b)0.5 (i)0.5 (n)0.5 (d)0.5 (i)0.5 (n)0.5 (g)0.5 ( )0.5 (t)0.6 (o)0.5 ( )0.5 (p)0.5 (l)0.5 (a)0.5 (s)0.5 (m)0.5 (a)0.5 ( )0.5 (p)0.5 (r)0.5 (o)0.5 (t)0.5 (e)0.6 (in)0.6 ( )0.5 (w)0.5 (a)0.5 (s)0.5 ( )0.5 (9)0.5 (5)0.5 (.)0.5 (4)0.5 (%)0.5 ( )]TJ
/T1_2 1 Tf
17.55 0 Td
[(i)0.5 (n)0.5 ( )0.5 (v)0.5 (i)0.5 (t)0.5 (r)0.5 (o)]TJ
/T1_0 1 Tf
2.444 0 Td
[(.)37.5 ( )37.5 (T)0.5 (h)0.5 (e)0.5 ( )0.5 (b)0.5 (l)0.5 (o)0.5 (o)0.5 (d)0.5 (-)0.5 (t)0.5 (o)0.6 (-)0.5 (p)0.5 (l)0.5 (a)0.5 (s)0.5 (m)0.5 (a)0.5 ( )0.5 (r)0.5 (a)-9.5 (t)0.6 (io)0.6 ( )0.5 (w)0.5 (a)0.5 (s)-16 ( )]TJ
-0.017 Tc 0.017 Tw -19.994 -1.05 Td
(0.56 )Tj
/T1_2 1 Tf
0.048 Tw 1.882 0 Td
(in vitro)Tj
/T1_0 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw -1.882 -1.654 Td
[(Elimina)-9.8 (tion)]TJ
0.048 Tw 0 -1.478 Td
[(Repotrectinib elimina)-9.8 (tion is time-dependent due to autoinduction of CYP3A4.)]TJ
-0.02 Tc 0.036 Tw 0 -1.635 Td
[(The repotrectinib mean terminal half-life is a)-9.9 (pproxima)-9.9 (tely 60.7 h for pa)-9.9 (tients with cancer)-20 ( )]TJ
-0.017 Tc 0.047 Tw 0 -1.05 Td
[(follo)-9.8 (wing a single dose.)37.2 ( )36.7 (The stead)-9.7 (y sta)-9.8 (te repotrectinib terminal half-life is a)-9.8 (pproxima)-9.7 (tely)-17 ( )]TJ
0.048 Tw 0 -1.05 Td
[(40.3 h for pa)-9.7 (tients with cancer)74.2 (.)]TJ
-0.005 Tc 0.108 Tw 0 -1.635 Td
[(The geometric mean \(CV%\) a)-9.8 (pparent oral c)20.2 (learance \(CL/F\) was 15.9 L/h \(45.5%\) in)-5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.05 Td
[(pa)-9.8 (tients with cancer follo)-9.8 (wing a single 160 mg oral dose of )37.2 (AUGTYRO.)]TJ
/T1_2 1 Tf
0.017 Tw 0 -1.587 Td
(Metabolism)Tj
/T1_0 1 Tf
-0.02 Tc 0.036 Tw 0 -1.478 Td
[(Repotrectinib is primarily metabolized by CYP3A4 follo)-10.1 (wed by secondar)-18.1 (y glucuronida)-10.1 (tion.)]TJ
/T1_2 1 Tf
-0.017 Tc 0.017 Tw 0 -1.587 Td
(Excretion)Tj
/T1_0 1 Tf
-0.007 Tc 0.1 Tw 0 -1.478 Td
[(F)19.8 (ollo)-10.3 (wing a single oral 160 mg dose of radiolabeled repotrectinib,)36.8 ( 4.84% \(0.56% as)-7 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.05 Td
(unchanged\) was recovered in urine and 88.8% \(50.6% unchanged\) in fece\s.)Tj
0 -1.654 Td
[(Speci\037c P)18.2 (opula)-9.8 (tions)]TJ
0.004 Tc 0.153 Tw 0 -1.478 Td
[(No c)20.2 (linically significant differences in the pharmacokinetics of repotrectin\ib were)4 ( )]TJ
-0.014 Tc 0.063 Tw 0 -1.05 Td
[(obser)-17.8 (ved )0.5 (based on )0.5 (a)-9.7 (ge )0.5 (\(12 )0.5 (to )0.5 (93 years\),)37.3 ( sex,)37.2 ( )0.5 (race \(White )0.5 (50%,)37.2 ( )37.5 (Asian )0.5 (38%,)37.2 ( )0.5 (Black )0.5 (7%\),)23 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.023 Tc 0.034 Tw -31.5 -1.05 Td
[(mild to modera)-10.3 (te renal impairment \(eGFR 30 to <90 mL/min\),)36.8 ( or mild hepa)-10.3 (tic impairment)-23 ( )]TJ
-0.017 Tc 0.059 Tw 0 -1.05 Td
[(\(total bilirubin >1 )0.5 (to )0.5 (1.5 times ULN or )37.5 (AST )0.5 (>ULN\).)37.2 ( )37.4 (The )0.5 (effect of modera)-9.8 (te )0.5 (\(total )0.5 (bilirubin)-17 ( )]TJ
ET
q 1 0 0 1 324 696.3681 cm
0 0 m
68.834 0 l
S
Q
BT
-0.009 Tc 0.088 Tw 8 0 0 8 324 727.2481 Tm
[(>1.5 to 3 times ULN with an)-9.9 (y )36.7 (AST\) or severe \(total bilirubin >3 x ULN with an)-9.8 (y )36.8 (AST\))-9 ( )]TJ
-0.005 Tc 0.112 Tw 0 -1.044 Td
[(hepa)-10.5 (tic impairment,)36.5 ( severe renal impairment,)36.6 ( kidney failure \(eGFR <30 mL/min\),)36.6 ( or)-5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(dialysis on repotrectinib pharmacokinetics is unkno)-9.8 (wn or not fully characterized.)]TJ
0 -1.647 Td
(Drug Interaction Studies)Tj
/T1_2 1 Tf
0 -1.423 Td
(Clinical Studies)Tj
0.012 Tc 0.194 Tw 0 -1.471 Td
[(Strong )0.5 (CYP3A and )0.5 (P-gp )0.5 (inhibitors:)]TJ
/T1_0 1 Tf
-0.198 Tw /Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
13.824 0 Td
[( )-391.5 (Repotrectinib )-354.5 (AUC)]TJ
-0.012 Tw 5.6 0 0 5.6 494.3581 672.9781 Tm
(0-inf)Tj
0.194 Tw 8 0 0 8 504.5364 674.2181 Tm
[( )0.5 (increased )0.5 (by )0.6 (5.9-fold)12 ( )]TJ
0 Tc 0 Tw 8.933 0 Td
( )Tj
-0.008 Tc 0.097 Tw -31.5 -1.044 Td
[(and )0.5 (C)]TJ
0.008 Tw 5.6 0 0 5.6 341.4969 664.6282 Tm
(max)Tj
0.097 Tw 8 0 0 8 350.1725 665.8682 Tm
[( )0.5 (by )0.5 (1.7-fold )0.5 (follo)-10.3 (wing )0.5 (concomitant )0.5 (use )0.6 (with )0.6 (itraconazole )0.5 (\(strong )0.5 (CYP3A )0.5 (and)-8 ( )]TJ
-0.017 Tc 0.048 Tw -3.272 -1.044 Td
(P-gp inhibitor\).)Tj
/T1_2 1 Tf
-0.008 Tc 0.093 Tw 0 -1.629 Td
(Strong CYP3A and P-gp inducers:)Tj
/T1_0 1 Tf
-0.198 Tw /Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
12.515 0 Td
[( )-291 (Repotrectinib )-254 (AUC)]TJ
0.008 Tw 5.6 0 0 5.6 479.3853 643.2482 Tm
(0-inf)Tj
0.093 Tw 8 0 0 8 489.0013 644.4882 Tm
( decreased by 92% and C)Tj
0.008 Tw 5.6 0 0 5.6 567.2885 643.2482 Tm
(max)Tj
0 Tc 0 Tw 8 0 0 8 576 644.4882 Tm
( )Tj
T*
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.044 Td
[(by 79% follo)-9.8 (wing concomitant use with rifampin \(strong CYP3A and P-gp inducer\).)]TJ
/T1_2 1 Tf
-0.009 Tc 0.09 Tw 0 -1.629 Td
[(CYP3A substra)-10.2 (tes:)]TJ
/T1_0 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
6.754 0 Td
[( Midazolam \(CYP3A substra)-10.2 (te )36.7 (AUC)]TJ
0.009 Tw 5.6 0 0 5.6 479.6486 621.8682 Tm
(0-inf)Tj
0.09 Tw 8 0 0 8 489.2471 623.1082 Tm
( decreased by 69% and C)Tj
0.009 Tw 5.6 0 0 5.6 567.2954 621.8682 Tm
(max)Tj
0 Tc 0 Tw 8 0 0 8 576 623.1082 Tm
( )Tj
T*
( )Tj
0.002 Tc 0.146 Tw -31.5 -1.044 Td
[(by 48% follo)-10.2 (wing concomitant use )0.5 (in subjects )0.5 (who were previously administered)2 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(160 mg repotrectinib once daily for 14 days follo)-9.8 (wed by 160 mg twice daily for 7 days.)]TJ
/T1_2 1 Tf
0 -1.58 Td
(In vitro Studies)Tj
0.06 Tw 0 -1.471 Td
(CYP Enzymes:)Tj
/T1_0 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
5.114 0 Td
[( Repotrectinib induces CYP3A4,)37.2 ( CYP2B6,)37.2 ( CYP2C8,)37.2 ( CYP2C19,)37.2 ( CYP2C9 and)-17 ( )]TJ
0.048 Tw -5.114 -1.044 Td
[(inhibits CYP3A4/5 \(GI tract\).)37.2 ( Repotrectinib does not induce CYP1A2.)]TJ
/T1_2 1 Tf
0 -1.629 Td
[(Other Metabolic P)18.2 (a)-9.8 (thways:)]TJ
/T1_0 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
9.564 0 Td
( Repotrectinib inhibits UGT1A1.)Tj
/T1_2 1 Tf
0.006 Tc 0.161 Tw -9.564 -1.629 Td
[(T)74.5 (r)0.5 (a)0.5 (n)0.5 (sp)0.5 (o)0.5 (r)0.5 (t)0.5 (e)0.5 (r)0.5 ( Sy)0.5 (s)0.5 (t)0.5 (e)0.5 (m)0.5 (s)0.5 (:)]TJ
/T1_0 1 Tf
/Span<</ActualText<FEFF200A>>> BDC 
8.098 0 Td
( )Tj
EMC 
0.047 0 Td
[( R)0.5 (e)0.5 (p)0.5 (o)0.5 (t)0.5 (r)0.5 (e)0.5 (c)0.5 (t)0.5 (i)0.5 (n)0.5 (i)0.5 (b i)0.5 (n)0.5 (hi)0.5 (b)0.5 (i)0.5 (t)0.5 (s)0.5 ( P)0.5 (-)0.5 (g)0.5 (p)0.5 (,)37.5 ( B)0.5 (C)0.5 (R)0.5 (P)129.5 (,)37.5 ( O)0.5 (A)55.5 (T)0.5 (P)0.5 (1)0.5 (B1)0.5 (,)37.5 ( a)0.5 (n)0.5 (d)0.5 ( M)0.5 (A)55.4 (T)0.5 (E)0.5 (2)0.5 (-)0.5 (K)0.5 (.)43 ( )]TJ
-0.017 Tc 0.048 Tw -8.145 -1.044 Td
[(Repotrectinib is a substra)-9.7 (te for P-gp.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.98 Td
(13)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(NONCLINIC)18.2 (AL TOXICOLOGY)]TJ
0.017 Tw -3.375 -1.467 Td
(13.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Carcinogenesis,)37.2 ( Mutagenesis,)37.2 ( Impairment of F)20.2 (ertility)]TJ
/T1_0 1 Tf
-3.375 -1.498 Td
(Carcinogenicity studies with repotrectinib were not conducted.)Tj
-0.006 Tc 0.107 Tw 0 -1.629 Td
[(Repotrectinib )0.6 (was )0.6 (genotoxic )0.5 (in )0.6 (an )0.6 (in )0.6 (vitro )0.6 (assay )0.6 (in )0.5 (human )0.6 (lymphoblastoid )37.5 (TK6 )0.6 (cells)-6 ( )]TJ
-0.009 Tc 0.091 Tw 0 -1.044 Td
[(and in an in vivo ra)-10.3 (t bone marro)-10.4 (w micronuc)19.7 (leus assay via an aneugenic mechanism)-9 ( )]TJ
-0.006 Tc 0.103 Tw 0 -1.044 Td
[(of action.)37.1 ( Repotrectinib was not muta)-9.8 (genic in vitro in the bacterial reverse muta)-9.9 (tion)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(\(Ames\) assay)55.2 (.)]TJ
-0.015 Tc 0.06 Tw 0 -1.629 Td
[(Dedica)-10.1 (ted fertility studies were not conducted with repotrectinib.)36.9 ( )36.9 (There were no effects)-15 ( )]TJ
-0.007 Tc 0.097 Tw 0 -1.044 Td
[(on ma)0.5 (le and fema)0.5 (le reproducti)0.5 (ve organs o)0.5 (bser)-17.6 (ved in ge)0.5 (neral repea)-9.5 (t-dose toxic)0.5 (olog)-9.6 (y)-7 ( )]TJ
0.098 Tw 0 -1.044 Td
[(studies of up to 3 months in dura)-9.8 (tion in ra)-9.8 (ts and monkeys a)-9.8 (t an)-9.7 (y dose level tested,)30 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.044 Td
[(which equa)-9.9 (ted to exposures of up to a)-9.8 (pproxima)-9.8 (tely 3 times the human exposure a)-9.9 (t the)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(160 mg twice daily dose based on )37.3 (AUC.)]TJ
/T1_1 1 Tf
0.017 Tw 0 -1.98 Td
(14)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(CLINIC)18.3 (AL STUDIES)]TJ
0.017 Tw -3.375 -1.467 Td
(14.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw /Span<</ActualText<FEFF200A>>> BDC 
3.375 0 Td
( )Tj
EMC 
0.024 0 Td
[(Locally Adv)16.2 (anced or Metastatic )]TJ
/T1_3 1 Tf
0.017 Tw (ROS1)Tj
/T1_1 1 Tf
0.048 Tw [(-)-59.8 (P)24.2 (ositive NSCLC)]TJ
/T1_0 1 Tf
0.004 Tc 0.151 Tw -3.399 -1.498 Td
[(T)0.5 (h)0.5 (e e)0.5 (f)0.5 (f)0.5 (ic)0.5 (a)0.5 (c)20.5 (y)0.5 ( o)0.5 (f)0.5 ( )36.9 (AU)0.5 (G)0.5 (T)0.5 (Y)0.5 (RO)0.5 ( w)0.5 (as)0.5 ( e)0.5 (v)0.5 (al)0.5 (u)0.5 (a)-9.5 (t)0.5 (e)0.5 (d i)0.5 (n)0.5 ( )36.8 (T)0.5 (R)0.5 (ID)0.5 (E)0.5 (N)0.5 (T)55.4 (-)0.5 (1)0.5 (,)37.5 ( a)0.5 ( m)0.5 (u)0.5 (lt)0.5 (i)0.5 (c)0.5 (e)0.5 (nt)0.5 (e)0.5 (r)74.5 (,)37.4 ( s)0.5 (i)0.5 (n)0.5 (gl)0.5 (e)0.5 (-)0.5 (a)0.5 (r)0.5 (m,)41 ( )]TJ
0.011 Tc 0.187 Tw 0 -1.044 Td
[(op)0.5 (en-)0.5 (lab)0.5 (el,)37.5 ( )0.5 (mu)0.5 (lti)0.5 (-co)0.5 (hor)0.5 (t )0.6 (c)20.4 (li)0.5 (nica)0.5 (l )0.6 (tri)0.5 (al )0.6 (\(NC)0.5 (T030)0.5 (931)0.5 (16\).)37.5 ( )0.5 (P)18.4 (a)-9.5 (ti)0.5 (ent)0.5 (s )0.5 (w)0.5 (ere)0.5 ( )0.5 (r)0.5 (equ)0.5 (ire)0.5 (d )0.6 (to)11 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.044 Td
[(ha)-10 (ve )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.02 Tw 1.965 0 Td
(RO)Tj
-0.06 Tc 0.06 Tw (S1)Tj
/T1_0 1 Tf
-0.02 Tc 0.036 Tw [(-positive locally advanced or metasta)-10.1 (tic NSCLC,)36.9 ( ECOG performance sta)-10 (tus \0341,)17 ( )]TJ
0 Tc 0 Tw 29.535 0 Td
( )Tj
0.001 Tc 0.141 Tw -31.5 -1.044 Td
[(measurable disease per RECIST v1.)39.6 (1,)36.6 ( and \0368 months from \037rst dose.)36.6 ( )36.5 (All pa)-10.4 (tients)1 ( )]TJ
0.004 Tc 0.151 Tw 0 -1.044 Td
[(w)0.5 (e)0.5 (r)0.5 (e)0.5 ( a)0.5 (s)0.5 (s)0.5 (e)0.5 (s)0.5 (s)0.5 (e)0.5 (d)0.5 ( f)0.5 (o)0.5 (r)0.5 ( C)0.5 (N)0.5 (S)0.5 ( l)0.5 (e)0.5 (s)0.5 (i)0.5 (o)0.5 (n)0.5 (s)0.5 ( a)-9.5 (t)0.5 ( b)0.5 (a)0.5 (s)0.5 (e)0.5 (l)0.5 (i)0.5 (n)0.5 (e)0.5 (,)37.5 ( a)0.5 (n)0.5 (d)0.5 ( p)0.5 (a)-9.5 (t)0.5 (i)0.5 (e)0.5 (n)0.5 (t)0.5 (s)0.5 ( w)0.5 (i)0.5 (t)0.6 (h)0.5 ( s)0.5 (y)0.5 (m)0.5 (p)0.5 (t)0.5 (o)0.5 (m)0.6 (a)-9.5 (t)0.5 (i)0.5 (c)0.5 ( b)0.5 (r)0.5 (a)0.5 (i)0.5 (n)4 ( )]TJ
-0.005 Tc 0.108 Tw 0 -1.044 Td
[(metastases were exc)20.2 (luded from the trial.)37.2 ( P)18.2 (a)-9.9 (tients received )37.1 (AUGTYRO 160 mg orally)-5 ( )]TJ
-0.014 Tc 0.067 Tw 0 -1.044 Td
[(once daily for 14 days,)36.5 ( then increased to 160 mg twice daily until disease progression)-14 ( )]TJ
-0.01 Tc 0.084 Tw 0 -1.044 Td
[(or unacceptable toxicity)55 (.)37 ( )36.9 (T)74 (umor assessments were performed a)-10 (t least ever)-17.9 (y 8 weeks.)27 ( )]TJ
-0.012 Tc 0.073 Tw 0 -1.044 Td
[(Identi\037ca)-9.8 (tion of )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.012 Tw 5.901 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.498 0 Td
(1)Tj
/T1_0 1 Tf
-0.012 Tc 0.073 Tw 0.468 0 Td
[( gene fusions in tumor specimens was prospectively determined)-12 ( )]TJ
-0.017 Tc 0.049 Tw -7.868 -1.044 Td
[(in local labora)-9.7 (tories using next-genera)-9.8 (tion sequencing \(NGS\),)37.2 ( polymerase chain reaction)-17 ( )]TJ
-0.006 Tc 0.105 Tw 0 -1.044 Td
[(\(PCR\) or \033uorescence in situ hybridiza)-10.2 (tion \(FISH\) tests.)36.8 ( )37.2 (All )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.006 Tw 21.971 0 Td
(RO)Tj
-0.046 Tc 0.046 Tw (S1)Tj
/T1_0 1 Tf
-0.006 Tc 0.105 Tw [(-positive pa)-10.1 (tients by)-6 ( )]TJ
0 Tc 0 Tw 9.529 0 Td
( )Tj
-0.003 Tc 0.119 Tw -31.5 -1.044 Td
[(local FISH testing required central labora)-10.1 (tor)-18.1 (y con\037rma)-10 (tion of )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.003 Tw 23.316 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.526 0 Td
(1)Tj
/T1_0 1 Tf
-0.003 Tc 0.119 Tw 0.477 0 Td
[( fusion using an)-3 ( )]TJ
-0.024 Tc 0.029 Tw -25.319 -1.044 Td
[(a)0.5 (n)0.5 (a)0.6 (l)0.5 (y)0.5 (t)0.5 (i)0.5 (c)0.5 (a)0.6 (l)0.5 (l)0.5 (y)0.5 ( v)0.5 (a)0.6 (l)0.5 (i)0.5 (d)0.5 (a)-9.5 (t)0.6 (e)0.5 (d)0.5 ( N)0.5 (G)0.5 (S)0.6 ( t)0.5 (e)0.5 (s)0.5 (t)0.5 (.)37.5 ( )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.024 Tw 10.901 0 Td
[(R)0.5 (O)]TJ
0 Tc 0 Tw 1.026 0 Td
(S)Tj
0.435 0 Td
(1)Tj
/T1_0 1 Tf
-0.024 Tc 0.029 Tw 0.455 0 Td
[( f)0.5 (u)0.5 (s)0.6 (i)0.5 (o)0.5 (n)0.5 (s)0.5 ( w)0.5 (e)0.6 (r)0.5 (e)0.5 ( i)0.5 (d)0.6 (e)0.5 (n)0.5 (t)0.5 (i)0.5 (\037)0.5 (e)0.6 (d)0.5 ( b)0.5 (y)0.5 ( N)0.5 (G)0.6 (S)0.5 ( i)0.5 (n)0.5 ( 5)0.5 (1)0.5 (%)0.6 (,)37.5 ( F)0.5 (I)0.5 (S)0.5 (H)0.6 ( i)0.5 (n)0.5 ( 2)0.5 (6)0.5 (%)0.6 (,)12.9 ( )]TJ
0 Tc 0 Tw 18.682 0 Td
( )Tj
-0.005 Tc 0.109 Tw -31.5 -1.044 Td
[(and PCR in 23%.)37 ( )37 (The major ef\037cac)20 (y outcome measures were overall response ra)-10 (te)-5 ( )]TJ
0.005 Tc 0.157 Tw 0 -1.044 Td
[(\(ORR\) and dura)-9.6 (tion of response \(DOR\) according to RECIST v1.)40.4 (1 as assessed by)5 ( )]TJ
-0.012 Tc 0.071 Tw 0 -1.044 Td
[(b)0.5 (l)0.6 (i)0.5 (n)0.6 (d)0.5 (e)0.6 (d)0.5 ( i)0.5 (n)0.6 (d)0.5 (e)0.5 (p)0.6 (e)0.5 (n)0.6 (d)0.5 (e)0.6 (n)0.5 (t)0.5 ( c)0.5 (e)0.5 (n)0.6 (t)0.5 (r)0.6 (a)0.5 (l)0.6 ( r)0.5 (e)0.6 (v)0.5 (i)0.6 (e)0.5 (w)0.5 ( \()0.6 (B)0.5 (I)0.6 (C)0.5 (R)0.5 (\))0.6 (.)37.5 ( I)0.6 (n)0.5 (t)0.5 (r)0.6 (a)0.5 (c)0.6 (r)0.5 (a)0.6 (n)0.5 (i)0.5 (a)0.6 (l)0.5 ( r)0.6 (e)0.5 (s)0.6 (p)0.5 (o)0.6 (n)0.5 (s)0.5 (e)0.6 ( a)0.5 (c)0.6 (c)0.5 (o)0.6 (r)0.5 (d)0.6 (i)0.5 (n)0.5 (g)0.6 ( t)0.5 (o)0.6 ( m)0.5 (o)0.6 (d)0.5 (i)0.5 (\037)0.6 (e)0.5 (d)-12 ( )]TJ
-0.015 Tc 0.062 Tw 0 -1.044 Td
[(RECIST )0.5 (v1.1 )0.5 (was )0.6 (assessed )0.6 (by )0.5 (BICR.)36.6 ( )37.5 (T)73.6 (umor )0.6 (assessments )0.6 (with )0.5 (ima)-10.4 (ging )0.5 (were )0.6 (performed)-15 ( )]TJ
-0.001 Tc 0.127 Tw 0 -1.044 Td
[(ever)-17.6 (y 8 weeks.)37.4 ( )37.3 (The ef\037cac)20.3 (y popula)-9.6 (tions inc)20.3 (luded 71 ROS)40.4 (1 )37.3 (TKI-na\357ve pa)-9.6 (tients who)-1 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.044 Td
[(received up to 1 prior line of pla)-9.9 (tinum-based chemothera)-9.8 (py and/or immunothera)-9.8 (py and)-17 ( )]TJ
-0.016 Tc 0 -1.044 Td
[(56 pa)-10.2 (tients who received 1 prior ROS)39.8 (1 )36.8 (TKI with no prior pla)-10.1 (tinum-based chemothera)-10.2 (py)-16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(or immunothera)-9.8 (py)55.2 (.)]TJ
0.041 Tw 0 -1.629 Td
[(Among the 71 ROS)40.2 (1 )37.2 (TKI-na\357ve pa)-9.7 (tients,)37.2 ( the median a)-9.8 (ge was 57 years \(range:)37.2 ( 28 to 80\);)-17 ( )]TJ
-0.022 Tc 0.036 Tw 0 -1.044 Td
[(female \(60.6%\); )36.6 (Asian \(67.6%\),)36.6 ( )36.7 (White \(25.4%\),)36.6 ( Hispanic or La)-10.3 (tino \(4.2%\),)36.7 ( Black or )36.6 (African)-22.1 ( )]TJ
-0.018 Tc 0 -1.044 Td
[(American \(1.4%\); never smoked \(63.4%\); and ECOG performance sta)-9.8 (tus of 1 a)-9.7 (t baseline)-18 ( )]TJ
-0.013 Tc 0.066 Tw 0 -1.044 Td
[(\(66)0.5 (.2)0.5 (%\).)37.4 ( )36.6 (At ba)0.5 (sel)0.5 (ine)0.5 (,)37.4 ( 94.4)0.5 (% of pa)-9.5 (tie)0.5 (nt)0.5 (s h)0.5 (ad me)0.5 (ta)0.5 (sta)-9.5 (tic)0.5 ( di)0.5 (sea)0.5 (se,)37.5 ( 2)0.5 (5.4)0.5 (% of pa)-9.5 (tie)0.5 (nts)0.5 ( ha)0.5 (d)-13 ( )]TJ
-0.01 Tc 0.085 Tw 0 -1.044 Td
[(CNS metastases by )0.5 (BICR; 97.2% had adenocarcinoma; and 28.2% pa)-10 (tients had prior)-10 ( )]TJ
0.084 Tw 0 -1.044 Td
[(chemothera)-10 (py consisting of pla)-10.1 (tinum-based chemothera)-10 (py and/or immunothera)-10.1 (py for)-10 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(locally advanced or metasta)-9.8 (tic disease.)]TJ
-0.011 Tc 0.081 Tw 0 -1.629 Td
[(Among the 56 pa)-10.3 (tients who had received 1 prior ROS)39.7 (1 )37.3 (TKI \(inc)19.7 (luding crizotinib [82%])-11 ( )]TJ
-0.013 Tc 0.071 Tw 0 -1.044 Td
[(and entrectinib [16%]\) with no prior pla)-10.2 (tinum-based chemothera)-10.3 (py or immunothera)-10.3 (py)54.7 (,)24 ( )]TJ
-0.009 Tc 0.09 Tw 0 -1.044 Td
[(the median a)-10.1 (ge was 57 years \(range:)36.9 ( 33)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
15.322 0 Td
(\226)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
0.607 0 Td
[(78\); female \(67.9%\); )37.3 (Asian \(48.2%\),)36.8 ( )37.4 (White)-8.9 ( )]TJ
-0.013 Tc 0.068 Tw -15.929 -1.044 Td
[(\(44.6%\),)37.2 ( Black or )36.8 (African )36.8 (American and Hispanic or La)-9.9 (tino \(1.8% each\); never smoked)-13 ( )]TJ
-0.008 Tc 0.096 Tw 0 -1.044 Td
[(\(64.3%\); and ECOG performance sta)-10.3 (tus of 1 a)-10.3 (t baseline \(67.9%\).)36.7 ( )37 (At baseline,)36.6 ( 98.2%)-8 ( )]TJ
-0.015 Tc 0.062 Tw 0 -1.044 Td
[(pa)-10.4 (tients )0.5 (had )0.5 (metasta)-10.4 (tic )0.5 (disease,)36.6 ( )0.5 (42.9% )0.5 (with )0.5 (CNS )0.5 (metastases )0.5 (by )0.5 (BICR,)36.5 ( )0.5 (and )0.5 (94.6% )0.5 (had)-15 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
(adenocarcinoma.)Tj
0.048 Tw 0 -1.629 Td
[(Ef\037cac)20.2 (y results are summarized in )37.2 (T)74.2 (able 5.)]TJ
ET
endstreamendobj5 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 86 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 20 0 R>>/Font<</T1_0 22 0 R/T1_1 21 0 R/T1_2 23 0 R>>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320030005A>/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 474>>/PageWidthList<</0 612.0>>>>>>>>endobj6 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 87 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R/GS2 27 0 R>>/Font<</T1_0 22 0 R/T1_1 24 0 R/T1_2 21 0 R/T1_3 23 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 88 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320030005A>/NumberOfPageItemsInPage 1/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[377.0 0.0 3.0 18.0 -358.937 270.0 -345.784 1.0 0.0 0.0 1.0 288.0 1.0625]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 626>>/PageWidthList<</0 612.0>>>>>>>>endobj7 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 89 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R>>/Font<</T1_0 22 0 R/T1_1 21 0 R/T1_2 23 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 25 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320030005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 678>>/PageWidthList<</0 612.0>>>>>>>>endobj8 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 90 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R/GS2 27 0 R>>/Font<</T1_0 22 0 R/T1_1 21 0 R/T1_2 23 0 R/T1_3 24 0 R>>/ProcSet[/PDF/Text]/XObject<</Fm0 25 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320030005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 730>>/PageWidthList<</0 612.0>>>>>>>>endobj9 0 obj<</ArtBox[0.0 0.0 612.0 792.0]/BleedBox[0.0 0.0 612.0 792.0]/Contents 91 0 R/CropBox[0.0 0.0 612.0 792.0]/MediaBox[0.0 0.0 612.0 792.0]/Parent 14 0 R/Resources<</ExtGState<</GS0 19 0 R/GS1 20 0 R>>/Font<</T1_0 22 0 R/T1_1 21 0 R/T1_2 23 0 R/T1_3 92 0 R/T1_4 93 0 R>>/ProcSet[/PDF/Text]/Properties<</MC0 94 0 R>>/XObject<</Fm0 25 0 R>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo<</InDesign<</DocumentID<FEFF0078006D0070002E006400690064003A00660038003200630064003900620031002D0034006600300036002D0034006600360034002D0039006100360039002D003400300035003300300061003200370063003600300030>/LastModified<FEFF0044003A00320030003200340030003600310033003100380032003100320030005A>/NumberOfPageItemsInPage 2/NumberofPages 1/OriginalDocumentID<FEFF0078006D0070002E006400690064003A00340033003600620065006100360038002D0038003800660039002D0034006600360030002D0039006200370036002D003800360065006600330066003100390033006300310038>/PageItemUIDToLocationDataMap<</0[410.0 0.0 3.0 -270.0 -360.0 -18.0 -346.846 1.0 0.0 0.0 1.0 0.0 0.0]/1[432.0 1.0 3.0 18.0 -359.889 270.0 -346.736 1.0 0.0 0.0 1.0 288.0 0.11058]>>/PageTransformationMatrixList<</0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<</0 35199>>/PageWidthList<</0 612.0>>>>>>>>endobj91 0 obj<</Length 29575>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 703.6063 cm
0 0 m
109.614 0 l
S
Q
q 1 0 0 1 36 645.3588 cm
0 0 m
41.705 0 l
S
Q
q 1 0 0 1 36 603.8372 cm
0 0 m
107.961 0 l
S
Q
q 1 0 0 1 36 541.9838 cm
0 0 m
77.328 0 l
S
Q
q 1 0 0 1 36 463.0504 cm
0 0 m
42.034 0 l
S
Q
q 1 0 0 1 36 374.6411 cm
0 0 m
41.95 0 l
S
Q
q 1 0 0 1 36 269.8991 cm
0 0 m
13.291 0 l
S
Q
q 1 0 0 1 36 138.4052 cm
0 0 m
41.95 0 l
S
Q
q 1 0 0 1 36 55.1459 cm
0 0 m
51.766 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 36 727.2481 Tm
(7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(DR)-9.8 (UG INTERACTIONS)]TJ
0.017 Tw -3.375 -1.334 Td
(7.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Effects of Other Drugs on AUGTYRO)Tj
/T1_1 1 Tf
-3.375 -1.496 Td
[(Strong and Modera)-9.8 (te CYP3A Inhibitors)]TJ
-0.002 Tc 0.122 Tw 0 -1.473 Td
[(Avo)0.5 (id )0.5 (c)0.5 (onco)0.5 (mita)0.5 (nt )0.5 (us)0.5 (e )0.5 (wi)0.5 (th )0.5 (st)0.5 (rong)0.5 ( )0.5 (or )0.5 (m)0.5 (ode)0.5 (ra)-9.6 (te)0.5 ( )0.5 (CYP)0.5 (3A )0.5 (in)0.5 (hibit)0.5 (ors)0.5 (.)37.4 ( )0.5 (Conc)0.5 (omit)0.5 (ant)0.5 ( )0.5 (use)-2 ( )]TJ
-0.008 Tc 0.096 Tw 0 -1.045 Td
[(of )37.1 (AUGTYRO with a strong or a modera)-10.3 (te CYP3A inhibitor may increase repotrectinib)-8 ( )]TJ
0.002 Tc 0.145 Tw 0 -1.045 Td
[(exposure,)36.9 ( )0.6 (which )0.5 (may )0.5 (increase )0.5 (the )0.5 (incidence )0.6 (and )0.6 (severity )0.5 (of )0.5 (adverse )0.5 (reactions )0.5 (of)2 ( )]TJ
-0.009 Tc 0.086 Tw 0 -1.045 Td
[(A)0.5 (UG)0.5 (T)0.5 (YR)0.5 (O)0.5 (.)37.4 ( D)0.5 (is)0.5 (c)0.5 (on)0.5 (t)0.5 (in)0.5 (u)0.5 (e C)0.5 (Y)0.5 (P3)0.5 (A)0.5 ( in)0.5 (h)0.5 (ib)0.5 (i)0.5 (to)0.5 (r)0.5 (s f)0.5 (o)0.5 (r 3)0.5 ( t)0.5 (o)0.5 ( 5)0.5 ( e)0.5 (li)0.5 (m)0.5 (in)0.5 (a)-9.5 (t)0.5 (io)0.5 (n)0.5 ( ha)0.5 (l)0.5 (f-)0.5 (l)0.5 (iv)0.5 (e)0.5 (s)0.5 ( o)0.5 (f)0.5 ( th)0.5 (e)0.5 ( C)0.5 (YP)0.5 (3)0.5 (A)-9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(inhibitor prior to initia)-9.7 (ting )37.2 (AUGTYRO )]TJ
/T1_2 1 Tf
([see Clinical Pharmacolog)Tj
22.097 0 Td
(y \(12.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -22.097 -1.627 Td
(P-gp Inhibitors)Tj
-0.013 Tc 0.072 Tw 0 -1.473 Td
[(Avoid )0.6 (concomitant )0.5 (use )0.6 (with )0.5 (P-gp )0.6 (inhibitors.)36.5 ( )0.6 (Concomitant )0.6 (use )0.6 (of )37.6 (AUGTYRO )0.6 (with )0.6 (a )0.5 (P-gp)-13 ( )]TJ
-0.009 Tc 0.091 Tw 0 -1.045 Td
[(inhibitor may increase repotrectinib exposure,)36.7 ( which may increase the incidence and)-9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(severity of adverse reactions of )37.2 (AUGTYRO )]TJ
/T1_2 1 Tf
([see Clinical Pharmacolog)Tj
24.313 0 Td
(y \(12.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.048 Tw -24.313 -1.627 Td
[(Strong and Modera)-9.8 (te CYP3A Inducers)]TJ
0 Tc 0.131 Tw 0 -1.473 Td
[(A)0.5 (v)0.6 (o)0.6 (i)0.5 (d)0.5 ( c)0.6 (o)0.5 (n)0.6 (c)0.5 (o)0.6 (m)0.5 (i)0.6 (t)0.5 (a)0.6 (n)0.5 (t)0.6 ( u)0.6 (s)0.5 (e)0.6 ( w)0.5 (i)0.5 (t)0.6 (h)0.5 ( s)0.6 (t)0.5 (r)0.6 (o)0.5 (n)0.6 (g)0.5 ( o)0.5 (r)0.6 ( m)0.6 (o)0.5 (d)0.6 (e)0.6 (r)0.5 (a)-9.4 (t)0.5 (e)0.6 ( C)0.5 (Y)0.5 (P)0.6 (3)0.5 (A)0.6 ( i)0.6 (n)0.5 (d)0.6 (u)0.5 (c)0.6 (e)0.5 (r)0.6 (s)0.5 (.)37.6 ( C)0.6 (o)0.5 (n)0.6 (c)0.5 (o)0.6 (m)0.5 (i)0.6 (t)0.5 (a)0.6 (n)0.5 (t)0.6 ( u)0.5 (s)0.6 (e )]TJ
-0.002 Tc 0.124 Tw 0 -1.045 Td
[(of )36.7 (AUGTYRO with a strong or modera)-10 (te CYP3A inducer may decrease repotrectinib)-2 ( )]TJ
0.011 Tc 0.192 Tw 0 -1.045 Td
[(plasma )0.5 (concentra)-10.3 (tions,)36.5 ( )0.5 (which )0.5 (may )0.5 (decrease efficac)19.5 (y )0.5 (of )37.4 (AUGTYRO )]TJ
/T1_2 1 Tf
[([see )0.5 (Clinical)11 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.045 Td
(Pharmacolog)Tj
0.048 Tw 4.652 0 Td
(y \(12.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw -4.652 -1.627 Td
(7.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Effects of AUGTYRO on Other Drugs)Tj
/T1_1 1 Tf
-3.375 -1.496 Td
[(Certain CYP3A4 Substra)-9.8 (tes)]TJ
-0.02 Tc 0.036 Tw 0 -1.45 Td
[(Avoid concomitant use unless otherwise recommended in the Prescribing In\forma)-10.2 (tion for)-20 ( )]TJ
-0.01 Tc 0.081 Tw 0 -1.045 Td
[(CY)0.5 (P)0.5 (3A su)0.5 (bs)0.5 (tr)0.5 (a)-9.5 (te)0.5 (s,)37.4 ( wh)0.5 (er)0.5 (e m)0.5 (ini)0.5 (ma)0.5 (l)0.5 ( c)0.5 (on)0.5 (ce)0.5 (nt)0.5 (ra)-9.5 (t)0.5 (io)0.5 (n c)0.5 (ha)0.5 (ng)0.5 (es)0.5 ( c)0.5 (an)0.5 ( c)0.5 (au)0.5 (se)0.5 ( r)0.5 (ed)0.5 (uc)0.5 (ed)0.5 ( e)0.5 (f\037)0.5 (ca)0.5 (c)20.4 (y)55.5 (.)27 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.038 Tw -31.5 -1.045 Td
[(If concomitant use is una)-9.8 (voidable,)37.2 ( increase the CYP3A4 substra)-9.8 (te dosa)-9.7 (ge in accordance)-17 ( )]TJ
0.048 Tw 0 -1.045 Td
[(with a)-9.7 (pproved product labeling.)]TJ
-0.002 Tc 0.124 Tw 0 -1.585 Td
[(Repotrectinib is a CYP3A4 inducer)74 (.)37 ( Concomitant use of repotrectinib decreases the)-2 ( )]TJ
0 Tc 0.133 Tw 0 -1.045 Td
[(concentra)-9.7 (tion of CYP3A4 substra)-9.8 (tes )]TJ
/T1_2 1 Tf
[([see Clinical Pharmacolog)-9.8 (y \(12.3\)])]TJ
/T1_1 1 Tf
[(,)37.2 ( which can )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(reduce the ef\037cac)20.2 (y of these substra)-9.8 (tes.)]TJ
0.017 Tw 0 -1.604 Td
(Contraceptives)Tj
-0.015 Tc 0.06 Tw 0 -1.473 Td
[(Repotrectinib is a CYP3A4 inducer)73.8 (,)36.8 ( which can decrease progestin or estrogen exposure)-15 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(to an extent tha)-9.8 (t could reduce the effectiveness of hormonal contraceptives.)]TJ
-0.012 Tc 0.072 Tw 0 -1.63 Td
[(Avo)0.5 (id)0.5 ( )0.5 (con)0.5 (com)0.5 (ita)0.5 (nt )0.6 (use)0.5 ( )0.5 (of)0.5 ( )37.5 (AUG)0.5 (TYR)0.5 (O )0.5 (wi)0.5 (th )0.6 (hor)0.5 (mon)0.5 (al )0.6 (con)0.5 (tra)0.5 (cep)0.5 (tiv)0.5 (es )]TJ
/T1_2 1 Tf
24.271 0 Td
[([s)0.5 (ee )0.6 (Use)0.5 ( )0.5 (in )0.6 (Spe)0.5 (ci\037c)-12 ( )]TJ
-0.002 Tc 0.123 Tw -24.271 -1.045 Td
[(P)18.2 (opula)-9.8 (tions \(8.1,)37.2 ( 8.3\)])]TJ
/T1_1 1 Tf
[(.)37.2 ( )37 (Advise females of reproductive potential to use an effective)-2 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
(nonhormonal contraceptive )Tj
/T1_2 1 Tf
[([see Use in Speci\037c P)18.2 (opula)-9.8 (tions \(8)]TJ
[(.1,)37.2 ( 8.3\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.982 Td
(8)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(USE IN SPECIFIC POPULA)55.2 (TIONS)]TJ
0.017 Tw -3.375 -1.334 Td
(8.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
[(Pregnanc)10.2 (y)]TJ
/T1_1 1 Tf
0.048 Tw -3.375 -1.496 Td
[(Risk Summar)-17.8 (y)]TJ
-0.007 Tc 0.1 Tw 0 -1.473 Td
[(Based on litera)-10.2 (ture reports in humans with congenital muta)-10.2 (tions leading to changes)-7 ( )]TJ
0.003 Tc 0.147 Tw 0 -1.045 Td
[(in )36.9 (TRK signaling,)37.3 ( findings from animal studies,)37.3 ( and its mechanism of action )]TJ
/T1_2 1 Tf
-0.003 Tw [([see)3 ( )]TJ
-0.007 Tc 0.1 Tw 0 -1.045 Td
[(Clinical Pharmacolog)-10.1 (y \(12.1\)])]TJ
/T1_1 1 Tf
[(,)36.8 ( )37.1 (AUGTYRO can cause fetal harm when administered to)-6.9 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.045 Td
[(a pregnant woman.)36.9 ( )37.4 (There are no a)-10.1 (vailable da)-10 (ta on )37.4 (AUGTYRO use in pregnant women.)25 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.045 Td
[(Oral administra)-10.2 (tion of repotrectinib to pregnant ra)-10.1 (ts during the period of organogenesis)-15 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.045 Td
[(resulted in fetal malforma)-9.7 (tions a)-9.7 (t doses a)-9.7 (pproxima)-9.8 (tely 0.3 times the recommended dose)-20 ( )]TJ
-0.017 Tc 0 -1.045 Td
[(o)0.5 (f )0.5 (16)0.5 (0 )0.5 (mg)0.5 ( t)0.5 (wi)0.5 (ce)0.5 ( )0.5 (da)0.5 (il)0.5 (y )0.5 (ba)0.5 (se)0.5 (d )0.5 (on)0.5 ( B)0.5 (SA)0.5 ( )]TJ
/T1_2 1 Tf
[(\()0.5 (se)0.5 (e)0.5 ( Da)-9.5 (t)0.5 (a\))]TJ
/T1_1 1 Tf
16.866 0 Td
[(.)37.4 ( )37.5 (Ad)0.5 (vi)0.5 (se)0.5 ( p)0.5 (re)0.5 (g)0.5 (na)0.5 (nt)0.5 ( w)0.5 (om)0.5 (en)0.5 ( )0.5 (of)0.5 ( t)0.5 (he)0.5 ( p)0.5 (ot)0.5 (e)0.5 (nt)0.5 (ia)0.5 (l)-17 ( )]TJ
0.048 Tw -16.866 -1.045 Td
(risk to a fetus.)Tj
-0.023 Tc 0.091 Tw 0 -1.63 Td
[(I)0.5 (n t)0.5 (he)0.5 ( U)0.5 (.)0.5 (S.)37.5 ( ge)0.5 (n)0.5 (er)0.5 (a)0.5 (l po)0.5 (p)0.5 (ul)0.5 (a)-9.5 (t)0.5 (io)0.5 (n)0.5 (,)37.4 ( t)0.5 (he)0.5 ( e)0.5 (s)0.5 (t)0.5 (im)0.5 (a)-9.5 (t)0.5 (ed)0.5 ( b)0.5 (a)0.5 (ck)0.5 (g)0.5 (r)0.5 (ou)0.5 (n)0.5 (d ri)0.5 (s)0.5 (k o)0.5 (f m)0.5 (a)0.5 (jo)0.5 (r b)0.5 (ir)0.5 (t)0.5 (h d)0.5 (ef)0.5 (e)0.5 (c)0.5 (ts)0.5 ( a)0.5 (n)0.5 (d)-23 ( )]TJ
-0.032 Tc 0.036 Tw 0 -1.045 Td
[(m)0.5 (i)0.5 (sc)0.5 (a)0.5 (rr)0.5 (i)0.5 (a)-9.5 (ge)0.5 ( )0.5 (i)0.5 (n)0.5 ( c)20.5 (li)0.5 (n)0.5 (i)0.5 (ca)0.5 (l)0.5 (l)0.5 (y )0.5 (r)0.5 (e)0.5 (co)0.5 (g)0.5 (n)0.5 (iz)0.5 (e)0.5 (d )0.5 (p)0.5 (r)0.5 (eg)0.5 (n)0.5 (a)0.5 (nc)0.5 (i)0.5 (e)0.5 (s )0.5 (i)0.5 (s )0.5 (2)0.5 (%)0.5 ( t)0.5 (o)0.5 ( )0.5 (4%)0.5 ( )0.5 (a)0.5 (nd)0.5 ( )0.5 (1)0.5 (5%)0.5 ( )0.5 (to)0.5 ( )0.5 (2)0.5 (0%)0.5 (,)37.5 ( )0.5 (re)0.5 (s)0.5 (p)0.5 (ec)0.5 (t)0.5 (i)0.5 (ve)0.5 (l)0.5 (y)55.5 (.)]TJ
-0.017 Tc 0.017 Tw 0 -1.627 Td
[(Da)-9.8 (ta)]TJ
/T1_2 1 Tf
0.048 Tw 0 -1.424 Td
[(Human Da)-9.8 (ta)]TJ
/T1_1 1 Tf
-0.003 Tc 0.121 Tw 0 -1.473 Td
[(Published )0.5 (reports )0.6 (of )0.5 (individuals )0.6 (with )0.5 (congenital )0.5 (muta)-10.3 (tions )0.5 (in )37.5 (TRK )0.5 (pa)-10.2 (thway )0.6 (proteins)-3 ( )]TJ
0.013 Tc 0.197 Tw 0 -1.045 Td
[(sugge)0.5 (st )0.5 (tha)-9.6 (t )0.5 (dec)0.5 (reases)0.5 ( in)0.5 ( )37.4 (TRK-)0.5 (media)-9.5 (ted )0.5 (signal)0.5 (ing )0.5 (are )0.5 (cor)0.5 (rela)-9.6 (t)0.5 (ed )0.5 (with )0.5 (obes)0.5 (ity)55.4 (,)50 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(developmental delays,)37.2 ( cognitive impairment,)37.3 ( insensitivity to pain,)37.2 ( and anhidrosis.)]TJ
/T1_2 1 Tf
0 -1.627 Td
[(Animal Da)-9.8 (ta)]TJ
/T1_1 1 Tf
-0.015 Tc 0.06 Tw 0 -1.473 Td
[(In an embr)-18.2 (yo-fetal development stud)-10.3 (y)54.8 (,)36.8 ( once daily oral administra)-10.2 (tion of repotrectinib to)-15 ( )]TJ
-0.01 Tc 0.081 Tw 0 -1.045 Td
[(p)0.5 (re)0.5 (g)0.5 (na)0.5 (n)0.5 (t ra)-9.5 (t)0.5 (s)0.5 ( d)0.5 (ur)0.5 (i)0.5 (ng)0.5 ( t)0.5 (he)0.5 ( pe)0.5 (r)0.5 (io)0.5 (d)0.5 ( o)0.5 (f)0.5 ( o)0.5 (rg)0.5 (a)0.5 (no)0.5 (g)0.5 (e)0.5 (ne)0.5 (si)0.5 (s)0.5 ( f)0.5 (r)0.5 (om)0.5 ( g)0.5 (e)0.5 (st)0.5 (a)-9.5 (t)0.5 (io)0.5 (n)0.5 ( d)0.5 (ay)0.5 ( 6)0.5 ( t)0.5 (o)0.5 ( 1)0.5 (7)0.5 ( r)0.5 (es)0.5 (u)0.5 (lt)0.5 (e)0.5 (d)-10 ( )]TJ
-0.009 Tc 0.086 Tw 0 -1.045 Td
[(i)0.5 (n m)0.5 (a)-9.6 (t)0.5 (e)0.5 (rn)0.5 (al)0.5 ( ef)0.5 (f)0.5 (ec)0.5 (t)0.5 (s o)0.5 (f in)0.5 (c)0.5 (re)0.5 (a)0.5 (se)0.5 (d)0.5 ( b)0.5 (od)-9.5 (y)0.5 ( w)0.5 (e)0.5 (ig)0.5 (ht)0.5 ( an)0.5 (d)0.5 ( s)0.5 (ki)0.5 (n)0.5 ( a)0.5 (br)0.5 (a)0.5 (si)0.5 (o)0.5 (ns)0.5 (/u)0.5 (l)0.5 (ce)0.5 (r)0.5 (a)-9.6 (t)0.5 (i)0.5 (on)0.5 (s)0.5 ( a)-9.5 (t)0.5 ( d)0.5 (os)0.5 (e)0.5 (s)-9 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.045 Td
[(\0366 mg/kg,)37.2 ( fetal malforma)-9.8 (tions of malrota)-9.7 (ted hindlimbs and lo)-9.7 (wer fetal bod)-9.8 (y weights a)-9.8 (t)-15 ( )]TJ
-0.009 Tc 0.088 Tw 0 -1.045 Td
[(doses \03612 mg/kg [a)-9.7 (pproxima)-9.7 (tely )0.5 (0.3 )0.5 (times the )0.5 (recommended )0.5 (dose )0.5 (of )0.5 (160 )0.5 (mg )0.5 (twice)-9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(daily based on BSA].)37.2 ( No embr)-17.8 (yolethality was obser)-17.8 (ved.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.627 Td
(8.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Lactation)Tj
/T1_1 1 Tf
0.048 Tw -3.375 -1.496 Td
[(Risk Summar)-17.8 (y)]TJ
-0.012 Tc 0.075 Tw 0 -1.473 Td
[(There are no da)-10.2 (ta on the presence of )36.6 (AUGTYRO in human milk or its effects on either)-12 ( )]TJ
0.071 Tw 0 -1.045 Td
[(t)0.5 (h)0.5 (e)0.5 ( b)0.5 (r)0.5 (e)0.5 (a)0.5 (s)0.5 (tf)0.5 (e)0.5 (d)0.5 ( ch)0.5 (i)0.5 (l)0.5 (d o)0.5 (r)0.5 ( o)0.5 (n)0.5 ( mi)0.5 (l)0.5 (k)0.5 ( pr)0.5 (o)0.5 (d)0.5 (u)0.5 (c)0.5 (t)0.5 (io)0.5 (n)0.5 (.)37.5 ( B)0.5 (e)0.5 (c)0.5 (a)0.5 (u)0.5 (se)0.5 ( o)0.5 (f)0.5 ( t)0.5 (h)0.5 (e)0.5 ( p)0.5 (o)0.5 (t)0.5 (e)0.5 (n)0.5 (ti)0.5 (a)0.5 (l)0.5 ( f)0.5 (o)0.5 (r)0.5 ( s)0.5 (e)0.5 (ri)0.5 (o)0.5 (u)0.5 (s)0.5 ( a)0.5 (d)0.5 (v)0.5 (e)0.5 (r)0.5 (se)-11.9 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.045 Td
[(reactions in breastfed children from )36.6 (AUGTYRO,)36.5 ( advise a lacta)-10.5 (ting woman to discontinue)-17 ( )]TJ
0.048 Tw 0 -1.045 Td
[(breastfeeding during trea)-9.7 (tment with )37.2 (AUGTYRO and for 10 days after the last dose.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.627 Td
(8.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(F)20.2 (emales and Males of Reproductive P)24.2 (otential)]TJ
/T1_1 1 Tf
-0.011 Tc 0.079 Tw -3.375 -1.5 Td
(AUGTYRO can cause fetal harm when administered to a pregnant woman )Tj
/T1_2 1 Tf
[([see Use in)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.045 Td
[(Speci\037c P)18.2 (opula)-9.8 (tio)]TJ
(ns \(8.1\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.011 Tw 0 -1.627 Td
[(Pregnanc)20.2 (y T)74.2 (esting)]TJ
0.003 Tc 0.15 Tw 0 -1.473 Td
[(V)17.8 (erify the pregnanc)19.9 (y sta)-10.1 (tus of females of childbearing potential prior to initia)-10.1 (ting)3 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.045 Td
(AUGTYRO )Tj
/T1_2 1 Tf
0.048 Tw 3.706 0 Td
[([see Use in Speci\037c P)18.2 (opula)-9.7 (tio)]TJ
(ns \(8.1\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
ET
q 1 0 0 1 324 726.248 cm
0 0 m
39.372 0 l
S
Q
q 1 0 0 1 324 451.2444 cm
0 0 m
60.128 0 l
S
Q
BT
-0.017 Tc 0.017 Tw 8 0 0 8 324 727.248 Tm
(Contraception)Tj
-0.014 Tc 0.061 Tw 0 -1.476 Td
[(A)0.5 (U)0.5 (G)0.5 (T)0.5 (Y)0.5 (R)0.5 (O)0.5 ( c)0.5 (a)0.5 (n)0.5 ( c)0.5 (a)0.5 (u)0.5 (s)0.5 (e)0.5 ( e)0.5 (m)0.5 (b)0.5 (r)-17.5 (y)0.5 (o)0.5 (-)0.5 (f)0.5 (e)0.5 (t)0.5 (a)0.6 (l h)0.5 (a)0.5 (r)0.5 (m)0.5 ( w)0.5 (h)0.5 (e)0.5 (n)0.5 ( a)0.5 (d)0.5 (m)0.5 (i)0.6 (ni)0.5 (s)0.5 (t)0.6 (e)0.5 (r)0.5 (e)0.5 (d)0.5 ( t)0.5 (o)0.5 ( a)0.5 ( p)0.5 (r)0.5 (e)0.5 (g)0.5 (n)0.5 (a)0.5 (n)0.5 (t)0.5 ( w)0.5 (o)0.5 (m)0.5 (a)0.5 (n)0.5 ( )]TJ
/T1_2 1 Tf
0.014 Tw [([)0.6 (s)0.5 (e)0.5 (e)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(Use in Speci\037c P)18.2 (opula)-9.8 (tio)]TJ
(ns \(8.1\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_2 1 Tf
-0.017 Tc 0.017 Tw 0 -1.584 Td
[(F)24.2 (emales)]TJ
/T1_1 1 Tf
-0.008 Tc 0.093 Tw 0 -1.476 Td
[(Advise females of childbearing potential to use effective non-hormonal c\ontraception)-8 ( )]TJ
-0.017 Tc 0.039 Tw 0 -1.048 Td
[(during )0.6 (trea)-9.8 (tment )0.5 (with )37.5 (AUGTYRO )0.5 (and )0.5 (for )0.5 (2 )0.5 (months )0.5 (follo)-9.8 (wing )0.5 (the )0.5 (last )0.5 (dose.)37.2 ( )37.5 (AUGTYRO )0.5 (can)-17 ( )]TJ
0.048 Tw 0 -1.048 Td
(render some hormonal contraceptives ineffective )Tj
/T1_2 1 Tf
([see Drug Interactio)Tj
(ns \(7.2\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_2 1 Tf
-0.017 Tc 0.017 Tw 0 -1.584 Td
(Males)Tj
/T1_1 1 Tf
-0.021 Tc 0.036 Tw 0 -1.476 Td
[(Based on genotoxicity \037ndings,)36.8 ( advise male pa)-10.2 (tients with female partners of childbearing)-21 ( )]TJ
0 -1.048 Td
[(p)0.5 (ot)0.5 (en)0.5 (t)0.5 (ia)0.5 (l )0.5 (to)0.5 ( u)0.5 (s)0.5 (e )0.5 (ef)0.5 (f)0.5 (ec)0.5 (ti)0.5 (ve)0.5 ( )0.5 (co)0.5 (nt)0.5 (r)0.5 (ac)0.5 (ep)0.5 (ti)0.5 (o)0.5 (n )0.5 (du)0.5 (ri)0.5 (ng)0.5 ( t)0.5 (r)0.5 (ea)-9.5 (tm)0.5 (e)0.5 (nt)0.5 ( w)0.5 (it)0.5 (h)0.5 ( )37.4 (A)0.5 (UG)0.5 (TY)0.5 (RO)0.5 ( a)0.5 (nd)0.5 ( f)0.5 (o)0.5 (r )0.5 (4 )0.5 (m)0.5 (on)0.5 (th)0.5 (s)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(follo)-9.8 (wing the last dose )]TJ
/T1_2 1 Tf
0.011 Tw [([see )-36.8 (Nonc)20.1 (linical T)74.2 (oxicolog)]TJ
0.048 Tw 17.418 0 Td
(y \(13)Tj
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw 1.972 0 Td
(1\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw -19.389 -1.629 Td
(8.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(P)24.2 (ediatric Use)]TJ
/T1_1 1 Tf
-0.02 Tc 0.036 Tw -3.375 -1.48 Td
[(T)0.5 (h)0.6 (e)0.6 ( )0.5 (s)0.5 (a)0.6 (f)0.6 (e)0.5 (t)0.6 (y)0.5 ( )0.6 (a)0.5 (n)0.6 (d)0.5 ( )0.5 (e)0.6 (f)0.6 (f)0.5 (e)0.6 (c)0.5 (t)0.6 (i)0.5 (v)0.6 (e)0.5 (n)0.6 (e)0.5 (s)0.6 (s)0.5 ( )0.6 (o)0.5 (f)0.6 ( )37.5 (A)0.6 (U)0.5 (G)0.6 (T)0.5 (Y)0.6 (R)0.5 (O)0.5 ( )0.6 (i)0.5 (n)0.6 ( )0.5 (p)0.6 (e)0.5 (d)0.6 (i)0.5 (a)-9.4 (t)0.5 (r)0.6 (i)0.5 (c)0.6 ( )0.5 (p)0.6 (a)-9.4 (t)0.5 (i)0.6 (e)0.5 (n)0.6 (t)0.5 (s)0.6 ( )0.5 (w)0.6 (i)0.5 (t)0.5 (h)0.6 ( )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
23.837 0 Td
( )Tj
EMC 
/T1_2 1 Tf
0.02 Tw 0.021 0 Td
[(R)0.5 (O)]TJ
0 Tc 0 Tw 1.034 0 Td
(S)Tj
0.439 0 Td
(1)Tj
/T1_1 1 Tf
-0.02 Tc 0.036 Tw 0.459 0 Td
[(-)0.6 (p)0.5 (o)0.6 (s)0.5 (i)0.5 (t)0.6 (i)0.6 (v)0.5 (e)0.6 ( )0.5 (N)0.6 (S)0.5 (C)0.5 (L)0.6 (C)-20 ( )]TJ
-0.017 Tc 0.048 Tw -25.791 -1.048 Td
[(ha)-9.8 (ve not been established.)]TJ
-0.019 Tc 0.036 Tw 0 -1.588 Td
[(The safety and effectiveness of )37.1 (AUGTYRO ha)-9.9 (ve not been established in pedia)-9.9 (tric pa)-9.9 (tients)-19 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(younger than 12 years of a)-9.8 (ge with solid tumors who ha)-9.8 (ve an )]TJ
/T1_2 1 Tf
0.017 Tw (NTRK)Tj
/T1_1 1 Tf
0.048 Tw ( gene fusion.)Tj
0.008 Tc 0.171 Tw 0 -1.588 Td
[(T)0.5 (he)0.5 ( s)0.5 (a)0.5 (fe)0.5 (t)0.5 (y)0.5 ( a)0.5 (nd)0.5 ( e)0.5 (f)0.5 (fe)0.5 (c)0.5 (t)0.5 (iv)0.5 (e)0.5 (n)0.5 (es)0.5 (s)0.5 ( o)0.5 (f )36.9 (AU)0.5 (G)0.5 (TY)0.5 (R)0.5 (O f)0.5 (o)0.5 (r)0.5 ( t)0.5 (he)0.5 ( t)0.5 (r)0.5 (e)0.5 (a)-9.6 (t)0.5 (m)0.5 (e)0.5 (nt)0.5 ( o)0.5 (f)0.5 ( l)0.5 (oc)0.5 (a)0.5 (l)0.5 (ly)0.5 ( a)0.5 (d)0.5 (va)0.5 (n)0.5 (c)0.5 (ed)]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.008 Tc 0.096 Tw -31.5 -1.048 Td
[(or metasta)-10.3 (tic )]TJ
/T1_2 1 Tf
0.008 Tw (NTR)Tj
0 Tc 0 Tw (K)Tj
/T1_1 1 Tf
-0.008 Tc 0.096 Tw 7.208 0 Td
[(-positive solid tumors ha)-10.2 (ve been established in pedia)-10.3 (tric pa)-10.3 (tients)-8 ( )]TJ
-0.024 Tc 0.03 Tw -7.208 -1.048 Td
[(12 years of a)-9.6 (ge or older)74.3 (.)37.3 ( Use of )37 (AUGTYRO in this a)-9.7 (ge group is supported by evidence from)-24 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.048 Td
[(an )0.5 (adequa)-9.8 (te )0.6 (and )0.5 (well-controlled )0.5 (stud)-9.8 (y )0.5 (in )0.5 (adult )0.5 (pa)-9.8 (tients )0.5 (with )0.6 (additional )0.5 (pharmacokinetic)-17 ( )]TJ
0.002 Tc 0.144 Tw 0 -1.048 Td
[(and safety da)-9.9 (ta in pedia)-10 (tric pa)-10 (tients a)-10 (ged 12 years and older)74 (.)37 ( )36.9 (This inc)20 (ludes da)-9.9 (ta)2 ( )]TJ
-0.01 Tc 0.081 Tw 0 -1.048 Td
[(d)0.5 (e)0.5 (m)0.5 (on)0.5 (s)0.5 (t)0.5 (r)0.5 (a)-9.5 (t)0.5 (in)0.5 (g)0.5 ( t)0.5 (h)0.5 (a)-9.5 (t)0.5 ( t)0.5 (h)0.5 (e)0.5 ( e)0.5 (x)0.5 (p)0.5 (o)0.5 (su)0.5 (r)0.5 (e)0.5 ( o)0.5 (f)0.5 ( r)0.5 (e)0.5 (p)0.5 (o)0.5 (t)0.5 (re)0.5 (c)0.5 (t)0.5 (i)0.5 (n)0.5 (ib)0.5 ( i)0.5 (n)0.5 ( p)0.5 (e)0.5 (d)0.5 (i)0.5 (a)-9.5 (t)0.5 (ri)0.5 (c)0.5 ( p)0.5 (a)-9.5 (t)0.5 (i)0.5 (e)0.5 (nt)0.5 (s)0.5 ( 1)0.5 (2)0.5 ( y)0.5 (e)0.5 (a)0.5 (r)0.5 (s)0.5 ( o)0.5 (f)0.5 ( a)-9.5 (g)0.5 (e)-10 ( )]TJ
-0.013 Tc 0.072 Tw 0 -1.048 Td
[(and )0.5 (older )0.5 (is )0.5 (expected )0.5 (to )0.6 (result )0.6 (in )0.6 (similar )0.5 (safety )0.5 (and )0.5 (ef\037cac)19.5 (y )0.6 (to )0.5 (tha)-10.4 (t )0.5 (of )0.5 (adults,)36.5 ( )0.6 (and )0.6 (tha)-10.3 (t)-13 ( )]TJ
-0.012 Tc 0.076 Tw 0 -1.048 Td
[(the course of locally advanced or metasta)-10.3 (tic )]TJ
/T1_2 1 Tf
0.012 Tw (NTR)Tj
0 Tc 0 Tw (K)Tj
/T1_1 1 Tf
-0.012 Tc 0.076 Tw 18.551 0 Td
[(-positive solid tumors is suf\037ciently)-12 ( )]TJ
-0.011 Tc 0.079 Tw -18.551 -1.048 Td
[(similar in adults and pedia)-10 (tric pa)-10 (tients 12 years of a)-10 (ge or older to allo)-10.1 (w extra)-10 (pola)-10 (tion)-11 ( )]TJ
0.006 Tc 0.163 Tw 0 -1.048 Td
[(of da)-9.8 (ta in adult to pedia)-9.9 (tric pa)-9.8 (tients 12 years of a)-9.8 (ge or older )]TJ
/T1_2 1 Tf
[([see Dosa)-9.8 (ge and)6 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.048 Td
[(A)0.5 (dm)0.5 (i)0.5 (n)0.5 (is)0.5 (t)0.5 (r)0.5 (a)-9.6 (t)0.5 (i)0.5 (o)0.5 (n)0.5 ( \()0.5 (2)0.5 (.4)0.5 (\))0.5 (,)37.4 ( )37.5 (W)18.5 (a)0.5 (rn)0.5 (i)0.5 (n)0.5 (gs)0.5 ( )0.5 (a)0.5 (nd)0.5 ( )0.5 (P)0.5 (re)0.5 (c)0.5 (a)0.5 (u)0.5 (ti)0.5 (o)0.5 (n)0.5 (s )0.5 (\()0.5 (5.)0.5 (7)0.5 (\))0.5 (,)37.4 ( )37.5 (A)0.5 (dv)0.5 (e)0.5 (r)0.5 (se)0.5 ( )0.5 (R)0.5 (ea)0.5 (c)0.5 (t)0.5 (i)0.5 (on)0.5 (s)0.5 ( )0.5 (\(6)0.5 (.)0.5 (1)0.5 (\) )0.5 (a)0.5 (nd)0.5 ( )0.5 (C)0.5 (li)0.5 (n)0.5 (ic)0.5 (a)0.5 (l)-19 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.048 Td
(Pharmacolog)Tj
0.048 Tw 4.652 0 Td
(y \(12.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.011 Tw -4.652 -1.629 Td
[(Juvenile Animal )-36.8 (Da)-9.7 (ta)]TJ
0.005 Tc 0.156 Tw 0 -1.476 Td
[(D)0.5 (a)0.5 (i)0.6 (l)0.5 (y)0.5 ( o)0.5 (r)0.5 (a)0.6 (l)0.5 ( a)0.6 (d)0.5 (m)0.5 (i)0.5 (n)0.6 (i)0.5 (s)0.5 (t)0.5 (r)0.5 (a)-9.4 (t)0.5 (i)0.5 (o)0.5 (n)0.6 ( o)0.6 (f)0.5 ( r)0.5 (e)0.5 (p)0.5 (o)0.5 (t)0.6 (r)0.5 (e)0.5 (c)0.5 (t)0.6 (i)0.5 (n)0.5 (i)0.5 (b)0.6 ( t)0.5 (o)0.6 ( j)0.6 (u)0.5 (v)0.5 (e)0.5 (n)0.5 (i)0.6 (l)0.5 (e)0.5 ( r)0.5 (a)-9.5 (t)0.6 (s)0.5 ( f)0.5 (o)0.5 (r)0.5 ( 8)0.5 ( w)0.5 (e)0.6 (e)0.5 (k)0.5 (s)0.5 ( s)0.5 (t)0.5 (a)0.6 (r)0.5 (t)0.5 (i)0.5 (n)0.6 (g)0.5 ( o)0.6 (n)5 ( )]TJ
0.007 Tc 0.171 Tw 0 -1.048 Td
[(postna)-10.3 (tal )0.5 (day )0.5 (12 )0.5 (\(a)-10.2 (pproxima)-10.2 (tely )0.5 (equal )0.5 (to )0.5 (a )0.5 (human )0.5 (pedia)-10.2 (tric )0.5 (a)-10.3 (ge )0.5 (of a )0.5 (newborn\))7 ( )]TJ
-0.006 Tc 0.104 Tw 0 -1.048 Td
[(resulted in toxicities similar to those obser)-18.1 (ved in adult ra)-10 (ts,)37 ( though juvenile animals)-6 ( )]TJ
-0.008 Tc 0.094 Tw 0 -1.048 Td
[(sho)-9.9 (wed decreased bod)-9.9 (y weight gain a)-9.9 (t doses \0361 mg/kg \(a)-9.9 (pproxima)-9.9 (tely \0360.04 times)-8 ( )]TJ
-0.012 Tc 0.072 Tw 0 -1.048 Td
[(the human exposure based on )36.9 (AUC a)-9.6 (t the recommended c)20.3 (linical dose of 160 mg BID\))-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(and decreased femur lengths a)-9.7 (t 3 mg/kg \(a)-9.7 (pproxima)-9.8 (tely 0.1 times the human exposure)-17 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.048 Td
[(ba)0.5 (se)0.5 (d o)0.5 (n )37.5 (AUC)0.5 ( a)-9.5 (t t)0.5 (he)0.5 ( r)0.5 (ec)0.5 (om)0.5 (me)0.5 (nde)0.5 (d )0.5 (c)20.4 (li)0.5 (ni)0.5 (cal)0.5 ( d)0.5 (os)0.5 (e o)0.5 (f )0.5 (16)0.5 (0 m)0.5 (g )0.5 (BID)0.5 (\).)37.4 ( )0.5 (De)0.5 (cr)0.5 (ea)0.5 (sed)0.5 ( b)0.5 (od)-9.5 (y w)0.5 (ei)0.5 (gh)0.5 (t)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(gain and decreased femur lengths persisted follo)-9.8 (wing 4 weeks of recover)-17.8 (y)55.2 (.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.629 Td
(8.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Geriatric Use)Tj
/T1_1 1 Tf
-0.013 Tc 0.071 Tw -3.375 -1.503 Td
[(Of the 426 pa)-10.4 (tients who received )36.6 (AUGTYRO,)36.6 ( in the )36.6 (TRIDENT)54.5 (-1 stud)-10.4 (y for )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.013 Tw 26.473 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.497 0 Td
(1)Tj
/T1_1 1 Tf
-0.013 Tc 0.013 Tw 0.447 0 Td
[(-positive)-13 ( )]TJ
-0.015 Tc 0.061 Tw -28.418 -1.048 Td
(non-small cell lung cancer or )Tj
/T1_2 1 Tf
0.015 Tw (NTRK)Tj
/T1_1 1 Tf
0.061 Tw [( gene fusion-positive solid tumors,)36.7 ( 19% were 65 to)-15 ( )]TJ
-0.017 Tc 0.036 Tw 0 -1.048 Td
[(75 years old,)37.2 ( and 6% were 75 years of a)-9.8 (ge or older)74.2 (.)37.2 ( )36.9 (There were no c)20.2 (linically meaningful)-17 ( )]TJ
0 Tc 0.136 Tw 0 -1.048 Td
[(differences in safety and ef\037cac)19.6 (y between pa)-10.4 (tients younger than 65 years of a)-10.4 (ge )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(and pa)-9.8 (tients 65 years of a)-9.8 (ge or older)74.1 (.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.629 Td
(8.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Renal Impairment)Tj
/T1_1 1 Tf
-0.019 Tc 0.036 Tw -3.375 -1.503 Td
[(The recommended dosa)-9.9 (ge of )37 (AUGTYRO has not been established in pa)-10 (tients with severe)-19 ( )]TJ
-0.006 Tc 0.103 Tw 0 -1.048 Td
[(renal )0.5 (impairment or kidney failure \(eGFR )0.5 (<30 mL/min\) and )0.5 (pa)-9.7 (tients )0.5 (on )0.5 (dialysis )]TJ
/T1_2 1 Tf
0.006 Tw 29.965 0 Td
[([see)-6 ( )]TJ
-0.017 Tc 0.048 Tw -29.965 -1.048 Td
(Clinical Pharmacolog)Tj
7.453 0 Td
(y \(12.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
0.133 Tw -7.453 -1.633 Td
[(No dosa)-9.9 (ge modi\037ca)-9.9 (tion is recommended for pa)-9.9 (tients with mild or modera)-9.8 (te renal )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
(impairment \(eGFR 30 to 90 mL/min\).)Tj
/T1_0 1 Tf
0.017 Tw 0 -1.629 Td
(8.7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Hepatic Impairment)Tj
/T1_1 1 Tf
0.001 Tc 0.138 Tw -3.375 -1.503 Td
[(The )0.5 (recommended dosa)-9.7 (ge of )37.5 (AUGTYRO has not been established in pa)-9.8 (tients )0.5 (with)1 ( )]TJ
-0.005 Tc 0.112 Tw 0 -1.048 Td
[(modera)-10.4 (te \(total bilirubin >1.5 to 3 times upper limit of normal [ULN] with an\)-10.5 (y )37.4 (AST\))-5 ( )]TJ
-0.011 Tc 0.077 Tw 0 -1.048 Td
[(or)0.5 ( )0.5 (sever)0.5 (e )0.5 (\(to)0.5 (tal )0.5 (b)0.5 (ilirub)0.5 (in )0.5 (>3 )0.5 (t)0.5 (imes )0.5 (U)0.5 (LN )0.5 (wit)0.5 (h )0.5 (an)-9.6 (y)0.5 ( )37.4 (A)0.5 (ST\) )0.5 (hep)0.5 (a)-9.6 (tic )0.6 (impai)0.5 (rmen)0.5 (t )]TJ
/T1_2 1 Tf
27.098 0 Td
[([se)0.5 (e )0.5 (Cli)0.5 (nical)-11 ( )]TJ
-0.017 Tc 0.017 Tw -27.098 -1.048 Td
(Pharmacolog)Tj
0.048 Tw 4.652 0 Td
(y \(12.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.006 Tc 0.103 Tw -4.652 -1.633 Td
[(No dosa)-9.8 (ge modi\037ca)-9.8 (tion is recommended for pa)-9.9 (tients with mild \(total bilirubin >1 to)-6 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(1.5\035)-47.8 (times ULN or )37.2 (AST > ULN\) hepa)-9.8 (tic impairment.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.984 Td
(11)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(DESCRIPTION)Tj
/T1_1 1 Tf
-0.02 Tc 0.036 Tw -3.375 -1.476 Td
[(Repotrectinib is a kinase inhibitor)74.2 (.)37.3 ( )37.3 (The molecular formula for repotrectinib is C)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.02 Tw 5.6 0 0 5.6 543.8311 159.3042 Tm
(18)Tj
8 0 0 8 548.98 160.5443 Tm
(H)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
5.6 0 0 5.6 553.2849 159.3042 Tm
(18)Tj
8 0 0 8 558.4338 160.5443 Tm
(FN)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 566.2805 159.3042 Tm
(5)Tj
-0.02 Tc 0.02 Tw 8 0 0 8 568.855 160.5443 Tm
(O)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.6 0 0 5.6 573.312 159.3042 Tm
(2)Tj
8 0 0 8 576 160.5443 Tm
( )Tj
0.006 Tc 0.164 Tw -31.5 -1.048 Td
[(and the molecular weight is 355.37 Daltons.)37 ( )37.2 (The chemical name is \(3R,11S\)-6-)]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
0.009 Tc -0.009 Tw -31.5 -1.048 Td
[(Fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaaza)-10.1 (tetrac)19.8 (yc)19.8 (lo[13.5.2.0)]TJ
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
5.6 0 0 5.6 546.9038 146.4391 Tm
(4,9)Tj
-0.198 Tw /Span<</ActualText<FEFF200A>>> BDC 
8 0 0 8 553.7786 143.7751 Tm
( )Tj
EMC 
(.0)Tj
/Span<</ActualText<FEFF2009>>> BDC 
( )Tj
EMC 
-0.009 Tw 5.6 0 0 5.6 561.167 146.4391 Tm
(18,22)Tj
0 Tc -0.189 Tw /Span<</ActualText<FEFF200A>>> BDC 
8 0 0 8 573.521 143.7751 Tm
( )Tj
EMC 
(])Tj
-0.022 Tc 0.036 Tw -31.19 -1.048 Td
[(docosa-1\(21\),4,6,8,15\(22\),16,19-heptaen-14-one.)36.9 ( )36.9 (The chemical structure of repotrectinib)-22 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.048 Td
[(is as follo)-9.8 (ws:)]TJ
ET
/PlacedGraphic /MC0 BDC 
EMC 
/GS0 gs
q 1 0 0 1 467.6948 54.6388 cm
0 0 m
-5.365 -3.429 l
-15.726 2.082 l
-15.726 13.37 l
-9.731 16.923 l
-10.129 17.594 l
-16.36 13.901 l
-25.778 15.807 l
-25.933 15.043 l
-16.506 13.135 l
-16.506 1.614 l
-5.328 -4.332 l
0.421 -0.657 l
h
f
Q
q 1 0 0 1 453.9532 66.3762 cm
0 0 m
-0.396 0.672 l
4.817 3.737 l
5.212 3.065 l
h
f
Q
q 1 0 0 1 461.9898 52.994 cm
0 0 m
-8.192 4.468 l
-7.819 5.153 l
0.373 0.684 l
h
f
Q
q 1 0 0 1 474.4943 66.827 cm
0 0 m
-0.232 0.745 l
8.075 3.323 l
8.306 2.578 l
h
f
Q
q 1 0 0 1 485.0071 58.1509 cm
0 0 m
-0.634 0.453 l
2.516 4.864 l
3.151 4.411 l
h
f
Q
q 1 0 0 1 479.284 54.1734 cm
0 0 m
-3.38 1.26 l
-3.108 1.992 l
0.272 0.732 l
h
f
Q
q 1 0 0 1 487.1188 82.0098 cm
0 0 m
7.568 1.709 l
7.396 2.47 l
0.279 0.863 l
0.467 1.444 l
-0.269 2.278 l
7.166 3.943 l
6.996 4.704 l
-0.859 2.946 l
-3.161 5.555 l
-3.746 5.039 l
-0.411 1.261 l
-3.793 -9.183 l
-14.925 -12.95 l
-20.497 -9.495 l
-20.909 -10.158 l
-15.364 -13.595 l
-15.364 -21.055 l
-14.584 -21.055 l
-14.584 -13.658 l
-3.722 -9.982 l
2.821 -19.164 l
-1.028 -24.552 l
-0.393 -25.004 l
3.779 -19.164 l
-3.086 -9.531 l
h
f
Q
q 1 0 0 1 427.6263 91.7405 cm
0 0 m
-11.273 2.039 l
-15.019 12.728 l
-7.521 21.549 l
3.667 19.344 l
7.525 8.71 l
h
8.31 8.833 m
4.25 20.024 l
-7.819 22.402 l
-15.47 13.402 l
-23.923 15.026 l
-24.071 14.26 l
-15.828 12.676 l
-11.859 1.353 l
-0.165 -0.763 l
2.801 -12.118 l
6.405 -16.594 l
7.012 -16.104 l
3.513 -11.759 l
0.579 -0.523 l
8.023 8.094 l
15.285 6.698 l
15.433 7.464 l
h
f
Q
q 1 0 0 1 429.902 109.2095 cm
0 0 m
-9.109 1.891 l
-8.95 2.654 l
0.158 0.764 l
h
f
Q
q 1 0 0 1 427.2972 93.5824 cm
0 0 m
-0.59 0.511 l
5.368 7.385 l
5.958 6.874 l
h
f
Q
q 1 0 0 1 417.4124 95.1951 cm
0 0 m
-3.151 8.765 l
-2.417 9.029 l
0.734 0.264 l
h
f
Q
q 1 0 0 1 425.3741 74.0674 cm
0 0 m
-1.432 1.89 l
-0.811 2.362 l
0.622 0.471 l
h
f
Q
q 1 0 0 1 427.032 76.1913 cm
0 0 m
-0.802 1.089 l
-0.174 1.551 l
0.628 0.463 l
h
f
Q
q 1 0 0 1 428.8671 77.9072 cm
0 0 m
-0.515 0.688 l
0.109 1.155 l
0.624 0.468 l
h
f
Q
q 1 0 0 1 469.3702 104.0981 cm
0 0 m
-11.97 0 l
-12.352 6.983 l
-15.156 6.127 l
-12.121 -0.04 l
-18.811 -3.674 l
-18.439 -4.359 l
-11.85 -0.78 l
-0.353 -0.78 l
6.377 -8.407 l
6.962 -7.891 l
h
f
Q
BT
/T1_3 1 Tf
0.421 Tc -0.421 Tw 8.32 0 0 8.32 441.8333 111.7988 Tm
(HC)Tj
0 Tc 0 Tw 6.24 0 0 6.24 447.84 110.2254 Tm
(3)Tj
8.32 0 0 8.32 476.3626 88.9681 Tm
(NH)Tj
-3.886 0.67 Td
(O)Tj
6.174 -1.389 Td
(O)Tj
-11.709 2.472 Td
(F)Tj
3.713 -4.358 Td
(HN)Tj
4.871 -1.651 Td
(N)Tj
-1.217 2.107 Td
(N)Tj
2.553 -2.545 Td
(N)Tj
0.421 Tc -0.421 Tw -8.604 2.325 Td
(HC)Tj
0 Tc 0 Tw 6.24 0 0 6.24 414.9289 67.69 Tm
(3)Tj
/T1_4 1 Tf
6.548 4.484 Td
(\(S)Tj
(\))Tj
-3.559 -2.511 Td
(\(R\))Tj
/GS1 gs
/T1_1 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 324 35.9999 Tm
[(Repotrectinib is a white to off-white po)-9.7 (wder)74.2 (.)]TJ
ET
endstreamendobj94 0 obj<</Metadata 95 0 R>>endobj95 0 obj<</Length 38964/Subtype/XML/Type/Metadata>>stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 9.1-c002 79.a6a6396, 2024/03/12-07:48:23        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:illustrator="http://ns.adobe.com/illustrator/1.0/"
            xmlns:xmpTPg="http://ns.adobe.com/xap/1.0/t/pg/"
            xmlns:stDim="http://ns.adobe.com/xap/1.0/sType/Dimensions#"
            xmlns:stFnt="http://ns.adobe.com/xap/1.0/sType/Font#"
            xmlns:xmpG="http://ns.adobe.com/xap/1.0/g/"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
            xmlns:ExtensisFontSense="http://www.extensis.com/meta/FontSense/">
         <dc:format>application/postscript</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Repotrectinib Chemical Structure Layered</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>(Steve Burgos)</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <xmp:MetadataDate>2023-11-03T07:06:24-04:00</xmp:MetadataDate>
         <xmp:ModifyDate>2023-11-03T07:06:24-04:00</xmp:ModifyDate>
         <xmp:CreateDate>2023-11-03T07:06:24-04:00</xmp:CreateDate>
         <xmp:CreatorTool>Adobe Illustrator 28.0 (Macintosh)</xmp:CreatorTool>
         <xmpMM:InstanceID>xmp.iid:e0d17f48-4dec-466d-b4ac-c47241b092e8</xmpMM:InstanceID>
         <xmpMM:DocumentID>xmp.did:e0d17f48-4dec-466d-b4ac-c47241b092e8</xmpMM:DocumentID>
         <xmpMM:OriginalDocumentID>uuid:5D20892493BFDB11914A8590D31508C8</xmpMM:OriginalDocumentID>
         <xmpMM:RenditionClass>default</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>uuid:98d3dbfc-0b50-284b-8b3c-0b0991f5c7c7</stRef:instanceID>
            <stRef:documentID>xmp.did:3c8b4d31-2e94-45a9-818a-06e72cdd0cc5</stRef:documentID>
            <stRef:originalDocumentID>uuid:5D20892493BFDB11914A8590D31508C8</stRef:originalDocumentID>
            <stRef:renditionClass>default</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:3c8b4d31-2e94-45a9-818a-06e72cdd0cc5</stEvt:instanceID>
                  <stEvt:when>2023-07-10T13:46:17-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 27.7 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>saved</stEvt:action>
                  <stEvt:instanceID>xmp.iid:e0d17f48-4dec-466d-b4ac-c47241b092e8</stEvt:instanceID>
                  <stEvt:when>2023-11-03T07:06:24-04:00</stEvt:when>
                  <stEvt:softwareAgent>Adobe Illustrator 28.0 (Macintosh)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <illustrator:StartupProfile>Print</illustrator:StartupProfile>
         <illustrator:CreatorSubTool>Adobe Illustrator</illustrator:CreatorSubTool>
         <xmpTPg:HasVisibleOverprint>False</xmpTPg:HasVisibleOverprint>
         <xmpTPg:HasVisibleTransparency>False</xmpTPg:HasVisibleTransparency>
         <xmpTPg:NPages>1</xmpTPg:NPages>
         <xmpTPg:MaxPageSize rdf:parseType="Resource">
            <stDim:w>4.030260</stDim:w>
            <stDim:h>3.093844</stDim:h>
            <stDim:unit>Inches</stDim:unit>
         </xmpTPg:MaxPageSize>
         <xmpTPg:Fonts>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-Roman</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>55 Roman</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.100;PS 005.000;hotconv 1.0.67;makeotf.lib2.5.33168</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-Roman.otf</stFnt:fontFileName>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <stFnt:fontName>HelveticaNeueLTStd-It</stFnt:fontName>
                  <stFnt:fontFamily>Helvetica Neue LT Std</stFnt:fontFamily>
                  <stFnt:fontFace>56 Italic</stFnt:fontFace>
                  <stFnt:fontType>Open Type</stFnt:fontType>
                  <stFnt:versionString>Version 2.100;PS 005.000;hotconv 1.0.67;makeotf.lib2.5.33168</stFnt:versionString>
                  <stFnt:composite>False</stFnt:composite>
                  <stFnt:fontFileName>HelveticaNeueLTStd-It.otf</stFnt:fontFileName>
               </rdf:li>
            </rdf:Bag>
         </xmpTPg:Fonts>
         <xmpTPg:PlateNames>
            <rdf:Seq>
               <rdf:li>Black</rdf:li>
            </rdf:Seq>
         </xmpTPg:PlateNames>
         <xmpTPg:SwatchGroups>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Default Swatch Group</xmpG:groupName>
                  <xmpG:groupType>0</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>White</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>Black</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>CMYK Red</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>CMYK Yellow</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>CMYK Green</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>100.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>CMYK Cyan</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>100.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>CMYK Blue</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>100.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>CMYK Magenta</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=15 M=100 Y=90 K=10</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>15.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>90.000000</xmpG:yellow>
                           <xmpG:black>10.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=90 Y=85 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>90.000000</xmpG:magenta>
                           <xmpG:yellow>85.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=80 Y=95 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>80.000000</xmpG:magenta>
                           <xmpG:yellow>95.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=50 Y=100 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>50.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=35 Y=85 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>35.000000</xmpG:magenta>
                           <xmpG:yellow>85.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=5 M=0 Y=90 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>5.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>90.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=20 M=0 Y=100 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>20.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=50 M=0 Y=100 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>50.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=75 M=0 Y=100 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>75.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=85 M=10 Y=100 K=10</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>85.000000</xmpG:cyan>
                           <xmpG:magenta>10.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>10.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=90 M=30 Y=95 K=30</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>90.000000</xmpG:cyan>
                           <xmpG:magenta>30.000000</xmpG:magenta>
                           <xmpG:yellow>95.000000</xmpG:yellow>
                           <xmpG:black>30.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=75 M=0 Y=75 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>75.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>75.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=80 M=10 Y=45 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>80.000000</xmpG:cyan>
                           <xmpG:magenta>10.000000</xmpG:magenta>
                           <xmpG:yellow>45.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=70 M=15 Y=0 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>70.000000</xmpG:cyan>
                           <xmpG:magenta>15.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=85 M=50 Y=0 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>85.000000</xmpG:cyan>
                           <xmpG:magenta>50.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=100 M=95 Y=5 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>100.000000</xmpG:cyan>
                           <xmpG:magenta>95.000000</xmpG:magenta>
                           <xmpG:yellow>5.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=100 M=100 Y=25 K=25</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>100.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>25.000000</xmpG:yellow>
                           <xmpG:black>25.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=75 M=100 Y=0 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>75.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=50 M=100 Y=0 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>50.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=35 M=100 Y=35 K=10</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>35.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>35.000000</xmpG:yellow>
                           <xmpG:black>10.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=10 M=100 Y=50 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>10.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>50.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=95 Y=20 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>95.000000</xmpG:magenta>
                           <xmpG:yellow>20.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=25 M=25 Y=40 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>25.000000</xmpG:cyan>
                           <xmpG:magenta>25.000000</xmpG:magenta>
                           <xmpG:yellow>40.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=40 M=45 Y=50 K=5</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>40.000000</xmpG:cyan>
                           <xmpG:magenta>45.000000</xmpG:magenta>
                           <xmpG:yellow>50.000000</xmpG:yellow>
                           <xmpG:black>5.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=50 M=50 Y=60 K=25</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>50.000000</xmpG:cyan>
                           <xmpG:magenta>50.000000</xmpG:magenta>
                           <xmpG:yellow>60.000000</xmpG:yellow>
                           <xmpG:black>25.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=55 M=60 Y=65 K=40</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>55.000000</xmpG:cyan>
                           <xmpG:magenta>60.000000</xmpG:magenta>
                           <xmpG:yellow>65.000000</xmpG:yellow>
                           <xmpG:black>40.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=25 M=40 Y=65 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>25.000000</xmpG:cyan>
                           <xmpG:magenta>40.000000</xmpG:magenta>
                           <xmpG:yellow>65.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=30 M=50 Y=75 K=10</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>30.000000</xmpG:cyan>
                           <xmpG:magenta>50.000000</xmpG:magenta>
                           <xmpG:yellow>75.000000</xmpG:yellow>
                           <xmpG:black>10.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=35 M=60 Y=80 K=25</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>35.000000</xmpG:cyan>
                           <xmpG:magenta>60.000000</xmpG:magenta>
                           <xmpG:yellow>80.000000</xmpG:yellow>
                           <xmpG:black>25.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=40 M=65 Y=90 K=35</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>40.000000</xmpG:cyan>
                           <xmpG:magenta>65.000000</xmpG:magenta>
                           <xmpG:yellow>90.000000</xmpG:yellow>
                           <xmpG:black>35.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=40 M=70 Y=100 K=50</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>40.000000</xmpG:cyan>
                           <xmpG:magenta>70.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>50.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=50 M=70 Y=80 K=70</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>50.000000</xmpG:cyan>
                           <xmpG:magenta>70.000000</xmpG:magenta>
                           <xmpG:yellow>80.000000</xmpG:yellow>
                           <xmpG:black>70.000000</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Grays</xmpG:groupName>
                  <xmpG:groupType>1</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=100</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>100.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=90</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>89.999400</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=80</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>79.998800</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=70</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>69.999700</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=60</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>59.999100</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=50</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>50.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=40</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>39.999400</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=30</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>29.998800</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=20</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>19.999700</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=10</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>9.999100</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=0 Y=0 K=5</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>0.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>4.998800</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <xmpG:groupName>Brights</xmpG:groupName>
                  <xmpG:groupType>1</xmpG:groupType>
                  <xmpG:Colorants>
                     <rdf:Seq>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=100 Y=100 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>100.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=75 Y=100 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>75.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=0 M=10 Y=95 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>0.000000</xmpG:cyan>
                           <xmpG:magenta>10.000000</xmpG:magenta>
                           <xmpG:yellow>95.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=85 M=10 Y=100 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>85.000000</xmpG:cyan>
                           <xmpG:magenta>10.000000</xmpG:magenta>
                           <xmpG:yellow>100.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=100 M=90 Y=0 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>100.000000</xmpG:cyan>
                           <xmpG:magenta>90.000000</xmpG:magenta>
                           <xmpG:yellow>0.000000</xmpG:yellow>
                           <xmpG:black>0.000000</xmpG:black>
                        </rdf:li>
                        <rdf:li rdf:parseType="Resource">
                           <xmpG:swatchName>C=60 M=90 Y=0 K=0</xmpG:swatchName>
                           <xmpG:mode>CMYK</xmpG:mode>
                           <xmpG:type>PROCESS</xmpG:type>
                           <xmpG:cyan>60.000000</xmpG:cyan>
                           <xmpG:magenta>90.000000</xmpG:magenta>
                           <xmpG:yellow>0.003100</xmpG:yellow>
                           <xmpG:black>0.003100</xmpG:black>
                        </rdf:li>
                     </rdf:Seq>
                  </xmpG:Colorants>
               </rdf:li>
            </rdf:Seq>
         </xmpTPg:SwatchGroups>
         <pdf:Producer>Adobe PDF library 17.00</pdf:Producer>
         <ExtensisFontSense:slug>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>4027012699</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>4027012699</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-It</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.100</ExtensisFontSense:Version>
               </rdf:li>
               <rdf:li rdf:parseType="Resource">
                  <ExtensisFontSense:Checksum>2129167444</ExtensisFontSense:Checksum>
                  <ExtensisFontSense:Family>Helvetica Neue LT Std</ExtensisFontSense:Family>
                  <ExtensisFontSense:FontKind>OpenType - PS</ExtensisFontSense:FontKind>
                  <ExtensisFontSense:FontSense_1.2_Checksum>2129167444</ExtensisFontSense:FontSense_1.2_Checksum>
                  <ExtensisFontSense:Foundry>Adobe Systems</ExtensisFontSense:Foundry>
                  <ExtensisFontSense:OutlineFileSize>0</ExtensisFontSense:OutlineFileSize>
                  <ExtensisFontSense:PostScriptName>HelveticaNeueLTStd-Roman</ExtensisFontSense:PostScriptName>
                  <ExtensisFontSense:Version>2.100</ExtensisFontSense:Version>
               </rdf:li>
            </rdf:Bag>
         </ExtensisFontSense:slug>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
<?xpacket end="r"?>endstreamendobj92 0 obj<</BaseFont/QULRDW+HelveticaNeueLTStd-Roman/Encoding/WinAnsiEncoding/FirstChar 51/FontDescriptor 96 0 R/LastChar 79/Subtype/Type1/Type/Font/Widths[556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 574 0 722 0 0 0 0 0 722 760]>>endobj93 0 obj<</BaseFont/QULRDW+HelveticaNeueLTStd-It/Encoding/WinAnsiEncoding/FirstChar 40/FontDescriptor 97 0 R/LastChar 83/Subtype/Type1/Type/Font/Widths[259 259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 685 648]>>endobj97 0 obj<</Ascent 957/CapHeight 700/CharSet(/parenleft/parenright/R/S)/Descent -214/Flags 96/FontBBox[-166 -214 1106 957]/FontFile3 98 0 R/FontName/QULRDW+HelveticaNeueLTStd-It/FontStretch/Normal/FontWeight 400/ItalicAngle -12/StemV 75/Type/FontDescriptor/XHeight 500>>endobj98 0 obj<</Filter/FlateDecode/Length 754/Subtype/Type1C>>stream
HâÑR[Haûiù— Vrõ®µvì‘6]‘¬4ØÖ]◊KE„Óø:ÊŒËÏ§Æt{4DÀ5êD#à!ä¥á Í!!∞@M|bübõÆOùqœ>4+TE/ÁúÔﬂ«˘Y&i√≤Ï÷u'+õrki{’$Øxî^†uıÕ∑Îêñxêed∞∆¶§+©´å-©Ç±5u#ñ`[Ï]Ïgtßó◊OƒúÈå%!÷¬jÏµ
•#§J-≠)(.* 3kq˛J-Ã#Ó¸|7)˜)ÕîxBAçÇ‰êÏU‘E5ÍsëÚˆv≤Bï©⁄ïX˛W±Ní-‘AIM†πˆ"?Û)HD¢©¢èDı<Q¸ø¯¶óIjëLs*ıI&Z+%.èã7- e©ˇ…>Ê˜K^∫≤à!b˚ùÌ•™&ö]1eT“vAïÇ>…´Iä¸!.ã˙äJ$3Aª)/)˝#‰ÓjO}Ï!>Íˇ˚ÌñYÕ2Ö,√ô∑ajòÀÃc÷…ì˛ß∆«ßÏ¸F£o˘xºèáAú∞Ü9àÚHπ 	'«˘s+3î¢ây„ôêò0Å¨X’€€Õ>åX†œ˛o!	8;Ù~ÇF»ÇrGèŸÊG±‡~Ï∂c Ã~≤ÕÒÉÈÀYìŸPÿ›vX#¡ˆ≥¿8<¸#2ärvÏÕ¡F‹Åek¯NL/¡¿R∫!Gát[Æ.[8Õœœˆ∏Ou`é€x¨åÇŒœ¿4-ºÌÎ‰áq,8/l∏ŸôÚôó_‹}y˝U¯MhÊ»ÌîÅd[Tøı˙≠náL‰'qù'xk†w…à,•èÍuò“Îu€Ç3˙(ºÅi≥òôÅ6‹\çémãMÕ˘±ì≥EÁz^t¥Á4ª1eﬂCé<+Æ¿∫PñÏú3Sn(ötﬂuÊﬁ„lá«OMÃ⁄#˙˝πO≥≠»ı9¨ΩcÀÁ∆∞mÑá{·/·¯˚ë‰≈5ëµ0≤aπD¯.¿ R)Ö
endstreamendobj96 0 obj<</Ascent 952/CapHeight 714/CharSet(/three/C/F/H/N/O)/Descent -214/Flags 32/FontBBox[-166 -214 1076 952]/FontFile3 99 0 R/FontName/QULRDW+HelveticaNeueLTStd-Roman/FontStretch/Normal/FontWeight 400/ItalicAngle 0/StemV 75/Type/FontDescriptor/XHeight 500>>endobj99 0 obj<</Filter/FlateDecode/Length 824/Subtype/Type1C>>stream
HâÑQ]hSg>giO∞Üõ¶”≈5ﬂJËhMc≠u∞é&Í*ƒ˘”üUê¬1ÁK=59ßúú6¥Éºòi'‘´Ûb2ºî¡º*[/f'ÇRuU9≈eÉ0=àÇ^º_˙ûã}©(äﬂÔˇÛ>|¢PˆÅ ä"Ÿ◊ﬂø˝Îu45LM5!Eáhº´”TöˆÎiY+Ì‘±Ä»Vó±µ?˚ÿSÉü·¿“üKÒr6Z…é≠˙yÈõ*¡U"ÎMq"¶éjˇaìlÿ÷⁄Ê~[Û≤ﬂ&-ÕÕ-§]—Q“9í1i:Cvi	›‘Ÿ§JÑ¥ßRdú!ÕPc∏‘|/c\’tsdêí/”á:ﬁAÚRQ3D&¶!+4-Gàû|ÖèÒS"‘ØÚ„™U#ÊaJ∫#ù≤óü®ôD÷“ıΩ'ôTtπôñGˆ::ASÊQÁ42‘å¢&LU◊2/»59MﬂrÖnï+Hqz-CÈ"◊ÔÏÏ*õàBìÔ¸;˛™Öê©– ¨ö7ˇ$a∑0+Vãõƒ‚qÒ_íõagDÓC3Æ\/Óu∆%¯ˇcú(á˚¸›•¬ôr;Rﬂrm»kâ˝Ê/eX™ºΩcp˛:å.T]»Ô»√©¬ûÇÔ	hèÚÙôâÈ¿ﬂ◊∂lﬁﬁ€⁄ÿ{ıøÒ‡	Î«Ì-
¿p˝uy˘˙Ê≥¡I∑Ô·ÏOófØ|F.c%÷≈ö0]m^∫7ÒÀç˚Åõ≥âˆ∂∏ÀM|ÙéZ,oâø⁄¨€v∑≤c~a•Öƒ
¸®ÄÄ≠`@∏@ÄùgÇa	+é∆6‚™ ~Éµ∞nÅ∂GãΩı?ΩÁÜ¡≤ kâwm◊›,X¥p≤¨¬rT…˚l<óÂcÊyæ¡<hŸ≈æ0Œ9òKﬁPfÛI.[uß¿÷|Ô‘$_äÕO∫Ÿ
gæ¸i±oÉ‰õvnÔv<ÏvyΩ‰Ö¶gz.⁄Ï®Ì∫E?ˆÄ; ÀÕÕÙ@ÚàYnºè=µvÑnA#D!z1Ñ°(QåFy3TÎù.ˆM„¿I	ŒO=ûrút/T‰Wì’Ï©ˇ ¥ÇƒHendstreamendobj90 0 obj<</Length 32898>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 36 727.248 Tm
(6.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Clinical T)74.2 (rials Experience)]TJ
/T1_1 1 Tf
-0.014 Tc 0.066 Tw -3.375 -1.498 Td
[(Because c)19.6 (linical trials are conducted under widely var)-18.4 (ying conditions,)36.6 ( adverse reaction)-14 ( )]TJ
-0.017 Tc 0.06 Tw 0 -1.044 Td
[(ra)-10.3 (tes reported in the c)19.8 (linical trials of a drug cannot be directly compared to ra)-10.2 (tes in the)-17 ( )]TJ
0.048 Tw 0 -1.044 Td
[(c)20.2 (linical trials of another drug and may not re\033ect the ra)-9.7 (tes obser)-17.8 (ved in practice.)]TJ
-0.007 Tc 0.098 Tw 0 -1.629 Td
[(The )0.5 (pooled )0.5 (safety )0.5 (popula)-9.7 (tion described in )37.5 (W)18.2 (ARNINGS )37.5 (AND )0.5 (PRECAUTIONS )0.5 (and )0.5 (belo)-9.7 (w)-7 ( )]TJ
-0.001 Tc 0.127 Tw 0 -1.044 Td
[(re\033ects exposure to )36.9 (AUGTYRO in 426 pa)-9.7 (tients with )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
0.001 Tw 19.877 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.531 0 Td
(1)Tj
/T1_1 1 Tf
-0.001 Tc 0.127 Tw 0.479 0 Td
[(-positive NSCLC \(n=320\),)36 ( )]TJ
/T1_2 1 Tf
-0.006 Tc 0.006 Tw -21.887 -1.044 Td
(NTRK1)Tj
(/2/)Tj
0 Tc 0 Tw (3)Tj
/T1_1 1 Tf
-0.006 Tc 0.102 Tw 4.037 0 Td
[(-positive solid tumors \(n=104\),)37.4 ( or other solid tumors \(n=2\) in )37.2 (TRIDENT)55.4 (-1.)31 ( )]TJ
-0.014 Tc 0.064 Tw -4.037 -1.044 Td
[(P)18 (a)-10 (tients received )36.9 (AUGTYRO a)-10 (t a dose of 160 mg orally once daily for the \037rst 14 days,)23 ( )]TJ
-0.011 Tc 0.076 Tw 0 -1.044 Td
[(t)0.5 (h)0.5 (e)0.5 (n)0.5 ( i)0.5 (n)0.5 (c)0.5 (r)0.5 (e)0.5 (a)0.5 (s)0.5 (e)0.5 (d)0.5 ( t)0.5 (o)0.5 ( 1)0.5 (6)0.5 (0)0.5 ( m)0.5 (g)0.5 ( o)0.5 (r)0.5 (a)0.5 (l)0.5 (l)0.5 (y)0.5 ( t)0.5 (w)0.5 (i)0.5 (ce)0.6 ( da)0.5 (i)0.5 (l)0.5 (y)0.5 ( u)0.5 (n)0.5 (t)0.5 (i)0.5 (l)0.5 ( d)0.5 (i)0.5 (s)0.5 (e)0.5 (a)0.5 (s)0.5 (e)0.5 ( p)0.5 (r)0.5 (o)0.5 (g)0.5 (r)0.5 (e)0.5 (s)0.5 (s)0.5 (i)0.5 (o)0.5 (n)0.5 ( o)0.5 (r)0.5 ( u)0.5 (n)0.5 (a)0.5 (c)0.5 (c)0.5 (e)0.5 (p)0.5 (t)0.5 (a)0.5 (b)0.5 (l)0.5 (e)-11 ( )]TJ
-0.013 Tc 0.013 Tw 0 -1.044 Td
(toxicity )Tj
/T1_2 1 Tf
0.072 Tw 2.806 0 Td
([see Clinical Studies \(14)Tj
0 Tc 0 Tw (.)Tj
-0.013 Tc 0.072 Tw 8.95 0 Td
[(1\),)36.6 ( \(14.2\)])]TJ
/T1_1 1 Tf
[(.)36.5 ( Eligible pa)-10.4 (tients had an ECOG sta)-10.4 (tus of \0341.)24 ( )]TJ
-0.015 Tc 0.06 Tw -11.756 -1.044 Td
[(P)18.5 (a)-9.6 (t)0.5 (i)0.5 (en)0.5 (ts)0.5 ( )0.5 (wi)0.5 (th)0.5 ( )0.5 (a )0.5 (hi)0.5 (s)0.5 (to)0.5 (r)-17.5 (y )0.5 (o)0.5 (f )0.5 (IL)0.5 (D)0.5 (,)37.4 ( )0.5 (dr)0.5 (u)0.5 (g-)0.5 (re)0.5 (l)0.5 (a)-9.6 (t)0.5 (e)0.5 (d )0.5 (pn)0.5 (e)0.5 (um)0.5 (on)0.5 (i)0.5 (ti)0.5 (s)0.5 (,)37.4 ( )0.5 (si)0.5 (gn)0.5 (i)0.5 (\037c)0.5 (an)0.5 (t)0.5 (,)37.4 ( )0.5 (un)0.5 (co)0.5 (nt)0.5 (r)0.5 (o)0.5 (ll)0.5 (ed)0.5 (,)37.4 ( )0.5 (a)0.5 (ct)0.5 (i)0.5 (ve)-15 ( )]TJ
-0.017 Tc 0.051 Tw 0 -1.044 Td
[(cardiovascular disease,)37.2 ( or prolonged QTc inter)-17.7 (val were exc)20.2 (luded from enrollment in this)-17 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.044 Td
[(trial.)37 ( F)19.9 (orty-eight percent of pa)-10 (tients were exposed to )36.9 (AUGTYRO for a)-10 (t least 6 months,)37 ( and)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(28% were exposed for grea)-9.8 (ter than 1 year)74.2 (.)]TJ
-0.008 Tc 0.094 Tw 0 -1.629 Td
[(The median a)-10 (ge of pa)-10 (tients who received )36.7 (AUGTYRO was 57 years \(range:)37 ( 18 to 93\);)-7.9 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(59% female; 43% )36.6 (White,)36.6 ( 47% )36.6 (Asian,)36.6 ( 2.8% Black,)36.6 ( 0.5% Na)-10.4 (tive Ha)-10.4 (waiian or Other P)17.6 (aci\037c)-19 ( )]TJ
-0.012 Tc 0.076 Tw 0 -1.044 Td
[(Islander)73.6 (,)36.7 ( 0.5% )37.1 (American Indian or )37 (Alaska Na)-10.3 (tive,)36.7 ( 6.1% race not reported or other)73.7 (,)36.6 ( and)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(0.7% unkno)-9.8 (wn.)]TJ
-0.016 Tc 0.06 Tw 0 -1.629 Td
[(Serious adverse reactions occurred in 35% of pa)-10.1 (tients who received )37 (AUGTYRO.)37 ( Serious)-16 ( )]TJ
-0.001 Tc 0.126 Tw 0 -1.044 Td
[(a)0.5 (d)0.6 (v)0.5 (e)0.6 (r)0.5 (s)0.6 (e)0.5 ( r)0.5 (e)0.6 (a)0.5 (c)0.6 (t)0.5 (i)0.6 (o)0.5 (n)0.5 (s)0.6 ( i)0.6 (n)0.5 ( \036)0.5 (2)0.6 (%)0.5 ( o)0.5 (f)0.6 ( p)0.6 (a)-9.5 (t)0.6 (i)0.5 (e)0.6 (n)0.5 (t)0.5 (s)0.6 ( i)0.6 (n)0.5 (c)20.6 (l)0.5 (u)0.5 (d)0.6 (e)0.5 (d)0.6 ( p)0.6 (n)0.5 (e)0.5 (u)0.6 (m)0.5 (o)0.6 (n)0.5 (i)0.6 (a)0.5 ( \()0.5 (6)0.6 (.)0.5 (3)0.5 (%)0.6 (\))0.5 (,)37.5 ( d)-9.4 (y)0.5 (s)0.5 (p)0.6 (n)0.5 (e)0.6 (a)0.5 ( \()0.5 (3)0.6 (.)0.5 (1)0.5 (%)0.6 (\))0.5 (,)36 ( )]TJ
-0.011 Tc 0.079 Tw 0 -1.044 Td
[(pleural effusion \(2.8%\),)37 ( and hypoxia \(2.6%\).)36.9 ( F)20 (a)-10.1 (tal adverse reactions occurred in 3.5%)-11 ( )]TJ
-0.017 Tc 0.045 Tw 0 -1.044 Td
[(of pa)-9.8 (tients who received )36.8 (AUGTYRO,)37.2 ( inc)20.2 (luding pneumonia,)37.2 ( pneumonia aspira)-9.7 (tion,)37.2 ( cardiac)-17 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.044 Td
[(arrest,)37.2 ( sudden cardiac dea)-9.7 (th,)37.2 ( cardiac failure,)37.2 ( hypoxia,)37.2 ( d)-9.8 (yspnea,)37.2 ( respira)-9.8 (tor)-17.8 (y failure,)37.2 ( tremor)74.2 (,)16 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(and dissemina)-9.8 (ted intra)-9.8 (vascular coa)-9.8 (gula)-9.8 (tion.)]TJ
-0.011 Tc 0.078 Tw 0 -1.629 Td
[(P)18.1 (ermanent discontinua)-9.9 (tion of )36.8 (AUGTYRO due to an adverse reaction occurred in 7% of)-11 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(pa)-9.8 (tients.)37.1 ( )37.1 (There were no speci\037c adverse reactions tha)-9.9 (t accounted for \0361% of permanent)-19 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
[(discontinua)-9.8 (tions.)]TJ
0.001 Tc 0.14 Tw 0 -1.629 Td
[(Dosa)-10.1 (ge )0.6 (interruptions )0.6 (of )37.5 (AUGTYRO )0.6 (due )0.5 (to )0.6 (an )0.5 (adverse )0.5 (reaction )0.6 (occurred )0.5 (in )0.5 (50% )0.6 (of)1 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.044 Td
[(pa)-9.9 (tients.)37.2 ( )36.9 (Adverse reactions tha)-9.9 (t required dosa)-9.8 (ge interruption in \0362% of pa)-9.9 (tients were)-10 ( )]TJ
-0.001 Tc 0.131 Tw 0 -1.044 Td
[(dizziness,)36.6 ( d)-10.4 (yspnea,)36.6 ( muscular weakness,)36.6 ( a)-10.4 (taxia,)36.6 ( pneumonia,)36.6 ( peripheral neuropa)-10.3 (thy)54.6 (,)36 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(anemia,)37.2 ( and vomiting.)]TJ
-0.011 Tc 0.076 Tw 0 -1.629 Td
[(Do)0.5 (se)0.5 ( r)0.5 (ed)0.5 (uc)0.5 (ti)0.5 (on)0.5 (s of)0.5 ( )36.6 (AU)0.5 (GT)0.5 (YR)0.5 (O du)0.5 (e to)0.5 ( a)0.5 (n ad)0.5 (ve)0.5 (rs)0.5 (e re)0.5 (ac)0.5 (ti)0.5 (on)0.5 ( o)0.5 (cc)0.5 (urr)0.5 (e)0.5 (d i)0.5 (n 38)0.5 (% of)0.5 ( p)0.5 (a)-9.6 (t)0.5 (ie)0.5 (nt)0.5 (s.)26 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.044 Td
[(Adverse reactions tha)-9.7 (t required dosa)-9.8 (ge reductions in \0362% of pa)-9.7 (tients inc)20.3 (luded dizziness,)18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(a)-9.8 (taxia,)37.2 ( muscular weakness,)37.2 ( peripheral neuropa)-9.8 (thy)55.2 (,)37.2 ( and cognitive impairment.)]TJ
0.006 Tc 0.161 Tw 0 -1.629 Td
[(T)0.5 (h)0.5 (e)0.6 ( m)0.6 (o)0.5 (s)0.5 (t)0.5 ( c)0.5 (o)0.6 (m)0.5 (m)0.5 (o)0.5 (n)0.6 ( \()0.6 (\036)0.5 (2)0.5 (0)0.5 (%)0.5 (\))0.5 ( a)0.6 (d)0.5 (v)0.5 (e)0.5 (r)0.6 (s)0.5 (e)0.5 ( r)0.5 (e)0.5 (a)0.6 (c)0.5 (t)0.5 (i)0.5 (o)0.5 (n)0.6 (s)0.5 ( t)0.5 (h)0.5 (a)-9.5 (t)0.5 ( o)0.6 (c)0.5 (c)0.5 (u)0.5 (r)0.5 (r)0.5 (e)0.6 (d)0.5 ( i)0.5 (n)0.5 ( p)0.5 (a)-9.5 (t)0.6 (i)0.5 (e)0.5 (n)0.5 (t)0.6 (s)0.5 ( r)0.6 (e)0.5 (c)0.5 (e)0.5 (i)0.6 (v)0.5 (i)0.5 (n)0.5 (g)6 ( )]TJ
0 Tc 0.133 Tw 0 -1.044 Td
[(AUGTYRO were dizziness,)37.1 ( d)-9.9 (ysgeusia,)37.1 ( peripheral neuropa)-9.8 (thy)55.1 (,)37.1 ( constipa)-9.9 (tion,)37.1 ( d)-9.9 (yspnea,)37 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(fa)-9.8 (tigue,)37.2 ( a)-9.8 (taxia,)37.2 ( cognitive impairment,)37.2 ( muscular weakness and nausea.)]TJ
0 -1.629 Td
[(T)74.2 (able 3 summarizes the adverse reactions tha)-9.8 (t occurred in )37.3 (TRIDENT)55.2 (-1.)]TJ
ET
0 0 0 1 K
0.5 w 
/GS2 gs
q 1 0 0 1 144 327.3002 cm
0 0 m
0 20.23 l
S
Q
q 1 0 0 1 36 306.0703 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 143.75 327.0502 cm
0 0 m
72.25 0 l
S
Q
q 1 0 0 1 144 306.3203 cm
0 0 m
0 20.48 l
S
Q
q 1 0 0 1 144 306.0703 cm
0 0 m
72 0 l
S
Q
1 w 
q 1 0 0 1 36 348.0301 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 348.0301 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 348.0301 cm
0 0 m
72 0 l
S
Q
0.5 w 
q 1 0 0 1 216 327.0502 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 306.3203 cm
0 0 m
0 20.48 l
S
Q
q 1 0 0 1 216 306.0703 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 36 295.3184 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 295.3184 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 144 284.5665 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 295.3184 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 284.5665 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 144 273.8146 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 273.8146 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 263.0627 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 263.0627 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 252.3107 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 252.3107 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 241.5588 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 241.5588 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 231.0569 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 231.0569 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 144 209.3031 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 209.3031 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 144 198.5512 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 198.5512 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 187.7992 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 187.7992 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 177.2973 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 177.2973 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 144 155.5435 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 155.5435 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 144 144.7916 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 144.7916 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 91.282 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 91.282 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 144 69.5282 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 69.5282 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 144 59.0263 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 59.0263 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 36 80.2801 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 80.2801 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 80.2801 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 36 230.8069 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 230.8069 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 230.8069 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 36 220.055 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 220.055 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 220.055 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 36 123.2878 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 123.2878 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 144 112.5358 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 123.2878 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 112.5358 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 36 177.0473 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 177.0473 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 177.0473 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 36 166.2954 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 166.2954 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 166.2954 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 36 91.032 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 91.032 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 91.032 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 36 58.7763 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 58.7763 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 58.7763 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 144 101.7839 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 216 101.7839 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 144 134.2897 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 216 134.2897 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 36 134.0397 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 144 134.0397 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 216 134.0397 cm
0 0 m
72 0 l
S
Q
BT
/GS1 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 36 360.1301 Tm
[(T)74.2 (able 3:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Adverse Reactions \(\03610%\) in P)24.2 (atients with )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
0.017 Tw 16.38 0 Td
(ROS1)Tj
/T1_0 1 Tf
0 Tw 2.002 0 Td
[(-)-19.8 (P)24.2 (ositive NSCLC or)-16.9 ( )]TJ
/T1_3 1 Tf
0.017 Tw -18.382 -1.062 Td
(NTRK)Tj
/T1_0 1 Tf
0 Tw 2.138 0 Td
[(-P)24.2 (ositive Solid T)74.2 (umors Who Received AUGTYRO in TRIDENT)55.2 (-)40.2 (1)]TJ
-0.012 Tc 0.048 Tw 7.6 0 0 8 36 324.1942 Tm
(Adverse Reaction)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 87.7116 326.8582 Tm
(1)Tj
7.6 0 0 8 90.2652 324.1942 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.716 1.842 Td
(AUGTYRO)Tj
0 Tc 0 Tw 7.6 0 0 8 230.1424 338.9342 Tm
( )Tj
-0.012 Tc -0.198 Tw 7.6 0 0 8 206.1534 330.4342 Tm
(N)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.591 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
(426)Tj
0.048 Tw -6.645 -1.56 Td
(All Grades)Tj
0 Tc 0 Tw 7.6 0 0 8 195.1663 317.9543 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 174.8868 309.4543 Tm
(\(%\))Tj
0.048 Tw 7.745 1.062 Td
(Grade 3 or 4)Tj
0 Tc 0 Tw 7.6 0 0 8 270.5007 317.9543 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 247.0118 309.4543 Tm
(\(%\))Tj
0.048 Tw -27.765 -1.452 Td
[(Ner)-17.7 (vous System Disorders)]TJ
/T1_1 1 Tf
0.012 Tw 0 -1.344 Td
(Dizziness)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 61.7078 289.7505 Tm
(a)Tj
7.6 0 0 8 64.0698 287.0865 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.78 0 Td
(65)Tj
9.376 0 Td
(2.8)Tj
-27.85 -1.344 Td
(Dysgeusia)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 64.2234 278.9986 Tm
(b)Tj
7.6 0 0 8 66.6865 276.3346 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.436 0 Td
(54)Tj
0 Tc 0 Tw 9.724 0 Td
(0)Tj
-0.012 Tc 0.048 Tw -28.198 -1.344 Td
[(P)18.2 (eripheral neuropa)-9.8 (thy)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 96.3217 268.2466 Tm
(c)Tj
7.6 0 0 8 98.588 265.5826 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.238 0 Td
(49)Tj
9.376 0 Td
(1.4)Tj
-27.85 -1.344 Td
(Ataxia)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 52.8204 257.4947 Tm
(d)Tj
7.6 0 0 8 55.2835 254.8307 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.936 0 Td
(28)Tj
9.376 0 Td
(0.5)Tj
0.048 Tw -27.85 -1.344 Td
(Cognitive impairment)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 94.5221 246.7428 Tm
(e)Tj
7.6 0 0 8 96.8841 244.0788 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 10.462 0 Td
(25)Tj
9.376 0 Td
(0.9)Tj
-27.85 -1.344 Td
(Headache)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 63.3355 235.9909 Tm
(f)Tj
7.6 0 0 8 64.7133 233.3269 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.695 0 Td
(19)Tj
0 Tc 0 Tw 9.724 0 Td
(0)Tj
/T1_0 1 Tf
-0.012 Tc 0.048 Tw -28.198 -1.344 Td
(Gastrointestinal Disorders)Tj
/T1_1 1 Tf
0.012 Tw 0 -1.344 Td
[(Constipa)-9.8 (tion)]TJ
18.473 0 Td
(38)Tj
9.376 0 Td
(0.2)Tj
-27.85 -1.344 Td
(Nausea)Tj
18.473 0 Td
(20)Tj
9.376 0 Td
(0.7)Tj
-27.85 -1.344 Td
[(Diarrhea)-12 (\035)]TJ
18.473 0 Td
(14)Tj
9.376 0 Td
(0.7)Tj
-27.85 -1.344 Td
[(V)18.2 (omiting)]TJ
18.473 0 Td
(12)Tj
9.376 0 Td
(1.2)Tj
/T1_0 1 Tf
0.048 Tw -27.85 -1.344 Td
[(Respirator)-17.7 (y)55.2 (,)37.2 ( Thoracic,)37.2 ( and Mediastinal Disorders)]TJ
/T1_1 1 Tf
0.012 Tw 0 -1.344 Td
(Dyspnea)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 59.7653 160.7275 Tm
(g)Tj
7.6 0 0 8 62.2285 158.0635 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.022 0 Td
(30)Tj
0 Tc 0 Tw 9.724 0 Td
(6)Tj
-0.012 Tc 0.012 Tw -28.198 -1.344 Td
(Cough)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 53.6353 149.9756 Tm
(h)Tj
7.6 0 0 8 56.0985 147.3116 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.829 0 Td
(18)Tj
9.376 0 Td
(0.2)Tj
-27.85 -1.344 Td
(Pneumonia)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 66.7616 139.2237 Tm
(i)Tj
7.6 0 0 8 67.8468 136.5597 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.283 0 Td
(11)Tj
0 Tc 0 Tw 9.724 0 Td
(6)Tj
/T1_0 1 Tf
-0.012 Tc 0.048 Tw -28.198 -1.344 Td
(General Disorders)Tj
/T1_1 1 Tf
0.012 Tw 0 -1.344 Td
[(F)20.2 (a)-9.8 (tigue)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 56.178 117.7198 Tm
(j)Tj
7.6 0 0 8 57.2632 115.0558 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.676 0 Td
(30)Tj
9.376 0 Td
(1.2)Tj
-27.85 -1.344 Td
(Edema)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 55.0335 106.9679 Tm
(k)Tj
7.6 0 0 8 57.3955 104.3039 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.658 0 Td
(15)Tj
9.376 0 Td
(0.5)Tj
0.048 Tw -27.85 -1.344 Td
[(Decreased a)-9.8 (ppetite)]TJ
0.012 Tw 18.473 0 Td
(11)Tj
9.376 0 Td
(0.2)Tj
/T1_0 1 Tf
0.048 Tw -27.85 -1.344 Td
[(Musculoskeletal and Connective T)18.2 (issue Disorders)]TJ
/T1_1 1 Tf
0 -1.344 Td
(Muscular weakness)Tj
0.012 Tw 18.473 0 Td
(20)Tj
0 Tc 0 Tw 9.724 0 Td
(2)Tj
-0.012 Tc 0.012 Tw -28.198 -1.344 Td
[(My)-9.8 (algia)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 57.4548 63.9603 Tm
(l)Tj
7.6 0 0 8 58.5401 61.2963 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 15.508 0 Td
(13)Tj
9.376 0 Td
(0.7)Tj
/T1_2 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 255.24 50.3784 Tm
(\(Continued\))Tj
ET
/GS2 gs
q 1 0 0 1 432 694.4182 cm
0 0 m
0 20.23 l
S
Q
q 1 0 0 1 324 673.1882 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 431.75 694.1682 cm
0 0 m
72.25 0 l
S
Q
q 1 0 0 1 432 673.4382 cm
0 0 m
0 20.48 l
S
Q
q 1 0 0 1 432 673.1882 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 324 396.0186 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 432 396.0186 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 504 396.0186 cm
0 0 m
72 0 l
S
Q
1 w 
q 1 0 0 1 324 715.1481 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 432 715.1481 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 504 715.1481 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 324 629.9305 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 432 629.9305 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 504 629.9305 cm
0 0 m
72 0 l
S
Q
0.5 w 
q 1 0 0 1 504 694.1682 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 504 673.4382 cm
0 0 m
0 20.48 l
S
Q
q 1 0 0 1 504 673.1882 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 324 662.1863 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 432 662.1863 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 432 651.6844 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 504 662.1863 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 504 651.6844 cm
0 0 m
0 10.252 l
S
Q
q 1 0 0 1 324 651.4344 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 432 651.4344 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 504 651.4344 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 324 640.6825 cm
0 0 m
108 0 l
S
Q
q 1 0 0 1 432 640.6825 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 432 630.4305 cm
0 0 m
0 10.002 l
S
Q
q 1 0 0 1 504 640.6825 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 504 630.4305 cm
0 0 m
0 10.002 l
S
Q
BT
/GS1 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 324 727.248 Tm
[(T)74.2 (able 3:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Adverse Reactions \(\03610%\) in P)24.2 (atients with )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
0.017 Tw 16.38 0 Td
(ROS1)Tj
/T1_0 1 Tf
0 Tw 2.002 0 Td
[(-)-19.8 (P)24.2 (ositive NSCLC or)-17 ( )]TJ
/T1_3 1 Tf
0.017 Tw -18.382 -1.062 Td
(NTRK)Tj
/T1_0 1 Tf
0 Tw 2.138 0 Td
[(-P)24.2 (ositive Solid T)74.2 (umors Who Received AUGTYRO in TRIDENT)55.2 (-)40.2 (1)]TJ
-0.012 Tc 0.048 Tw 7.6 0 0 8 324 691.3122 Tm
(Adverse Reaction)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 375.7116 693.9762 Tm
(1)Tj
7.6 0 0 8 378.2652 691.3122 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 14.716 1.842 Td
(AUGTYRO)Tj
0 Tc 0 Tw 7.6 0 0 8 518.1424 706.0521 Tm
( )Tj
-0.012 Tc -0.198 Tw 7.6 0 0 8 494.1534 697.5521 Tm
(N)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.591 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
(426)Tj
0.048 Tw -6.645 -1.56 Td
(All Grades)Tj
0 Tc 0 Tw 7.6 0 0 8 483.1663 685.0722 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 462.8868 676.5722 Tm
(\(%\))Tj
0.048 Tw 7.745 1.062 Td
(Grade 3 or 4)Tj
0 Tc 0 Tw 7.6 0 0 8 558.5007 685.0722 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 535.0118 676.5722 Tm
(\(%\))Tj
0.048 Tw -27.765 -1.483 Td
(Metabolism and Nutritional)Tj
/T1_1 1 Tf
0 -1.344 Td
(Increased weight)Tj
0.012 Tw 18.473 0 Td
(16)Tj
0 Tc 0 Tw 9.724 0 Td
(3)Tj
/T1_0 1 Tf
-0.012 Tc 0.048 Tw -28.198 -1.344 Td
(Eye Disorders)Tj
/T1_1 1 Tf
0 -1.344 Td
(Vision disorders)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 367.549 635.1146 Tm
(m)Tj
7.6 0 0 8 371.3899 632.4506 Tm
(\035)Tj
-0.012 Tc 0.012 Tw 12.238 0 Td
(12)Tj
9.376 0 Td
(0.5)Tj
-0.017 Tc 0.017 Tw 5.32 0 0 5.6 323.9999 623.2827 Tm
(1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 620.6187 Tm
(Based on NCI CTCAE v4.03)Tj
-0.658 -1.062 Td
(\252)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.658 0 Td
[(Inc)20.2 (ludes terms dizziness,)37.2 ( vertigo,)37.2 ( dizziness postural,)37.2 ( dizziness exertional,)37.2 ( vertigo positional)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 606.2827 Tm
(b)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 603.6187 Tm
[(Inc)20.2 (ludes terms d)-9.8 (ysgeusia,)37.2 ( a)-9.8 (geusia,)37.2 ( anosmia,)37.1 ( hypogeusia)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 597.7827 Tm
(c)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 595.1187 Tm
[(Inc)20.2 (ludes terms neuralgia,)37.2 ( neuropa)-9.7 (thy peripheral,)37.2 ( peripheral sensor)-17.8 (y neuropa)-9.8 (thy)55.2 (,)20 ( )]TJ
0 -1.062 Td
[(d)-9.8 (ysesthesia,)37.2 ( peripheral motor neuropa)-9.8 (thy)55.2 (,)37.2 ( polyneuropa)-9.8 (thy)55.2 (,)37.2 ( paresthesia,)37.2 ( hypoesthesia,)20 ( )]TJ
0.017 Tw 0 -1.062 Td
(hyperesthesia)Tj
5.32 0 0 5.6 323.9999 572.2827 Tm
(d)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 569.6187 Tm
[(Inc)20.2 (ludes terms a)-9.8 (taxia,)37.3 ( gait disturbance,)37.2 ( balance disorder)74.2 (,)37.2 ( cerebellar a)-9.8 (taxia and)-17 ( )]TJ
0 -1.062 Td
[(coordina)-9.8 (tion abnormal)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 555.2827 Tm
(e)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 552.6187 Tm
[(Inc)20.2 (ludes terms memor)-17.7 (y impairment,)37.2 ( disturbance in a)-9.8 (ttention,)37.2 ( cognitive disorder)74.2 (,)20 ( )]TJ
0 -1.062 Td
[(confusional sta)-9.8 (te,)37.2 ( amnesia,)37.2 ( a)-9.8 (ttention deficit hyperactivity disorder)74.2 (,)37.2 ( delirium,)37.2 ( altered sta)-9.8 (te of)-16.9 ( )]TJ
0 -1.062 Td
[(consciousness,)37.2 ( a)-9.7 (phasia,)37.2 ( delusion,)37.2 ( depressed level of consciousness,)37.2 ( hallucina)-9.7 (tion,)37.2 ( mental)-17 ( )]TJ
0 -1.062 Td
[(sta)-9.7 (tus changes,)37.3 ( neurological decompensa)-9.8 (tion)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 521.2827 Tm
(f)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 518.6187 Tm
[(Inc)20.2 (ludes terms headache,)37.3 ( migraine,)37.2 ( tension headache)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 512.7827 Tm
(g)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 510.1187 Tm
[(Inc)20.2 (ludes terms d)-9.8 (yspnea and d)-9.8 (yspnea exertional)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 504.2827 Tm
(h)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 501.6187 Tm
[(Inc)20.2 (ludes terms productive cough,)37.2 ( cough,)37.2 ( and upper)37.2 (-airway cough syndrome)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 495.7827 Tm
(i)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 493.1187 Tm
[(Inc)20.2 (ludes terms pneumonia,)37.3 ( pneumonia aspira)-9.7 (tion,)37.2 ( lo)-9.7 (wer respira)-9.8 (tor)-17.8 (y tract infection,)20 ( )]TJ
0 -1.062 Td
[(pneumonia viral,)37.2 ( pneumonia bacterial,)37.2 ( lo)-9.7 (wer respira)-9.8 (tor)-17.7 (y tract infection bacterial,)20 ( )]TJ
0 -1.062 Td
(pneumonia klebsiella)Tj
0.017 Tw 5.32 0 0 5.6 323.9999 470.2827 Tm
(j)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 467.6187 Tm
[(Inc)20.2 (ludes terms fa)-9.8 (tigue and asthenia)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 461.7827 Tm
(k)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 459.1187 Tm
[(Inc)20.2 (ludes terms generalized edema,)37.2 ( periorbital edema,)37.2 ( localized edema,)37.2 ( face edema,)20 ( )]TJ
0 -1.062 Td
[(edema peripheral,)37.2 ( edema,)37.2 ( eye edema,)37.3 ( scrotal edema)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 444.7827 Tm
(l)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 442.1187 Tm
[(Inc)20.2 (ludes terms my)-9.8 (algia,)37.3 ( myositis,)37.2 ( musculoskeletal discomfort,)37.2 ( musculoskeletal pain)]TJ
0.017 Tw 5.32 0 0 5.6 323.9999 436.2827 Tm
(m)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 433.6187 Tm
[(Inc)20.2 (ludes terms vision blurred,)37.2 ( dr)-17.8 (y eye,)37.2 ( visual impairment,)37.2 ( visual field defect,)37.2 ( ca)-9.8 (taract,)20 ( )]TJ
0 -1.062 Td
[(conjunctivitis,)37.2 ( eye pain,)37.2 ( photophobia,)37.2 ( photosensitivity reaction,)37.2 ( visual acuity reduced,)20 ( )]TJ
0 -1.062 Td
[(vitreous floa)-9.7 (ters,)37.2 ( blepharospasm,)37.2 ( color blindness,)37.2 ( diplopia,)37.2 ( eye hema)-9.8 (toma,)37.3 ( eye s)-9.8 (welling,)20 ( )]TJ
0 -1.062 Td
[(eyelid disorder)74.2 (,)37.1 ( eyelid injur)-17.8 (y)55.2 (,)37.2 ( eyelids pruritus,)37.2 ( glaucoma,)37.2 ( night blindness,)37.2 ( ophthalmic)-17 ( )]TJ
0 -1.062 Td
(herpes zoster)Tj
-0.013 Tc 0.068 Tw 8 0 0 8 323.9999 380.6187 Tm
[(Clinically relevant adverse reactions occurring in <10% of pa)-9.9 (tients receiving )36.8 (AUGTYRO)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
(were pyrexia \(9.2%\) and fall \(3.8%\).)Tj
0 -1.629 Td
[(T)74.2 (able 4 summarizes the labora)-9.8 (tor)-17.8 (y abnormalities in )37.2 (TRIDENT)55.2 (-1.)]TJ
ET
/GS2 gs
q 1 0 0 1 464.3999 296.2448 cm
0 0 m
0 19.942 l
S
Q
q 1 0 0 1 323.9999 275.3029 cm
0 0 m
140.4 0 l
S
Q
q 1 0 0 1 323.9999 264.551 cm
0 0 m
140.4 0 l
S
Q
q 1 0 0 1 464.1499 295.9948 cm
0 0 m
56.05 0 l
S
Q
q 1 0 0 1 464.3999 275.5529 cm
0 0 m
0 20.192 l
S
Q
q 1 0 0 1 464.3999 275.3029 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 464.3999 264.551 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 464.3999 253.7991 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 464.3999 243.0472 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 189.2876 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 464.3999 178.5357 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 167.7838 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 157.0319 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 146.2799 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 135.528 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 124.7761 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 114.0242 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 103.2723 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 92.5204 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 82.2685 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 323.9999 81.7685 cm
0 0 m
140.4 0 l
S
Q
q 1 0 0 1 464.3999 81.7685 cm
0 0 m
55.8 0 l
S
Q
0.5 w 
q 1 0 0 1 323.9999 51.8565 cm
0 0 m
140.4 0 l
S
Q
q 1 0 0 1 464.3999 51.8565 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 520.1999 51.8565 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 520.1999 264.551 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 520.1999 253.7991 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 520.1999 243.0472 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 189.2876 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 520.1999 178.5357 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 167.7838 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 157.0319 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 146.2799 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 135.528 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 124.7761 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 114.0242 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 103.2723 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 92.5204 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 82.2685 cm
0 0 m
0 10.252 l
S
Q
1 w 
q 1 0 0 1 520.1999 81.7685 cm
0 0 m
55.8 0 l
S
Q
0.5 w 
q 1 0 0 1 520.1999 295.9948 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 520.1999 275.5529 cm
0 0 m
0 20.192 l
S
Q
q 1 0 0 1 520.1999 275.3029 cm
0 0 m
55.8 0 l
S
Q
1 w 
q 1 0 0 1 323.9999 316.6867 cm
0 0 m
140.4 0 l
S
Q
q 1 0 0 1 464.3999 316.6867 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 520.1999 316.6867 cm
0 0 m
55.8 0 l
S
Q
0.5 w 
q 1 0 0 1 520.1999 232.2953 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 221.5433 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 520.1999 211.0414 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 464.3999 232.2953 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 221.5433 cm
0 0 m
0 10.752 l
S
Q
q 1 0 0 1 464.3999 211.0414 cm
0 0 m
0 10.502 l
S
Q
q 1 0 0 1 323.9999 210.7914 cm
0 0 m
140.4 0 l
S
Q
q 1 0 0 1 464.3999 210.7914 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 520.1999 210.7914 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 323.9999 200.0395 cm
0 0 m
140.4 0 l
S
Q
q 1 0 0 1 464.3999 200.0395 cm
0 0 m
55.8 0 l
S
Q
q 1 0 0 1 520.1999 200.0395 cm
0 0 m
55.8 0 l
S
Q
BT
/GS1 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 323.9999 338.1867 Tm
[(T)74.2 (able 4:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Laborator)-17.8 (y Abnormalities \(\03620%\) that W)18.2 (orsened from Baseline in)-17 ( )]TJ
0 -1.062 Td
[(P)24.2 (atients with )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
0.017 Tw 5.219 0 Td
(ROS1)Tj
/T1_0 1 Tf
0 Tw [(-P)24.2 (ositive NSCLC or )]TJ
/T1_3 1 Tf
0.017 Tw (NTRK)Tj
/T1_0 1 Tf
0 Tw 11.488 0 Td
[(-P)24.2 (ositive Solid T)74.2 (umors)-17 ( )]TJ
-16.707 -1.062 Td
[(Who Received AUGTYRO in TRIDENT)55.2 (-)40.2 (1)]TJ
-0.012 Tc 0.048 Tw 7.6 0 0 8 323.9999 293.1389 Tm
[(Laborator)-17.8 (y Abnormality)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 393.8126 295.8029 Tm
(1)Tj
7.6 0 0 8 396.3662 293.1389 Tm
(\035)Tj
-0.012 Tc -0.198 Tw 14.275 1.824 Td
(AUGTYRO)Tj
/Span<</ActualText<FEFF200A200A>>> BDC 
[( )0.5 ( )]TJ
EMC 
0 Tc 0 Tw 5.32 0 0 5.6 533.243 310.3988 Tm
(2)Tj
7.6 0 0 8 535.7966 307.7348 Tm
(\035)Tj
7.6 0 0 8 537.8277 307.7348 Tm
( )Tj
-0.012 Tc -0.198 Tw 7.6 0 0 8 510.3533 299.2348 Tm
(N)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.591 0 Td
(=)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
0.617 0 Td
[(426)-12 (\035)]TJ
0.048 Tw -5.58 -1.524 Td
(All Grades)Tj
0 Tc 0 Tw 7.6 0 0 8 507.4662 287.0429 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 487.1867 278.5429 Tm
(\(%\))Tj
0.048 Tw 5.613 1.062 Td
(Grade 3 or 4)Tj
0 Tc 0 Tw 7.6 0 0 8 566.6006 287.0429 Tm
( )Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 543.1117 278.5429 Tm
(\(%\))Tj
-28.83 -1.434 Td
[(Hematolog)-9.8 (y)]TJ
/T1_1 1 Tf
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Decreased hemoglobin)Tj
0.012 Tw 21.079 0 Td
(79)Tj
7.245 0 Td
(8.4)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Decreased lymphoc)20.2 (ytes)]TJ
0.012 Tw 21.079 0 Td
(43)Tj
7.359 0 Td
(10)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.029 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Decreased neutrophils)Tj
0.012 Tw 21.079 0 Td
(34)Tj
0 Tc 0 Tw 7.592 0 Td
(9)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.263 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Increased activa)-9.7 (ted partial thromboplastin time)]TJ
0.012 Tw 21.079 0 Td
(26)Tj
7.245 0 Td
(0.3)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Increased INR)Tj
0.012 Tw 21.079 0 Td
(24)Tj
0 Tc 0 Tw 7.592 0 Td
(0)Tj
/T1_0 1 Tf
-0.012 Tc 0.012 Tw -29.263 -1.344 Td
[(Chemistr)-17.8 (y)]TJ
/T1_1 1 Tf
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
0 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Increased crea)-9.8 (tine phosphokinase)]TJ
0.012 Tw 21.079 0 Td
(61)Tj
0 Tc 0 Tw 7.592 0 Td
(7)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.263 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Increased gamma glutamyl transferase)Tj
0.012 Tw 21.079 0 Td
(50)Tj
7.359 0 Td
(13)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.029 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Increased asparta)-9.8 (te aminotransferase)]TJ
0.012 Tw 21.079 0 Td
(41)Tj
7.245 0 Td
(2.9)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Increased alanine aminotransferase)Tj
0.012 Tw 21.079 0 Td
(38)Tj
7.245 0 Td
(3.3)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Increased sodium)-11.9 ( )]TJ
0.012 Tw 21.079 0 Td
(33)Tj
7.245 0 Td
(0.2)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Increased alkaline phospha)-9.8 (tase)]TJ
0.012 Tw 21.079 0 Td
(29)Tj
7.245 0 Td
(2.1)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Increased glucose)Tj
0.012 Tw 21.079 0 Td
(26)Tj
7.245 0 Td
(2.4)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Increased ura)-9.8 (te)]TJ
0.012 Tw 21.079 0 Td
(23)Tj
7.359 0 Td
(12)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.029 -1.344 Td
( )Tj
EMC 
0.592 0 Td
[(Decreased phospha)-9.7 (te)]TJ
0.012 Tw 21.079 0 Td
(22)Tj
0 Tc 0 Tw 7.592 0 Td
(6)Tj
-0.012 Tc 0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-29.263 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Increased potassium)Tj
0.012 Tw 21.079 0 Td
(22)Tj
7.245 0 Td
(0.7)Tj
0.048 Tw /Span<</ActualText<FEFF0009>>> BDC 
-28.916 -1.344 Td
( )Tj
EMC 
0.592 0 Td
(Decreased glucose)Tj
0.012 Tw 21.079 0 Td
(20)Tj
7.245 0 Td
(0.2)Tj
-0.017 Tc 0.017 Tw 5.32 0 0 5.6 323.9999 75.1205 Tm
(1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 72.4565 Tm
(Based on NCI CTCAE v4.03)Tj
0.017 Tw 5.32 0 0 5.6 323.9999 66.6205 Tm
(2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 7.6 0 0 8 328.9999 63.9565 Tm
[(The denomina)-9.8 (tor used to calcula)-9.8 (te the ra)-9.8 (te varied from 233 to 423 based on the number)-17 ( )]TJ
0 -1.062 Td
[(of pa)-9.8 (tients with a baseline value and a)-9.8 (t least one post-trea)-9.8 (tment value.)]TJ
ET
1 w 4 M 
q 1 0 0 1 319.5 41.6519 cm
0 0 m
S
Q
BT
/T1_2 1 Tf
0.017 Tw 8 0 0 8 324 718.776 Tm
(\(Continued\))Tj
ET
endstreamendobj89 0 obj<</Length 22158>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 8 0 0 8 36 727.248 Tm
(2.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Administration)Tj
/T1_1 1 Tf
-0.005 Tc 0.111 Tw -3.375 -1.512 Td
[(T)73.6 (ake )36.6 (AUGTYRO a)-10.4 (t a)-10.4 (pproxima)-10.4 (tely the same time each day with or without food )]TJ
/T1_2 1 Tf
0.005 Tw [([see)-5 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.057 Td
(Pharmacokinetic)Tj
0.048 Tw (s \(12.3\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.012 Tc 0.077 Tw 0 -1.642 Td
[(Swallo)-10.4 (w )37.3 (AUGTYRO ca)-10.4 (psules whole.)36.5 ( Do not open,)36.6 ( chew)36.6 (,)36.5 ( crush,)36.6 ( or dissolve the ca)-10.5 (psule)-12 ( )]TJ
-0.001 Tc 0.129 Tw 0 -1.057 Td
[(prior to s)-10 (wallo)-10 (wing.)36.9 ( Do not take an)-10.1 (y )36.8 (AUGTYRO ca)-10.1 (psules tha)-10 (t are broken,)36.9 ( cracked,)36 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
[(or dama)-9.8 (ged.)]TJ
-0.011 Tc 0.078 Tw 0 -1.642 Td
[(If a dose of )36.8 (AUGTYRO is missed or if vomiting occurs a)-9.9 (t an)-9.8 (y time after taking a dose,)26 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
[(skip the dose and resume )37.2 (AUGTYRO a)-9.8 (t its regularly scheduled time.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.994 Td
(3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(DOSAGE FORMS AND STRENGTHS)Tj
/T1_1 1 Tf
-0.009 Tc 0.089 Tw -3.375 -1.485 Td
[(Ca)-10 (psules:)37.1 ( 40 mg,)37.1 ( white,)37.1 ( opaque,)37.1 ( immedia)-9.9 (te release,)37 ( Size 0,)37.1 ( hard shell ca)-9.9 (psule,)37 ( )0.5 (\037lled)-9 ( )]TJ
-0.012 Tc 0.074 Tw 0 -1.057 Td
[(with white to off-white po)-9.9 (wder which may a)-10 (ppear as a plug,)37 ( imprinted with )37.2 (\223REP 40\224)25 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
[(in blue text on the ca)-9.8 (p.)]TJ
-0.009 Tc 0.087 Tw 0 -1.642 Td
[(Ca)-9.6 (psules:)37.3 ( 160 mg,)37.3 ( blue,)37.3 ( opaque,)37.3 ( immedia)-9.7 (te release,)37.3 ( Size 0,)37.3 ( hard shell ca)-9.7 (psule,)37.3 ( \037lled)-9 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.057 Td
[(with white to off-white po)-9.6 (wder which may a)-9.7 (ppear as a plug,)37.4 ( imprinted with )37.3 (\223REP 160\224)22 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
[(in white text on the ca)-9.8 (p.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.994 Td
(4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
[(CONTRAINDIC)18.2 (A)55.2 (TIONS)]TJ
/T1_1 1 Tf
-3.375 -1.462 Td
(None.)Tj
/T1_0 1 Tf
0 -1.769 Td
(5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(W)18.2 (ARNINGS AND PREC)18.2 (AUTIONS)]TJ
0.017 Tw -3.375 -1.481 Td
(5.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Central Ner)-17.8 (vous System Adverse Reactions)]TJ
/T1_1 1 Tf
-3.375 -1.489 Td
[(AUGTYRO can cause central ner)-17.8 (vous system adverse reactions.)]TJ
0.055 Tw 0 -1.597 Td
[(Among the 426 pa)-9.8 (tients who received )37.3 (AUGTYRO in Stud)-9.8 (y )37.3 (TRIDENT)55.2 (-1,)37.2 ( a broad spectrum)-17 ( )]TJ
-0.001 Tc 0.13 Tw 0 -1.057 Td
[(of central ner)-18.2 (vous system \(CNS\) adverse reactions inc)19.8 (luding dizziness,)36.7 ( a)-10.2 (taxia,)36.8 ( and)-1 ( )]TJ
-0.013 Tc 0.069 Tw 0 -1.057 Td
[(cognitive disorders occurred in 77% of pa)-10.1 (tients,)36.9 ( with Grade 3 or 4 events occurring in)-13 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
[(4.5% of pa)-9.8 (tients.)]TJ
-0.008 Tc 0.092 Tw 0 -1.597 Td
[(Dizziness,)37.4 ( inc)20.3 (luding vertigo,)37.4 ( occurred in 65% of pa)-9.6 (tients; Grade 3 dizziness occurred)-8 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.057 Td
[(in 2.8% of pa)-9.8 (tients.)37.1 ( )36.8 (The median time to onset was 7 days \(1 day to 1.4 years\).)37.2 ( Dose)-10 ( )]TJ
0.002 Tc 0.147 Tw 0 -1.057 Td
[(interruption )0.5 (was )0.5 (required )0.6 (in )0.6 (9% )0.5 (of )0.6 (pa)-10.4 (tients,)36.6 ( )0.5 (and )0.5 (11% )0.6 (required )0.6 (dose )0.5 (reduction )0.5 (of)2.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
(AUGTYRO due to dizziness.)Tj
-0.008 Tc 0.097 Tw 0 -1.597 Td
[(Ataxia,)36.6 ( inc)19.5 (luding )0.5 (gait disturbance )0.5 (and )0.5 (balance disorder)73.6 (,)36.5 ( )0.5 (occurred )0.5 (in )0.5 (28% )0.5 (of )0.5 (pa)-10.5 (tients;)-8 ( )]TJ
-0.009 Tc 0.092 Tw 0 -1.057 Td
[(Grade 3 a)-10.4 (taxia occurred in )0.5 (0.5% of )0.5 (pa)-10.4 (tients.)36.5 ( )37.4 (The median )0.5 (time to onset was 15 days)-9 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.057 Td
[(\(1 day to 1.4 years\).)36.6 ( Dose interruption was required in 5% of pa)-10.3 (tients,)36.6 ( 8% required dose)-17.9 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
[(reduction,)37.2 ( and one pa)-9.8 (tient \(0.2%\) permanently discontinued )37.2 (AUGTYRO due to a)-9.7 (taxia.)]TJ
0.002 Tc 0.145 Tw 0 -1.597 Td
[(Cognitive impairment,)36.9 ( inc)19.8 (luding memor)-18.1 (y impairment and disturbance in a)-10.2 (ttention,)39 ( )]TJ
-0.017 Tc 0.059 Tw 0 -1.057 Td
[(occurred in 25% of pa)-9.8 (tients.)37.2 ( Cognitive impairment inc)20.2 (luded memor)-17.8 (y impairment \(15%\),)20 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.057 Td
[(disturbance in a)-9.7 (ttention \(12%\),)37.2 ( and confusional sta)-9.8 (te \(2%\); Grade 3 cognitive impairment)-20 ( )]TJ
-0.026 Tc 0.026 Tw 0 -1.057 Td
[(occurred in 0.9% of pa)-10.1 (tients.)36.8 ( )36.6 (The median time to onset of cognitive disorders was 37 days)-26 ( )]TJ
-0.01 Tc 0.082 Tw 0 -1.057 Td
[(\(1 day to 1.4 years\).)37.3 ( Dose interruption was required in 2% of pa)-9.6 (tients,)37.3 ( 2.1% required)-10 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.059 Tw -31.5 -1.057 Td
[(dose reduction,)37.2 ( and 0.5% pa)-9.7 (tients permanently discontinued )37.2 (AUGTYRO due to cognitive)-17 ( )]TJ
0.048 Tw 0 -1.057 Td
(adverse reactions.)Tj
-0.02 Tc 0.036 Tw 0 -1.597 Td
[(Mood disorders occurred in 6% of pa)-9.8 (tients.)37.1 ( Mood disorders occurring in >1% of pa)-9.8 (tients)-20 ( )]TJ
-0.014 Tc 0.062 Tw 0 -1.057 Td
[(inc)20.4 (luded anxiety \(2.6%\); Grade 4 mood disorders \(mania\) occurred in 0.2\% of pa)-9.6 (tients.)23 ( )]TJ
-0.018 Tc 0.036 Tw 0 -1.057 Td
[(Do)0.5 (se)0.5 ( i)0.5 (nt)0.5 (er)0.5 (ru)0.5 (pt)0.5 (io)0.5 (n w)0.5 (as)0.5 ( r)0.5 (eq)0.5 (ui)0.5 (re)0.5 (d )0.5 (in )0.5 (0.)0.5 (2%)0.5 ( o)0.5 (f )0.5 (pa)-9.5 (ti)0.5 (en)0.5 (ts)0.5 ( a)0.5 (nd )0.5 (0.)0.5 (2%)0.5 ( o)0.5 (f )0.5 (pa)-9.5 (ti)0.5 (en)0.5 (ts)0.5 ( re)0.5 (qu)0.5 (ir)0.5 (ed)0.5 ( a)0.5 ( d)0.5 (os)0.5 (e)-18 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
(reduction due to mood disorders.)Tj
0.042 Tw 0 -1.597 Td
[(Sleep )0.6 (disorders )0.5 (inc)20.2 (luding )0.5 (insomnia )0.5 (and )0.6 (hypersomnia )0.5 (occurred )0.6 (in )0.5 (18% )0.6 (of )0.6 (pa)-9.8 (tients.)37.2 ( )0.6 (Sleep)-17 ( )]TJ
-0.002 Tc 0.125 Tw 0 -1.057 Td
[(disorders obser)-18.1 (ved in >1% of pa)-10.2 (tients were somnolence \(9%\),)36.9 ( insomnia \(6%\) and)-2 ( )]TJ
-0.011 Tc 0.078 Tw 0 -1.057 Td
[(hypersomnia \(1.6%\).)37.2 ( Dose interruption was required in 0.7% of pa)-9.9 (tients,)37.1 ( and 0.2% of)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
[(pa)-9.8 (tients required a dose reduction due to sleep disorders.)]TJ
-0.008 Tc 0.094 Tw 0 -1.597 Td
[(The incidences of CNS adverse reactions obser)-18 (ved were similar in pa)-9.9 (tients with and)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.057 Td
(without CNS metastases.)Tj
-0.005 Tc 0.111 Tw 0 -1.597 Td
[(Advise pa)-10.3 (tients and caregivers of the risk of CNS adverse reactions with )36.9 (AUGTYRO.)32 ( )]TJ
-0.003 Tc 0.118 Tw 0 -1.057 Td
[(Advise pa)-9.8 (tients not to drive or use machines if they are experiencing CNS adverse\)-3 ( )]TJ
-0.002 Tc 0.123 Tw 0 -1.057 Td
[(reactions.)37.3 ( )37.4 (Withhold and then )0.5 (resume a)-9.7 (t )0.5 (same or )0.5 (reduced )0.5 (dose upon improvement,)35 ( )]TJ
0.03 Tc 0.283 Tw 0 -1.057 Td
[(or permanently discontinue )37 (AUGTYRO based on severity )]TJ
/T1_2 1 Tf
[([see Dosa)-9.8 (ge and)30 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.057 Td
[(Administra)-9.8 (ti)]TJ
0.048 Tw (on \(2.5\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.616 Td
(5.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Interstitial Lung Disease/Pneumonitis)Tj
/T1_1 1 Tf
-3.375 -1.489 Td
(AUGTYRO can cause interstitial lung disease \(ILD\)/pneumonitis.)Tj
-0.01 Tc 0.086 Tw 0 -1.597 Td
[(Among the 426 pa)-10.2 (tients trea)-10.3 (ted with )37.2 (AUGTYRO,)36.7 ( ILD/pneumonitis \(pneumonitis [2.8%])-10 ( )]TJ
-0.005 Tc 0.11 Tw 0 -1.057 Td
[(and ILD [0.2%]\) occurred in 3.1% of pa)-10.2 (tients; Grade 3 ILD/pneumonitis occurred in)-5 ( )]TJ
-0.012 Tc 0.071 Tw 0 -1.057 Td
[(1)0.5 (.2)0.5 (%)0.5 ( of)0.5 ( pa)-9.5 (t)0.5 (i)0.5 (e)0.5 (nt)0.5 (s)0.5 (.)37.4 ( )36.8 (T)0.5 (he)0.5 ( m)0.5 (ed)0.5 (i)0.5 (a)0.5 (n t)0.5 (im)0.5 (e)0.5 ( to)0.5 ( o)0.5 (ns)0.5 (e)0.5 (t)0.5 ( w)0.5 (a)0.5 (s)0.5 ( 4)0.5 (5)0.5 ( d)0.5 (a)0.5 (y)0.5 (s \()0.5 (19)0.5 ( da)0.5 (y)0.5 (s)0.5 ( t)0.5 (o)0.5 ( 0)0.5 (.)0.5 (9)0.5 ( y)0.5 (e)0.5 (a)0.5 (rs)0.5 (\))0.5 (.)37.4 ( D)0.5 (os)0.5 (e)-12 ( )]TJ
-0.017 Tc 0.057 Tw 0 -1.057 Td
[(interruption was required in 1.4% of pa)-9.7 (tients,)37.2 ( 0.5% of pa)-9.8 (tients required dose reduction,)20 ( )]TJ
0.048 Tw 0 -1.057 Td
[(and 1.1% of pa)-9.7 (tients permanently discontinued )37.2 (AUGTYRO due to ILD/pneumonitis.)]TJ
-0.026 Tc 0.025 Tw 0 -1.597 Td
[(Monitor pa)-9.8 (tients for new or worsening pulmonar)-17.8 (y symptoms indica)-9.8 (tive of ILD/pneumonitis.)11.1 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
0.008 Tc 0.176 Tw -31.5 -1.057 Td
[(Immedia)-10.4 (tely withhold )36.6 (AUGTYRO in pa)-10.4 (tients with suspected ILD/pneumonitis and)8 ( )]TJ
-0.006 Tc 0.104 Tw 0 -1.057 Td
[(permanently discontinue )37.3 (AUGTYRO if ILD/pneumonitis is con\037rmed )]TJ
/T1_2 1 Tf
[([see Dosa)-9.9 (ge and)-6 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.057 Td
[(Administra)-9.8 (ti)]TJ
0.048 Tw (on \(2.5\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.616 Td
(5.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Hepatotoxicity)Tj
/T1_1 1 Tf
0.048 Tw -3.375 -1.597 Td
[(AUGTYRO can cause hepa)-9.8 (totoxicity)55.2 (.)]TJ
-0.01 Tc 0.082 Tw 0 -1.597 Td
[(Am)0.5 (ong )0.6 (the)0.5 ( )0.5 (42)0.5 (6 )0.5 (pa)-9.5 (tie)0.5 (nt)0.5 (s )0.5 (tr)0.5 (ea)-9.5 (ted )0.6 (wit)0.5 (h )37.5 (AU)0.5 (GTY)0.5 (RO,)37.4 ( )0.6 (incr)0.5 (ea)0.5 (sed )0.6 (ala)0.5 (nine)0.5 ( )0.5 (t)0.5 (rans)0.5 (am)0.5 (inas)0.5 (e )0.5 (\()0.5 (AL)94.4 (T)0.5 (\))-10 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.057 Td
[(occurred in 38%,)37.3 ( increased asparta)-9.6 (te aminotransferase \(AST\) occurred in 41%,)37.4 ( inc)20.4 (luding)-20 ( )]TJ
-0.009 Tc 0.087 Tw 36 86.406 Td
[(Grade 3 or 4 increased )36.9 (AL)94.3 (T in 3.3% and increased )36.9 (AST in 2.9%.)37.3 ( )36.9 (The median time to)-9 ( )]TJ
-0.017 Tc 0.039 Tw 0 -1.067 Td
[(onset of increased )36.8 (AL)94.2 (T or )36.8 (AST was 15 days \(range:)37.2 ( 1 day to 1.9 years\).)37.2 ( Increased )36.8 (AL)94.2 (T or)-17 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.067 Td
[(AST leading to dose interruptions or reductions occurred in 2.8% and 1.2\% of pa)-10.1 (tients,)21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
[(respectively)55.2 (.)37.2 ( Hyperbilirubinemia leading to dose interruptions occurred in 0.5%.)]TJ
-0.012 Tc 0.076 Tw 0 -1.607 Td
[(Monitor liver function tests,)36.6 ( inc)19.7 (luding )37 (AL)93.7 (T)91.6 (,)36.7 ( )36.9 (AST and bilirubin,)36.7 ( ever)-18.3 (y 2 weeks during the)-12 ( )]TJ
-0.009 Tc 0.09 Tw 0 -1.067 Td
[(\037rst )0.5 (month of trea)-10.1 (tment,)36.9 ( )0.5 (then )0.5 (monthly )0.5 (thereafter )0.5 (and )0.5 (as )0.5 (c)19.9 (linically indica)-10.1 (ted.)36.9 ( )37.4 (Withhold)-9 ( )]TJ
-0.003 Tc 0.119 Tw 0 -1.067 Td
[(and then resume a)-9.9 (t the same or reduced dose upon improvement,)37 ( or permanently)-3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
[(discontinue )37.2 (AUGTYRO based on the severity )]TJ
/T1_2 1 Tf
[([see Dosa)-9.8 (ge and )37.2 (Administra)-9.8 (ti)]TJ
(on \(2.5\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.626 Td
(5.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(My)16.2 (algia with Creatine Phosphokinase Elev)16.3 (ation)]TJ
/T1_1 1 Tf
-3.375 -1.607 Td
[(AUGTYRO can cause my)-9.8 (algia with or without crea)-9.8 (tine phosphokinase \(CPK\) eleva)-9.8 (tion.)]TJ
-0.024 Tc 0.03 Tw 0 -1.607 Td
[(Among the 426 pa)-9.9 (tients trea)-9.8 (ted with )36.7 (AUGTYRO,)37.2 ( my)-9.8 (algia occurred in 13% of pa)-9.8 (tients,)37.2 ( with)-24 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.067 Td
[(Grade 3 in 0.7%.)36.7 ( Median time to onset of my)-10.2 (algia was 19 days \(range:)36.7 ( 1 day to 2 years\).)16 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.009 Tc 0.09 Tw -31.5 -1.067 Td
[(Concurrent increased CPK within a 7-day windo)-10.1 (w was obser)-18.1 (ved in 3.7% of pa)-10.1 (tients.)28 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
[(AUGTYRO was interrupted in one pa)-9.8 (tient with my)-9.8 (algia and concurrent CPK eleva)-9.8 (tion.)]TJ
0 -1.607 Td
[(Advise pa)-9.8 (tients to report an)-9.8 (y unexplained musc)20.2 (le pain,)37.2 ( tenderness,)37.2 ( or weakness.)]TJ
-0.005 Tc 0.109 Tw 0 -1.607 Td
[(Monitor serum CPK levels during )37.2 (AUGTYRO trea)-10 (tment and monitor CPK levels ever)-18 (y)-5 ( )]TJ
0.002 Tc 0.144 Tw 0 -1.067 Td
[(2 weeks during the \037rst month of trea)-9.9 (tment and as needed in pa)-10 (tients reporting)2 ( )]TJ
-0.015 Tc 0.06 Tw 0 -1.067 Td
[(unexplained musc)19.8 (le pain,)36.8 ( tenderness,)36.8 ( or weakness.)36.8 ( Initia)-10.2 (te supportive care as c)19.7 (linically)-15 ( )]TJ
0.001 Tc 0.14 Tw 0 -1.067 Td
[(indica)-10.1 (ted.)36.8 ( Based on severity)54.9 (,)36.8 ( withhold and then resume )37.2 (AUGTYRO a)-10.1 (t the same or)1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
(reduced dose upon improvement )Tj
/T1_2 1 Tf
[([see Dosa)-9.7 (ge and )37.2 (Administra)-9.8 (ti)]TJ
(on \(2.5\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw -0 -1.626 Td
(5.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.375 0 Td
(Hyperuricemia)Tj
/T1_1 1 Tf
0.048 Tw -3.375 -1.522 Td
(AUGTYRO can cause hyperuricemia.)Tj
-0.032 Tc 0.012 Tw 0 -1.652 Td
[(Among the 426 pa)-10.1 (tients trea)-10.1 (ted with )37.4 (AUGTYRO,)36.9 ( 21 pa)-10.2 (tients \(5%\) experienced hyperuricemia)-32 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
0.004 Tc 0.152 Tw -31.5 -1.067 Td
[(reported as an adverse reaction and 0.7% of pa)-9.6 (tients experienced Grade 3 or 4)4 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.067 Td
[(hyperuricemia.)37.4 ( One pa)-9.6 (tient without pre-existing gout required ura)-9.6 (te-lo)-9.6 (wering medica)-9.7 (tion.)]TJ
0.001 Tc 0.141 Tw 0 -1.652 Td
[(Monitor serum uric acid levels prior to initia)-10.3 (ting )37.1 (AUGTYRO and periodically during)1 ( )]TJ
-0.004 Tc 0.114 Tw 0 -1.067 Td
[(trea)-10.1 (tment.)36.9 ( Initia)-10.1 (te trea)-10 (tment with ura)-10 (te-lo)-10.1 (wering medica)-10 (tions as c)19.9 (linically indica)-10.1 (ted.)33 ( )]TJ
0.007 Tc 0.172 Tw 0 -1.067 Td
[(Withhold )0.5 (and then )0.5 (resume )0.5 (a)-10.4 (t )0.5 (the same )0.5 (or )0.5 (reduced )0.5 (dose )0.5 (upon )0.5 (improvement,)36.5 ( )0.5 (or)7 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.032 Tc 0.032 Tw -31.5 -1.067 Td
[(permanently )0.5 (discontinue )37.5 (AUGTYRO )0.5 (based )0.5 (on )0.5 (severity )]TJ
/T1_2 1 Tf
18.396 0 Td
[([see Dosa)-10.1 (ge )]TJ
-0.005 Tw 4.482 0 Td
[(and )0.5 (Administra)-10.1 (ti)]TJ
0.032 Tw (on)Tj
-0.024 Tc [( )0.5 (\(2.5\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw -22.879 -1.649 Td
(5.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Skeletal Fractures)Tj
/T1_1 1 Tf
-3.375 -1.522 Td
(AUGTYRO can cause skeletal fractures.)Tj
-0.019 Tc 0.036 Tw 0 -1.652 Td
[(Among 426 adult pa)-9.7 (tients who received )37.2 (AUGTYRO,)37.2 ( fractures occurred in 2.3%.)37.3 ( F)20.3 (ractures)-19 ( )]TJ
-0.016 Tc 0.06 Tw 0 -1.067 Td
[(involved the ribs \(0.5%\),)36.8 ( feet \(0.5%\),)36.8 ( spine \(0.2%\),)36.9 ( acetabulum \(0.2%\),)36.8 ( sternum \(0.2%\),)21 ( )]TJ
-0.002 Tc 0.122 Tw 0 -1.067 Td
[(and ankles \(0.2%\).)37.3 ( Some fractures occurred a)-9.7 (t sites of disease and prior radia)-9.7 (tion)-2 ( )]TJ
-0.024 Tc 0.031 Tw 0 -1.067 Td
[(thera)-10 (py)55 (.)37 ( )37.1 (The median time to fracture was 71 days \(range:)37.1 ( 31 days to 1.4 years\).)37 ( )37 (AUGTYRO)-24 ( )]TJ
0 Tc 0 Tw 31.5 0 Td
( )Tj
-0.017 Tc 0.048 Tw -31.5 -1.067 Td
[(was interrupted in 0.3% of pa)-9.8 (tients.)]TJ
-0.014 Tc 0.066 Tw 0 -1.652 Td
[(Of 26 evaluable pa)-10.3 (tients in an ongoing open-label stud)-10.3 (y in pedia)-10.3 (tric pa)-10.3 (tients,)36.7 ( fractures)-14 ( )]TJ
-0.005 Tc 0.112 Tw 0 -1.067 Td
[(occurred )0.6 (in )0.6 (one )0.5 (12-year)36.6 (-old )0.5 (pa)-10.4 (tient )0.5 (\(ankle/foot\) )0.6 (and )0.6 (one )0.5 (10-year)36.5 (-old )0.6 (pa)-10.4 (tient )0.5 (\(stress)-5 ( )]TJ
-0.019 Tc 0.036 Tw 0 -1.067 Td
[(fracture\).)37.2 ( )37.2 (AUGTYRO was interrupted in both pa)-9.8 (tients.)37.2 ( )37.2 (AUGTYRO is not a)-9.7 (pproved for use in)-19 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
[(pedia)-9.7 (tric pa)-9.8 (tients less than 12 years of a)-9.8 (ge )]TJ
/T1_2 1 Tf
[([see P)18.2 (edia)-9.8 (tric U)]TJ
(se \(8.4\)])Tj
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
-0.003 Tc 0.116 Tw 0 -1.652 Td
[(P)0.6 (r)0.5 (o)0.6 (m)0.5 (p)0.6 (t)0.5 (l)0.6 (y)0.5 ( e)0.6 (v)0.5 (a)0.6 (l)0.5 (u)0.6 (a)-9.4 (t)0.5 (e)0.6 ( p)0.5 (a)-9.4 (t)0.5 (i)0.6 (e)0.6 (n)0.5 (t)0.6 (s)0.5 ( w)0.5 (i)0.6 (t)0.6 (h)0.5 ( s)0.5 (i)0.6 (g)0.5 (n)0.6 (s)0.5 ( o)0.6 (r)0.5 ( s)0.5 (y)0.6 (m)0.5 (p)0.5 (t)0.6 (o)0.6 (m)0.5 (s)0.6 ( \()0.5 (e)0.6 (.)0.5 (g)0.6 (.)0.5 (,)37.6 ( p)0.5 (a)0.6 (i)0.5 (n)0.6 (,)37.5 ( c)0.6 (h)0.5 (a)0.6 (n)0.5 (g)0.6 (e)0.5 (s)0.6 ( i)0.5 (n)0.6 ( m)0.5 (o)0.6 (b)0.5 (i)0.6 (l)0.5 (i)0.6 (t)0.5 (y)55.6 (,)34 ( )]TJ
-0.004 Tc 0 -1.067 Td
[(deformity\) of fractures.)36.6 ( )36.7 (There are no da)-10.4 (ta on the effects of )36.7 (AUGTYRO on healing of)-4 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
[(kno)-9.8 (wn fractures and risk of future fractures.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.649 Td
(5.7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Embr)-17.8 (yo-F)20.1 (etal T)74.2 (oxicity)]TJ
/T1_1 1 Tf
-0.007 Tc 0.1 Tw -3.375 -1.522 Td
[(Based on litera)-10.2 (ture reports in humans with congenital muta)-10.2 (tions leading to changes)-6.9 ( )]TJ
-0.01 Tc 0.085 Tw 0 -1.067 Td
[(in tropomyosin receptor tyrosine kinase \(TRK\) signaling,)36.8 ( \037ndings from animal studies,)27 ( )]TJ
-0.011 Tc 0.079 Tw 0 -1.067 Td
[(and its mechanism of action,)37 ( )37.3 (AUGTYRO can cause fetal harm when administered to a)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
(pregnant woman.)Tj
-0.015 Tc 0.06 Tw 0 -1.652 Td
[(Oral administra)-10.2 (tion of repotrectinib to pregnant ra)-10.1 (ts during the period of organogenesis)-15 ( )]TJ
-0.005 Tc 0.109 Tw 0 -1.067 Td
[(resulted in fetal malforma)-10 (tions a)-9.9 (t doses a)-9.9 (pproxima)-10 (tely 0.3 times the recommended)-5 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
[(160 mg twice daily dose based on bod)-9.8 (y surface area \(BSA\).)]TJ
-0.013 Tc 0.067 Tw 0 -1.652 Td
[(Advise pregnant women of the potential risk to a fetus.)37.4 ( )37.3 (Advise female)0.5 (s of repro)0.5 (duc)0.5 (tiv)0.5 (e)-13 ( )]TJ
-0.012 Tc 0.076 Tw 0 -1.067 Td
[(potential )0.5 (to )0.5 (use )0.5 (effective )0.6 (non-hormonal )0.5 (contraception )0.6 (during )0.6 (trea)-10.2 (tment )0.5 (with )37.6 (AUGTYRO)-12 ( )]TJ
-0.01 Tc 0.084 Tw 0 -1.067 Td
[(and )0.5 (for 2 )0.5 (months follo)-9.9 (wing )0.5 (the )0.5 (last )0.5 (dose,)37 ( )0.5 (since )37.5 (AUGTYRO )0.5 (can )0.5 (render )0.5 (some )0.5 (hormonal)-10 ( )]TJ
-0.017 Tc 0.04 Tw 0 -1.067 Td
(contraceptives ineffective )Tj
/T1_2 1 Tf
([see Drug Interactions \(7.2\)])Tj
/T1_1 1 Tf
[(.)37.2 ( )37.1 (Advise male pa)-9.8 (tients with female)-17 ( )]TJ
0.003 Tc 0.151 Tw 0 -1.067 Td
[(partners of reproductive potential to use effective contraception during\ trea)-10.3 (tment)3 ( )]TJ
-0.008 Tc 0.096 Tw 0 -1.067 Td
[(with )37.4 (AUGTYRO and for )0.5 (4 months after the last dose )]TJ
/T1_2 1 Tf
[([see )0.5 (Use in Speci\037c )0.5 (P)17.7 (opula)-10.3 (tions)-7.9 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.067 Td
(\(8)Tj
0.048 Tw [(.1,)37.2 ( 8.3\)])]TJ
/T1_1 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw 0 -1.891 Td
(6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(ADVERSE REACTIONS)Tj
/T1_1 1 Tf
0.007 Tc 0.171 Tw -3.375 -1.495 Td
[(The follo)-10.3 (wing c)19.6 (linically significant adverse reactions are described elsewhere in)7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.067 Td
(the labeling:)Tj
0.017 Tw 1.193 -1.559 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Central Ner)-17.8 (vous System )37.3 (Adverse Reactions )]TJ
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5)]TJ
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw 27.776 0 Td
(1\)])Tj
/T1_1 1 Tf
-29.283 -1.518 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
(Interstitial Lung Disease \(ILD\)/Pneumonitis )Tj
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.2\)])]TJ
/T1_1 1 Tf
0.017 Tw -1.508 -1.518 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
1.508 0 Td
[(Hepa)-9.7 (totoxicity )]TJ
/T1_2 1 Tf
0.048 Tw 5.239 0 Td
[([see )37.3 (W)18.2 (arnings and Precautions \(5.3\)])]TJ
/T1_1 1 Tf
-0.029 Tc 0.029 Tw -6.746 -1.518 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.033 Tc 0.036 Tw 1.508 0 Td
[(My)-9.8 (algia with Crea)-9.8 (tine Phosphokinase Eleva)-9.8 (tion )]TJ
/T1_2 1 Tf
[([see )37.2 (W)18.3 (arnings and Precautions \()]TJ
0 Tc 0 Tw (5)Tj
27.76 0 Td
(.)Tj
-0.033 Tc 0.033 Tw 0.127 0 Td
(4\)])Tj
/T1_1 1 Tf
-0.017 Tc 0.017 Tw -29.394 -1.518 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
1.508 0 Td
(Hyperuricemia )Tj
/T1_2 1 Tf
0.048 Tw 5.396 0 Td
[([see )37.2 (W)18.2 (arnings and Precautions \(5.5\)])]TJ
/T1_1 1 Tf
0.017 Tw -6.904 -1.518 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(Skeletal F)20.2 (ractures )]TJ
/T1_2 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.6\)])]TJ
/T1_1 1 Tf
0.017 Tw -1.508 -1.518 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.508 0 Td
[(Embr)-17.7 (yo-F)24.2 (etal T)74.2 (oxicity )]TJ
/T1_2 1 Tf
0.048 Tw 7.833 0 Td
[([see )37.3 (W)18.1 (arnings and Precautions \(5)]TJ
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw 12.127 0 Td
(7\)])Tj
ET
0 0 0 1 K
4 M 
q 1 0 0 1 319.5 366.1495 cm
0 0 m
0 -38.88 l
S
Q
endstreamendobj87 0 obj<</Length 22715>>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
0 0 0 1 K
0.5 w 
/GS1 gs
q 1 0 0 1 36 521.3901 cm
0 0 m
19.753 0 l
S
Q
q 1 0 0 1 36 471.3901 cm
0 0 m
36.782 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 36 750.2881 Tm
[(FULL PRESCRIBING INFORMA)55.1 (TION)]TJ
0.017 Tw 0 -1.8 Td
(1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(INDIC)18.2 (A)55.2 (TIONS AND USAGE)]TJ
0.017 Tw -3.375 -1.602 Td
(1.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
3.375 0 Td
(ROS1)Tj
/T1_0 1 Tf
0.048 Tw [(-P)24.2 (ositive Non-Small Cell Lung Cancer)]TJ
/T1_2 1 Tf
0 Tc 0.135 Tw -3.375 -1.498 Td
[(AUGTYRO is indica)-10.1 (ted for )0.5 (the )0.5 (trea)-10.1 (tment of adult )0.5 (pa)-10.1 (tients )0.5 (with locally )0.5 (advanced )0.5 (or )]TJ
0.01 Tc 0.187 Tw 0 -1.044 Td
[(metasta)-10.4 (tic )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
-0.01 Tw 4.471 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.566 0 Td
(1)Tj
/T1_2 1 Tf
0.01 Tc 0.187 Tw 0.47 0 Td
(-positive non-small cell lung cancer \(NSCLC\) )Tj
/T1_3 1 Tf
[([see Dosa)-10.4 (ge and)10 ( )]TJ
-0.017 Tc 0.017 Tw -6.508 -1.044 Td
[(Administra)-9.8 (ti)]TJ
0.048 Tw (on \(2)Tj
0 Tc 0 Tw (.)Tj
-0.017 Tc 0.017 Tw 6.221 0 Td
(1\)])Tj
/T1_2 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw -6.221 -2.143 Td
(1.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_1 1 Tf
3.375 0 Td
(NTRK)Tj
/T1_0 1 Tf
0.048 Tw [( Gene Fusion-P)24.2 (ositive Solid T)74.1 (umors)]TJ
/T1_2 1 Tf
-0.014 Tc 0.065 Tw -3.375 -1.498 Td
[(AUGTYRO is indica)-10.2 (ted for the trea)-10.2 (tment of adult and pedia)-10.2 (tric pa)-10.2 (tients 12 years of a)-10.2 (ge)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(and older with solid tumors tha)-9.8 (t:)]TJ
0.017 Tw 1.192 -1.535 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.009 Tc 0.089 Tw 1.508 0 Td
[(ha)-10.1 (ve a neurotrophic tyrosine receptor kinase \()]TJ
/T1_3 1 Tf
0.009 Tw (NTRK)Tj
/T1_2 1 Tf
0.089 Tw (\) gene fusion )Tj
/T1_3 1 Tf
[([see Dosa)-10 (ge)-9 ( )]TJ
-0.017 Tc 0.011 Tw 0 -1.062 Td
[(and Administra)-9.8 (tion )-36.8 (\(2.1\)])]TJ
/T1_2 1 Tf
0 Tc 0 Tw (,)Tj
-0.017 Tc 0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.014 Tc 0.063 Tw 1.508 0 Td
[(are locally advanced or metasta)-9.9 (tic or where surgical resection is likely to result)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.062 Td
[(in severe morbidity)55.2 (,)37.2 ( )]TJ
/T1_3 1 Tf
0.017 Tw (and)Tj
/T1_2 1 Tf
0 Tc 0 Tw /Span<</ActualText<FEFF200A>>> BDC 
8.555 0 Td
( )Tj
EMC 
-0.017 Tc 0.017 Tw -10.063 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(ha)-9.8 (ve progressed follo)-9.8 (wing trea)-9.8 (tment or ha)-9.8 (ve no sa)-9.8 (tisfactor)-17.8 (y alterna)-9.8 (tive thera)-9.8 (py)55.2 (.)]TJ
0 Tc 0.136 Tw -2.7 -1.516 Td
[(This indica)-10.3 (tion is a)-10.4 (pproved under accelera)-10.4 (ted a)-10.3 (pproval based on overall response )]TJ
-0.012 Tc 0.075 Tw 0 -1.044 Td
[(ra)-10.2 (te and dura)-10.1 (tion of response )]TJ
/T1_3 1 Tf
([see Clinical Studies \(14.2\)])Tj
/T1_2 1 Tf
[(.)36.9 ( Continued a)-10.1 (pproval for this)-12 ( )]TJ
-0.008 Tc 0.093 Tw 0 -1.044 Td
[(indica)-9.8 (tion may be contingent upon veri\037ca)-9.8 (tion and description of c)20.2 (linical bene\037t in a)-8 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(con\037rma)-9.8 (tor)-17.8 (y trial\(s\).)]TJ
/T1_0 1 Tf
0.017 Tw 0 -2.543 Td
(2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(DOSAGE AND ADMINISTRA)55.2 (TION)]TJ
0.017 Tw -3.375 -1.602 Td
(2.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(P)24.2 (atient Selection)]TJ
/T1_2 1 Tf
0.017 Tw -3.375 -1.517 Td
(NSCLC)Tj
0.008 Tc 0.175 Tw 0 -1.471 Td
[(Select pa)-10.1 (tients for the trea)-10.1 (tment of locally advanced or metasta)-10.1 (tic NSCLC with)8 ( )]TJ
-0.01 Tc 0.083 Tw 0 -1.044 Td
[(AUGTYRO )0.5 (based on )0.5 (the presence )0.5 (of )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
13.539 0 Td
( )Tj
EMC 
/T1_3 1 Tf
0.01 Tw 0.031 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.504 0 Td
(1)Tj
/T1_2 1 Tf
-0.01 Tc 0.083 Tw 0.47 0 Td
[( )0.5 (rearrangement\(s\) )0.5 (in tumor )0.5 (specimens )]TJ
/T1_3 1 Tf
0.01 Tw [([see)-10 ( )]TJ
0.002 Tc 0.142 Tw -15.544 -1.044 Td
(Clinical Studies \(14.1\)])Tj
/T1_2 1 Tf
[(.)37.4 ( )37.3 (An FDA-a)-9.6 (pproved test to detect )]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
/T1_3 1 Tf
-0.002 Tw 21.802 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.54 0 Td
(1)Tj
/T1_2 1 Tf
0.002 Tc 0.142 Tw 0.482 0 Td
[( rearrangements for)2 ( )]TJ
-0.017 Tc 0.048 Tw -23.823 -1.044 Td
[(selecting pa)-9.8 (tients for trea)-9.8 (tment with )37.2 (AUGTYRO is not currently a)-9.8 (vailable.)]TJ
0.011 Tw 0 -1.647 Td
[(Solid T)74.2 (umors)]TJ
-0.014 Tc 0.061 Tw 0 -1.471 Td
[(S)0.5 (e)0.5 (l)0.5 (e)0.5 (c)0.5 (t)0.5 ( p)0.5 (a)-9.4 (t)0.5 (ie)0.5 (n)0.6 (t)0.5 (s f)0.5 (o)0.5 (r)0.5 ( t)0.5 (h)0.5 (e)0.5 ( t)0.6 (r)0.5 (e)0.5 (a)-9.5 (t)0.5 (m)0.5 (e)0.5 (n)0.5 (t)0.5 ( o)0.5 (f)0.5 ( s)0.5 (o)0.5 (l)0.5 (i)0.5 (d)0.5 ( t)0.5 (u)0.5 (m)0.5 (o)0.5 (r)0.5 (s)0.5 ( w)0.5 (i)0.5 (t)0.5 (h)0.5 ( )37 (A)0.5 (U)0.5 (G)0.5 (T)0.5 (Y)0.5 (R)0.5 (O)0.5 ( b)0.5 (a)0.5 (s)0.5 (e)0.5 (d)0.5 ( o)0.6 (n t)0.5 (h)0.5 (e)0.5 ( p)0.5 (r)0.5 (e)0.5 (s)0.5 (e)0.5 (n)0.5 (c)0.5 (e)-14 ( )]TJ
-0.002 Tc 0.002 Tw 0 -1.044 Td
(of )Tj
/T1_3 1 Tf
1.064 0 Td
(NTRK1)Tj
(/2/3)Tj
/T1_2 1 Tf
0.127 Tw [( )0.5 (rearrangements )0.5 (in )0.6 (tumor )0.6 (specimens )]TJ
/T1_3 1 Tf
18.51 0 Td
[([see )0.5 (Clinical )0.5 (Studies )0.5 (\(14.2\)])]TJ
/T1_2 1 Tf
-0.039 Tc [(. )0.5 (A)-37.4 (n)-39 ( )]TJ
0.002 Tc 0.147 Tw -19.575 -1.044 Td
[(FDA-a)-10.4 (pproved )0.5 (test )0.5 (to )0.5 (detect )]TJ
/T1_3 1 Tf
-0.002 Tw 11.264 0 Td
(NTRK1)Tj
(/2/3)Tj
/T1_2 1 Tf
0.147 Tw [( rearrangements )0.5 (for )0.5 (selecting pa)-10.4 (tients )0.5 (for)2.1 ( )]TJ
-0.017 Tc 0.048 Tw -11.264 -1.044 Td
[(trea)-9.7 (tment with )37.2 (AUGTYRO is not currently a)-9.8 (vailable.)]TJ
0.017 Tw 1.192 -1.535 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.018 Tc 0.036 Tw 1.508 0 Td
[(In pa)-10.3 (tients with secretor)-18.4 (y breast cancer or mammar)-18.4 (y analogue secretor)-18.4 (y cancer)73.6 (,)19 ( )]TJ
0.002 Tc 0.143 Tw 0 -1.062 Td
[(consider trea)-9.9 (tment without con\037rma)-9.9 (tion of )]TJ
/T1_3 1 Tf
-0.002 Tw (NTRK)Tj
/T1_2 1 Tf
0.143 Tw [( rearrangements in tumor)2 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.062 Td
(specimens.)Tj
/T1_0 1 Tf
-2.7 -2.03 Td
(2.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Important Information Prior to Initiating AUGTYRO)Tj
/T1_2 1 Tf
0.001 Tc 0.139 Tw -3.375 -1.498 Td
[(Prior to initia)-9.9 (ting )37.4 (AUGTYRO,)37.1 ( discontinue )0.5 (strong )0.5 (and modera)-9.9 (te CYP3A inhibitors )0.5 (for)1 ( )]TJ
-0.013 Tc 0.07 Tw 0 -1.044 Td
[(3\035)-70.1 (to\035)-70.1 (5 elimina)-10.1 (tion half-lives of the CYP3A inhibitor )]TJ
/T1_3 1 Tf
[([see Drug Interactions \(7.1\),)36.8 ( Clinical)-13 ( )]TJ
-0.017 Tc 0.017 Tw 0 -1.044 Td
(Pharmacolog)Tj
0.048 Tw 4.652 0 Td
(y \(12.3\)])Tj
/T1_2 1 Tf
0 Tc 0 Tw (.)Tj
/T1_0 1 Tf
-0.017 Tc 0.017 Tw -4.652 -2.143 Td
(2.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
[(Recommended Ev)16.2 (aluation and T)74.2 (esting Before Initiating AUGTYRO)]TJ
/T1_2 1 Tf
-3.375 -1.498 Td
[(Prior to initia)-9.8 (tion of )37.2 (AUGTYRO,)37.2 ( evalua)-9.8 (te:)]TJ
0.017 Tw 1.192 -1.535 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
[(liver function tests inc)20.2 (luding bilirubin )]TJ
/T1_3 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.3\)])]TJ
/T1_2 1 Tf
0.017 Tw -1.508 -1.423 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.508 0 Td
(uric acid level )Tj
/T1_3 1 Tf
[([see )37.2 (W)18.2 (arnings and Precautions \(5.5\)])]TJ
/T1_0 1 Tf
0.017 Tw -2.7 -2.03 Td
(2.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Recommended Dosage)Tj
/T1_2 1 Tf
0.004 Tc 0.152 Tw -3.375 -1.498 Td
[(The )0.5 (recomm)0.5 (ended d)0.5 (osa)-9.6 (ge )0.5 (of )37.4 (AUG)0.5 (TYRO for)0.5 ( adult)0.5 ( and )0.5 (pedia)-9.6 (tr)0.5 (ic pa)-9.6 (t)0.5 (ients 1)0.5 (2 year)0.5 (s)4 ( )]TJ
-0.009 Tc 0.09 Tw 0 -1.044 Td
[(of a)-10.2 (ge and older is 160 mg taken orally once daily with or without food )]TJ
/T1_3 1 Tf
[([see Clinical)-9 ( )]TJ
-0.021 Tc 0.036 Tw 0 -1.044 Td
[(Pharmacolog)-10 (y \(12.3\)])]TJ
/T1_2 1 Tf
[( for 14 days,)37 ( then increase to 160 mg twice daily and continue until)-21 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(disease progression or unacceptable toxicity)55.2 (.)]TJ
/T1_0 1 Tf
0.017 Tw 0 -2.143 Td
(2.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.375 0 Td
(Dosage Modi\037cations for Adverse Reactions)Tj
/T1_2 1 Tf
-0.003 Tc 0.12 Tw -3.375 -1.498 Td
[(The recommended dosa)-10.1 (ge reductions of )37.4 (AUGTYRO for the mana)-10.1 (gement of adverse)-3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(reactions are provided in )37.2 (T)74.2 (able 1.)]TJ
ET
/GS2 gs
q 1 0 0 1 112.25 153.7884 cm
0 0 m
0 12.412 l
S
Q
q 1 0 0 1 200.125 153.7884 cm
0 0 m
0 12.412 l
S
Q
q 1 0 0 1 36 153.5384 cm
0 0 m
76.25 0 l
S
Q
q 1 0 0 1 112.25 153.5384 cm
0 0 m
87.875 0 l
S
Q
q 1 0 0 1 112.25 141.1265 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 200.125 153.5384 cm
0 0 m
87.875 0 l
S
Q
q 1 0 0 1 200.125 141.1265 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 36 166.4503 cm
0 0 m
76.25 0 l
S
Q
1 w 
q 1 0 0 1 36 192.2742 cm
0 0 m
76.25 0 l
S
Q
q 1 0 0 1 112.25 192.2742 cm
0 0 m
87.875 0 l
S
Q
q 1 0 0 1 200.125 192.2742 cm
0 0 m
87.875 0 l
S
Q
0.5 w 
q 1 0 0 1 112.25 179.6123 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 112 179.3623 cm
0 0 m
88.125 0 l
S
Q
q 1 0 0 1 112.25 166.7003 cm
0 0 m
0 12.412 l
S
Q
q 1 0 0 1 112.25 166.4503 cm
0 0 m
87.875 0 l
S
Q
q 1 0 0 1 200.125 179.3623 cm
0 0 m
87.875 0 l
S
Q
q 1 0 0 1 200.125 166.7003 cm
0 0 m
0 12.412 l
S
Q
q 1 0 0 1 200.125 166.4503 cm
0 0 m
87.875 0 l
S
Q
1 w 
q 1 0 0 1 36 140.6265 cm
0 0 m
76.25 0 l
S
Q
q 1 0 0 1 112.25 140.6265 cm
0 0 m
87.875 0 l
S
Q
q 1 0 0 1 200.125 140.6265 cm
0 0 m
87.875 0 l
S
Q
BT
/GS1 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 36 196.7742 Tm
[(T)74.2 (able 1:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
(Recommended Dose Reductions for AUGTYRO Adverse Reactions)Tj
-0.012 Tc 0.012 Tw 7.6 0 0 8 37.44 176.5063 Tm
(Dose)Tj
0.048 Tw 11.028 0.807 Td
(Dose Reduction)Tj
0.012 Tw 0 -1.614 Td
(First)Tj
11.563 0 Td
(Second)Tj
/T1_2 1 Tf
0.048 Tw -22.78 -1.614 Td
[(160 mg Once Daily)-11.9 ( )]TJ
11.217 0 Td
(120 mg Once Daily)Tj
11.563 0 Td
(80 mg Once Daily)Tj
-22.78 -1.614 Td
[(160 mg )37.2 (T)74.2 (wice Daily)-11.9 ( )]TJ
11.217 0 Td
[(120 mg )37.2 (T)74.2 (wice Daily)]TJ
11.563 0 Td
[(80 mg )37.2 (T)74.2 (wice Daily)]TJ
0.001 Tc 0.137 Tw 8 0 0 8 36 115.4365 Tm
[(Recommended dosa)-9.6 (ge modi\037ca)-9.6 (tions of )36.8 (AUGTYRO for the mana)-9.7 (gement of adverse)1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.044 Td
[(reactions are provided in )37.2 (T)74.2 (able 2.)]TJ
ET
4 M 
q 1 0 0 1 31.5 478.8032 cm
0 0 m
0 -47.663 l
S
Q
q 1 0 0 1 40.5 431.14 cm
0 0 m
0 -29.52 l
S
Q
0.5 w 10 M 
/GS2 gs
q 1 0 0 1 324 701.3361 cm
0 0 m
76.32 0 l
S
Q
1 w 
q 1 0 0 1 324 714.248 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 714.248 cm
0 0 m
72 0 l
S
Q
0.5 w 
q 1 0 0 1 400.32 701.5861 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 400.32 701.3361 cm
0 0 m
72 0 l
S
Q
1 w 
q 1 0 0 1 472.32 714.248 cm
0 0 m
103.68 0 l
S
Q
0.5 w 
q 1 0 0 1 472.32 701.5861 cm
0 0 m
0 12.162 l
S
Q
q 1 0 0 1 472.32 701.3361 cm
0 0 m
103.68 0 l
S
Q
1 w 
q 1 0 0 1 324 70.6451 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 70.6451 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 472.32 70.6451 cm
0 0 m
103.68 0 l
S
Q
0.5 w 
q 1 0 0 1 324 57.7332 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 57.7332 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 472.32 57.7332 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 400.32 659.9342 cm
0 0 m
0 41.152 l
S
Q
q 1 0 0 1 472.32 659.9342 cm
0 0 m
0 41.152 l
S
Q
q 1 0 0 1 400.07 659.6842 cm
0 0 m
72.25 0 l
S
Q
q 1 0 0 1 400.32 626.7823 cm
0 0 m
0 32.652 l
S
Q
q 1 0 0 1 472.32 659.6842 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 626.7823 cm
0 0 m
0 32.652 l
S
Q
q 1 0 0 1 400.07 626.5323 cm
0 0 m
72.25 0 l
S
Q
q 1 0 0 1 400.32 604.6504 cm
0 0 m
0 21.632 l
S
Q
q 1 0 0 1 472.32 626.5323 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 604.6504 cm
0 0 m
0 21.632 l
S
Q
q 1 0 0 1 472.32 484.8266 cm
0 0 m
0 77.672 l
S
Q
q 1 0 0 1 400.32 322.5027 cm
0 0 m
0 81.132 l
S
Q
q 1 0 0 1 472.32 322.5027 cm
0 0 m
0 81.132 l
S
Q
q 1 0 0 1 324 322.2527 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 322.2527 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 400.32 283.3708 cm
0 0 m
0 38.632 l
S
Q
q 1 0 0 1 472.32 322.2527 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 283.3708 cm
0 0 m
0 38.632 l
S
Q
q 1 0 0 1 400.07 283.1208 cm
0 0 m
72.25 0 l
S
Q
q 1 0 0 1 400.32 218.7389 cm
0 0 m
0 64.132 l
S
Q
q 1 0 0 1 472.32 283.1208 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 218.7389 cm
0 0 m
0 64.132 l
S
Q
q 1 0 0 1 324 218.4889 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 218.4889 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 400.32 168.587 cm
0 0 m
0 49.652 l
S
Q
q 1 0 0 1 472.32 218.4889 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 168.587 cm
0 0 m
0 49.652 l
S
Q
q 1 0 0 1 324 168.337 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 168.337 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 400.32 71.1451 cm
0 0 m
0 96.942 l
S
Q
q 1 0 0 1 472.32 168.337 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 71.1451 cm
0 0 m
0 96.942 l
S
Q
q 1 0 0 1 400.32 484.8266 cm
0 0 m
0 77.672 l
S
Q
q 1 0 0 1 400.07 484.5766 cm
0 0 m
72.25 0 l
S
Q
q 1 0 0 1 400.32 404.1346 cm
0 0 m
0 80.192 l
S
Q
q 1 0 0 1 472.32 484.5766 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 404.1346 cm
0 0 m
0 80.192 l
S
Q
q 1 0 0 1 400.07 403.8846 cm
0 0 m
72.25 0 l
S
Q
q 1 0 0 1 472.32 403.8846 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 324 604.4004 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 604.4004 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 400.32 562.9985 cm
0 0 m
0 41.152 l
S
Q
q 1 0 0 1 472.32 604.4004 cm
0 0 m
103.68 0 l
S
Q
q 1 0 0 1 472.32 562.9985 cm
0 0 m
0 41.152 l
S
Q
q 1 0 0 1 324 562.7485 cm
0 0 m
76.32 0 l
S
Q
q 1 0 0 1 400.32 562.7485 cm
0 0 m
72 0 l
S
Q
q 1 0 0 1 472.32 562.7485 cm
0 0 m
103.68 0 l
S
Q
BT
/GS1 gs
/T1_0 1 Tf
0 Tw 8 0 0 8 324 727.248 Tm
[(T)74.2 (able 2:)]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
5.375 0 Td
[(Recommended Dosage Modifications for AUGTYRO Adverse)-17 ( )]TJ
0.017 Tw 0 -1.062 Td
(Reactions)Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 325.44 704.9362 Tm
(Adverse Reaction)Tj
0.012 Tw 11.037 0 Td
(Severity*)Tj
0.048 Tw 9.474 0 Td
(Dosage Modification)Tj
/T1_2 1 Tf
-20.7 -1.659 Td
[(Central Ner)-17.8 (vous System)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(Effects )Tj
/T1_3 1 Tf
0.011 Tw 2.707 0 Td
[([see W)18.2 (arnings )-36.8 (and)-11.9 ( )]TJ
0.048 Tw -2.707 -1.062 Td
(Precautions \(5.1\)])Tj
/T1_2 1 Tf
0.012 Tw 11.226 2.125 Td
(Intolerable)Tj
0.048 Tw 0 -1.062 Td
(Grade 2)Tj
0.012 Tw 9.474 1.062 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.184 0 Td
[(Withhold AUGTYRO )-36.8 (until)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
(\034Grade 1 or baseline.)Tj
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Resume a)-9.7 (t same or reduced)-11.9 ( )]TJ
0 -1.062 Td
[(dose,)37.2 ( as c)20.2 (linically a)-9.8 (ppropria)-9.7 (te.)]TJ
-10.658 -1.704 Td
(Grade 3)Tj
0.012 Tw 9.474 0 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.184 0 Td
[(Withhold AUGTYRO )-36.8 (until)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
(\034Grade 1 or baseline.)Tj
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Resume a)-9.7 (t reduced dose.)]TJ
-10.658 -1.704 Td
(Grade 4)Tj
0.012 Tw 9.474 0 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(P)18.2 (ermanently discontinue)-11.9 ( )]TJ
0.012 Tw 0 -1.062 Td
(AUGTYRO.)Tj
0.048 Tw -21.884 -1.704 Td
[(Interstitial Lung Disease)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(\(ILD\)/Pneumonitis )Tj
/T1_3 1 Tf
6.586 0 Td
[([see)-12 ( )]TJ
0.048 Tw -6.586 -1.062 Td
[(W)18.2 (arnings and Precautions)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(\(5.2\)])Tj
/T1_2 1 Tf
0.048 Tw 11.226 3.188 Td
[(An)-9.8 (y Grade)]TJ
0.012 Tw 9.474 0 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.184 0 Td
[(Withhold AUGTYRO )-36.8 (if)-11.9 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 549.7813 594.7285 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 490.32 586.2285 Tm
(ILD/pneumonitis is suspected.)Tj
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(P)18.2 (ermanently discontinue if)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 565.1447 575.2084 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 490.32 566.7084 Tm
(ILD/pneumonitis is confirmed.)Tj
0.012 Tw -21.884 -1.704 Td
[(Hepa)-9.8 (totoxicity)]TJ
0 Tc 0 Tw 7.6 0 0 8 362.3818 553.0765 Tm
( )Tj
/T1_3 1 Tf
-0.012 Tc 0.011 Tw 7.6 0 0 8 324 544.5765 Tm
[([see W)18.2 (arnings )-36.8 (and)-11.9 ( )]TJ
0.048 Tw 0 -1.062 Td
(Precautions \(5.3\)])Tj
/T1_2 1 Tf
11.226 2.125 Td
(Grade 3)Tj
0.012 Tw 9.474 0 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.184 0 Td
[(Withhold AUGTYRO )-36.8 (until)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(\034Grade\035)-47.8 (1 or baseline.)]TJ
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Resume a)-9.7 (t same dose if)-12 ( )]TJ
0 -1.062 Td
[(resolution occurs within)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
[(4\035)-47.8 (weeks.)]TJ
-1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Resume a)-9.7 (t a reduced dose for)-12 ( )]TJ
0 -1.062 Td
[(recurrent Grade\035)-47.8 (3 events tha)-9.8 (t)-12 ( )]TJ
0 -1.062 Td
[(resolve within 4\035)-47.8 (weeks.)]TJ
-10.658 -1.704 Td
(Grade 4)Tj
0.012 Tw 9.474 0 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.184 0 Td
[(Withhold AUGTYRO )-36.8 (until)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(\034Grade\035)-47.8 (1 or baseline.)]TJ
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Resume a)-9.7 (t reduced dose.)]TJ
0.012 Tw -1.184 -1.378 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(P)18.2 (ermanently discontinue if)-12 ( )]TJ
0 -1.062 Td
[(adverse reaction does not)-12 ( )]TJ
0 -1.062 Td
[(resolve within 4\035)-47.8 (weeks.)]TJ
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(P)18.2 (ermanently discontinue for)-11.9 ( )]TJ
0 -1.062 Td
[(recurrent Grade\035)-47.8 (4 events.)]TJ
-10.658 -1.704 Td
[(AL)94.2 (T or )37.2 (AST grea)-9.8 (ter)-12 ( )]TJ
0 -1.062 Td
[(than 3\035)-47.8 (times ULN)-12 ( )]TJ
0 -1.062 Td
[(with concurrent)-12 ( )]TJ
0 -1.062 Td
[(total bilirubin)-12 ( )]TJ
0 -1.062 Td
[(grea)-9.8 (ter than)-12 ( )]TJ
0 -1.062 Td
[(1.5\035)-47.7 (times ULN)-12 ( )]TJ
0 -1.062 Td
[(\(in the absence)-11.9 ( )]TJ
0 -1.062 Td
[(of cholestasis or)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(hemolysis\))Tj
9.474 8.5 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(P)18.2 (ermanently discontinue)-11.9 ( )]TJ
0.012 Tw 0 -1.062 Td
(AUGTYRO.)Tj
0.048 Tw -21.884 -9.141 Td
[(Crea)-9.8 (tine Phosphokinase)-11.9 ( )]TJ
0 -1.062 Td
[(\(CPK\) Eleva)-9.7 (tion )]TJ
/T1_3 1 Tf
0.012 Tw [([see)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(W)18.2 (arnings and Precautions)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(\(5.4\)])Tj
/T1_2 1 Tf
0.048 Tw 11.226 3.188 Td
[(CPK eleva)-9.7 (tion)-12 ( )]TJ
0 -1.062 Td
[(grea)-9.8 (ter than 5)-12 ( )]TJ
0 -1.062 Td
(times ULN)Tj
0.012 Tw 9.474 2.125 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Withhold until recover)-17.8 (y to)-11.9 ( )]TJ
0 -1.062 Td
[(baseline or to less than or)-12 ( )]TJ
0 -1.062 Td
[(equal to 2.5\035)-47.8 (times ULN,)37.2 ( then)-12 ( )]TJ
0 -1.062 Td
[(resume a)-9.7 (t same dose.)]TJ
-10.658 -1.704 Td
[(CPK eleva)-9.7 (tion)-12 ( )]TJ
0 -1.062 Td
[(grea)-9.8 (ter than)-12 ( )]TJ
0 -1.062 Td
[(10\035)-47.8 (times ULN or)-11.9 ( )]TJ
0 -1.062 Td
[(second occurrence)-12 ( )]TJ
0 -1.062 Td
[(of CPK eleva)-9.8 (tion)-12 ( )]TJ
0 -1.062 Td
[(of grea)-9.8 (ter than)-12 ( )]TJ
0 -1.062 Td
[(5\035)-47.8 (times ULN)]TJ
0.012 Tw 9.474 6.375 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Withhold until recover)-17.8 (y to)-11.9 ( )]TJ
0 -1.062 Td
[(baseline or to less than or)-12 ( )]TJ
0 -1.062 Td
[(equal to 2.5\035)-47.8 (times ULN,)37.2 ( then)-12 ( )]TJ
0 -1.062 Td
[(resume a)-9.7 (t reduced dose.)]TJ
0.012 Tw -21.884 -4.891 Td
(Hyperuricemia)Tj
/T1_3 1 Tf
0.011 Tw 0 -1.062 Td
[([see W)18.2 (arnings )-36.8 (and)-11.9 ( )]TJ
0.048 Tw 0 -1.062 Td
(Precautions \(5.5\)])Tj
/T1_2 1 Tf
11.226 2.125 Td
(Grade 3 or Grade 4)Tj
0.012 Tw 9.474 0 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.184 0 Td
[(Withhold AUGTYRO )-36.8 (until)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
[(improvement of signs or)-12 ( )]TJ
0.012 Tw 0 -1.062 Td
(symptoms.)Tj
-1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Resume )37.2 (AUGTYRO a)-9.8 (t same or)-12 ( )]TJ
0 -1.062 Td
(reduced dose.)Tj
-21.884 -1.704 Td
[(Other Clinically Relevant)-12 ( )]TJ
0 -1.062 Td
(Adverse Reactions )Tj
/T1_3 1 Tf
0.012 Tw [([see)-12 ( )]TJ
0.048 Tw 0 -1.062 Td
(Adverse Reactions \(6.1\)])Tj
/T1_2 1 Tf
0.012 Tw 11.226 2.125 Td
[(Intolerable)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 439.7996 158.6651 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 409.32 150.1651 Tm
[(Grade 2 or)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 440.7359 150.1651 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 409.32 141.6651 Tm
[(Grade 3 or)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 440.7359 141.6651 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 409.32 133.1651 Tm
(Grade 4)Tj
0.012 Tw 9.474 3.188 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 1.184 0 Td
[(Withhold AUGTYRO)-12 ( )]TJ
0 Tc 0 Tw 7.6 0 0 8 544.3521 158.6651 Tm
( )Tj
-0.012 Tc 0.048 Tw 7.6 0 0 8 490.32 150.1651 Tm
[(until \034Grade\035)-47.8 (1 or baseline.)]TJ
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(Resume a)-9.7 (t the same or)-12 ( )]TJ
0 -1.062 Td
[(reduced dose if resolution)-12 ( )]TJ
0 -1.062 Td
[(occurs within 4\035)-47.8 (weeks.)]TJ
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(P)18.2 (ermanently discontinue if)-12 ( )]TJ
0 -1.062 Td
[(adverse reaction does not)-12 ( )]TJ
0 -1.062 Td
[(resolve within 4\035)-47.8 (weeks.)]TJ
0.012 Tw -1.184 -1.377 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.184 0 Td
[(P)18.2 (ermanently discontinue for)-11.9 ( )]TJ
0 -1.062 Td
[(recurrent Grade\035)-47.8 (4 events.)]TJ
-21.884 -1.659 Td
[(*)-39.8 (Graded per Common )37.2 (T)74.2 (erminolog)-9.8 (y Criteria for )37.3 (Adverse Events v4.03)]TJ
ET
1 w 4 M 
q 1 0 0 1 31.5 672.03 cm
0 0 m
0 -72.27 l
S
Q
endstreamendobj88 0 obj<</BBox[0.0 792.0 612.0 0.0]/Length 312/Matrix[1.0 0.0 0.0 1.0 0.0 0.0]/Resources<</ExtGState<</GS0 20 0 R>>/Font<</T1_0 100 0 R>>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.75 w 
/GS0 gs
q 1 0 0 1 324 747.8506 cm
0 0 m
252 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.008 Tc 0.008 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 476.407 749.2256 Tm
(AUGTYRO)Tj
0 Tc 0 Tw 5.6 0 0 5.6 515.1636 751.1396 Tm
(\231)Tj
-0.008 Tc 0.055 Tw 8 0 0 8 520.7169 749.2256 Tm
[( \(r)18.3 (epotr)18.4 (ectinib\))]TJ
ET
endstreamendobj100 0 obj<</BaseFont/RCVXRU+HelveticaNeueLTStd-Bd/Encoding/WinAnsiEncoding/FirstChar 32/FontDescriptor 101 0 R/LastChar 153/Subtype/Type1/ToUnicode 102 0 R/Type/Font/Widths[278 0 0 0 0 0 0 0 296 296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 685 0 0 0 0 0 759 0 0 0 0 0 0 0 778 0 0 722 0 611 741 0 0 0 667 0 0 0 0 0 0 0 0 611 574 0 574 0 0 0 258 0 0 0 0 593 611 611 0 389 0 352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1000]>>endobj101 0 obj<</Ascent 975/CapHeight 714/CharSet(/space/parenleft/parenright/A/G/O/R/T/U/Y/b/c/e/i/n/o/p/r/t/trademark)/Descent -218/Flags 32/FontBBox[-166 -218 1078 975]/FontFamily(HelveticaNeueLT Std)/FontFile3 103 0 R/FontName/RCVXRU+HelveticaNeueLTStd-Bd/FontStretch/Normal/FontWeight 700/ItalicAngle 0/StemV 144/Type/FontDescriptor/XHeight 517>>endobj102 0 obj<</Filter/FlateDecode/Length 325>>stream
Hâ\íœnÉ0∆Ôyä€C§Ö¥Bö∫V‚∞?€–ƒtH#DÅx˚Ÿq’Iã˛E˘¸Ÿ8$«˙πv˝,ì˜0öfŸıŒò∆[0 /pÌù»î¥ΩôÔª¯6CÎEÇ…Õ2Õ0‘ÆEY ‰ß9,rıd«¨EÚ,Ñﬁ]ÂÍÎÿ¨e“‹ºˇÅ‹,SYU“BáF/≠mêIL€‘œ˚yŸ`Œü‚sÒ U‹g‹å-Læ5ZwQ¶∏*YûqUú˝wÆRNªtÊª¢T$NS»{Ê=ÒÅ˘ÄºÀ"c@÷Ãö¯ÃåÖ \E∆ÄºcﬁÁÃ91{Ê‰Y∞æ }±eﬁ≥æ }¡˙"ÍOÃ'bÆ[P]Õ˝kÍ_≥ß&OÕ=hÍ·@>*S*‰˛Â4ºA˘òªπÖÄ#è◊gMSÓ<˛?zâYÙà_ ®…õ‹endstreamendobj103 0 obj<</Filter/FlateDecode/Length 1632/Subtype/Type1C>>stream
HâlîP◊«wÛ„∆ o;6fnñ[-6$¢»hÍ*»Ùó8Å,ÑDìHûéºNô>UtÜZÖ>}⁄±ZÍØ h[f™£Ùçæ÷é3¥éøh€äµB«⁄ZŒ∆ì?z7}ÛfﬁÓÃ=˜‹ΩÁsœ˜‹Ωóe4*ÜeŸÈÂÖU/ñØ»\$56K≠wô¥^*©¨à¯û}ŒßL∞»fVN—»i…<Œ¡¿√kµ2ˇÑ\0ÂÀ4ùk*£R0V6´0∏vC»ø∫>":<yy≥iÎ±'⁄ÏŸ¢”nwä|¡I¨ÿéHMaqq†6Zy#íœ&.hl¡a1$Ö•P≥2¯8%—Ωb$‰ıIMﬁ–1X'ñ¯¡»ÜµíXH)6¥⁄Oπ!…'˙b§^Wÿ*lb•"¢7‡+Gó÷’˘k•ƒ`ìwÉHs˙ﬂËZ)ÒR§òêÿ∞>‰˚¸µ0~xõ§ˇìE0$˙©ÇFäÑ%Èøüüo™YdÀ*Æ®Tú—'’1Ùa=ìƒXôôåù…fr3á)d2≈Ã¶î)cñ3Ã
¶õ·iÖôe‘mg˙ôªä˝D5MÂVÖUÔ©@]†ﬁ¶>°˛M„÷Ï‘\◊¶h´qÒñ”Úÿiñ∂ß’[4r[¨,ﬁF`û„± ﬁ÷¬Ç"ûÂAq‚ù∫8©NÙ° ©O‰3º“C≈„‚Osò€¸pFî=V5îƒÇ|6Va)ŒJE˚itﬁ¿4í»»Éú©êuó!]xw_â”‡˛Gò˙)î¬¨T∞øNL0â\∆G—âŒTÃ™G«n˚æf»Ωº$ æ+UøaÑlÚ/»÷¬^“è‘∏	ÓçUk1ó\«Ö|¡wµ¯·Æo”≥ÕË¡¶©Ω‡ê∞N6…øÔ…F<ãzp√©ô≠eï3Ãò^…0¶ú•&˝Ú˘ö¸=xÜÄk#
#¯î◊°=Xè5@-¨∏tõœ-‹]E˛+òXÖoá∫∆˘GsËk‘@=RK	∆âÖ ˝,&„ú\EM˙Dwíä>X	; 8B…F⁄92ÿ”0ßÂÌÚˆ‚VO¢~ƒ÷·∂æÕó÷_)ÿ;©C7x¯ËÖ·T`Ê‹¬!Œp «√|ÚuoSq°‘Td¡˘Ñ+⁄◊,“¥!J…•hÍ6Ä)~M–@∏+∫F£ÏE∫ÊgtJÃ´Ê—/#È´_F¢◊Ærô2¢√*–ÿ†*Ä¸+Æe_s¨: BßÇÓT≤>H`è\¢≈BBØåc8éi±à¿?‚ã¥\QÀ∏Ìè√“Ë‘~∞¬ÎˇŸ§~#òÈÊ\Ï–ï∫πj˛‘CPÀQ=î±ti∏™ﬁ“]h%ÚÒW˘‹∫|∑ªn˚éœœ8±eú2ÈÆX’Ú«#¶V‘|ÖúÛ3q2Êb÷TÅ“Ó^ÅÈ{,8ùî¥Jﬁ≈fg‡÷Â´˛t˚¸Ò∆Â;,	Ã¥Pç≥=
È$Dx»~«3q°"&aÊ¸äpÉ˛Ê‡NXp
Y”∫≤æ‹úøÍ‰»õñÕâé_èòIÖ].>ó÷Ω;zÙÏ9
<g´‹MUP›/Òh•§ïpŸté˚óY†I‘c%≠G≠ÜˆìG>πvÒ}ØK¿>Í£ÉÈ&fñæ\æZh#Ükó–¨S
:!∂”5za'èyê∏ y‡±ÉntYëAè V„Pœ–ËXO^û'ê˜Lf`ËÜ¿—„
˘t«6ûHc3M„ª~zniˇ≠Ú‚—Ûkø4CÊU‡AÄßüÉiËZZ™Ù[⁄âaÏ"Õ∫„˘|÷öoá-ÜÔÜ?∫s˚àÀ#∆‹MsmÙ2Ë£üÑ$L”Êƒæ∫[à°ÁˆGW~ﬂΩØΩ≠K0tÅIgËŸ÷˙Z«ÎÊ‚¢Í%Î¸£äLºÒwz@Ó≤?)7 ﬂb9J˝≤rgèÁH∆’Ë⁄∫}ø j]€¶ñ∑6ô_ym◊gÿÒ˚›'u\äqﬂ≤¸}(ÖﬁQı√ÂÁ6ì‹ü˚µò∑èB_˘˚¥‰Ë”v`ﬂ(âîÌ<ﬁözºynÇûpw«™wcC7Ã€B`˜é˚;‚◊∫uÉª&¡ÅŒ{ùÒüwÈ«ì¿:y¸ù‰d∞æõ¸ó≠…úJâÕ„ˇ` ØÀ~Ûendstreamendobj86 0 obj<</Length 21952>>stream
0 0 0 1 K
0.5 w 
/GS0 gs
q 1 0 0 1 45 487.1281 cm
0 0 m
69.321 0 l
S
Q
BT
0 0 0 1 k
/T1_0 1 Tf
-0.017 Tc 0.048 Tw 8 0 0 8 36 750.2881 Tm
[(HIGHLIGHTS OF PRESCRIBING INFORMA)55.2 (TION)]TJ
0.042 Tw 0 -1.166 Td
[(These )0.5 (highlights )0.5 (do not inc)20.2 (lude )0.5 (all )0.5 (the information )0.5 (needed to use )0.5 (AUGTYRO )0.5 (safely)-17 ( )]TJ
0.048 Tw 0 -1.031 Td
[(and effectively)55.2 (.)37.2 ( See full prescribing information for AUGTYRO)24.2 (.)]TJ
0 -1.594 Td
[(AUGTYRO\231 \(repotrectinib\) capsules,)37.3 ( for oral use)]TJ
0 -1.211 Td
[(Initial U.S.)37.2 ( Appro)-9.8 (v)16.3 (al: 2023)]TJ
0.017 Tw 0 -1.301 Td
(------------------------------)Tj
0.048 Tw 10.755 0 Td
(RECENT MAJOR CHANGES)Tj
-0.153 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
10.06 0 Td
(------------------------------)Tj
/T1_1 1 Tf
0.048 Tw -20.815 -1.508 Td
[(Indica)-9.7 (tions and Usa)-9.8 (ge \(1.2\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.445 0 Td
(06/2024)Tj
-28.445 -1.355 Td
[(Dosa)-9.7 (ge and )37.2 (Administra)-9.8 (tion \(2.1\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.445 0 Td
(06/2024)Tj
-28.445 -1.355 Td
[(W)18.2 (arnings and Precautions \(5.6\))]TJ
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
28.445 0 Td
(06/2024)Tj
/T1_0 1 Tf
0.017 Tw -28.445 -1.463 Td
(-------------------------------)Tj
0.048 Tw 10.93 0 Td
[(INDIC)18.2 (A)55.2 (TIONS AND USAGE)]TJ
0.022 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(------------------------------)Tj
/T1_1 1 Tf
0.048 Tw -10.93 -1.508 Td
[(AUGTYRO is a kinase inhibitor indica)-9.8 (ted for the trea)-9.8 (tment of)]TJ
0.017 Tw 0 -1.283 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.015 Tc 0.06 Tw 1.125 0 Td
[(ad)0.5 (ult pa)-9.5 (tien)0.5 (ts wi)0.5 (th l)0.5 (ocall)0.5 (y a)0.5 (dvanc)0.5 (ed or)0.5 ( me)0.5 (tasta)-9.5 (tic)0.5 ( )]TJ
/T1_2 1 Tf
0.015 Tw (RO)Tj
0 Tc 0 Tw (S)Tj
19.685 0 Td
(1)Tj
/T1_1 1 Tf
-0.015 Tc 0.06 Tw 0.465 0 Td
[(-po)0.5 (sitiv)0.5 (e no)0.5 (n-sm)0.5 (all c)0.5 (ell )0.5 (lung)-15 ( )]TJ
-0.017 Tc 0.048 Tw -20.15 -1.031 Td
[(cancer \(NSCLC\).)37.2 ( \(1.1\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(adult and pedia)-9.7 (tric pa)-9.8 (tients 12 years of a)-9.8 (ge and older with solid tumors tha)-9.8 (t:)]TJ
0.017 Tw 0 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(ha)-9.8 (ve a neurotrophic tyrosine receptor kinase \()]TJ
/T1_2 1 Tf
0.017 Tw (NTR)Tj
0 Tc 0 Tw (K)Tj
/T1_1 1 Tf
-0.017 Tc 0.048 Tw 18.604 0 Td
(\) gene fusion and)Tj
0.017 Tw -19.729 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.011 Tc 0.079 Tw 1.125 0 Td
[(are locally advanced or metasta)-10.1 (tic or where surgical resection is likely to result)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(in severe morbidity)55.2 (.)]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(ha)-9.8 (ve progressed follo)-9.8 (wing trea)-9.8 (tment or ha)-9.8 (ve no sa)-9.8 (tisfactor)-17.8 (y alterna)-9.8 (tive thera)-9.8 (py)55.2 (.)]TJ
-0.022 Tc 0.036 Tw -1.125 -1.283 Td
[(This indica)-10.3 (tion is a)-10.3 (pproved under accelera)-10.3 (ted a)-10.3 (pproval based on overall response ra)-10.2 (te)-22 ( )]TJ
-0.012 Tc 0.075 Tw 0 -1.031 Td
[(and dura)-10.1 (tion of response.)36.8 ( Continued a)-10.1 (pproval for this indica)-10.2 (tion may be contingent)-12 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(upon veri\037ca)-9.8 (tion and description of c)20.2 (linical bene\037t in the con\037rma)-9.8 (tor)-17.8 (y trials.)37.2 ( \(1.2\))]TJ
/T1_0 1 Tf
0.017 Tw -1.125 -1.756 Td
(---------------------------)Tj
0.048 Tw /Span<</ActualText<FEFF200A>>> BDC 
9.738 0 Td
( )Tj
EMC 
0.024 0 Td
[(DOSAGE AND ADMINISTRA)55.2 (TION)]TJ
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
-0.112 Tw /Span<</ActualText<FEFF002D>>> BDC 
12 0 Td
( )Tj
EMC 
(---------------------------)Tj
/T1_1 1 Tf
0.017 Tw -21.762 -1.436 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.014 Tc 0.064 Tw 1.125 0 Td
[(Select pa)-10 (tients for the trea)-10 (tment of locally advanced or metasta)-9.9 (tic NSCLC based on)-14 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
(the presence of )Tj
/T1_2 1 Tf
0.017 Tw (RO)Tj
0 Tc 0 Tw (S)Tj
7.348 0 Td
(1)Tj
/T1_1 1 Tf
-0.017 Tc 0.048 Tw 0.463 0 Td
[( rearrangement\(s\) in tumor specimens.)37.2 ( \(2.1\))]TJ
0.017 Tw -8.936 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.039 Tw 1.125 0 Td
[(Select pa)-9.8 (tients )0.5 (for )0.5 (trea)-9.8 (tment )0.5 (of )0.5 (locally )0.5 (advanced )0.5 (or )0.5 (metasta)-9.8 (tic )0.5 (solid tumors )0.5 (based )0.5 (on)-17 ( )]TJ
0.048 Tw 0 -1.031 Td
(the presence of an )Tj
/T1_2 1 Tf
0.017 Tw (NTRK)Tj
/T1_1 1 Tf
0.048 Tw [( gene fusion.)37.2 ( \(2.1\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.001 Tc 0.127 Tw 1.125 0 Td
[(Recommended Dosa)-9.6 (ge)]TJ
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
8.944 0 Td
[( 160 mg orally once daily for 14 days,)37.3 ( then increase to)-1 ( )]TJ
-0.017 Tc 0.048 Tw -8.944 -1.031 Td
[(160 mg twice daily)55.2 (,)37.2 ( with or without food.)37.2 ( \(2.4\))]TJ
/T1_0 1 Tf
0.017 Tw -1.125 -1.684 Td
(--------------------------)Tj
0.048 Tw 9.291 0 Td
(DOSAGE FORMS AND STRENGTHS)Tj
-0.206 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(--------------------------)Tj
/T1_1 1 Tf
0.048 Tw -9.291 -1.508 Td
[(Ca)-9.8 (psules:)37.2 ( 40 mg,)37.2 ( 160 mg \(3\))]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.756 Td
(---------------------------------)Tj
11.731 0 Td
[(CONTRAINDIC)18.2 (A)55.2 (TIONS)]TJ
8.025 0 Td
(---------------------------------)Tj
/T1_1 1 Tf
0.048 Tw -19.757 -1.508 Td
[(None.)37.2 ( \(4\))]TJ
/T1_0 1 Tf
0.017 Tw 0 -1.756 Td
(----------------------------)Tj
0.048 Tw 9.871 0 Td
[(W)18.2 (ARNINGS AND PREC)18.2 (AUTIONS)]TJ
0.021 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(---------------------------)Tj
/T1_1 1 Tf
0.017 Tw -9.871 -1.436 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.011 Tc 0.082 Tw 1.125 0 Td
[(Central Ner)-18.4 (vous System \(CNS\) Effects:)36.5 ( Can cause CNS adverse reactions inc)19.6 (luding)-11 ( )]TJ
-0.009 Tc 0.087 Tw 0 -1.031 Td
[(diz)0.5 (zine)0.5 (ss,)37.4 ( )0.6 (a)-9.6 (ta)0.5 (xia,)37.5 ( )0.5 (and)0.5 ( )0.5 (co)0.5 (gnit)0.5 (ive )0.6 (impa)0.5 (irm)0.5 (ent.)37.4 ( )37.6 (Wit)0.5 (hhol)0.5 (d )0.5 (an)0.5 (d )0.5 (th)0.5 (en )0.6 (resu)0.5 (me )0.5 (a)-9.5 (t )0.6 (same)0.5 ( )0.5 (or)-8.9 ( )]TJ
-0.007 Tc 0.096 Tw 0 -1.031 Td
[(r)0.5 (e)0.5 (d)0.5 (u)0.5 (c)0.5 (e)0.6 (d)0.5 ( d)0.5 (o)0.5 (s)0.5 (e)0.5 ( u)0.5 (p)0.5 (o)0.5 (n)0.5 ( i)0.5 (m)0.5 (p)0.5 (r)0.5 (o)0.5 (v)0.5 (e)0.5 (m)0.5 (e)0.6 (n)0.5 (t)0.5 (,)37.5 ( o)0.5 (r)0.5 ( p)0.5 (e)0.6 (r)0.5 (m)0.5 (a)0.5 (n)0.5 (e)0.5 (n)0.5 (t)0.5 (l)0.5 (y)0.5 ( d)0.5 (i)0.5 (s)0.5 (c)0.5 (o)0.5 (n)0.5 (t)0.5 (i)0.5 (n)0.5 (u)0.5 (e)0.5 ( )37 (A)0.5 (U)0.5 (G)0.6 (T)0.5 (Y)0.5 (R)0.5 (O)0.5 ( b)0.5 (a)0.5 (s)0.5 (e)0.5 (d)0.5 ( o)0.6 (n)-7 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(severity)55.2 (.)37.2 ( \(5.1\))]TJ
ET
q 1 0 0 1 333 499.6141 cm
0 0 m
109.476 0 l
S
Q
q 1 0 0 1 333 489.9241 cm
0 0 m
41.567 0 l
S
Q
q 1 0 0 1 333 480.2341 cm
0 0 m
107.823 0 l
S
Q
q 1 0 0 1 333 470.5441 cm
0 0 m
77.006 0 l
S
Q
q 1 0 0 1 333 452.6041 cm
0 0 m
70.649 0 l
S
Q
q 1 0 0 1 333 428.9041 cm
0 0 m
25.937 0 l
S
Q
BT
0.017 Tw 8 0 0 8 324 750.2881 Tm
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.008 Tc 0.095 Tw 1.125 0 Td
[(Interstitial Lung Disease \(ILD\)/Pneumonitis:)36.8 ( Monitor pa)-10.1 (tients for new or worsening)-8 ( )]TJ
-0.017 Tc 0.044 Tw 0 -1.031 Td
[(pulmonar)-17.8 (y symptoms indica)-9.7 (tive of ILD/pneumonitis.)37.2 ( Immedia)-9.8 (tely withhold in pa)-9.8 (tients)-17 ( )]TJ
-0.011 Tc 0.08 Tw 0 -1.031 Td
[(with suspected ILD/pneumonitis and permanently discontinue if ILD/pneumo\nitis is)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(con\037rmed.)37.2 ( \(5.2\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.011 Tc 0.081 Tw 1.125 0 Td
[(Hepa)-10.2 (totoxicity:)36.7 ( )0.6 (Monitor )0.6 (liver )0.5 (function )0.5 (tests )0.6 (ever)-18.3 (y )0.5 (2 )0.5 (weeks )0.5 (during )0.6 (the )0.5 (\037rst )0.6 (month )0.5 (of)-11 ( )]TJ
-0.017 Tc 0.051 Tw 0 -1.031 Td
[(trea)-9.7 (tment,)37.2 ( and as c)20.2 (linically indica)-9.7 (ted thereafter)74.2 (.)37.2 ( Based on severity)55.2 (,)37.2 ( withhold and then)-17 ( )]TJ
0.048 Tw 0 -1.031 Td
[(resume a)-9.8 (t same or reduced dose,)37.2 ( or permanently discontinue.)37.2 ( \(5.3\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.003 Tc 0.118 Tw 1.125 0 Td
[(My)-9.8 (algia with Crea)-9.8 (tine Phosphokinase \(CPK\) Eleva)-9.9 (tion:)37.1 ( Monitor serum CPK levels)-3 ( )]TJ
0.002 Tc 0.141 Tw 0 -1.031 Td
[(d)0.5 (ur)0.5 (in)0.5 (g tr)0.5 (e)0.5 (a)-9.5 (tm)0.5 (en)0.5 (t)0.5 ( i)0.5 (n pa)-9.5 (ti)0.5 (e)0.5 (nt)0.5 (s)0.5 ( r)0.5 (ep)0.5 (o)0.5 (rt)0.5 (in)0.5 (g un)0.5 (e)0.5 (xp)0.5 (la)0.5 (i)0.5 (ne)0.5 (d)0.5 ( m)0.5 (us)0.5 (c)20.4 (l)0.5 (e pa)0.5 (i)0.5 (n,)37.5 ( t)0.5 (en)0.5 (d)0.5 (er)0.5 (ne)0.5 (s)0.5 (s,)37.5 ( o)0.5 (r)2 ( )]TJ
-0.011 Tc 0.076 Tw 0 -1.031 Td
[(w)0.5 (e)0.6 (a)0.5 (k)0.6 (n)0.5 (e)0.6 (s)0.5 (s)0.5 (.)37.5 ( B)0.5 (a)0.5 (s)0.5 (e)0.6 (d)0.5 ( o)0.6 (n)0.5 ( s)0.6 (e)0.5 (v)0.5 (e)0.6 (r)0.5 (i)0.6 (t)0.5 (y)55.5 (,)37.6 ( w)0.5 (i)0.5 (t)0.6 (h)0.5 (h)0.5 (o)0.6 (l)0.5 (d)0.6 ( a)0.5 (n)0.5 (d)0.6 ( r)0.5 (e)0.6 (s)0.5 (u)0.5 (m)0.6 (e)0.5 ( a)-9.4 (t)0.5 ( s)0.6 (a)0.5 (m)0.5 (e)0.6 ( o)0.5 (r)0.6 ( r)0.5 (e)0.6 (d)0.5 (u)0.5 (c)0.6 (e)0.5 (d)0.5 ( d)0.5 (o)0.5 (s)0.6 (e)0.5 ( u)0.6 (p)0.5 (o)0.5 (n)-11 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(improvement.)37.2 ( \(5.4\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.002 Tc 0.124 Tw 1.125 0 Td
[(Hyperuricemia:)36.9 ( Monitor serum uric acid levels prior to initia)-10 (ting and periodically)-2 ( )]TJ
-0.003 Tc 0.118 Tw 0 -1.031 Td
[(during trea)-9.8 (tment.)37.2 ( Initia)-9.8 (te trea)-9.8 (tment with ura)-9.8 (te-lo)-9.8 (wering medica)-9.8 (tions as c)20.1 (linically)-3 ( )]TJ
-0.02 Tc 0.036 Tw 0 -1.031 Td
[(indica)-10.3 (ted.)36.7 ( )36.6 (Withhold and resume a)-10.3 (t same or reduced dose,)36.7 ( or permanently discontinue)-20 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(based on severity)55.2 (.)37.2 ( \(5.5\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.008 Tc 0.096 Tw 1.125 0 Td
[(Skeletal F)19.7 (ractures:)36.7 ( Promptly evalua)-10.3 (te pa)-10.3 (tients with signs or symptoms \(e.g.,)36.7 ( pain,)29 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(changes in mobility)55.2 (,)37.2 ( deformity\) of fractures.)37.2 ( \(5.6\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.043 Tw 1.125 0 Td
[(Embr)-17.7 (yo-F)24.2 (etal )37.5 (T)74.2 (oxicity:)37.1 ( )0.5 (Can )0.5 (cause )0.5 (fetal harm.)37.2 ( )37.4 (Advise females )0.5 (of )0.5 (reproductive potential)-17 ( )]TJ
-0.003 Tc 0.122 Tw 0 -1.031 Td
[(of )0.5 (the )0.5 (potential )0.5 (risk )0.5 (to )0.5 (a )0.5 (fetus )0.5 (and )0.5 (to )0.5 (use )0.5 (an )0.5 (effective )0.5 (non-hormonal )0.5 (method )0.6 (of)-3 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(contraception.)37.2 ( \(5.7\))]TJ
/T1_0 1 Tf
0.017 Tw -1.125 -1.531 Td
(---------------------------------)Tj
0.048 Tw 11.651 0 Td
(ADVERSE REACTIONS)Tj
0.037 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(--------------------------------)Tj
/T1_1 1 Tf
-0.003 Tc 0.121 Tw -11.651 -1.508 Td
[(The most common adverse reactions \(\03620%\) were dizziness,)36.6 ( d)-10.4 (ysgeusia,)36.6 ( peripheral)-3.1 ( )]TJ
0.002 Tc 0.145 Tw 0 -1.031 Td
[(neuropa)-10.2 (thy)54.8 (,)36.7 ( constipa)-10.2 (tion,)36.8 ( d)-10.2 (yspnea,)36.8 ( fa)-10.2 (tigue,)36.8 ( a)-10.2 (taxia,)36.8 ( cognitive impairment,)36.8 ( muscular)2 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(weakness,)37.2 ( and nausea.)37.2 ( \(6.1\))]TJ
/T1_0 1 Tf
0.002 Tc 0.147 Tw 0 -1.486 Td
[(T)73.6 (o report SUSPECTED ADVERSE REACTIONS,)36.5 ( contact Bristol-Myers Squibb at)2.1 ( )]TJ
-0.017 Tc 0.048 Tw 0 -1.031 Td
[(1-800-721-5072 or FD)34.2 (A at 1-800-FD)34.3 (A-1088 or www)37.2 (.fda.go)-9.8 (v/medwatch.)]TJ
0.017 Tw 0 -1.598 Td
(---------------------------------)Tj
0.048 Tw 11.721 0 Td
[(DR)-9.8 (UG INTERACTIONS)]TJ
0.107 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(--------------------------------)Tj
/T1_1 1 Tf
0.017 Tw -11.721 -1.436 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(Strong and Modera)-9.8 (te CYP3A Inhibitors)]TJ
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
13.932 0 Td
[( )37.2 (Avoid concomitant use.)37.2 ( \(7.1\))]TJ
0.017 Tw -15.057 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
(P-gp inhibitors)Tj
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
5.443 0 Td
[( )37.2 (Avoid concomitant use.)37.2 ( \(7.1\))]TJ
0.017 Tw -6.568 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
[(Strong and Modera)-9.8 (te CYP3A Inducers)]TJ
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
13.725 0 Td
[( )37.2 (Avoid concomitant use.)37.2 ( \(7.1\))]TJ
0.017 Tw -14.85 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
-0.004 Tc 0.112 Tw 1.125 0 Td
[(Certain CYP3A Substra)-9.7 (tes)]TJ
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
9.899 0 Td
[( )36.6 (Avoid concomitant use with CYP3A substra)-9.7 (tes,)37.2 ( where)-4 ( )]TJ
-0.017 Tc 0.048 Tw -9.899 -1.031 Td
[(minimal concentra)-9.8 (tion changes can cause reduced ef\037cac)20.2 (y)55.2 (.)37.2 ( \(7.2\))]TJ
0.017 Tw -1.125 -1.211 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 1.125 0 Td
(Hormonal contraceptives)Tj
(:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
9.078 0 Td
[( )37.2 (Avoid concomitant use.)37.2 ( \(7.2\))]TJ
/T1_0 1 Tf
0.017 Tw -10.203 -1.526 Td
(---------------------------)Tj
0.048 Tw 9.838 0 Td
[(USE IN SPECIFIC POPULA)55.2 (TIONS)]TJ
-0.012 Tw /Span<</ActualText<FEFF002D>>> BDC 
( )Tj
EMC 
(---------------------------)Tj
/T1_1 1 Tf
0.017 Tw -9.838 -1.436 Td
(\225)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
1.125 0 Td
[(Lacta)-9.8 (tion)]TJ
0.048 Tw (:)Tj
/Span<</ActualText<FEFF200A>>> BDC 
( )Tj
EMC 
3.489 0 Td
[( )37.2 (Advise not to breastfeed.)37.2 ( \(8.2\))]TJ
/T1_0 1 Tf
-0.021 Tc 0.036 Tw -4.614 -2.471 Td
[(See 17 for P)53.9 (A)55 (TIENT COUNSELING INFORMA)54.9 (TION and FD)34 (A-appro)-10 (ved patient labeling.)]TJ
-0.017 Tc 0.048 Tw 24.908 -1.324 Td
(Revised: 06/2024)Tj
ET
1 w 4 M 
q 1 0 0 1 36 39.73 cm
0 0 m
540 0 l
S
Q
q 1 0 0 1 36 363.2701 cm
0 0 m
540 0 l
S
Q
BT
8 0 0 8 36 334.3162 Tm
[(FULL PRESCRIBING INFORMA)55.1 (TION: CONTENTS*)]TJ
0.017 Tw 0 -1.602 Td
(1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(INDIC)18.2 (A)55.2 (TIONS AND USAGE)]TJ
/T1_1 1 Tf
0.017 Tw 0.003 -1.361 Td
(1.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
3.06 0 Td
(RO)Tj
0 Tc 0 Tw (S)Tj
1.503 0 Td
(1)Tj
/T1_1 1 Tf
-0.017 Tc 0.048 Tw /Span<</ActualText<FEFF200A>>> BDC 
0.463 0 Td
( )Tj
EMC 
0.024 0 Td
[(-P)18.2 (ositive Non-Small Cell Lung Cancer)]TJ
0.017 Tw -5.051 -1.343 Td
(1.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
/T1_2 1 Tf
3.06 0 Td
(NTRK)Tj
/T1_1 1 Tf
0.048 Tw [( Gene Fusion-P)18.2 (ositive Solid )37.2 (T)74.2 (umors)]TJ
/T1_0 1 Tf
0.017 Tw -6.187 -1.405 Td
(2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(DOSAGE AND ADMINISTRA)55.2 (TION)]TJ
/T1_1 1 Tf
0.017 Tw 0.003 -1.361 Td
(2.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(P)18.2 (a)-9.8 (tient Selection)]TJ
0.017 Tw -3.06 -1.343 Td
(2.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Important Informa)-9.8 (tion Prior to Initia)-9.8 (ting )37.2 (AUGTYRO)]TJ
0.017 Tw -3.06 -1.343 Td
(2.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Recommended Evalua)-9.8 (tion and )37.2 (T)74.2 (esting Before Initia)-9.8 (ting )37.2 (AUGTYRO)]TJ
0.017 Tw -3.06 -1.343 Td
(2.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Recommended Dosa)-9.8 (ge)]TJ
0.017 Tw -3.06 -1.343 Td
(2.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Dosa)-9.7 (ge Modi\037ca)-9.8 (tions for )37.2 (Adverse Reactions)]TJ
0.017 Tw -3.06 -1.343 Td
(2.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.06 0 Td
[(Administra)-9.8 (tion)]TJ
/T1_0 1 Tf
-6.187 -1.405 Td
(3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
(DOSAGE FORMS AND STRENGTHS)Tj
0.017 Tw -3.125 -1.423 Td
(4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.125 0 Td
[(CONTRAINDIC)18.2 (A)55.2 (TIONS)]TJ
-3.125 -1.423 Td
(5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(W)18.2 (ARNINGS AND PREC)18.2 (AUTIONS)]TJ
/T1_1 1 Tf
0.017 Tw 8 0 0 8.0947 61.02 178.7036 Tm
(5.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Central Ner)-17.8 (vous System )37.3 (Adverse Reactions)]TJ
0.017 Tw -3.06 -1.249 Td
(5.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
(Interstitial Lung Disease/Pneumonitis)Tj
0.017 Tw -3.06 -1.249 Td
(5.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.06 0 Td
[(Hepa)-9.7 (totoxicity)]TJ
-3.06 -1.249 Td
(5.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(My)-9.8 (algia with Crea)-9.8 (tine Phosphokinase Eleva)-9.7 (tion)]TJ
0.017 Tw 8 0 0 8 61.02 138.7039 Tm
(5.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.06 0 Td
(Hyperuricemia)Tj
8 0 0 8.0947 61.02 127.5113 Tm
(5.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Skeletal F)20.2 (ractures)]TJ
0.017 Tw -3.06 -1.249 Td
(5.7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 3.06 0 Td
[(Embr)-17.7 (yo-F)24.2 (etal T)74.2 (oxicity)]TJ
/T1_0 1 Tf
0.017 Tw 8 0 0 8 36 107.2427 Tm
(6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
(ADVERSE REACTIONS)Tj
/T1_1 1 Tf
0.017 Tw 8 0 0 8.0947 61.02 95.9061 Tm
(6.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 3.06 0 Td
[(Clinical T)74.1 (rials )-36.8 (Experience)]TJ
/T1_0 1 Tf
0.017 Tw -6.187 -1.285 Td
(7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(DR)-9.8 (UG INTERACTIONS)]TJ
/T1_1 1 Tf
0.017 Tw 0.003 -1.4 Td
(7.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Effects of Other Drugs on )37.2 (AUGTYRO)]TJ
0.017 Tw -3.06 -1.383 Td
(7.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Effects of )37.2 (AUGTYRO on Other Drugs)]TJ
/T1_0 1 Tf
0.017 Tw 8 0 0 8 324 320.6722 Tm
(8)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(USE IN SPECIFIC POPULA)55.2 (TIONS)]TJ
/T1_1 1 Tf
0.017 Tw 8 0 0 8.0947 349.02 309.3356 Tm
(8.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.06 0 Td
[(Pregnanc)20.2 (y)]TJ
-3.06 -1.268 Td
(8.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.06 0 Td
[(Lacta)-9.8 (tion)]TJ
-3.06 -1.268 Td
(8.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(F)24.2 (emales and Males of Reproductive P)18.2 (otential)]TJ
0.017 Tw -3.06 -1.268 Td
(8.4)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(P)18.2 (edia)-9.7 (tric Use)]TJ
0.017 Tw -3.06 -1.268 Td
(8.5)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Geria)-9.7 (tric Use)]TJ
0.017 Tw 8 0 0 8 349.02 258.4819 Tm
(8.6)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
(Renal Impairment)Tj
0.017 Tw -3.06 -1.343 Td
(8.7)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Hepa)-9.7 (tic Impairment)]TJ
/T1_0 1 Tf
0.017 Tw -6.187 -1.405 Td
(11)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.125 0 Td
(DESCRIPTION)Tj
-3.125 -1.423 Td
(12)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(CLINIC)18.2 (AL PHARMACOLOGY)]TJ
/T1_1 1 Tf
0.017 Tw 0.003 -1.311 Td
(12.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.011 Tw 3.06 0 Td
[(Mechanism )-36.8 (of Action)]TJ
0.017 Tw -3.06 -1.293 Td
(12.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.06 0 Td
[(Pharmacod)-9.8 (ynamics)]TJ
-3.06 -1.343 Td
(12.3)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
3.06 0 Td
(Pharmacokinetics)Tj
/T1_0 1 Tf
-6.187 -1.405 Td
(13)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(NONCLINIC)18.2 (AL TOXICOLOGY)]TJ
/T1_1 1 Tf
0.017 Tw 0.003 -1.361 Td
(13.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Carcinogenesis,)37.2 ( Muta)-9.8 (genesis,)37.2 ( Impairment of F)24.2 (ertility)]TJ
/T1_0 1 Tf
0.017 Tw -6.187 -1.405 Td
(14)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(CLINIC)18.2 (AL STUDIES)]TJ
/T1_1 1 Tf
0.017 Tw 0.003 -1.361 Td
(14.1)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Locally )37.2 (Advanced or Metasta)-9.8 (tic )]TJ
/T1_2 1 Tf
0.017 Tw (RO)Tj
0 Tc 0 Tw (S)Tj
12.866 0 Td
(1)Tj
/T1_1 1 Tf
-0.017 Tc -0.198 Tw /Span<</ActualText<FEFF200A>>> BDC 
0.383 0 Td
( )Tj
EMC 
0.024 0 Td
[(-)-19.8 (P)18.2 (ositive )-245.8 (NSCLC)]TJ
0.017 Tw -16.333 -1.343 Td
(14.2)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.06 0 Td
[(Locally )37.2 (Advanced or Metasta)-9.8 (tic )]TJ
/T1_2 1 Tf
0.017 Tw (NTRK)Tj
/T1_1 1 Tf
0.048 Tw [( Gene Fusion-P)18.2 (ositive Solid)-17 ( )]TJ
0.017 Tw 0 -1.019 Td
[(T)74.2 (umors)]TJ
/T1_0 1 Tf
-6.187 -1.405 Td
(16)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
(HOW SUPPLIED/STORAGE AND HANDLING)Tj
0.017 Tw -3.125 -1.423 Td
(17)Tj
/Span<</ActualText<FEFF0009>>> BDC 
( )Tj
EMC 
0.048 Tw 3.125 0 Td
[(P)54.2 (A)55.2 (TIENT COUNSELING INFORMA)55.2 (TION)]TJ
/T1_1 1 Tf
-0.012 Tc -3.125 -2.368 Td
[(*)-39.8 (Sections or subsections omitted from the full prescribing informa)-9.8 (tion are not listed.)]TJ
ET
endstreamendobj104 0 obj<</CreationDate(D:20240613142120-04'00')/Creator(Adobe InDesign 19.4 \(Macintosh\))/ModDate(D:20240613142121-04'00')/Producer(Adobe PDF Library 17.0)/Trapped/False>>endobjxref
0 105
0000000000 65535 f
0000000016 00000 n
0000000124 00000 n
0000011044 00000 n
0000000000 00000 f
0000351769 00000 n
0000352710 00000 n
0000353842 00000 n
0000355022 00000 n
0000356225 00000 n
0000011294 00000 n
0000012489 00000 n
0000013695 00000 n
0000014901 00000 n
0000011104 00000 n
0000011193 00000 n
0000016039 00000 n
0000017154 00000 n
0000325591 00000 n
0000140376 00000 n
0000056293 00000 n
0000264433 00000 n
0000262927 00000 n
0000263942 00000 n
0000263673 00000 n
0000259255 00000 n
0000285694 00000 n
0000285582 00000 n
0000227887 00000 n
0000164959 00000 n
0000062285 00000 n
0000193266 00000 n
0000062414 00000 n
0000062960 00000 n
0000193400 00000 n
0000035353 00000 n
0000140489 00000 n
0000018295 00000 n
0000056404 00000 n
0000035896 00000 n
0000036356 00000 n
0000036609 00000 n
0000037003 00000 n
0000056441 00000 n
0000107692 00000 n
0000107717 00000 n
0000077756 00000 n
0000078009 00000 n
0000063133 00000 n
0000063380 00000 n
0000063675 00000 n
0000078589 00000 n
0000108354 00000 n
0000108846 00000 n
0000108915 00000 n
0000109175 00000 n
0000109285 00000 n
0000207628 00000 n
0000207653 00000 n
0000193662 00000 n
0000193916 00000 n
0000194253 00000 n
0000208104 00000 n
0000208437 00000 n
0000208506 00000 n
0000208772 00000 n
0000208868 00000 n
0000259997 00000 n
0000260463 00000 n
0000260816 00000 n
0000261210 00000 n
0000279568 00000 n
0000279673 00000 n
0000280242 00000 n
0000277867 00000 n
0000278178 00000 n
0000272200 00000 n
0000272284 00000 n
0000272800 00000 n
0000265215 00000 n
0000265334 00000 n
0000266050 00000 n
0000266758 00000 n
0000273397 00000 n
0000278515 00000 n
0000280878 00000 n
0000510329 00000 n
0000484112 00000 n
0000506879 00000 n
0000461902 00000 n
0000428952 00000 n
0000357457 00000 n
0000426163 00000 n
0000426399 00000 n
0000387084 00000 n
0000387121 00000 n
0000427774 00000 n
0000426658 00000 n
0000426936 00000 n
0000428044 00000 n
0000507392 00000 n
0000507861 00000 n
0000508216 00000 n
0000508611 00000 n
0000532333 00000 n
trailer<</Size 105/Root 1 0 R/Info 104 0 R/ID[<71A383D6DEC84DD2999894AA2AB80E60><F43B70F5D5F048EC8E9C03DBCFB8953C>]>>startxref532516%%EOF